data_6acv_residue ############################ # Computer software used # ############################ save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 6acv _Structure_validation_residue.Date_analyzed 2019-07-26 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 30.4 m . . . . . 0 N--CA 1.479 0.98 0 N-CA-C 111.907 0.336 . . . . 0.0 111.907 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 60.9 p -143.69 129.35 19.21 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 123.526 0.731 . . . . 0.0 109.709 179.021 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 99.4 t -108.32 125.44 65.06 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 C-N-CA 124.337 1.055 . . . . 0.0 108.565 175.651 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -79.87 110.38 15.18 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 176.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.572 ' HB2' ' HZ2' ' A' ' 41' ' ' LYS . 3.9 mm? -85.8 162.06 48.47 Favored Pre-proline 0 N--CA 1.485 1.29 0 C-N-CA 124.145 0.978 . . . . 0.0 109.399 178.959 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_endo -62.08 155.93 52.98 Favored 'Trans proline' 0 C--N 1.388 2.651 0 C-N-CA 122.628 2.219 . . . . 0.0 113.407 -179.667 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . 0.444 ' HB1' ' CB ' ' A' ' 41' ' ' LYS . . . -161.65 171.2 7.08 Favored Pre-proline 0 N--CA 1.48 1.064 0 C-N-CA 123.741 0.816 . . . . 0.0 111.307 -171.11 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 13.7 Cg_endo -57.02 137.82 83.63 Favored 'Trans proline' 0 C--N 1.384 2.422 0 C-N-CA 122.053 1.835 . . . . 0.0 110.053 158.456 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 24.8 m -67.87 -15.9 63.84 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 123.601 0.76 . . . . 0.0 112.042 -176.383 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 17.8 p -69.15 -39.57 78.74 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 123.956 0.902 . . . . 0.0 110.455 172.646 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 25.5 m95 -105.03 -168.38 1.46 Allowed 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 123.92 0.888 . . . . 0.0 110.179 177.24 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.646 ' HB3' ' HB ' ' A' ' 59' ' ' VAL . 14.2 tppt? -143.77 144.2 31.7 Favored 'General case' 0 C--O 1.234 0.246 0 N-CA-C 107.581 -1.266 . . . . 0.0 107.581 167.93 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.572 ' HZ2' ' HB2' ' A' ' 33' ' ' LEU . 24.6 tptp -108.85 125.4 51.94 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 177.818 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 6.6 tt -122.41 141.76 51.25 Favored 'General case' 0 C--N 1.322 -0.622 0 C-N-CA 124.31 1.044 . . . . 0.0 108.259 174.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . 0.505 ' HB2' ' NZ ' ' A' ' 41' ' ' LYS . 29.1 t80 -123.84 136.18 54.22 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 171.184 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 10.5 m-85 -96.03 100.84 7.17 Favored Pre-proline 0 CA--C 1.546 0.811 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 169.363 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 65.8 Cg_endo . . . . . 0 C--N 1.371 1.761 0 C-N-CA 122.329 2.019 . . . . 0.0 111.646 173.485 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.481 1.078 0 CA-C-O 121.409 0.623 . . . . 0.0 111.496 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 42.9 t -82.66 137.36 21.17 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.723 0 C-N-CA 124.841 1.257 . . . . 0.0 110.661 -179.578 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 86.2 t -126.67 125.34 66.85 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.883 0 C-N-CA 124.224 1.01 . . . . 0.0 108.751 173.138 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.471 ' CZ ' ' HD3' ' A' ' 41' ' ' LYS . 14.0 m-85 -94.67 124.0 38.44 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 123.185 0.594 . . . . 0.0 109.65 172.254 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.646 ' HB ' ' HB3' ' A' ' 40' ' ' LYS . 6.0 t -80.88 128.82 38.4 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.522 0 C-N-CA 123.493 0.717 . . . . 0.0 109.681 174.648 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -87.27 153.16 53.61 Favored Pre-proline 0 CA--C 1.543 0.674 0 CA-C-N 115.079 -0.964 . . . . 0.0 110.429 -178.372 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_endo -63.03 -20.84 72.45 Favored 'Trans proline' 0 C--N 1.375 1.958 0 C-N-CA 123.213 2.609 . . . . 0.0 113.514 178.68 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 10.5 t -101.83 -4.22 26.67 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 123.837 0.855 . . . . 0.0 111.834 178.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 91.31 -9.62 76.97 Favored Glycine 0 C--N 1.352 1.439 0 CA-C-O 119.895 -0.392 . . . . 0.0 113.728 -178.79 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -76.98 73.42 3.57 Favored 'General case' 0 N--CA 1.486 1.35 0 CA-C-O 122.03 0.919 . . . . 0.0 109.248 178.207 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -72.65 159.82 33.25 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 114.384 -1.28 . . . . 0.0 112.239 -166.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . 0.466 HG22 ' HB2' ' A' ' 71' ' ' GLN . 45.8 mm -115.24 123.32 70.71 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.676 0 C-N-CA 125.041 1.337 . . . . 0.0 109.588 -173.412 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 17.4 m -94.18 -22.22 18.57 Favored 'General case' 0 N--CA 1.486 1.331 0 C-N-CA 122.957 0.503 . . . . 0.0 112.096 -176.718 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 3.2 p-10 -148.59 155.08 40.63 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 123.032 0.533 . . . . 0.0 110.373 -172.799 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 74.0 ttt-85 -62.4 -31.35 72.02 Favored 'General case' 0 CA--C 1.554 1.117 0 C-N-CA 124.67 1.188 . . . . 0.0 113.682 -166.221 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 1.6 tmtp? -61.85 -46.89 87.48 Favored 'General case' 0 N--CA 1.486 1.355 0 C-N-CA 123.243 0.617 . . . . 0.0 109.627 177.519 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.466 ' HB2' HG22 ' A' ' 66' ' ' ILE . 96.7 mt-30 -61.0 -27.53 68.38 Favored 'General case' 0 N--CA 1.484 1.234 0 CA-C-N 115.646 -0.707 . . . . 0.0 111.599 -178.835 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.421 ' O ' ' HG ' ' A' ' 76' ' ' LEU . 0.6 OUTLIER -67.47 -53.83 25.44 Favored 'General case' 0 N--CA 1.477 0.893 0 O-C-N 123.883 0.739 . . . . 0.0 109.248 179.44 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -60.75 -47.28 87.01 Favored 'General case' 0 N--CA 1.485 1.31 0 C-N-CA 123.621 0.768 . . . . 0.0 111.669 -176.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 5.2 pp0? -68.99 -25.33 64.47 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.199 179.516 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 42.2 t80 -67.13 -50.97 59.54 Favored 'General case' 0 N--CA 1.475 0.813 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 174.858 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.421 ' HG ' ' O ' ' A' ' 72' ' ' LEU . 69.7 mt -62.29 -42.13 99.09 Favored 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 123.371 0.669 . . . . 0.0 111.935 -173.267 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -70.18 -26.64 64.0 Favored 'General case' 0 N--CA 1.478 0.965 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.973 178.987 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 48.6 m -92.99 -12.27 31.11 Favored 'General case' 0 N--CA 1.493 1.701 0 C-N-CA 123.34 0.656 . . . . 0.0 111.739 177.463 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 64.8 m80 -135.47 84.19 35.1 Favored Pre-proline 0 N--CA 1.484 1.227 0 C-N-CA 123.965 0.906 . . . . 0.0 109.409 -176.268 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -68.45 147.93 72.2 Favored 'Trans proline' 0 C--N 1.377 2.06 0 C-N-CA 122.608 2.206 . . . . 0.0 111.498 175.818 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 107.12 -31.51 8.08 Favored Glycine 0 C--N 1.341 0.861 0 N-CA-C 111.198 -0.761 . . . . 0.0 111.198 -172.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 40.4 m-80 -76.55 136.45 67.82 Favored Pre-proline 0 N--CA 1.48 1.025 0 C-N-CA 123.324 0.65 . . . . 0.0 110.085 177.364 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -66.91 162.38 38.1 Favored 'Trans proline' 0 C--N 1.38 2.195 0 C-N-CA 123.108 2.539 . . . . 0.0 113.141 -176.38 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -75.28 149.65 38.74 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-N 115.021 -0.99 . . . . 0.0 111.895 -172.878 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 15.8 tt -66.29 -11.81 13.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 C-N-CA 124.155 0.982 . . . . 0.0 111.814 -176.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -54.26 -41.93 69.36 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 123.95 0.9 . . . . 0.0 111.848 172.685 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -92.79 4.76 53.21 Favored 'General case' 0 N--CA 1.481 1.115 0 N-CA-C 112.089 0.403 . . . . 0.0 112.089 179.783 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -94.76 109.97 21.88 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 123.346 0.658 . . . . 0.0 109.545 176.85 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -84.43 85.96 7.33 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 123.981 0.912 . . . . 0.0 111.292 -176.155 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 93.5 m95 -77.85 -27.07 49.73 Favored 'General case' 0 CA--C 1.547 0.841 0 CA-C-N 115.341 -0.845 . . . . 0.0 109.909 169.179 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 14.7 t . . . . . 0 CA--C 1.557 1.224 0 C-N-CA 124.529 1.132 . . . . 0.0 112.252 -175.582 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 28.1 m . . . . . 0 N--CA 1.48 1.047 0 CA-C-O 120.902 0.382 . . . . 0.0 111.313 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.4 ' HA ' ' HD2' ' A' ' 45' ' ' PRO . 36.6 p -157.64 122.37 4.37 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 124.317 1.047 . . . . 0.0 108.694 177.359 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 65.5 t -103.34 123.97 57.21 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 C-N-CA 123.885 0.874 . . . . 0.0 109.075 -177.121 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -83.38 114.63 21.57 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 123.08 0.552 . . . . 0.0 110.396 177.476 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.439 HD23 ' HB3' ' A' ' 43' ' ' PHE . 4.5 mm? -92.19 168.88 11.92 Favored Pre-proline 0 CA--C 1.562 1.438 0 C-N-CA 124.44 1.096 . . . . 0.0 109.766 -179.712 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -57.37 143.12 94.8 Favored 'Trans proline' 0 C--N 1.39 2.755 0 C-N-CA 122.739 2.293 . . . . 0.0 115.13 -177.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . 0.716 ' HB1' ' HB3' ' A' ' 41' ' ' LYS . . . -144.97 167.07 15.57 Favored Pre-proline 0 N--CA 1.484 1.272 0 C-N-CA 124.648 1.179 . . . . 0.0 111.349 -177.501 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.594 ' HG2' ' HB2' ' A' ' 39' ' ' TRP . 31.3 Cg_endo -63.95 162.79 27.69 Favored 'Trans proline' 0 C--N 1.382 2.314 0 C-N-CA 122.645 2.23 . . . . 0.0 111.522 161.22 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 25.2 p -71.93 -24.77 61.68 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 123.52 0.728 . . . . 0.0 112.28 -176.756 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 45.7 m -75.38 -28.64 59.57 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 122.871 0.468 . . . . 0.0 111.319 176.107 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' TRP . . . . . 0.594 ' HB2' ' HG2' ' A' ' 36' ' ' PRO . 36.0 m95 -111.76 175.83 5.27 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 123.692 0.797 . . . . 0.0 110.563 -176.134 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 19.9 mtmt -140.92 128.34 21.2 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 165.5 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.716 ' HB3' ' HB1' ' A' ' 35' ' ' ALA . 13.6 tptm -99.95 126.49 46.12 Favored 'General case' 0 C--N 1.32 -0.679 0 C-N-CA 125.527 1.531 . . . . 0.0 108.502 -174.934 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 6.9 tt -129.07 132.52 47.45 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 114.495 -1.23 . . . . 0.0 107.84 178.867 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . 0.439 ' HB3' HD23 ' A' ' 33' ' ' LEU . 28.9 t80 -110.84 141.93 43.55 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 124.148 0.979 . . . . 0.0 108.785 170.833 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -102.18 99.19 11.9 Favored Pre-proline 0 CA--C 1.55 0.945 0 C-N-CA 123.344 0.658 . . . . 0.0 110.064 174.038 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . 0.4 ' HD2' ' HA ' ' A' ' 30' ' ' SER . 83.4 Cg_endo . . . . . 0 C--N 1.377 2.035 0 C-N-CA 122.626 2.217 . . . . 0.0 111.114 171.057 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.243 0.731 0 CA-C-O 121.995 0.903 . . . . 0.0 110.911 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 48.2 t -81.67 138.99 18.62 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.787 0 CA-C-N 114.821 -1.082 . . . . 0.0 111.199 -170.847 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 59.1 t -112.13 115.33 49.53 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.945 0 C-N-CA 124.336 1.055 . . . . 0.0 109.206 174.854 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 45.6 m-85 -100.1 113.41 26.02 Favored 'General case' 0 N--CA 1.481 1.124 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 172.362 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 5.1 p -81.27 131.93 32.74 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 N-CA-C 109.168 -0.679 . . . . 0.0 109.168 179.671 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -92.26 145.62 31.05 Favored Pre-proline 0 CA--C 1.546 0.792 0 C-N-CA 122.814 0.445 . . . . 0.0 112.066 -171.345 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_endo -60.14 -36.42 88.87 Favored 'Trans proline' 0 C--N 1.381 2.285 0 C-N-CA 124.104 3.203 . . . . 0.0 113.724 -177.025 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 6.6 t -77.86 -9.52 59.1 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 122.779 0.432 . . . . 0.0 111.283 -179.368 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 94.57 23.92 19.87 Favored Glycine 0 C--N 1.35 1.342 0 CA-C-N 116.348 -0.387 . . . . 0.0 113.826 179.294 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -112.96 71.31 0.74 Allowed 'General case' 0 N--CA 1.474 0.73 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 178.729 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -58.81 145.78 39.5 Favored 'General case' 0 N--CA 1.48 1.032 0 CA-C-N 115.211 -0.904 . . . . 0.0 112.062 -173.299 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . 0.41 HG13 HD21 ' A' ' 72' ' ' LEU . 44.5 mm -111.24 127.26 68.5 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.589 0 C-N-CA 124.301 1.04 . . . . 0.0 110.062 -172.347 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 42.8 p -101.27 -13.58 18.01 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 123.88 0.872 . . . . 0.0 111.754 -178.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 11.5 p-10 -160.01 152.2 20.64 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 123.228 0.611 . . . . 0.0 111.045 -167.65 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.521 ' HG3' HD13 ' A' ' 85' ' ' ILE . 72.5 ttt-85 -56.17 -36.09 67.95 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 125.194 1.397 . . . . 0.0 113.357 -171.562 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 7.4 tmtm? -57.57 -49.94 74.74 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 123.885 0.874 . . . . 0.0 110.281 178.868 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.467 ' HA ' ' HG3' ' A' ' 74' ' ' GLN . 86.7 mm-40 -68.1 -24.07 64.99 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 115.14 -0.937 . . . . 0.0 111.733 -175.602 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.41 HD21 HG13 ' A' ' 66' ' ' ILE . 0.3 OUTLIER -66.35 -50.46 63.47 Favored 'General case' 0 N--CA 1.477 0.913 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 175.636 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -64.16 -47.99 77.73 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 124.233 1.013 . . . . 0.0 111.211 -176.081 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . 0.467 ' HG3' ' HA ' ' A' ' 71' ' ' GLN . 0.0 OUTLIER -68.29 -26.99 65.92 Favored 'General case' 0 CA--C 1.548 0.903 0 CA-C-N 115.802 -0.636 . . . . 0.0 111.427 179.4 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 59.2 t80 -63.66 -52.36 61.05 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 122.943 0.497 . . . . 0.0 110.202 173.854 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 96.6 mt -64.9 -39.24 93.21 Favored 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 123.487 0.715 . . . . 0.0 112.461 -171.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -73.42 -21.6 60.43 Favored 'General case' 0 N--CA 1.479 0.982 0 CA-C-N 116.667 -0.242 . . . . 0.0 111.133 178.25 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 46.2 m -99.58 -6.37 27.51 Favored 'General case' 0 N--CA 1.487 1.414 0 C-N-CA 123.093 0.557 . . . . 0.0 112.393 175.309 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 73.8 m80 -141.92 80.88 15.1 Favored Pre-proline 0 N--CA 1.479 1.0 0 C-N-CA 124.022 0.929 . . . . 0.0 108.54 179.147 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -68.31 149.86 75.85 Favored 'Trans proline' 0 C--N 1.375 1.922 0 C-N-CA 122.541 2.16 . . . . 0.0 111.996 178.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 103.23 -20.65 42.14 Favored Glycine 0 C--N 1.34 0.795 0 CA-C-N 116.262 -0.426 . . . . 0.0 112.693 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 18.7 m120 -82.42 142.07 46.29 Favored Pre-proline 0 CA--C 1.548 0.893 0 C-N-CA 123.238 0.615 . . . . 0.0 110.555 179.343 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_endo -55.72 145.94 68.67 Favored 'Trans proline' 0 C--N 1.385 2.466 0 C-N-CA 123.428 2.752 . . . . 0.0 113.395 -174.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -68.98 160.01 31.69 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 124.156 0.982 . . . . 0.0 112.332 -170.865 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.521 HD13 ' HG3' ' A' ' 69' ' ' ARG . 14.1 tt -73.19 -22.69 19.55 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.966 0 C-N-CA 123.071 0.548 . . . . 0.0 110.8 177.345 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -63.32 -26.69 68.88 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 123.658 0.783 . . . . 0.0 111.863 -179.83 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 15.0 pt-20 -96.71 -3.17 43.03 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 122.972 0.509 . . . . 0.0 111.567 177.874 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 5.3 m-30 -93.13 120.47 33.46 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 123.524 0.729 . . . . 0.0 109.655 178.188 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 13.8 p-10 -91.59 98.87 11.92 Favored 'General case' 0 N--CA 1.476 0.826 0 CA-C-O 122.042 0.925 . . . . 0.0 111.182 -176.74 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 88.0 m95 -83.19 -25.68 31.56 Favored 'General case' 0 N--CA 1.48 1.063 0 CA-C-N 115.095 -0.957 . . . . 0.0 110.297 171.763 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 14.9 t . . . . . 0 CA--C 1.554 1.123 0 C-N-CA 124.372 1.069 . . . . 0.0 112.485 -173.863 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 17.1 m . . . . . 0 N--CA 1.474 0.745 0 N-CA-C 110.197 -0.297 . . . . 0.0 110.197 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 60.9 p -146.7 113.48 6.07 Favored 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 174.519 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 61.1 t -101.7 131.33 49.8 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 -178.233 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 -84.11 111.66 19.52 Favored 'General case' 0 CA--C 1.536 0.436 0 N-CA-C 108.971 -0.752 . . . . 0.0 108.971 178.521 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -91.92 165.13 21.14 Favored Pre-proline 0 CA--C 1.559 1.321 0 C-N-CA 124.704 1.202 . . . . 0.0 109.95 -177.118 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_endo -59.76 143.96 99.53 Favored 'Trans proline' 0 C--N 1.393 2.908 0 C-N-CA 122.927 2.418 . . . . 0.0 113.356 -177.851 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . 0.432 ' HB1' ' HB3' ' A' ' 41' ' ' LYS . . . -138.58 165.22 34.39 Favored Pre-proline 0 N--CA 1.474 0.746 0 C-N-CA 123.972 0.909 . . . . 0.0 111.632 -169.561 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.68 ' HG2' ' HB2' ' A' ' 39' ' ' TRP . 37.4 Cg_endo -65.09 155.61 67.35 Favored 'Trans proline' 0 C--N 1.381 2.253 0 C-N-CA 122.468 2.112 . . . . 0.0 110.8 162.663 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 34.3 t -57.55 -38.49 74.85 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 124.622 1.169 . . . . 0.0 112.895 -171.473 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 11.0 p -77.78 -40.19 41.6 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 123.342 0.657 . . . . 0.0 111.878 -177.582 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' TRP . . . . . 0.68 ' HB2' ' HG2' ' A' ' 36' ' ' PRO . 29.4 m95 -93.26 -174.63 3.59 Favored 'General case' 0 N--CA 1.478 0.944 0 CA-C-O 121.628 0.728 . . . . 0.0 111.336 -178.495 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.693 ' HB3' ' HB ' ' A' ' 59' ' ' VAL . 40.2 ttmt -143.55 144.83 32.12 Favored 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 107.336 -1.357 . . . . 0.0 107.336 173.452 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.432 ' HB3' ' HB1' ' A' ' 35' ' ' ALA . 18.4 tptp -120.23 125.9 49.28 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 124.063 0.945 . . . . 0.0 109.092 -174.511 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.43 HD22 ' HB ' ' A' ' 57' ' ' VAL . 4.3 tt -124.85 149.43 47.49 Favored 'General case' 0 C--O 1.236 0.393 0 C-N-CA 125.127 1.371 . . . . 0.0 108.694 176.648 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 34.3 t80 -135.26 135.58 41.0 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 124.943 1.297 . . . . 0.0 108.27 175.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 36.1 m-85 -95.93 103.96 15.05 Favored Pre-proline 0 N--CA 1.48 1.058 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 170.233 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 63.8 Cg_endo . . . . . 0 C--N 1.37 1.669 0 C-N-CA 122.717 2.278 . . . . 0.0 111.397 170.452 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 . . . . . 0 CA--C 1.557 1.217 0 CA-C-O 121.334 0.587 . . . . 0.0 111.492 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 46.7 t -81.72 134.77 26.35 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.668 0 C-N-CA 124.2 1.0 . . . . 0.0 110.416 -176.263 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.43 ' HB ' HD22 ' A' ' 42' ' ' LEU . 96.7 t -120.4 122.65 68.72 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 C-N-CA 124.005 0.922 . . . . 0.0 108.913 177.745 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 24.7 m-85 -97.85 121.15 39.42 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 123.602 0.761 . . . . 0.0 109.864 172.266 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.693 ' HB ' ' HB3' ' A' ' 40' ' ' LYS . 11.0 t -79.43 129.92 36.86 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 172.134 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -84.45 158.42 60.38 Favored Pre-proline 0 CA--C 1.542 0.659 0 CA-C-N 114.904 -1.044 . . . . 0.0 110.912 -175.766 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -63.53 -25.72 69.94 Favored 'Trans proline' 0 C--N 1.374 1.893 0 C-N-CA 123.005 2.47 . . . . 0.0 113.1 176.226 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.416 HG21 ' OH ' ' A' ' 75' ' ' TYR . 14.7 t -97.52 -3.7 39.33 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 123.5 0.72 . . . . 0.0 111.241 177.729 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 93.79 -12.83 68.69 Favored Glycine 0 C--N 1.354 1.577 0 CA-C-O 119.701 -0.5 . . . . 0.0 113.473 179.351 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 44.6 tt0 -73.88 77.63 1.63 Allowed 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 123.903 0.881 . . . . 0.0 109.77 178.862 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -67.41 158.39 31.86 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-N 114.786 -1.097 . . . . 0.0 112.229 -170.006 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 47.7 mm -121.21 131.2 73.6 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.598 0 C-N-CA 125.168 1.387 . . . . 0.0 108.891 -172.201 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 24.3 p -105.86 -17.94 14.21 Favored 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 123.984 0.914 . . . . 0.0 112.141 179.206 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 9.2 p30 -143.64 157.24 44.56 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 122.538 0.335 . . . . 0.0 111.235 -173.284 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 29.7 ttp180 -63.38 -30.62 71.72 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 123.917 0.887 . . . . 0.0 112.342 -171.585 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 5.5 tmtm? -59.89 -54.85 41.39 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 123.793 0.837 . . . . 0.0 109.116 -179.67 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 88.3 mm-40 -64.1 -25.55 68.15 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-N 115.006 -0.997 . . . . 0.0 111.597 -177.791 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -66.47 -56.71 9.66 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 123.477 0.711 . . . . 0.0 109.131 176.672 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -58.74 -48.93 79.47 Favored 'General case' 0 N--CA 1.486 1.334 0 C-N-CA 124.393 1.077 . . . . 0.0 111.71 -176.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.6 -24.24 62.71 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-N 115.472 -0.785 . . . . 0.0 111.538 -177.375 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . 0.416 ' OH ' HG21 ' A' ' 62' ' ' THR . 18.9 t80 -68.18 -49.56 60.07 Favored 'General case' 0 N--CA 1.479 0.985 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 172.561 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 69.0 mt -59.68 -41.36 90.51 Favored 'General case' 0 N--CA 1.485 1.306 0 C-N-CA 123.053 0.541 . . . . 0.0 111.563 -173.17 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 54.9 pttt -73.39 -34.54 65.58 Favored 'General case' 0 N--CA 1.479 1.014 0 O-C-N 123.181 0.301 . . . . 0.0 111.63 -179.729 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 80.9 p -83.02 -17.7 42.4 Favored 'General case' 0 N--CA 1.487 1.423 0 C-N-CA 122.828 0.451 . . . . 0.0 111.582 -178.181 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 75.5 m80 -122.89 102.79 37.59 Favored Pre-proline 0 N--CA 1.48 1.027 0 C-N-CA 123.832 0.853 . . . . 0.0 109.237 -177.465 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -67.68 154.69 72.62 Favored 'Trans proline' 0 C--N 1.378 2.099 0 C-N-CA 122.928 2.418 . . . . 0.0 113.051 -177.785 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 84.04 -9.73 62.58 Favored Glycine 0 C--N 1.349 1.285 0 CA-C-N 115.631 -0.713 . . . . 0.0 114.293 175.243 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 25.0 m-80 -74.65 148.1 85.04 Favored Pre-proline 0 N--CA 1.483 1.211 0 C-N-CA 123.432 0.693 . . . . 0.0 111.178 -178.058 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -68.92 163.99 35.36 Favored 'Trans proline' 0 C--N 1.377 2.068 0 C-N-CA 123.233 2.622 . . . . 0.0 113.176 -177.794 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . 0.466 ' O ' ' HG2' ' A' ' 87' ' ' GLU . . . -71.48 150.74 44.58 Favored 'General case' 0 N--CA 1.476 0.841 0 CA-C-N 115.066 -0.97 . . . . 0.0 111.243 -175.698 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 19.6 tt -72.88 -20.83 19.19 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.111 0 CA-C-O 120.968 0.413 . . . . 0.0 110.877 179.759 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -63.93 -30.13 71.24 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 123.681 0.793 . . . . 0.0 112.377 -179.019 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.466 ' HG2' ' O ' ' A' ' 84' ' ' ALA . 13.4 pt-20 -88.61 -7.49 56.31 Favored 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 123.215 0.606 . . . . 0.0 111.275 178.553 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -83.14 116.48 22.36 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 123.64 0.776 . . . . 0.0 110.365 176.356 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -75.69 128.47 35.27 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 123.86 0.864 . . . . 0.0 110.268 175.662 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 81.1 m95 -119.0 -1.2 11.01 Favored 'General case' 0 CA--C 1.555 1.138 0 C-N-CA 123.28 0.632 . . . . 0.0 110.151 166.325 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 14.2 t . . . . . 0 CA--C 1.565 1.538 0 N-CA-C 113.569 0.952 . . . . 0.0 113.569 -165.992 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 28.8 m . . . . . 0 N--CA 1.483 1.188 0 CA-C-O 121.204 0.526 . . . . 0.0 112.311 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.415 ' HB3' ' CE2' ' A' ' 44' ' ' TYR . 45.7 p -135.41 141.66 45.5 Favored 'General case' 0 C--O 1.241 0.646 0 C-N-CA 124.224 1.01 . . . . 0.0 109.376 -178.258 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 95.7 t -123.99 123.78 67.55 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 C-N-CA 124.266 1.026 . . . . 0.0 108.718 174.881 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -82.36 110.38 17.45 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 123.137 0.575 . . . . 0.0 110.201 176.472 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.5 ' HB2' ' HG3' ' A' ' 41' ' ' LYS . 4.1 mm? -85.38 165.19 37.32 Favored Pre-proline 0 CA--C 1.556 1.19 0 C-N-CA 124.584 1.154 . . . . 0.0 110.084 179.92 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 25.1 Cg_endo -59.88 149.46 83.57 Favored 'Trans proline' 0 C--N 1.389 2.674 0 C-N-CA 122.716 2.277 . . . . 0.0 113.834 179.838 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -149.32 170.29 7.88 Favored Pre-proline 0 CA--C 1.551 0.999 0 C-N-CA 124.32 1.048 . . . . 0.0 110.321 -172.264 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_exo -52.54 157.63 6.9 Favored 'Trans proline' 0 C--N 1.385 2.498 0 C-N-CA 122.946 2.43 . . . . 0.0 112.981 165.133 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 44.9 m -60.04 -29.72 68.71 Favored 'General case' 0 CA--C 1.552 1.021 0 C-N-CA 124.07 0.948 . . . . 0.0 112.233 -179.548 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 37.0 t -84.64 -24.57 29.02 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 123.121 0.568 . . . . 0.0 111.713 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 32.1 m95 -114.25 177.15 4.74 Favored 'General case' 0 N--CA 1.483 1.18 0 CA-C-O 121.467 0.651 . . . . 0.0 112.058 -173.331 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 33.5 mtmt -136.45 145.14 44.88 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 124.712 1.205 . . . . 0.0 108.179 170.093 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.519 ' NZ ' ' HB2' ' A' ' 43' ' ' PHE . 22.4 tptp -114.25 135.25 54.26 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 124.523 1.129 . . . . 0.0 108.707 -178.489 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.447 HD23 ' HB ' ' A' ' 57' ' ' VAL . 5.5 tt -125.95 142.42 51.53 Favored 'General case' 0 C--O 1.238 0.481 0 C-N-CA 124.166 0.986 . . . . 0.0 108.803 176.896 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . 0.519 ' HB2' ' NZ ' ' A' ' 41' ' ' LYS . 65.5 t80 -127.09 144.9 50.92 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 124.884 1.274 . . . . 0.0 108.027 172.807 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . 0.415 ' CE2' ' HB3' ' A' ' 30' ' ' SER . 17.8 m-85 -102.44 97.65 9.25 Favored Pre-proline 0 CA--C 1.548 0.868 0 C-N-CA 122.557 0.343 . . . . 0.0 110.12 171.914 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo . . . . . 0 C--N 1.38 2.234 0 C-N-CA 122.945 2.43 . . . . 0.0 112.006 176.029 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 CA--C 1.541 0.631 0 CA-C-O 121.516 0.674 . . . . 0.0 111.671 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.403 ' CG1' ' HE2' ' A' ' 41' ' ' LYS . 31.9 t -81.85 134.29 27.38 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.404 0 CA-C-N 114.891 -1.05 . . . . 0.0 110.052 177.52 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.447 ' HB ' HD23 ' A' ' 42' ' ' LEU . 98.6 t -121.11 130.23 74.88 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 C-N-CA 124.089 0.956 . . . . 0.0 108.928 175.137 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 9.1 m-85 -101.86 119.5 38.88 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 123.297 0.639 . . . . 0.0 109.281 171.376 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.417 ' HA ' ' HG2' ' A' ' 65' ' ' GLU . 14.8 t -78.37 123.81 35.78 Favored 'Isoleucine or valine' 0 C--O 1.239 0.532 0 C-N-CA 123.518 0.727 . . . . 0.0 109.744 176.331 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -82.07 151.98 67.62 Favored Pre-proline 0 CA--C 1.54 0.582 0 CA-C-N 114.335 -1.302 . . . . 0.0 110.873 -175.639 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_endo -60.48 -33.3 94.08 Favored 'Trans proline' 0 C--N 1.374 1.894 0 C-N-CA 123.245 2.63 . . . . 0.0 112.697 177.41 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.424 HG21 ' H ' ' A' ' 64' ' ' GLU . 11.4 t -85.82 -12.82 49.9 Favored 'General case' 0 CA--C 1.545 0.781 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.292 178.207 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 94.57 -1.12 65.98 Favored Glycine 0 C--N 1.357 1.7 0 CA-C-O 120.053 -0.304 . . . . 0.0 113.64 -177.276 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.424 ' H ' HG21 ' A' ' 62' ' ' THR . 33.0 tt0 -78.31 71.87 4.8 Favored 'General case' 0 N--CA 1.48 1.064 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 174.497 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . 0.417 ' HG2' ' HA ' ' A' ' 59' ' ' VAL . 34.1 mt-10 -66.01 148.57 51.59 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-N 114.775 -1.102 . . . . 0.0 111.771 -169.138 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 48.6 mm -115.17 131.11 68.4 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.557 0 C-N-CA 124.44 1.096 . . . . 0.0 110.167 -168.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 61.0 p -101.52 -21.12 14.83 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 123.596 0.758 . . . . 0.0 112.482 -178.758 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 7.8 p30 -143.52 159.36 42.57 Favored 'General case' 0 N--CA 1.481 1.111 0 CA-C-O 120.8 0.333 . . . . 0.0 111.802 -172.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 55.1 ttt-85 -65.69 -29.29 69.81 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 124.144 0.978 . . . . 0.0 111.968 -171.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 7.8 tmtm? -61.18 -54.94 38.0 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 123.352 0.661 . . . . 0.0 109.318 176.782 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 14.2 mm100 -67.5 -20.13 65.41 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-N 115.591 -0.732 . . . . 0.0 111.821 -176.581 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.414 ' O ' ' HG ' ' A' ' 76' ' ' LEU . 0.6 OUTLIER -70.91 -56.45 6.22 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 176.221 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -62.94 -41.83 99.62 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 123.526 0.731 . . . . 0.0 111.191 -176.784 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.47 -28.69 66.31 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 122.684 0.394 . . . . 0.0 110.648 177.467 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . 0.41 ' OH ' HG22 ' A' ' 62' ' ' THR . 20.9 t80 -63.06 -49.72 73.41 Favored 'General case' 0 N--CA 1.482 1.128 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 172.789 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.414 ' HG ' ' O ' ' A' ' 72' ' ' LEU . 72.5 mt -61.62 -37.15 82.9 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 123.313 0.645 . . . . 0.0 111.869 -172.341 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.04 -35.71 49.4 Favored 'General case' 0 CA--C 1.548 0.885 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.13 176.847 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 30.0 t -79.03 -16.38 56.94 Favored 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 123.011 0.524 . . . . 0.0 111.541 -179.412 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 76.9 m-70 -129.57 82.81 66.5 Favored Pre-proline 0 CA--C 1.544 0.72 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 178.091 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -64.76 142.26 75.65 Favored 'Trans proline' 0 C--N 1.372 1.803 0 C-N-CA 122.776 2.318 . . . . 0.0 112.543 -178.902 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 105.18 -14.8 47.88 Favored Glycine 0 C--N 1.348 1.246 0 CA-C-N 116.125 -0.489 . . . . 0.0 112.67 -178.024 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 18.4 m-80 -76.62 146.49 76.88 Favored Pre-proline 0 N--CA 1.485 1.316 0 C-N-CA 123.588 0.755 . . . . 0.0 111.526 179.633 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -63.37 158.43 45.07 Favored 'Trans proline' 0 C--N 1.383 2.393 0 C-N-CA 123.019 2.479 . . . . 0.0 113.541 -178.023 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . 0.419 ' O ' ' HG2' ' A' ' 87' ' ' GLU . . . -73.83 144.52 45.47 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-N 114.879 -1.055 . . . . 0.0 111.756 -174.941 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 16.7 tt -67.03 -12.32 14.98 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.311 0 C-N-CA 123.129 0.572 . . . . 0.0 111.657 179.736 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -57.0 -38.86 73.67 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 124.38 1.072 . . . . 0.0 112.297 173.687 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.419 ' HG2' ' O ' ' A' ' 84' ' ' ALA . 11.6 pt-20 -92.76 0.21 57.38 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 123.235 0.614 . . . . 0.0 111.518 -179.569 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -85.26 110.75 19.29 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 123.044 0.537 . . . . 0.0 109.746 177.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -83.17 93.78 7.72 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 123.962 0.905 . . . . 0.0 109.941 -178.625 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 78.7 m95 -79.43 -42.45 25.38 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 123.433 0.693 . . . . 0.0 109.996 171.418 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 12.8 t . . . . . 0 CA--C 1.559 1.294 0 C-N-CA 124.4 1.08 . . . . 0.0 112.483 -172.859 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 12.8 m . . . . . 0 CA--C 1.549 0.938 0 CA-C-O 121.697 0.76 . . . . 0.0 110.98 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 15.5 p -145.93 137.32 24.83 Favored 'General case' 0 C--O 1.24 0.597 0 C-N-CA 124.671 1.188 . . . . 0.0 108.74 -178.605 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.409 HG13 HD23 ' A' ' 33' ' ' LEU . 86.3 t -125.62 125.54 68.78 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 C-N-CA 124.048 0.939 . . . . 0.0 108.972 -179.411 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -79.6 104.91 10.52 Favored 'General case' 0 CA--C 1.537 0.473 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 173.546 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.655 ' HB2' ' HZ3' ' A' ' 41' ' ' LYS . 4.4 mm? -80.64 159.95 68.11 Favored Pre-proline 0 CA--C 1.552 1.023 0 C-N-CA 123.611 0.764 . . . . 0.0 109.537 177.068 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_endo -59.85 151.04 74.03 Favored 'Trans proline' 0 C--N 1.381 2.283 0 C-N-CA 122.378 2.052 . . . . 0.0 113.468 -178.016 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -144.81 168.13 12.99 Favored Pre-proline 0 N--CA 1.476 0.848 0 C-N-CA 124.203 1.001 . . . . 0.0 110.979 -168.698 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.511 ' HG2' ' HB2' ' A' ' 39' ' ' TRP . 30.3 Cg_endo -62.93 151.27 85.33 Favored 'Trans proline' 0 C--N 1.381 2.259 0 C-N-CA 122.0 1.8 . . . . 0.0 110.423 160.991 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 57.4 p -64.12 -23.33 67.28 Favored 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 123.528 0.731 . . . . 0.0 111.898 -177.225 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 18.3 m -74.64 -33.6 62.57 Favored 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 123.54 0.736 . . . . 0.0 111.745 178.226 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' TRP . . . . . 0.511 ' HB2' ' HG2' ' A' ' 36' ' ' PRO . 28.4 m95 -117.25 -174.38 2.59 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 123.942 0.897 . . . . 0.0 110.562 -176.866 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 44.8 mtmt -138.74 149.52 45.13 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 124.18 0.992 . . . . 0.0 108.612 168.888 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.655 ' HZ3' ' HB2' ' A' ' 33' ' ' LEU . 24.6 tptp -118.95 127.25 53.3 Favored 'General case' 0 C--N 1.331 -0.206 0 C-N-CA 124.815 1.246 . . . . 0.0 109.311 -175.214 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 4.1 tt -124.28 145.77 49.18 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 124.259 1.024 . . . . 0.0 108.647 174.68 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . 0.467 ' HB2' ' NZ ' ' A' ' 41' ' ' LYS . 48.3 t80 -128.94 142.46 50.93 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 124.994 1.318 . . . . 0.0 108.124 170.934 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 36.5 m-85 -101.1 100.47 13.26 Favored Pre-proline 0 N--CA 1.48 1.058 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 171.243 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 62.2 Cg_endo . . . . . 0 C--N 1.372 1.816 0 C-N-CA 122.736 2.291 . . . . 0.0 111.598 172.499 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 . . . . . 0 CA--C 1.551 0.993 0 CA-C-O 121.731 0.777 . . . . 0.0 111.31 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 11.7 t -81.75 138.04 20.2 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.416 0 C-N-CA 124.581 1.152 . . . . 0.0 110.707 -174.657 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 49.3 t -123.13 116.12 47.66 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.744 0 C-N-CA 123.674 0.79 . . . . 0.0 109.059 171.848 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 15.2 m-85 -86.36 120.64 27.92 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 123.36 0.664 . . . . 0.0 109.585 170.395 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 2.8 t -78.71 127.98 38.63 Favored 'Isoleucine or valine' 0 C--O 1.238 0.494 0 C-N-CA 123.56 0.744 . . . . 0.0 109.039 174.414 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -86.53 153.41 55.79 Favored Pre-proline 0 CA--C 1.539 0.553 0 CA-C-N 114.959 -1.019 . . . . 0.0 110.801 -176.869 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -59.54 -29.88 91.04 Favored 'Trans proline' 0 C--N 1.369 1.613 0 C-N-CA 122.898 2.398 . . . . 0.0 113.076 173.893 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.412 HG21 ' HH ' ' A' ' 75' ' ' TYR . 14.5 t -93.32 -3.97 52.51 Favored 'General case' 0 N--CA 1.486 1.343 0 C-N-CA 122.565 0.346 . . . . 0.0 111.522 176.894 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 90.04 -8.71 79.31 Favored Glycine 0 C--N 1.35 1.358 0 CA-C-O 119.576 -0.569 . . . . 0.0 113.996 -179.795 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -72.63 77.64 1.09 Allowed 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 123.686 0.794 . . . . 0.0 109.306 175.316 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -73.06 158.34 35.57 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-N 115.013 -0.994 . . . . 0.0 111.581 -168.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . 0.532 HG21 ' HB2' ' A' ' 71' ' ' GLN . 49.2 mm -122.14 115.42 46.16 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 CA-C-N 114.522 -1.217 . . . . 0.0 109.701 -166.723 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 14.1 p -88.5 -17.57 30.03 Favored 'General case' 0 CA--C 1.553 1.067 0 C-N-CA 123.765 0.826 . . . . 0.0 112.306 179.651 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 2.0 p-10 -156.67 157.65 35.57 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 112.133 0.42 . . . . 0.0 112.133 -174.558 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 41.9 mtm105 -56.6 -36.58 69.57 Favored 'General case' 0 N--CA 1.493 1.724 0 C-N-CA 124.35 1.06 . . . . 0.0 113.858 -170.868 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 7.0 tmtm? -54.62 -49.35 70.7 Favored 'General case' 0 N--CA 1.484 1.232 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 179.544 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.532 ' HB2' HG21 ' A' ' 66' ' ' ILE . 91.1 mt-30 -64.06 -35.16 79.84 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 123.693 0.797 . . . . 0.0 111.312 -179.544 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.448 ' O ' ' HG ' ' A' ' 76' ' ' LEU . 0.6 OUTLIER -64.68 -51.71 61.06 Favored 'General case' 0 N--CA 1.483 1.178 0 O-C-N 123.739 0.649 . . . . 0.0 109.369 -179.813 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -69.34 -42.16 75.68 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 124.298 1.039 . . . . 0.0 111.599 -173.523 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 1.1 pp0? -66.44 -33.12 75.0 Favored 'General case' 0 N--CA 1.472 0.665 0 O-C-N 123.427 0.454 . . . . 0.0 109.897 176.091 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . 0.412 ' HH ' HG21 ' A' ' 62' ' ' THR . 12.2 t80 -61.92 -47.1 86.45 Favored 'General case' 0 C--N 1.357 0.909 0 O-C-N 123.656 0.597 . . . . 0.0 109.447 175.41 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.448 ' HG ' ' O ' ' A' ' 72' ' ' LEU . 81.9 mt -62.21 -48.98 77.6 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 123.038 0.535 . . . . 0.0 111.195 -175.738 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.76 -17.61 61.08 Favored 'General case' 0 CA--C 1.551 0.989 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.754 -176.806 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 30.7 t -92.77 -27.7 17.04 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 123.381 0.672 . . . . 0.0 110.781 175.654 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 51.9 m80 -127.72 92.25 43.19 Favored Pre-proline 0 N--CA 1.479 0.979 0 C-N-CA 124.204 1.002 . . . . 0.0 108.735 -174.334 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -64.63 159.79 43.25 Favored 'Trans proline' 0 C--N 1.371 1.756 0 C-N-CA 122.858 2.372 . . . . 0.0 112.551 179.131 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 91.62 -24.35 20.74 Favored Glycine 0 C--N 1.346 1.093 0 CA-C-N 115.989 -0.551 . . . . 0.0 112.971 179.06 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 41.7 m-80 -72.59 132.05 83.91 Favored Pre-proline 0 CA--C 1.546 0.817 0 C-N-CA 123.454 0.702 . . . . 0.0 110.308 177.651 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_endo -60.56 148.49 90.94 Favored 'Trans proline' 0 C--N 1.376 2.0 0 C-N-CA 123.226 2.617 . . . . 0.0 113.017 -176.123 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . 0.41 ' HA ' HD13 ' A' ' 76' ' ' LEU . . . -68.42 148.44 50.65 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 123.549 0.74 . . . . 0.0 112.088 -175.185 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.415 ' HB ' HD11 ' A' ' 72' ' ' LEU . 15.7 tt -63.49 -13.91 13.66 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.399 0 C-N-CA 124.329 1.052 . . . . 0.0 112.21 -177.459 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -57.76 -38.67 75.82 Favored 'General case' 0 CA--C 1.553 1.074 0 C-N-CA 124.153 0.981 . . . . 0.0 112.213 175.588 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -90.55 -10.32 43.93 Favored 'General case' 0 N--CA 1.487 1.404 0 C-N-CA 122.993 0.517 . . . . 0.0 111.947 178.138 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -77.31 115.63 17.24 Favored 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 175.804 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 6.5 t0 -91.38 109.8 21.08 Favored 'General case' 0 CA--C 1.54 0.591 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 -176.122 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 69.8 m95 -96.99 -22.97 16.52 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 123.909 0.884 . . . . 0.0 110.106 176.119 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 12.9 t . . . . . 0 N--CA 1.486 1.329 0 C-N-CA 123.428 0.691 . . . . 0.0 111.718 -174.528 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 15.3 m . . . . . 0 CA--C 1.548 0.884 0 CA-C-O 121.764 0.792 . . . . 0.0 110.345 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 30.8 p -161.99 113.48 1.67 Allowed 'General case' 0 C--O 1.239 0.513 0 C-N-CA 124.52 1.128 . . . . 0.0 108.078 -177.34 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 83.3 t -105.59 124.33 60.53 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.517 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . 0.469 ' HA ' ' HA ' ' A' ' 42' ' ' LEU . 51.6 mt-10 -76.72 113.21 14.12 Favored 'General case' 0 CA--C 1.533 0.317 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 173.761 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.421 HD22 ' HB3' ' A' ' 43' ' ' PHE . 3.7 mm? -87.28 166.4 26.03 Favored Pre-proline 0 CA--C 1.555 1.166 0 C-N-CA 123.69 0.796 . . . . 0.0 109.017 -179.786 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -51.54 134.72 46.9 Favored 'Trans proline' 0 C--N 1.388 2.633 0 C-N-CA 123.012 2.475 . . . . 0.0 113.161 175.854 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . 0.417 ' HB3' ' HB3' ' A' ' 41' ' ' LYS . . . -128.91 158.97 70.89 Favored Pre-proline 0 N--CA 1.477 0.89 0 C-N-CA 125.335 1.454 . . . . 0.0 110.913 -170.648 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.632 ' HG2' ' HB2' ' A' ' 39' ' ' TRP . 58.9 Cg_endo -70.16 177.96 5.32 Favored 'Trans proline' 0 C--N 1.381 2.262 0 C-N-CA 122.686 2.257 . . . . 0.0 111.44 166.057 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 77.2 p -71.22 -47.67 55.96 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 123.694 0.798 . . . . 0.0 112.498 -169.741 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 22.2 m -74.65 -35.61 62.85 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 123.809 0.844 . . . . 0.0 110.884 -175.594 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' TRP . . . . . 0.632 ' HB2' ' HG2' ' A' ' 36' ' ' PRO . 39.7 m95 -100.3 174.3 6.19 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 123.693 0.797 . . . . 0.0 111.28 -175.297 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.769 ' HB3' ' HB ' ' A' ' 59' ' ' VAL . 15.7 tppt? -126.94 148.39 50.06 Favored 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 107.187 -1.412 . . . . 0.0 107.187 169.127 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.475 ' HZ3' ' HB3' ' A' ' 89' ' ' ASP . 0.0 OUTLIER -120.97 127.94 52.26 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 107.688 -1.227 . . . . 0.0 107.688 179.41 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.469 ' HA ' ' HA ' ' A' ' 32' ' ' GLU . 4.5 tt -128.55 146.1 50.93 Favored 'General case' 0 C--N 1.324 -0.541 0 C-N-CA 125.29 1.436 . . . . 0.0 107.569 174.033 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . 0.421 ' HB3' HD22 ' A' ' 33' ' ' LEU . 31.6 t80 -126.94 142.92 51.43 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 124.707 1.203 . . . . 0.0 107.923 172.509 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 14.1 m-85 -100.84 99.09 9.52 Favored Pre-proline 0 N--CA 1.488 1.44 0 C-N-CA 123.17 0.588 . . . . 0.0 110.91 174.084 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo . . . . . 0 C--N 1.378 2.108 0 C-N-CA 123.066 2.511 . . . . 0.0 111.999 171.909 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 15.1 pt-20 . . . . . 0 CA--C 1.55 0.959 0 CA-C-O 121.86 0.838 . . . . 0.0 111.431 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 75.4 t -80.28 137.57 21.28 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.76 0 CA-C-N 114.988 -1.005 . . . . 0.0 109.274 179.575 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 87.3 t -117.81 115.2 47.75 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 178.223 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.412 ' CZ ' ' HE3' ' A' ' 41' ' ' LYS . 19.6 m-85 -94.94 115.1 27.03 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 123.657 0.783 . . . . 0.0 109.378 174.635 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.769 ' HB ' ' HB3' ' A' ' 40' ' ' LYS . 2.8 t -79.48 129.84 36.97 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 175.359 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -84.31 153.62 62.54 Favored Pre-proline 0 CA--C 1.54 0.565 0 CA-C-N 114.939 -1.028 . . . . 0.0 111.003 -175.035 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_endo -61.02 -32.72 92.45 Favored 'Trans proline' 0 C--N 1.379 2.147 0 C-N-CA 122.913 2.408 . . . . 0.0 113.101 177.02 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 13.2 t -84.49 -6.35 59.37 Favored 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 122.981 0.512 . . . . 0.0 111.627 179.796 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 94.16 -19.87 50.89 Favored Glycine 0 C--N 1.357 1.702 0 CA-C-O 119.686 -0.508 . . . . 0.0 113.179 179.486 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -69.63 75.74 0.42 Allowed 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 124.299 1.039 . . . . 0.0 109.09 175.608 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -75.36 150.24 38.46 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-O 121.892 0.853 . . . . 0.0 111.548 -166.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 39.8 mm -102.27 123.32 55.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 114.047 -1.433 . . . . 0.0 109.555 -175.72 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 24.3 m -105.69 -1.34 24.63 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 123.153 0.581 . . . . 0.0 111.093 -179.404 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 14.5 p-10 -158.01 145.65 18.4 Favored 'General case' 0 C--N 1.353 0.749 0 C-N-CA 123.076 0.55 . . . . 0.0 111.241 -174.062 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.418 ' HG3' HD11 ' A' ' 85' ' ' ILE . 44.1 ttp180 -61.35 -30.61 70.63 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 124.839 1.255 . . . . 0.0 113.864 -166.969 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 6.4 tmtm? -62.28 -49.06 77.16 Favored 'General case' 0 N--CA 1.489 1.508 0 C-N-CA 123.139 0.576 . . . . 0.0 109.554 177.196 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.531 ' HA ' ' HG3' ' A' ' 74' ' ' GLN . 86.4 mm-40 -66.35 -21.61 66.25 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-N 115.406 -0.815 . . . . 0.0 111.515 -176.565 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.416 ' HB3' HD13 ' A' ' 85' ' ' ILE . 0.6 OUTLIER -65.44 -54.95 21.16 Favored 'General case' 0 N--CA 1.477 0.894 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 174.77 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -59.15 -49.74 76.69 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 123.877 0.871 . . . . 0.0 111.031 -176.05 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . 0.531 ' HG3' ' HA ' ' A' ' 71' ' ' GLN . 0.0 OUTLIER -67.57 -25.89 66.01 Favored 'General case' 0 CA--C 1.547 0.864 0 CA-C-N 115.414 -0.812 . . . . 0.0 111.369 -177.226 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 34.0 t80 -66.45 -50.43 63.38 Favored 'General case' 0 C--N 1.357 0.897 0 C-N-CA 123.211 0.605 . . . . 0.0 109.592 173.445 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 81.5 mt -58.28 -43.13 87.84 Favored 'General case' 0 N--CA 1.486 1.347 0 O-C-N 123.787 0.679 . . . . 0.0 111.873 -173.679 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 58.3 pttt -68.03 -41.0 82.78 Favored 'General case' 0 N--CA 1.478 0.932 0 O-C-N 123.32 0.387 . . . . 0.0 111.035 -179.354 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 77.4 p -85.52 -10.37 56.11 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 112.012 0.375 . . . . 0.0 112.012 -177.17 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 53.1 m-70 -130.06 84.25 60.95 Favored Pre-proline 0 N--CA 1.482 1.167 0 C-N-CA 124.322 1.049 . . . . 0.0 108.714 177.654 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -67.9 147.29 74.22 Favored 'Trans proline' 0 C--N 1.375 1.924 0 C-N-CA 122.631 2.22 . . . . 0.0 111.786 178.838 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 101.41 -6.43 55.63 Favored Glycine 0 CA--C 1.53 0.995 0 CA-C-N 116.071 -0.513 . . . . 0.0 112.698 -177.192 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 40.2 m-80 -90.68 141.05 26.68 Favored Pre-proline 0 N--CA 1.48 1.062 0 C-N-CA 123.164 0.586 . . . . 0.0 110.595 177.239 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_endo -62.0 149.57 89.79 Favored 'Trans proline' 0 C--N 1.38 2.236 0 C-N-CA 123.384 2.723 . . . . 0.0 112.783 179.091 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -66.28 158.89 27.84 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 124.22 1.008 . . . . 0.0 111.882 -173.162 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.418 HD11 ' HG3' ' A' ' 69' ' ' ARG . 19.3 tt -77.87 -17.58 14.0 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.544 177.485 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -60.7 -34.48 74.42 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 123.8 0.84 . . . . 0.0 111.471 177.089 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -92.81 -11.35 33.91 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 123.492 0.717 . . . . 0.0 110.976 179.65 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 5.8 m-30 -82.01 127.7 33.34 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 123.273 0.629 . . . . 0.0 109.832 176.083 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . 0.475 ' HB3' ' HZ3' ' A' ' 41' ' ' LYS . 12.0 t70 -92.47 122.18 34.66 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 123.909 0.884 . . . . 0.0 109.785 -178.317 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 77.5 m95 -115.73 6.7 14.48 Favored 'General case' 0 N--CA 1.488 1.471 0 C-N-CA 123.837 0.855 . . . . 0.0 110.729 176.637 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 9.9 t . . . . . 0 CA--C 1.557 1.22 0 C-N-CA 124.815 1.246 . . . . 0.0 110.662 -177.315 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 23.2 m . . . . . 0 CA--C 1.547 0.833 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.469 ' HA ' ' HD2' ' A' ' 45' ' ' PRO . 31.2 p -155.28 129.78 9.08 Favored 'General case' 0 C--O 1.239 0.508 0 CA-C-N 114.97 -1.013 . . . . 0.0 109.09 -173.143 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 65.4 t -114.36 124.89 71.45 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 175.784 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . 0.448 ' HA ' ' HA ' ' A' ' 42' ' ' LEU . 47.1 mt-10 -80.33 110.47 15.79 Favored 'General case' 0 C--O 1.237 0.433 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 177.856 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.496 HD21 ' HB3' ' A' ' 43' ' ' PHE . 4.2 mm? -86.61 160.42 50.54 Favored Pre-proline 0 N--CA 1.476 0.841 0 C-N-CA 123.814 0.846 . . . . 0.0 108.779 -178.775 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 14.0 Cg_endo -51.54 125.68 17.42 Favored 'Trans proline' 0 C--N 1.39 2.735 0 C-N-CA 123.073 2.515 . . . . 0.0 113.101 -172.65 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . 0.407 ' HB3' ' HB3' ' A' ' 41' ' ' LYS . . . -110.51 153.68 43.4 Favored Pre-proline 0 N--CA 1.469 0.483 0 CA-C-N 114.659 -1.155 . . . . 0.0 111.39 -170.876 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.661 ' HG2' ' HB2' ' A' ' 39' ' ' TRP . 56.3 Cg_endo -68.29 153.49 74.24 Favored 'Trans proline' 0 C--N 1.373 1.835 0 C-N-CA 122.584 2.189 . . . . 0.0 109.811 165.561 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 21.0 m -64.23 -29.31 70.42 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 123.468 0.707 . . . . 0.0 112.815 -172.138 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 16.0 m -83.56 -29.26 27.98 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 123.312 0.645 . . . . 0.0 111.609 -176.42 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' TRP . . . . . 0.661 ' HB2' ' HG2' ' A' ' 36' ' ' PRO . 17.5 m95 -114.19 -178.55 3.4 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 123.812 0.845 . . . . 0.0 109.668 -177.283 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.458 ' HB2' ' HB ' ' A' ' 59' ' ' VAL . 0.0 OUTLIER -119.7 165.63 14.26 Favored 'General case' 0 N--CA 1.473 0.713 0 N-CA-C 107.836 -1.172 . . . . 0.0 107.836 164.861 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.407 ' HB3' ' HB3' ' A' ' 35' ' ' ALA . 14.4 tptm -150.73 119.49 6.58 Favored 'General case' 0 C--O 1.238 0.496 0 C-N-CA 124.187 0.995 . . . . 0.0 108.77 -172.776 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.448 ' HA ' ' HA ' ' A' ' 32' ' ' GLU . 2.7 tt -129.1 150.21 50.59 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 113.579 -1.646 . . . . 0.0 108.29 -175.872 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . 0.496 ' HB3' HD21 ' A' ' 33' ' ' LEU . 33.8 t80 -130.24 139.82 50.76 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 124.353 1.061 . . . . 0.0 108.398 170.07 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 22.2 m-85 -96.8 103.11 13.52 Favored Pre-proline 0 CA--C 1.552 1.028 0 C-N-CA 122.849 0.46 . . . . 0.0 109.952 173.696 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . 0.469 ' HD2' ' HA ' ' A' ' 30' ' ' SER . 95.3 Cg_endo . . . . . 0 C--N 1.373 1.854 0 C-N-CA 122.526 2.151 . . . . 0.0 111.983 172.61 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 CA--C 1.555 1.162 0 CA-C-O 121.299 0.571 . . . . 0.0 111.713 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 86.9 t -82.95 138.77 18.79 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.885 0 C-N-CA 125.056 1.342 . . . . 0.0 110.529 -178.162 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 61.4 t -121.17 115.39 46.57 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.002 0 C-N-CA 124.039 0.936 . . . . 0.0 109.327 175.423 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 23.8 m-85 -88.8 112.93 23.79 Favored 'General case' 0 N--CA 1.479 1.014 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 170.282 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.458 ' HB ' ' HB2' ' A' ' 40' ' ' LYS . 9.1 t -79.14 133.49 29.83 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 CA-C-O 121.231 0.539 . . . . 0.0 109.907 -179.843 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -86.5 154.15 56.34 Favored Pre-proline 0 CA--C 1.543 0.681 0 CA-C-N 114.567 -1.197 . . . . 0.0 111.785 -172.92 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_endo -61.06 -26.17 82.5 Favored 'Trans proline' 0 C--N 1.377 2.057 0 C-N-CA 123.386 2.724 . . . . 0.0 113.31 173.816 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.422 HG22 ' H ' ' A' ' 64' ' ' GLU . 9.8 t -89.2 -12.27 41.37 Favored 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 122.537 0.335 . . . . 0.0 111.213 176.217 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 95.45 -8.21 68.99 Favored Glycine 0 C--N 1.355 1.607 0 CA-C-O 119.621 -0.544 . . . . 0.0 113.942 -178.164 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.422 ' H ' HG22 ' A' ' 62' ' ' THR . 40.4 tt0 -76.15 78.15 2.97 Favored 'General case' 0 N--CA 1.481 1.092 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 172.47 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -65.34 134.28 53.21 Favored 'General case' 0 CA--C 1.543 0.705 0 CA-C-N 115.325 -0.852 . . . . 0.0 110.781 -173.325 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . 0.598 HG22 ' HB2' ' A' ' 71' ' ' GLN . 44.7 mm -91.69 122.7 43.37 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.659 0 C-N-CA 125.068 1.347 . . . . 0.0 110.114 -175.094 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 6.0 p -94.63 -19.83 20.11 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 123.725 0.81 . . . . 0.0 111.989 177.491 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 1.9 p-10 -150.87 150.23 30.64 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 122.959 0.504 . . . . 0.0 111.417 -173.139 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 65.8 mtp85 -55.57 -30.11 60.24 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 125.193 1.397 . . . . 0.0 114.149 -170.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 6.4 tmtm? -58.69 -50.61 73.26 Favored 'General case' 0 N--CA 1.48 1.063 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 179.572 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.598 ' HB2' HG22 ' A' ' 66' ' ' ILE . 54.1 mt-30 -63.27 -35.27 79.79 Favored 'General case' 0 N--CA 1.477 0.912 0 O-C-N 124.312 1.008 . . . . 0.0 111.073 -179.766 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.442 ' O ' ' HG ' ' A' ' 76' ' ' LEU . 0.2 OUTLIER -60.52 -52.31 65.73 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 123.482 0.713 . . . . 0.0 109.158 179.004 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -63.1 -50.02 72.16 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 123.839 0.855 . . . . 0.0 111.537 -175.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -66.87 -24.98 66.19 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.147 0.579 . . . . 0.0 111.261 -178.459 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 28.8 t80 -69.12 -47.22 65.69 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 123.818 0.847 . . . . 0.0 109.591 175.194 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.443 HD12 ' HA ' ' A' ' 84' ' ' ALA . 92.7 mt -66.01 -44.92 83.36 Favored 'General case' 0 N--CA 1.481 1.09 0 O-C-N 123.822 0.701 . . . . 0.0 111.815 -174.281 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -69.36 -25.89 64.4 Favored 'General case' 0 N--CA 1.48 1.069 0 CA-C-N 116.531 -0.304 . . . . 0.0 110.278 179.106 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 47.0 t -79.71 -29.37 40.68 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 123.046 0.538 . . . . 0.0 111.016 175.117 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 54.6 m80 -132.5 89.43 36.24 Favored Pre-proline 0 CA--C 1.546 0.791 0 C-N-CA 123.548 0.739 . . . . 0.0 109.562 -172.146 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -68.76 151.15 74.55 Favored 'Trans proline' 0 C--N 1.38 2.195 0 C-N-CA 122.664 2.243 . . . . 0.0 112.593 -177.287 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 95.05 -22.85 36.1 Favored Glycine 0 C--N 1.347 1.151 0 CA-C-N 116.141 -0.481 . . . . 0.0 113.052 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 14.7 m120 -68.0 131.52 92.31 Favored Pre-proline 0 N--CA 1.482 1.133 0 CA-C-O 119.102 -0.475 . . . . 0.0 109.821 173.162 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -55.78 141.53 84.69 Favored 'Trans proline' 0 C--N 1.38 2.209 0 C-N-CA 123.133 2.555 . . . . 0.0 112.723 -175.258 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . 0.443 ' HA ' HD12 ' A' ' 76' ' ' LEU . . . -66.53 159.52 27.13 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 123.937 0.895 . . . . 0.0 112.811 -170.675 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.402 ' HB ' HD13 ' A' ' 72' ' ' LEU . 16.3 tt -67.9 -20.72 26.28 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.014 0 C-N-CA 123.863 0.865 . . . . 0.0 110.567 176.26 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -63.68 -36.54 84.17 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 124.457 1.103 . . . . 0.0 112.204 179.741 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -92.35 -1.49 57.01 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 123.442 0.697 . . . . 0.0 111.213 179.086 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 5.3 m-30 -93.82 112.38 24.23 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 123.923 0.889 . . . . 0.0 109.864 178.008 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 11.0 p-10 -86.65 115.06 23.86 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-O 121.494 0.664 . . . . 0.0 110.221 -179.502 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 74.2 m95 -94.12 -20.05 20.25 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 123.588 0.755 . . . . 0.0 109.701 172.822 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 15.1 t . . . . . 0 N--CA 1.484 1.229 0 C-N-CA 125.01 1.324 . . . . 0.0 112.65 -176.734 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 17.1 m . . . . . 0 N--CA 1.479 0.988 0 CA-C-O 121.639 0.733 . . . . 0.0 110.422 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 13.6 p -151.08 113.79 4.69 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 124.561 1.145 . . . . 0.0 108.408 -177.858 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 82.3 t -111.79 122.76 66.73 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 C-N-CA 124.38 1.072 . . . . 0.0 108.843 -176.759 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -79.5 116.74 19.89 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 123.112 0.565 . . . . 0.0 110.109 178.772 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.469 HD23 ' HB3' ' A' ' 43' ' ' PHE . 4.3 mm? -94.27 160.6 31.62 Favored Pre-proline 0 CA--C 1.555 1.167 0 C-N-CA 124.438 1.095 . . . . 0.0 109.128 177.362 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 13.1 Cg_endo -53.7 147.8 38.73 Favored 'Trans proline' 0 C--N 1.391 2.797 0 C-N-CA 123.22 2.613 . . . . 0.0 113.687 -177.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . 0.559 ' HB3' ' HB3' ' A' ' 41' ' ' LYS . . . -152.23 167.24 13.61 Favored Pre-proline 0 CA--C 1.538 0.498 0 C-N-CA 123.884 0.874 . . . . 0.0 111.871 -167.92 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_exo -56.1 146.57 69.59 Favored 'Trans proline' 0 C--N 1.38 2.214 0 C-N-CA 122.571 2.181 . . . . 0.0 110.83 158.059 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 61.4 p -66.34 -33.74 76.41 Favored 'General case' 0 CA--C 1.552 1.026 0 C-N-CA 123.149 0.58 . . . . 0.0 110.695 177.451 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 37.1 m -64.79 -41.3 95.93 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 124.686 1.194 . . . . 0.0 111.3 177.136 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' TRP . . . . . 0.41 ' HE1' ' HD2' ' A' ' 83' ' ' PRO . 41.8 m95 -102.04 -166.48 1.29 Allowed 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 123.93 0.892 . . . . 0.0 110.127 178.735 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.492 ' HB3' ' HB ' ' A' ' 59' ' ' VAL . 1.1 tppt? -148.41 154.35 39.79 Favored 'General case' 0 CA--C 1.535 0.38 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 164.468 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.559 ' HB3' ' HB3' ' A' ' 35' ' ' ALA . 17.5 tptm -121.66 122.48 39.7 Favored 'General case' 0 N--CA 1.468 0.444 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 -179.055 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 4.5 tt -124.55 136.93 54.38 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 175.359 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . 0.469 ' HB3' HD23 ' A' ' 33' ' ' LEU . 28.9 t80 -115.62 133.88 55.6 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 125.007 1.323 . . . . 0.0 108.021 172.81 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 13.2 m-85 -94.77 106.75 26.42 Favored Pre-proline 0 CA--C 1.547 0.854 0 C-N-CA 123.284 0.634 . . . . 0.0 109.479 171.66 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo . . . . . 0 C--N 1.37 1.66 0 C-N-CA 122.728 2.286 . . . . 0.0 111.522 169.41 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 CA--C 1.557 1.213 0 CA-C-O 121.136 0.493 . . . . 0.0 111.888 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 64.4 t -83.11 131.08 34.59 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 C-N-CA 124.06 0.944 . . . . 0.0 109.745 176.705 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 61.0 t -121.91 117.81 53.59 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.858 0 C-N-CA 124.052 0.941 . . . . 0.0 109.297 179.448 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 36.1 m-85 -87.18 131.1 34.28 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 123.61 0.764 . . . . 0.0 110.064 169.6 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.539 ' HA ' ' HG3' ' A' ' 65' ' ' GLU . 10.8 t -82.35 129.27 37.75 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 171.045 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -85.26 150.41 54.65 Favored Pre-proline 0 CA--C 1.542 0.672 0 CA-C-N 114.889 -1.051 . . . . 0.0 110.71 179.052 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_endo -61.4 -24.86 79.19 Favored 'Trans proline' 0 CA--C 1.557 1.643 0 C-N-CA 123.543 2.829 . . . . 0.0 111.477 169.715 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 85.2 m -74.53 -35.08 63.13 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 125.296 1.438 . . . . 0.0 112.078 176.193 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 94.2 11.24 57.64 Favored Glycine 0 CA--C 1.534 1.227 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.763 -162.538 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -94.72 70.37 3.49 Favored 'General case' 0 CA--C 1.542 0.641 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 174.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . 0.539 ' HG3' ' HA ' ' A' ' 59' ' ' VAL . 0.7 OUTLIER -57.78 129.89 43.95 Favored 'General case' 0 N--CA 1.478 0.943 0 CA-C-N 115.501 -0.772 . . . . 0.0 111.738 -174.599 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . 0.409 HG22 ' HB2' ' A' ' 71' ' ' GLN . 40.2 mm -100.7 128.45 52.8 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 CA-C-N 114.982 -1.008 . . . . 0.0 109.58 -177.906 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 12.2 p -110.27 -0.73 17.61 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 124.064 0.946 . . . . 0.0 111.451 -178.226 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 11.8 p-10 -162.26 149.82 14.11 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 122.757 0.423 . . . . 0.0 111.113 -169.577 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.506 ' HG2' HD13 ' A' ' 85' ' ' ILE . 16.3 mtp180 -52.53 -40.3 62.33 Favored 'General case' 0 N--CA 1.486 1.337 0 C-N-CA 124.346 1.058 . . . . 0.0 112.831 -175.555 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 5.0 tmtm? -53.63 -56.6 15.85 Favored 'General case' 0 N--CA 1.48 1.07 0 O-C-N 124.29 0.993 . . . . 0.0 109.307 -177.857 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.409 ' HB2' HG22 ' A' ' 66' ' ' ILE . 14.8 mm100 -67.18 -25.74 66.29 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 115.485 -0.78 . . . . 0.0 111.814 -175.314 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.421 HD12 ' HB ' ' A' ' 85' ' ' ILE . 0.6 OUTLIER -69.12 -54.68 13.69 Favored 'General case' 0 N--CA 1.482 1.155 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 178.398 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -68.49 -41.15 80.5 Favored 'General case' 0 C--O 1.241 0.642 0 C-N-CA 123.81 0.844 . . . . 0.0 111.005 -171.731 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -68.63 -29.41 67.9 Favored 'General case' 0 C--N 1.355 0.805 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.87 175.484 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 47.1 t80 -64.89 -40.96 95.91 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 122.882 0.473 . . . . 0.0 110.398 174.105 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 79.9 mt -68.07 -37.21 81.01 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 122.974 0.51 . . . . 0.0 111.604 -176.756 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.1 -16.96 36.36 Favored 'General case' 0 N--CA 1.484 1.26 0 C-N-CA 122.772 0.429 . . . . 0.0 111.661 -179.91 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 34.1 t -93.77 -22.0 18.96 Favored 'General case' 0 N--CA 1.492 1.652 0 C-N-CA 123.12 0.568 . . . . 0.0 110.78 174.785 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 54.2 m80 -135.81 79.36 46.18 Favored Pre-proline 0 CA--C 1.547 0.855 0 N-CA-C 107.364 -1.347 . . . . 0.0 107.364 179.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_endo -61.92 144.06 96.17 Favored 'Trans proline' 0 C--N 1.376 1.98 0 C-N-CA 123.386 2.724 . . . . 0.0 112.838 -179.113 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 115.21 -33.55 5.24 Favored Glycine 0 C--N 1.344 0.995 0 CA-C-N 116.195 -0.457 . . . . 0.0 112.756 178.136 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 54.0 m-80 -68.17 140.19 93.03 Favored Pre-proline 0 CA--C 1.555 1.142 0 C-N-CA 122.922 0.489 . . . . 0.0 111.323 -177.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . 0.41 ' HD2' ' HE1' ' A' ' 39' ' ' TRP . 81.9 Cg_exo -46.78 150.58 2.5 Favored 'Trans proline' 0 C--N 1.381 2.262 0 C-N-CA 124.682 3.588 . . . . 0.0 115.194 -178.375 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -71.99 158.17 36.47 Favored 'General case' 0 N--CA 1.484 1.258 0 C-N-CA 124.145 0.978 . . . . 0.0 112.247 -171.608 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.506 HD13 ' HG2' ' A' ' 69' ' ' ARG . 16.8 tt -76.79 -22.15 14.87 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.825 0 N-CA-C 110.253 -0.277 . . . . 0.0 110.253 175.051 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -64.58 -19.38 65.62 Favored 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 123.759 0.824 . . . . 0.0 112.616 178.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 -102.54 -14.86 16.61 Favored 'General case' 0 CA--C 1.553 1.076 0 C-N-CA 123.189 0.596 . . . . 0.0 110.85 174.65 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 7.1 m-30 -81.51 113.41 19.54 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 123.659 0.784 . . . . 0.0 110.352 179.612 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -80.59 125.2 29.7 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 123.439 0.696 . . . . 0.0 109.556 177.396 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 64.1 m95 -111.56 -8.25 14.25 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 124.139 0.976 . . . . 0.0 109.623 169.741 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 9.4 t . . . . . 0 CA--C 1.553 1.085 0 C-N-CA 124.111 0.964 . . . . 0.0 112.667 -163.579 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 27.2 m . . . . . 0 CA--C 1.549 0.922 0 CA-C-O 121.398 0.618 . . . . 0.0 110.408 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.409 ' HA ' ' HD2' ' A' ' 45' ' ' PRO . 24.6 p -142.46 118.05 10.38 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 123.974 0.91 . . . . 0.0 108.773 177.41 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 65.7 t -100.31 115.55 41.82 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 -175.144 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -80.61 105.99 12.28 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 123.423 0.689 . . . . 0.0 109.94 -179.367 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.431 HD22 ' HB3' ' A' ' 43' ' ' PHE . 4.5 mm? -83.68 163.94 47.0 Favored Pre-proline 0 N--CA 1.484 1.239 0 C-N-CA 124.281 1.033 . . . . 0.0 109.69 178.933 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -63.2 150.31 88.94 Favored 'Trans proline' 0 C--N 1.385 2.489 0 C-N-CA 122.025 1.817 . . . . 0.0 113.339 -175.407 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -141.8 167.77 15.82 Favored Pre-proline 0 CA--C 1.545 0.759 0 C-N-CA 124.226 1.01 . . . . 0.0 110.255 -173.484 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_endo -63.5 155.76 60.66 Favored 'Trans proline' 0 C--N 1.383 2.362 0 C-N-CA 121.902 1.735 . . . . 0.0 110.575 162.463 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 21.6 m -61.81 -23.53 66.29 Favored 'General case' 0 N--CA 1.484 1.274 0 C-N-CA 123.586 0.754 . . . . 0.0 111.511 179.205 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 12.6 m -71.24 -38.3 71.96 Favored 'General case' 0 CA--C 1.552 1.033 0 C-N-CA 124.134 0.974 . . . . 0.0 111.841 179.293 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 26.5 m95 -119.24 -172.44 2.31 Favored 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 124.091 0.957 . . . . 0.0 111.051 -173.885 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 37.3 mtmt -138.7 143.87 39.32 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 124.677 1.191 . . . . 0.0 108.677 168.007 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 17.2 tptm -114.14 118.17 33.27 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 125.631 1.572 . . . . 0.0 108.638 -179.471 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 8.6 tt -120.02 125.96 49.65 Favored 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 175.698 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . 0.431 ' HB3' HD22 ' A' ' 33' ' ' LEU . 87.0 t80 -103.58 134.57 46.7 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 124.441 1.096 . . . . 0.0 108.137 171.663 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . 0.401 ' HB2' ' O ' ' A' ' 55' ' ' GLU . 0.6 OUTLIER -100.01 104.52 29.47 Favored Pre-proline 0 CA--C 1.552 1.027 0 N-CA-C 109.392 -0.596 . . . . 0.0 109.392 174.635 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . 0.409 ' HD2' ' HA ' ' A' ' 30' ' ' SER . 85.5 Cg_endo . . . . . 0 C--N 1.37 1.71 0 C-N-CA 122.328 2.019 . . . . 0.0 110.431 166.452 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.401 ' O ' ' HB2' ' A' ' 44' ' ' TYR . 0.4 OUTLIER . . . . . 0 N--CA 1.485 1.309 0 CA-C-O 121.394 0.616 . . . . 0.0 112.387 . . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.419 HG23 ' HD1' ' A' ' 43' ' ' PHE . 79.7 t -84.09 132.83 30.6 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.963 0 C-N-CA 124.651 1.18 . . . . 0.0 110.353 179.019 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 98.9 t -122.37 120.93 62.46 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 C-N-CA 123.842 0.857 . . . . 0.0 109.617 173.627 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 15.3 m-85 -90.93 123.96 34.83 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 123.233 0.613 . . . . 0.0 109.378 170.364 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 5.2 t -80.94 124.27 38.5 Favored 'Isoleucine or valine' 0 C--O 1.237 0.431 0 C-N-CA 123.377 0.671 . . . . 0.0 109.317 172.607 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -81.61 153.49 70.68 Favored Pre-proline 0 N--CA 1.468 0.473 0 CA-C-N 114.946 -1.024 . . . . 0.0 110.186 -179.701 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_endo -59.34 -33.19 97.65 Favored 'Trans proline' 0 C--N 1.377 2.073 0 C-N-CA 123.186 2.591 . . . . 0.0 112.787 178.063 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 14.8 t -91.09 -7.22 52.33 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 123.569 0.748 . . . . 0.0 111.551 -179.059 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 93.59 -1.58 69.17 Favored Glycine 0 C--N 1.351 1.365 0 CA-C-O 119.52 -0.6 . . . . 0.0 113.952 179.337 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -80.99 75.04 7.97 Favored 'General case' 0 N--CA 1.481 1.086 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 173.85 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -65.9 145.33 56.06 Favored 'General case' 0 CA--C 1.543 0.686 0 CA-C-N 114.886 -1.052 . . . . 0.0 111.879 -170.392 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . 0.409 HG13 HD23 ' A' ' 72' ' ' LEU . 46.4 mm -101.11 127.31 54.46 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.571 0 C-N-CA 124.39 1.076 . . . . 0.0 109.813 -179.2 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 21.9 p -98.21 -14.5 20.3 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 123.668 0.787 . . . . 0.0 111.896 -177.878 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 13.1 p-10 -155.33 145.02 21.32 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 123.281 0.632 . . . . 0.0 110.543 -167.331 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.49 ' HG3' HD11 ' A' ' 85' ' ' ILE . 69.1 ttt180 -63.38 -26.74 68.89 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 124.459 1.104 . . . . 0.0 113.897 -165.559 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 1.4 tmtp? -66.0 -48.47 71.1 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 176.852 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.423 ' HA ' ' HG3' ' A' ' 74' ' ' GLN . 15.2 mm100 -63.76 -23.94 67.57 Favored 'General case' 0 N--CA 1.477 0.916 0 O-C-N 123.654 0.597 . . . . 0.0 112.034 -177.837 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.414 ' HB3' HD13 ' A' ' 85' ' ' ILE . 0.4 OUTLIER -64.28 -54.03 39.67 Favored 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 175.759 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.401 ' HG2' HG21 ' A' ' 85' ' ' ILE . 43.5 mt-10 -63.34 -46.5 86.35 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 123.85 0.86 . . . . 0.0 111.212 -174.02 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . 0.423 ' HG3' ' HA ' ' A' ' 71' ' ' GLN . 0.0 OUTLIER -69.97 -25.54 63.67 Favored 'General case' 0 CA--C 1.551 0.989 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.018 -178.851 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 28.1 t80 -65.34 -51.28 61.59 Favored 'General case' 0 C--N 1.358 0.959 0 C-N-CA 123.355 0.662 . . . . 0.0 109.534 173.47 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.403 ' HG ' ' O ' ' A' ' 72' ' ' LEU . 85.0 mt -60.83 -45.37 94.75 Favored 'General case' 0 N--CA 1.488 1.445 0 C-N-CA 123.668 0.787 . . . . 0.0 112.073 -172.621 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 19.0 ptpt -67.22 -32.54 73.65 Favored 'General case' 0 N--CA 1.481 1.122 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.207 178.688 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 34.8 t -85.54 -13.83 47.76 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 123.55 0.74 . . . . 0.0 111.594 -179.312 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 54.9 m80 -136.63 92.38 15.0 Favored Pre-proline 0 N--CA 1.485 1.298 0 C-N-CA 123.62 0.768 . . . . 0.0 109.368 -176.321 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -72.96 154.44 53.05 Favored 'Trans proline' 0 C--N 1.374 1.902 0 C-N-CA 122.7 2.267 . . . . 0.0 112.258 -179.3 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 102.81 -20.9 42.25 Favored Glycine 0 C--N 1.346 1.136 0 CA-C-N 115.893 -0.594 . . . . 0.0 112.205 -174.076 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 21.1 m120 -87.76 137.01 32.03 Favored Pre-proline 0 CA--C 1.553 1.069 0 C-N-CA 124.181 0.992 . . . . 0.0 110.194 179.422 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -72.38 159.43 49.34 Favored 'Trans proline' 0 C--N 1.38 2.234 0 C-N-CA 123.17 2.58 . . . . 0.0 112.908 -176.009 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -68.03 149.69 49.37 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 123.578 0.751 . . . . 0.0 112.138 -174.433 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.49 HD11 ' HG3' ' A' ' 69' ' ' ARG . 15.5 tt -68.05 -11.65 14.54 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.18 0 C-N-CA 123.922 0.889 . . . . 0.0 111.797 -178.928 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -56.92 -31.59 65.08 Favored 'General case' 0 CA--C 1.552 1.027 0 C-N-CA 124.311 1.045 . . . . 0.0 112.218 175.501 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -99.38 3.04 45.75 Favored 'General case' 0 N--CA 1.49 1.538 0 C-N-CA 123.4 0.68 . . . . 0.0 112.274 178.011 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -93.78 113.86 26.0 Favored 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 123.484 0.714 . . . . 0.0 109.386 -179.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -78.33 124.92 28.64 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 123.044 0.538 . . . . 0.0 110.454 -179.58 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 86.1 m95 -115.72 -6.55 12.14 Favored 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 123.821 0.848 . . . . 0.0 110.321 171.126 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 9.0 t . . . . . 0 N--CA 1.488 1.454 0 C-N-CA 124.708 1.203 . . . . 0.0 112.307 -166.261 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 31.6 m . . . . . 0 CA--C 1.546 0.795 0 CA-C-O 121.204 0.526 . . . . 0.0 110.05 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 3.8 m -142.96 128.2 18.73 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 123.998 0.919 . . . . 0.0 108.661 -175.619 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 26.2 t -122.4 124.76 71.6 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.935 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 178.75 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . 0.49 ' HA ' ' HA ' ' A' ' 42' ' ' LEU . 48.0 mt-10 -82.31 108.05 15.45 Favored 'General case' 0 C--O 1.237 0.432 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 174.74 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.513 HD23 ' HB3' ' A' ' 43' ' ' PHE . 3.8 mm? -77.89 159.88 75.25 Favored Pre-proline 0 CA--C 1.555 1.167 0 CA-C-N 115.206 -0.907 . . . . 0.0 109.352 178.756 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -53.78 127.0 23.75 Favored 'Trans proline' 0 C--N 1.385 2.475 0 C-N-CA 122.952 2.435 . . . . 0.0 112.693 -174.293 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -113.15 158.1 39.03 Favored Pre-proline 0 N--CA 1.468 0.469 0 C-N-CA 124.063 0.945 . . . . 0.0 111.576 -169.187 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.621 ' HG2' ' HB2' ' A' ' 39' ' ' TRP . 46.6 Cg_endo -68.66 142.88 54.43 Favored 'Trans proline' 0 C--N 1.374 1.871 0 C-N-CA 122.007 1.804 . . . . 0.0 110.046 162.453 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 36.8 m -58.15 -25.38 61.41 Favored 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 124.095 0.958 . . . . 0.0 112.823 -175.007 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 45.8 t -74.61 -41.47 60.36 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 123.175 0.59 . . . . 0.0 110.822 178.185 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' TRP . . . . . 0.621 ' HB2' ' HG2' ' A' ' 36' ' ' PRO . 21.4 m95 -108.2 -167.61 1.26 Allowed 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 123.678 0.791 . . . . 0.0 110.724 -175.418 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.472 ' HB2' ' HB ' ' A' ' 59' ' ' VAL . 8.4 mtmt -137.47 150.32 47.49 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 124.679 1.192 . . . . 0.0 108.099 167.739 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 18.8 tptm -127.59 115.7 19.2 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 124.855 1.262 . . . . 0.0 108.289 -173.194 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.49 ' HA ' ' HA ' ' A' ' 32' ' ' GLU . 3.6 tt -119.26 147.49 44.21 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 124.407 1.083 . . . . 0.0 108.951 178.536 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . 0.513 ' HB3' HD23 ' A' ' 33' ' ' LEU . 45.6 t80 -134.18 140.54 46.6 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 124.844 1.258 . . . . 0.0 108.392 171.734 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 33.3 m-85 -97.16 105.57 25.51 Favored Pre-proline 0 CA--C 1.55 0.948 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 173.141 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 79.1 Cg_endo . . . . . 0 C--N 1.377 2.036 0 C-N-CA 122.497 2.132 . . . . 0.0 112.719 174.793 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 CA--C 1.55 0.959 0 CA-C-O 121.529 0.68 . . . . 0.0 111.223 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 47.1 t -79.26 138.43 20.02 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.637 0 C-N-CA 123.974 0.909 . . . . 0.0 109.912 -179.735 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 60.5 t -125.46 118.43 52.42 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.663 0 C-N-CA 123.823 0.849 . . . . 0.0 108.824 174.791 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 24.7 m-85 -86.71 126.69 34.73 Favored 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 170.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.472 ' HB ' ' HB2' ' A' ' 40' ' ' LYS . 4.6 t -81.72 128.54 38.63 Favored 'Isoleucine or valine' 0 C--O 1.241 0.623 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 170.213 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -84.65 147.91 50.39 Favored Pre-proline 0 C--O 1.242 0.7 0 CA-C-N 115.246 -0.888 . . . . 0.0 110.916 -178.747 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 27.4 Cg_endo -63.18 -23.47 72.89 Favored 'Trans proline' 0 C--N 1.371 1.713 0 C-N-CA 123.112 2.541 . . . . 0.0 112.826 174.569 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.552 HG23 ' H ' ' A' ' 64' ' ' GLU . 12.9 t -91.94 -10.95 37.62 Favored 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 123.059 0.544 . . . . 0.0 111.413 176.308 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 91.99 -8.8 77.67 Favored Glycine 0 C--N 1.355 1.607 0 CA-C-O 120.03 -0.317 . . . . 0.0 113.813 -178.034 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.552 ' H ' HG23 ' A' ' 62' ' ' THR . 9.4 tp10 -76.94 76.68 3.51 Favored 'General case' 0 N--CA 1.486 1.335 0 N-CA-C 108.612 -0.885 . . . . 0.0 108.612 173.137 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -63.76 149.17 47.39 Favored 'General case' 0 C--O 1.241 0.611 0 CA-C-N 115.083 -0.962 . . . . 0.0 111.706 -171.299 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . 0.455 HG23 ' HB2' ' A' ' 71' ' ' GLN . 46.7 mm -115.59 119.96 63.35 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.732 0 CA-C-N 114.638 -1.165 . . . . 0.0 109.309 -174.726 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 14.4 p -106.47 -8.99 16.85 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 123.403 0.681 . . . . 0.0 112.511 -177.0 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 10.9 p30 -144.36 159.26 43.01 Favored 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 122.499 0.32 . . . . 0.0 111.084 175.231 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.481 ' HG3' HD13 ' A' ' 85' ' ' ILE . 50.7 ttt-85 -60.1 -35.85 76.14 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 124.446 1.098 . . . . 0.0 112.349 -173.49 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 1.8 tmtp? -59.91 -51.21 70.66 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 123.255 0.622 . . . . 0.0 109.372 179.189 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.455 ' HB2' HG23 ' A' ' 66' ' ' ILE . 84.1 mm-40 -57.86 -31.49 66.74 Favored 'General case' 0 CA--C 1.55 0.963 0 O-C-N 123.932 0.77 . . . . 0.0 110.949 -179.003 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -67.73 -51.28 51.2 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 123.666 0.786 . . . . 0.0 109.52 178.334 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -61.65 -50.87 70.77 Favored 'General case' 0 N--CA 1.484 1.259 0 C-N-CA 124.087 0.955 . . . . 0.0 111.472 -175.663 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 1.3 pp0? -65.86 -32.2 73.59 Favored 'General case' 0 CA--C 1.544 0.747 0 CA-C-N 115.495 -0.775 . . . . 0.0 111.178 -178.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 29.8 t80 -60.64 -51.11 70.77 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 123.334 0.654 . . . . 0.0 110.213 176.1 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.467 HD13 ' HA ' ' A' ' 84' ' ' ALA . 89.0 mt -65.33 -45.21 85.15 Favored 'General case' 0 N--CA 1.479 0.986 0 O-C-N 123.799 0.687 . . . . 0.0 111.994 -172.191 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.28 -20.24 63.05 Favored 'General case' 0 N--CA 1.481 1.094 0 CA-C-O 120.902 0.382 . . . . 0.0 111.211 179.601 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 34.2 t -92.53 -18.78 22.69 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 123.766 0.826 . . . . 0.0 111.574 175.184 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 54.3 m80 -135.2 93.7 16.6 Favored Pre-proline 0 N--CA 1.476 0.86 0 C-N-CA 123.587 0.755 . . . . 0.0 109.663 -174.71 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -71.92 162.71 41.1 Favored 'Trans proline' 0 C--N 1.371 1.732 0 C-N-CA 122.394 2.063 . . . . 0.0 111.804 175.742 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 87.9 -4.06 85.75 Favored Glycine 0 N--CA 1.472 1.05 0 CA-C-N 116.413 -0.358 . . . . 0.0 113.298 -177.51 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 32.0 m-80 -97.43 145.0 28.91 Favored Pre-proline 0 N--CA 1.482 1.171 0 C-N-CA 123.659 0.784 . . . . 0.0 109.991 177.698 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_endo -65.32 144.43 80.45 Favored 'Trans proline' 0 C--N 1.377 2.049 0 C-N-CA 122.561 2.174 . . . . 0.0 111.878 179.286 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . 0.467 ' HA ' HD13 ' A' ' 76' ' ' LEU . . . -70.68 162.03 29.75 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 123.809 0.843 . . . . 0.0 112.305 -171.219 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.481 HD13 ' HG3' ' A' ' 69' ' ' ARG . 17.5 tt -74.29 -15.54 16.45 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.095 0 CA-C-O 120.941 0.401 . . . . 0.0 110.924 179.24 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -60.02 -34.35 73.25 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 124.304 1.042 . . . . 0.0 112.081 175.649 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.425 ' HG2' ' O ' ' A' ' 84' ' ' ALA . 10.2 pt-20 -98.13 -2.65 39.5 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 123.761 0.825 . . . . 0.0 111.172 -178.715 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 3.6 m-30 -90.49 152.48 20.92 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 123.471 0.708 . . . . 0.0 110.144 176.055 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -120.3 122.74 41.5 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 123.464 0.706 . . . . 0.0 109.943 178.167 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 88.9 m95 -111.64 -2.0 15.54 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 123.798 0.839 . . . . 0.0 110.512 172.075 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 12.5 t . . . . . 0 N--CA 1.479 0.983 0 C-N-CA 123.639 0.776 . . . . 0.0 112.145 -168.252 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 19.2 m . . . . . 0 CA--C 1.555 1.162 0 CA-C-O 121.898 0.856 . . . . 0.0 109.815 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 39.9 p -171.91 141.22 1.34 Allowed 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 125.202 1.401 . . . . 0.0 107.948 -177.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.431 HG21 ' HG3' ' A' ' 45' ' ' PRO . 59.9 t -117.92 126.51 74.9 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 -178.972 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -84.97 105.13 15.5 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 123.58 0.752 . . . . 0.0 108.982 176.512 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.476 HD22 ' HB3' ' A' ' 43' ' ' PHE . 4.4 mm? -82.56 163.54 51.48 Favored Pre-proline 0 N--CA 1.48 1.057 0 C-N-CA 123.82 0.848 . . . . 0.0 110.192 -178.564 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -57.25 137.16 80.45 Favored 'Trans proline' 0 C--N 1.39 2.759 0 C-N-CA 122.683 2.255 . . . . 0.0 112.797 -179.536 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . 0.531 ' HB1' ' HB3' ' A' ' 41' ' ' LYS . . . -123.48 161.72 44.19 Favored Pre-proline 0 N--CA 1.476 0.86 0 C-N-CA 124.298 1.039 . . . . 0.0 111.742 -172.766 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.687 ' HG2' ' HB2' ' A' ' 39' ' ' TRP . 31.6 Cg_endo -63.72 146.36 92.07 Favored 'Trans proline' 0 C--N 1.375 1.926 0 C-N-CA 122.551 2.167 . . . . 0.0 109.669 159.028 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 18.5 m -59.04 -37.95 78.18 Favored 'General case' 0 N--CA 1.489 1.477 0 C-N-CA 124.179 0.992 . . . . 0.0 112.838 -169.734 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 48.5 m -69.81 -35.05 74.51 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 123.574 0.75 . . . . 0.0 111.528 -179.907 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' TRP . . . . . 0.687 ' HB2' ' HG2' ' A' ' 36' ' ' PRO . 33.3 m95 -104.6 -179.89 4.08 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 123.782 0.833 . . . . 0.0 110.566 -175.678 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.36 152.42 51.44 Favored 'General case' 0 N--CA 1.476 0.844 0 N-CA-C 107.556 -1.276 . . . . 0.0 107.556 173.743 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.531 ' HB3' ' HB1' ' A' ' 35' ' ' ALA . 18.2 tptm -132.53 117.8 18.45 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 123.922 0.889 . . . . 0.0 109.812 -171.717 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 2.3 tt -122.24 144.7 48.82 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 124.762 1.225 . . . . 0.0 108.604 174.459 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . 0.476 ' HB3' HD22 ' A' ' 33' ' ' LEU . 47.6 t80 -128.1 147.64 50.54 Favored 'General case' 0 C--O 1.238 0.482 0 C-N-CA 124.701 1.201 . . . . 0.0 108.98 171.405 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 18.2 m-85 -102.18 100.97 16.78 Favored Pre-proline 0 CA--C 1.551 0.994 0 C-N-CA 123.651 0.781 . . . . 0.0 110.147 171.895 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . 0.431 ' HG3' HG21 ' A' ' 31' ' ' VAL . 30.9 Cg_endo . . . . . 0 C--N 1.373 1.852 0 C-N-CA 123.435 2.756 . . . . 0.0 113.342 175.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 . . . . . 0 CA--C 1.549 0.939 0 CA-C-O 122.547 1.165 . . . . 0.0 112.16 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 20.5 t -80.52 145.88 8.41 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.668 0 CA-C-N 113.764 -1.562 . . . . 0.0 110.519 -174.512 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 49.1 t -121.77 116.55 49.72 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.804 0 C-N-CA 123.969 0.908 . . . . 0.0 109.007 172.219 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 33.9 m-85 -90.3 132.79 35.36 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 123.618 0.767 . . . . 0.0 110.255 171.424 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.419 ' HA ' ' HG2' ' A' ' 65' ' ' GLU . 14.8 t -85.59 132.19 32.49 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 168.477 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -87.4 153.7 53.6 Favored Pre-proline 0 C--O 1.244 0.772 0 CA-C-N 115.317 -0.856 . . . . 0.0 110.638 179.739 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_endo -69.43 -3.02 10.94 Favored 'Trans proline' 0 C--N 1.376 1.974 0 C-N-CA 122.865 2.377 . . . . 0.0 113.062 177.667 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.478 HG22 ' H ' ' A' ' 64' ' ' GLU . 12.3 t -115.62 -7.97 12.13 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 124.129 0.972 . . . . 0.0 111.401 -179.902 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 94.16 -15.2 63.72 Favored Glycine 0 C--N 1.358 1.783 0 CA-C-O 119.695 -0.503 . . . . 0.0 113.791 -179.547 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.478 ' H ' HG22 ' A' ' 62' ' ' THR . 42.9 tt0 -78.4 80.12 4.81 Favored 'General case' 0 N--CA 1.484 1.265 0 CA-C-O 121.67 0.748 . . . . 0.0 109.335 173.394 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . 0.419 ' HG2' ' HA ' ' A' ' 59' ' ' VAL . 28.3 mt-10 -69.73 156.46 38.96 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 124.43 1.092 . . . . 0.0 111.73 -170.224 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 41.0 mm -111.19 122.51 65.78 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.613 0 C-N-CA 123.855 0.862 . . . . 0.0 109.481 178.138 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 61.6 p -99.65 -11.45 20.91 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 123.481 0.712 . . . . 0.0 112.506 -177.817 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -153.94 150.54 28.43 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 122.598 0.359 . . . . 0.0 111.315 -177.804 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.429 ' HG3' HD11 ' A' ' 85' ' ' ILE . 41.5 ttm105 -54.98 -32.4 61.64 Favored 'General case' 0 N--CA 1.491 1.588 0 C-N-CA 125.369 1.468 . . . . 0.0 114.143 -168.196 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -60.05 -54.37 46.83 Favored 'General case' 0 N--CA 1.487 1.404 0 C-N-CA 123.356 0.662 . . . . 0.0 109.648 -179.798 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.456 ' O ' ' HB2' ' A' ' 75' ' ' TYR . 90.1 mm-40 -64.2 -20.97 66.38 Favored 'General case' 0 N--CA 1.476 0.841 0 CA-C-N 115.347 -0.842 . . . . 0.0 111.778 -176.564 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.431 ' O ' ' HG ' ' A' ' 76' ' ' LEU . 0.9 OUTLIER -69.85 -52.97 20.43 Favored 'General case' 0 N--CA 1.481 1.091 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 175.697 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -58.0 -54.42 47.11 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 123.971 0.908 . . . . 0.0 111.766 -178.752 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . 0.426 ' HG3' ' HA ' ' A' ' 71' ' ' GLN . 0.0 OUTLIER -67.5 -24.29 65.56 Favored 'General case' 0 CA--C 1.551 0.993 0 CA-C-N 115.455 -0.793 . . . . 0.0 111.077 -177.685 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . 0.456 ' HB2' ' O ' ' A' ' 71' ' ' GLN . 35.6 t80 -65.94 -55.27 17.71 Favored 'General case' 0 C--N 1.36 1.032 0 C-N-CA 123.097 0.559 . . . . 0.0 109.706 174.383 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.431 ' HG ' ' O ' ' A' ' 72' ' ' LEU . 71.2 mt -59.96 -39.47 85.71 Favored 'General case' 0 N--CA 1.489 1.514 0 C-N-CA 123.436 0.694 . . . . 0.0 111.855 -172.629 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.95 -14.35 58.66 Favored 'General case' 0 N--CA 1.484 1.269 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.824 -179.517 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 37.5 t -102.02 -9.6 20.47 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 123.621 0.768 . . . . 0.0 111.198 172.697 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 86.5 m-70 -137.45 87.23 18.05 Favored Pre-proline 0 N--CA 1.481 1.083 0 C-N-CA 124.189 0.995 . . . . 0.0 109.363 -177.132 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 63.2 Cg_endo -71.35 141.65 39.4 Favored 'Trans proline' 0 C--N 1.374 1.874 0 C-N-CA 122.403 2.069 . . . . 0.0 111.126 174.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 116.58 -20.24 12.24 Favored Glycine 0 N--CA 1.471 1.032 0 N-CA-C 111.695 -0.562 . . . . 0.0 111.695 -174.245 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 39.4 m-80 -91.67 140.51 25.17 Favored Pre-proline 0 CA--C 1.548 0.892 0 C-N-CA 123.435 0.694 . . . . 0.0 109.717 177.351 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -70.07 159.42 53.24 Favored 'Trans proline' 0 C--N 1.377 2.045 0 C-N-CA 122.845 2.363 . . . . 0.0 112.983 -178.65 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -70.0 154.55 41.81 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 123.949 0.9 . . . . 0.0 112.477 -173.432 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.429 HD11 ' HG3' ' A' ' 69' ' ' ARG . 16.2 tt -66.82 -12.01 14.34 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.209 0 C-N-CA 124.171 0.988 . . . . 0.0 111.686 -179.227 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -52.89 -39.8 62.99 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 124.505 1.122 . . . . 0.0 112.05 174.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -94.4 -8.14 39.57 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 123.526 0.73 . . . . 0.0 112.044 178.902 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -86.56 110.86 20.09 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 123.444 0.698 . . . . 0.0 109.314 176.39 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . 0.42 ' HB3' ' HZ2' ' A' ' 41' ' ' LYS . 11.6 t70 -87.63 126.56 35.02 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 123.683 0.793 . . . . 0.0 109.882 -178.744 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 85.2 m95 -118.29 -3.96 10.96 Favored 'General case' 0 CA--C 1.555 1.173 0 C-N-CA 125.126 1.37 . . . . 0.0 110.106 172.456 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 15.1 t . . . . . 0 N--CA 1.482 1.145 0 C-N-CA 124.025 0.93 . . . . 0.0 112.18 -168.046 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 15.3 m . . . . . 0 CA--C 1.545 0.774 0 CA-C-O 121.221 0.534 . . . . 0.0 109.854 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 50.1 p -152.99 123.83 7.37 Favored 'General case' 0 C--O 1.239 0.541 0 C-N-CA 123.934 0.893 . . . . 0.0 108.804 178.249 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 48.6 t -103.15 119.83 52.17 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 -178.582 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . 0.448 ' HA ' ' HA ' ' A' ' 42' ' ' LEU . 37.4 mt-10 -79.11 117.07 19.81 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.011 177.166 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -92.0 164.1 24.83 Favored Pre-proline 0 N--CA 1.483 1.195 0 C-N-CA 124.26 1.024 . . . . 0.0 109.6 -178.033 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -53.46 140.15 64.4 Favored 'Trans proline' 0 C--N 1.394 2.968 0 C-N-CA 123.127 2.551 . . . . 0.0 114.027 179.927 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . 0.719 ' HB3' ' HB3' ' A' ' 41' ' ' LYS . . . -140.19 156.84 69.9 Favored Pre-proline 0 N--CA 1.472 0.672 0 C-N-CA 124.419 1.087 . . . . 0.0 111.473 -170.068 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -58.41 140.73 95.68 Favored 'Trans proline' 0 C--N 1.372 1.784 0 C-N-CA 122.798 2.332 . . . . 0.0 110.504 155.269 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 70.5 p -63.51 -28.15 69.75 Favored 'General case' 0 N--CA 1.487 1.422 0 C-N-CA 122.993 0.517 . . . . 0.0 111.884 -177.007 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 31.8 m -67.24 -40.03 86.24 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 123.282 0.633 . . . . 0.0 110.612 176.911 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 33.8 m95 -100.46 -179.46 4.11 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 123.743 0.817 . . . . 0.0 110.25 179.266 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.5 150.51 52.15 Favored 'General case' 0 N--CA 1.469 0.482 0 N-CA-C 106.768 -1.568 . . . . 0.0 106.768 169.893 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.719 ' HB3' ' HB3' ' A' ' 35' ' ' ALA . 15.2 tptm -133.0 128.96 37.52 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.676 0.751 . . . . 0.0 108.998 -174.493 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.448 ' HA ' ' HA ' ' A' ' 32' ' ' GLU . 3.3 tt -135.37 151.32 50.37 Favored 'General case' 0 C--O 1.241 0.607 0 CA-C-N 114.001 -1.454 . . . . 0.0 108.62 -177.146 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 32.9 t80 -133.61 137.84 45.65 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.782 1.233 . . . . 0.0 108.267 173.735 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 38.5 m-85 -100.59 103.53 24.7 Favored Pre-proline 0 N--CA 1.484 1.231 0 C-N-CA 122.692 0.397 . . . . 0.0 111.025 175.544 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 65.0 Cg_endo . . . . . 0 C--N 1.371 1.727 0 C-N-CA 122.421 2.081 . . . . 0.0 110.994 166.676 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 4.0 pm0 . . . . . 0 CA--C 1.555 1.164 0 CA-C-O 121.694 0.759 . . . . 0.0 111.674 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 75.2 t -83.02 141.87 14.33 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.695 0 C-N-CA 124.33 1.052 . . . . 0.0 110.241 -177.317 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 57.7 t -123.56 124.01 68.6 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 C-N-CA 123.737 0.815 . . . . 0.0 109.555 179.594 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 29.6 m-85 -101.83 113.68 27.09 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 123.582 0.753 . . . . 0.0 109.27 171.774 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 3.4 t -79.1 130.45 36.11 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 C-N-CA 123.323 0.649 . . . . 0.0 109.587 175.939 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . 0.459 ' HB2' ' HH ' ' A' ' 75' ' ' TYR . . . -84.18 154.47 63.48 Favored Pre-proline 0 CA--C 1.541 0.622 0 CA-C-N 115.022 -0.99 . . . . 0.0 111.593 -175.796 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 26.5 Cg_endo -60.42 -33.6 93.95 Favored 'Trans proline' 0 C--N 1.377 2.071 0 C-N-CA 123.251 2.634 . . . . 0.0 113.179 177.226 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.521 HG22 ' HH ' ' A' ' 75' ' ' TYR . 14.8 t -85.47 -2.49 58.18 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 123.027 0.531 . . . . 0.0 111.602 179.256 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 94.21 -18.01 57.71 Favored Glycine 0 C--N 1.35 1.308 0 CA-C-O 119.635 -0.536 . . . . 0.0 113.682 178.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -72.46 76.82 1.04 Allowed 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 123.983 0.913 . . . . 0.0 109.638 178.198 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -65.57 157.86 28.64 Favored 'General case' 0 N--CA 1.477 0.881 0 CA-C-N 115.024 -0.989 . . . . 0.0 111.682 -172.744 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 47.4 mm -118.44 122.52 69.72 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.445 0 CA-C-N 114.83 -1.077 . . . . 0.0 109.386 -170.741 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 7.6 p -93.82 -21.26 19.39 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 123.932 0.893 . . . . 0.0 112.403 -178.44 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 2.4 p-10 -153.95 165.95 34.52 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 122.674 0.39 . . . . 0.0 111.393 -172.401 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 34.8 ttp180 -58.91 -41.93 88.45 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 124.314 1.046 . . . . 0.0 111.954 -171.059 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 5.0 tmtm? -55.99 -51.6 67.15 Favored 'General case' 0 N--CA 1.486 1.335 0 C-N-CA 123.821 0.848 . . . . 0.0 109.76 -179.52 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 77.5 mt-30 -60.3 -31.63 70.44 Favored 'General case' 0 N--CA 1.476 0.839 0 O-C-N 124.144 0.903 . . . . 0.0 111.422 -178.729 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -67.62 -50.42 58.19 Favored 'General case' 0 N--CA 1.481 1.12 0 N-CA-C 109.338 -0.615 . . . . 0.0 109.338 177.898 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -62.8 -51.0 68.77 Favored 'General case' 0 C--O 1.242 0.693 0 CA-C-N 115.236 -0.893 . . . . 0.0 111.225 -174.897 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -66.36 -29.42 69.6 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 122.556 0.343 . . . . 0.0 111.223 179.799 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . 0.521 ' HH ' HG22 ' A' ' 62' ' ' THR . 43.7 t80 -62.53 -54.68 36.28 Favored 'General case' 0 C--N 1.357 0.913 0 C-N-CA 122.946 0.498 . . . . 0.0 109.824 176.06 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 67.1 mt -60.71 -44.5 96.5 Favored 'General case' 0 N--CA 1.481 1.095 0 O-C-N 123.579 0.549 . . . . 0.0 111.847 -173.143 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -69.1 -25.04 64.21 Favored 'General case' 0 N--CA 1.48 1.037 0 CA-C-N 116.589 -0.278 . . . . 0.0 111.402 -177.813 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 100.0 p -98.47 -12.4 21.36 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 122.91 0.484 . . . . 0.0 111.811 178.715 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 90.4 m-70 -130.84 91.02 38.15 Favored Pre-proline 0 N--CA 1.476 0.841 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 179.673 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_endo -67.01 166.04 24.26 Favored 'Trans proline' 0 C--N 1.372 1.783 0 C-N-CA 122.412 2.075 . . . . 0.0 112.071 175.661 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 90.81 -17.22 55.98 Favored Glycine 0 C--N 1.347 1.15 0 CA-C-N 116.565 -0.289 . . . . 0.0 113.259 -179.776 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 40.2 m-80 -84.16 144.64 44.42 Favored Pre-proline 0 CA--C 1.547 0.856 0 C-N-CA 123.652 0.781 . . . . 0.0 111.269 -178.013 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_exo -56.18 152.01 40.28 Favored 'Trans proline' 0 C--N 1.378 2.081 0 C-N-CA 123.875 3.05 . . . . 0.0 112.794 170.97 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -77.04 161.56 28.22 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 123.526 0.73 . . . . 0.0 112.207 -173.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 16.9 tt -72.93 -23.45 20.38 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.222 0 C-N-CA 123.347 0.659 . . . . 0.0 111.488 -178.71 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -65.13 -31.58 72.85 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 123.308 0.643 . . . . 0.0 111.854 -177.728 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -90.52 0.2 57.42 Favored 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 123.432 0.693 . . . . 0.0 111.247 177.106 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 6.0 m-30 -92.74 111.42 23.02 Favored 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 123.499 0.72 . . . . 0.0 109.248 177.149 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -84.0 88.79 7.17 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 123.559 0.744 . . . . 0.0 110.618 -175.872 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 89.5 m95 -76.19 -17.69 59.42 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 122.695 0.398 . . . . 0.0 110.902 173.171 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 14.5 t . . . . . 0 N--CA 1.488 1.425 0 C-N-CA 125.623 1.569 . . . . 0.0 111.979 177.697 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 34.7 m . . . . . 0 CA--C 1.551 1.019 0 CA-C-O 121.444 0.64 . . . . 0.0 110.435 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 56.2 p -134.71 124.29 25.04 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 124.013 0.925 . . . . 0.0 109.87 -176.064 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 95.4 t -109.55 116.61 52.6 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.448 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 174.372 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . 0.477 ' HA ' ' HA ' ' A' ' 42' ' ' LEU . 44.0 mt-10 -77.27 125.3 29.1 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 123.257 0.623 . . . . 0.0 110.387 177.455 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -100.64 169.03 8.4 Favored Pre-proline 0 CA--C 1.559 1.304 0 C-N-CA 124.613 1.165 . . . . 0.0 109.316 -177.144 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -54.94 126.44 22.54 Favored 'Trans proline' 0 C--N 1.395 3.005 0 C-N-CA 122.99 2.46 . . . . 0.0 113.147 -177.745 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . 0.423 ' HB1' ' HB3' ' A' ' 41' ' ' LYS . . . -114.9 156.83 44.57 Favored Pre-proline 0 N--CA 1.48 1.069 0 C-N-CA 124.374 1.069 . . . . 0.0 111.88 -171.697 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.55 ' HG2' ' HB2' ' A' ' 39' ' ' TRP . 72.6 Cg_endo -73.25 171.07 18.38 Favored 'Trans proline' 0 C--N 1.372 1.806 0 C-N-CA 122.544 2.163 . . . . 0.0 111.13 166.727 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 43.6 p -66.57 -46.13 77.02 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 123.421 0.689 . . . . 0.0 111.803 -176.937 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' SER . . . . . 0.417 ' HB2' ' HD1' ' A' ' 39' ' ' TRP . 9.8 m -72.68 -40.74 66.02 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-N 115.174 -0.921 . . . . 0.0 111.78 -174.187 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' TRP . . . . . 0.55 ' HB2' ' HG2' ' A' ' 36' ' ' PRO . 18.4 m95 -105.02 -173.86 2.4 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 123.535 0.734 . . . . 0.0 110.989 -175.273 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -130.28 158.02 40.93 Favored 'General case' 0 C--O 1.239 0.537 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 172.222 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.423 ' HB3' ' HB1' ' A' ' 35' ' ' ALA . 16.7 tptm -136.88 126.64 25.56 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.741 0.782 . . . . 0.0 109.135 -174.973 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.477 ' HA ' ' HA ' ' A' ' 32' ' ' GLU . 3.3 tt -136.05 151.97 50.41 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 113.653 -1.612 . . . . 0.0 108.195 -177.613 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 31.5 t80 -132.89 140.26 47.8 Favored 'General case' 0 C--O 1.235 0.309 0 C-N-CA 124.154 0.982 . . . . 0.0 108.491 171.405 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 25.3 m-85 -102.7 99.53 13.74 Favored Pre-proline 0 CA--C 1.547 0.833 0 C-N-CA 122.933 0.493 . . . . 0.0 109.687 174.654 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_endo . . . . . 0 C--N 1.368 1.603 0 C-N-CA 122.765 2.31 . . . . 0.0 111.705 173.942 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 CA--C 1.557 1.235 0 CA-C-O 121.325 0.583 . . . . 0.0 111.631 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 87.5 t -82.1 144.66 9.91 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.77 0 C-N-CA 124.848 1.259 . . . . 0.0 110.353 -179.104 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 60.7 t -126.82 129.16 71.41 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.068 0 C-N-CA 124.325 1.05 . . . . 0.0 109.333 177.545 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.406 ' CZ ' ' HD3' ' A' ' 41' ' ' LYS . 31.2 m-85 -105.84 114.98 29.46 Favored 'General case' 0 N--CA 1.477 0.879 0 N-CA-C 108.752 -0.832 . . . . 0.0 108.752 170.622 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 6.9 t -80.14 133.91 28.61 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 C-N-CA 123.073 0.549 . . . . 0.0 109.764 178.11 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . 0.438 ' HB3' ' HH ' ' A' ' 75' ' ' TYR . . . -85.94 155.57 58.25 Favored Pre-proline 0 CA--C 1.542 0.64 0 CA-C-N 115.166 -0.925 . . . . 0.0 111.4 -176.337 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -69.79 7.49 0.99 Allowed 'Trans proline' 0 N--CA 1.504 2.131 0 C-N-CA 123.258 2.639 . . . . 0.0 114.702 -179.016 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.43 HG21 ' H ' ' A' ' 64' ' ' GLU . 9.0 t -128.93 -7.1 4.97 Favored 'General case' 0 N--CA 1.484 1.26 0 C-N-CA 123.484 0.714 . . . . 0.0 111.263 -176.478 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 95.57 -11.03 68.82 Favored Glycine 0 C--N 1.351 1.382 0 CA-C-O 119.572 -0.571 . . . . 0.0 114.497 -176.687 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.43 ' H ' HG21 ' A' ' 62' ' ' THR . 44.3 tt0 -79.76 73.22 6.5 Favored 'General case' 0 N--CA 1.483 1.204 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 172.932 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -69.73 158.04 36.16 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-N 114.823 -1.08 . . . . 0.0 111.568 -171.298 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . 0.428 HD12 ' HB3' ' A' ' 71' ' ' GLN . 44.7 mm -113.95 120.31 63.41 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 CA-C-N 115.157 -0.929 . . . . 0.0 109.757 -173.741 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 77.4 p -93.06 -24.33 18.34 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 123.691 0.797 . . . . 0.0 111.762 -177.147 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 8.9 p30 -141.23 157.8 44.75 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 122.775 0.43 . . . . 0.0 111.325 -175.42 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 70.1 ttt180 -62.92 -27.33 69.3 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 124.524 1.13 . . . . 0.0 112.562 -173.391 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 6.5 tmtm? -65.51 -50.37 65.52 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 123.316 0.646 . . . . 0.0 109.298 176.483 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.428 ' HB3' HD12 ' A' ' 66' ' ' ILE . 46.9 mt-30 -55.82 -31.37 62.63 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 123.942 0.897 . . . . 0.0 111.562 179.463 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.419 ' O ' ' HG ' ' A' ' 76' ' ' LEU . 0.2 OUTLIER -64.7 -51.77 60.72 Favored 'General case' 0 CA--C 1.551 1.017 0 O-C-N 123.613 0.571 . . . . 0.0 109.722 178.801 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -59.99 -50.4 73.88 Favored 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 122.859 0.464 . . . . 0.0 111.504 -178.116 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.2 -25.54 66.18 Favored 'General case' 0 CA--C 1.543 0.694 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.385 -177.033 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . 0.438 ' HH ' ' HB3' ' A' ' 60' ' ' ALA . 22.1 t80 -65.64 -49.51 68.4 Favored 'General case' 0 C--N 1.351 0.662 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 171.794 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.419 ' HG ' ' O ' ' A' ' 72' ' ' LEU . 80.2 mt -66.42 -39.4 88.94 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 123.135 0.574 . . . . 0.0 112.404 -172.24 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.02 -24.3 61.53 Favored 'General case' 0 N--CA 1.481 1.117 0 CA-C-O 120.817 0.342 . . . . 0.0 110.753 178.094 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 43.8 t -85.21 -27.57 26.01 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 123.409 0.684 . . . . 0.0 111.131 175.536 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 59.9 m80 -132.61 88.48 38.51 Favored Pre-proline 0 N--CA 1.475 0.781 0 C-N-CA 123.694 0.798 . . . . 0.0 109.511 -172.44 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -70.02 160.17 50.6 Favored 'Trans proline' 0 C--N 1.373 1.856 0 C-N-CA 122.468 2.112 . . . . 0.0 111.341 177.011 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 95.46 -32.78 5.95 Favored Glycine 0 CA--C 1.532 1.119 0 N-CA-C 112.353 -0.299 . . . . 0.0 112.353 -176.799 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 32.2 m-80 -65.49 143.72 98.75 Favored Pre-proline 0 CA--C 1.551 0.998 0 C-N-CA 123.593 0.757 . . . . 0.0 110.698 176.66 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . 0.41 ' HB2' ' CE2' ' A' ' 88' ' ' PHE . 42.5 Cg_exo -53.98 157.12 11.22 Favored 'Trans proline' 0 C--N 1.375 1.944 0 C-N-CA 123.809 3.006 . . . . 0.0 113.587 -179.008 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -68.78 152.37 45.41 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 123.983 0.913 . . . . 0.0 111.412 -177.603 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 12.8 tt -75.11 -21.61 16.63 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.17 0 CA-C-O 120.744 0.307 . . . . 0.0 110.288 175.08 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -58.85 -40.07 83.2 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 124.246 1.018 . . . . 0.0 112.078 178.011 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -84.48 -8.89 58.79 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 123.474 0.71 . . . . 0.0 111.587 179.583 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . 0.41 ' CE2' ' HB2' ' A' ' 83' ' ' PRO . 4.4 m-30 -84.45 112.93 20.81 Favored 'General case' 0 N--CA 1.476 0.835 0 CA-C-O 121.652 0.739 . . . . 0.0 109.778 177.483 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 19.4 p-10 -93.12 88.52 6.11 Favored 'General case' 0 CA--C 1.543 0.703 0 CA-C-N 114.451 -1.25 . . . . 0.0 111.191 -171.166 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 76.0 m95 -76.23 -21.89 55.84 Favored 'General case' 0 N--CA 1.485 1.309 0 CA-C-N 115.441 -0.799 . . . . 0.0 110.51 173.406 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 10.7 t . . . . . 0 CA--C 1.556 1.209 0 C-N-CA 125.652 1.581 . . . . 0.0 111.775 -178.761 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 14.9 m . . . . . 0 N--CA 1.475 0.821 0 CA-C-O 121.703 0.763 . . . . 0.0 111.347 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 3.8 p -144.44 118.12 9.22 Favored 'General case' 0 C--O 1.239 0.515 0 C-N-CA 124.305 1.042 . . . . 0.0 109.304 -179.507 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 90.4 t -101.65 130.98 50.43 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.483 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 179.268 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . 0.405 ' HA ' ' HA ' ' A' ' 42' ' ' LEU . 42.9 mt-10 -81.89 107.17 14.39 Favored 'General case' 0 C--O 1.238 0.474 0 C-N-CA 123.09 0.556 . . . . 0.0 109.873 175.084 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.497 HD23 ' HB3' ' A' ' 43' ' ' PHE . 4.3 mm? -83.31 161.06 58.27 Favored Pre-proline 0 CA--C 1.553 1.064 0 C-N-CA 124.324 1.049 . . . . 0.0 109.742 -179.836 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -53.37 136.46 63.15 Favored 'Trans proline' 0 C--N 1.388 2.645 0 C-N-CA 122.988 2.459 . . . . 0.0 113.178 -179.149 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -121.18 163.39 30.31 Favored Pre-proline 0 N--CA 1.481 1.086 0 C-N-CA 124.361 1.065 . . . . 0.0 112.961 -164.142 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.59 ' HG2' ' HB2' ' A' ' 39' ' ' TRP . 40.9 Cg_endo -67.72 156.96 63.94 Favored 'Trans proline' 0 C--N 1.381 2.27 0 C-N-CA 122.52 2.147 . . . . 0.0 110.587 161.324 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 55.2 p -62.36 -39.04 91.85 Favored 'General case' 0 N--CA 1.486 1.354 0 N-CA-C 113.874 1.064 . . . . 0.0 113.874 -166.725 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 15.0 p -89.21 -21.6 23.18 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 112.375 0.509 . . . . 0.0 112.375 -174.952 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' TRP . . . . . 0.59 ' HB2' ' HG2' ' A' ' 36' ' ' PRO . 16.3 m95 -109.97 174.37 5.89 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-O 121.758 0.79 . . . . 0.0 110.469 179.463 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.419 ' HB2' ' HB ' ' A' ' 59' ' ' VAL . 0.0 OUTLIER -117.54 158.14 25.09 Favored 'General case' 0 C--O 1.24 0.559 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 170.371 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.406 ' HD3' ' CZ ' ' A' ' 58' ' ' PHE . 16.8 tptm -130.33 122.14 27.34 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 124.445 1.098 . . . . 0.0 108.133 -176.862 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.48 HD22 ' HB ' ' A' ' 57' ' ' VAL . 4.7 tt -125.19 150.31 47.1 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 124.743 1.217 . . . . 0.0 108.668 177.443 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . 0.497 ' HB3' HD23 ' A' ' 33' ' ' LEU . 36.2 t80 -136.78 145.33 44.42 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 125.053 1.341 . . . . 0.0 108.347 174.064 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 16.4 m-85 -102.14 96.75 7.35 Favored Pre-proline 0 CA--C 1.555 1.17 0 C-N-CA 123.113 0.565 . . . . 0.0 110.114 174.33 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo . . . . . 0 C--N 1.374 1.906 0 C-N-CA 122.734 2.289 . . . . 0.0 111.806 175.437 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 . . . . . 0 CA--C 1.552 1.049 0 CA-C-O 121.419 0.628 . . . . 0.0 111.168 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 48.9 t -81.33 138.67 19.21 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.661 0 C-N-CA 124.145 0.978 . . . . 0.0 110.435 -176.723 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.48 ' HB ' HD22 ' A' ' 42' ' ' LEU . 87.2 t -123.5 115.82 46.5 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.952 0 C-N-CA 124.738 1.215 . . . . 0.0 108.512 176.213 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.406 ' CZ ' ' HD3' ' A' ' 41' ' ' LYS . 15.9 m-85 -91.99 118.39 30.73 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 123.465 0.706 . . . . 0.0 109.873 177.227 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.419 ' HB ' ' HB2' ' A' ' 40' ' ' LYS . 3.3 t -80.2 131.17 34.71 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 C-N-CA 123.439 0.696 . . . . 0.0 110.712 179.914 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -88.35 158.95 48.36 Favored Pre-proline 0 N--CA 1.476 0.834 0 C-N-CA 124.276 1.031 . . . . 0.0 111.677 -173.905 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -68.29 -19.18 44.33 Favored 'Trans proline' 0 C--N 1.38 2.223 0 C-N-CA 122.878 2.386 . . . . 0.0 113.191 178.305 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.481 HG22 ' H ' ' A' ' 64' ' ' GLU . 14.8 t -88.09 -11.31 47.47 Favored 'General case' 0 CA--C 1.55 0.957 0 C-N-CA 123.327 0.651 . . . . 0.0 111.198 175.934 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 96.36 -25.64 25.03 Favored Glycine 0 C--N 1.355 1.605 0 C-N-CA 122.601 0.143 . . . . 0.0 113.206 -177.609 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.481 ' H ' HG22 ' A' ' 62' ' ' THR . 37.7 tt0 -72.74 83.94 1.18 Allowed 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 124.08 0.952 . . . . 0.0 109.717 174.326 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.43 159.14 24.92 Favored 'General case' 0 N--CA 1.473 0.707 0 CA-C-N 114.878 -1.055 . . . . 0.0 112.072 -177.027 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . 0.445 HG21 ' HB2' ' A' ' 71' ' ' GLN . 35.1 mm -102.44 127.53 55.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 C-N-CA 125.33 1.452 . . . . 0.0 109.08 177.522 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 29.9 m -97.59 -30.03 13.09 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 122.774 0.43 . . . . 0.0 111.504 -174.5 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 2.8 p-10 -135.08 159.43 41.54 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 123.038 0.535 . . . . 0.0 110.47 -179.068 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 32.3 ttm180 -64.79 -30.43 71.43 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 124.271 1.028 . . . . 0.0 113.155 -168.45 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 6.2 tmtm? -63.73 -47.73 79.89 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 123.384 0.674 . . . . 0.0 109.449 176.341 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.445 ' HB2' HG21 ' A' ' 66' ' ' ILE . 68.0 mt-30 -55.27 -32.76 62.62 Favored 'General case' 0 N--CA 1.49 1.547 0 C-N-CA 123.679 0.792 . . . . 0.0 111.598 179.341 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.466 ' O ' ' HG ' ' A' ' 76' ' ' LEU . 0.4 OUTLIER -61.22 -52.94 62.68 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 123.125 0.57 . . . . 0.0 109.56 -179.276 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -67.85 -42.91 80.64 Favored 'General case' 0 C--O 1.248 0.992 0 C-N-CA 123.781 0.832 . . . . 0.0 111.691 -174.372 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.36 -22.65 61.87 Favored 'General case' 0 N--CA 1.478 0.971 0 CA-C-N 116.779 -0.192 . . . . 0.0 111.094 179.263 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . 0.475 ' HH ' HG23 ' A' ' 62' ' ' THR . 39.7 t80 -70.36 -42.83 71.3 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 122.969 0.508 . . . . 0.0 109.822 172.214 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.466 ' HG ' ' O ' ' A' ' 72' ' ' LEU . 80.1 mt -64.19 -33.83 76.7 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 123.166 0.586 . . . . 0.0 111.739 -175.991 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 14.3 ptpt -79.98 -32.61 39.79 Favored 'General case' 0 N--CA 1.482 1.171 0 N-CA-C 111.607 0.225 . . . . 0.0 111.607 175.06 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 40.9 t -71.28 -29.91 65.64 Favored 'General case' 0 N--CA 1.485 1.302 0 CA-C-O 121.427 0.632 . . . . 0.0 110.955 178.737 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 42.1 m80 -143.01 86.08 9.47 Favored Pre-proline 0 C--O 1.24 0.563 0 C-N-CA 124.677 1.191 . . . . 0.0 108.423 -178.267 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -67.58 163.01 36.66 Favored 'Trans proline' 0 C--N 1.378 2.09 0 C-N-CA 122.652 2.235 . . . . 0.0 111.704 173.516 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 101.82 -31.21 8.95 Favored Glycine 0 C--N 1.342 0.889 0 N-CA-C 111.283 -0.727 . . . . 0.0 111.283 -173.658 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 37.0 m-80 -66.79 144.52 98.62 Favored Pre-proline 0 CA--C 1.553 1.08 0 C-N-CA 123.535 0.734 . . . . 0.0 110.606 174.464 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -63.77 154.25 70.64 Favored 'Trans proline' 0 C--N 1.373 1.862 0 C-N-CA 123.067 2.511 . . . . 0.0 112.984 -176.097 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . 0.464 ' O ' ' HG2' ' A' ' 87' ' ' GLU . . . -71.02 146.41 49.38 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 114.6 -1.182 . . . . 0.0 111.396 -174.745 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 17.1 tt -64.81 -14.41 16.24 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.258 0 C-N-CA 123.637 0.775 . . . . 0.0 111.739 -179.274 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -53.76 -40.26 66.05 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 124.205 1.002 . . . . 0.0 112.576 175.325 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.464 ' HG2' ' O ' ' A' ' 84' ' ' ALA . 10.6 pt-20 -86.32 -17.81 33.59 Favored 'General case' 0 N--CA 1.486 1.35 0 C-N-CA 123.306 0.643 . . . . 0.0 111.429 178.619 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -77.31 109.04 10.88 Favored 'General case' 0 N--CA 1.478 0.959 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 177.92 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -94.83 121.01 35.98 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-O 121.311 0.577 . . . . 0.0 109.725 -177.71 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 49.6 m95 -103.38 -3.7 25.14 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 123.857 0.863 . . . . 0.0 109.446 174.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 14.8 t . . . . . 0 CA--C 1.55 0.976 0 C-N-CA 125.118 1.367 . . . . 0.0 112.14 -176.041 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 27.1 m . . . . . 0 CA--C 1.542 0.642 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 39.2 p -157.33 118.65 3.65 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 123.943 0.897 . . . . 0.0 108.891 -177.929 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 48.1 t -106.06 125.71 61.61 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 C-N-CA 123.879 0.872 . . . . 0.0 109.056 -177.514 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . 0.463 ' HA ' ' HA ' ' A' ' 42' ' ' LEU . 45.6 mt-10 -79.66 101.54 8.43 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 123.068 0.547 . . . . 0.0 110.092 178.942 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -81.21 152.77 71.33 Favored Pre-proline 0 CA--C 1.559 1.298 0 C-N-CA 124.379 1.071 . . . . 0.0 110.773 -176.178 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -62.84 137.74 64.7 Favored 'Trans proline' 0 C--N 1.384 2.401 0 C-N-CA 123.073 2.515 . . . . 0.0 114.085 -177.718 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -146.07 169.98 8.71 Favored Pre-proline 0 CA--C 1.557 1.218 0 C-N-CA 124.276 1.03 . . . . 0.0 108.933 -178.541 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -51.25 145.26 27.45 Favored 'Trans proline' 0 C--N 1.392 2.848 0 C-N-CA 122.691 2.26 . . . . 0.0 112.168 173.894 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 49.2 m -64.01 -20.04 65.62 Favored 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 113.164 0.802 . . . . 0.0 113.164 -171.717 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 33.4 m -72.23 -40.23 67.93 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 123.197 0.599 . . . . 0.0 110.16 174.581 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 25.6 m95 -104.83 -168.3 1.46 Allowed 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 123.958 0.903 . . . . 0.0 110.038 179.449 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.508 ' HB3' ' HB ' ' A' ' 59' ' ' VAL . 40.7 ttmt -156.41 170.78 21.51 Favored 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 106.565 -1.643 . . . . 0.0 106.565 171.584 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.713 ' HD2' HG11 ' A' ' 56' ' ' VAL . 21.3 pttm -151.34 154.06 35.97 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-O 121.845 0.831 . . . . 0.0 110.904 171.434 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.463 ' HA ' ' HA ' ' A' ' 32' ' ' GLU . 0.8 OUTLIER -127.0 130.76 50.66 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 113.348 -1.751 . . . . 0.0 107.726 178.433 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 28.7 t80 -101.39 141.04 34.85 Favored 'General case' 0 CA--C 1.542 0.647 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 170.728 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 11.6 m-85 -99.37 100.14 9.86 Favored Pre-proline 0 N--CA 1.481 1.111 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 171.487 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo . . . . . 0 C--N 1.365 1.413 0 C-N-CA 122.411 2.074 . . . . 0.0 112.43 175.489 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 . . . . . 0 CA--C 1.549 0.905 0 CA-C-O 122.11 0.957 . . . . 0.0 112.133 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.713 HG11 ' HD2' ' A' ' 41' ' ' LYS . 51.0 t -82.35 147.42 6.04 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.771 0 CA-C-N 114.799 -1.091 . . . . 0.0 111.376 -168.896 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 65.8 t -124.52 116.5 47.73 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.693 0 C-N-CA 125.074 1.35 . . . . 0.0 107.681 175.276 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 36.7 m-85 -87.25 123.77 32.61 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 123.486 0.714 . . . . 0.0 110.982 -179.146 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.508 ' HB ' ' HB3' ' A' ' 40' ' ' LYS . 6.8 t -81.16 130.28 36.12 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.411 0 C-N-CA 123.677 0.791 . . . . 0.0 110.141 175.534 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -85.59 157.21 58.5 Favored Pre-proline 0 N--CA 1.475 0.794 0 O-C-N 124.157 0.911 . . . . 0.0 111.211 -178.618 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -63.7 -22.49 69.82 Favored 'Trans proline' 0 C--N 1.382 2.314 0 C-N-CA 122.934 2.423 . . . . 0.0 112.703 176.491 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.551 HG21 ' H ' ' A' ' 64' ' ' GLU . 12.1 t -91.53 -12.17 35.25 Favored 'General case' 0 CA--C 1.549 0.924 0 C-N-CA 123.822 0.849 . . . . 0.0 111.181 178.957 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 95.23 -11.73 68.81 Favored Glycine 0 C--N 1.349 1.283 0 CA-C-O 119.769 -0.462 . . . . 0.0 113.559 -177.591 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.551 ' H ' HG21 ' A' ' 62' ' ' THR . 36.4 tt0 -77.97 78.14 4.47 Favored 'General case' 0 N--CA 1.481 1.121 0 CA-C-N 117.576 0.688 . . . . 0.0 109.341 174.334 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -67.96 139.22 56.38 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-N 115.119 -0.946 . . . . 0.0 111.028 -174.075 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 36.8 mm -94.77 130.92 42.92 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.663 0 C-N-CA 124.484 1.114 . . . . 0.0 109.883 -179.927 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 6.0 p -96.59 -11.65 25.06 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 123.784 0.834 . . . . 0.0 112.414 -175.375 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 11.1 p-10 -153.53 151.32 29.67 Favored 'General case' 0 N--CA 1.48 1.052 0 N-CA-C 111.941 0.349 . . . . 0.0 111.941 -168.044 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 30.1 ttm180 -59.06 -39.55 82.42 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 124.759 1.224 . . . . 0.0 112.817 -168.582 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 4.3 tmtm? -59.71 -54.4 46.79 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 123.419 0.688 . . . . 0.0 109.923 -177.743 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.411 ' HA ' ' HG3' ' A' ' 74' ' ' GLN . 87.4 mm-40 -66.2 -22.32 66.34 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-N 115.032 -0.985 . . . . 0.0 111.309 -175.674 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.489 ' O ' ' HG ' ' A' ' 76' ' ' LEU . 0.8 OUTLIER -66.47 -56.36 11.3 Favored 'General case' 0 CA--C 1.544 0.742 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 174.318 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -57.41 -50.24 73.62 Favored 'General case' 0 N--CA 1.486 1.355 0 C-N-CA 124.404 1.082 . . . . 0.0 111.473 -176.314 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . 0.411 ' HG3' ' HA ' ' A' ' 71' ' ' GLN . 0.0 OUTLIER -70.31 -25.04 63.13 Favored 'General case' 0 CA--C 1.545 0.768 0 CA-C-N 115.4 -0.818 . . . . 0.0 111.608 -177.903 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 45.5 t80 -66.44 -45.99 77.96 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 122.75 0.42 . . . . 0.0 109.907 174.503 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.489 ' HG ' ' O ' ' A' ' 72' ' ' LEU . 52.4 mt -62.58 -45.23 93.86 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 123.033 0.533 . . . . 0.0 110.913 -175.36 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.11 -24.16 59.41 Favored 'General case' 0 CA--C 1.551 0.983 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.589 -179.835 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 46.3 t -78.19 -27.68 47.95 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 122.857 0.463 . . . . 0.0 110.806 174.949 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 59.0 m80 -127.4 84.89 62.22 Favored Pre-proline 0 N--CA 1.472 0.671 0 C-N-CA 123.401 0.681 . . . . 0.0 109.751 -175.435 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -62.8 122.18 10.38 Favored 'Trans proline' 0 C--N 1.372 1.788 0 C-N-CA 122.953 2.435 . . . . 0.0 111.709 177.431 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 133.23 -30.56 3.02 Favored Glycine 0 C--N 1.342 0.888 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.795 -174.042 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 40.2 m-80 -72.5 137.13 80.73 Favored Pre-proline 0 N--CA 1.476 0.864 0 C-N-CA 123.468 0.707 . . . . 0.0 110.456 177.109 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -62.88 154.25 67.67 Favored 'Trans proline' 0 C--N 1.375 1.971 0 C-N-CA 123.111 2.541 . . . . 0.0 112.777 -179.138 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . 0.475 ' O ' ' HG2' ' A' ' 87' ' ' GLU . . . -73.96 148.07 42.46 Favored 'General case' 0 N--CA 1.476 0.842 0 CA-C-N 115.313 -0.858 . . . . 0.0 111.866 -173.674 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 17.3 tt -65.44 -11.72 12.5 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.194 0 C-N-CA 124.087 0.955 . . . . 0.0 112.366 -176.629 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -57.23 -38.66 74.13 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 123.678 0.791 . . . . 0.0 112.08 174.044 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.475 ' HG2' ' O ' ' A' ' 84' ' ' ALA . 12.6 pt-20 -90.81 -3.98 56.98 Favored 'General case' 0 N--CA 1.487 1.414 0 C-N-CA 123.14 0.576 . . . . 0.0 111.769 178.31 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -87.81 107.82 18.85 Favored 'General case' 0 N--CA 1.477 0.911 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 176.709 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 14.5 p-10 -93.48 88.0 5.76 Favored 'General case' 0 CA--C 1.547 0.842 0 CA-C-O 122.21 1.005 . . . . 0.0 111.174 -172.405 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 82.2 m95 -69.25 -26.15 64.63 Favored 'General case' 0 N--CA 1.481 1.111 0 CA-C-N 115.064 -0.971 . . . . 0.0 110.202 170.216 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 12.5 t . . . . . 0 CA--C 1.556 1.184 0 C-N-CA 125.196 1.398 . . . . 0.0 112.64 -175.443 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 13.8 m . . . . . 0 N--CA 1.472 0.656 0 CA-C-O 120.566 0.222 . . . . 0.0 110.686 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 54.7 p -142.82 114.06 7.79 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 123.53 0.732 . . . . 0.0 109.5 178.604 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 62.1 t -101.85 127.81 54.95 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 C-N-CA 124.16 0.984 . . . . 0.0 108.959 179.565 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 53.3 mt-10 -83.02 106.79 15.13 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-O 121.011 0.434 . . . . 0.0 109.987 178.517 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.725 ' HB2' ' HZ2' ' A' ' 41' ' ' LYS . 3.6 mm? -82.7 164.26 47.84 Favored Pre-proline 0 CA--C 1.559 1.325 0 C-N-CA 124.619 1.167 . . . . 0.0 109.877 178.938 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -49.89 143.42 23.75 Favored 'Trans proline' 0 C--N 1.393 2.891 0 C-N-CA 123.334 2.689 . . . . 0.0 114.097 -175.914 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -146.03 155.49 51.24 Favored Pre-proline 0 CA--C 1.542 0.673 0 C-N-CA 123.633 0.773 . . . . 0.0 111.255 -167.396 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_exo -58.51 149.82 72.71 Favored 'Trans proline' 0 C--N 1.381 2.255 0 C-N-CA 123.158 2.572 . . . . 0.0 110.598 163.525 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 20.7 p -58.66 -42.66 88.92 Favored 'General case' 0 CA--C 1.551 1.019 0 C-N-CA 123.72 0.808 . . . . 0.0 111.914 -176.241 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 26.6 t -67.49 -33.65 75.54 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 123.768 0.827 . . . . 0.0 111.452 -179.966 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 21.7 m95 -105.45 -176.12 2.99 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 123.469 0.707 . . . . 0.0 111.211 -177.095 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 45.3 mtmt -137.98 149.16 45.87 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 114.926 -1.034 . . . . 0.0 108.51 162.881 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.725 ' HZ2' ' HB2' ' A' ' 33' ' ' LEU . 19.6 tptp -117.13 121.12 40.37 Favored 'General case' 0 N--CA 1.464 0.265 0 C-N-CA 124.899 1.28 . . . . 0.0 107.552 178.487 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.472 HD22 ' HB ' ' A' ' 57' ' ' VAL . 5.7 tt -119.19 143.92 46.98 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 124.171 0.988 . . . . 0.0 108.968 177.932 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . 0.46 ' HB3' HD22 ' A' ' 33' ' ' LEU . 24.3 t80 -130.63 128.14 40.37 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 125.293 1.437 . . . . 0.0 107.822 174.881 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 24.8 m-85 -86.63 111.55 40.47 Favored Pre-proline 0 CA--C 1.55 0.979 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 169.456 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo . . . . . 0 C--N 1.372 1.769 0 C-N-CA 122.427 2.085 . . . . 0.0 111.034 165.724 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 CA--C 1.557 1.232 0 CA-C-O 121.226 0.536 . . . . 0.0 111.524 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 37.5 t -80.51 130.87 35.25 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.625 0 C-N-CA 123.917 0.887 . . . . 0.0 110.038 -179.581 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.489 ' HA ' ' O ' ' A' ' 66' ' ' ILE . 38.3 t -122.92 120.7 61.34 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.695 0 C-N-CA 123.525 0.73 . . . . 0.0 109.503 179.589 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.47 ' CZ ' ' HD3' ' A' ' 41' ' ' LYS . 27.0 m-85 -92.87 118.38 31.06 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 123.231 0.612 . . . . 0.0 109.947 174.1 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 2.0 t -78.43 123.82 35.87 Favored 'Isoleucine or valine' 0 C--O 1.239 0.509 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 177.049 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . 0.401 ' HB2' ' H ' ' A' ' 64' ' ' GLU . . . -88.72 147.4 39.2 Favored Pre-proline 0 CA--C 1.544 0.734 0 CA-C-N 114.796 -1.093 . . . . 0.0 111.087 -175.478 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_endo -61.9 -30.69 84.19 Favored 'Trans proline' 0 C--N 1.369 1.636 0 C-N-CA 123.871 3.047 . . . . 0.0 114.064 -179.437 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 5.7 t -87.05 -1.46 57.9 Favored 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 122.242 0.217 . . . . 0.0 111.013 179.328 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 77.97 61.72 2.48 Favored Glycine 0 C--N 1.353 1.516 0 N-CA-C 112.011 -0.436 . . . . 0.0 112.011 -177.072 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.401 ' H ' ' HB2' ' A' ' 60' ' ' ALA . 40.8 tt0 -151.02 70.65 0.99 Allowed 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 107.999 -1.112 . . . . 0.0 107.999 179.318 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -65.4 158.15 27.43 Favored 'General case' 0 CA--C 1.544 0.74 0 CA-C-N 115.203 -0.908 . . . . 0.0 112.237 -171.885 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . 0.554 HG22 ' HB2' ' A' ' 71' ' ' GLN . 44.4 mm -121.8 110.12 26.56 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 CA-C-N 115.169 -0.923 . . . . 0.0 110.484 -163.21 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 11.1 p -83.94 -17.08 41.85 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 123.249 0.62 . . . . 0.0 112.265 178.954 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 2.2 p-10 -157.26 152.52 26.19 Favored 'General case' 0 N--CA 1.476 0.854 0 N-CA-C 111.779 0.289 . . . . 0.0 111.779 -174.943 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 85.2 mtt180 -55.43 -31.76 62.15 Favored 'General case' 0 N--CA 1.493 1.686 0 C-N-CA 124.743 1.217 . . . . 0.0 114.215 -169.784 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 1.8 tmtp? -54.88 -53.92 49.18 Favored 'General case' 0 N--CA 1.486 1.371 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 177.861 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.554 ' HB2' HG22 ' A' ' 66' ' ' ILE . 84.3 mt-30 -61.68 -34.27 75.45 Favored 'General case' 0 N--CA 1.475 0.797 0 CA-C-N 114.741 -1.118 . . . . 0.0 111.126 -177.239 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.431 ' HB2' HG21 ' A' ' 66' ' ' ILE . 0.6 OUTLIER -60.74 -53.3 59.02 Favored 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 123.65 0.78 . . . . 0.0 109.755 179.153 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -68.41 -49.52 59.42 Favored 'General case' 0 C--O 1.238 0.491 0 CA-C-N 114.976 -1.011 . . . . 0.0 111.326 -172.782 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -63.5 -24.2 67.72 Favored 'General case' 0 C--N 1.356 0.865 0 O-C-N 123.635 0.584 . . . . 0.0 110.935 178.981 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 36.8 t80 -67.29 -50.62 59.59 Favored 'General case' 0 C--N 1.356 0.849 0 C-N-CA 123.224 0.61 . . . . 0.0 109.488 173.058 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.469 HD12 ' HA ' ' A' ' 84' ' ' ALA . 85.0 mt -61.84 -45.22 94.74 Favored 'General case' 0 N--CA 1.487 1.401 0 C-N-CA 123.337 0.655 . . . . 0.0 111.243 -174.4 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.06 -7.23 56.66 Favored 'General case' 0 CA--C 1.555 1.166 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.972 179.229 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 43.4 t -96.42 -22.99 16.81 Favored 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 123.744 0.818 . . . . 0.0 111.039 168.535 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 74.4 m80 -132.56 95.73 19.87 Favored Pre-proline 0 N--CA 1.476 0.871 0 C-N-CA 124.053 0.941 . . . . 0.0 109.43 -172.387 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -75.18 153.07 40.66 Favored 'Trans proline' 0 C--N 1.37 1.687 0 C-N-CA 122.382 2.055 . . . . 0.0 111.857 177.442 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 87.95 7.32 74.36 Favored Glycine 0 C--N 1.345 1.074 0 CA-C-N 115.975 -0.557 . . . . 0.0 112.686 -174.426 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 25.2 m-80 -103.69 127.33 29.71 Favored Pre-proline 0 N--CA 1.479 0.982 0 C-N-CA 123.801 0.84 . . . . 0.0 110.026 177.447 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -54.45 143.53 66.26 Favored 'Trans proline' 0 C--N 1.38 2.197 0 C-N-CA 123.606 2.871 . . . . 0.0 113.13 -178.058 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . 0.469 ' HA ' HD12 ' A' ' 76' ' ' LEU . . . -71.16 159.1 35.28 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 123.649 0.78 . . . . 0.0 112.206 -172.283 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 15.1 tt -67.64 -16.21 20.76 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.218 0 C-N-CA 123.698 0.799 . . . . 0.0 111.385 -179.536 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -61.02 -29.91 69.99 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 124.351 1.061 . . . . 0.0 112.937 179.229 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.421 ' HG3' ' HD2' ' A' ' 88' ' ' PHE . 10.0 pt-20 -97.57 -8.05 29.9 Favored 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 122.728 0.411 . . . . 0.0 111.327 177.271 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . 0.421 ' HD2' ' HG3' ' A' ' 87' ' ' GLU . 4.3 m-30 -85.23 116.38 23.55 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 123.423 0.689 . . . . 0.0 110.344 -176.471 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -94.37 124.79 38.61 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 123.114 0.566 . . . . 0.0 110.97 -174.721 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 52.3 m95 -110.36 -20.68 12.53 Favored 'General case' 0 CA--C 1.551 0.989 0 C-N-CA 124.451 1.101 . . . . 0.0 109.632 176.889 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 11.3 t . . . . . 0 N--CA 1.489 1.507 0 C-N-CA 123.767 0.827 . . . . 0.0 112.298 -172.501 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 16.7 m . . . . . 0 N--CA 1.478 0.967 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 23.7 p -162.68 118.15 1.84 Allowed 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 122.915 0.486 . . . . 0.0 110.7 -171.685 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 63.1 t -105.77 133.4 50.23 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 C-N-CA 124.372 1.069 . . . . 0.0 108.533 176.835 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -83.37 113.49 20.77 Favored 'General case' 0 CA--C 1.539 0.523 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 176.148 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.51 HD21 ' HB3' ' A' ' 43' ' ' PHE . 3.8 mm? -89.88 165.13 25.9 Favored Pre-proline 0 CA--C 1.556 1.208 0 C-N-CA 124.337 1.055 . . . . 0.0 110.088 -179.797 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -56.72 142.74 91.48 Favored 'Trans proline' 0 C--N 1.394 2.941 0 C-N-CA 122.92 2.414 . . . . 0.0 113.113 179.192 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . 0.478 ' HB1' ' HB3' ' A' ' 41' ' ' LYS . . . -136.24 166.04 31.0 Favored Pre-proline 0 CA--C 1.539 0.537 0 C-N-CA 124.216 1.007 . . . . 0.0 111.098 -169.091 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 81.5 Cg_exo -52.58 164.32 1.48 Allowed 'Trans proline' 0 C--N 1.376 2.011 0 C-N-CA 123.161 2.574 . . . . 0.0 112.538 160.8 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 66.0 p -63.95 -39.92 95.26 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 123.535 0.734 . . . . 0.0 111.748 -176.251 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 22.0 m -82.1 -37.8 25.78 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 123.641 0.776 . . . . 0.0 111.554 -177.612 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 45.0 m95 -97.17 158.12 15.6 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 123.369 0.668 . . . . 0.0 111.059 -173.389 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.523 ' HB2' ' HB ' ' A' ' 59' ' ' VAL . 0.1 OUTLIER -111.86 152.63 27.72 Favored 'General case' 0 C--O 1.236 0.352 0 N-CA-C 107.906 -1.146 . . . . 0.0 107.906 168.632 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.478 ' HB3' ' HB1' ' A' ' 35' ' ' ALA . 17.1 tptm -126.74 119.13 26.17 Favored 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 -175.309 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 4.8 tt -115.1 144.91 42.92 Favored 'General case' 0 C--N 1.322 -0.599 0 C-N-CA 124.726 1.21 . . . . 0.0 108.638 174.322 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . 0.51 ' HB3' HD21 ' A' ' 33' ' ' LEU . 27.6 t80 -131.21 128.75 40.59 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 125.31 1.444 . . . . 0.0 108.436 174.975 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 39.0 m-85 -87.74 105.46 8.95 Favored Pre-proline 0 CA--C 1.554 1.132 0 N-CA-C 108.782 -0.822 . . . . 0.0 108.782 170.649 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo . . . . . 0 C--N 1.37 1.684 0 C-N-CA 122.735 2.29 . . . . 0.0 112.173 173.28 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.482 1.137 0 N-CA-C 112.9 0.704 . . . . 0.0 112.9 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 64.9 t -82.86 140.82 15.78 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.847 0 C-N-CA 124.455 1.102 . . . . 0.0 111.519 -170.648 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 63.2 t -122.23 128.61 75.56 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.9 0 C-N-CA 124.052 0.941 . . . . 0.0 108.97 176.819 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 13.3 m-85 -102.05 123.02 45.22 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 123.282 0.633 . . . . 0.0 109.563 171.583 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.523 ' HB ' ' HB2' ' A' ' 40' ' ' LYS . 2.3 t -79.58 129.47 37.51 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.611 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 174.456 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -83.85 154.61 64.67 Favored Pre-proline 0 CA--C 1.539 0.556 0 CA-C-N 114.901 -1.045 . . . . 0.0 111.446 -176.368 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -62.14 -22.86 74.92 Favored 'Trans proline' 0 C--N 1.379 2.164 0 C-N-CA 123.153 2.568 . . . . 0.0 113.447 177.251 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.408 HG23 ' OH ' ' A' ' 75' ' ' TYR . 12.1 t -99.86 -7.23 25.59 Favored 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 123.027 0.531 . . . . 0.0 111.86 177.798 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 94.16 -4.17 70.54 Favored Glycine 0 CA--C 1.531 1.043 0 CA-C-O 119.849 -0.417 . . . . 0.0 113.859 -179.386 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -78.97 75.76 5.47 Favored 'General case' 0 N--CA 1.482 1.127 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 174.801 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -67.48 157.77 33.47 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-O 121.979 0.895 . . . . 0.0 111.596 -168.833 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . 0.516 HG21 ' HB2' ' A' ' 71' ' ' GLN . 42.7 mm -116.61 120.15 64.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 C-N-CA 125.141 1.376 . . . . 0.0 108.876 -171.016 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 18.5 p -89.19 -19.94 24.82 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 123.315 0.646 . . . . 0.0 112.349 -176.665 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 2.0 p-10 -157.95 165.33 35.42 Favored 'General case' 0 N--CA 1.481 1.109 0 CA-C-O 120.968 0.413 . . . . 0.0 111.651 -174.919 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 20.3 ttm180 -57.51 -42.17 82.25 Favored 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 125.211 1.404 . . . . 0.0 113.101 -167.702 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 8.6 tmtm? -54.27 -49.92 68.45 Favored 'General case' 0 N--CA 1.487 1.378 0 C-N-CA 123.953 0.901 . . . . 0.0 110.527 -179.702 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.516 ' HB2' HG21 ' A' ' 66' ' ' ILE . 80.5 mt-30 -61.96 -32.74 73.2 Favored 'General case' 0 N--CA 1.475 0.802 0 CA-C-N 114.765 -1.107 . . . . 0.0 111.254 -179.136 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.414 ' O ' ' HG ' ' A' ' 76' ' ' LEU . 0.5 OUTLIER -65.82 -50.88 63.05 Favored 'General case' 0 CA--C 1.551 1.004 0 C-N-CA 123.466 0.707 . . . . 0.0 109.283 179.043 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -66.29 -43.98 84.81 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 124.155 0.982 . . . . 0.0 111.81 -174.705 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -68.24 -26.69 65.81 Favored 'General case' 0 N--CA 1.482 1.144 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.799 177.872 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . 0.408 ' OH ' HG23 ' A' ' 62' ' ' THR . 19.7 t80 -69.55 -47.09 64.83 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 123.374 0.67 . . . . 0.0 109.914 176.106 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.414 ' HG ' ' O ' ' A' ' 72' ' ' LEU . 74.8 mt -69.89 -28.43 65.62 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 113.03 0.752 . . . . 0.0 113.03 -172.631 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 66.0 pttt -75.51 -36.2 60.61 Favored 'General case' 0 N--CA 1.476 0.846 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 173.485 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 34.2 t -73.97 -20.36 60.37 Favored 'General case' 0 N--CA 1.485 1.292 0 C-N-CA 123.593 0.757 . . . . 0.0 111.125 176.206 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 58.3 m80 -137.25 76.14 44.83 Favored Pre-proline 0 CA--C 1.548 0.867 0 C-N-CA 124.394 1.077 . . . . 0.0 108.354 -177.29 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -67.64 -16.75 47.35 Favored 'Trans proline' 0 C--N 1.381 2.253 0 C-N-CA 123.032 2.488 . . . . 0.0 113.155 -178.269 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -70.84 -14.75 73.28 Favored Glycine 0 C--N 1.347 1.161 0 CA-C-N 116.046 -0.525 . . . . 0.0 112.928 175.108 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 16.1 m120 -94.29 146.08 30.9 Favored Pre-proline 0 CA--C 1.547 0.845 0 C-N-CA 123.959 0.904 . . . . 0.0 110.214 176.108 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -68.97 159.94 51.89 Favored 'Trans proline' 0 C--N 1.378 2.104 0 C-N-CA 123.05 2.5 . . . . 0.0 113.752 -170.808 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -71.5 148.93 46.28 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 124.295 1.038 . . . . 0.0 112.166 -174.474 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 17.8 tt -68.08 -11.62 14.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 C-N-CA 123.778 0.831 . . . . 0.0 111.457 -179.068 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -58.7 -28.96 66.28 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 124.458 1.103 . . . . 0.0 112.797 174.263 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -100.69 -8.26 23.01 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 122.947 0.499 . . . . 0.0 111.515 176.666 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -80.42 110.02 15.48 Favored 'General case' 0 N--CA 1.48 1.03 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 177.768 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -78.43 119.81 22.27 Favored 'General case' 0 CA--C 1.537 0.45 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 175.509 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 76.2 m95 -109.13 -7.79 15.26 Favored 'General case' 0 CA--C 1.55 0.972 0 C-N-CA 124.215 1.006 . . . . 0.0 109.451 168.081 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 15.0 t . . . . . 0 CA--C 1.558 1.267 0 C-N-CA 124.28 1.032 . . . . 0.0 112.598 -164.286 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 30.9 m . . . . . 0 N--CA 1.481 1.109 0 N-CA-C 109.918 -0.401 . . . . 0.0 109.918 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.448 ' HA ' ' HD2' ' A' ' 45' ' ' PRO . 76.2 p -148.1 145.85 28.57 Favored 'General case' 0 C--O 1.241 0.635 0 C-N-CA 123.274 0.63 . . . . 0.0 110.336 -178.495 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 43.9 t -114.6 131.22 67.35 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.405 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 172.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -81.55 109.88 16.41 Favored 'General case' 0 CA--C 1.54 0.586 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 173.803 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.483 HD22 ' HB3' ' A' ' 43' ' ' PHE . 4.2 mm? -87.76 168.98 15.2 Favored Pre-proline 0 CA--C 1.557 1.222 0 C-N-CA 123.849 0.86 . . . . 0.0 109.885 -177.065 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -53.68 129.03 31.95 Favored 'Trans proline' 0 C--N 1.397 3.101 0 C-N-CA 122.949 2.433 . . . . 0.0 113.118 -177.173 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -114.98 154.0 47.08 Favored Pre-proline 0 N--CA 1.48 1.031 0 C-N-CA 123.998 0.919 . . . . 0.0 112.466 -167.815 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.782 ' HG2' ' HB2' ' A' ' 39' ' ' TRP . 38.4 Cg_endo -70.96 148.01 56.35 Favored 'Trans proline' 0 C--N 1.377 2.054 0 C-N-CA 122.388 2.059 . . . . 0.0 110.233 166.091 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 33.2 t -64.43 -25.39 67.99 Favored 'General case' 0 N--CA 1.485 1.287 0 C-N-CA 123.595 0.758 . . . . 0.0 112.983 -169.967 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 40.7 t -81.46 -37.24 28.3 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 123.122 0.569 . . . . 0.0 110.766 177.823 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' TRP . . . . . 0.782 ' HB2' ' HG2' ' A' ' 36' ' ' PRO . 20.7 m95 -107.09 -164.99 1.03 Allowed 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 123.603 0.761 . . . . 0.0 110.639 -173.746 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.639 ' HB3' ' HB ' ' A' ' 59' ' ' VAL . 34.1 ttmt -142.7 152.64 42.58 Favored 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 171.248 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.436 ' HD3' ' CZ ' ' A' ' 58' ' ' PHE . 16.0 tptm -130.25 127.8 40.32 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 123.66 0.784 . . . . 0.0 109.983 -170.367 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.409 HD23 ' CE1' ' A' ' 44' ' ' TYR . 3.2 tt -134.48 149.72 50.74 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 114.784 -1.098 . . . . 0.0 109.302 179.254 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . 0.483 ' HB3' HD22 ' A' ' 33' ' ' LEU . 32.6 t80 -135.34 136.97 41.95 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 125.317 1.447 . . . . 0.0 108.484 175.653 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . 0.409 ' CE1' HD23 ' A' ' 42' ' ' LEU . 40.5 m-85 -96.32 106.17 27.29 Favored Pre-proline 0 CA--C 1.55 0.958 0 C-N-CA 122.975 0.51 . . . . 0.0 109.661 172.025 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . 0.448 ' HD2' ' HA ' ' A' ' 30' ' ' SER . 94.8 Cg_endo . . . . . 0 C--N 1.374 1.883 0 C-N-CA 122.961 2.441 . . . . 0.0 112.383 172.797 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.499 ' HG3' ' O ' ' A' ' 67' ' ' SER . 1.1 pm0 . . . . . 0 CA--C 1.551 0.996 0 CA-C-O 121.491 0.662 . . . . 0.0 112.586 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 77.6 t -80.62 121.07 33.43 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 CA-C-N 115.151 -0.931 . . . . 0.0 108.54 175.18 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 40.4 t -111.64 118.97 58.84 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.572 0 C-N-CA 123.099 0.56 . . . . 0.0 109.569 -178.465 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.436 ' CZ ' ' HD3' ' A' ' 41' ' ' LYS . 36.1 m-85 -93.15 120.31 33.3 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 123.458 0.703 . . . . 0.0 109.507 171.541 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.639 ' HB ' ' HB3' ' A' ' 40' ' ' LYS . 3.3 t -79.71 126.61 39.3 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.449 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 174.027 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . 0.482 ' HB2' ' H ' ' A' ' 64' ' ' GLU . . . -84.61 148.57 52.21 Favored Pre-proline 0 CA--C 1.541 0.616 0 CA-C-N 114.97 -1.014 . . . . 0.0 110.781 -177.488 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -63.04 -17.36 59.78 Favored 'Trans proline' 0 N--CA 1.494 1.557 0 C-N-CA 123.394 2.729 . . . . 0.0 114.143 -176.705 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 14.1 t -110.83 0.36 17.21 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 123.365 0.666 . . . . 0.0 111.738 -178.878 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 76.35 65.32 2.03 Favored Glycine 0 CA--C 1.533 1.182 0 CA-C-O 121.385 0.436 . . . . 0.0 112.064 -175.976 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.482 ' H ' ' HB2' ' A' ' 60' ' ' ALA . 39.0 tt0 -150.6 72.54 1.09 Allowed 'General case' 0 N--CA 1.474 0.746 0 N-CA-C 106.622 -1.621 . . . . 0.0 106.622 175.244 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 4.6 mp0 -66.99 155.47 38.51 Favored 'General case' 0 N--CA 1.475 0.812 0 CA-C-N 114.756 -1.111 . . . . 0.0 112.094 -165.418 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . 0.438 HG22 ' HB2' ' A' ' 71' ' ' GLN . 48.5 mm -116.87 143.86 26.05 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.508 0 C-N-CA 124.941 1.297 . . . . 0.0 108.965 -176.741 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.499 ' O ' ' HG3' ' A' ' 55' ' ' GLU . 35.9 p -129.37 -2.8 4.95 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 122.93 0.492 . . . . 0.0 112.038 178.533 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 9.6 p30 -151.67 158.81 43.92 Favored 'General case' 0 N--CA 1.486 1.352 0 O-C-N 121.842 -0.536 . . . . 0.0 111.123 176.442 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 55.3 mtp180 -60.61 -31.84 70.99 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 123.89 0.876 . . . . 0.0 112.78 -176.64 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 2.7 tmtp? -60.69 -54.16 48.6 Favored 'General case' 0 N--CA 1.478 0.934 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 178.4 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.438 ' HB2' HG22 ' A' ' 66' ' ' ILE . 45.8 mt-30 -54.86 -40.53 69.77 Favored 'General case' 0 N--CA 1.48 1.045 0 O-C-N 124.12 0.887 . . . . 0.0 111.849 177.867 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.47 ' O ' ' HG ' ' A' ' 76' ' ' LEU . 0.7 OUTLIER -64.74 -53.04 53.41 Favored 'General case' 0 N--CA 1.478 0.949 0 O-C-N 123.699 0.624 . . . . 0.0 110.074 -175.912 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -71.08 -37.23 72.45 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 123.184 0.593 . . . . 0.0 111.692 -172.374 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.98 -26.46 63.16 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 122.245 0.218 . . . . 0.0 111.049 174.653 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 20.0 t80 -65.08 -49.93 68.11 Favored 'General case' 0 N--CA 1.479 0.99 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 175.147 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.47 ' HG ' ' O ' ' A' ' 72' ' ' LEU . 68.3 mt -60.91 -47.29 87.09 Favored 'General case' 0 N--CA 1.479 0.995 0 O-C-N 123.983 0.802 . . . . 0.0 111.936 -173.91 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -69.53 -26.93 64.75 Favored 'General case' 0 CA--C 1.551 1.009 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.873 -177.846 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 59.2 m -89.0 -23.68 22.56 Favored 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 123.024 0.53 . . . . 0.0 111.792 178.177 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 92.8 m-70 -124.72 94.29 44.64 Favored Pre-proline 0 N--CA 1.474 0.731 0 C-N-CA 123.483 0.713 . . . . 0.0 109.959 -173.759 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -68.54 149.66 74.47 Favored 'Trans proline' 0 C--N 1.376 1.992 0 C-N-CA 122.707 2.272 . . . . 0.0 112.448 178.501 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 100.99 -20.08 49.28 Favored Glycine 0 C--N 1.345 1.051 0 CA-C-N 116.167 -0.47 . . . . 0.0 112.723 -178.821 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 40.6 m-80 -77.42 144.42 70.3 Favored Pre-proline 0 CA--C 1.549 0.939 0 C-N-CA 123.132 0.573 . . . . 0.0 110.4 176.527 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -74.8 158.9 42.64 Favored 'Trans proline' 0 C--N 1.374 1.913 0 C-N-CA 122.6 2.2 . . . . 0.0 112.625 177.462 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . 0.413 ' HA ' HD13 ' A' ' 76' ' ' LEU . . . -75.03 153.69 38.33 Favored 'General case' 0 N--CA 1.477 0.89 0 CA-C-N 115.389 -0.823 . . . . 0.0 112.561 -173.045 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.45 ' HB ' HD12 ' A' ' 72' ' ' LEU . 15.9 tt -68.08 -11.64 14.55 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.335 0 C-N-CA 123.899 0.88 . . . . 0.0 111.436 179.954 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -55.68 -31.87 62.78 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 124.226 1.01 . . . . 0.0 112.262 174.138 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -98.08 -15.74 19.86 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 122.988 0.515 . . . . 0.0 111.908 176.477 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -81.27 108.86 15.26 Favored 'General case' 0 N--CA 1.484 1.241 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 177.016 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 10.3 p-10 -97.11 120.62 37.81 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-O 121.395 0.617 . . . . 0.0 110.196 -177.558 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 65.4 m95 -96.72 -9.01 29.92 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 124.053 0.941 . . . . 0.0 109.791 173.762 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 11.0 t . . . . . 0 CA--C 1.557 1.225 0 C-N-CA 125.581 1.552 . . . . 0.0 111.294 179.665 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 17.7 m . . . . . 0 CA--C 1.551 0.993 0 CA-C-O 121.464 0.65 . . . . 0.0 110.078 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 11.0 p -159.87 127.05 4.56 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 124.167 0.987 . . . . 0.0 109.425 -176.083 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 96.7 t -117.92 127.53 75.17 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 C-N-CA 123.885 0.874 . . . . 0.0 108.839 179.406 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . 0.471 ' HA ' ' HA ' ' A' ' 42' ' ' LEU . 2.6 mp0 -87.48 117.0 25.98 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-O 121.206 0.527 . . . . 0.0 110.172 179.609 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.693 ' HB2' ' HZ2' ' A' ' 41' ' ' LYS . 3.3 mm? -94.89 169.57 9.29 Favored Pre-proline 0 N--CA 1.491 1.583 0 C-N-CA 124.635 1.174 . . . . 0.0 110.354 -171.788 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -51.03 137.14 44.86 Favored 'Trans proline' 0 C--N 1.397 3.091 0 C-N-CA 123.195 2.597 . . . . 0.0 113.044 176.241 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -130.56 156.98 78.9 Favored Pre-proline 0 CA--C 1.544 0.725 0 C-N-CA 123.661 0.784 . . . . 0.0 112.417 -164.474 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_exo -54.62 138.07 74.67 Favored 'Trans proline' 0 C--N 1.375 1.947 0 C-N-CA 123.38 2.72 . . . . 0.0 110.786 157.354 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 57.1 p -63.15 -28.84 70.33 Favored 'General case' 0 CA--C 1.55 0.961 0 C-N-CA 123.719 0.808 . . . . 0.0 112.641 -175.146 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 35.3 t -85.16 -14.19 47.74 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 123.362 0.665 . . . . 0.0 111.765 179.356 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 16.3 m95 -122.74 -169.16 1.87 Allowed 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 124.034 0.934 . . . . 0.0 110.186 -178.815 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 28.7 mtmt -140.13 145.67 37.86 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 124.491 1.116 . . . . 0.0 108.462 169.184 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.693 ' HZ2' ' HB2' ' A' ' 33' ' ' LEU . 23.4 tptp -114.66 130.97 56.87 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 124.642 1.177 . . . . 0.0 109.349 -175.961 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.471 ' HA ' ' HA ' ' A' ' 32' ' ' GLU . 6.5 tt -128.36 149.16 50.64 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 124.478 1.111 . . . . 0.0 108.936 175.629 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . 0.503 ' HB2' ' NZ ' ' A' ' 41' ' ' LYS . 25.9 t80 -131.32 139.71 49.61 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 125.06 1.344 . . . . 0.0 108.349 174.917 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 10.2 m-85 -103.4 98.52 12.56 Favored Pre-proline 0 CA--C 1.552 1.02 0 C-N-CA 122.944 0.498 . . . . 0.0 109.861 173.391 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo . . . . . 0 C--N 1.37 1.669 0 C-N-CA 121.963 1.775 . . . . 0.0 110.231 168.231 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 CA--C 1.551 1.018 0 CA-C-O 121.903 0.858 . . . . 0.0 112.246 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 15.3 t -82.4 138.77 18.87 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 C-N-CA 124.72 1.208 . . . . 0.0 110.417 -178.865 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.421 ' HB ' HD22 ' A' ' 42' ' ' LEU . 68.7 t -121.21 124.62 72.45 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.772 0 C-N-CA 124.173 0.989 . . . . 0.0 109.531 175.81 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.455 ' CZ ' ' HD3' ' A' ' 41' ' ' LYS . 16.0 m-85 -98.24 123.79 42.5 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 123.356 0.662 . . . . 0.0 109.904 173.179 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 3.4 t -79.17 122.73 34.99 Favored 'Isoleucine or valine' 0 C--O 1.241 0.606 0 C-N-CA 123.47 0.708 . . . . 0.0 109.359 175.936 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -81.45 154.53 71.56 Favored Pre-proline 0 CA--C 1.542 0.651 0 CA-C-N 114.238 -1.346 . . . . 0.0 110.956 -176.266 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_endo -62.17 -27.52 78.72 Favored 'Trans proline' 0 C--N 1.375 1.955 0 C-N-CA 122.759 2.306 . . . . 0.0 112.947 178.939 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 12.4 t -96.89 -7.71 32.69 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 122.72 0.408 . . . . 0.0 111.085 177.309 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 93.99 -1.04 67.42 Favored Glycine 0 C--N 1.353 1.483 0 CA-C-O 119.866 -0.408 . . . . 0.0 113.957 178.816 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -78.79 73.27 5.34 Favored 'General case' 0 N--CA 1.479 0.982 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 174.477 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -67.76 158.43 32.42 Favored 'General case' 0 C--N 1.35 0.594 0 CA-C-N 114.98 -1.009 . . . . 0.0 112.01 -168.777 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 47.3 mm -116.04 125.44 73.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 C-N-CA 124.707 1.203 . . . . 0.0 109.354 -166.879 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 12.3 p -110.93 5.36 20.38 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 123.645 0.778 . . . . 0.0 112.797 -175.184 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 11.2 p30 -163.31 164.56 24.82 Favored 'General case' 0 N--CA 1.486 1.335 0 C-N-CA 122.988 0.515 . . . . 0.0 110.393 172.085 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 19.7 ttp180 -63.67 -34.42 77.82 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 123.683 0.793 . . . . 0.0 112.218 -171.856 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 8.2 tmtm? -60.86 -50.41 73.54 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 123.434 0.694 . . . . 0.0 109.828 179.015 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 75.5 mt-30 -55.84 -34.89 65.82 Favored 'General case' 0 N--CA 1.477 0.917 0 O-C-N 124.288 0.993 . . . . 0.0 111.406 179.123 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.416 ' O ' ' HG ' ' A' ' 76' ' ' LEU . 0.5 OUTLIER -65.33 -54.95 21.44 Favored 'General case' 0 CA--C 1.547 0.858 0 N-CA-C 109.489 -0.559 . . . . 0.0 109.489 179.559 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -59.86 -47.16 86.86 Favored 'General case' 0 N--CA 1.486 1.364 0 C-N-CA 124.19 0.996 . . . . 0.0 111.633 -175.117 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 5.3 pp0? -68.15 -30.77 69.98 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.374 -179.308 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 32.9 t80 -65.83 -45.17 83.22 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 123.248 0.619 . . . . 0.0 109.523 176.732 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.416 ' HG ' ' O ' ' A' ' 72' ' ' LEU . 69.9 mt -63.14 -44.09 96.54 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 123.108 0.563 . . . . 0.0 111.655 -176.115 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.92 -19.39 58.84 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 122.806 0.442 . . . . 0.0 111.414 -179.842 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 46.1 t -91.62 -12.31 34.61 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 123.236 0.615 . . . . 0.0 111.382 174.006 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 57.7 m-70 -133.55 83.51 48.47 Favored Pre-proline 0 CA--C 1.551 1.007 0 C-N-CA 123.462 0.705 . . . . 0.0 109.631 -179.402 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -65.73 128.62 20.35 Favored 'Trans proline' 0 C--N 1.379 2.143 0 C-N-CA 122.802 2.334 . . . . 0.0 112.065 176.691 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 124.01 -22.53 6.75 Favored Glycine 0 C--N 1.342 0.91 0 CA-C-N 115.76 -0.655 . . . . 0.0 111.837 -177.96 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 12.3 m120 -74.25 151.85 87.99 Favored Pre-proline 0 CA--C 1.553 1.072 0 C-N-CA 123.064 0.546 . . . . 0.0 110.785 177.379 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -69.61 160.45 49.7 Favored 'Trans proline' 0 C--N 1.375 1.927 0 C-N-CA 122.73 2.287 . . . . 0.0 112.853 178.887 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -75.82 148.71 38.19 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 123.565 0.746 . . . . 0.0 111.167 -176.299 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 16.1 tt -65.63 -12.53 14.01 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.383 0 C-N-CA 123.729 0.811 . . . . 0.0 112.371 -177.59 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -57.97 -35.46 71.21 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 124.49 1.116 . . . . 0.0 112.215 176.156 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -91.03 -11.88 37.47 Favored 'General case' 0 N--CA 1.485 1.282 0 N-CA-C 112.38 0.511 . . . . 0.0 112.38 177.883 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 4.9 m-85 -76.16 108.55 9.16 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 177.259 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 4.5 t0 -86.97 102.24 14.19 Favored 'General case' 0 CA--C 1.541 0.635 0 CA-C-N 115.995 -0.548 . . . . 0.0 109.964 -173.0 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 82.1 m95 -89.6 -31.94 17.34 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 123.746 0.819 . . . . 0.0 109.99 174.251 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 8.9 t . . . . . 0 CA--C 1.557 1.215 0 C-N-CA 124.059 0.944 . . . . 0.0 112.532 -172.373 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 21.0 m . . . . . 0 N--CA 1.476 0.836 0 CA-C-O 121.222 0.534 . . . . 0.0 110.325 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 58.5 p -140.46 123.74 16.79 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 123.826 0.85 . . . . 0.0 109.49 177.569 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 48.5 t -110.83 124.45 67.64 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 C-N-CA 124.184 0.994 . . . . 0.0 109.464 178.559 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 53.4 mt-10 -80.9 104.08 11.16 Favored 'General case' 0 CA--C 1.545 0.76 0 CA-C-O 121.235 0.54 . . . . 0.0 110.188 176.758 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.431 HD21 ' HB3' ' A' ' 43' ' ' PHE . 3.9 mm? -79.32 163.3 60.16 Favored Pre-proline 0 CA--C 1.564 1.519 0 C-N-CA 124.881 1.272 . . . . 0.0 110.409 177.573 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo -60.04 145.51 98.23 Favored 'Trans proline' 0 C--N 1.391 2.769 0 C-N-CA 122.741 2.294 . . . . 0.0 114.157 -174.467 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . 0.526 ' HB3' ' HB3' ' A' ' 41' ' ' LYS . . . -157.29 163.06 26.19 Favored Pre-proline 0 CA--C 1.542 0.671 0 C-N-CA 124.18 0.992 . . . . 0.0 110.839 -172.2 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_exo -52.73 147.66 30.76 Favored 'Trans proline' 0 C--N 1.379 2.139 0 C-N-CA 123.004 2.469 . . . . 0.0 112.122 164.319 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 37.4 p -71.42 -15.22 62.34 Favored 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 123.519 0.728 . . . . 0.0 111.929 -176.818 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 42.7 t -75.93 -34.85 59.9 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 123.585 0.754 . . . . 0.0 110.19 172.007 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 28.2 m95 -109.83 -169.93 1.56 Allowed 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 123.883 0.873 . . . . 0.0 110.86 -175.515 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.714 ' HB3' ' HB ' ' A' ' 59' ' ' VAL . 1.7 tpmt? -148.35 144.64 27.67 Favored 'General case' 0 CA--C 1.533 0.327 0 CA-C-N 114.939 -1.028 . . . . 0.0 108.266 166.821 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.526 ' HB3' ' HB3' ' A' ' 35' ' ' ALA . 19.6 tptp -112.74 115.48 28.59 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 177.183 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.412 HD22 ' HB ' ' A' ' 57' ' ' VAL . 7.3 tt -111.43 139.78 46.56 Favored 'General case' 0 C--N 1.319 -0.748 0 C-N-CA 124.518 1.127 . . . . 0.0 108.262 174.635 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . 0.431 ' HB3' HD21 ' A' ' 33' ' ' LEU . 38.1 t80 -125.74 135.57 52.21 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 124.619 1.168 . . . . 0.0 107.9 173.286 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 8.6 m-85 -94.24 103.02 9.56 Favored Pre-proline 0 CA--C 1.55 0.969 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 172.812 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo . . . . . 0 C--N 1.374 1.905 0 C-N-CA 122.951 2.434 . . . . 0.0 111.792 172.752 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 CA--C 1.554 1.13 0 CA-C-O 121.657 0.741 . . . . 0.0 112.085 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 48.1 t -82.58 140.09 16.88 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.594 0 C-N-CA 124.909 1.284 . . . . 0.0 110.578 -179.157 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.412 ' HB ' HD22 ' A' ' 42' ' ' LEU . 81.6 t -123.97 130.69 73.76 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.682 0 C-N-CA 124.079 0.951 . . . . 0.0 109.062 173.022 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 16.2 m-85 -102.03 122.22 43.68 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 123.198 0.599 . . . . 0.0 109.504 171.228 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.714 ' HB ' ' HB3' ' A' ' 40' ' ' LYS . 4.3 t -81.15 130.52 35.72 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 173.122 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -95.06 155.65 38.76 Favored Pre-proline 0 CA--C 1.548 0.87 0 C-N-CA 124.167 0.987 . . . . 0.0 110.754 -176.175 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -66.01 -8.19 19.24 Favored 'Trans proline' 0 C--N 1.38 2.236 0 C-N-CA 123.067 2.511 . . . . 0.0 114.202 -177.259 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 9.6 t -120.98 12.66 11.23 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 123.602 0.761 . . . . 0.0 111.412 -175.174 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 81.03 -22.83 4.79 Favored Glycine 0 C--N 1.353 1.494 0 N-CA-C 114.531 0.572 . . . . 0.0 114.531 179.336 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 49.7 tt0 -72.84 75.0 1.15 Allowed 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 124.551 1.14 . . . . 0.0 109.487 177.626 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -80.97 157.98 25.34 Favored 'General case' 0 N--CA 1.476 0.839 0 CA-C-N 115.287 -0.87 . . . . 0.0 111.707 -168.785 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 42.5 mm -107.9 139.84 28.49 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.755 0 C-N-CA 124.905 1.282 . . . . 0.0 110.379 -173.35 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 16.3 p -108.33 -9.84 15.42 Favored 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 123.584 0.754 . . . . 0.0 112.66 -179.885 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 13.1 p-10 -160.74 162.64 32.53 Favored 'General case' 0 N--CA 1.486 1.337 0 N-CA-C 112.348 0.499 . . . . 0.0 112.348 -168.378 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 3.8 ttm180 -59.92 -41.33 91.49 Favored 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 124.613 1.165 . . . . 0.0 112.17 -170.789 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 7.4 tmtm? -60.91 -54.43 45.12 Favored 'General case' 0 N--CA 1.478 0.929 0 CA-C-N 115.145 -0.934 . . . . 0.0 109.507 -176.622 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.405 ' HA ' ' HG3' ' A' ' 74' ' ' GLN . 87.3 mm-40 -64.2 -25.17 67.95 Favored 'General case' 0 N--CA 1.475 0.797 0 O-C-N 124.03 0.831 . . . . 0.0 111.45 -176.676 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.413 ' O ' ' HG ' ' A' ' 76' ' ' LEU . 0.6 OUTLIER -66.52 -52.67 43.32 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 123.375 0.67 . . . . 0.0 109.224 175.88 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -64.08 -50.54 67.92 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 123.634 0.774 . . . . 0.0 111.363 -175.602 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . 0.405 ' HG3' ' HA ' ' A' ' 71' ' ' GLN . 0.0 OUTLIER -66.16 -23.92 66.55 Favored 'General case' 0 CA--C 1.547 0.861 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.365 179.582 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 38.5 t80 -66.88 -51.79 51.2 Favored 'General case' 0 C--O 1.212 -0.873 0 C-N-CA 122.92 0.488 . . . . 0.0 109.736 171.703 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.413 ' HG ' ' O ' ' A' ' 72' ' ' LEU . 83.1 mt -62.51 -37.78 87.35 Favored 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 123.225 0.61 . . . . 0.0 112.495 -172.105 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.77 -26.57 57.49 Favored 'General case' 0 CA--C 1.553 1.072 0 CA-C-O 120.83 0.347 . . . . 0.0 110.95 178.033 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 41.6 t -83.19 -26.68 30.62 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 123.203 0.601 . . . . 0.0 111.044 175.834 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 53.6 m80 -125.7 89.54 52.24 Favored Pre-proline 0 C--O 1.241 0.613 0 C-N-CA 124.395 1.078 . . . . 0.0 108.594 -173.447 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -68.67 164.85 31.53 Favored 'Trans proline' 0 C--N 1.369 1.62 0 C-N-CA 122.311 2.007 . . . . 0.0 111.666 176.076 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 89.81 -29.46 6.34 Favored Glycine 0 CA--C 1.532 1.123 0 CA-C-N 116.468 -0.333 . . . . 0.0 112.678 -176.049 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 36.1 m-80 -71.73 141.05 84.39 Favored Pre-proline 0 CA--C 1.549 0.932 0 C-N-CA 123.871 0.868 . . . . 0.0 110.778 178.828 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -67.02 163.03 35.51 Favored 'Trans proline' 0 C--N 1.374 1.895 0 C-N-CA 123.114 2.543 . . . . 0.0 112.863 179.959 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -74.7 161.03 30.03 Favored 'General case' 0 N--CA 1.488 1.442 0 C-N-CA 124.017 0.927 . . . . 0.0 112.266 -170.317 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 16.3 tt -78.71 -19.93 13.1 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.253 0 CA-C-O 120.808 0.337 . . . . 0.0 111.158 179.283 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -61.89 -38.17 87.32 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 123.344 0.658 . . . . 0.0 111.777 177.991 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -83.89 -9.75 58.5 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 123.282 0.633 . . . . 0.0 111.51 179.322 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 5.5 m-30 -82.62 129.69 34.99 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 123.397 0.679 . . . . 0.0 110.17 177.769 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -84.57 125.79 32.75 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 123.893 0.877 . . . . 0.0 110.32 177.568 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 86.2 m95 -118.43 -11.56 9.97 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 123.969 0.908 . . . . 0.0 109.439 168.203 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 13.7 t . . . . . 0 CA--C 1.555 1.15 0 C-N-CA 124.371 1.069 . . . . 0.0 112.571 -163.728 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.444 ' SD ' ' N ' ' A' ' 1' ' ' MET . 1.2 mpt? . . . . . 0 N--CA 1.478 0.938 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 35.2 m170 -129.6 -55.91 1.15 Allowed 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 123.802 0.841 . . . . 0.0 109.704 178.094 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 20.3 m-70 61.31 84.44 0.13 Allowed 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 124.453 1.101 . . . . 0.0 111.251 -176.221 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 9.9 t-160 -106.1 119.28 38.8 Favored 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 179.122 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 51.3 t-80 -109.39 143.3 39.14 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 123.95 0.9 . . . . 0.0 110.149 -174.839 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 37.1 m170 -130.1 174.0 10.21 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 124.436 1.094 . . . . 0.0 110.204 175.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 56.3 p-80 -158.54 125.94 5.0 Favored 'General case' 0 CA--C 1.545 0.767 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 169.78 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 38.8 p -157.12 118.47 3.7 Favored 'General case' 0 C--O 1.238 0.467 0 C-N-CA 124.058 0.943 . . . . 0.0 109.096 179.077 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 26.0 m -87.95 -0.94 57.64 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 123.071 0.549 . . . . 0.0 111.036 178.757 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 106.63 -89.37 0.59 Allowed Glycine 0 C--N 1.348 1.203 0 CA-C-N 115.869 -0.605 . . . . 0.0 112.499 178.011 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 14.8 mmt85 -87.86 158.27 18.76 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 123.54 0.736 . . . . 0.0 110.972 -175.07 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.403 ' HG2' HD11 ' A' ' 14' ' ' LEU . 31.2 tt0 -130.99 77.04 1.76 Allowed 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 124.14 0.976 . . . . 0.0 108.421 176.279 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 28.0 t-20 -95.1 107.23 19.29 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-N 115.603 -0.726 . . . . 0.0 109.895 -179.685 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.403 HD11 ' HG2' ' A' ' 12' ' ' GLU . 0.0 OUTLIER -157.09 151.02 24.66 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 124.352 1.061 . . . . 0.0 108.802 -179.477 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 70.2 m-85 -132.13 109.48 10.0 Favored 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 123.239 0.615 . . . . 0.0 110.562 -172.793 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 59.7 t80 -96.85 38.05 1.25 Allowed 'General case' 0 CA--C 1.555 1.145 0 CA-C-O 122.598 1.189 . . . . 0.0 108.44 170.614 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 64.8 mm-40 -98.14 21.22 11.14 Favored 'General case' 0 N--CA 1.477 0.876 0 CA-C-N 115.347 -0.842 . . . . 0.0 111.341 -169.907 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -80.19 19.22 6.93 Favored Glycine 0 C--N 1.348 1.219 0 CA-C-N 116.302 -0.408 . . . . 0.0 114.068 -179.453 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 48.6 m-70 -109.49 119.79 40.53 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 123.838 0.855 . . . . 0.0 108.79 175.777 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 27.1 ptt? -75.83 -16.68 60.04 Favored 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 123.358 0.663 . . . . 0.0 111.075 175.374 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . 65.81 179.59 0.2 Allowed 'General case' 0 C--N 1.362 1.11 0 C-N-CA 125.315 1.446 . . . . 0.0 111.786 -177.367 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 16.9 t 61.01 -152.3 0.39 Allowed 'General case' 0 CA--C 1.56 1.336 0 C-N-CA 124.309 1.044 . . . . 0.0 111.057 178.219 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 99.55 8.06 52.89 Favored Glycine 0 C--N 1.35 1.317 0 N-CA-C 112.436 -0.266 . . . . 0.0 112.436 -179.107 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 13.8 m -93.26 166.12 12.47 Favored 'General case' 0 C--O 1.245 0.86 0 C-N-CA 123.755 0.822 . . . . 0.0 109.661 174.641 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -69.9 109.44 4.47 Favored 'General case' 0 N--CA 1.473 0.694 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 175.491 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -81.29 162.16 23.6 Favored 'General case' 0 CA--C 1.55 0.957 0 C-N-CA 123.349 0.66 . . . . 0.0 109.464 178.368 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 67.78 42.46 1.96 Allowed 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 124.63 1.172 . . . . 0.0 109.992 -179.607 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 5.7 m -98.97 126.18 52.25 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.08 0 CA-C-N 114.616 -1.174 . . . . 0.0 109.019 172.534 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 30.4 m -71.68 135.11 28.63 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.98 0 C-N-CA 123.722 0.809 . . . . 0.0 111.907 -172.376 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 60.9 p -143.69 129.35 19.21 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 123.526 0.731 . . . . 0.0 109.709 179.021 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 99.4 t -108.32 125.44 65.06 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 C-N-CA 124.337 1.055 . . . . 0.0 108.565 175.651 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -79.87 110.38 15.18 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 176.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.572 ' HB2' ' HZ2' ' A' ' 41' ' ' LYS . 3.9 mm? -85.8 162.06 48.47 Favored Pre-proline 0 N--CA 1.485 1.29 0 C-N-CA 124.145 0.978 . . . . 0.0 109.399 178.959 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_endo -62.08 155.93 52.98 Favored 'Trans proline' 0 C--N 1.388 2.651 0 C-N-CA 122.628 2.219 . . . . 0.0 113.407 -179.667 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . 0.444 ' HB1' ' CB ' ' A' ' 41' ' ' LYS . . . -161.65 171.2 7.08 Favored Pre-proline 0 N--CA 1.48 1.064 0 C-N-CA 123.741 0.816 . . . . 0.0 111.307 -171.11 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 13.7 Cg_endo -57.02 137.82 83.63 Favored 'Trans proline' 0 C--N 1.384 2.422 0 C-N-CA 122.053 1.835 . . . . 0.0 110.053 158.456 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 24.8 m -67.87 -15.9 63.84 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 123.601 0.76 . . . . 0.0 112.042 -176.383 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 17.8 p -69.15 -39.57 78.74 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 123.956 0.902 . . . . 0.0 110.455 172.646 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 25.5 m95 -105.03 -168.38 1.46 Allowed 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 123.92 0.888 . . . . 0.0 110.179 177.24 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.646 ' HB3' ' HB ' ' A' ' 59' ' ' VAL . 14.2 tppt? -143.77 144.2 31.7 Favored 'General case' 0 C--O 1.234 0.246 0 N-CA-C 107.581 -1.266 . . . . 0.0 107.581 167.93 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.572 ' HZ2' ' HB2' ' A' ' 33' ' ' LEU . 24.6 tptp -108.85 125.4 51.94 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 177.818 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 6.6 tt -122.41 141.76 51.25 Favored 'General case' 0 C--N 1.322 -0.622 0 C-N-CA 124.31 1.044 . . . . 0.0 108.259 174.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.505 ' HB2' ' NZ ' ' A' ' 41' ' ' LYS . 29.1 t80 -123.84 136.18 54.22 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 171.184 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . 0.525 ' HB3' ' HB ' ' A' ' 54' ' ' THR . 10.5 m-85 -96.03 100.84 7.17 Favored Pre-proline 0 CA--C 1.546 0.811 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 169.363 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 65.8 Cg_endo -80.65 -178.71 4.62 Favored 'Trans proline' 0 C--N 1.371 1.761 0 C-N-CA 122.329 2.019 . . . . 0.0 111.646 173.485 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 12.0 t-20 -153.35 -84.39 0.07 Allowed 'General case' 0 CA--C 1.538 0.494 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 172.536 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 67.0 mttm -135.65 -79.08 0.43 Allowed 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 123.255 0.622 . . . . 0.0 109.609 179.802 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 59.5 t -128.38 -72.34 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.055 0 N-CA-C 109.287 -0.634 . . . . 0.0 109.287 -178.329 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -171.97 -39.45 0.03 OUTLIER Glycine 0 C--N 1.354 1.568 0 C-N-CA 121.702 -0.285 . . . . 0.0 112.724 -176.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 50.0 m -80.83 60.04 3.94 Favored 'General case' 0 N--CA 1.486 1.325 0 C-N-CA 123.769 0.827 . . . . 0.0 110.381 176.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 9.5 m -143.53 -173.09 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.934 0 C-N-CA 125.384 1.474 . . . . 0.0 108.835 -176.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -59.34 -60.84 3.21 Favored 'General case' 0 N--CA 1.478 0.954 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 173.266 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 77.1 tttt 64.04 151.0 0.04 OUTLIER 'General case' 0 CA--C 1.558 1.285 0 C-N-CA 124.448 1.099 . . . . 0.0 112.906 173.096 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.525 ' HB ' ' HB3' ' A' ' 44' ' ' TYR . 8.3 m -132.31 158.71 41.18 Favored 'General case' 0 CA--C 1.554 1.125 0 N-CA-C 107.66 -1.237 . . . . 0.0 107.66 169.635 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -92.56 -168.19 1.91 Allowed 'General case' 0 N--CA 1.481 1.078 0 CA-C-O 121.409 0.623 . . . . 0.0 111.496 -174.86 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 42.9 t -82.66 137.36 21.17 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.723 0 C-N-CA 124.841 1.257 . . . . 0.0 110.661 -179.578 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 86.2 t -126.67 125.34 66.85 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.883 0 C-N-CA 124.224 1.01 . . . . 0.0 108.751 173.138 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.471 ' CZ ' ' HD3' ' A' ' 41' ' ' LYS . 14.0 m-85 -94.67 124.0 38.44 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 123.185 0.594 . . . . 0.0 109.65 172.254 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.646 ' HB ' ' HB3' ' A' ' 40' ' ' LYS . 6.0 t -80.88 128.82 38.4 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.522 0 C-N-CA 123.493 0.717 . . . . 0.0 109.681 174.648 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -87.27 153.16 53.61 Favored Pre-proline 0 CA--C 1.543 0.674 0 CA-C-N 115.079 -0.964 . . . . 0.0 110.429 -178.372 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_endo -63.03 -20.84 72.45 Favored 'Trans proline' 0 C--N 1.375 1.958 0 C-N-CA 123.213 2.609 . . . . 0.0 113.514 178.68 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 10.5 t -101.83 -4.22 26.67 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 123.837 0.855 . . . . 0.0 111.834 178.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 91.31 -9.62 76.97 Favored Glycine 0 C--N 1.352 1.439 0 CA-C-O 119.895 -0.392 . . . . 0.0 113.728 -178.79 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -76.98 73.42 3.57 Favored 'General case' 0 N--CA 1.486 1.35 0 CA-C-O 122.03 0.919 . . . . 0.0 109.248 178.207 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -72.65 159.82 33.25 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 114.384 -1.28 . . . . 0.0 112.239 -166.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.466 HG22 ' HB2' ' A' ' 71' ' ' GLN . 45.8 mm -115.24 123.32 70.71 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.676 0 C-N-CA 125.041 1.337 . . . . 0.0 109.588 -173.412 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 17.4 m -94.18 -22.22 18.57 Favored 'General case' 0 N--CA 1.486 1.331 0 C-N-CA 122.957 0.503 . . . . 0.0 112.096 -176.718 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 3.2 p-10 -148.59 155.08 40.63 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 123.032 0.533 . . . . 0.0 110.373 -172.799 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 74.0 ttt-85 -62.4 -31.35 72.02 Favored 'General case' 0 CA--C 1.554 1.117 0 C-N-CA 124.67 1.188 . . . . 0.0 113.682 -166.221 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 1.6 tmtp? -61.85 -46.89 87.48 Favored 'General case' 0 N--CA 1.486 1.355 0 C-N-CA 123.243 0.617 . . . . 0.0 109.627 177.519 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.466 ' HB2' HG22 ' A' ' 66' ' ' ILE . 96.7 mt-30 -61.0 -27.53 68.38 Favored 'General case' 0 N--CA 1.484 1.234 0 CA-C-N 115.646 -0.707 . . . . 0.0 111.599 -178.835 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.421 ' O ' ' HG ' ' A' ' 76' ' ' LEU . 0.6 OUTLIER -67.47 -53.83 25.44 Favored 'General case' 0 N--CA 1.477 0.893 0 O-C-N 123.883 0.739 . . . . 0.0 109.248 179.44 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -60.75 -47.28 87.01 Favored 'General case' 0 N--CA 1.485 1.31 0 C-N-CA 123.621 0.768 . . . . 0.0 111.669 -176.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 5.2 pp0? -68.99 -25.33 64.47 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.199 179.516 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 42.2 t80 -67.13 -50.97 59.54 Favored 'General case' 0 N--CA 1.475 0.813 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 174.858 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.421 ' HG ' ' O ' ' A' ' 72' ' ' LEU . 69.7 mt -62.29 -42.13 99.09 Favored 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 123.371 0.669 . . . . 0.0 111.935 -173.267 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -70.18 -26.64 64.0 Favored 'General case' 0 N--CA 1.478 0.965 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.973 178.987 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 48.6 m -92.99 -12.27 31.11 Favored 'General case' 0 N--CA 1.493 1.701 0 C-N-CA 123.34 0.656 . . . . 0.0 111.739 177.463 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 64.8 m80 -135.47 84.19 35.1 Favored Pre-proline 0 N--CA 1.484 1.227 0 C-N-CA 123.965 0.906 . . . . 0.0 109.409 -176.268 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -68.45 147.93 72.2 Favored 'Trans proline' 0 C--N 1.377 2.06 0 C-N-CA 122.608 2.206 . . . . 0.0 111.498 175.818 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 107.12 -31.51 8.08 Favored Glycine 0 C--N 1.341 0.861 0 N-CA-C 111.198 -0.761 . . . . 0.0 111.198 -172.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 40.4 m-80 -76.55 136.45 67.82 Favored Pre-proline 0 N--CA 1.48 1.025 0 C-N-CA 123.324 0.65 . . . . 0.0 110.085 177.364 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -66.91 162.38 38.1 Favored 'Trans proline' 0 C--N 1.38 2.195 0 C-N-CA 123.108 2.539 . . . . 0.0 113.141 -176.38 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -75.28 149.65 38.74 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-N 115.021 -0.99 . . . . 0.0 111.895 -172.878 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 15.8 tt -66.29 -11.81 13.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 C-N-CA 124.155 0.982 . . . . 0.0 111.814 -176.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -54.26 -41.93 69.36 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 123.95 0.9 . . . . 0.0 111.848 172.685 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -92.79 4.76 53.21 Favored 'General case' 0 N--CA 1.481 1.115 0 N-CA-C 112.089 0.403 . . . . 0.0 112.089 179.783 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -94.76 109.97 21.88 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 123.346 0.658 . . . . 0.0 109.545 176.85 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -84.43 85.96 7.33 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 123.981 0.912 . . . . 0.0 111.292 -176.155 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 93.5 m95 -77.85 -27.07 49.73 Favored 'General case' 0 CA--C 1.547 0.841 0 CA-C-N 115.341 -0.845 . . . . 0.0 109.909 169.179 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 14.7 t -86.58 11.52 12.57 Favored 'General case' 0 CA--C 1.557 1.224 0 C-N-CA 124.529 1.132 . . . . 0.0 112.252 -175.582 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 12.8 t -63.18 -24.97 68.13 Favored 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 123.346 0.658 . . . . 0.0 111.68 176.477 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 12.9 p -83.75 -30.58 26.55 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 124.453 1.101 . . . . 0.0 111.354 -179.521 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -106.28 -126.69 5.7 Favored Glycine 0 C--N 1.35 1.361 0 N-CA-C 111.773 -0.531 . . . . 0.0 111.773 -178.511 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 30.4 p . . . . . 0 C--O 1.25 1.092 0 C-N-CA 124.044 0.938 . . . . 0.0 109.611 -179.079 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 48.5 ttm . . . . . 0 N--CA 1.477 0.913 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 8.1 p80 -147.09 145.8 29.74 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 123.141 0.577 . . . . 0.0 109.985 -178.792 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 53.9 t-80 -153.9 -50.44 0.09 Allowed 'General case' 0 N--CA 1.47 0.529 0 N-CA-C 107.75 -1.204 . . . . 0.0 107.75 172.035 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 74.2 m-70 69.73 153.68 0.11 Allowed 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 124.775 1.23 . . . . 0.0 112.361 174.137 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 21.5 m80 -152.09 140.62 20.68 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 124.805 1.242 . . . . 0.0 109.382 177.01 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 17.3 m-70 -83.35 90.09 7.11 Favored 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 171.053 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 25.9 t-80 -80.28 113.22 18.29 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 115.303 -0.862 . . . . 0.0 109.876 179.551 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 33.4 t -85.31 179.67 7.14 Favored 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 123.729 0.811 . . . . 0.0 109.753 172.629 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 49.1 m -130.58 132.65 45.65 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 123.357 0.663 . . . . 0.0 110.035 -179.629 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -72.72 143.25 33.47 Favored Glycine 0 C--N 1.348 1.236 0 O-C-N 123.549 0.531 . . . . 0.0 112.805 -179.259 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 24.4 mmt85 -92.0 112.24 24.1 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 123.721 0.808 . . . . 0.0 109.444 -177.078 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -78.0 83.82 4.29 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 123.262 0.625 . . . . 0.0 109.832 179.873 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 6.7 t30 -86.81 78.55 9.05 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.644 -172.794 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -171.14 154.67 4.12 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 124.537 1.135 . . . . 0.0 109.484 171.538 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 6.3 p90 -75.93 94.89 3.44 Favored 'General case' 0 CA--C 1.546 0.811 0 CA-C-O 121.696 0.76 . . . . 0.0 109.404 175.067 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 16.2 t80 -89.47 23.05 2.71 Favored 'General case' 0 N--CA 1.484 1.267 0 CA-C-O 121.216 0.532 . . . . 0.0 110.738 -177.661 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 19.3 pt20 -66.81 -36.21 81.84 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 123.652 0.781 . . . . 0.0 111.221 174.636 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 75.89 153.45 4.42 Favored Glycine 0 C--N 1.352 1.445 0 CA-C-N 116.081 -0.509 . . . . 0.0 113.084 -175.063 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 14.6 t60 -104.94 128.94 53.41 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 175.445 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 26.6 ttt -146.29 119.32 8.79 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 123.397 0.679 . . . . 0.0 109.866 177.809 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -77.26 127.27 32.32 Favored 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 171.381 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 22.7 t -152.31 170.87 19.0 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 122.906 0.482 . . . . 0.0 110.851 -177.094 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 85.8 -79.35 1.88 Allowed Glycine 0 C--N 1.349 1.284 0 CA-C-N 116.046 -0.524 . . . . 0.0 111.935 -178.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 27.1 m -71.5 -28.56 64.0 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 123.49 0.716 . . . . 0.0 111.743 -178.267 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -78.47 86.43 4.5 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 123.008 0.523 . . . . 0.0 110.42 -178.439 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 59.58 -87.49 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 124.759 1.224 . . . . 0.0 111.895 175.628 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER 55.03 69.98 0.67 Allowed 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 125.081 1.352 . . . . 0.0 109.989 -178.74 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 22.0 m -107.68 160.48 6.82 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.052 0 C-N-CA 124.188 0.995 . . . . 0.0 110.993 -173.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 28.1 m -83.91 147.9 5.4 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.047 0 C-N-CA 122.959 0.503 . . . . 0.0 111.313 -179.458 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.4 ' HA ' ' HD2' ' A' ' 45' ' ' PRO . 36.6 p -157.64 122.37 4.37 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 124.317 1.047 . . . . 0.0 108.694 177.359 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 65.5 t -103.34 123.97 57.21 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 C-N-CA 123.885 0.874 . . . . 0.0 109.075 -177.121 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -83.38 114.63 21.57 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 123.08 0.552 . . . . 0.0 110.396 177.476 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.439 HD23 ' HB3' ' A' ' 43' ' ' PHE . 4.5 mm? -92.19 168.88 11.92 Favored Pre-proline 0 CA--C 1.562 1.438 0 C-N-CA 124.44 1.096 . . . . 0.0 109.766 -179.712 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -57.37 143.12 94.8 Favored 'Trans proline' 0 C--N 1.39 2.755 0 C-N-CA 122.739 2.293 . . . . 0.0 115.13 -177.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . 0.716 ' HB1' ' HB3' ' A' ' 41' ' ' LYS . . . -144.97 167.07 15.57 Favored Pre-proline 0 N--CA 1.484 1.272 0 C-N-CA 124.648 1.179 . . . . 0.0 111.349 -177.501 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.594 ' HG2' ' HB2' ' A' ' 39' ' ' TRP . 31.3 Cg_endo -63.95 162.79 27.69 Favored 'Trans proline' 0 C--N 1.382 2.314 0 C-N-CA 122.645 2.23 . . . . 0.0 111.522 161.22 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 25.2 p -71.93 -24.77 61.68 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 123.52 0.728 . . . . 0.0 112.28 -176.756 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 45.7 m -75.38 -28.64 59.57 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 122.871 0.468 . . . . 0.0 111.319 176.107 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' TRP . . . . . 0.594 ' HB2' ' HG2' ' A' ' 36' ' ' PRO . 36.0 m95 -111.76 175.83 5.27 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 123.692 0.797 . . . . 0.0 110.563 -176.134 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 19.9 mtmt -140.92 128.34 21.2 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 165.5 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.716 ' HB3' ' HB1' ' A' ' 35' ' ' ALA . 13.6 tptm -99.95 126.49 46.12 Favored 'General case' 0 C--N 1.32 -0.679 0 C-N-CA 125.527 1.531 . . . . 0.0 108.502 -174.934 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 6.9 tt -129.07 132.52 47.45 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 114.495 -1.23 . . . . 0.0 107.84 178.867 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.439 ' HB3' HD23 ' A' ' 33' ' ' LEU . 28.9 t80 -110.84 141.93 43.55 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 124.148 0.979 . . . . 0.0 108.785 170.833 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -102.18 99.19 11.9 Favored Pre-proline 0 CA--C 1.55 0.945 0 C-N-CA 123.344 0.658 . . . . 0.0 110.064 174.038 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.4 ' HD2' ' HA ' ' A' ' 30' ' ' SER . 83.4 Cg_endo -79.83 141.54 15.25 Favored 'Trans proline' 0 C--N 1.377 2.035 0 C-N-CA 122.626 2.217 . . . . 0.0 111.114 171.057 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . 0.485 HD21 ' HB3' ' A' ' 53' ' ' LYS . 9.0 p30 -85.69 162.2 18.87 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 110.077 -0.342 . . . . 0.0 110.077 176.938 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 93.1 mttt -65.01 -40.37 94.81 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 123.679 0.792 . . . . 0.0 112.115 -172.347 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.444 ' HB ' HG23 ' A' ' 51' ' ' VAL . 53.2 t -72.93 -34.42 46.15 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.195 0 C-N-CA 123.589 0.756 . . . . 0.0 110.724 179.421 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 92.6 -50.71 2.63 Favored Glycine 0 CA--C 1.532 1.137 0 CA-C-N 115.392 -0.822 . . . . 0.0 112.47 -172.575 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 38.3 m -79.34 -27.76 42.03 Favored 'General case' 0 N--CA 1.479 0.986 0 N-CA-C 113.395 0.887 . . . . 0.0 113.395 -171.642 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.444 HG23 ' HB ' ' A' ' 48' ' ' VAL . 25.2 m -88.85 -167.26 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 N-CA-C 112.335 0.494 . . . . 0.0 112.335 -170.894 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 94.9 mttt -56.96 138.86 53.56 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 124.172 0.989 . . . . 0.0 111.898 179.176 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.492 ' HE3' ' H ' ' A' ' 53' ' ' LYS . 0.0 OUTLIER -140.17 154.84 47.08 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 124.126 0.97 . . . . 0.0 108.818 179.213 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 50.6 m -71.94 138.97 48.46 Favored 'General case' 0 C--O 1.243 0.752 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 171.901 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -69.07 -172.97 0.45 Allowed 'General case' 0 C--O 1.243 0.731 0 CA-C-O 121.995 0.903 . . . . 0.0 110.911 179.273 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 48.2 t -81.67 138.99 18.62 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.787 0 CA-C-N 114.821 -1.082 . . . . 0.0 111.199 -170.847 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 59.1 t -112.13 115.33 49.53 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.945 0 C-N-CA 124.336 1.055 . . . . 0.0 109.206 174.854 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 45.6 m-85 -100.1 113.41 26.02 Favored 'General case' 0 N--CA 1.481 1.124 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 172.362 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 5.1 p -81.27 131.93 32.74 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 N-CA-C 109.168 -0.679 . . . . 0.0 109.168 179.671 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -92.26 145.62 31.05 Favored Pre-proline 0 CA--C 1.546 0.792 0 C-N-CA 122.814 0.445 . . . . 0.0 112.066 -171.345 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_endo -60.14 -36.42 88.87 Favored 'Trans proline' 0 C--N 1.381 2.285 0 C-N-CA 124.104 3.203 . . . . 0.0 113.724 -177.025 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 6.6 t -77.86 -9.52 59.1 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 122.779 0.432 . . . . 0.0 111.283 -179.368 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 94.57 23.92 19.87 Favored Glycine 0 C--N 1.35 1.342 0 CA-C-N 116.348 -0.387 . . . . 0.0 113.826 179.294 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -112.96 71.31 0.74 Allowed 'General case' 0 N--CA 1.474 0.73 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 178.729 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -58.81 145.78 39.5 Favored 'General case' 0 N--CA 1.48 1.032 0 CA-C-N 115.211 -0.904 . . . . 0.0 112.062 -173.299 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.41 HG13 HD21 ' A' ' 72' ' ' LEU . 44.5 mm -111.24 127.26 68.5 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.589 0 C-N-CA 124.301 1.04 . . . . 0.0 110.062 -172.347 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 42.8 p -101.27 -13.58 18.01 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 123.88 0.872 . . . . 0.0 111.754 -178.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 11.5 p-10 -160.01 152.2 20.64 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 123.228 0.611 . . . . 0.0 111.045 -167.65 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.521 ' HG3' HD13 ' A' ' 85' ' ' ILE . 72.5 ttt-85 -56.17 -36.09 67.95 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 125.194 1.397 . . . . 0.0 113.357 -171.562 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 7.4 tmtm? -57.57 -49.94 74.74 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 123.885 0.874 . . . . 0.0 110.281 178.868 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.467 ' HA ' ' HG3' ' A' ' 74' ' ' GLN . 86.7 mm-40 -68.1 -24.07 64.99 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 115.14 -0.937 . . . . 0.0 111.733 -175.602 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.41 HD21 HG13 ' A' ' 66' ' ' ILE . 0.3 OUTLIER -66.35 -50.46 63.47 Favored 'General case' 0 N--CA 1.477 0.913 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 175.636 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -64.16 -47.99 77.73 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 124.233 1.013 . . . . 0.0 111.211 -176.081 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . 0.467 ' HG3' ' HA ' ' A' ' 71' ' ' GLN . 0.0 OUTLIER -68.29 -26.99 65.92 Favored 'General case' 0 CA--C 1.548 0.903 0 CA-C-N 115.802 -0.636 . . . . 0.0 111.427 179.4 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 59.2 t80 -63.66 -52.36 61.05 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 122.943 0.497 . . . . 0.0 110.202 173.854 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 96.6 mt -64.9 -39.24 93.21 Favored 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 123.487 0.715 . . . . 0.0 112.461 -171.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -73.42 -21.6 60.43 Favored 'General case' 0 N--CA 1.479 0.982 0 CA-C-N 116.667 -0.242 . . . . 0.0 111.133 178.25 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 46.2 m -99.58 -6.37 27.51 Favored 'General case' 0 N--CA 1.487 1.414 0 C-N-CA 123.093 0.557 . . . . 0.0 112.393 175.309 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 73.8 m80 -141.92 80.88 15.1 Favored Pre-proline 0 N--CA 1.479 1.0 0 C-N-CA 124.022 0.929 . . . . 0.0 108.54 179.147 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -68.31 149.86 75.85 Favored 'Trans proline' 0 C--N 1.375 1.922 0 C-N-CA 122.541 2.16 . . . . 0.0 111.996 178.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 103.23 -20.65 42.14 Favored Glycine 0 C--N 1.34 0.795 0 CA-C-N 116.262 -0.426 . . . . 0.0 112.693 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 18.7 m120 -82.42 142.07 46.29 Favored Pre-proline 0 CA--C 1.548 0.893 0 C-N-CA 123.238 0.615 . . . . 0.0 110.555 179.343 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_endo -55.72 145.94 68.67 Favored 'Trans proline' 0 C--N 1.385 2.466 0 C-N-CA 123.428 2.752 . . . . 0.0 113.395 -174.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -68.98 160.01 31.69 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 124.156 0.982 . . . . 0.0 112.332 -170.865 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.521 HD13 ' HG3' ' A' ' 69' ' ' ARG . 14.1 tt -73.19 -22.69 19.55 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.966 0 C-N-CA 123.071 0.548 . . . . 0.0 110.8 177.345 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -63.32 -26.69 68.88 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 123.658 0.783 . . . . 0.0 111.863 -179.83 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 15.0 pt-20 -96.71 -3.17 43.03 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 122.972 0.509 . . . . 0.0 111.567 177.874 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 5.3 m-30 -93.13 120.47 33.46 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 123.524 0.729 . . . . 0.0 109.655 178.188 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 13.8 p-10 -91.59 98.87 11.92 Favored 'General case' 0 N--CA 1.476 0.826 0 CA-C-O 122.042 0.925 . . . . 0.0 111.182 -176.74 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 88.0 m95 -83.19 -25.68 31.56 Favored 'General case' 0 N--CA 1.48 1.063 0 CA-C-N 115.095 -0.957 . . . . 0.0 110.297 171.763 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 14.9 t -82.22 13.35 3.55 Favored 'General case' 0 CA--C 1.554 1.123 0 C-N-CA 124.372 1.069 . . . . 0.0 112.485 -173.863 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 15.0 t -62.73 -24.12 67.52 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 122.726 0.41 . . . . 0.0 111.269 174.807 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 27.1 p -82.4 -41.94 19.26 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 123.871 0.869 . . . . 0.0 110.362 172.782 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -89.45 58.92 3.79 Favored Glycine 0 C--N 1.347 1.189 0 CA-C-N 115.496 -0.774 . . . . 0.0 112.916 -176.508 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 3.7 t . . . . . 0 CA--C 1.56 1.341 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 173.891 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.1 tpt . . . . . 0 N--CA 1.488 1.463 0 N-CA-C 110.31 -0.256 . . . . 0.0 110.31 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 42.5 m80 -86.06 82.98 7.88 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 123.535 0.734 . . . . 0.0 109.724 -179.274 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 22.4 t-160 -136.06 -66.73 0.54 Allowed 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 123.126 0.57 . . . . 0.0 109.657 -179.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 10.0 p-80 -86.7 56.93 4.22 Favored 'General case' 0 N--CA 1.486 1.334 0 CA-C-O 121.808 0.814 . . . . 0.0 110.267 177.384 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 56.1 t-80 -164.27 154.39 14.56 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 108.312 -0.996 . . . . 0.0 108.312 -175.694 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 31.6 t60 -56.4 114.81 2.16 Favored 'General case' 0 N--CA 1.486 1.368 0 C-N-CA 123.219 0.607 . . . . 0.0 110.192 176.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 23.1 m170 -59.79 133.12 55.8 Favored 'General case' 0 CA--C 1.548 0.89 0 O-C-N 124.236 0.96 . . . . 0.0 111.113 -175.676 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 13.9 m -65.87 -26.05 67.46 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 124.463 1.105 . . . . 0.0 112.489 -172.904 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 34.4 t -71.24 -27.38 63.42 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 123.027 0.531 . . . . 0.0 110.824 176.69 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -92.68 26.76 12.76 Favored Glycine 0 C--N 1.346 1.117 0 CA-C-N 116.024 -0.534 . . . . 0.0 112.851 178.423 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 77.9 ttt180 -71.24 -38.0 71.97 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 123.387 0.675 . . . . 0.0 110.603 178.018 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -70.83 92.94 0.93 Allowed 'General case' 0 CA--C 1.545 0.777 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 -178.761 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 12.3 m120 -110.47 89.82 3.14 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 123.795 0.838 . . . . 0.0 108.806 179.277 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 1.1 pp -162.78 -47.89 0.04 OUTLIER 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 124.624 1.17 . . . . 0.0 108.624 -179.052 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 74.6 m-85 -143.92 -71.27 0.29 Allowed 'General case' 0 C--O 1.237 0.415 0 C-N-CA 124.729 1.212 . . . . 0.0 108.083 171.394 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 49.7 t80 57.11 30.18 17.84 Favored 'General case' 0 CA--C 1.556 1.184 0 C-N-CA 124.482 1.113 . . . . 0.0 111.028 -178.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 81.4 mm-40 -86.62 176.18 7.92 Favored 'General case' 0 N--CA 1.476 0.873 0 CA-C-N 114.96 -1.018 . . . . 0.0 110.769 -174.255 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -108.79 160.52 13.6 Favored Glycine 0 C--O 1.24 0.504 0 N-CA-C 111.003 -0.839 . . . . 0.0 111.003 171.367 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 23.2 p80 -69.91 122.04 18.52 Favored 'General case' 0 N--CA 1.484 1.261 0 CA-C-N 117.416 0.608 . . . . 0.0 109.555 178.168 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 46.1 ttm 62.85 95.26 0.04 OUTLIER 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 124.684 1.194 . . . . 0.0 111.174 -179.564 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -63.39 105.84 0.81 Allowed 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 123.796 0.838 . . . . 0.0 111.505 -175.264 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 21.1 t -155.84 143.05 19.22 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 124.189 0.995 . . . . 0.0 108.993 179.082 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 130.76 -5.52 5.8 Favored Glycine 0 N--CA 1.472 1.06 0 CA-C-O 119.358 -0.69 . . . . 0.0 113.159 -179.655 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 22.0 t 68.7 107.75 0.05 Allowed 'General case' 0 CA--C 1.553 1.076 0 C-N-CA 125.387 1.475 . . . . 0.0 110.815 -179.766 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -66.93 118.16 10.01 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 124.183 0.993 . . . . 0.0 111.812 -173.235 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 63.8 mm-40 55.81 34.02 22.64 Favored 'General case' 0 N--CA 1.489 1.5 0 C-N-CA 124.381 1.072 . . . . 0.0 112.507 174.727 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -66.92 99.81 0.67 Allowed 'General case' 0 C--N 1.355 0.815 0 CA-C-O 121.007 0.432 . . . . 0.0 110.328 -177.229 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 35.8 m -108.75 167.72 3.94 Favored 'Isoleucine or valine' 0 C--O 1.241 0.639 0 C-N-CA 124.239 1.016 . . . . 0.0 109.599 176.74 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 17.1 m -98.73 132.79 43.27 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 C-N-CA 123.365 0.666 . . . . 0.0 110.197 177.827 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 60.9 p -146.7 113.48 6.07 Favored 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 174.519 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 61.1 t -101.7 131.33 49.8 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 -178.233 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 -84.11 111.66 19.52 Favored 'General case' 0 CA--C 1.536 0.436 0 N-CA-C 108.971 -0.752 . . . . 0.0 108.971 178.521 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.464 ' HG ' HG21 ' A' ' 92' ' ' THR . 4.1 mm? -91.92 165.13 21.14 Favored Pre-proline 0 CA--C 1.559 1.321 0 C-N-CA 124.704 1.202 . . . . 0.0 109.95 -177.118 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_endo -59.76 143.96 99.53 Favored 'Trans proline' 0 C--N 1.393 2.908 0 C-N-CA 122.927 2.418 . . . . 0.0 113.356 -177.851 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . 0.432 ' HB1' ' HB3' ' A' ' 41' ' ' LYS . . . -138.58 165.22 34.39 Favored Pre-proline 0 N--CA 1.474 0.746 0 C-N-CA 123.972 0.909 . . . . 0.0 111.632 -169.561 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.68 ' HG2' ' HB2' ' A' ' 39' ' ' TRP . 37.4 Cg_endo -65.09 155.61 67.35 Favored 'Trans proline' 0 C--N 1.381 2.253 0 C-N-CA 122.468 2.112 . . . . 0.0 110.8 162.663 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 34.3 t -57.55 -38.49 74.85 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 124.622 1.169 . . . . 0.0 112.895 -171.473 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 11.0 p -77.78 -40.19 41.6 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 123.342 0.657 . . . . 0.0 111.878 -177.582 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' TRP . . . . . 0.68 ' HB2' ' HG2' ' A' ' 36' ' ' PRO . 29.4 m95 -93.26 -174.63 3.59 Favored 'General case' 0 N--CA 1.478 0.944 0 CA-C-O 121.628 0.728 . . . . 0.0 111.336 -178.495 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.693 ' HB3' ' HB ' ' A' ' 59' ' ' VAL . 40.2 ttmt -143.55 144.83 32.12 Favored 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 107.336 -1.357 . . . . 0.0 107.336 173.452 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.432 ' HB3' ' HB1' ' A' ' 35' ' ' ALA . 18.4 tptp -120.23 125.9 49.28 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 124.063 0.945 . . . . 0.0 109.092 -174.511 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.43 HD22 ' HB ' ' A' ' 57' ' ' VAL . 4.3 tt -124.85 149.43 47.49 Favored 'General case' 0 C--O 1.236 0.393 0 C-N-CA 125.127 1.371 . . . . 0.0 108.694 176.648 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 34.3 t80 -135.26 135.58 41.0 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 124.943 1.297 . . . . 0.0 108.27 175.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 36.1 m-85 -95.93 103.96 15.05 Favored Pre-proline 0 N--CA 1.48 1.058 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 170.233 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 63.8 Cg_endo -83.4 -162.06 0.16 Allowed 'Trans proline' 0 C--N 1.37 1.669 0 C-N-CA 122.717 2.278 . . . . 0.0 111.397 170.452 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . 0.554 ' HB3' ' HA ' ' A' ' 51' ' ' VAL . 7.4 p30 -115.47 172.58 7.01 Favored 'General case' 0 N--CA 1.472 0.64 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 169.798 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 38.7 ttpt -111.25 -60.91 1.77 Allowed 'General case' 0 CA--C 1.539 0.543 0 N-CA-C 108.374 -0.973 . . . . 0.0 108.374 175.866 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 60.3 t -131.13 -63.68 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 N-CA-C 107.999 -1.111 . . . . 0.0 107.999 172.251 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -95.91 166.97 25.14 Favored Glycine 0 C--N 1.345 1.076 0 CA-C-N 115.272 -0.876 . . . . 0.0 112.66 179.581 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 25.6 m 58.33 69.82 0.7 Allowed 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 124.917 1.287 . . . . 0.0 111.6 179.05 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.554 ' HA ' ' HB3' ' A' ' 46' ' ' ASN . 33.5 m -72.59 142.88 14.59 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 CA-C-N 115.599 -0.728 . . . . 0.0 109.752 175.628 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.548 ' HZ1' ' HB3' ' A' ' 52' ' ' LYS . 8.4 mtpm? 58.19 54.77 5.56 Favored 'General case' 0 N--CA 1.48 1.025 0 C-N-CA 123.863 0.865 . . . . 0.0 109.291 -169.758 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 7.1 tmtt? -55.9 -59.04 5.45 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 124.479 1.112 . . . . 0.0 109.667 -173.486 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 33.6 m -134.47 157.2 47.09 Favored 'General case' 0 CA--C 1.548 0.904 0 C-N-CA 124.614 1.165 . . . . 0.0 107.911 169.529 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -75.6 -169.52 1.06 Allowed 'General case' 0 CA--C 1.557 1.217 0 C-N-CA 123.478 0.711 . . . . 0.0 111.492 178.844 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 46.7 t -81.72 134.77 26.35 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.668 0 C-N-CA 124.2 1.0 . . . . 0.0 110.416 -176.263 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.43 ' HB ' HD22 ' A' ' 42' ' ' LEU . 96.7 t -120.4 122.65 68.72 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 C-N-CA 124.005 0.922 . . . . 0.0 108.913 177.745 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 24.7 m-85 -97.85 121.15 39.42 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 123.602 0.761 . . . . 0.0 109.864 172.266 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.693 ' HB ' ' HB3' ' A' ' 40' ' ' LYS . 11.0 t -79.43 129.92 36.86 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 172.134 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -84.45 158.42 60.38 Favored Pre-proline 0 CA--C 1.542 0.659 0 CA-C-N 114.904 -1.044 . . . . 0.0 110.912 -175.766 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -63.53 -25.72 69.94 Favored 'Trans proline' 0 C--N 1.374 1.893 0 C-N-CA 123.005 2.47 . . . . 0.0 113.1 176.226 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.416 HG21 ' OH ' ' A' ' 75' ' ' TYR . 14.7 t -97.52 -3.7 39.33 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 123.5 0.72 . . . . 0.0 111.241 177.729 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 93.79 -12.83 68.69 Favored Glycine 0 C--N 1.354 1.577 0 CA-C-O 119.701 -0.5 . . . . 0.0 113.473 179.351 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 44.6 tt0 -73.88 77.63 1.63 Allowed 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 123.903 0.881 . . . . 0.0 109.77 178.862 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -67.41 158.39 31.86 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-N 114.786 -1.097 . . . . 0.0 112.229 -170.006 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 47.7 mm -121.21 131.2 73.6 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.598 0 C-N-CA 125.168 1.387 . . . . 0.0 108.891 -172.201 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 24.3 p -105.86 -17.94 14.21 Favored 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 123.984 0.914 . . . . 0.0 112.141 179.206 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 9.2 p30 -143.64 157.24 44.56 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 122.538 0.335 . . . . 0.0 111.235 -173.284 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 29.7 ttp180 -63.38 -30.62 71.72 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 123.917 0.887 . . . . 0.0 112.342 -171.585 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 5.5 tmtm? -59.89 -54.85 41.39 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 123.793 0.837 . . . . 0.0 109.116 -179.67 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 88.3 mm-40 -64.1 -25.55 68.15 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-N 115.006 -0.997 . . . . 0.0 111.597 -177.791 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -66.47 -56.71 9.66 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 123.477 0.711 . . . . 0.0 109.131 176.672 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -58.74 -48.93 79.47 Favored 'General case' 0 N--CA 1.486 1.334 0 C-N-CA 124.393 1.077 . . . . 0.0 111.71 -176.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.6 -24.24 62.71 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-N 115.472 -0.785 . . . . 0.0 111.538 -177.375 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . 0.416 ' OH ' HG21 ' A' ' 62' ' ' THR . 18.9 t80 -68.18 -49.56 60.07 Favored 'General case' 0 N--CA 1.479 0.985 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 172.561 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 69.0 mt -59.68 -41.36 90.51 Favored 'General case' 0 N--CA 1.485 1.306 0 C-N-CA 123.053 0.541 . . . . 0.0 111.563 -173.17 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 54.9 pttt -73.39 -34.54 65.58 Favored 'General case' 0 N--CA 1.479 1.014 0 O-C-N 123.181 0.301 . . . . 0.0 111.63 -179.729 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 80.9 p -83.02 -17.7 42.4 Favored 'General case' 0 N--CA 1.487 1.423 0 C-N-CA 122.828 0.451 . . . . 0.0 111.582 -178.181 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 75.5 m80 -122.89 102.79 37.59 Favored Pre-proline 0 N--CA 1.48 1.027 0 C-N-CA 123.832 0.853 . . . . 0.0 109.237 -177.465 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -67.68 154.69 72.62 Favored 'Trans proline' 0 C--N 1.378 2.099 0 C-N-CA 122.928 2.418 . . . . 0.0 113.051 -177.785 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 84.04 -9.73 62.58 Favored Glycine 0 C--N 1.349 1.285 0 CA-C-N 115.631 -0.713 . . . . 0.0 114.293 175.243 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 25.0 m-80 -74.65 148.1 85.04 Favored Pre-proline 0 N--CA 1.483 1.211 0 C-N-CA 123.432 0.693 . . . . 0.0 111.178 -178.058 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -68.92 163.99 35.36 Favored 'Trans proline' 0 C--N 1.377 2.068 0 C-N-CA 123.233 2.622 . . . . 0.0 113.176 -177.794 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . 0.466 ' O ' ' HG2' ' A' ' 87' ' ' GLU . . . -71.48 150.74 44.58 Favored 'General case' 0 N--CA 1.476 0.841 0 CA-C-N 115.066 -0.97 . . . . 0.0 111.243 -175.698 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 19.6 tt -72.88 -20.83 19.19 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.111 0 CA-C-O 120.968 0.413 . . . . 0.0 110.877 179.759 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -63.93 -30.13 71.24 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 123.681 0.793 . . . . 0.0 112.377 -179.019 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.466 ' HG2' ' O ' ' A' ' 84' ' ' ALA . 13.4 pt-20 -88.61 -7.49 56.31 Favored 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 123.215 0.606 . . . . 0.0 111.275 178.553 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -83.14 116.48 22.36 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 123.64 0.776 . . . . 0.0 110.365 176.356 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -75.69 128.47 35.27 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 123.86 0.864 . . . . 0.0 110.268 175.662 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 81.1 m95 -119.0 -1.2 11.01 Favored 'General case' 0 CA--C 1.555 1.138 0 C-N-CA 123.28 0.632 . . . . 0.0 110.151 166.325 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 14.2 t -112.39 12.67 20.17 Favored 'General case' 0 CA--C 1.565 1.538 0 N-CA-C 113.569 0.952 . . . . 0.0 113.569 -165.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' THR . . . . . 0.464 HG21 ' HG ' ' A' ' 33' ' ' LEU . 15.1 t -63.28 -14.35 48.55 Favored 'General case' 0 N--CA 1.502 2.171 0 N-CA-C 113.515 0.931 . . . . 0.0 113.515 -174.342 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 32.4 p -61.44 -26.42 67.86 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 123.629 0.772 . . . . 0.0 111.803 178.093 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 110.03 91.53 2.12 Favored Glycine 0 C--N 1.344 1.007 0 N-CA-C 111.487 -0.645 . . . . 0.0 111.487 177.777 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 8.9 t . . . . . 0 CA--C 1.565 1.536 0 C-N-CA 123.688 0.795 . . . . 0.0 111.064 179.325 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.2 mmt . . . . . 0 N--CA 1.472 0.674 0 CA-C-O 120.714 0.293 . . . . 0.0 110.49 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 33.1 p80 -76.48 17.36 0.39 Allowed 'General case' 0 N--CA 1.486 1.35 0 N-CA-C 112.968 0.729 . . . . 0.0 112.968 -177.69 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 39.0 t60 -138.61 147.06 42.51 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 124.573 1.149 . . . . 0.0 108.204 171.747 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 54.9 m80 -130.86 147.9 52.56 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 123.102 0.561 . . . . 0.0 109.748 177.022 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 61.6 t-80 -96.59 153.53 17.8 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 124.03 0.932 . . . . 0.0 110.353 -175.261 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 30.0 m-70 -57.69 146.13 32.0 Favored 'General case' 0 N--CA 1.486 1.356 0 C-N-CA 123.483 0.713 . . . . 0.0 111.179 176.451 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 47.6 p-80 -154.74 143.28 20.62 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 123.88 0.872 . . . . 0.0 109.255 -178.119 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 22.5 p -72.53 -61.24 1.87 Allowed 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 175.808 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 73.8 m -160.41 -45.23 0.05 OUTLIER 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 124.563 1.145 . . . . 0.0 109.661 177.329 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 81.18 -152.29 32.54 Favored Glycine 0 C--N 1.346 1.122 0 CA-C-N 115.016 -0.993 . . . . 0.0 111.891 -175.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 76.1 ttt180 -151.42 110.59 3.92 Favored 'General case' 0 CA--C 1.538 0.481 0 N-CA-C 108.682 -0.858 . . . . 0.0 108.682 -179.882 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 3.3 tm-20 -145.79 97.79 3.02 Favored 'General case' 0 N--CA 1.472 0.672 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 -178.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 23.7 m-80 -149.8 85.18 1.42 Allowed 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 124.342 1.057 . . . . 0.0 108.209 177.583 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -137.9 141.21 40.65 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 123.421 0.688 . . . . 0.0 109.708 173.457 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 9.2 p90 -59.37 -36.56 75.98 Favored 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 123.42 0.688 . . . . 0.0 111.362 179.481 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 54.4 t80 66.62 -1.88 1.2 Allowed 'General case' 0 N--CA 1.489 1.485 0 C-N-CA 125.333 1.453 . . . . 0.0 113.282 173.558 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 15.4 mm100 -76.53 83.44 3.22 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 123.591 0.757 . . . . 0.0 109.377 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -148.96 127.16 2.43 Favored Glycine 0 C--N 1.339 0.747 0 N-CA-C 110.834 -0.906 . . . . 0.0 110.834 -178.443 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 68.5 m80 -84.46 118.84 24.53 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 123.834 0.854 . . . . 0.0 110.133 -177.74 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 21.0 ptt? -139.62 100.9 4.08 Favored 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 124.412 1.085 . . . . 0.0 108.83 -178.752 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -161.93 170.15 19.91 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.861 -174.634 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 38.1 t -150.94 134.07 16.04 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 123.621 0.769 . . . . 0.0 109.12 175.575 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -98.01 -1.94 58.31 Favored Glycine 0 C--N 1.348 1.225 0 O-C-N 123.353 0.408 . . . . 0.0 113.535 -178.851 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 52.8 p -64.72 111.31 2.71 Favored 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 123.136 0.574 . . . . 0.0 110.601 -177.811 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -155.14 121.74 5.35 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 123.056 0.543 . . . . 0.0 109.834 -174.794 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -167.69 114.81 0.74 Allowed 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 123.893 0.877 . . . . 0.0 108.648 176.384 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -78.24 103.69 8.34 Favored 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 177.046 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 24.1 m -71.42 140.51 18.1 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.959 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.82 178.167 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 28.8 m -63.86 122.86 15.55 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.188 0 C-N-CA 123.182 0.593 . . . . 0.0 112.311 -171.468 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.415 ' HB3' ' CE2' ' A' ' 44' ' ' TYR . 45.7 p -135.41 141.66 45.5 Favored 'General case' 0 C--O 1.241 0.646 0 C-N-CA 124.224 1.01 . . . . 0.0 109.376 -178.258 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 95.7 t -123.99 123.78 67.55 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 C-N-CA 124.266 1.026 . . . . 0.0 108.718 174.881 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -82.36 110.38 17.45 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 123.137 0.575 . . . . 0.0 110.201 176.472 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.5 ' HB2' ' HG3' ' A' ' 41' ' ' LYS . 4.1 mm? -85.38 165.19 37.32 Favored Pre-proline 0 CA--C 1.556 1.19 0 C-N-CA 124.584 1.154 . . . . 0.0 110.084 179.92 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 25.1 Cg_endo -59.88 149.46 83.57 Favored 'Trans proline' 0 C--N 1.389 2.674 0 C-N-CA 122.716 2.277 . . . . 0.0 113.834 179.838 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -149.32 170.29 7.88 Favored Pre-proline 0 CA--C 1.551 0.999 0 C-N-CA 124.32 1.048 . . . . 0.0 110.321 -172.264 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_exo -52.54 157.63 6.9 Favored 'Trans proline' 0 C--N 1.385 2.498 0 C-N-CA 122.946 2.43 . . . . 0.0 112.981 165.133 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 44.9 m -60.04 -29.72 68.71 Favored 'General case' 0 CA--C 1.552 1.021 0 C-N-CA 124.07 0.948 . . . . 0.0 112.233 -179.548 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 37.0 t -84.64 -24.57 29.02 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 123.121 0.568 . . . . 0.0 111.713 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 32.1 m95 -114.25 177.15 4.74 Favored 'General case' 0 N--CA 1.483 1.18 0 CA-C-O 121.467 0.651 . . . . 0.0 112.058 -173.331 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 33.5 mtmt -136.45 145.14 44.88 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 124.712 1.205 . . . . 0.0 108.179 170.093 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.519 ' NZ ' ' HB2' ' A' ' 43' ' ' PHE . 22.4 tptp -114.25 135.25 54.26 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 124.523 1.129 . . . . 0.0 108.707 -178.489 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.447 HD23 ' HB ' ' A' ' 57' ' ' VAL . 5.5 tt -125.95 142.42 51.53 Favored 'General case' 0 C--O 1.238 0.481 0 C-N-CA 124.166 0.986 . . . . 0.0 108.803 176.896 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.519 ' HB2' ' NZ ' ' A' ' 41' ' ' LYS . 65.5 t80 -127.09 144.9 50.92 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 124.884 1.274 . . . . 0.0 108.027 172.807 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . 0.415 ' CE2' ' HB3' ' A' ' 30' ' ' SER . 17.8 m-85 -102.44 97.65 9.25 Favored Pre-proline 0 CA--C 1.548 0.868 0 C-N-CA 122.557 0.343 . . . . 0.0 110.12 171.914 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -82.49 89.23 1.19 Allowed 'Trans proline' 0 C--N 1.38 2.234 0 C-N-CA 122.945 2.43 . . . . 0.0 112.006 176.029 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . 0.411 ' ND2' ' HA ' ' A' ' 53' ' ' LYS . 23.6 m120 -74.07 105.93 5.52 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 115.033 -0.985 . . . . 0.0 109.764 179.27 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.537 ' HE2' ' HA ' ' A' ' 47' ' ' LYS . 11.9 mmpt? -64.38 -38.39 90.86 Favored 'General case' 0 CA--C 1.543 0.694 0 CA-C-N 114.528 -1.215 . . . . 0.0 111.639 -174.819 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.467 HG12 ' H ' ' A' ' 50' ' ' SER . 71.4 t -122.15 131.6 72.81 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 N-CA-C 107.445 -1.317 . . . . 0.0 107.445 171.08 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -67.98 -16.03 67.93 Favored Glycine 0 CA--C 1.535 1.293 0 N-CA-C 114.087 0.395 . . . . 0.0 114.087 -177.649 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' SER . . . . . 0.467 ' H ' HG12 ' A' ' 48' ' ' VAL . 25.6 m -73.45 -17.25 61.26 Favored 'General case' 0 CA--C 1.552 1.037 0 C-N-CA 123.531 0.732 . . . . 0.0 112.416 -179.738 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.464 HG21 ' O ' ' A' ' 48' ' ' VAL . 5.8 m -83.23 -175.77 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 C-N-CA 122.597 0.359 . . . . 0.0 110.796 -179.02 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 12.6 mptt -66.93 88.65 0.15 Allowed 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 123.134 0.574 . . . . 0.0 110.248 -179.39 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.463 ' H ' ' HD3' ' A' ' 53' ' ' LYS . 0.2 OUTLIER -77.5 120.81 23.0 Favored 'General case' 0 C--N 1.349 0.562 0 CA-C-N 115.595 -0.73 . . . . 0.0 109.897 -178.608 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 1.1 p -129.93 165.49 21.98 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 123.578 0.751 . . . . 0.0 109.852 -176.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -98.1 -167.11 1.46 Allowed 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 123.965 0.906 . . . . 0.0 111.671 -167.416 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.403 ' CG1' ' HE2' ' A' ' 41' ' ' LYS . 31.9 t -81.85 134.29 27.38 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.404 0 CA-C-N 114.891 -1.05 . . . . 0.0 110.052 177.52 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.447 ' HB ' HD23 ' A' ' 42' ' ' LEU . 98.6 t -121.11 130.23 74.88 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 C-N-CA 124.089 0.956 . . . . 0.0 108.928 175.137 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 9.1 m-85 -101.86 119.5 38.88 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 123.297 0.639 . . . . 0.0 109.281 171.376 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.417 ' HA ' ' HG2' ' A' ' 65' ' ' GLU . 14.8 t -78.37 123.81 35.78 Favored 'Isoleucine or valine' 0 C--O 1.239 0.532 0 C-N-CA 123.518 0.727 . . . . 0.0 109.744 176.331 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -82.07 151.98 67.62 Favored Pre-proline 0 CA--C 1.54 0.582 0 CA-C-N 114.335 -1.302 . . . . 0.0 110.873 -175.639 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_endo -60.48 -33.3 94.08 Favored 'Trans proline' 0 C--N 1.374 1.894 0 C-N-CA 123.245 2.63 . . . . 0.0 112.697 177.41 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.424 HG21 ' H ' ' A' ' 64' ' ' GLU . 11.4 t -85.82 -12.82 49.9 Favored 'General case' 0 CA--C 1.545 0.781 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.292 178.207 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 94.57 -1.12 65.98 Favored Glycine 0 C--N 1.357 1.7 0 CA-C-O 120.053 -0.304 . . . . 0.0 113.64 -177.276 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.424 ' H ' HG21 ' A' ' 62' ' ' THR . 33.0 tt0 -78.31 71.87 4.8 Favored 'General case' 0 N--CA 1.48 1.064 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 174.497 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 0.417 ' HG2' ' HA ' ' A' ' 59' ' ' VAL . 34.1 mt-10 -66.01 148.57 51.59 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-N 114.775 -1.102 . . . . 0.0 111.771 -169.138 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 48.6 mm -115.17 131.11 68.4 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.557 0 C-N-CA 124.44 1.096 . . . . 0.0 110.167 -168.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 61.0 p -101.52 -21.12 14.83 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 123.596 0.758 . . . . 0.0 112.482 -178.758 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 7.8 p30 -143.52 159.36 42.57 Favored 'General case' 0 N--CA 1.481 1.111 0 CA-C-O 120.8 0.333 . . . . 0.0 111.802 -172.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 55.1 ttt-85 -65.69 -29.29 69.81 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 124.144 0.978 . . . . 0.0 111.968 -171.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 7.8 tmtm? -61.18 -54.94 38.0 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 123.352 0.661 . . . . 0.0 109.318 176.782 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 14.2 mm100 -67.5 -20.13 65.41 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-N 115.591 -0.732 . . . . 0.0 111.821 -176.581 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.414 ' O ' ' HG ' ' A' ' 76' ' ' LEU . 0.6 OUTLIER -70.91 -56.45 6.22 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 176.221 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -62.94 -41.83 99.62 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 123.526 0.731 . . . . 0.0 111.191 -176.784 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.47 -28.69 66.31 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 122.684 0.394 . . . . 0.0 110.648 177.467 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . 0.41 ' OH ' HG22 ' A' ' 62' ' ' THR . 20.9 t80 -63.06 -49.72 73.41 Favored 'General case' 0 N--CA 1.482 1.128 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 172.789 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.414 ' HG ' ' O ' ' A' ' 72' ' ' LEU . 72.5 mt -61.62 -37.15 82.9 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 123.313 0.645 . . . . 0.0 111.869 -172.341 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.04 -35.71 49.4 Favored 'General case' 0 CA--C 1.548 0.885 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.13 176.847 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 30.0 t -79.03 -16.38 56.94 Favored 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 123.011 0.524 . . . . 0.0 111.541 -179.412 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 76.9 m-70 -129.57 82.81 66.5 Favored Pre-proline 0 CA--C 1.544 0.72 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 178.091 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -64.76 142.26 75.65 Favored 'Trans proline' 0 C--N 1.372 1.803 0 C-N-CA 122.776 2.318 . . . . 0.0 112.543 -178.902 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 105.18 -14.8 47.88 Favored Glycine 0 C--N 1.348 1.246 0 CA-C-N 116.125 -0.489 . . . . 0.0 112.67 -178.024 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 18.4 m-80 -76.62 146.49 76.88 Favored Pre-proline 0 N--CA 1.485 1.316 0 C-N-CA 123.588 0.755 . . . . 0.0 111.526 179.633 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -63.37 158.43 45.07 Favored 'Trans proline' 0 C--N 1.383 2.393 0 C-N-CA 123.019 2.479 . . . . 0.0 113.541 -178.023 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . 0.419 ' O ' ' HG2' ' A' ' 87' ' ' GLU . . . -73.83 144.52 45.47 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-N 114.879 -1.055 . . . . 0.0 111.756 -174.941 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 16.7 tt -67.03 -12.32 14.98 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.311 0 C-N-CA 123.129 0.572 . . . . 0.0 111.657 179.736 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -57.0 -38.86 73.67 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 124.38 1.072 . . . . 0.0 112.297 173.687 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.419 ' HG2' ' O ' ' A' ' 84' ' ' ALA . 11.6 pt-20 -92.76 0.21 57.38 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 123.235 0.614 . . . . 0.0 111.518 -179.569 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -85.26 110.75 19.29 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 123.044 0.537 . . . . 0.0 109.746 177.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -83.17 93.78 7.72 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 123.962 0.905 . . . . 0.0 109.941 -178.625 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 78.7 m95 -79.43 -42.45 25.38 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 123.433 0.693 . . . . 0.0 109.996 171.418 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 12.8 t -82.05 13.84 3.16 Favored 'General case' 0 CA--C 1.559 1.294 0 C-N-CA 124.4 1.08 . . . . 0.0 112.483 -172.859 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 11.4 t -80.12 51.82 1.44 Allowed 'General case' 0 CA--C 1.561 1.397 0 CA-C-O 122.119 0.961 . . . . 0.0 110.716 172.79 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 14.9 p -58.59 105.55 0.31 Allowed 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 123.95 0.9 . . . . 0.0 110.771 179.597 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -59.37 105.73 0.78 Allowed Glycine 0 C--N 1.349 1.305 0 O-C-N 123.791 0.682 . . . . 0.0 112.316 179.022 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 34.5 p . . . . . 0 C--O 1.251 1.167 0 C-N-CA 124.398 1.079 . . . . 0.0 109.101 179.439 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.36 0 CA-C-O 120.835 0.35 . . . . 0.0 110.663 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 17.0 p80 -133.71 104.32 6.28 Favored 'General case' 0 C--O 1.246 0.921 0 N-CA-C 107.147 -1.427 . . . . 0.0 107.147 172.806 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 38.3 m80 64.03 -175.62 0.16 Allowed 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 123.903 0.881 . . . . 0.0 110.941 -171.229 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 95.8 m-70 -141.54 162.36 35.68 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 123.201 0.6 . . . . 0.0 111.328 -179.327 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 30.9 m-70 -97.95 148.37 23.53 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 114.836 -1.074 . . . . 0.0 110.173 176.913 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 8.6 p-80 -142.49 31.49 1.5 Allowed 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 124.044 0.938 . . . . 0.0 109.36 175.507 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 16.8 t60 -61.25 136.34 58.02 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 124.331 1.052 . . . . 0.0 110.572 -176.881 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 48.1 m -63.92 97.93 0.18 Allowed 'General case' 0 CA--C 1.547 0.828 0 O-C-N 123.636 0.585 . . . . 0.0 110.39 178.473 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 62.7 m -140.63 160.34 40.23 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-N 115.199 -0.909 . . . . 0.0 110.884 -173.273 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 108.64 141.03 9.36 Favored Glycine 0 C--N 1.349 1.265 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.578 -177.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -80.96 124.23 28.97 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 123.143 0.577 . . . . 0.0 109.72 179.792 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -150.29 155.49 39.78 Favored 'General case' 0 CA--C 1.552 1.026 0 N-CA-C 106.732 -1.581 . . . . 0.0 106.732 179.226 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 70.75 19.77 5.83 Favored 'General case' 0 N--CA 1.499 1.985 0 C-N-CA 124.126 0.97 . . . . 0.0 109.435 -169.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 2.5 pp -68.44 -43.8 76.29 Favored 'General case' 0 N--CA 1.478 0.944 0 CA-C-N 114.547 -1.206 . . . . 0.0 110.971 -178.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 76.3 m-85 -141.95 -84.73 0.18 Allowed 'General case' 0 CA--C 1.54 0.587 0 N-CA-C 106.948 -1.501 . . . . 0.0 106.948 171.327 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 54.5 t80 50.95 35.49 12.7 Favored 'General case' 0 CA--C 1.559 1.32 0 C-N-CA 124.374 1.07 . . . . 0.0 111.478 177.264 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 28.1 mm-40 -68.17 -59.69 3.04 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 124.578 1.151 . . . . 0.0 110.919 -176.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 137.85 81.63 0.1 OUTLIER Glycine 0 C--N 1.347 1.152 0 N-CA-C 111.785 -0.526 . . . . 0.0 111.785 179.089 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 39.0 p-80 -68.55 127.44 33.01 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 123.2 0.6 . . . . 0.0 110.077 176.044 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -100.81 121.04 41.02 Favored 'General case' 0 N--CA 1.473 0.721 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 173.097 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -79.88 -77.18 0.19 Allowed 'General case' 0 CA--C 1.545 0.785 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 178.843 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 28.5 t 179.95 164.32 1.13 Allowed 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 124.434 1.094 . . . . 0.0 109.025 179.122 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -167.0 -159.33 12.39 Favored Glycine 0 C--N 1.341 0.81 0 N-CA-C 111.569 -0.613 . . . . 0.0 111.569 -179.715 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 41.4 m -95.19 83.49 3.9 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 123.439 0.696 . . . . 0.0 110.098 179.183 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 11.6 tp10 -130.73 120.06 23.27 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 124.0 0.92 . . . . 0.0 109.874 177.83 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 4.5 mp0 -93.11 97.14 10.48 Favored 'General case' 0 C--O 1.242 0.678 0 N-CA-C 109.063 -0.718 . . . . 0.0 109.063 -178.227 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -79.88 78.47 6.48 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-O 121.654 0.74 . . . . 0.0 109.39 178.599 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 27.4 m -95.56 175.99 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 CA-C-N 115.008 -0.996 . . . . 0.0 110.984 -176.504 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.493 HG11 ' HG2' ' A' ' 47' ' ' LYS . 12.8 m -67.8 112.47 2.97 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.938 0 CA-C-N 115.359 -0.837 . . . . 0.0 110.98 178.539 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 15.5 p -145.93 137.32 24.83 Favored 'General case' 0 C--O 1.24 0.597 0 C-N-CA 124.671 1.188 . . . . 0.0 108.74 -178.605 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.409 HG13 HD23 ' A' ' 33' ' ' LEU . 86.3 t -125.62 125.54 68.78 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 C-N-CA 124.048 0.939 . . . . 0.0 108.972 -179.411 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -79.6 104.91 10.52 Favored 'General case' 0 CA--C 1.537 0.473 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 173.546 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.655 ' HB2' ' HZ3' ' A' ' 41' ' ' LYS . 4.4 mm? -80.64 159.95 68.11 Favored Pre-proline 0 CA--C 1.552 1.023 0 C-N-CA 123.611 0.764 . . . . 0.0 109.537 177.068 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_endo -59.85 151.04 74.03 Favored 'Trans proline' 0 C--N 1.381 2.283 0 C-N-CA 122.378 2.052 . . . . 0.0 113.468 -178.016 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -144.81 168.13 12.99 Favored Pre-proline 0 N--CA 1.476 0.848 0 C-N-CA 124.203 1.001 . . . . 0.0 110.979 -168.698 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.511 ' HG2' ' HB2' ' A' ' 39' ' ' TRP . 30.3 Cg_endo -62.93 151.27 85.33 Favored 'Trans proline' 0 C--N 1.381 2.259 0 C-N-CA 122.0 1.8 . . . . 0.0 110.423 160.991 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 57.4 p -64.12 -23.33 67.28 Favored 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 123.528 0.731 . . . . 0.0 111.898 -177.225 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 18.3 m -74.64 -33.6 62.57 Favored 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 123.54 0.736 . . . . 0.0 111.745 178.226 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' TRP . . . . . 0.511 ' HB2' ' HG2' ' A' ' 36' ' ' PRO . 28.4 m95 -117.25 -174.38 2.59 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 123.942 0.897 . . . . 0.0 110.562 -176.866 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 44.8 mtmt -138.74 149.52 45.13 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 124.18 0.992 . . . . 0.0 108.612 168.888 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.655 ' HZ3' ' HB2' ' A' ' 33' ' ' LEU . 24.6 tptp -118.95 127.25 53.3 Favored 'General case' 0 C--N 1.331 -0.206 0 C-N-CA 124.815 1.246 . . . . 0.0 109.311 -175.214 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 4.1 tt -124.28 145.77 49.18 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 124.259 1.024 . . . . 0.0 108.647 174.68 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.467 ' HB2' ' NZ ' ' A' ' 41' ' ' LYS . 48.3 t80 -128.94 142.46 50.93 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 124.994 1.318 . . . . 0.0 108.124 170.934 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 36.5 m-85 -101.1 100.47 13.26 Favored Pre-proline 0 N--CA 1.48 1.058 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 171.243 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 62.2 Cg_endo -84.24 156.9 12.89 Favored 'Trans proline' 0 C--N 1.372 1.816 0 C-N-CA 122.736 2.291 . . . . 0.0 111.598 172.499 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 46.6 t-20 -83.76 152.07 24.87 Favored 'General case' 0 CA--C 1.545 0.768 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 171.22 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.493 ' HG2' HG11 ' A' ' 29' ' ' VAL . 96.4 mttt -62.19 -23.99 66.94 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 122.987 0.515 . . . . 0.0 111.435 179.007 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 65.3 t -60.52 -46.25 95.75 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.75 0 C-N-CA 123.127 0.571 . . . . 0.0 110.156 172.915 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 100.79 159.33 27.65 Favored Glycine 0 C--N 1.341 0.852 0 CA-C-N 115.496 -0.774 . . . . 0.0 111.387 -174.824 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' SER . . . . . 0.513 ' HA ' ' HA ' ' A' ' 95' ' ' THR . 32.6 t 71.74 -66.22 0.31 Allowed 'General case' 0 N--CA 1.49 1.574 0 C-N-CA 125.644 1.577 . . . . 0.0 110.823 -176.94 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 34.0 m -68.47 148.31 11.85 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.75 0 CA-C-N 115.227 -0.897 . . . . 0.0 111.769 177.875 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.402 ' HZ1' ' HB3' ' A' ' 55' ' ' GLU . 21.9 ptmt -79.0 158.06 28.0 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-N 114.196 -1.366 . . . . 0.0 111.157 179.301 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 12.9 tmtt? -102.38 -53.81 2.82 Favored 'General case' 0 N--CA 1.477 0.915 0 N-CA-C 106.626 -1.62 . . . . 0.0 106.626 169.442 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 26.4 m -132.04 162.11 31.57 Favored 'General case' 0 CA--C 1.55 0.946 0 N-CA-C 106.59 -1.633 . . . . 0.0 106.59 173.766 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.402 ' HB3' ' HZ1' ' A' ' 52' ' ' LYS . 1.1 pm0 -72.42 -171.01 0.72 Allowed 'General case' 0 CA--C 1.551 0.993 0 CA-C-O 121.731 0.777 . . . . 0.0 111.31 179.217 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 11.7 t -81.75 138.04 20.2 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.416 0 C-N-CA 124.581 1.152 . . . . 0.0 110.707 -174.657 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 49.3 t -123.13 116.12 47.66 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.744 0 C-N-CA 123.674 0.79 . . . . 0.0 109.059 171.848 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 15.2 m-85 -86.36 120.64 27.92 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 123.36 0.664 . . . . 0.0 109.585 170.395 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 2.8 t -78.71 127.98 38.63 Favored 'Isoleucine or valine' 0 C--O 1.238 0.494 0 C-N-CA 123.56 0.744 . . . . 0.0 109.039 174.414 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -86.53 153.41 55.79 Favored Pre-proline 0 CA--C 1.539 0.553 0 CA-C-N 114.959 -1.019 . . . . 0.0 110.801 -176.869 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -59.54 -29.88 91.04 Favored 'Trans proline' 0 C--N 1.369 1.613 0 C-N-CA 122.898 2.398 . . . . 0.0 113.076 173.893 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.412 HG21 ' HH ' ' A' ' 75' ' ' TYR . 14.5 t -93.32 -3.97 52.51 Favored 'General case' 0 N--CA 1.486 1.343 0 C-N-CA 122.565 0.346 . . . . 0.0 111.522 176.894 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 90.04 -8.71 79.31 Favored Glycine 0 C--N 1.35 1.358 0 CA-C-O 119.576 -0.569 . . . . 0.0 113.996 -179.795 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -72.63 77.64 1.09 Allowed 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 123.686 0.794 . . . . 0.0 109.306 175.316 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -73.06 158.34 35.57 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-N 115.013 -0.994 . . . . 0.0 111.581 -168.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.532 HG21 ' HB2' ' A' ' 71' ' ' GLN . 49.2 mm -122.14 115.42 46.16 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 CA-C-N 114.522 -1.217 . . . . 0.0 109.701 -166.723 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 14.1 p -88.5 -17.57 30.03 Favored 'General case' 0 CA--C 1.553 1.067 0 C-N-CA 123.765 0.826 . . . . 0.0 112.306 179.651 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 2.0 p-10 -156.67 157.65 35.57 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 112.133 0.42 . . . . 0.0 112.133 -174.558 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 41.9 mtm105 -56.6 -36.58 69.57 Favored 'General case' 0 N--CA 1.493 1.724 0 C-N-CA 124.35 1.06 . . . . 0.0 113.858 -170.868 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 7.0 tmtm? -54.62 -49.35 70.7 Favored 'General case' 0 N--CA 1.484 1.232 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 179.544 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.532 ' HB2' HG21 ' A' ' 66' ' ' ILE . 91.1 mt-30 -64.06 -35.16 79.84 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 123.693 0.797 . . . . 0.0 111.312 -179.544 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.448 ' O ' ' HG ' ' A' ' 76' ' ' LEU . 0.6 OUTLIER -64.68 -51.71 61.06 Favored 'General case' 0 N--CA 1.483 1.178 0 O-C-N 123.739 0.649 . . . . 0.0 109.369 -179.813 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -69.34 -42.16 75.68 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 124.298 1.039 . . . . 0.0 111.599 -173.523 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 1.1 pp0? -66.44 -33.12 75.0 Favored 'General case' 0 N--CA 1.472 0.665 0 O-C-N 123.427 0.454 . . . . 0.0 109.897 176.091 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . 0.412 ' HH ' HG21 ' A' ' 62' ' ' THR . 12.2 t80 -61.92 -47.1 86.45 Favored 'General case' 0 C--N 1.357 0.909 0 O-C-N 123.656 0.597 . . . . 0.0 109.447 175.41 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.448 ' HG ' ' O ' ' A' ' 72' ' ' LEU . 81.9 mt -62.21 -48.98 77.6 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 123.038 0.535 . . . . 0.0 111.195 -175.738 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.76 -17.61 61.08 Favored 'General case' 0 CA--C 1.551 0.989 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.754 -176.806 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 30.7 t -92.77 -27.7 17.04 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 123.381 0.672 . . . . 0.0 110.781 175.654 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 51.9 m80 -127.72 92.25 43.19 Favored Pre-proline 0 N--CA 1.479 0.979 0 C-N-CA 124.204 1.002 . . . . 0.0 108.735 -174.334 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -64.63 159.79 43.25 Favored 'Trans proline' 0 C--N 1.371 1.756 0 C-N-CA 122.858 2.372 . . . . 0.0 112.551 179.131 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 91.62 -24.35 20.74 Favored Glycine 0 C--N 1.346 1.093 0 CA-C-N 115.989 -0.551 . . . . 0.0 112.971 179.06 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 41.7 m-80 -72.59 132.05 83.91 Favored Pre-proline 0 CA--C 1.546 0.817 0 C-N-CA 123.454 0.702 . . . . 0.0 110.308 177.651 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_endo -60.56 148.49 90.94 Favored 'Trans proline' 0 C--N 1.376 2.0 0 C-N-CA 123.226 2.617 . . . . 0.0 113.017 -176.123 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . 0.41 ' HA ' HD13 ' A' ' 76' ' ' LEU . . . -68.42 148.44 50.65 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 123.549 0.74 . . . . 0.0 112.088 -175.185 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.415 ' HB ' HD11 ' A' ' 72' ' ' LEU . 15.7 tt -63.49 -13.91 13.66 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.399 0 C-N-CA 124.329 1.052 . . . . 0.0 112.21 -177.459 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -57.76 -38.67 75.82 Favored 'General case' 0 CA--C 1.553 1.074 0 C-N-CA 124.153 0.981 . . . . 0.0 112.213 175.588 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -90.55 -10.32 43.93 Favored 'General case' 0 N--CA 1.487 1.404 0 C-N-CA 122.993 0.517 . . . . 0.0 111.947 178.138 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -77.31 115.63 17.24 Favored 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 175.804 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 6.5 t0 -91.38 109.8 21.08 Favored 'General case' 0 CA--C 1.54 0.591 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 -176.122 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 69.8 m95 -96.99 -22.97 16.52 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 123.909 0.884 . . . . 0.0 110.106 176.119 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 12.9 t -88.16 7.81 29.98 Favored 'General case' 0 N--CA 1.486 1.329 0 C-N-CA 123.428 0.691 . . . . 0.0 111.718 -174.528 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 9.4 t -81.11 51.35 1.57 Allowed 'General case' 0 CA--C 1.56 1.344 0 CA-C-O 122.28 1.038 . . . . 0.0 111.431 175.79 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 46.4 m -74.13 101.84 4.06 Favored 'General case' 0 CA--C 1.545 0.751 0 CA-C-N 115.323 -0.853 . . . . 0.0 109.84 174.112 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -64.86 125.11 29.94 Favored Glycine 0 C--N 1.351 1.389 0 CA-C-N 115.684 -0.689 . . . . 0.0 112.918 -177.545 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' THR . . . . . 0.513 ' HA ' ' HA ' ' A' ' 50' ' ' SER . 96.3 m . . . . . 0 CA--C 1.552 1.047 0 CA-C-O 118.595 -0.716 . . . . 0.0 110.563 177.327 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.6 ptp . . . . . 0 N--CA 1.493 1.698 0 CA-C-O 120.611 0.243 . . . . 0.0 110.761 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 85.3 t60 -155.85 103.27 2.23 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 123.125 0.57 . . . . 0.0 109.67 178.002 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 15.1 t-80 -155.52 -39.82 0.08 Allowed 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 124.785 1.234 . . . . 0.0 108.022 169.587 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 29.1 t-80 -77.8 90.89 4.07 Favored 'General case' 0 CA--C 1.547 0.845 0 N-CA-C 109.333 -0.618 . . . . 0.0 109.333 171.11 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 42.5 t-80 -111.83 90.62 3.39 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 124.259 1.024 . . . . 0.0 108.305 175.497 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 22.9 t-80 -164.38 112.76 1.12 Allowed 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 -177.089 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 48.6 m170 -103.12 119.22 38.46 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 123.415 0.686 . . . . 0.0 109.538 176.409 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 38.0 m -143.22 92.9 2.43 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 124.215 1.006 . . . . 0.0 108.666 173.19 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 50.3 m -141.01 113.36 8.02 Favored 'General case' 0 C--O 1.241 0.609 0 C-N-CA 124.002 0.921 . . . . 0.0 108.735 178.827 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -164.5 -171.89 31.31 Favored Glycine 0 C--N 1.339 0.724 0 O-C-N 123.664 0.602 . . . . 0.0 111.936 179.207 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 66.6 mtt-85 -123.72 117.86 25.9 Favored 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 177.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -72.66 78.35 1.09 Allowed 'General case' 0 N--CA 1.476 0.825 0 CA-C-O 121.698 0.761 . . . . 0.0 109.839 178.204 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 51.8 t-20 -132.19 92.56 3.12 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 107.654 -1.239 . . . . 0.0 107.654 -179.121 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -146.58 174.17 11.66 Favored 'General case' 0 C--O 1.244 0.775 0 CA-C-N 114.899 -1.046 . . . . 0.0 109.239 178.042 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 25.2 p90 -65.95 108.63 2.25 Favored 'General case' 0 CA--C 1.553 1.081 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 173.001 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 51.2 p90 -91.18 -16.92 26.92 Favored 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 123.466 0.706 . . . . 0.0 110.613 177.284 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 86.0 mm-40 56.42 80.86 0.14 Allowed 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 125.202 1.401 . . . . 0.0 111.839 178.646 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -85.19 62.65 4.48 Favored Glycine 0 C--N 1.348 1.212 0 CA-C-N 115.662 -0.699 . . . . 0.0 112.38 -179.573 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 5.8 p-80 -83.07 123.99 30.02 Favored 'General case' 0 CA--C 1.548 0.896 0 C-N-CA 124.067 0.947 . . . . 0.0 109.867 -179.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 69.17 -67.42 0.22 Allowed 'General case' 0 N--CA 1.489 1.485 0 C-N-CA 125.624 1.57 . . . . 0.0 110.594 -177.858 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -68.17 139.36 56.1 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 123.227 0.611 . . . . 0.0 110.253 172.305 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 22.8 t 68.21 25.32 7.29 Favored 'General case' 0 CA--C 1.556 1.174 0 C-N-CA 124.619 1.168 . . . . 0.0 111.436 -178.794 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -157.06 -71.4 0.01 OUTLIER Glycine 0 C--N 1.35 1.355 0 N-CA-C 111.15 -0.78 . . . . 0.0 111.15 176.019 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 47.7 t 58.7 68.58 0.81 Allowed 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 124.872 1.269 . . . . 0.0 110.485 179.274 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 -87.21 52.17 2.44 Favored 'General case' 0 CA--C 1.546 0.815 0 CA-C-N 115.219 -0.901 . . . . 0.0 108.849 177.105 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 58.31 -171.27 0.11 Allowed 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 124.393 1.077 . . . . 0.0 111.933 -170.401 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -132.56 86.79 2.35 Favored 'General case' 0 C--O 1.237 0.41 0 N-CA-C 106.617 -1.624 . . . . 0.0 106.617 170.073 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 33.6 m -64.51 152.48 8.54 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 CA-C-N 115.135 -0.938 . . . . 0.0 111.088 -177.508 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 15.3 m -63.42 104.81 0.41 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.884 0 CA-C-O 121.764 0.792 . . . . 0.0 110.345 -179.039 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 30.8 p -161.99 113.48 1.67 Allowed 'General case' 0 C--O 1.239 0.513 0 C-N-CA 124.52 1.128 . . . . 0.0 108.078 -177.34 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 83.3 t -105.59 124.33 60.53 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.517 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.469 ' HA ' ' HA ' ' A' ' 42' ' ' LEU . 51.6 mt-10 -76.72 113.21 14.12 Favored 'General case' 0 CA--C 1.533 0.317 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 173.761 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.421 HD22 ' HB3' ' A' ' 43' ' ' PHE . 3.7 mm? -87.28 166.4 26.03 Favored Pre-proline 0 CA--C 1.555 1.166 0 C-N-CA 123.69 0.796 . . . . 0.0 109.017 -179.786 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -51.54 134.72 46.9 Favored 'Trans proline' 0 C--N 1.388 2.633 0 C-N-CA 123.012 2.475 . . . . 0.0 113.161 175.854 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . 0.417 ' HB3' ' HB3' ' A' ' 41' ' ' LYS . . . -128.91 158.97 70.89 Favored Pre-proline 0 N--CA 1.477 0.89 0 C-N-CA 125.335 1.454 . . . . 0.0 110.913 -170.648 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.632 ' HG2' ' HB2' ' A' ' 39' ' ' TRP . 58.9 Cg_endo -70.16 177.96 5.32 Favored 'Trans proline' 0 C--N 1.381 2.262 0 C-N-CA 122.686 2.257 . . . . 0.0 111.44 166.057 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 77.2 p -71.22 -47.67 55.96 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 123.694 0.798 . . . . 0.0 112.498 -169.741 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 22.2 m -74.65 -35.61 62.85 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 123.809 0.844 . . . . 0.0 110.884 -175.594 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' TRP . . . . . 0.632 ' HB2' ' HG2' ' A' ' 36' ' ' PRO . 39.7 m95 -100.3 174.3 6.19 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 123.693 0.797 . . . . 0.0 111.28 -175.297 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.769 ' HB3' ' HB ' ' A' ' 59' ' ' VAL . 15.7 tppt? -126.94 148.39 50.06 Favored 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 107.187 -1.412 . . . . 0.0 107.187 169.127 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.475 ' HZ3' ' HB3' ' A' ' 89' ' ' ASP . 0.0 OUTLIER -120.97 127.94 52.26 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 107.688 -1.227 . . . . 0.0 107.688 179.41 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.469 ' HA ' ' HA ' ' A' ' 32' ' ' GLU . 4.5 tt -128.55 146.1 50.93 Favored 'General case' 0 C--N 1.324 -0.541 0 C-N-CA 125.29 1.436 . . . . 0.0 107.569 174.033 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.421 ' HB3' HD22 ' A' ' 33' ' ' LEU . 31.6 t80 -126.94 142.92 51.43 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 124.707 1.203 . . . . 0.0 107.923 172.509 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 14.1 m-85 -100.84 99.09 9.52 Favored Pre-proline 0 N--CA 1.488 1.44 0 C-N-CA 123.17 0.588 . . . . 0.0 110.91 174.084 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -82.36 89.41 1.18 Allowed 'Trans proline' 0 C--N 1.378 2.108 0 C-N-CA 123.066 2.511 . . . . 0.0 111.999 171.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 45.8 t-20 -71.09 147.91 48.01 Favored 'General case' 0 N--CA 1.479 0.979 0 CA-C-N 115.815 -0.63 . . . . 0.0 109.536 178.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 31.1 mmmt -51.07 -54.35 25.64 Favored 'General case' 0 N--CA 1.48 1.025 0 C-N-CA 124.485 1.114 . . . . 0.0 111.618 176.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 65.7 t -105.12 128.79 58.68 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 -179.704 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.402 ' HA2' ' HD3' ' A' ' 53' ' ' LYS . . . -78.34 -30.33 50.27 Favored Glycine 0 CA--C 1.53 1.011 0 CA-C-N 116.309 -0.405 . . . . 0.0 112.757 178.847 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 29.7 m -69.71 -24.44 63.56 Favored 'General case' 0 CA--C 1.551 0.994 0 C-N-CA 123.851 0.861 . . . . 0.0 112.464 -177.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 27.5 m -86.75 -169.82 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.408 0 C-N-CA 122.787 0.435 . . . . 0.0 109.942 175.607 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 19.0 ptpt -65.41 77.33 0.06 Allowed 'General case' 0 CA--C 1.558 1.251 0 C-N-CA 123.735 0.814 . . . . 0.0 112.534 178.09 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.402 ' HD3' ' HA2' ' A' ' 49' ' ' GLY . 23.6 pttm -78.24 104.43 8.82 Favored 'General case' 0 C--N 1.346 0.446 0 N-CA-C 107.449 -1.315 . . . . 0.0 107.449 171.295 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 20.1 m -61.18 139.35 58.14 Favored 'General case' 0 CA--C 1.543 0.701 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.605 -176.866 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 15.1 pt-20 -73.37 -165.92 0.29 Allowed 'General case' 0 CA--C 1.55 0.959 0 CA-C-O 121.86 0.838 . . . . 0.0 111.431 -174.236 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 75.4 t -80.28 137.57 21.28 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.76 0 CA-C-N 114.988 -1.005 . . . . 0.0 109.274 179.575 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 87.3 t -117.81 115.2 47.75 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 178.223 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.412 ' CZ ' ' HE3' ' A' ' 41' ' ' LYS . 19.6 m-85 -94.94 115.1 27.03 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 123.657 0.783 . . . . 0.0 109.378 174.635 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.769 ' HB ' ' HB3' ' A' ' 40' ' ' LYS . 2.8 t -79.48 129.84 36.97 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 175.359 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -84.31 153.62 62.54 Favored Pre-proline 0 CA--C 1.54 0.565 0 CA-C-N 114.939 -1.028 . . . . 0.0 111.003 -175.035 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_endo -61.02 -32.72 92.45 Favored 'Trans proline' 0 C--N 1.379 2.147 0 C-N-CA 122.913 2.408 . . . . 0.0 113.101 177.02 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 13.2 t -84.49 -6.35 59.37 Favored 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 122.981 0.512 . . . . 0.0 111.627 179.796 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 94.16 -19.87 50.89 Favored Glycine 0 C--N 1.357 1.702 0 CA-C-O 119.686 -0.508 . . . . 0.0 113.179 179.486 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -69.63 75.74 0.42 Allowed 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 124.299 1.039 . . . . 0.0 109.09 175.608 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -75.36 150.24 38.46 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-O 121.892 0.853 . . . . 0.0 111.548 -166.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 39.8 mm -102.27 123.32 55.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 114.047 -1.433 . . . . 0.0 109.555 -175.72 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 24.3 m -105.69 -1.34 24.63 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 123.153 0.581 . . . . 0.0 111.093 -179.404 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 14.5 p-10 -158.01 145.65 18.4 Favored 'General case' 0 C--N 1.353 0.749 0 C-N-CA 123.076 0.55 . . . . 0.0 111.241 -174.062 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.418 ' HG3' HD11 ' A' ' 85' ' ' ILE . 44.1 ttp180 -61.35 -30.61 70.63 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 124.839 1.255 . . . . 0.0 113.864 -166.969 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 6.4 tmtm? -62.28 -49.06 77.16 Favored 'General case' 0 N--CA 1.489 1.508 0 C-N-CA 123.139 0.576 . . . . 0.0 109.554 177.196 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.531 ' HA ' ' HG3' ' A' ' 74' ' ' GLN . 86.4 mm-40 -66.35 -21.61 66.25 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-N 115.406 -0.815 . . . . 0.0 111.515 -176.565 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.416 ' HB3' HD13 ' A' ' 85' ' ' ILE . 0.6 OUTLIER -65.44 -54.95 21.16 Favored 'General case' 0 N--CA 1.477 0.894 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 174.77 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -59.15 -49.74 76.69 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 123.877 0.871 . . . . 0.0 111.031 -176.05 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . 0.531 ' HG3' ' HA ' ' A' ' 71' ' ' GLN . 0.0 OUTLIER -67.57 -25.89 66.01 Favored 'General case' 0 CA--C 1.547 0.864 0 CA-C-N 115.414 -0.812 . . . . 0.0 111.369 -177.226 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 34.0 t80 -66.45 -50.43 63.38 Favored 'General case' 0 C--N 1.357 0.897 0 C-N-CA 123.211 0.605 . . . . 0.0 109.592 173.445 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 81.5 mt -58.28 -43.13 87.84 Favored 'General case' 0 N--CA 1.486 1.347 0 O-C-N 123.787 0.679 . . . . 0.0 111.873 -173.679 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 58.3 pttt -68.03 -41.0 82.78 Favored 'General case' 0 N--CA 1.478 0.932 0 O-C-N 123.32 0.387 . . . . 0.0 111.035 -179.354 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 77.4 p -85.52 -10.37 56.11 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 112.012 0.375 . . . . 0.0 112.012 -177.17 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 53.1 m-70 -130.06 84.25 60.95 Favored Pre-proline 0 N--CA 1.482 1.167 0 C-N-CA 124.322 1.049 . . . . 0.0 108.714 177.654 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -67.9 147.29 74.22 Favored 'Trans proline' 0 C--N 1.375 1.924 0 C-N-CA 122.631 2.22 . . . . 0.0 111.786 178.838 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 101.41 -6.43 55.63 Favored Glycine 0 CA--C 1.53 0.995 0 CA-C-N 116.071 -0.513 . . . . 0.0 112.698 -177.192 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 40.2 m-80 -90.68 141.05 26.68 Favored Pre-proline 0 N--CA 1.48 1.062 0 C-N-CA 123.164 0.586 . . . . 0.0 110.595 177.239 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_endo -62.0 149.57 89.79 Favored 'Trans proline' 0 C--N 1.38 2.236 0 C-N-CA 123.384 2.723 . . . . 0.0 112.783 179.091 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -66.28 158.89 27.84 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 124.22 1.008 . . . . 0.0 111.882 -173.162 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.418 HD11 ' HG3' ' A' ' 69' ' ' ARG . 19.3 tt -77.87 -17.58 14.0 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.544 177.485 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -60.7 -34.48 74.42 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 123.8 0.84 . . . . 0.0 111.471 177.089 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -92.81 -11.35 33.91 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 123.492 0.717 . . . . 0.0 110.976 179.65 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 5.8 m-30 -82.01 127.7 33.34 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 123.273 0.629 . . . . 0.0 109.832 176.083 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . 0.475 ' HB3' ' HZ3' ' A' ' 41' ' ' LYS . 12.0 t70 -92.47 122.18 34.66 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 123.909 0.884 . . . . 0.0 109.785 -178.317 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 77.5 m95 -115.73 6.7 14.48 Favored 'General case' 0 N--CA 1.488 1.471 0 C-N-CA 123.837 0.855 . . . . 0.0 110.729 176.637 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 9.9 t -108.55 17.41 22.05 Favored 'General case' 0 CA--C 1.557 1.22 0 C-N-CA 124.815 1.246 . . . . 0.0 110.662 -177.315 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 9.9 t -77.88 31.72 0.17 Allowed 'General case' 0 CA--C 1.563 1.452 0 C-N-CA 124.205 1.002 . . . . 0.0 113.027 -176.153 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 22.0 t -89.24 15.21 9.32 Favored 'General case' 0 CA--C 1.552 1.029 0 C-N-CA 124.096 0.958 . . . . 0.0 111.028 178.541 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 82.8 100.51 0.49 Allowed Glycine 0 C--N 1.354 1.541 0 N-CA-C 109.672 -1.371 . . . . 0.0 109.672 -168.518 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 37.8 p . . . . . 0 CA--C 1.558 1.263 0 C-N-CA 123.862 0.865 . . . . 0.0 111.219 -173.626 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 83.3 mtp . . . . . 0 N--CA 1.481 1.111 0 N-CA-C 110.329 -0.249 . . . . 0.0 110.329 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 20.5 t60 -110.41 23.6 14.05 Favored 'General case' 0 CA--C 1.554 1.099 0 C-N-CA 123.962 0.905 . . . . 0.0 108.774 175.47 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 27.5 t60 -56.0 -36.14 67.57 Favored 'General case' 0 N--CA 1.488 1.426 0 C-N-CA 124.121 0.969 . . . . 0.0 111.247 -177.308 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 65.9 t-80 -76.26 86.05 3.07 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.143 174.204 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 19.0 p-80 -106.52 130.61 54.27 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 115.714 -0.676 . . . . 0.0 109.916 179.237 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 58.0 t-80 -148.85 99.64 3.0 Favored 'General case' 0 N--CA 1.466 0.325 0 N-CA-C 108.663 -0.865 . . . . 0.0 108.663 174.447 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 64.3 t-80 -155.11 81.5 1.07 Allowed 'General case' 0 CA--C 1.545 0.767 0 N-CA-C 108.358 -0.979 . . . . 0.0 108.358 176.856 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 20.4 p -107.78 98.99 8.5 Favored 'General case' 0 CA--C 1.545 0.784 0 CA-C-N 115.363 -0.835 . . . . 0.0 109.92 179.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 25.9 p -89.81 100.67 13.43 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 123.148 0.579 . . . . 0.0 109.634 176.316 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -133.39 -152.77 6.93 Favored Glycine 0 C--N 1.349 1.294 0 N-CA-C 111.334 -0.706 . . . . 0.0 111.334 178.467 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 30.0 tpt180 -130.79 -57.72 1.04 Allowed 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 123.438 0.695 . . . . 0.0 109.359 179.141 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 69.08 160.68 0.19 Allowed 'General case' 0 CA--C 1.564 1.505 0 C-N-CA 125.09 1.356 . . . . 0.0 111.727 179.57 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 32.3 m-80 72.05 96.84 0.07 Allowed 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 125.488 1.515 . . . . 0.0 111.317 175.392 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -93.22 133.09 36.78 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 122.984 0.514 . . . . 0.0 110.146 176.535 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 5.1 p90 -98.26 -51.5 3.97 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 124.506 1.123 . . . . 0.0 109.08 177.676 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 47.4 t80 49.7 87.7 0.03 OUTLIER 'General case' 0 CA--C 1.559 1.313 0 C-N-CA 124.844 1.258 . . . . 0.0 112.314 177.267 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 11.1 pt20 -159.3 164.73 34.61 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 123.523 0.729 . . . . 0.0 111.097 -174.9 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 121.13 156.6 9.84 Favored Glycine 0 C--N 1.349 1.302 0 CA-C-N 115.843 -0.617 . . . . 0.0 113.127 176.169 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 30.0 p80 -81.79 135.58 35.45 Favored 'General case' 0 N--CA 1.476 0.845 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 174.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 51.2 ttm -162.0 -48.54 0.04 OUTLIER 'General case' 0 C--O 1.243 0.732 0 C-N-CA 123.389 0.676 . . . . 0.0 109.85 -173.001 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . 63.93 -88.48 0.03 OUTLIER 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 124.978 1.311 . . . . 0.0 110.199 -173.454 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 23.0 t 53.8 25.07 4.86 Favored 'General case' 0 C--N 1.369 1.443 0 C-N-CA 124.238 1.015 . . . . 0.0 112.271 176.173 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -90.72 26.64 10.29 Favored Glycine 0 C--N 1.35 1.346 0 C-N-CA 123.537 0.589 . . . . 0.0 114.012 -169.596 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 59.3 m -148.08 -46.61 0.16 Allowed 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 124.236 1.014 . . . . 0.0 109.008 177.183 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -129.43 143.58 50.9 Favored 'General case' 0 C--N 1.348 0.541 0 C-N-CA 123.905 0.882 . . . . 0.0 109.272 175.02 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -81.96 150.98 27.39 Favored 'General case' 0 C--O 1.241 0.645 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 174.132 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 31.9 mt-10 -63.85 100.43 0.3 Allowed 'General case' 0 CA--C 1.55 0.946 0 C-N-CA 123.394 0.678 . . . . 0.0 110.888 -172.445 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 32.6 m -68.04 129.12 32.39 Favored 'Isoleucine or valine' 0 C--O 1.245 0.867 0 C-N-CA 123.489 0.715 . . . . 0.0 110.904 -175.771 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 23.2 m -75.21 106.69 5.16 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.833 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 176.678 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.469 ' HA ' ' HD2' ' A' ' 45' ' ' PRO . 31.2 p -155.28 129.78 9.08 Favored 'General case' 0 C--O 1.239 0.508 0 CA-C-N 114.97 -1.013 . . . . 0.0 109.09 -173.143 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 65.4 t -114.36 124.89 71.45 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 175.784 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.448 ' HA ' ' HA ' ' A' ' 42' ' ' LEU . 47.1 mt-10 -80.33 110.47 15.79 Favored 'General case' 0 C--O 1.237 0.433 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 177.856 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.496 HD21 ' HB3' ' A' ' 43' ' ' PHE . 4.2 mm? -86.61 160.42 50.54 Favored Pre-proline 0 N--CA 1.476 0.841 0 C-N-CA 123.814 0.846 . . . . 0.0 108.779 -178.775 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 14.0 Cg_endo -51.54 125.68 17.42 Favored 'Trans proline' 0 C--N 1.39 2.735 0 C-N-CA 123.073 2.515 . . . . 0.0 113.101 -172.65 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . 0.407 ' HB3' ' HB3' ' A' ' 41' ' ' LYS . . . -110.51 153.68 43.4 Favored Pre-proline 0 N--CA 1.469 0.483 0 CA-C-N 114.659 -1.155 . . . . 0.0 111.39 -170.876 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.661 ' HG2' ' HB2' ' A' ' 39' ' ' TRP . 56.3 Cg_endo -68.29 153.49 74.24 Favored 'Trans proline' 0 C--N 1.373 1.835 0 C-N-CA 122.584 2.189 . . . . 0.0 109.811 165.561 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 21.0 m -64.23 -29.31 70.42 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 123.468 0.707 . . . . 0.0 112.815 -172.138 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 16.0 m -83.56 -29.26 27.98 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 123.312 0.645 . . . . 0.0 111.609 -176.42 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' TRP . . . . . 0.661 ' HB2' ' HG2' ' A' ' 36' ' ' PRO . 17.5 m95 -114.19 -178.55 3.4 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 123.812 0.845 . . . . 0.0 109.668 -177.283 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.458 ' HB2' ' HB ' ' A' ' 59' ' ' VAL . 0.0 OUTLIER -119.7 165.63 14.26 Favored 'General case' 0 N--CA 1.473 0.713 0 N-CA-C 107.836 -1.172 . . . . 0.0 107.836 164.861 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.436 ' HE2' HG22 ' A' ' 92' ' ' THR . 14.4 tptm -150.73 119.49 6.58 Favored 'General case' 0 C--O 1.238 0.496 0 C-N-CA 124.187 0.995 . . . . 0.0 108.77 -172.776 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.448 ' HA ' ' HA ' ' A' ' 32' ' ' GLU . 2.7 tt -129.1 150.21 50.59 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 113.579 -1.646 . . . . 0.0 108.29 -175.872 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.496 ' HB3' HD21 ' A' ' 33' ' ' LEU . 33.8 t80 -130.24 139.82 50.76 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 124.353 1.061 . . . . 0.0 108.398 170.07 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 22.2 m-85 -96.8 103.11 13.52 Favored Pre-proline 0 CA--C 1.552 1.028 0 C-N-CA 122.849 0.46 . . . . 0.0 109.952 173.696 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.469 ' HD2' ' HA ' ' A' ' 30' ' ' SER . 95.3 Cg_endo -76.28 154.25 36.46 Favored 'Trans proline' 0 C--N 1.373 1.854 0 C-N-CA 122.526 2.151 . . . . 0.0 111.983 172.61 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -80.17 -15.33 57.29 Favored 'General case' 0 CA--C 1.555 1.165 0 C-N-CA 123.686 0.794 . . . . 0.0 109.312 174.98 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 84.8 tttt 68.97 34.25 3.21 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 125.674 1.59 . . . . 0.0 108.579 -174.189 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 60.1 t -129.76 -44.13 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 CA-C-N 114.39 -1.277 . . . . 0.0 108.192 179.364 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 96.93 146.65 21.38 Favored Glycine 0 C--N 1.351 1.378 0 CA-C-N 115.111 -0.95 . . . . 0.0 110.818 -171.786 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 30.0 t 73.7 -68.05 0.24 Allowed 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 125.33 1.452 . . . . 0.0 111.641 179.803 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 15.6 m -64.46 130.63 29.72 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.921 0 C-N-CA 123.568 0.747 . . . . 0.0 111.446 177.885 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 46.1 mtmt -101.44 114.71 28.96 Favored 'General case' 0 N--CA 1.472 0.651 0 N-CA-C 108.925 -0.768 . . . . 0.0 108.925 178.39 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -72.13 -51.22 22.4 Favored 'General case' 0 N--CA 1.475 0.812 0 CA-C-O 122.064 0.935 . . . . 0.0 108.784 171.396 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 58.7 m -133.04 156.74 46.81 Favored 'General case' 0 CA--C 1.553 1.061 0 CA-C-N 114.369 -1.287 . . . . 0.0 108.768 176.242 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -90.26 -166.86 1.69 Allowed 'General case' 0 CA--C 1.555 1.162 0 C-N-CA 124.14 0.976 . . . . 0.0 111.713 -174.929 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 86.9 t -82.95 138.77 18.79 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.885 0 C-N-CA 125.056 1.342 . . . . 0.0 110.529 -178.162 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 61.4 t -121.17 115.39 46.57 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.002 0 C-N-CA 124.039 0.936 . . . . 0.0 109.327 175.423 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 23.8 m-85 -88.8 112.93 23.79 Favored 'General case' 0 N--CA 1.479 1.014 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 170.282 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.458 ' HB ' ' HB2' ' A' ' 40' ' ' LYS . 9.1 t -79.14 133.49 29.83 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 CA-C-O 121.231 0.539 . . . . 0.0 109.907 -179.843 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -86.5 154.15 56.34 Favored Pre-proline 0 CA--C 1.543 0.681 0 CA-C-N 114.567 -1.197 . . . . 0.0 111.785 -172.92 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_endo -61.06 -26.17 82.5 Favored 'Trans proline' 0 C--N 1.377 2.057 0 C-N-CA 123.386 2.724 . . . . 0.0 113.31 173.816 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.422 HG22 ' H ' ' A' ' 64' ' ' GLU . 9.8 t -89.2 -12.27 41.37 Favored 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 122.537 0.335 . . . . 0.0 111.213 176.217 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 95.45 -8.21 68.99 Favored Glycine 0 C--N 1.355 1.607 0 CA-C-O 119.621 -0.544 . . . . 0.0 113.942 -178.164 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.422 ' H ' HG22 ' A' ' 62' ' ' THR . 40.4 tt0 -76.15 78.15 2.97 Favored 'General case' 0 N--CA 1.481 1.092 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 172.47 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -65.34 134.28 53.21 Favored 'General case' 0 CA--C 1.543 0.705 0 CA-C-N 115.325 -0.852 . . . . 0.0 110.781 -173.325 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.598 HG22 ' HB2' ' A' ' 71' ' ' GLN . 44.7 mm -91.69 122.7 43.37 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.659 0 C-N-CA 125.068 1.347 . . . . 0.0 110.114 -175.094 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 6.0 p -94.63 -19.83 20.11 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 123.725 0.81 . . . . 0.0 111.989 177.491 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 1.9 p-10 -150.87 150.23 30.64 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 122.959 0.504 . . . . 0.0 111.417 -173.139 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 65.8 mtp85 -55.57 -30.11 60.24 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 125.193 1.397 . . . . 0.0 114.149 -170.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 6.4 tmtm? -58.69 -50.61 73.26 Favored 'General case' 0 N--CA 1.48 1.063 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 179.572 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.598 ' HB2' HG22 ' A' ' 66' ' ' ILE . 54.1 mt-30 -63.27 -35.27 79.79 Favored 'General case' 0 N--CA 1.477 0.912 0 O-C-N 124.312 1.008 . . . . 0.0 111.073 -179.766 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.442 ' O ' ' HG ' ' A' ' 76' ' ' LEU . 0.2 OUTLIER -60.52 -52.31 65.73 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 123.482 0.713 . . . . 0.0 109.158 179.004 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -63.1 -50.02 72.16 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 123.839 0.855 . . . . 0.0 111.537 -175.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -66.87 -24.98 66.19 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.147 0.579 . . . . 0.0 111.261 -178.459 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 28.8 t80 -69.12 -47.22 65.69 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 123.818 0.847 . . . . 0.0 109.591 175.194 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.443 HD12 ' HA ' ' A' ' 84' ' ' ALA . 92.7 mt -66.01 -44.92 83.36 Favored 'General case' 0 N--CA 1.481 1.09 0 O-C-N 123.822 0.701 . . . . 0.0 111.815 -174.281 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -69.36 -25.89 64.4 Favored 'General case' 0 N--CA 1.48 1.069 0 CA-C-N 116.531 -0.304 . . . . 0.0 110.278 179.106 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 47.0 t -79.71 -29.37 40.68 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 123.046 0.538 . . . . 0.0 111.016 175.117 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 54.6 m80 -132.5 89.43 36.24 Favored Pre-proline 0 CA--C 1.546 0.791 0 C-N-CA 123.548 0.739 . . . . 0.0 109.562 -172.146 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -68.76 151.15 74.55 Favored 'Trans proline' 0 C--N 1.38 2.195 0 C-N-CA 122.664 2.243 . . . . 0.0 112.593 -177.287 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 95.05 -22.85 36.1 Favored Glycine 0 C--N 1.347 1.151 0 CA-C-N 116.141 -0.481 . . . . 0.0 113.052 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 14.7 m120 -68.0 131.52 92.31 Favored Pre-proline 0 N--CA 1.482 1.133 0 CA-C-O 119.102 -0.475 . . . . 0.0 109.821 173.162 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -55.78 141.53 84.69 Favored 'Trans proline' 0 C--N 1.38 2.209 0 C-N-CA 123.133 2.555 . . . . 0.0 112.723 -175.258 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . 0.443 ' HA ' HD12 ' A' ' 76' ' ' LEU . . . -66.53 159.52 27.13 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 123.937 0.895 . . . . 0.0 112.811 -170.675 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.402 ' HB ' HD13 ' A' ' 72' ' ' LEU . 16.3 tt -67.9 -20.72 26.28 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.014 0 C-N-CA 123.863 0.865 . . . . 0.0 110.567 176.26 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -63.68 -36.54 84.17 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 124.457 1.103 . . . . 0.0 112.204 179.741 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -92.35 -1.49 57.01 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 123.442 0.697 . . . . 0.0 111.213 179.086 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 5.3 m-30 -93.82 112.38 24.23 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 123.923 0.889 . . . . 0.0 109.864 178.008 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 11.0 p-10 -86.65 115.06 23.86 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-O 121.494 0.664 . . . . 0.0 110.221 -179.502 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 74.2 m95 -94.12 -20.05 20.25 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 123.588 0.755 . . . . 0.0 109.701 172.822 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 15.1 t -73.82 7.0 2.79 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 125.01 1.324 . . . . 0.0 112.65 -176.734 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' THR . . . . . 0.436 HG22 ' HE2' ' A' ' 41' ' ' LYS . 2.7 t -64.11 -18.34 64.31 Favored 'General case' 0 CA--C 1.553 1.063 0 C-N-CA 123.276 0.63 . . . . 0.0 111.81 177.206 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 16.8 p -61.55 -30.26 70.54 Favored 'General case' 0 CA--C 1.549 0.929 0 C-N-CA 124.207 1.003 . . . . 0.0 111.167 174.593 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 136.06 -147.94 19.44 Favored Glycine 0 C--N 1.343 0.939 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.627 175.226 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 4.3 t . . . . . 0 C--O 1.251 1.134 0 C-N-CA 124.011 0.924 . . . . 0.0 109.168 175.363 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.444 ' SD ' ' N ' ' A' ' 1' ' ' MET . 1.3 mpt? . . . . . 0 N--CA 1.475 0.795 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 38.6 m170 -86.6 114.54 23.41 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 123.447 0.699 . . . . 0.0 109.462 176.213 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 61.0 m80 -75.37 -29.07 59.75 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 124.395 1.078 . . . . 0.0 111.632 -177.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 11.4 m-70 68.64 115.24 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.693 0 C-N-CA 124.861 1.264 . . . . 0.0 112.23 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 36.6 m80 -120.45 137.39 54.36 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 123.672 0.789 . . . . 0.0 109.283 173.498 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 40.2 t60 -155.56 81.33 1.03 Allowed 'General case' 0 CA--C 1.542 0.638 0 N-CA-C 107.373 -1.343 . . . . 0.0 107.373 173.202 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 18.1 p-80 -82.56 136.98 34.7 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 123.857 0.863 . . . . 0.0 110.263 -178.403 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 20.1 m -82.84 -63.56 1.34 Allowed 'General case' 0 C--O 1.243 0.713 0 C-N-CA 122.974 0.51 . . . . 0.0 109.977 178.136 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 23.5 m 57.15 39.96 28.57 Favored 'General case' 0 CA--C 1.552 1.033 0 C-N-CA 124.13 0.972 . . . . 0.0 111.218 178.117 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -66.06 -23.35 71.23 Favored Glycine 0 C--N 1.357 1.698 0 CA-C-N 115.555 -0.748 . . . . 0.0 113.751 -175.437 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 26.1 mtm180 -99.73 142.05 31.73 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 123.394 0.678 . . . . 0.0 110.272 174.679 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -70.77 -56.64 5.91 Favored 'General case' 0 CA--C 1.539 0.557 0 O-C-N 124.241 0.963 . . . . 0.0 109.436 172.058 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 65.4 t30 58.64 18.84 6.18 Favored 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 125.281 1.432 . . . . 0.0 112.118 175.651 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.426 HD12 ' HB2' ' A' ' 15' ' ' TYR . 3.9 pp -80.66 -46.18 16.02 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 123.099 0.56 . . . . 0.0 111.173 -173.76 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . 0.426 ' HB2' HD12 ' A' ' 14' ' ' LEU . 33.1 m-85 -153.65 -80.6 0.09 Allowed 'General case' 0 N--CA 1.483 1.175 0 C-N-CA 124.336 1.054 . . . . 0.0 108.404 178.833 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 76.9 t80 47.59 77.61 0.09 Allowed 'General case' 0 CA--C 1.552 1.043 0 C-N-CA 125.498 1.519 . . . . 0.0 112.105 -178.388 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -123.94 -61.24 1.38 Allowed 'General case' 0 N--CA 1.479 1.002 0 N-CA-C 107.742 -1.207 . . . . 0.0 107.742 178.218 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 117.25 117.17 2.88 Favored Glycine 0 C--N 1.352 1.442 0 CA-C-N 115.155 -0.929 . . . . 0.0 111.486 179.354 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . 0.424 ' HD1' ' HB2' ' A' ' 21' ' ' ALA . 18.6 p80 -85.06 132.24 34.35 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 122.919 0.488 . . . . 0.0 110.122 -179.338 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 22.5 ptp -83.67 -31.91 25.88 Favored 'General case' 0 N--CA 1.474 0.768 0 CA-C-N 115.846 -0.616 . . . . 0.0 111.302 -177.845 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.424 ' HB2' ' HD1' ' A' ' 19' ' ' HIS . . . 52.33 93.44 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.379 0 C-N-CA 124.825 1.25 . . . . 0.0 112.52 177.302 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 28.3 m -60.88 -49.97 75.3 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 122.872 0.469 . . . . 0.0 111.183 -175.875 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 63.48 -95.62 0.15 Allowed Glycine 0 C--N 1.353 1.484 0 CA-C-N 115.483 -0.78 . . . . 0.0 111.486 -178.401 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 22.7 t -169.61 -179.39 3.35 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 124.628 1.171 . . . . 0.0 108.223 175.253 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 28.3 tt0 -145.42 29.13 1.16 Allowed 'General case' 0 N--CA 1.483 1.185 0 CA-C-O 121.956 0.884 . . . . 0.0 109.721 175.133 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -78.4 118.77 20.89 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 115.047 -0.979 . . . . 0.0 110.4 -179.53 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -91.48 30.04 1.38 Allowed 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 124.491 1.117 . . . . 0.0 110.8 -179.824 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 33.6 m -73.51 157.71 6.28 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.789 0 C-N-CA 124.784 1.234 . . . . 0.0 110.766 -177.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.404 HG21 ' HA ' ' A' ' 46' ' ' ASN . 17.1 m -68.36 109.27 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.988 0 CA-C-O 121.639 0.733 . . . . 0.0 110.422 -178.604 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 13.6 p -151.08 113.79 4.69 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 124.561 1.145 . . . . 0.0 108.408 -177.858 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 82.3 t -111.79 122.76 66.73 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 C-N-CA 124.38 1.072 . . . . 0.0 108.843 -176.759 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -79.5 116.74 19.89 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 123.112 0.565 . . . . 0.0 110.109 178.772 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.469 HD23 ' HB3' ' A' ' 43' ' ' PHE . 4.3 mm? -94.27 160.6 31.62 Favored Pre-proline 0 CA--C 1.555 1.167 0 C-N-CA 124.438 1.095 . . . . 0.0 109.128 177.362 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 13.1 Cg_endo -53.7 147.8 38.73 Favored 'Trans proline' 0 C--N 1.391 2.797 0 C-N-CA 123.22 2.613 . . . . 0.0 113.687 -177.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . 0.559 ' HB3' ' HB3' ' A' ' 41' ' ' LYS . . . -152.23 167.24 13.61 Favored Pre-proline 0 CA--C 1.538 0.498 0 C-N-CA 123.884 0.874 . . . . 0.0 111.871 -167.92 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_exo -56.1 146.57 69.59 Favored 'Trans proline' 0 C--N 1.38 2.214 0 C-N-CA 122.571 2.181 . . . . 0.0 110.83 158.059 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 61.4 p -66.34 -33.74 76.41 Favored 'General case' 0 CA--C 1.552 1.026 0 C-N-CA 123.149 0.58 . . . . 0.0 110.695 177.451 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 37.1 m -64.79 -41.3 95.93 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 124.686 1.194 . . . . 0.0 111.3 177.136 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' TRP . . . . . 0.41 ' HE1' ' HD2' ' A' ' 83' ' ' PRO . 41.8 m95 -102.04 -166.48 1.29 Allowed 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 123.93 0.892 . . . . 0.0 110.127 178.735 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.492 ' HB3' ' HB ' ' A' ' 59' ' ' VAL . 1.1 tppt? -148.41 154.35 39.79 Favored 'General case' 0 CA--C 1.535 0.38 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 164.468 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.559 ' HB3' ' HB3' ' A' ' 35' ' ' ALA . 17.5 tptm -121.66 122.48 39.7 Favored 'General case' 0 N--CA 1.468 0.444 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 -179.055 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 4.5 tt -124.55 136.93 54.38 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 175.359 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.469 ' HB3' HD23 ' A' ' 33' ' ' LEU . 28.9 t80 -115.62 133.88 55.6 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 125.007 1.323 . . . . 0.0 108.021 172.81 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 13.2 m-85 -94.77 106.75 26.42 Favored Pre-proline 0 CA--C 1.547 0.854 0 C-N-CA 123.284 0.634 . . . . 0.0 109.479 171.66 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -82.72 -161.26 0.14 Allowed 'Trans proline' 0 C--N 1.37 1.66 0 C-N-CA 122.728 2.286 . . . . 0.0 111.522 169.41 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . 0.404 ' HA ' HG21 ' A' ' 29' ' ' VAL . 34.7 t30 -155.82 -82.35 0.07 Allowed 'General case' 0 CA--C 1.544 0.735 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 172.59 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 58.7 tttp 176.64 -54.91 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 125.162 1.385 . . . . 0.0 107.759 -178.327 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 63.5 t -121.96 137.04 56.87 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.759 0 C-N-CA 124.104 0.962 . . . . 0.0 108.604 173.541 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -87.41 29.61 5.2 Favored Glycine 0 C--N 1.348 1.243 0 N-CA-C 113.958 0.343 . . . . 0.0 113.958 -177.454 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 44.7 m -106.97 7.44 29.92 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 123.707 0.803 . . . . 0.0 111.263 178.617 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 31.3 m -100.03 -172.01 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.055 0 C-N-CA 124.166 0.986 . . . . 0.0 109.836 178.507 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 80.9 tttt -63.77 -58.44 6.85 Favored 'General case' 0 CA--C 1.549 0.939 0 N-CA-C 109.581 -0.526 . . . . 0.0 109.581 170.133 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 28.8 ttpt 66.63 164.73 0.2 Allowed 'General case' 0 N--CA 1.486 1.368 0 C-N-CA 125.207 1.403 . . . . 0.0 110.326 -174.653 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 16.5 m -110.33 151.35 27.53 Favored 'General case' 0 CA--C 1.545 0.772 0 N-CA-C 108.134 -1.062 . . . . 0.0 108.134 173.281 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -83.45 -170.13 2.9 Favored 'General case' 0 CA--C 1.557 1.213 0 C-N-CA 123.826 0.85 . . . . 0.0 111.888 -172.186 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 64.4 t -83.11 131.08 34.59 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 C-N-CA 124.06 0.944 . . . . 0.0 109.745 176.705 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 61.0 t -121.91 117.81 53.59 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.858 0 C-N-CA 124.052 0.941 . . . . 0.0 109.297 179.448 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 36.1 m-85 -87.18 131.1 34.28 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 123.61 0.764 . . . . 0.0 110.064 169.6 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.539 ' HA ' ' HG3' ' A' ' 65' ' ' GLU . 10.8 t -82.35 129.27 37.75 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 171.045 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -85.26 150.41 54.65 Favored Pre-proline 0 CA--C 1.542 0.672 0 CA-C-N 114.889 -1.051 . . . . 0.0 110.71 179.052 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_endo -61.4 -24.86 79.19 Favored 'Trans proline' 0 CA--C 1.557 1.643 0 C-N-CA 123.543 2.829 . . . . 0.0 111.477 169.715 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 85.2 m -74.53 -35.08 63.13 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 125.296 1.438 . . . . 0.0 112.078 176.193 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 94.2 11.24 57.64 Favored Glycine 0 CA--C 1.534 1.227 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.763 -162.538 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -94.72 70.37 3.49 Favored 'General case' 0 CA--C 1.542 0.641 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 174.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 0.539 ' HG3' ' HA ' ' A' ' 59' ' ' VAL . 0.7 OUTLIER -57.78 129.89 43.95 Favored 'General case' 0 N--CA 1.478 0.943 0 CA-C-N 115.501 -0.772 . . . . 0.0 111.738 -174.599 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.409 HG22 ' HB2' ' A' ' 71' ' ' GLN . 40.2 mm -100.7 128.45 52.8 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 CA-C-N 114.982 -1.008 . . . . 0.0 109.58 -177.906 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 12.2 p -110.27 -0.73 17.61 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 124.064 0.946 . . . . 0.0 111.451 -178.226 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 11.8 p-10 -162.26 149.82 14.11 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 122.757 0.423 . . . . 0.0 111.113 -169.577 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.506 ' HG2' HD13 ' A' ' 85' ' ' ILE . 16.3 mtp180 -52.53 -40.3 62.33 Favored 'General case' 0 N--CA 1.486 1.337 0 C-N-CA 124.346 1.058 . . . . 0.0 112.831 -175.555 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 5.0 tmtm? -53.63 -56.6 15.85 Favored 'General case' 0 N--CA 1.48 1.07 0 O-C-N 124.29 0.993 . . . . 0.0 109.307 -177.857 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.409 ' HB2' HG22 ' A' ' 66' ' ' ILE . 14.8 mm100 -67.18 -25.74 66.29 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 115.485 -0.78 . . . . 0.0 111.814 -175.314 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.421 HD12 ' HB ' ' A' ' 85' ' ' ILE . 0.6 OUTLIER -69.12 -54.68 13.69 Favored 'General case' 0 N--CA 1.482 1.155 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 178.398 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -68.49 -41.15 80.5 Favored 'General case' 0 C--O 1.241 0.642 0 C-N-CA 123.81 0.844 . . . . 0.0 111.005 -171.731 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -68.63 -29.41 67.9 Favored 'General case' 0 C--N 1.355 0.805 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.87 175.484 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 47.1 t80 -64.89 -40.96 95.91 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 122.882 0.473 . . . . 0.0 110.398 174.105 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 79.9 mt -68.07 -37.21 81.01 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 122.974 0.51 . . . . 0.0 111.604 -176.756 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.1 -16.96 36.36 Favored 'General case' 0 N--CA 1.484 1.26 0 C-N-CA 122.772 0.429 . . . . 0.0 111.661 -179.91 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 34.1 t -93.77 -22.0 18.96 Favored 'General case' 0 N--CA 1.492 1.652 0 C-N-CA 123.12 0.568 . . . . 0.0 110.78 174.785 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 54.2 m80 -135.81 79.36 46.18 Favored Pre-proline 0 CA--C 1.547 0.855 0 N-CA-C 107.364 -1.347 . . . . 0.0 107.364 179.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_endo -61.92 144.06 96.17 Favored 'Trans proline' 0 C--N 1.376 1.98 0 C-N-CA 123.386 2.724 . . . . 0.0 112.838 -179.113 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 115.21 -33.55 5.24 Favored Glycine 0 C--N 1.344 0.995 0 CA-C-N 116.195 -0.457 . . . . 0.0 112.756 178.136 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 54.0 m-80 -68.17 140.19 93.03 Favored Pre-proline 0 CA--C 1.555 1.142 0 C-N-CA 122.922 0.489 . . . . 0.0 111.323 -177.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . 0.41 ' HD2' ' HE1' ' A' ' 39' ' ' TRP . 81.9 Cg_exo -46.78 150.58 2.5 Favored 'Trans proline' 0 C--N 1.381 2.262 0 C-N-CA 124.682 3.588 . . . . 0.0 115.194 -178.375 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -71.99 158.17 36.47 Favored 'General case' 0 N--CA 1.484 1.258 0 C-N-CA 124.145 0.978 . . . . 0.0 112.247 -171.608 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.506 HD13 ' HG2' ' A' ' 69' ' ' ARG . 16.8 tt -76.79 -22.15 14.87 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.825 0 N-CA-C 110.253 -0.277 . . . . 0.0 110.253 175.051 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -64.58 -19.38 65.62 Favored 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 123.759 0.824 . . . . 0.0 112.616 178.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 -102.54 -14.86 16.61 Favored 'General case' 0 CA--C 1.553 1.076 0 C-N-CA 123.189 0.596 . . . . 0.0 110.85 174.65 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 7.1 m-30 -81.51 113.41 19.54 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 123.659 0.784 . . . . 0.0 110.352 179.612 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -80.59 125.2 29.7 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 123.439 0.696 . . . . 0.0 109.556 177.396 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 64.1 m95 -111.56 -8.25 14.25 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 124.139 0.976 . . . . 0.0 109.623 169.741 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 9.4 t -107.65 15.56 24.57 Favored 'General case' 0 CA--C 1.553 1.085 0 C-N-CA 124.111 0.964 . . . . 0.0 112.667 -163.579 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 13.2 t -62.42 -16.7 56.52 Favored 'General case' 0 N--CA 1.496 1.861 0 C-N-CA 122.987 0.515 . . . . 0.0 111.452 175.766 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 15.7 t -60.47 -24.52 65.32 Favored 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 124.139 0.976 . . . . 0.0 112.251 177.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -139.8 -65.87 0.04 OUTLIER Glycine 0 C--N 1.347 1.192 0 N-CA-C 112.48 -0.248 . . . . 0.0 112.48 -178.203 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 2.7 t . . . . . 0 CA--C 1.562 1.411 0 C-N-CA 123.319 0.648 . . . . 0.0 110.728 -170.735 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 63.4 mtt . . . . . 0 N--CA 1.475 0.798 0 N-CA-C 109.832 -0.433 . . . . 0.0 109.832 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -176.15 92.21 0.05 OUTLIER 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 124.822 1.249 . . . . 0.0 109.257 168.19 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 55.5 t60 -72.46 87.72 1.19 Allowed 'General case' 0 CA--C 1.54 0.589 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 174.264 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 20.2 t60 -132.04 125.77 32.27 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 123.477 0.711 . . . . 0.0 109.854 -173.392 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 55.0 m80 -126.25 133.87 51.34 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 123.763 0.825 . . . . 0.0 108.776 174.607 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 6.0 t60 -132.09 112.28 12.19 Favored 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 107.937 -1.135 . . . . 0.0 107.937 177.715 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 81.1 m-70 -114.58 153.34 30.27 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 123.753 0.821 . . . . 0.0 109.22 174.274 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 24.9 t -157.37 164.49 37.5 Favored 'General case' 0 C--O 1.242 0.659 0 C-N-CA 123.236 0.614 . . . . 0.0 110.303 -174.416 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 32.4 p -79.76 -29.08 40.37 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 124.017 0.927 . . . . 0.0 111.173 -179.667 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 77.39 29.42 55.99 Favored Glycine 0 C--N 1.351 1.364 0 CA-C-N 116.002 -0.545 . . . . 0.0 112.224 -177.802 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 36.0 mmt180 -68.59 134.05 49.4 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 123.812 0.845 . . . . 0.0 111.62 -177.824 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -120.86 135.5 55.16 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 124.605 1.162 . . . . 0.0 109.482 -177.13 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 58.7 t30 -153.89 124.05 6.92 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 123.872 0.869 . . . . 0.0 108.724 174.58 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -146.08 179.64 7.35 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 124.626 1.17 . . . . 0.0 109.537 -179.094 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 40.0 p90 -81.83 127.79 33.36 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 122.795 0.438 . . . . 0.0 110.554 178.678 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 38.6 p90 -104.9 7.26 34.23 Favored 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 124.095 0.958 . . . . 0.0 111.078 -179.304 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 12.6 pt20 -61.16 147.31 44.53 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 124.142 0.977 . . . . 0.0 111.477 179.071 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -179.43 72.29 0.07 OUTLIER Glycine 0 C--N 1.342 0.882 0 CA-C-N 115.991 -0.549 . . . . 0.0 111.983 -179.299 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 34.3 m170 -103.65 126.87 51.07 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 123.312 0.645 . . . . 0.0 110.182 175.853 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 54.5 ttm -152.25 113.18 4.2 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 123.081 0.552 . . . . 0.0 110.384 177.144 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -147.55 101.86 3.39 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 107.742 -1.206 . . . . 0.0 107.742 173.876 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 65.4 p -159.3 172.23 18.38 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 123.008 0.523 . . . . 0.0 111.157 -173.445 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 95.3 137.82 9.27 Favored Glycine 0 C--N 1.348 1.247 0 CA-C-N 115.534 -0.757 . . . . 0.0 112.177 177.498 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 50.8 p -82.79 162.68 21.61 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 123.176 0.59 . . . . 0.0 110.515 174.684 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -79.17 71.93 5.7 Favored 'General case' 0 N--CA 1.477 0.904 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 176.041 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -138.34 99.54 3.88 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 123.963 0.905 . . . . 0.0 108.82 179.662 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -81.0 83.55 6.68 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 123.563 0.745 . . . . 0.0 109.127 175.652 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 2.8 m -136.03 145.61 30.73 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.874 0 C-N-CA 124.831 1.253 . . . . 0.0 109.391 -179.293 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 27.2 m -80.29 128.53 38.57 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.922 0 CA-C-O 121.398 0.618 . . . . 0.0 110.408 179.448 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.409 ' HA ' ' HD2' ' A' ' 45' ' ' PRO . 24.6 p -142.46 118.05 10.38 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 123.974 0.91 . . . . 0.0 108.773 177.41 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 65.7 t -100.31 115.55 41.82 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 -175.144 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -80.61 105.99 12.28 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 123.423 0.689 . . . . 0.0 109.94 -179.367 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.431 HD22 ' HB3' ' A' ' 43' ' ' PHE . 4.5 mm? -83.68 163.94 47.0 Favored Pre-proline 0 N--CA 1.484 1.239 0 C-N-CA 124.281 1.033 . . . . 0.0 109.69 178.933 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -63.2 150.31 88.94 Favored 'Trans proline' 0 C--N 1.385 2.489 0 C-N-CA 122.025 1.817 . . . . 0.0 113.339 -175.407 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -141.8 167.77 15.82 Favored Pre-proline 0 CA--C 1.545 0.759 0 C-N-CA 124.226 1.01 . . . . 0.0 110.255 -173.484 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_endo -63.5 155.76 60.66 Favored 'Trans proline' 0 C--N 1.383 2.362 0 C-N-CA 121.902 1.735 . . . . 0.0 110.575 162.463 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 21.6 m -61.81 -23.53 66.29 Favored 'General case' 0 N--CA 1.484 1.274 0 C-N-CA 123.586 0.754 . . . . 0.0 111.511 179.205 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 12.6 m -71.24 -38.3 71.96 Favored 'General case' 0 CA--C 1.552 1.033 0 C-N-CA 124.134 0.974 . . . . 0.0 111.841 179.293 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 26.5 m95 -119.24 -172.44 2.31 Favored 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 124.091 0.957 . . . . 0.0 111.051 -173.885 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 37.3 mtmt -138.7 143.87 39.32 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 124.677 1.191 . . . . 0.0 108.677 168.007 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 17.2 tptm -114.14 118.17 33.27 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 125.631 1.572 . . . . 0.0 108.638 -179.471 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 8.6 tt -120.02 125.96 49.65 Favored 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 175.698 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.431 ' HB3' HD22 ' A' ' 33' ' ' LEU . 87.0 t80 -103.58 134.57 46.7 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 124.441 1.096 . . . . 0.0 108.137 171.663 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . 0.401 ' HB2' ' O ' ' A' ' 55' ' ' GLU . 0.6 OUTLIER -100.01 104.52 29.47 Favored Pre-proline 0 CA--C 1.552 1.027 0 N-CA-C 109.392 -0.596 . . . . 0.0 109.392 174.635 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.409 ' HD2' ' HA ' ' A' ' 30' ' ' SER . 85.5 Cg_endo -79.38 158.89 26.02 Favored 'Trans proline' 0 C--N 1.37 1.71 0 C-N-CA 122.328 2.019 . . . . 0.0 110.431 166.452 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 24.5 t-20 -121.49 -84.45 0.66 Allowed 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 -178.828 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -137.77 -93.44 0.21 Allowed 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 123.605 0.762 . . . . 0.0 109.413 179.252 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 85.6 t -142.47 -60.39 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 N-CA-C 107.874 -1.158 . . . . 0.0 107.874 179.432 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -173.03 178.05 45.2 Favored Glycine 0 C--N 1.353 1.482 0 CA-C-N 115.796 -0.638 . . . . 0.0 112.76 -178.311 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 27.2 m 60.41 33.52 20.69 Favored 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 124.859 1.264 . . . . 0.0 111.107 -174.402 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 17.5 m -129.04 170.52 18.45 Favored 'Isoleucine or valine' 0 C--O 1.242 0.69 0 C-N-CA 124.555 1.142 . . . . 0.0 110.124 -174.738 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 60.3 pttt -65.23 -41.61 94.2 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 123.881 0.873 . . . . 0.0 110.164 174.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.632 ' HB3' ' HZ1' ' A' ' 53' ' ' LYS . 0.0 OUTLIER 66.14 141.85 0.03 OUTLIER 'General case' 0 C--N 1.372 1.582 0 C-N-CA 125.063 1.345 . . . . 0.0 111.851 175.71 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 6.1 p -110.65 153.54 25.07 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 123.969 0.908 . . . . 0.0 111.026 -177.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.401 ' O ' ' HB2' ' A' ' 44' ' ' TYR . 0.4 OUTLIER -102.69 -178.09 3.57 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 125.019 1.328 . . . . 0.0 112.387 -166.87 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.419 HG23 ' HD1' ' A' ' 43' ' ' PHE . 79.7 t -84.09 132.83 30.6 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.963 0 C-N-CA 124.651 1.18 . . . . 0.0 110.353 179.019 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 98.9 t -122.37 120.93 62.46 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 C-N-CA 123.842 0.857 . . . . 0.0 109.617 173.627 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 15.3 m-85 -90.93 123.96 34.83 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 123.233 0.613 . . . . 0.0 109.378 170.364 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 5.2 t -80.94 124.27 38.5 Favored 'Isoleucine or valine' 0 C--O 1.237 0.431 0 C-N-CA 123.377 0.671 . . . . 0.0 109.317 172.607 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -81.61 153.49 70.68 Favored Pre-proline 0 N--CA 1.468 0.473 0 CA-C-N 114.946 -1.024 . . . . 0.0 110.186 -179.701 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_endo -59.34 -33.19 97.65 Favored 'Trans proline' 0 C--N 1.377 2.073 0 C-N-CA 123.186 2.591 . . . . 0.0 112.787 178.063 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 14.8 t -91.09 -7.22 52.33 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 123.569 0.748 . . . . 0.0 111.551 -179.059 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 93.59 -1.58 69.17 Favored Glycine 0 C--N 1.351 1.365 0 CA-C-O 119.52 -0.6 . . . . 0.0 113.952 179.337 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -80.99 75.04 7.97 Favored 'General case' 0 N--CA 1.481 1.086 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 173.85 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -65.9 145.33 56.06 Favored 'General case' 0 CA--C 1.543 0.686 0 CA-C-N 114.886 -1.052 . . . . 0.0 111.879 -170.392 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.409 HG13 HD23 ' A' ' 72' ' ' LEU . 46.4 mm -101.11 127.31 54.46 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.571 0 C-N-CA 124.39 1.076 . . . . 0.0 109.813 -179.2 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 21.9 p -98.21 -14.5 20.3 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 123.668 0.787 . . . . 0.0 111.896 -177.878 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 13.1 p-10 -155.33 145.02 21.32 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 123.281 0.632 . . . . 0.0 110.543 -167.331 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.49 ' HG3' HD11 ' A' ' 85' ' ' ILE . 69.1 ttt180 -63.38 -26.74 68.89 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 124.459 1.104 . . . . 0.0 113.897 -165.559 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 1.4 tmtp? -66.0 -48.47 71.1 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 176.852 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.423 ' HA ' ' HG3' ' A' ' 74' ' ' GLN . 15.2 mm100 -63.76 -23.94 67.57 Favored 'General case' 0 N--CA 1.477 0.916 0 O-C-N 123.654 0.597 . . . . 0.0 112.034 -177.837 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.414 ' HB3' HD13 ' A' ' 85' ' ' ILE . 0.4 OUTLIER -64.28 -54.03 39.67 Favored 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 175.759 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.401 ' HG2' HG21 ' A' ' 85' ' ' ILE . 43.5 mt-10 -63.34 -46.5 86.35 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 123.85 0.86 . . . . 0.0 111.212 -174.02 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . 0.423 ' HG3' ' HA ' ' A' ' 71' ' ' GLN . 0.0 OUTLIER -69.97 -25.54 63.67 Favored 'General case' 0 CA--C 1.551 0.989 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.018 -178.851 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 28.1 t80 -65.34 -51.28 61.59 Favored 'General case' 0 C--N 1.358 0.959 0 C-N-CA 123.355 0.662 . . . . 0.0 109.534 173.47 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.403 ' HG ' ' O ' ' A' ' 72' ' ' LEU . 85.0 mt -60.83 -45.37 94.75 Favored 'General case' 0 N--CA 1.488 1.445 0 C-N-CA 123.668 0.787 . . . . 0.0 112.073 -172.621 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 19.0 ptpt -67.22 -32.54 73.65 Favored 'General case' 0 N--CA 1.481 1.122 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.207 178.688 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 34.8 t -85.54 -13.83 47.76 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 123.55 0.74 . . . . 0.0 111.594 -179.312 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 54.9 m80 -136.63 92.38 15.0 Favored Pre-proline 0 N--CA 1.485 1.298 0 C-N-CA 123.62 0.768 . . . . 0.0 109.368 -176.321 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -72.96 154.44 53.05 Favored 'Trans proline' 0 C--N 1.374 1.902 0 C-N-CA 122.7 2.267 . . . . 0.0 112.258 -179.3 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 102.81 -20.9 42.25 Favored Glycine 0 C--N 1.346 1.136 0 CA-C-N 115.893 -0.594 . . . . 0.0 112.205 -174.076 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 21.1 m120 -87.76 137.01 32.03 Favored Pre-proline 0 CA--C 1.553 1.069 0 C-N-CA 124.181 0.992 . . . . 0.0 110.194 179.422 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -72.38 159.43 49.34 Favored 'Trans proline' 0 C--N 1.38 2.234 0 C-N-CA 123.17 2.58 . . . . 0.0 112.908 -176.009 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -68.03 149.69 49.37 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 123.578 0.751 . . . . 0.0 112.138 -174.433 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.49 HD11 ' HG3' ' A' ' 69' ' ' ARG . 15.5 tt -68.05 -11.65 14.54 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.18 0 C-N-CA 123.922 0.889 . . . . 0.0 111.797 -178.928 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -56.92 -31.59 65.08 Favored 'General case' 0 CA--C 1.552 1.027 0 C-N-CA 124.311 1.045 . . . . 0.0 112.218 175.501 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -99.38 3.04 45.75 Favored 'General case' 0 N--CA 1.49 1.538 0 C-N-CA 123.4 0.68 . . . . 0.0 112.274 178.011 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -93.78 113.86 26.0 Favored 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 123.484 0.714 . . . . 0.0 109.386 -179.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -78.33 124.92 28.64 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 123.044 0.538 . . . . 0.0 110.454 -179.58 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 86.1 m95 -115.72 -6.55 12.14 Favored 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 123.821 0.848 . . . . 0.0 110.321 171.126 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 9.0 t -104.47 14.6 29.75 Favored 'General case' 0 N--CA 1.488 1.454 0 C-N-CA 124.708 1.203 . . . . 0.0 112.307 -166.261 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 12.9 t -65.7 -7.47 15.68 Favored 'General case' 0 N--CA 1.491 1.625 0 N-CA-C 113.571 0.952 . . . . 0.0 113.571 -176.718 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 15.7 m -45.9 100.52 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 125.382 1.473 . . . . 0.0 112.548 -175.676 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 95.79 -115.42 5.15 Favored Glycine 0 C--N 1.349 1.285 0 N-CA-C 110.981 -0.848 . . . . 0.0 110.981 -173.614 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 19.2 p . . . . . 0 N--CA 1.484 1.245 0 C-N-CA 124.133 0.973 . . . . 0.0 109.518 178.297 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.409 ' SD ' ' N ' ' A' ' 1' ' ' MET . 1.3 mpt? . . . . . 0 N--CA 1.479 1.021 0 N-CA-C 110.319 -0.252 . . . . 0.0 110.319 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 59.2 t-80 -132.05 75.42 1.64 Allowed 'General case' 0 N--CA 1.474 0.767 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 174.893 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 72.2 m-70 -132.88 156.71 46.71 Favored 'General case' 0 N--CA 1.482 1.162 0 CA-C-N 115.19 -0.914 . . . . 0.0 110.226 -179.689 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 73.1 m80 -105.5 130.97 53.45 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 123.672 0.789 . . . . 0.0 110.172 178.537 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 69.6 m-70 -134.32 150.14 50.94 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 124.539 1.135 . . . . 0.0 109.017 177.384 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 59.2 t-80 59.76 71.95 0.55 Allowed 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 124.432 1.093 . . . . 0.0 110.597 -178.349 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 9.4 t-160 -86.35 101.82 13.44 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-N 116.002 -0.545 . . . . 0.0 109.595 -179.629 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 17.1 m -67.69 106.85 2.35 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 123.709 0.804 . . . . 0.0 110.056 177.175 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 48.9 m -140.12 157.53 45.48 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 123.894 0.878 . . . . 0.0 110.317 -177.599 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -157.01 104.42 0.25 Allowed Glycine 0 C--N 1.344 1.027 0 CA-C-N 116.375 -0.375 . . . . 0.0 112.667 179.46 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 33.6 mmt180 -128.46 94.49 3.89 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 123.959 0.904 . . . . 0.0 109.483 179.446 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -118.11 104.71 11.1 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 124.639 1.176 . . . . 0.0 108.597 175.009 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 48.6 t-20 -146.93 127.0 13.7 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 123.659 0.784 . . . . 0.0 109.314 179.098 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -165.69 -179.0 5.12 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 124.605 1.162 . . . . 0.0 109.193 178.582 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 4.9 p90 -99.05 103.83 15.81 Favored 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 170.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 69.9 t80 -83.24 83.87 7.7 Favored 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 179.196 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 10.3 pt20 -163.2 151.3 13.64 Favored 'General case' 0 C--O 1.248 0.996 0 CA-C-N 115.459 -0.791 . . . . 0.0 109.315 -179.607 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -141.9 83.28 0.22 Allowed Glycine 0 C--N 1.341 0.825 0 N-CA-C 111.068 -0.813 . . . . 0.0 111.068 -178.287 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 58.6 m170 -70.99 138.07 49.63 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 123.446 0.698 . . . . 0.0 110.553 -178.742 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 19.6 ptp -108.08 102.88 12.0 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 123.502 0.721 . . . . 0.0 109.35 177.795 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -149.24 143.08 25.66 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 123.912 0.885 . . . . 0.0 109.872 -177.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 37.9 m -133.44 100.41 4.81 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 123.853 0.861 . . . . 0.0 109.168 179.667 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -150.16 -99.54 0.2 Allowed Glycine 0 C--N 1.347 1.191 0 N-CA-C 111.878 -0.489 . . . . 0.0 111.878 -179.901 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 55.8 p -169.57 165.45 10.26 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 124.249 1.019 . . . . 0.0 109.801 179.301 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -142.92 80.27 1.68 Allowed 'General case' 0 N--CA 1.479 0.983 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 178.117 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -124.22 85.87 2.48 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 123.436 0.694 . . . . 0.0 109.39 -177.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 11.7 tp10 -92.47 98.16 11.29 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-N 115.304 -0.862 . . . . 0.0 109.429 178.337 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 27.4 m -81.33 138.2 20.0 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.043 0 C-N-CA 122.93 0.492 . . . . 0.0 110.035 177.589 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 31.6 m -69.24 125.13 26.56 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.795 0 CA-C-O 121.204 0.526 . . . . 0.0 110.05 -179.894 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 3.8 m -142.96 128.2 18.73 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 123.998 0.919 . . . . 0.0 108.661 -175.619 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 26.2 t -122.4 124.76 71.6 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.935 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 178.75 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.49 ' HA ' ' HA ' ' A' ' 42' ' ' LEU . 48.0 mt-10 -82.31 108.05 15.45 Favored 'General case' 0 C--O 1.237 0.432 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 174.74 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.513 HD23 ' HB3' ' A' ' 43' ' ' PHE . 3.8 mm? -77.89 159.88 75.25 Favored Pre-proline 0 CA--C 1.555 1.167 0 CA-C-N 115.206 -0.907 . . . . 0.0 109.352 178.756 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -53.78 127.0 23.75 Favored 'Trans proline' 0 C--N 1.385 2.475 0 C-N-CA 122.952 2.435 . . . . 0.0 112.693 -174.293 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -113.15 158.1 39.03 Favored Pre-proline 0 N--CA 1.468 0.469 0 C-N-CA 124.063 0.945 . . . . 0.0 111.576 -169.187 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.621 ' HG2' ' HB2' ' A' ' 39' ' ' TRP . 46.6 Cg_endo -68.66 142.88 54.43 Favored 'Trans proline' 0 C--N 1.374 1.871 0 C-N-CA 122.007 1.804 . . . . 0.0 110.046 162.453 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 36.8 m -58.15 -25.38 61.41 Favored 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 124.095 0.958 . . . . 0.0 112.823 -175.007 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 45.8 t -74.61 -41.47 60.36 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 123.175 0.59 . . . . 0.0 110.822 178.185 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' TRP . . . . . 0.621 ' HB2' ' HG2' ' A' ' 36' ' ' PRO . 21.4 m95 -108.2 -167.61 1.26 Allowed 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 123.678 0.791 . . . . 0.0 110.724 -175.418 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.472 ' HB2' ' HB ' ' A' ' 59' ' ' VAL . 8.4 mtmt -137.47 150.32 47.49 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 124.679 1.192 . . . . 0.0 108.099 167.739 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 18.8 tptm -127.59 115.7 19.2 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 124.855 1.262 . . . . 0.0 108.289 -173.194 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.49 ' HA ' ' HA ' ' A' ' 32' ' ' GLU . 3.6 tt -119.26 147.49 44.21 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 124.407 1.083 . . . . 0.0 108.951 178.536 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.513 ' HB3' HD23 ' A' ' 33' ' ' LEU . 45.6 t80 -134.18 140.54 46.6 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 124.844 1.258 . . . . 0.0 108.392 171.734 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 33.3 m-85 -97.16 105.57 25.51 Favored Pre-proline 0 CA--C 1.55 0.948 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 173.141 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 79.1 Cg_endo -73.99 151.56 45.05 Favored 'Trans proline' 0 C--N 1.377 2.036 0 C-N-CA 122.497 2.132 . . . . 0.0 112.719 174.793 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 17.1 p-10 -90.8 129.0 36.91 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.077 174.578 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 58.0 tptt -57.85 -52.97 63.28 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 124.423 1.089 . . . . 0.0 110.681 -178.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 42.3 t -96.81 151.03 4.21 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 C-N-CA 124.282 1.033 . . . . 0.0 108.522 174.722 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -71.74 165.7 53.6 Favored Glycine 0 CA--C 1.543 1.814 0 CA-C-O 120.249 -0.195 . . . . 0.0 112.881 177.214 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 16.6 m 76.02 -47.35 0.56 Allowed 'General case' 0 N--CA 1.498 1.935 0 C-N-CA 126.157 1.783 . . . . 0.0 113.185 176.833 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 22.4 m -62.61 134.63 27.78 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.113 0 C-N-CA 123.623 0.769 . . . . 0.0 112.261 -178.4 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 57.4 mtpt -86.74 109.29 19.13 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 123.338 0.655 . . . . 0.0 110.646 -178.833 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.529 ' HE3' ' HA ' ' A' ' 53' ' ' LYS . 0.1 OUTLIER -93.61 -177.26 4.33 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 123.556 0.742 . . . . 0.0 109.979 171.806 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 23.9 m -55.86 142.69 34.25 Favored 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 124.013 0.925 . . . . 0.0 111.153 -178.329 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -77.33 -165.67 0.62 Allowed 'General case' 0 CA--C 1.55 0.959 0 C-N-CA 123.883 0.873 . . . . 0.0 111.223 -176.493 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 47.1 t -79.26 138.43 20.02 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.637 0 C-N-CA 123.974 0.909 . . . . 0.0 109.912 -179.735 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 60.5 t -125.46 118.43 52.42 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.663 0 C-N-CA 123.823 0.849 . . . . 0.0 108.824 174.791 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 24.7 m-85 -86.71 126.69 34.73 Favored 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 170.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.472 ' HB ' ' HB2' ' A' ' 40' ' ' LYS . 4.6 t -81.72 128.54 38.63 Favored 'Isoleucine or valine' 0 C--O 1.241 0.623 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 170.213 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -84.65 147.91 50.39 Favored Pre-proline 0 C--O 1.242 0.7 0 CA-C-N 115.246 -0.888 . . . . 0.0 110.916 -178.747 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 27.4 Cg_endo -63.18 -23.47 72.89 Favored 'Trans proline' 0 C--N 1.371 1.713 0 C-N-CA 123.112 2.541 . . . . 0.0 112.826 174.569 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.552 HG23 ' H ' ' A' ' 64' ' ' GLU . 12.9 t -91.94 -10.95 37.62 Favored 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 123.059 0.544 . . . . 0.0 111.413 176.308 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 91.99 -8.8 77.67 Favored Glycine 0 C--N 1.355 1.607 0 CA-C-O 120.03 -0.317 . . . . 0.0 113.813 -178.034 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.552 ' H ' HG23 ' A' ' 62' ' ' THR . 9.4 tp10 -76.94 76.68 3.51 Favored 'General case' 0 N--CA 1.486 1.335 0 N-CA-C 108.612 -0.885 . . . . 0.0 108.612 173.137 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -63.76 149.17 47.39 Favored 'General case' 0 C--O 1.241 0.611 0 CA-C-N 115.083 -0.962 . . . . 0.0 111.706 -171.299 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.455 HG23 ' HB2' ' A' ' 71' ' ' GLN . 46.7 mm -115.59 119.96 63.35 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.732 0 CA-C-N 114.638 -1.165 . . . . 0.0 109.309 -174.726 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 14.4 p -106.47 -8.99 16.85 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 123.403 0.681 . . . . 0.0 112.511 -177.0 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 10.9 p30 -144.36 159.26 43.01 Favored 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 122.499 0.32 . . . . 0.0 111.084 175.231 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.481 ' HG3' HD13 ' A' ' 85' ' ' ILE . 50.7 ttt-85 -60.1 -35.85 76.14 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 124.446 1.098 . . . . 0.0 112.349 -173.49 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 1.8 tmtp? -59.91 -51.21 70.66 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 123.255 0.622 . . . . 0.0 109.372 179.189 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.455 ' HB2' HG23 ' A' ' 66' ' ' ILE . 84.1 mm-40 -57.86 -31.49 66.74 Favored 'General case' 0 CA--C 1.55 0.963 0 O-C-N 123.932 0.77 . . . . 0.0 110.949 -179.003 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -67.73 -51.28 51.2 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 123.666 0.786 . . . . 0.0 109.52 178.334 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -61.65 -50.87 70.77 Favored 'General case' 0 N--CA 1.484 1.259 0 C-N-CA 124.087 0.955 . . . . 0.0 111.472 -175.663 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 1.3 pp0? -65.86 -32.2 73.59 Favored 'General case' 0 CA--C 1.544 0.747 0 CA-C-N 115.495 -0.775 . . . . 0.0 111.178 -178.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 29.8 t80 -60.64 -51.11 70.77 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 123.334 0.654 . . . . 0.0 110.213 176.1 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.467 HD13 ' HA ' ' A' ' 84' ' ' ALA . 89.0 mt -65.33 -45.21 85.15 Favored 'General case' 0 N--CA 1.479 0.986 0 O-C-N 123.799 0.687 . . . . 0.0 111.994 -172.191 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.28 -20.24 63.05 Favored 'General case' 0 N--CA 1.481 1.094 0 CA-C-O 120.902 0.382 . . . . 0.0 111.211 179.601 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 34.2 t -92.53 -18.78 22.69 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 123.766 0.826 . . . . 0.0 111.574 175.184 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 54.3 m80 -135.2 93.7 16.6 Favored Pre-proline 0 N--CA 1.476 0.86 0 C-N-CA 123.587 0.755 . . . . 0.0 109.663 -174.71 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -71.92 162.71 41.1 Favored 'Trans proline' 0 C--N 1.371 1.732 0 C-N-CA 122.394 2.063 . . . . 0.0 111.804 175.742 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 87.9 -4.06 85.75 Favored Glycine 0 N--CA 1.472 1.05 0 CA-C-N 116.413 -0.358 . . . . 0.0 113.298 -177.51 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 32.0 m-80 -97.43 145.0 28.91 Favored Pre-proline 0 N--CA 1.482 1.171 0 C-N-CA 123.659 0.784 . . . . 0.0 109.991 177.698 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_endo -65.32 144.43 80.45 Favored 'Trans proline' 0 C--N 1.377 2.049 0 C-N-CA 122.561 2.174 . . . . 0.0 111.878 179.286 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . 0.467 ' HA ' HD13 ' A' ' 76' ' ' LEU . . . -70.68 162.03 29.75 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 123.809 0.843 . . . . 0.0 112.305 -171.219 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.481 HD13 ' HG3' ' A' ' 69' ' ' ARG . 17.5 tt -74.29 -15.54 16.45 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.095 0 CA-C-O 120.941 0.401 . . . . 0.0 110.924 179.24 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -60.02 -34.35 73.25 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 124.304 1.042 . . . . 0.0 112.081 175.649 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.425 ' HG2' ' O ' ' A' ' 84' ' ' ALA . 10.2 pt-20 -98.13 -2.65 39.5 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 123.761 0.825 . . . . 0.0 111.172 -178.715 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 3.6 m-30 -90.49 152.48 20.92 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 123.471 0.708 . . . . 0.0 110.144 176.055 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -120.3 122.74 41.5 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 123.464 0.706 . . . . 0.0 109.943 178.167 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 88.9 m95 -111.64 -2.0 15.54 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 123.798 0.839 . . . . 0.0 110.512 172.075 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 12.5 t -107.54 15.83 24.39 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 123.639 0.776 . . . . 0.0 112.145 -168.252 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 15.4 t -62.05 -20.12 63.63 Favored 'General case' 0 N--CA 1.492 1.64 0 C-N-CA 123.077 0.551 . . . . 0.0 111.734 -179.908 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 15.3 p -72.55 79.88 1.07 Allowed 'General case' 0 CA--C 1.553 1.064 0 C-N-CA 123.835 0.854 . . . . 0.0 110.455 176.776 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -91.76 123.22 7.11 Favored Glycine 0 C--N 1.346 1.123 0 CA-C-N 115.519 -0.764 . . . . 0.0 111.212 176.091 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 31.8 p . . . . . 0 C--O 1.252 1.212 0 C-N-CA 123.505 0.722 . . . . 0.0 110.27 179.198 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.441 ' SD ' ' N ' ' A' ' 1' ' ' MET . 1.3 mpt? . . . . . 0 N--CA 1.48 1.051 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 35.5 t-80 -170.59 135.45 1.17 Allowed 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 124.416 1.086 . . . . 0.0 108.375 -179.38 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 13.8 t60 -87.11 75.3 9.47 Favored 'General case' 0 N--CA 1.479 0.981 0 CA-C-O 120.953 0.406 . . . . 0.0 109.961 -176.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 63.6 m170 53.52 -91.97 0.03 OUTLIER 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 125.496 1.518 . . . . 0.0 112.367 -179.505 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 3.2 p80 174.0 147.79 0.07 Allowed 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 125.35 1.46 . . . . 0.0 108.608 -176.831 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 92.4 m-70 -139.02 112.48 8.22 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 123.627 0.771 . . . . 0.0 109.252 179.831 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 62.3 m80 -144.98 135.11 23.94 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 124.457 1.103 . . . . 0.0 110.05 177.816 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 37.7 t -85.08 129.54 34.78 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 124.326 1.051 . . . . 0.0 109.753 -179.849 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 25.5 p -84.78 88.89 7.42 Favored 'General case' 0 CA--C 1.551 0.99 0 C-N-CA 123.841 0.856 . . . . 0.0 110.745 -176.709 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -103.07 161.2 16.51 Favored Glycine 0 C--N 1.347 1.15 0 CA-C-N 115.173 -0.921 . . . . 0.0 111.802 176.646 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 2.4 mpt_? -115.05 154.31 29.1 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 123.773 0.829 . . . . 0.0 109.617 -175.418 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -100.93 -63.35 1.14 Allowed 'General case' 0 N--CA 1.476 0.845 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 168.586 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 7.9 t30 56.53 83.93 0.09 Allowed 'General case' 0 C--N 1.357 0.906 0 C-N-CA 125.129 1.372 . . . . 0.0 112.144 179.88 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -118.17 128.48 54.76 Favored 'General case' 0 N--CA 1.477 0.915 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 170.111 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 27.8 p90 -94.61 -54.13 3.62 Favored 'General case' 0 C--O 1.239 0.502 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 171.285 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 41.7 t80 51.22 25.96 2.71 Favored 'General case' 0 CA--C 1.566 1.568 0 C-N-CA 125.467 1.507 . . . . 0.0 112.034 177.691 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 14.2 pt20 -100.03 147.32 25.74 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 124.119 0.968 . . . . 0.0 110.102 -175.902 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -171.03 133.47 2.78 Favored Glycine 0 C--N 1.338 0.688 0 N-CA-C 111.466 -0.654 . . . . 0.0 111.466 -177.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 50.3 p-80 -86.54 124.3 32.69 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 123.456 0.702 . . . . 0.0 109.157 178.917 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' MET . . . . . 0.502 ' HA ' ' HE3' ' A' ' 20' ' ' MET . 3.9 mmt -133.41 122.04 23.14 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 123.59 0.756 . . . . 0.0 109.703 -179.735 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -109.28 -19.24 13.37 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 123.798 0.839 . . . . 0.0 111.017 177.565 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 44.2 m -80.49 126.56 31.37 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 123.464 0.706 . . . . 0.0 110.217 179.254 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -73.74 -48.31 17.52 Favored Glycine 0 C--N 1.344 1.026 0 O-C-N 123.669 0.605 . . . . 0.0 111.982 178.921 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 56.0 p -80.68 79.69 7.28 Favored 'General case' 0 C--O 1.247 0.928 0 C-N-CA 123.519 0.727 . . . . 0.0 109.795 174.643 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -86.46 111.33 20.44 Favored 'General case' 0 C--O 1.239 0.505 0 CA-C-N 115.2 -0.909 . . . . 0.0 108.879 179.557 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 -102.07 33.38 3.08 Favored 'General case' 0 CA--C 1.552 1.049 0 C-N-CA 123.838 0.855 . . . . 0.0 110.724 -177.577 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 16.4 mm-40 -78.65 81.55 4.96 Favored 'General case' 0 N--CA 1.479 0.989 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 172.398 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 27.5 m -101.14 174.95 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 CA-C-N 114.166 -1.379 . . . . 0.0 110.558 -175.144 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 19.2 m -71.11 104.74 1.44 Allowed 'Isoleucine or valine' 0 CA--C 1.555 1.162 0 CA-C-O 121.898 0.856 . . . . 0.0 109.815 175.657 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 39.9 p -171.91 141.22 1.34 Allowed 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 125.202 1.401 . . . . 0.0 107.948 -177.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.431 HG21 ' HG3' ' A' ' 45' ' ' PRO . 59.9 t -117.92 126.51 74.9 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 -178.972 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -84.97 105.13 15.5 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 123.58 0.752 . . . . 0.0 108.982 176.512 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.476 HD22 ' HB3' ' A' ' 43' ' ' PHE . 4.4 mm? -82.56 163.54 51.48 Favored Pre-proline 0 N--CA 1.48 1.057 0 C-N-CA 123.82 0.848 . . . . 0.0 110.192 -178.564 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -57.25 137.16 80.45 Favored 'Trans proline' 0 C--N 1.39 2.759 0 C-N-CA 122.683 2.255 . . . . 0.0 112.797 -179.536 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . 0.531 ' HB1' ' HB3' ' A' ' 41' ' ' LYS . . . -123.48 161.72 44.19 Favored Pre-proline 0 N--CA 1.476 0.86 0 C-N-CA 124.298 1.039 . . . . 0.0 111.742 -172.766 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.687 ' HG2' ' HB2' ' A' ' 39' ' ' TRP . 31.6 Cg_endo -63.72 146.36 92.07 Favored 'Trans proline' 0 C--N 1.375 1.926 0 C-N-CA 122.551 2.167 . . . . 0.0 109.669 159.028 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 18.5 m -59.04 -37.95 78.18 Favored 'General case' 0 N--CA 1.489 1.477 0 C-N-CA 124.179 0.992 . . . . 0.0 112.838 -169.734 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 48.5 m -69.81 -35.05 74.51 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 123.574 0.75 . . . . 0.0 111.528 -179.907 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' TRP . . . . . 0.687 ' HB2' ' HG2' ' A' ' 36' ' ' PRO . 33.3 m95 -104.6 -179.89 4.08 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 123.782 0.833 . . . . 0.0 110.566 -175.678 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.36 152.42 51.44 Favored 'General case' 0 N--CA 1.476 0.844 0 N-CA-C 107.556 -1.276 . . . . 0.0 107.556 173.743 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.531 ' HB3' ' HB1' ' A' ' 35' ' ' ALA . 18.2 tptm -132.53 117.8 18.45 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 123.922 0.889 . . . . 0.0 109.812 -171.717 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 2.3 tt -122.24 144.7 48.82 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 124.762 1.225 . . . . 0.0 108.604 174.459 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.476 ' HB3' HD22 ' A' ' 33' ' ' LEU . 47.6 t80 -128.1 147.64 50.54 Favored 'General case' 0 C--O 1.238 0.482 0 C-N-CA 124.701 1.201 . . . . 0.0 108.98 171.405 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 18.2 m-85 -102.18 100.97 16.78 Favored Pre-proline 0 CA--C 1.551 0.994 0 C-N-CA 123.651 0.781 . . . . 0.0 110.147 171.895 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.431 ' HG3' HG21 ' A' ' 31' ' ' VAL . 30.9 Cg_endo -86.71 -174.65 1.46 Allowed 'Trans proline' 0 C--N 1.373 1.852 0 C-N-CA 123.435 2.756 . . . . 0.0 113.342 175.993 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . 0.624 ' HB2' ' HA ' ' A' ' 51' ' ' VAL . 3.9 p-10 -127.44 148.02 50.29 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 124.283 1.033 . . . . 0.0 108.765 174.251 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 73.0 mmtt -127.21 97.47 4.93 Favored 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 123.372 0.669 . . . . 0.0 111.461 -172.456 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 32.6 t 43.55 84.25 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 C-N-CA 126.179 1.792 . . . . 0.0 113.48 169.545 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 87.17 -46.54 3.54 Favored Glycine 0 C--N 1.341 0.828 0 CA-C-N 116.28 -0.418 . . . . 0.0 112.492 -177.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 49.4 m -71.19 81.52 0.71 Allowed 'General case' 0 C--N 1.359 0.984 0 CA-C-O 121.656 0.741 . . . . 0.0 109.999 175.122 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.624 ' HA ' ' HB2' ' A' ' 46' ' ' ASN . 16.4 m -94.87 115.85 34.75 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.613 0 CA-C-N 114.965 -1.016 . . . . 0.0 110.238 -178.235 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 44.5 tptt -155.7 30.54 0.37 Allowed 'General case' 0 CA--C 1.549 0.917 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 177.9 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -63.95 135.07 56.19 Favored 'General case' 0 C--N 1.354 0.796 0 CA-C-N 114.928 -1.033 . . . . 0.0 110.063 -178.549 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 24.9 m -130.82 162.49 29.47 Favored 'General case' 0 C--O 1.241 0.633 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 -177.097 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -60.4 172.95 0.75 Allowed 'General case' 0 CA--C 1.549 0.939 0 CA-C-O 122.547 1.165 . . . . 0.0 112.16 176.363 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 20.5 t -80.52 145.88 8.41 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.668 0 CA-C-N 113.764 -1.562 . . . . 0.0 110.519 -174.512 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 49.1 t -121.77 116.55 49.72 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.804 0 C-N-CA 123.969 0.908 . . . . 0.0 109.007 172.219 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 33.9 m-85 -90.3 132.79 35.36 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 123.618 0.767 . . . . 0.0 110.255 171.424 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.419 ' HA ' ' HG2' ' A' ' 65' ' ' GLU . 14.8 t -85.59 132.19 32.49 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 168.477 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -87.4 153.7 53.6 Favored Pre-proline 0 C--O 1.244 0.772 0 CA-C-N 115.317 -0.856 . . . . 0.0 110.638 179.739 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_endo -69.43 -3.02 10.94 Favored 'Trans proline' 0 C--N 1.376 1.974 0 C-N-CA 122.865 2.377 . . . . 0.0 113.062 177.667 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.478 HG22 ' H ' ' A' ' 64' ' ' GLU . 12.3 t -115.62 -7.97 12.13 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 124.129 0.972 . . . . 0.0 111.401 -179.902 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 94.16 -15.2 63.72 Favored Glycine 0 C--N 1.358 1.783 0 CA-C-O 119.695 -0.503 . . . . 0.0 113.791 -179.547 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.478 ' H ' HG22 ' A' ' 62' ' ' THR . 42.9 tt0 -78.4 80.12 4.81 Favored 'General case' 0 N--CA 1.484 1.265 0 CA-C-O 121.67 0.748 . . . . 0.0 109.335 173.394 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 0.419 ' HG2' ' HA ' ' A' ' 59' ' ' VAL . 28.3 mt-10 -69.73 156.46 38.96 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 124.43 1.092 . . . . 0.0 111.73 -170.224 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 41.0 mm -111.19 122.51 65.78 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.613 0 C-N-CA 123.855 0.862 . . . . 0.0 109.481 178.138 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 61.6 p -99.65 -11.45 20.91 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 123.481 0.712 . . . . 0.0 112.506 -177.817 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -153.94 150.54 28.43 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 122.598 0.359 . . . . 0.0 111.315 -177.804 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.429 ' HG3' HD11 ' A' ' 85' ' ' ILE . 41.5 ttm105 -54.98 -32.4 61.64 Favored 'General case' 0 N--CA 1.491 1.588 0 C-N-CA 125.369 1.468 . . . . 0.0 114.143 -168.196 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -60.05 -54.37 46.83 Favored 'General case' 0 N--CA 1.487 1.404 0 C-N-CA 123.356 0.662 . . . . 0.0 109.648 -179.798 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.456 ' O ' ' HB2' ' A' ' 75' ' ' TYR . 90.1 mm-40 -64.2 -20.97 66.38 Favored 'General case' 0 N--CA 1.476 0.841 0 CA-C-N 115.347 -0.842 . . . . 0.0 111.778 -176.564 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.431 ' O ' ' HG ' ' A' ' 76' ' ' LEU . 0.9 OUTLIER -69.85 -52.97 20.43 Favored 'General case' 0 N--CA 1.481 1.091 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 175.697 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -58.0 -54.42 47.11 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 123.971 0.908 . . . . 0.0 111.766 -178.752 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . 0.426 ' HG3' ' HA ' ' A' ' 71' ' ' GLN . 0.0 OUTLIER -67.5 -24.29 65.56 Favored 'General case' 0 CA--C 1.551 0.993 0 CA-C-N 115.455 -0.793 . . . . 0.0 111.077 -177.685 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . 0.456 ' HB2' ' O ' ' A' ' 71' ' ' GLN . 35.6 t80 -65.94 -55.27 17.71 Favored 'General case' 0 C--N 1.36 1.032 0 C-N-CA 123.097 0.559 . . . . 0.0 109.706 174.383 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.431 ' HG ' ' O ' ' A' ' 72' ' ' LEU . 71.2 mt -59.96 -39.47 85.71 Favored 'General case' 0 N--CA 1.489 1.514 0 C-N-CA 123.436 0.694 . . . . 0.0 111.855 -172.629 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.95 -14.35 58.66 Favored 'General case' 0 N--CA 1.484 1.269 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.824 -179.517 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 37.5 t -102.02 -9.6 20.47 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 123.621 0.768 . . . . 0.0 111.198 172.697 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 86.5 m-70 -137.45 87.23 18.05 Favored Pre-proline 0 N--CA 1.481 1.083 0 C-N-CA 124.189 0.995 . . . . 0.0 109.363 -177.132 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 63.2 Cg_endo -71.35 141.65 39.4 Favored 'Trans proline' 0 C--N 1.374 1.874 0 C-N-CA 122.403 2.069 . . . . 0.0 111.126 174.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 116.58 -20.24 12.24 Favored Glycine 0 N--CA 1.471 1.032 0 N-CA-C 111.695 -0.562 . . . . 0.0 111.695 -174.245 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 39.4 m-80 -91.67 140.51 25.17 Favored Pre-proline 0 CA--C 1.548 0.892 0 C-N-CA 123.435 0.694 . . . . 0.0 109.717 177.351 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -70.07 159.42 53.24 Favored 'Trans proline' 0 C--N 1.377 2.045 0 C-N-CA 122.845 2.363 . . . . 0.0 112.983 -178.65 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -70.0 154.55 41.81 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 123.949 0.9 . . . . 0.0 112.477 -173.432 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.429 HD11 ' HG3' ' A' ' 69' ' ' ARG . 16.2 tt -66.82 -12.01 14.34 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.209 0 C-N-CA 124.171 0.988 . . . . 0.0 111.686 -179.227 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -52.89 -39.8 62.99 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 124.505 1.122 . . . . 0.0 112.05 174.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -94.4 -8.14 39.57 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 123.526 0.73 . . . . 0.0 112.044 178.902 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -86.56 110.86 20.09 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 123.444 0.698 . . . . 0.0 109.314 176.39 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . 0.42 ' HB3' ' HZ2' ' A' ' 41' ' ' LYS . 11.6 t70 -87.63 126.56 35.02 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 123.683 0.793 . . . . 0.0 109.882 -178.744 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 85.2 m95 -118.29 -3.96 10.96 Favored 'General case' 0 CA--C 1.555 1.173 0 C-N-CA 125.126 1.37 . . . . 0.0 110.106 172.456 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 15.1 t -108.62 14.13 24.73 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 124.025 0.93 . . . . 0.0 112.18 -168.046 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 9.4 t -62.39 -15.31 48.12 Favored 'General case' 0 N--CA 1.493 1.709 0 C-N-CA 123.0 0.52 . . . . 0.0 112.248 178.617 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 10.4 p -57.93 -12.47 3.26 Favored 'General case' 0 CA--C 1.554 1.107 0 C-N-CA 125.549 1.539 . . . . 0.0 113.693 176.469 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -167.99 158.27 30.97 Favored Glycine 0 C--N 1.338 0.675 0 N-CA-C 111.551 -0.62 . . . . 0.0 111.551 173.63 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 12.4 t . . . . . 0 CA--C 1.559 1.293 0 C-N-CA 122.915 0.486 . . . . 0.0 110.089 177.619 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.5 mpp? . . . . . 0 N--CA 1.478 0.944 0 N-CA-C 109.519 -0.548 . . . . 0.0 109.519 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 22.4 m-70 -102.94 113.64 27.27 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 173.854 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 7.8 p-80 -68.35 -31.49 70.93 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 123.383 0.673 . . . . 0.0 112.115 -178.503 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 71.4 m-70 63.15 163.69 0.11 Allowed 'General case' 0 N--CA 1.493 1.684 0 C-N-CA 124.863 1.265 . . . . 0.0 111.679 -175.034 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 16.1 m170 -148.7 90.73 1.8 Allowed 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 123.859 0.864 . . . . 0.0 109.068 174.854 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 54.9 t-80 -80.03 86.2 5.53 Favored 'General case' 0 C--O 1.242 0.672 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 176.876 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 8.4 p80 -97.42 114.26 26.07 Favored 'General case' 0 C--O 1.242 0.658 0 CA-C-N 115.163 -0.926 . . . . 0.0 109.181 176.807 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 49.9 m -141.8 82.25 1.8 Allowed 'General case' 0 C--O 1.24 0.575 0 C-N-CA 123.628 0.771 . . . . 0.0 109.808 -179.528 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 47.9 p -156.78 133.98 10.51 Favored 'General case' 0 C--O 1.24 0.554 0 CA-C-N 114.825 -1.08 . . . . 0.0 108.959 -177.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 150.04 52.67 0.02 OUTLIER Glycine 0 C--N 1.346 1.125 0 N-CA-C 112.574 -0.21 . . . . 0.0 112.574 178.331 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 97.9 mtt180 -92.35 146.52 23.63 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 123.432 0.693 . . . . 0.0 109.665 175.411 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 13.3 tp10 -76.94 -64.9 1.02 Allowed 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 123.301 0.64 . . . . 0.0 109.693 178.316 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 4.6 m-20 59.45 21.12 9.52 Favored 'General case' 0 N--CA 1.493 1.694 0 C-N-CA 124.659 1.184 . . . . 0.0 112.65 176.85 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -84.66 116.7 23.34 Favored 'General case' 0 CA--C 1.536 0.414 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 -176.738 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . 0.408 ' HD2' ' HG2' ' A' ' 17' ' ' GLN . 19.5 p90 -110.44 -52.43 2.78 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 123.571 0.748 . . . . 0.0 110.646 178.332 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 45.1 t80 40.28 79.51 0.03 OUTLIER 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 125.761 1.624 . . . . 0.0 111.606 -171.651 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . 0.408 ' HG2' ' HD2' ' A' ' 15' ' ' TYR . 14.0 pt20 -135.85 -12.66 1.97 Allowed 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 123.239 0.616 . . . . 0.0 111.411 -173.502 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -85.65 52.31 4.58 Favored Glycine 0 C--N 1.351 1.403 0 CA-C-O 120.413 -0.104 . . . . 0.0 113.307 -175.842 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 23.9 p80 -84.69 116.82 23.42 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-O 121.309 0.576 . . . . 0.0 109.588 178.834 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 64.0 mtt -104.57 -65.58 1.02 Allowed 'General case' 0 C--O 1.242 0.672 0 N-CA-C 108.277 -1.009 . . . . 0.0 108.277 178.026 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . 51.12 33.65 9.68 Favored 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 124.213 1.005 . . . . 0.0 111.959 175.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 66.5 p -70.96 79.9 0.65 Allowed 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 124.342 1.057 . . . . 0.0 111.786 -167.351 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 81.04 -50.45 4.17 Favored Glycine 0 C--N 1.348 1.219 0 CA-C-N 115.408 -0.815 . . . . 0.0 113.278 -179.175 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 23.0 t 58.7 31.73 21.45 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 124.342 1.057 . . . . 0.0 109.438 -166.499 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -107.5 94.47 5.1 Favored 'General case' 0 C--O 1.241 0.625 0 C-N-CA 125.127 1.371 . . . . 0.0 108.578 -176.021 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 69.0 134.56 0.03 OUTLIER 'General case' 0 CA--C 1.55 0.978 0 C-N-CA 125.194 1.398 . . . . 0.0 111.97 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -150.4 103.84 3.18 Favored 'General case' 0 CA--C 1.542 0.666 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 178.177 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 25.2 m -95.36 176.54 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.982 0 C-N-CA 123.53 0.732 . . . . 0.0 110.469 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.481 HG12 ' HG3' ' A' ' 47' ' ' LYS . 15.3 m -87.17 125.62 40.98 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.774 0 CA-C-N 115.767 -0.651 . . . . 0.0 109.854 170.798 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 50.1 p -152.99 123.83 7.37 Favored 'General case' 0 C--O 1.239 0.541 0 C-N-CA 123.934 0.893 . . . . 0.0 108.804 178.249 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 48.6 t -103.15 119.83 52.17 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 -178.582 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.448 ' HA ' ' HA ' ' A' ' 42' ' ' LEU . 37.4 mt-10 -79.11 117.07 19.81 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.011 177.166 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -92.0 164.1 24.83 Favored Pre-proline 0 N--CA 1.483 1.195 0 C-N-CA 124.26 1.024 . . . . 0.0 109.6 -178.033 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -53.46 140.15 64.4 Favored 'Trans proline' 0 C--N 1.394 2.968 0 C-N-CA 123.127 2.551 . . . . 0.0 114.027 179.927 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . 0.719 ' HB3' ' HB3' ' A' ' 41' ' ' LYS . . . -140.19 156.84 69.9 Favored Pre-proline 0 N--CA 1.472 0.672 0 C-N-CA 124.419 1.087 . . . . 0.0 111.473 -170.068 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -58.41 140.73 95.68 Favored 'Trans proline' 0 C--N 1.372 1.784 0 C-N-CA 122.798 2.332 . . . . 0.0 110.504 155.269 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 70.5 p -63.51 -28.15 69.75 Favored 'General case' 0 N--CA 1.487 1.422 0 C-N-CA 122.993 0.517 . . . . 0.0 111.884 -177.007 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 31.8 m -67.24 -40.03 86.24 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 123.282 0.633 . . . . 0.0 110.612 176.911 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 33.8 m95 -100.46 -179.46 4.11 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 123.743 0.817 . . . . 0.0 110.25 179.266 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.5 150.51 52.15 Favored 'General case' 0 N--CA 1.469 0.482 0 N-CA-C 106.768 -1.568 . . . . 0.0 106.768 169.893 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.719 ' HB3' ' HB3' ' A' ' 35' ' ' ALA . 15.2 tptm -133.0 128.96 37.52 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.676 0.751 . . . . 0.0 108.998 -174.493 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.448 ' HA ' ' HA ' ' A' ' 32' ' ' GLU . 3.3 tt -135.37 151.32 50.37 Favored 'General case' 0 C--O 1.241 0.607 0 CA-C-N 114.001 -1.454 . . . . 0.0 108.62 -177.146 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 32.9 t80 -133.61 137.84 45.65 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.782 1.233 . . . . 0.0 108.267 173.735 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 38.5 m-85 -100.59 103.53 24.7 Favored Pre-proline 0 N--CA 1.484 1.231 0 C-N-CA 122.692 0.397 . . . . 0.0 111.025 175.544 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.634 ' HA ' ' HA ' ' A' ' 52' ' ' LYS . 65.0 Cg_endo -83.64 168.17 12.83 Favored 'Trans proline' 0 C--N 1.371 1.727 0 C-N-CA 122.421 2.081 . . . . 0.0 110.994 166.676 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . 0.466 ' HA ' ' HB2' ' A' ' 53' ' ' LYS . 48.3 t-20 -68.43 -44.3 75.25 Favored 'General case' 0 N--CA 1.478 0.929 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 169.787 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.537 ' HG2' HG23 ' A' ' 48' ' ' VAL . 36.8 ttpt 177.86 -75.3 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.618 0 O-C-N 125.229 1.581 . . . . 0.0 108.339 166.753 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.537 HG23 ' HG2' ' A' ' 47' ' ' LYS . 51.9 t -127.58 156.09 39.17 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.301 0 C-N-CA 124.317 1.047 . . . . 0.0 109.11 -177.592 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 105.59 7.98 35.83 Favored Glycine 0 C--N 1.349 1.303 0 C-N-CA 123.078 0.37 . . . . 0.0 112.339 -177.865 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 26.8 m 69.43 -3.83 1.5 Allowed 'General case' 0 N--CA 1.495 1.804 0 C-N-CA 125.593 1.557 . . . . 0.0 112.592 -177.816 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 26.6 m -74.53 140.0 18.29 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.454 0 C-N-CA 123.825 0.85 . . . . 0.0 110.526 -175.67 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.634 ' HA ' ' HA ' ' A' ' 45' ' ' PRO . 16.7 ptpt -93.6 160.97 14.54 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-N 115.636 -0.711 . . . . 0.0 111.089 178.407 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.466 ' HB2' ' HA ' ' A' ' 46' ' ' ASN . 88.3 tttt -121.13 -41.8 2.51 Favored 'General case' 0 N--CA 1.479 0.978 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 178.74 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 17.9 m -130.94 161.83 31.04 Favored 'General case' 0 CA--C 1.544 0.732 0 CA-C-N 114.529 -1.214 . . . . 0.0 108.008 176.391 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 4.0 pm0 -69.94 -177.97 1.45 Allowed 'General case' 0 CA--C 1.555 1.164 0 C-N-CA 123.658 0.783 . . . . 0.0 111.674 179.102 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 75.2 t -83.02 141.87 14.33 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.695 0 C-N-CA 124.33 1.052 . . . . 0.0 110.241 -177.317 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 57.7 t -123.56 124.01 68.6 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 C-N-CA 123.737 0.815 . . . . 0.0 109.555 179.594 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 29.6 m-85 -101.83 113.68 27.09 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 123.582 0.753 . . . . 0.0 109.27 171.774 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 3.4 t -79.1 130.45 36.11 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 C-N-CA 123.323 0.649 . . . . 0.0 109.587 175.939 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . 0.459 ' HB2' ' HH ' ' A' ' 75' ' ' TYR . . . -84.18 154.47 63.48 Favored Pre-proline 0 CA--C 1.541 0.622 0 CA-C-N 115.022 -0.99 . . . . 0.0 111.593 -175.796 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 26.5 Cg_endo -60.42 -33.6 93.95 Favored 'Trans proline' 0 C--N 1.377 2.071 0 C-N-CA 123.251 2.634 . . . . 0.0 113.179 177.226 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.521 HG22 ' HH ' ' A' ' 75' ' ' TYR . 14.8 t -85.47 -2.49 58.18 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 123.027 0.531 . . . . 0.0 111.602 179.256 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 94.21 -18.01 57.71 Favored Glycine 0 C--N 1.35 1.308 0 CA-C-O 119.635 -0.536 . . . . 0.0 113.682 178.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -72.46 76.82 1.04 Allowed 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 123.983 0.913 . . . . 0.0 109.638 178.198 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -65.57 157.86 28.64 Favored 'General case' 0 N--CA 1.477 0.881 0 CA-C-N 115.024 -0.989 . . . . 0.0 111.682 -172.744 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 47.4 mm -118.44 122.52 69.72 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.445 0 CA-C-N 114.83 -1.077 . . . . 0.0 109.386 -170.741 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 7.6 p -93.82 -21.26 19.39 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 123.932 0.893 . . . . 0.0 112.403 -178.44 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 2.4 p-10 -153.95 165.95 34.52 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 122.674 0.39 . . . . 0.0 111.393 -172.401 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 34.8 ttp180 -58.91 -41.93 88.45 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 124.314 1.046 . . . . 0.0 111.954 -171.059 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 5.0 tmtm? -55.99 -51.6 67.15 Favored 'General case' 0 N--CA 1.486 1.335 0 C-N-CA 123.821 0.848 . . . . 0.0 109.76 -179.52 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 77.5 mt-30 -60.3 -31.63 70.44 Favored 'General case' 0 N--CA 1.476 0.839 0 O-C-N 124.144 0.903 . . . . 0.0 111.422 -178.729 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -67.62 -50.42 58.19 Favored 'General case' 0 N--CA 1.481 1.12 0 N-CA-C 109.338 -0.615 . . . . 0.0 109.338 177.898 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -62.8 -51.0 68.77 Favored 'General case' 0 C--O 1.242 0.693 0 CA-C-N 115.236 -0.893 . . . . 0.0 111.225 -174.897 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -66.36 -29.42 69.6 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 122.556 0.343 . . . . 0.0 111.223 179.799 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . 0.521 ' HH ' HG22 ' A' ' 62' ' ' THR . 43.7 t80 -62.53 -54.68 36.28 Favored 'General case' 0 C--N 1.357 0.913 0 C-N-CA 122.946 0.498 . . . . 0.0 109.824 176.06 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 67.1 mt -60.71 -44.5 96.5 Favored 'General case' 0 N--CA 1.481 1.095 0 O-C-N 123.579 0.549 . . . . 0.0 111.847 -173.143 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -69.1 -25.04 64.21 Favored 'General case' 0 N--CA 1.48 1.037 0 CA-C-N 116.589 -0.278 . . . . 0.0 111.402 -177.813 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 100.0 p -98.47 -12.4 21.36 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 122.91 0.484 . . . . 0.0 111.811 178.715 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 90.4 m-70 -130.84 91.02 38.15 Favored Pre-proline 0 N--CA 1.476 0.841 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 179.673 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_endo -67.01 166.04 24.26 Favored 'Trans proline' 0 C--N 1.372 1.783 0 C-N-CA 122.412 2.075 . . . . 0.0 112.071 175.661 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 90.81 -17.22 55.98 Favored Glycine 0 C--N 1.347 1.15 0 CA-C-N 116.565 -0.289 . . . . 0.0 113.259 -179.776 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 40.2 m-80 -84.16 144.64 44.42 Favored Pre-proline 0 CA--C 1.547 0.856 0 C-N-CA 123.652 0.781 . . . . 0.0 111.269 -178.013 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_exo -56.18 152.01 40.28 Favored 'Trans proline' 0 C--N 1.378 2.081 0 C-N-CA 123.875 3.05 . . . . 0.0 112.794 170.97 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -77.04 161.56 28.22 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 123.526 0.73 . . . . 0.0 112.207 -173.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 16.9 tt -72.93 -23.45 20.38 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.222 0 C-N-CA 123.347 0.659 . . . . 0.0 111.488 -178.71 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -65.13 -31.58 72.85 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 123.308 0.643 . . . . 0.0 111.854 -177.728 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -90.52 0.2 57.42 Favored 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 123.432 0.693 . . . . 0.0 111.247 177.106 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 6.0 m-30 -92.74 111.42 23.02 Favored 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 123.499 0.72 . . . . 0.0 109.248 177.149 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -84.0 88.79 7.17 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 123.559 0.744 . . . . 0.0 110.618 -175.872 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 89.5 m95 -76.19 -17.69 59.42 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 122.695 0.398 . . . . 0.0 110.902 173.171 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 14.5 t -81.49 16.5 1.67 Allowed 'General case' 0 N--CA 1.488 1.425 0 C-N-CA 125.623 1.569 . . . . 0.0 111.979 177.697 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 4.8 t -62.68 -12.32 22.81 Favored 'General case' 0 CA--C 1.559 1.321 0 N-CA-C 114.965 1.469 . . . . 0.0 114.965 -163.073 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 50.2 m -67.78 90.28 0.28 Allowed 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 123.118 0.567 . . . . 0.0 110.26 177.338 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 66.57 -102.32 0.74 Allowed Glycine 0 C--N 1.349 1.303 0 N-CA-C 111.18 -0.768 . . . . 0.0 111.18 -172.891 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 8.5 t . . . . . 0 CA--C 1.553 1.06 0 C-N-CA 123.541 0.736 . . . . 0.0 109.864 175.605 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.8 mmt . . . . . 0 N--CA 1.481 1.093 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 33.9 t-80 -171.67 99.92 0.18 Allowed 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 124.299 1.04 . . . . 0.0 109.476 -178.609 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 38.4 m170 -123.5 141.81 51.63 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 123.655 0.782 . . . . 0.0 110.138 174.442 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 73.2 m80 -91.96 80.76 5.15 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 123.415 0.686 . . . . 0.0 109.515 -179.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 8.3 p80 -83.81 119.95 25.46 Favored 'General case' 0 N--CA 1.475 0.823 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 176.522 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 59.4 t-80 -148.43 142.26 25.71 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 123.915 0.886 . . . . 0.0 108.837 -178.947 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 45.1 m80 -65.11 121.67 15.26 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 122.761 0.424 . . . . 0.0 110.188 177.505 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 28.7 m -58.19 -39.68 79.56 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 123.658 0.783 . . . . 0.0 110.719 179.01 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 23.2 t 59.48 19.19 7.6 Favored 'General case' 0 CA--C 1.557 1.224 0 C-N-CA 124.701 1.2 . . . . 0.0 112.645 169.399 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -161.0 76.64 0.18 Allowed Glycine 0 C--N 1.343 0.942 0 N-CA-C 112.063 -0.415 . . . . 0.0 112.063 -175.78 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 53.8 ttp180 -86.35 98.04 10.76 Favored 'General case' 0 CA--C 1.541 0.623 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 173.293 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -85.54 74.18 10.35 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 123.53 0.732 . . . . 0.0 109.944 -176.035 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 89.0 m-20 -149.75 116.01 5.75 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 125.371 1.468 . . . . 0.0 108.536 -179.24 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -158.86 146.84 17.98 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 122.859 0.464 . . . . 0.0 110.242 171.65 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 22.1 m-85 -132.25 98.88 4.52 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-O 121.984 0.897 . . . . 0.0 109.045 169.484 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 25.5 p90 -81.61 10.12 6.52 Favored 'General case' 0 CA--C 1.55 0.971 0 CA-C-N 113.958 -1.474 . . . . 0.0 111.469 -178.878 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 8.0 mm100 -70.77 128.13 34.98 Favored 'General case' 0 C--O 1.241 0.648 0 C-N-CA 124.297 1.039 . . . . 0.0 109.839 -178.659 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -158.68 171.5 35.4 Favored Glycine 0 C--O 1.242 0.638 0 N-CA-C 111.51 -0.636 . . . . 0.0 111.51 176.52 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 52.5 m-70 -89.38 117.25 28.18 Favored 'General case' 0 N--CA 1.466 0.374 0 C-N-CA 122.749 0.42 . . . . 0.0 110.031 -175.852 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 25.8 mmt -81.22 -14.9 57.04 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 123.621 0.768 . . . . 0.0 110.827 174.036 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . 66.82 -169.96 0.2 Allowed 'General case' 0 C--N 1.355 0.814 0 C-N-CA 124.669 1.188 . . . . 0.0 111.186 -179.052 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 29.0 t -162.16 170.82 18.44 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 123.109 0.563 . . . . 0.0 110.177 179.893 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -89.92 37.05 3.4 Favored Glycine 0 C--N 1.344 1.012 0 CA-C-N 115.994 -0.548 . . . . 0.0 112.304 172.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 26.1 m -87.12 40.32 0.91 Allowed 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 124.213 1.005 . . . . 0.0 110.006 -178.502 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -116.41 -170.51 1.83 Allowed 'General case' 0 C--O 1.242 0.663 0 C-N-CA 124.686 1.194 . . . . 0.0 109.858 -174.125 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -151.89 141.99 22.23 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 122.947 0.499 . . . . 0.0 109.908 -179.063 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -69.67 107.16 3.33 Favored 'General case' 0 C--N 1.349 0.556 0 C-N-CA 123.323 0.649 . . . . 0.0 109.292 176.232 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 15.5 m -127.5 141.04 47.44 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 C-N-CA 123.821 0.848 . . . . 0.0 109.398 -178.754 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 34.7 m -76.71 110.62 12.45 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.019 0 CA-C-O 121.444 0.64 . . . . 0.0 110.435 -177.05 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 56.2 p -134.71 124.29 25.04 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 124.013 0.925 . . . . 0.0 109.87 -176.064 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 95.4 t -109.55 116.61 52.6 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.448 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 174.372 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.477 ' HA ' ' HA ' ' A' ' 42' ' ' LEU . 44.0 mt-10 -77.27 125.3 29.1 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 123.257 0.623 . . . . 0.0 110.387 177.455 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -100.64 169.03 8.4 Favored Pre-proline 0 CA--C 1.559 1.304 0 C-N-CA 124.613 1.165 . . . . 0.0 109.316 -177.144 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -54.94 126.44 22.54 Favored 'Trans proline' 0 C--N 1.395 3.005 0 C-N-CA 122.99 2.46 . . . . 0.0 113.147 -177.745 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . 0.423 ' HB1' ' HB3' ' A' ' 41' ' ' LYS . . . -114.9 156.83 44.57 Favored Pre-proline 0 N--CA 1.48 1.069 0 C-N-CA 124.374 1.069 . . . . 0.0 111.88 -171.697 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.55 ' HG2' ' HB2' ' A' ' 39' ' ' TRP . 72.6 Cg_endo -73.25 171.07 18.38 Favored 'Trans proline' 0 C--N 1.372 1.806 0 C-N-CA 122.544 2.163 . . . . 0.0 111.13 166.727 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 43.6 p -66.57 -46.13 77.02 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 123.421 0.689 . . . . 0.0 111.803 -176.937 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' SER . . . . . 0.417 ' HB2' ' HD1' ' A' ' 39' ' ' TRP . 9.8 m -72.68 -40.74 66.02 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-N 115.174 -0.921 . . . . 0.0 111.78 -174.187 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' TRP . . . . . 0.55 ' HB2' ' HG2' ' A' ' 36' ' ' PRO . 18.4 m95 -105.02 -173.86 2.4 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 123.535 0.734 . . . . 0.0 110.989 -175.273 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -130.28 158.02 40.93 Favored 'General case' 0 C--O 1.239 0.537 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 172.222 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.485 ' HZ3' ' HB ' ' A' ' 92' ' ' THR . 16.7 tptm -136.88 126.64 25.56 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.741 0.782 . . . . 0.0 109.135 -174.973 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.477 ' HA ' ' HA ' ' A' ' 32' ' ' GLU . 3.3 tt -136.05 151.97 50.41 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 113.653 -1.612 . . . . 0.0 108.195 -177.613 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 31.5 t80 -132.89 140.26 47.8 Favored 'General case' 0 C--O 1.235 0.309 0 C-N-CA 124.154 0.982 . . . . 0.0 108.491 171.405 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . 0.431 ' HB3' ' HB ' ' A' ' 54' ' ' THR . 25.3 m-85 -102.7 99.53 13.74 Favored Pre-proline 0 CA--C 1.547 0.833 0 C-N-CA 122.933 0.493 . . . . 0.0 109.687 174.654 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_endo -83.38 177.38 6.49 Favored 'Trans proline' 0 C--N 1.368 1.603 0 C-N-CA 122.765 2.31 . . . . 0.0 111.705 173.942 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 8.8 p30 -87.24 172.12 10.12 Favored 'General case' 0 C--O 1.243 0.724 0 CA-C-N 115.949 -0.569 . . . . 0.0 109.676 170.661 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 5.1 tmtt? -76.52 -74.29 0.24 Allowed 'General case' 0 CA--C 1.553 1.075 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 173.894 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 59.9 t -141.66 109.97 2.43 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.213 0 N-CA-C 108.088 -1.079 . . . . 0.0 108.088 172.75 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 174.87 163.86 28.72 Favored Glycine 0 C--N 1.344 1.003 0 O-C-N 123.28 0.362 . . . . 0.0 112.677 176.776 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 69.4 p -90.36 40.44 1.01 Allowed 'General case' 0 CA--C 1.551 1.019 0 C-N-CA 123.738 0.815 . . . . 0.0 110.408 178.231 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 30.8 m -117.21 162.97 14.77 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 C-N-CA 124.217 1.007 . . . . 0.0 109.636 -178.687 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 39.7 ttmt -81.47 -32.62 32.45 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 123.355 0.662 . . . . 0.0 109.339 174.008 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 14.8 tmtt? 71.33 -78.79 0.04 OUTLIER 'General case' 0 CA--C 1.553 1.065 0 C-N-CA 125.068 1.347 . . . . 0.0 109.716 -176.274 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.431 ' HB ' ' HB3' ' A' ' 44' ' ' TYR . 72.7 m -135.39 160.1 39.5 Favored 'General case' 0 CA--C 1.552 1.029 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 174.073 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -87.44 -169.82 2.77 Favored 'General case' 0 CA--C 1.557 1.235 0 CA-C-O 121.325 0.583 . . . . 0.0 111.631 -178.398 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 87.5 t -82.1 144.66 9.91 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.77 0 C-N-CA 124.848 1.259 . . . . 0.0 110.353 -179.104 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 60.7 t -126.82 129.16 71.41 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.068 0 C-N-CA 124.325 1.05 . . . . 0.0 109.333 177.545 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.406 ' CZ ' ' HD3' ' A' ' 41' ' ' LYS . 31.2 m-85 -105.84 114.98 29.46 Favored 'General case' 0 N--CA 1.477 0.879 0 N-CA-C 108.752 -0.832 . . . . 0.0 108.752 170.622 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 6.9 t -80.14 133.91 28.61 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 C-N-CA 123.073 0.549 . . . . 0.0 109.764 178.11 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . 0.438 ' HB3' ' HH ' ' A' ' 75' ' ' TYR . . . -85.94 155.57 58.25 Favored Pre-proline 0 CA--C 1.542 0.64 0 CA-C-N 115.166 -0.925 . . . . 0.0 111.4 -176.337 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -69.79 7.49 0.99 Allowed 'Trans proline' 0 N--CA 1.504 2.131 0 C-N-CA 123.258 2.639 . . . . 0.0 114.702 -179.016 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.43 HG21 ' H ' ' A' ' 64' ' ' GLU . 9.0 t -128.93 -7.1 4.97 Favored 'General case' 0 N--CA 1.484 1.26 0 C-N-CA 123.484 0.714 . . . . 0.0 111.263 -176.478 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 95.57 -11.03 68.82 Favored Glycine 0 C--N 1.351 1.382 0 CA-C-O 119.572 -0.571 . . . . 0.0 114.497 -176.687 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.43 ' H ' HG21 ' A' ' 62' ' ' THR . 44.3 tt0 -79.76 73.22 6.5 Favored 'General case' 0 N--CA 1.483 1.204 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 172.932 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -69.73 158.04 36.16 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-N 114.823 -1.08 . . . . 0.0 111.568 -171.298 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.428 HD12 ' HB3' ' A' ' 71' ' ' GLN . 44.7 mm -113.95 120.31 63.41 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 CA-C-N 115.157 -0.929 . . . . 0.0 109.757 -173.741 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 77.4 p -93.06 -24.33 18.34 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 123.691 0.797 . . . . 0.0 111.762 -177.147 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 8.9 p30 -141.23 157.8 44.75 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 122.775 0.43 . . . . 0.0 111.325 -175.42 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 70.1 ttt180 -62.92 -27.33 69.3 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 124.524 1.13 . . . . 0.0 112.562 -173.391 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 6.5 tmtm? -65.51 -50.37 65.52 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 123.316 0.646 . . . . 0.0 109.298 176.483 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.428 ' HB3' HD12 ' A' ' 66' ' ' ILE . 46.9 mt-30 -55.82 -31.37 62.63 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 123.942 0.897 . . . . 0.0 111.562 179.463 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.419 ' O ' ' HG ' ' A' ' 76' ' ' LEU . 0.2 OUTLIER -64.7 -51.77 60.72 Favored 'General case' 0 CA--C 1.551 1.017 0 O-C-N 123.613 0.571 . . . . 0.0 109.722 178.801 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -59.99 -50.4 73.88 Favored 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 122.859 0.464 . . . . 0.0 111.504 -178.116 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.2 -25.54 66.18 Favored 'General case' 0 CA--C 1.543 0.694 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.385 -177.033 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . 0.438 ' HH ' ' HB3' ' A' ' 60' ' ' ALA . 22.1 t80 -65.64 -49.51 68.4 Favored 'General case' 0 C--N 1.351 0.662 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 171.794 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.419 ' HG ' ' O ' ' A' ' 72' ' ' LEU . 80.2 mt -66.42 -39.4 88.94 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 123.135 0.574 . . . . 0.0 112.404 -172.24 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.02 -24.3 61.53 Favored 'General case' 0 N--CA 1.481 1.117 0 CA-C-O 120.817 0.342 . . . . 0.0 110.753 178.094 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 43.8 t -85.21 -27.57 26.01 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 123.409 0.684 . . . . 0.0 111.131 175.536 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 59.9 m80 -132.61 88.48 38.51 Favored Pre-proline 0 N--CA 1.475 0.781 0 C-N-CA 123.694 0.798 . . . . 0.0 109.511 -172.44 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -70.02 160.17 50.6 Favored 'Trans proline' 0 C--N 1.373 1.856 0 C-N-CA 122.468 2.112 . . . . 0.0 111.341 177.011 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 95.46 -32.78 5.95 Favored Glycine 0 CA--C 1.532 1.119 0 N-CA-C 112.353 -0.299 . . . . 0.0 112.353 -176.799 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 32.2 m-80 -65.49 143.72 98.75 Favored Pre-proline 0 CA--C 1.551 0.998 0 C-N-CA 123.593 0.757 . . . . 0.0 110.698 176.66 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . 0.41 ' HB2' ' CE2' ' A' ' 88' ' ' PHE . 42.5 Cg_exo -53.98 157.12 11.22 Favored 'Trans proline' 0 C--N 1.375 1.944 0 C-N-CA 123.809 3.006 . . . . 0.0 113.587 -179.008 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -68.78 152.37 45.41 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 123.983 0.913 . . . . 0.0 111.412 -177.603 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 12.8 tt -75.11 -21.61 16.63 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.17 0 CA-C-O 120.744 0.307 . . . . 0.0 110.288 175.08 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -58.85 -40.07 83.2 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 124.246 1.018 . . . . 0.0 112.078 178.011 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -84.48 -8.89 58.79 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 123.474 0.71 . . . . 0.0 111.587 179.583 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.41 ' CE2' ' HB2' ' A' ' 83' ' ' PRO . 4.4 m-30 -84.45 112.93 20.81 Favored 'General case' 0 N--CA 1.476 0.835 0 CA-C-O 121.652 0.739 . . . . 0.0 109.778 177.483 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 19.4 p-10 -93.12 88.52 6.11 Favored 'General case' 0 CA--C 1.543 0.703 0 CA-C-N 114.451 -1.25 . . . . 0.0 111.191 -171.166 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 76.0 m95 -76.23 -21.89 55.84 Favored 'General case' 0 N--CA 1.485 1.309 0 CA-C-N 115.441 -0.799 . . . . 0.0 110.51 173.406 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 10.7 t -86.27 16.01 4.78 Favored 'General case' 0 CA--C 1.556 1.209 0 C-N-CA 125.652 1.581 . . . . 0.0 111.775 -178.761 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' THR . . . . . 0.485 ' HB ' ' HZ3' ' A' ' 41' ' ' LYS . 9.9 t -59.3 -39.28 82.53 Favored 'General case' 0 CA--C 1.551 0.983 0 C-N-CA 124.336 1.054 . . . . 0.0 113.77 -166.259 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 65.6 m -158.4 125.89 5.06 Favored 'General case' 0 C--O 1.241 0.621 0 C-N-CA 123.867 0.867 . . . . 0.0 109.576 -176.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -80.78 73.39 2.56 Favored Glycine 0 C--N 1.346 1.101 0 N-CA-C 109.959 -1.256 . . . . 0.0 109.959 167.889 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 74.9 p . . . . . 0 CA--C 1.56 1.346 0 C-N-CA 125.725 1.61 . . . . 0.0 111.766 -168.567 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.482 ' SD ' ' N ' ' A' ' 1' ' ' MET . 0.9 OUTLIER . . . . . 0 N--CA 1.488 1.447 0 N-CA-C 110.4 -0.222 . . . . 0.0 110.4 . . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 31.7 m170 -75.18 -43.8 50.16 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 123.517 0.727 . . . . 0.0 111.249 -178.216 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 58.0 t-80 -78.7 88.11 4.6 Favored 'General case' 0 N--CA 1.475 0.815 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 178.314 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 97.0 m-70 -62.11 127.86 33.37 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-N 115.229 -0.896 . . . . 0.0 111.242 -174.767 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 44.3 m-70 -68.21 -21.01 64.88 Favored 'General case' 0 N--CA 1.48 1.067 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.586 175.563 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 65.5 m80 -79.83 120.66 24.38 Favored 'General case' 0 CA--C 1.537 0.455 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 166.285 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 7.1 t-160 -94.18 20.14 8.42 Favored 'General case' 0 CA--C 1.557 1.25 0 C-N-CA 123.365 0.666 . . . . 0.0 109.846 175.638 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 46.7 m -67.58 102.41 1.16 Allowed 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 124.181 0.992 . . . . 0.0 110.51 175.376 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 45.1 t -162.55 -42.31 0.04 OUTLIER 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 123.804 0.842 . . . . 0.0 109.638 -178.272 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 82.09 21.63 60.63 Favored Glycine 0 C--N 1.352 1.446 0 CA-C-N 115.525 -0.762 . . . . 0.0 112.46 -176.816 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 74.7 mtm180 66.28 127.51 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 C-N-CA 125.282 1.433 . . . . 0.0 112.275 -179.239 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -72.93 88.59 1.37 Allowed 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 172.747 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 8.0 t30 -136.27 -34.0 0.8 Allowed 'General case' 0 N--CA 1.472 0.659 0 CA-C-N 115.156 -0.929 . . . . 0.0 109.315 -177.805 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 3.3 mm? 63.66 -170.08 0.19 Allowed 'General case' 0 C--N 1.362 1.143 0 C-N-CA 124.44 1.096 . . . . 0.0 111.131 -177.59 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 20.4 p90 -142.68 -48.61 0.34 Allowed 'General case' 0 C--O 1.241 0.632 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 171.892 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 52.9 t80 46.18 61.82 2.55 Favored 'General case' 0 CA--C 1.554 1.108 0 C-N-CA 125.444 1.497 . . . . 0.0 111.342 -179.53 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 11.4 pt20 -136.6 111.74 9.03 Favored 'General case' 0 C--O 1.243 0.719 0 CA-C-N 114.86 -1.064 . . . . 0.0 108.49 -178.558 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 88.29 166.22 42.09 Favored Glycine 0 CA--C 1.532 1.099 0 CA-C-N 115.437 -0.801 . . . . 0.0 111.732 -169.51 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 12.6 m170 -78.87 112.9 16.5 Favored 'General case' 0 N--CA 1.476 0.852 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 179.888 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 68.5 mtt -149.55 142.87 25.19 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 124.751 1.22 . . . . 0.0 108.371 -179.417 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . 60.07 37.94 20.81 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 124.122 0.969 . . . . 0.0 109.93 -167.858 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 16.5 m -63.12 -24.51 67.93 Favored 'General case' 0 N--CA 1.481 1.088 0 CA-C-N 114.101 -1.409 . . . . 0.0 112.568 -175.881 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -81.76 60.06 4.79 Favored Glycine 0 C--N 1.343 0.963 0 CA-C-N 115.58 -0.736 . . . . 0.0 112.054 176.398 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 25.3 m -80.39 90.43 5.61 Favored 'General case' 0 C--O 1.24 0.58 0 C-N-CA 123.983 0.913 . . . . 0.0 109.779 -179.233 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -109.88 81.99 1.52 Allowed 'General case' 0 CA--C 1.54 0.579 0 N-CA-C 107.66 -1.237 . . . . 0.0 107.66 -178.387 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 66.06 9.22 6.05 Favored 'General case' 0 N--CA 1.488 1.462 0 C-N-CA 125.266 1.426 . . . . 0.0 113.049 -178.179 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 48.3 65.15 1.4 Allowed 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 125.649 1.579 . . . . 0.0 112.459 176.942 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 15.5 m -68.91 128.75 32.88 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.877 0 CA-C-N 115.213 -0.903 . . . . 0.0 110.875 178.839 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.449 HG11 ' HG2' ' A' ' 47' ' ' LYS . 14.9 m -69.92 111.91 4.26 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 CA-C-O 121.703 0.763 . . . . 0.0 111.347 -175.671 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 3.8 p -144.44 118.12 9.22 Favored 'General case' 0 C--O 1.239 0.515 0 C-N-CA 124.305 1.042 . . . . 0.0 109.304 -179.507 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 90.4 t -101.65 130.98 50.43 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.483 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 179.268 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.405 ' HA ' ' HA ' ' A' ' 42' ' ' LEU . 42.9 mt-10 -81.89 107.17 14.39 Favored 'General case' 0 C--O 1.238 0.474 0 C-N-CA 123.09 0.556 . . . . 0.0 109.873 175.084 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.497 HD23 ' HB3' ' A' ' 43' ' ' PHE . 4.3 mm? -83.31 161.06 58.27 Favored Pre-proline 0 CA--C 1.553 1.064 0 C-N-CA 124.324 1.049 . . . . 0.0 109.742 -179.836 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -53.37 136.46 63.15 Favored 'Trans proline' 0 C--N 1.388 2.645 0 C-N-CA 122.988 2.459 . . . . 0.0 113.178 -179.149 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -121.18 163.39 30.31 Favored Pre-proline 0 N--CA 1.481 1.086 0 C-N-CA 124.361 1.065 . . . . 0.0 112.961 -164.142 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.59 ' HG2' ' HB2' ' A' ' 39' ' ' TRP . 40.9 Cg_endo -67.72 156.96 63.94 Favored 'Trans proline' 0 C--N 1.381 2.27 0 C-N-CA 122.52 2.147 . . . . 0.0 110.587 161.324 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 55.2 p -62.36 -39.04 91.85 Favored 'General case' 0 N--CA 1.486 1.354 0 N-CA-C 113.874 1.064 . . . . 0.0 113.874 -166.725 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 15.0 p -89.21 -21.6 23.18 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 112.375 0.509 . . . . 0.0 112.375 -174.952 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' TRP . . . . . 0.59 ' HB2' ' HG2' ' A' ' 36' ' ' PRO . 16.3 m95 -109.97 174.37 5.89 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-O 121.758 0.79 . . . . 0.0 110.469 179.463 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.419 ' HB2' ' HB ' ' A' ' 59' ' ' VAL . 0.0 OUTLIER -117.54 158.14 25.09 Favored 'General case' 0 C--O 1.24 0.559 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 170.371 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.589 ' HZ1' ' HB ' ' A' ' 92' ' ' THR . 16.8 tptm -130.33 122.14 27.34 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 124.445 1.098 . . . . 0.0 108.133 -176.862 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.48 HD22 ' HB ' ' A' ' 57' ' ' VAL . 4.7 tt -125.19 150.31 47.1 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 124.743 1.217 . . . . 0.0 108.668 177.443 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.497 ' HB3' HD23 ' A' ' 33' ' ' LEU . 36.2 t80 -136.78 145.33 44.42 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 125.053 1.341 . . . . 0.0 108.347 174.064 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 16.4 m-85 -102.14 96.75 7.35 Favored Pre-proline 0 CA--C 1.555 1.17 0 C-N-CA 123.113 0.565 . . . . 0.0 110.114 174.33 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -82.72 163.49 16.26 Favored 'Trans proline' 0 C--N 1.374 1.906 0 C-N-CA 122.734 2.289 . . . . 0.0 111.806 175.437 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -81.79 147.95 29.14 Favored 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 170.363 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.449 ' HG2' HG11 ' A' ' 29' ' ' VAL . 96.5 mttt -62.73 -40.27 96.68 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 123.413 0.685 . . . . 0.0 111.706 -176.693 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 41.7 t -80.78 -36.34 15.48 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.958 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 173.548 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 104.25 -160.49 15.85 Favored Glycine 0 C--N 1.346 1.122 0 CA-C-N 115.225 -0.898 . . . . 0.0 112.316 -178.572 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 57.1 m 67.34 -71.56 0.1 Allowed 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 125.486 1.514 . . . . 0.0 111.769 -179.36 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 34.2 m -75.1 170.5 1.47 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.794 0 C-N-CA 123.553 0.741 . . . . 0.0 110.576 174.935 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.527 ' HZ3' ' HB2' ' A' ' 52' ' ' LYS . 4.8 ttmp? -108.61 135.32 50.06 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 123.997 0.919 . . . . 0.0 110.031 -175.36 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -78.18 -71.18 0.44 Allowed 'General case' 0 CA--C 1.55 0.953 0 N-CA-C 107.195 -1.409 . . . . 0.0 107.195 174.086 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 15.8 m -133.73 162.12 32.84 Favored 'General case' 0 CA--C 1.547 0.864 0 N-CA-C 106.947 -1.501 . . . . 0.0 106.947 173.607 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -73.01 -168.03 0.45 Allowed 'General case' 0 CA--C 1.552 1.049 0 CA-C-O 121.419 0.628 . . . . 0.0 111.168 178.783 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 48.9 t -81.33 138.67 19.21 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.661 0 C-N-CA 124.145 0.978 . . . . 0.0 110.435 -176.723 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.48 ' HB ' HD22 ' A' ' 42' ' ' LEU . 87.2 t -123.5 115.82 46.5 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.952 0 C-N-CA 124.738 1.215 . . . . 0.0 108.512 176.213 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.406 ' CZ ' ' HD3' ' A' ' 41' ' ' LYS . 15.9 m-85 -91.99 118.39 30.73 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 123.465 0.706 . . . . 0.0 109.873 177.227 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.419 ' HB ' ' HB2' ' A' ' 40' ' ' LYS . 3.3 t -80.2 131.17 34.71 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 C-N-CA 123.439 0.696 . . . . 0.0 110.712 179.914 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -88.35 158.95 48.36 Favored Pre-proline 0 N--CA 1.476 0.834 0 C-N-CA 124.276 1.031 . . . . 0.0 111.677 -173.905 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -68.29 -19.18 44.33 Favored 'Trans proline' 0 C--N 1.38 2.223 0 C-N-CA 122.878 2.386 . . . . 0.0 113.191 178.305 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.481 HG22 ' H ' ' A' ' 64' ' ' GLU . 14.8 t -88.09 -11.31 47.47 Favored 'General case' 0 CA--C 1.55 0.957 0 C-N-CA 123.327 0.651 . . . . 0.0 111.198 175.934 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 96.36 -25.64 25.03 Favored Glycine 0 C--N 1.355 1.605 0 C-N-CA 122.601 0.143 . . . . 0.0 113.206 -177.609 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.481 ' H ' HG22 ' A' ' 62' ' ' THR . 37.7 tt0 -72.74 83.94 1.18 Allowed 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 124.08 0.952 . . . . 0.0 109.717 174.326 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.43 159.14 24.92 Favored 'General case' 0 N--CA 1.473 0.707 0 CA-C-N 114.878 -1.055 . . . . 0.0 112.072 -177.027 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.445 HG21 ' HB2' ' A' ' 71' ' ' GLN . 35.1 mm -102.44 127.53 55.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 C-N-CA 125.33 1.452 . . . . 0.0 109.08 177.522 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 29.9 m -97.59 -30.03 13.09 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 122.774 0.43 . . . . 0.0 111.504 -174.5 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 2.8 p-10 -135.08 159.43 41.54 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 123.038 0.535 . . . . 0.0 110.47 -179.068 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 32.3 ttm180 -64.79 -30.43 71.43 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 124.271 1.028 . . . . 0.0 113.155 -168.45 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 6.2 tmtm? -63.73 -47.73 79.89 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 123.384 0.674 . . . . 0.0 109.449 176.341 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.445 ' HB2' HG21 ' A' ' 66' ' ' ILE . 68.0 mt-30 -55.27 -32.76 62.62 Favored 'General case' 0 N--CA 1.49 1.547 0 C-N-CA 123.679 0.792 . . . . 0.0 111.598 179.341 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.466 ' O ' ' HG ' ' A' ' 76' ' ' LEU . 0.4 OUTLIER -61.22 -52.94 62.68 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 123.125 0.57 . . . . 0.0 109.56 -179.276 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -67.85 -42.91 80.64 Favored 'General case' 0 C--O 1.248 0.992 0 C-N-CA 123.781 0.832 . . . . 0.0 111.691 -174.372 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.36 -22.65 61.87 Favored 'General case' 0 N--CA 1.478 0.971 0 CA-C-N 116.779 -0.192 . . . . 0.0 111.094 179.263 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . 0.475 ' HH ' HG23 ' A' ' 62' ' ' THR . 39.7 t80 -70.36 -42.83 71.3 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 122.969 0.508 . . . . 0.0 109.822 172.214 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.466 ' HG ' ' O ' ' A' ' 72' ' ' LEU . 80.1 mt -64.19 -33.83 76.7 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 123.166 0.586 . . . . 0.0 111.739 -175.991 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 14.3 ptpt -79.98 -32.61 39.79 Favored 'General case' 0 N--CA 1.482 1.171 0 N-CA-C 111.607 0.225 . . . . 0.0 111.607 175.06 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 40.9 t -71.28 -29.91 65.64 Favored 'General case' 0 N--CA 1.485 1.302 0 CA-C-O 121.427 0.632 . . . . 0.0 110.955 178.737 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 42.1 m80 -143.01 86.08 9.47 Favored Pre-proline 0 C--O 1.24 0.563 0 C-N-CA 124.677 1.191 . . . . 0.0 108.423 -178.267 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -67.58 163.01 36.66 Favored 'Trans proline' 0 C--N 1.378 2.09 0 C-N-CA 122.652 2.235 . . . . 0.0 111.704 173.516 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 101.82 -31.21 8.95 Favored Glycine 0 C--N 1.342 0.889 0 N-CA-C 111.283 -0.727 . . . . 0.0 111.283 -173.658 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 37.0 m-80 -66.79 144.52 98.62 Favored Pre-proline 0 CA--C 1.553 1.08 0 C-N-CA 123.535 0.734 . . . . 0.0 110.606 174.464 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -63.77 154.25 70.64 Favored 'Trans proline' 0 C--N 1.373 1.862 0 C-N-CA 123.067 2.511 . . . . 0.0 112.984 -176.097 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . 0.464 ' O ' ' HG2' ' A' ' 87' ' ' GLU . . . -71.02 146.41 49.38 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 114.6 -1.182 . . . . 0.0 111.396 -174.745 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 17.1 tt -64.81 -14.41 16.24 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.258 0 C-N-CA 123.637 0.775 . . . . 0.0 111.739 -179.274 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -53.76 -40.26 66.05 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 124.205 1.002 . . . . 0.0 112.576 175.325 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.464 ' HG2' ' O ' ' A' ' 84' ' ' ALA . 10.6 pt-20 -86.32 -17.81 33.59 Favored 'General case' 0 N--CA 1.486 1.35 0 C-N-CA 123.306 0.643 . . . . 0.0 111.429 178.619 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -77.31 109.04 10.88 Favored 'General case' 0 N--CA 1.478 0.959 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 177.92 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -94.83 121.01 35.98 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-O 121.311 0.577 . . . . 0.0 109.725 -177.71 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 49.6 m95 -103.38 -3.7 25.14 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 123.857 0.863 . . . . 0.0 109.446 174.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 14.8 t -91.03 13.42 16.79 Favored 'General case' 0 CA--C 1.55 0.976 0 C-N-CA 125.118 1.367 . . . . 0.0 112.14 -176.041 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' THR . . . . . 0.589 ' HB ' ' HZ1' ' A' ' 41' ' ' LYS . 7.1 t -62.36 -16.96 57.65 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 123.722 0.809 . . . . 0.0 112.577 -175.801 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 10.1 m -72.85 86.69 1.28 Allowed 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 123.324 0.65 . . . . 0.0 109.794 177.541 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -81.01 68.11 3.49 Favored Glycine 0 C--N 1.351 1.371 0 N-CA-C 111.068 -0.813 . . . . 0.0 111.068 175.624 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 1.8 t . . . . . 0 CA--C 1.559 1.301 0 C-N-CA 124.37 1.068 . . . . 0.0 110.95 -173.122 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.45 ' SD ' ' N ' ' A' ' 1' ' ' MET . 0.9 OUTLIER . . . . . 0 N--CA 1.482 1.146 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 . . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 62.4 t-80 -72.18 -48.81 40.45 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 123.443 0.697 . . . . 0.0 111.501 -173.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 8.9 p80 -112.2 132.64 54.79 Favored 'General case' 0 N--CA 1.48 1.038 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 178.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 49.0 t-80 -102.91 138.49 39.72 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 123.703 0.801 . . . . 0.0 111.759 -172.551 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 32.3 m170 -131.18 172.27 12.33 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 124.64 1.176 . . . . 0.0 109.456 169.627 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 46.4 m80 -93.42 93.36 8.1 Favored 'General case' 0 N--CA 1.469 0.483 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 170.295 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 53.3 t-80 -66.43 99.02 0.53 Allowed 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 123.271 0.628 . . . . 0.0 110.017 179.461 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 19.6 m 63.43 19.76 11.87 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 124.491 1.116 . . . . 0.0 112.128 175.509 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 41.2 p -124.35 163.48 21.63 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 123.794 0.838 . . . . 0.0 110.164 -178.357 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -129.75 -141.28 4.98 Favored Glycine 0 C--N 1.335 0.501 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.761 -178.667 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 26.5 mmm180 59.83 32.9 21.53 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 124.889 1.275 . . . . 0.0 111.597 -179.566 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -79.14 -8.99 59.43 Favored 'General case' 0 CA--C 1.554 1.13 0 C-N-CA 124.105 0.962 . . . . 0.0 110.191 175.869 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 24.8 p-10 -79.79 79.3 6.32 Favored 'General case' 0 CA--C 1.557 1.239 0 CA-C-O 122.105 0.955 . . . . 0.0 110.726 176.342 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -141.55 -176.39 4.73 Favored 'General case' 0 N--CA 1.478 0.943 0 CA-C-N 115.467 -0.788 . . . . 0.0 109.605 173.521 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 4.1 p90 -75.69 65.98 1.94 Allowed 'General case' 0 CA--C 1.561 1.398 0 CA-C-O 122.335 1.064 . . . . 0.0 110.762 175.56 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 58.7 t80 -81.15 77.46 8.04 Favored 'General case' 0 CA--C 1.543 0.704 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 177.56 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 9.0 pt20 -135.05 -47.0 0.72 Allowed 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 115.131 -0.94 . . . . 0.0 110.279 -171.688 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -111.78 42.76 1.87 Allowed Glycine 0 C--N 1.346 1.106 0 N-CA-C 111.904 -0.478 . . . . 0.0 111.904 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 31.9 t60 -78.56 117.41 19.72 Favored 'General case' 0 CA--C 1.542 0.658 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 176.24 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' MET . . . . . 0.442 ' HE3' ' HB2' ' A' ' 25' ' ' GLU . 39.8 tpp -135.97 148.06 48.3 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 123.569 0.747 . . . . 0.0 109.947 -178.147 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -144.01 18.82 1.78 Allowed 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 123.095 0.558 . . . . 0.0 111.675 -174.498 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 19.4 m 60.39 97.42 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 C-N-CA 124.632 1.173 . . . . 0.0 111.398 -176.687 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 103.26 -178.31 25.42 Favored Glycine 0 C--N 1.342 0.864 0 N-CA-C 110.707 -0.957 . . . . 0.0 110.707 -167.433 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 32.9 t 76.7 -32.98 0.2 Allowed 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 124.932 1.293 . . . . 0.0 113.332 176.005 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.442 ' HB2' ' HE3' ' A' ' 20' ' ' MET . 34.6 tt0 -56.25 102.96 0.09 Allowed 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 124.12 0.968 . . . . 0.0 111.43 -177.363 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 47.76 26.3 0.86 Allowed 'General case' 0 N--CA 1.497 1.885 0 C-N-CA 126.427 1.891 . . . . 0.0 112.746 -177.88 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -73.43 118.4 16.34 Favored 'General case' 0 C--O 1.24 0.566 0 CA-C-N 115.223 -0.899 . . . . 0.0 110.441 -170.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 34.6 m -77.91 154.63 5.24 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 C-N-CA 124.36 1.064 . . . . 0.0 110.899 -177.764 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 27.1 m -89.34 130.97 37.8 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.642 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 174.631 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 39.2 p -157.33 118.65 3.65 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 123.943 0.897 . . . . 0.0 108.891 -177.929 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 48.1 t -106.06 125.71 61.61 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 C-N-CA 123.879 0.872 . . . . 0.0 109.056 -177.514 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.463 ' HA ' ' HA ' ' A' ' 42' ' ' LEU . 45.6 mt-10 -79.66 101.54 8.43 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 123.068 0.547 . . . . 0.0 110.092 178.942 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -81.21 152.77 71.33 Favored Pre-proline 0 CA--C 1.559 1.298 0 C-N-CA 124.379 1.071 . . . . 0.0 110.773 -176.178 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -62.84 137.74 64.7 Favored 'Trans proline' 0 C--N 1.384 2.401 0 C-N-CA 123.073 2.515 . . . . 0.0 114.085 -177.718 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -146.07 169.98 8.71 Favored Pre-proline 0 CA--C 1.557 1.218 0 C-N-CA 124.276 1.03 . . . . 0.0 108.933 -178.541 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -51.25 145.26 27.45 Favored 'Trans proline' 0 C--N 1.392 2.848 0 C-N-CA 122.691 2.26 . . . . 0.0 112.168 173.894 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 49.2 m -64.01 -20.04 65.62 Favored 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 113.164 0.802 . . . . 0.0 113.164 -171.717 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 33.4 m -72.23 -40.23 67.93 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 123.197 0.599 . . . . 0.0 110.16 174.581 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 25.6 m95 -104.83 -168.3 1.46 Allowed 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 123.958 0.903 . . . . 0.0 110.038 179.449 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.508 ' HB3' ' HB ' ' A' ' 59' ' ' VAL . 40.7 ttmt -156.41 170.78 21.51 Favored 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 106.565 -1.643 . . . . 0.0 106.565 171.584 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.713 ' HD2' HG11 ' A' ' 56' ' ' VAL . 21.3 pttm -151.34 154.06 35.97 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-O 121.845 0.831 . . . . 0.0 110.904 171.434 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.463 ' HA ' ' HA ' ' A' ' 32' ' ' GLU . 0.8 OUTLIER -127.0 130.76 50.66 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 113.348 -1.751 . . . . 0.0 107.726 178.433 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 28.7 t80 -101.39 141.04 34.85 Favored 'General case' 0 CA--C 1.542 0.647 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 170.728 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 11.6 m-85 -99.37 100.14 9.86 Favored Pre-proline 0 N--CA 1.481 1.111 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 171.487 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -79.49 168.17 20.17 Favored 'Trans proline' 0 C--N 1.365 1.413 0 C-N-CA 122.411 2.074 . . . . 0.0 112.43 175.489 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . 0.468 ' HB2' ' HB ' ' A' ' 51' ' ' VAL . 30.1 p30 -86.95 156.7 19.69 Favored 'General case' 0 C--O 1.241 0.605 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 168.447 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -77.88 -87.3 0.05 Allowed 'General case' 0 N--CA 1.475 0.782 0 CA-C-O 119.33 -0.367 . . . . 0.0 111.2 -175.314 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 57.9 t -134.37 142.43 40.82 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.382 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 -179.789 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 85.34 -112.12 3.63 Favored Glycine 0 C--N 1.348 1.195 0 N-CA-C 111.43 -0.668 . . . . 0.0 111.43 -177.077 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 28.3 t -145.08 79.12 1.58 Allowed 'General case' 0 C--O 1.24 0.574 0 CA-C-O 121.784 0.802 . . . . 0.0 109.14 175.881 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.468 ' HB ' ' HB2' ' A' ' 46' ' ' ASN . 21.5 t -85.66 158.28 3.36 Favored 'Isoleucine or valine' 0 C--O 1.246 0.889 0 N-CA-C 107.555 -1.276 . . . . 0.0 107.555 170.099 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.527 ' HD3' ' H ' ' A' ' 52' ' ' LYS . 0.0 OUTLIER -68.08 109.25 3.42 Favored 'General case' 0 CA--C 1.553 1.082 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 174.933 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 25.3 pttm -79.87 139.42 37.16 Favored 'General case' 0 C--N 1.353 0.748 0 N-CA-C 107.896 -1.15 . . . . 0.0 107.896 172.818 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 96.3 m -102.74 141.39 35.62 Favored 'General case' 0 CA--C 1.538 0.489 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 177.673 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -61.28 177.98 0.32 Allowed 'General case' 0 CA--C 1.549 0.905 0 CA-C-O 122.11 0.957 . . . . 0.0 112.133 179.267 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.713 HG11 ' HD2' ' A' ' 41' ' ' LYS . 51.0 t -82.35 147.42 6.04 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.771 0 CA-C-N 114.799 -1.091 . . . . 0.0 111.376 -168.896 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 65.8 t -124.52 116.5 47.73 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.693 0 C-N-CA 125.074 1.35 . . . . 0.0 107.681 175.276 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 36.7 m-85 -87.25 123.77 32.61 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 123.486 0.714 . . . . 0.0 110.982 -179.146 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.508 ' HB ' ' HB3' ' A' ' 40' ' ' LYS . 6.8 t -81.16 130.28 36.12 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.411 0 C-N-CA 123.677 0.791 . . . . 0.0 110.141 175.534 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -85.59 157.21 58.5 Favored Pre-proline 0 N--CA 1.475 0.794 0 O-C-N 124.157 0.911 . . . . 0.0 111.211 -178.618 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -63.7 -22.49 69.82 Favored 'Trans proline' 0 C--N 1.382 2.314 0 C-N-CA 122.934 2.423 . . . . 0.0 112.703 176.491 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.551 HG21 ' H ' ' A' ' 64' ' ' GLU . 12.1 t -91.53 -12.17 35.25 Favored 'General case' 0 CA--C 1.549 0.924 0 C-N-CA 123.822 0.849 . . . . 0.0 111.181 178.957 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 95.23 -11.73 68.81 Favored Glycine 0 C--N 1.349 1.283 0 CA-C-O 119.769 -0.462 . . . . 0.0 113.559 -177.591 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.551 ' H ' HG21 ' A' ' 62' ' ' THR . 36.4 tt0 -77.97 78.14 4.47 Favored 'General case' 0 N--CA 1.481 1.121 0 CA-C-N 117.576 0.688 . . . . 0.0 109.341 174.334 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -67.96 139.22 56.38 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-N 115.119 -0.946 . . . . 0.0 111.028 -174.075 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 36.8 mm -94.77 130.92 42.92 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.663 0 C-N-CA 124.484 1.114 . . . . 0.0 109.883 -179.927 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 6.0 p -96.59 -11.65 25.06 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 123.784 0.834 . . . . 0.0 112.414 -175.375 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 11.1 p-10 -153.53 151.32 29.67 Favored 'General case' 0 N--CA 1.48 1.052 0 N-CA-C 111.941 0.349 . . . . 0.0 111.941 -168.044 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 30.1 ttm180 -59.06 -39.55 82.42 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 124.759 1.224 . . . . 0.0 112.817 -168.582 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 4.3 tmtm? -59.71 -54.4 46.79 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 123.419 0.688 . . . . 0.0 109.923 -177.743 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.411 ' HA ' ' HG3' ' A' ' 74' ' ' GLN . 87.4 mm-40 -66.2 -22.32 66.34 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-N 115.032 -0.985 . . . . 0.0 111.309 -175.674 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.489 ' O ' ' HG ' ' A' ' 76' ' ' LEU . 0.8 OUTLIER -66.47 -56.36 11.3 Favored 'General case' 0 CA--C 1.544 0.742 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 174.318 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -57.41 -50.24 73.62 Favored 'General case' 0 N--CA 1.486 1.355 0 C-N-CA 124.404 1.082 . . . . 0.0 111.473 -176.314 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . 0.411 ' HG3' ' HA ' ' A' ' 71' ' ' GLN . 0.0 OUTLIER -70.31 -25.04 63.13 Favored 'General case' 0 CA--C 1.545 0.768 0 CA-C-N 115.4 -0.818 . . . . 0.0 111.608 -177.903 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 45.5 t80 -66.44 -45.99 77.96 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 122.75 0.42 . . . . 0.0 109.907 174.503 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.489 ' HG ' ' O ' ' A' ' 72' ' ' LEU . 52.4 mt -62.58 -45.23 93.86 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 123.033 0.533 . . . . 0.0 110.913 -175.36 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.11 -24.16 59.41 Favored 'General case' 0 CA--C 1.551 0.983 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.589 -179.835 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 46.3 t -78.19 -27.68 47.95 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 122.857 0.463 . . . . 0.0 110.806 174.949 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 59.0 m80 -127.4 84.89 62.22 Favored Pre-proline 0 N--CA 1.472 0.671 0 C-N-CA 123.401 0.681 . . . . 0.0 109.751 -175.435 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -62.8 122.18 10.38 Favored 'Trans proline' 0 C--N 1.372 1.788 0 C-N-CA 122.953 2.435 . . . . 0.0 111.709 177.431 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 133.23 -30.56 3.02 Favored Glycine 0 C--N 1.342 0.888 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.795 -174.042 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 40.2 m-80 -72.5 137.13 80.73 Favored Pre-proline 0 N--CA 1.476 0.864 0 C-N-CA 123.468 0.707 . . . . 0.0 110.456 177.109 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -62.88 154.25 67.67 Favored 'Trans proline' 0 C--N 1.375 1.971 0 C-N-CA 123.111 2.541 . . . . 0.0 112.777 -179.138 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . 0.475 ' O ' ' HG2' ' A' ' 87' ' ' GLU . . . -73.96 148.07 42.46 Favored 'General case' 0 N--CA 1.476 0.842 0 CA-C-N 115.313 -0.858 . . . . 0.0 111.866 -173.674 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 17.3 tt -65.44 -11.72 12.5 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.194 0 C-N-CA 124.087 0.955 . . . . 0.0 112.366 -176.629 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -57.23 -38.66 74.13 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 123.678 0.791 . . . . 0.0 112.08 174.044 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.475 ' HG2' ' O ' ' A' ' 84' ' ' ALA . 12.6 pt-20 -90.81 -3.98 56.98 Favored 'General case' 0 N--CA 1.487 1.414 0 C-N-CA 123.14 0.576 . . . . 0.0 111.769 178.31 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -87.81 107.82 18.85 Favored 'General case' 0 N--CA 1.477 0.911 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 176.709 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 14.5 p-10 -93.48 88.0 5.76 Favored 'General case' 0 CA--C 1.547 0.842 0 CA-C-O 122.21 1.005 . . . . 0.0 111.174 -172.405 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 82.2 m95 -69.25 -26.15 64.63 Favored 'General case' 0 N--CA 1.481 1.111 0 CA-C-N 115.064 -0.971 . . . . 0.0 110.202 170.216 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 12.5 t -78.98 8.87 4.92 Favored 'General case' 0 CA--C 1.556 1.184 0 C-N-CA 125.196 1.398 . . . . 0.0 112.64 -175.443 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 14.1 t -63.0 -25.26 68.3 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 123.058 0.543 . . . . 0.0 111.13 176.482 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 21.3 p -68.4 99.29 0.93 Allowed 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 123.795 0.838 . . . . 0.0 109.676 175.062 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -69.81 136.29 27.33 Favored Glycine 0 C--N 1.348 1.199 0 CA-C-N 116.04 -0.527 . . . . 0.0 112.076 178.376 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 39.6 p . . . . . 0 CA--C 1.554 1.113 0 C-N-CA 123.863 0.865 . . . . 0.0 110.553 -178.683 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 52.8 ttp . . . . . 0 N--CA 1.481 1.106 0 N-CA-C 108.952 -0.758 . . . . 0.0 108.952 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 3.2 p80 -131.78 124.97 30.77 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 122.997 0.519 . . . . 0.0 109.968 -176.58 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 96.5 m-70 -128.93 95.0 3.97 Favored 'General case' 0 N--CA 1.472 0.651 0 N-CA-C 108.512 -0.922 . . . . 0.0 108.512 174.666 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 13.2 m-70 -89.42 45.09 1.25 Allowed 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 124.502 1.121 . . . . 0.0 110.891 -176.127 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 26.5 m170 -141.5 170.41 15.78 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 124.523 1.129 . . . . 0.0 109.547 175.456 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 26.9 p80 -69.5 168.13 15.25 Favored 'General case' 0 N--CA 1.483 1.202 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.641 -179.477 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 31.7 m170 -68.47 121.15 15.74 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.356 -179.084 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 28.0 t -146.08 176.99 9.3 Favored 'General case' 0 C--O 1.244 0.78 0 C-N-CA 124.084 0.953 . . . . 0.0 108.956 -179.037 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 32.8 t -76.58 70.02 3.07 Favored 'General case' 0 CA--C 1.555 1.157 0 C-N-CA 123.489 0.716 . . . . 0.0 109.752 177.495 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -97.39 76.89 0.65 Allowed Glycine 0 C--N 1.354 1.569 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.843 -175.092 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 6.8 mpt_? -81.1 -30.74 34.55 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 124.011 0.925 . . . . 0.0 110.047 179.658 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -77.21 -159.96 0.15 Allowed 'General case' 0 CA--C 1.558 1.286 0 C-N-CA 124.223 1.009 . . . . 0.0 111.023 178.652 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 33.3 m-80 72.18 69.63 0.14 Allowed 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 125.062 1.345 . . . . 0.0 109.86 -174.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -153.5 -166.77 2.5 Favored 'General case' 0 CA--C 1.548 0.874 0 CA-C-N 114.003 -1.453 . . . . 0.0 109.564 -179.956 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -145.85 95.51 2.65 Favored 'General case' 0 CA--C 1.55 0.966 0 C-N-CA 123.415 0.686 . . . . 0.0 109.741 -172.735 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 64.3 t80 -80.78 98.52 7.82 Favored 'General case' 0 N--CA 1.475 0.815 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 176.772 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 16.8 pt20 -160.18 178.59 9.5 Favored 'General case' 0 C--O 1.243 0.754 0 CA-C-N 115.115 -0.948 . . . . 0.0 109.594 -178.173 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -97.7 -134.88 8.46 Favored Glycine 0 C--N 1.343 0.937 0 N-CA-C 111.517 -0.633 . . . . 0.0 111.517 173.159 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 13.2 p-80 -89.31 150.38 22.62 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 123.818 0.847 . . . . 0.0 111.121 -179.293 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 63.7 mtt -144.47 109.42 5.02 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 124.285 1.034 . . . . 0.0 108.758 172.887 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -84.28 158.19 21.3 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 122.812 0.445 . . . . 0.0 110.103 177.107 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 78.8 p -80.92 -165.65 0.95 Allowed 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 123.394 0.678 . . . . 0.0 109.591 173.065 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -174.71 168.63 41.36 Favored Glycine 0 C--N 1.341 0.834 0 C-N-CA 121.219 -0.515 . . . . 0.0 112.589 177.614 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 22.7 t 64.54 -173.06 0.17 Allowed 'General case' 0 CA--C 1.556 1.182 0 C-N-CA 124.776 1.23 . . . . 0.0 111.536 177.303 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.402 ' HG2' ' H ' ' A' ' 26' ' ' GLU . 22.7 tt0 -153.55 -179.81 8.13 Favored 'General case' 0 CA--C 1.549 0.94 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 173.568 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.402 ' H ' ' HG2' ' A' ' 25' ' ' GLU . 40.4 tt0 -51.47 139.74 19.32 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 123.565 0.746 . . . . 0.0 111.685 175.063 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -72.39 86.42 1.13 Allowed 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 123.507 0.723 . . . . 0.0 110.111 -176.834 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 13.9 m -80.67 107.3 12.88 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.675 0 CA-C-O 121.858 0.837 . . . . 0.0 108.996 173.722 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 13.8 m -91.05 122.8 42.82 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 CA-C-N 114.823 -1.081 . . . . 0.0 110.686 -170.622 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 54.7 p -142.82 114.06 7.79 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 123.53 0.732 . . . . 0.0 109.5 178.604 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 62.1 t -101.85 127.81 54.95 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 C-N-CA 124.16 0.984 . . . . 0.0 108.959 179.565 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 53.3 mt-10 -83.02 106.79 15.13 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-O 121.011 0.434 . . . . 0.0 109.987 178.517 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.725 ' HB2' ' HZ2' ' A' ' 41' ' ' LYS . 3.6 mm? -82.7 164.26 47.84 Favored Pre-proline 0 CA--C 1.559 1.325 0 C-N-CA 124.619 1.167 . . . . 0.0 109.877 178.938 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -49.89 143.42 23.75 Favored 'Trans proline' 0 C--N 1.393 2.891 0 C-N-CA 123.334 2.689 . . . . 0.0 114.097 -175.914 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -146.03 155.49 51.24 Favored Pre-proline 0 CA--C 1.542 0.673 0 C-N-CA 123.633 0.773 . . . . 0.0 111.255 -167.396 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_exo -58.51 149.82 72.71 Favored 'Trans proline' 0 C--N 1.381 2.255 0 C-N-CA 123.158 2.572 . . . . 0.0 110.598 163.525 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 20.7 p -58.66 -42.66 88.92 Favored 'General case' 0 CA--C 1.551 1.019 0 C-N-CA 123.72 0.808 . . . . 0.0 111.914 -176.241 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 26.6 t -67.49 -33.65 75.54 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 123.768 0.827 . . . . 0.0 111.452 -179.966 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 21.7 m95 -105.45 -176.12 2.99 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 123.469 0.707 . . . . 0.0 111.211 -177.095 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 45.3 mtmt -137.98 149.16 45.87 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 114.926 -1.034 . . . . 0.0 108.51 162.881 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.725 ' HZ2' ' HB2' ' A' ' 33' ' ' LEU . 19.6 tptp -117.13 121.12 40.37 Favored 'General case' 0 N--CA 1.464 0.265 0 C-N-CA 124.899 1.28 . . . . 0.0 107.552 178.487 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.472 HD22 ' HB ' ' A' ' 57' ' ' VAL . 5.7 tt -119.19 143.92 46.98 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 124.171 0.988 . . . . 0.0 108.968 177.932 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.46 ' HB3' HD22 ' A' ' 33' ' ' LEU . 24.3 t80 -130.63 128.14 40.37 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 125.293 1.437 . . . . 0.0 107.822 174.881 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . 0.5 ' CG ' ' HB ' ' A' ' 54' ' ' THR . 24.8 m-85 -86.63 111.55 40.47 Favored Pre-proline 0 CA--C 1.55 0.979 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 169.456 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -76.65 -170.48 0.9 Allowed 'Trans proline' 0 C--N 1.372 1.769 0 C-N-CA 122.427 2.085 . . . . 0.0 111.034 165.724 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . 0.522 ' HB2' ' HB ' ' A' ' 51' ' ' VAL . 7.6 p30 -123.07 -175.12 3.1 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 123.756 0.822 . . . . 0.0 109.774 179.626 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 45.2 mmtm -85.0 -78.27 0.26 Allowed 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 110.017 -0.364 . . . . 0.0 110.017 172.821 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 44.7 t -130.61 75.71 0.48 Allowed 'Isoleucine or valine' 0 CA--C 1.553 1.074 0 C-N-CA 123.375 0.67 . . . . 0.0 109.948 -173.874 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 70.57 -78.68 0.46 Allowed Glycine 0 N--CA 1.476 1.326 0 N-CA-C 115.67 1.028 . . . . 0.0 115.67 169.851 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 26.7 p -82.77 43.17 0.82 Allowed 'General case' 0 CA--C 1.552 1.033 0 C-N-CA 125.196 1.398 . . . . 0.0 112.607 -170.022 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.522 ' HB ' ' HB2' ' A' ' 46' ' ' ASN . 16.9 t -102.93 153.41 5.59 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 C-N-CA 123.736 0.815 . . . . 0.0 109.094 179.679 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -65.61 -53.0 47.7 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 123.531 0.732 . . . . 0.0 110.742 -179.625 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 15.5 pttp 51.94 -168.7 0.04 OUTLIER 'General case' 0 CA--C 1.559 1.301 0 C-N-CA 126.143 1.777 . . . . 0.0 112.094 -177.893 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.5 ' HB ' ' CG ' ' A' ' 44' ' ' TYR . 51.4 m -122.31 159.66 26.96 Favored 'General case' 0 CA--C 1.55 0.976 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 175.628 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -78.83 -167.09 1.02 Allowed 'General case' 0 CA--C 1.557 1.232 0 C-N-CA 123.123 0.569 . . . . 0.0 111.524 179.525 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 37.5 t -80.51 130.87 35.25 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.625 0 C-N-CA 123.917 0.887 . . . . 0.0 110.038 -179.581 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.489 ' HA ' ' O ' ' A' ' 66' ' ' ILE . 38.3 t -122.92 120.7 61.34 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.695 0 C-N-CA 123.525 0.73 . . . . 0.0 109.503 179.589 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.47 ' CZ ' ' HD3' ' A' ' 41' ' ' LYS . 27.0 m-85 -92.87 118.38 31.06 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 123.231 0.612 . . . . 0.0 109.947 174.1 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 2.0 t -78.43 123.82 35.87 Favored 'Isoleucine or valine' 0 C--O 1.239 0.509 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 177.049 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . 0.401 ' HB2' ' H ' ' A' ' 64' ' ' GLU . . . -88.72 147.4 39.2 Favored Pre-proline 0 CA--C 1.544 0.734 0 CA-C-N 114.796 -1.093 . . . . 0.0 111.087 -175.478 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_endo -61.9 -30.69 84.19 Favored 'Trans proline' 0 C--N 1.369 1.636 0 C-N-CA 123.871 3.047 . . . . 0.0 114.064 -179.437 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 5.7 t -87.05 -1.46 57.9 Favored 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 122.242 0.217 . . . . 0.0 111.013 179.328 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 77.97 61.72 2.48 Favored Glycine 0 C--N 1.353 1.516 0 N-CA-C 112.011 -0.436 . . . . 0.0 112.011 -177.072 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.401 ' H ' ' HB2' ' A' ' 60' ' ' ALA . 40.8 tt0 -151.02 70.65 0.99 Allowed 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 107.999 -1.112 . . . . 0.0 107.999 179.318 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -65.4 158.15 27.43 Favored 'General case' 0 CA--C 1.544 0.74 0 CA-C-N 115.203 -0.908 . . . . 0.0 112.237 -171.885 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.554 HG22 ' HB2' ' A' ' 71' ' ' GLN . 44.4 mm -121.8 110.12 26.56 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 CA-C-N 115.169 -0.923 . . . . 0.0 110.484 -163.21 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 11.1 p -83.94 -17.08 41.85 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 123.249 0.62 . . . . 0.0 112.265 178.954 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 2.2 p-10 -157.26 152.52 26.19 Favored 'General case' 0 N--CA 1.476 0.854 0 N-CA-C 111.779 0.289 . . . . 0.0 111.779 -174.943 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 85.2 mtt180 -55.43 -31.76 62.15 Favored 'General case' 0 N--CA 1.493 1.686 0 C-N-CA 124.743 1.217 . . . . 0.0 114.215 -169.784 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 1.8 tmtp? -54.88 -53.92 49.18 Favored 'General case' 0 N--CA 1.486 1.371 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 177.861 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.554 ' HB2' HG22 ' A' ' 66' ' ' ILE . 84.3 mt-30 -61.68 -34.27 75.45 Favored 'General case' 0 N--CA 1.475 0.797 0 CA-C-N 114.741 -1.118 . . . . 0.0 111.126 -177.239 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.431 ' HB2' HG21 ' A' ' 66' ' ' ILE . 0.6 OUTLIER -60.74 -53.3 59.02 Favored 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 123.65 0.78 . . . . 0.0 109.755 179.153 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -68.41 -49.52 59.42 Favored 'General case' 0 C--O 1.238 0.491 0 CA-C-N 114.976 -1.011 . . . . 0.0 111.326 -172.782 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -63.5 -24.2 67.72 Favored 'General case' 0 C--N 1.356 0.865 0 O-C-N 123.635 0.584 . . . . 0.0 110.935 178.981 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 36.8 t80 -67.29 -50.62 59.59 Favored 'General case' 0 C--N 1.356 0.849 0 C-N-CA 123.224 0.61 . . . . 0.0 109.488 173.058 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.469 HD12 ' HA ' ' A' ' 84' ' ' ALA . 85.0 mt -61.84 -45.22 94.74 Favored 'General case' 0 N--CA 1.487 1.401 0 C-N-CA 123.337 0.655 . . . . 0.0 111.243 -174.4 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.06 -7.23 56.66 Favored 'General case' 0 CA--C 1.555 1.166 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.972 179.229 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 43.4 t -96.42 -22.99 16.81 Favored 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 123.744 0.818 . . . . 0.0 111.039 168.535 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 74.4 m80 -132.56 95.73 19.87 Favored Pre-proline 0 N--CA 1.476 0.871 0 C-N-CA 124.053 0.941 . . . . 0.0 109.43 -172.387 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -75.18 153.07 40.66 Favored 'Trans proline' 0 C--N 1.37 1.687 0 C-N-CA 122.382 2.055 . . . . 0.0 111.857 177.442 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 87.95 7.32 74.36 Favored Glycine 0 C--N 1.345 1.074 0 CA-C-N 115.975 -0.557 . . . . 0.0 112.686 -174.426 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 25.2 m-80 -103.69 127.33 29.71 Favored Pre-proline 0 N--CA 1.479 0.982 0 C-N-CA 123.801 0.84 . . . . 0.0 110.026 177.447 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -54.45 143.53 66.26 Favored 'Trans proline' 0 C--N 1.38 2.197 0 C-N-CA 123.606 2.871 . . . . 0.0 113.13 -178.058 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . 0.469 ' HA ' HD12 ' A' ' 76' ' ' LEU . . . -71.16 159.1 35.28 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 123.649 0.78 . . . . 0.0 112.206 -172.283 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 15.1 tt -67.64 -16.21 20.76 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.218 0 C-N-CA 123.698 0.799 . . . . 0.0 111.385 -179.536 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -61.02 -29.91 69.99 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 124.351 1.061 . . . . 0.0 112.937 179.229 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.421 ' HG3' ' HD2' ' A' ' 88' ' ' PHE . 10.0 pt-20 -97.57 -8.05 29.9 Favored 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 122.728 0.411 . . . . 0.0 111.327 177.271 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.421 ' HD2' ' HG3' ' A' ' 87' ' ' GLU . 4.3 m-30 -85.23 116.38 23.55 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 123.423 0.689 . . . . 0.0 110.344 -176.471 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -94.37 124.79 38.61 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 123.114 0.566 . . . . 0.0 110.97 -174.721 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 52.3 m95 -110.36 -20.68 12.53 Favored 'General case' 0 CA--C 1.551 0.989 0 C-N-CA 124.451 1.101 . . . . 0.0 109.632 176.889 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 11.3 t -80.86 5.46 15.99 Favored 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 123.767 0.827 . . . . 0.0 112.298 -172.501 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' THR . . . . . 0.603 HG23 ' HZ3' ' A' ' 41' ' ' LYS . 13.9 t -61.74 -21.42 64.51 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 123.251 0.621 . . . . 0.0 111.394 176.318 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 6.2 m -65.07 -27.28 68.67 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 124.977 1.311 . . . . 0.0 111.741 177.24 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 118.97 165.16 13.07 Favored Glycine 0 C--N 1.342 0.88 0 N-CA-C 110.632 -0.987 . . . . 0.0 110.632 -172.553 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 1.2 t . . . . . 0 C--O 1.252 1.194 0 CA-C-O 118.252 -0.88 . . . . 0.0 109.267 -179.088 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.467 ' SD ' ' N ' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.482 1.142 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 . . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 65.3 m80 -98.09 -35.42 10.42 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 123.573 0.749 . . . . 0.0 111.276 -176.894 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 36.6 m80 66.39 104.75 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 C-N-CA 125.31 1.444 . . . . 0.0 111.578 -176.526 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 76.7 m80 -105.42 119.71 39.78 Favored 'General case' 0 N--CA 1.472 0.674 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 173.543 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 31.4 m-70 -104.19 65.28 0.79 Allowed 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 123.678 0.791 . . . . 0.0 109.86 -176.545 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 29.7 m80 -139.13 102.5 4.53 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 123.641 0.776 . . . . 0.0 110.669 -179.908 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 10.5 p-80 -146.12 39.52 1.11 Allowed 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 125.158 1.383 . . . . 0.0 108.212 172.293 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 7.3 m -77.09 -4.25 43.41 Favored 'General case' 0 N--CA 1.479 0.992 0 CA-C-N 114.672 -1.149 . . . . 0.0 112.667 -173.405 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 32.3 m -74.52 113.42 11.75 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 123.312 0.645 . . . . 0.0 110.903 -177.502 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -153.32 54.89 0.44 Allowed Glycine 0 C--N 1.342 0.87 0 N-CA-C 111.354 -0.698 . . . . 0.0 111.354 -179.061 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 46.3 mtm180 -98.99 11.96 37.42 Favored 'General case' 0 N--CA 1.484 1.225 0 C-N-CA 123.964 0.905 . . . . 0.0 110.961 -178.567 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 44.3 tt0 -60.88 107.18 0.67 Allowed 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 123.639 0.776 . . . . 0.0 110.364 -177.812 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 32.4 t30 -128.2 96.83 4.57 Favored 'General case' 0 C--O 1.239 0.51 0 C-N-CA 124.031 0.932 . . . . 0.0 109.415 -174.697 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -110.18 135.32 51.14 Favored 'General case' 0 C--O 1.241 0.613 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 168.511 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 21.1 p90 -91.3 -36.58 13.79 Favored 'General case' 0 CA--C 1.537 0.474 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 169.502 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 35.0 t80 46.57 58.53 4.55 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 126.13 1.772 . . . . 0.0 111.764 173.534 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 13.8 pt20 -150.76 162.31 40.98 Favored 'General case' 0 C--O 1.241 0.613 0 CA-C-N 115.107 -0.952 . . . . 0.0 110.032 -176.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -170.3 174.53 44.34 Favored Glycine 0 C--O 1.24 0.53 0 CA-C-N 114.889 -1.05 . . . . 0.0 111.093 178.752 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 28.2 p-80 -88.55 137.57 32.21 Favored 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 109.781 -0.452 . . . . 0.0 109.781 177.726 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 25.7 mmt -118.38 102.12 8.7 Favored 'General case' 0 N--CA 1.477 0.912 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 -179.929 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -71.12 98.75 1.73 Allowed 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 123.471 0.709 . . . . 0.0 110.205 -179.522 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 20.7 m -133.53 68.77 1.49 Allowed 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 124.206 1.002 . . . . 0.0 108.604 179.833 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -90.3 -122.37 2.42 Favored Glycine 0 C--N 1.349 1.293 0 CA-C-N 115.397 -0.82 . . . . 0.0 111.539 175.861 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 60.0 p -87.38 27.09 1.12 Allowed 'General case' 0 CA--C 1.553 1.07 0 C-N-CA 123.61 0.764 . . . . 0.0 111.808 179.074 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -65.32 128.84 37.49 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 123.446 0.698 . . . . 0.0 111.051 179.175 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -88.4 143.05 27.23 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 123.767 0.827 . . . . 0.0 110.073 -179.525 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -84.93 83.45 8.05 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 123.403 0.681 . . . . 0.0 110.139 -175.435 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 32.8 m -99.33 128.69 50.79 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.959 0 C-N-CA 123.185 0.594 . . . . 0.0 109.399 175.867 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 16.7 m -73.74 105.48 3.07 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 178.888 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 23.7 p -162.68 118.15 1.84 Allowed 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 122.915 0.486 . . . . 0.0 110.7 -171.685 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 63.1 t -105.77 133.4 50.23 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 C-N-CA 124.372 1.069 . . . . 0.0 108.533 176.835 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -83.37 113.49 20.77 Favored 'General case' 0 CA--C 1.539 0.523 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 176.148 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.51 HD21 ' HB3' ' A' ' 43' ' ' PHE . 3.8 mm? -89.88 165.13 25.9 Favored Pre-proline 0 CA--C 1.556 1.208 0 C-N-CA 124.337 1.055 . . . . 0.0 110.088 -179.797 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -56.72 142.74 91.48 Favored 'Trans proline' 0 C--N 1.394 2.941 0 C-N-CA 122.92 2.414 . . . . 0.0 113.113 179.192 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . 0.478 ' HB1' ' HB3' ' A' ' 41' ' ' LYS . . . -136.24 166.04 31.0 Favored Pre-proline 0 CA--C 1.539 0.537 0 C-N-CA 124.216 1.007 . . . . 0.0 111.098 -169.091 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 81.5 Cg_exo -52.58 164.32 1.48 Allowed 'Trans proline' 0 C--N 1.376 2.011 0 C-N-CA 123.161 2.574 . . . . 0.0 112.538 160.8 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 66.0 p -63.95 -39.92 95.26 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 123.535 0.734 . . . . 0.0 111.748 -176.251 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 22.0 m -82.1 -37.8 25.78 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 123.641 0.776 . . . . 0.0 111.554 -177.612 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 45.0 m95 -97.17 158.12 15.6 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 123.369 0.668 . . . . 0.0 111.059 -173.389 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.523 ' HB2' ' HB ' ' A' ' 59' ' ' VAL . 0.1 OUTLIER -111.86 152.63 27.72 Favored 'General case' 0 C--O 1.236 0.352 0 N-CA-C 107.906 -1.146 . . . . 0.0 107.906 168.632 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.478 ' HB3' ' HB1' ' A' ' 35' ' ' ALA . 17.1 tptm -126.74 119.13 26.17 Favored 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 -175.309 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 4.8 tt -115.1 144.91 42.92 Favored 'General case' 0 C--N 1.322 -0.599 0 C-N-CA 124.726 1.21 . . . . 0.0 108.638 174.322 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.51 ' HB3' HD21 ' A' ' 33' ' ' LEU . 27.6 t80 -131.21 128.75 40.59 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 125.31 1.444 . . . . 0.0 108.436 174.975 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 39.0 m-85 -87.74 105.46 8.95 Favored Pre-proline 0 CA--C 1.554 1.132 0 N-CA-C 108.782 -0.822 . . . . 0.0 108.782 170.649 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -78.82 158.36 27.76 Favored 'Trans proline' 0 C--N 1.37 1.684 0 C-N-CA 122.735 2.29 . . . . 0.0 112.173 173.28 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . 0.444 ' HB2' ' HB3' ' A' ' 53' ' ' LYS . 24.6 t-20 -99.21 154.55 18.06 Favored 'General case' 0 N--CA 1.477 0.899 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 173.561 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 51.2 mtpt -57.03 -39.52 74.96 Favored 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 123.747 0.819 . . . . 0.0 111.673 -178.758 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 58.5 t -116.56 85.7 0.87 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.834 0 C-N-CA 124.139 0.976 . . . . 0.0 108.522 174.779 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 68.5 -101.55 0.78 Allowed Glycine 0 C--N 1.345 1.081 0 CA-C-N 115.772 -0.649 . . . . 0.0 113.786 175.926 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 48.7 m -127.77 -58.92 1.22 Allowed 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 123.412 0.685 . . . . 0.0 110.998 -174.227 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 46.2 t 50.83 -89.56 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 C-N-CA 124.758 1.223 . . . . 0.0 112.255 179.191 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -140.85 41.09 1.83 Allowed 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 124.45 1.1 . . . . 0.0 108.905 -177.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.478 ' HE3' ' HB3' ' A' ' 93' ' ' SER . 24.0 pttm -58.34 153.55 15.29 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 124.599 1.16 . . . . 0.0 112.041 -176.793 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 26.0 m -66.9 140.0 57.75 Favored 'General case' 0 CA--C 1.555 1.171 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 169.917 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -74.56 -178.31 3.52 Favored 'General case' 0 N--CA 1.482 1.137 0 N-CA-C 112.9 0.704 . . . . 0.0 112.9 -171.762 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 64.9 t -82.86 140.82 15.78 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.847 0 C-N-CA 124.455 1.102 . . . . 0.0 111.519 -170.648 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 63.2 t -122.23 128.61 75.56 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.9 0 C-N-CA 124.052 0.941 . . . . 0.0 108.97 176.819 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 13.3 m-85 -102.05 123.02 45.22 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 123.282 0.633 . . . . 0.0 109.563 171.583 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.523 ' HB ' ' HB2' ' A' ' 40' ' ' LYS . 2.3 t -79.58 129.47 37.51 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.611 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 174.456 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -83.85 154.61 64.67 Favored Pre-proline 0 CA--C 1.539 0.556 0 CA-C-N 114.901 -1.045 . . . . 0.0 111.446 -176.368 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -62.14 -22.86 74.92 Favored 'Trans proline' 0 C--N 1.379 2.164 0 C-N-CA 123.153 2.568 . . . . 0.0 113.447 177.251 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.408 HG23 ' OH ' ' A' ' 75' ' ' TYR . 12.1 t -99.86 -7.23 25.59 Favored 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 123.027 0.531 . . . . 0.0 111.86 177.798 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 94.16 -4.17 70.54 Favored Glycine 0 CA--C 1.531 1.043 0 CA-C-O 119.849 -0.417 . . . . 0.0 113.859 -179.386 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -78.97 75.76 5.47 Favored 'General case' 0 N--CA 1.482 1.127 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 174.801 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -67.48 157.77 33.47 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-O 121.979 0.895 . . . . 0.0 111.596 -168.833 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.516 HG21 ' HB2' ' A' ' 71' ' ' GLN . 42.7 mm -116.61 120.15 64.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 C-N-CA 125.141 1.376 . . . . 0.0 108.876 -171.016 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 18.5 p -89.19 -19.94 24.82 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 123.315 0.646 . . . . 0.0 112.349 -176.665 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 2.0 p-10 -157.95 165.33 35.42 Favored 'General case' 0 N--CA 1.481 1.109 0 CA-C-O 120.968 0.413 . . . . 0.0 111.651 -174.919 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 20.3 ttm180 -57.51 -42.17 82.25 Favored 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 125.211 1.404 . . . . 0.0 113.101 -167.702 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 8.6 tmtm? -54.27 -49.92 68.45 Favored 'General case' 0 N--CA 1.487 1.378 0 C-N-CA 123.953 0.901 . . . . 0.0 110.527 -179.702 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.516 ' HB2' HG21 ' A' ' 66' ' ' ILE . 80.5 mt-30 -61.96 -32.74 73.2 Favored 'General case' 0 N--CA 1.475 0.802 0 CA-C-N 114.765 -1.107 . . . . 0.0 111.254 -179.136 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.414 ' O ' ' HG ' ' A' ' 76' ' ' LEU . 0.5 OUTLIER -65.82 -50.88 63.05 Favored 'General case' 0 CA--C 1.551 1.004 0 C-N-CA 123.466 0.707 . . . . 0.0 109.283 179.043 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -66.29 -43.98 84.81 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 124.155 0.982 . . . . 0.0 111.81 -174.705 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -68.24 -26.69 65.81 Favored 'General case' 0 N--CA 1.482 1.144 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.799 177.872 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . 0.408 ' OH ' HG23 ' A' ' 62' ' ' THR . 19.7 t80 -69.55 -47.09 64.83 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 123.374 0.67 . . . . 0.0 109.914 176.106 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.414 ' HG ' ' O ' ' A' ' 72' ' ' LEU . 74.8 mt -69.89 -28.43 65.62 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 113.03 0.752 . . . . 0.0 113.03 -172.631 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 66.0 pttt -75.51 -36.2 60.61 Favored 'General case' 0 N--CA 1.476 0.846 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 173.485 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 34.2 t -73.97 -20.36 60.37 Favored 'General case' 0 N--CA 1.485 1.292 0 C-N-CA 123.593 0.757 . . . . 0.0 111.125 176.206 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 58.3 m80 -137.25 76.14 44.83 Favored Pre-proline 0 CA--C 1.548 0.867 0 C-N-CA 124.394 1.077 . . . . 0.0 108.354 -177.29 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -67.64 -16.75 47.35 Favored 'Trans proline' 0 C--N 1.381 2.253 0 C-N-CA 123.032 2.488 . . . . 0.0 113.155 -178.269 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -70.84 -14.75 73.28 Favored Glycine 0 C--N 1.347 1.161 0 CA-C-N 116.046 -0.525 . . . . 0.0 112.928 175.108 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 16.1 m120 -94.29 146.08 30.9 Favored Pre-proline 0 CA--C 1.547 0.845 0 C-N-CA 123.959 0.904 . . . . 0.0 110.214 176.108 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -68.97 159.94 51.89 Favored 'Trans proline' 0 C--N 1.378 2.104 0 C-N-CA 123.05 2.5 . . . . 0.0 113.752 -170.808 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -71.5 148.93 46.28 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 124.295 1.038 . . . . 0.0 112.166 -174.474 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 17.8 tt -68.08 -11.62 14.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 C-N-CA 123.778 0.831 . . . . 0.0 111.457 -179.068 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -58.7 -28.96 66.28 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 124.458 1.103 . . . . 0.0 112.797 174.263 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -100.69 -8.26 23.01 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 122.947 0.499 . . . . 0.0 111.515 176.666 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -80.42 110.02 15.48 Favored 'General case' 0 N--CA 1.48 1.03 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 177.768 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -78.43 119.81 22.27 Favored 'General case' 0 CA--C 1.537 0.45 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 175.509 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 76.2 m95 -109.13 -7.79 15.26 Favored 'General case' 0 CA--C 1.55 0.972 0 C-N-CA 124.215 1.006 . . . . 0.0 109.451 168.081 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 15.0 t -107.08 14.3 26.48 Favored 'General case' 0 CA--C 1.558 1.267 0 C-N-CA 124.28 1.032 . . . . 0.0 112.598 -164.286 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 14.6 t -61.32 -25.35 67.08 Favored 'General case' 0 N--CA 1.499 1.981 0 CA-C-O 121.393 0.616 . . . . 0.0 110.463 173.644 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' SER . . . . . 0.478 ' HB3' ' HE3' ' A' ' 53' ' ' LYS . 7.4 m -61.44 -30.37 70.54 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 125.529 1.532 . . . . 0.0 112.065 -179.838 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 71.0 -90.7 0.42 Allowed Glycine 0 C--N 1.345 1.057 0 N-CA-C 109.571 -1.412 . . . . 0.0 109.571 -167.121 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 18.1 p . . . . . 0 C--O 1.252 1.234 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 165.655 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.451 ' SD ' ' N ' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 CA--C 1.555 1.145 0 CA-C-O 121.936 0.874 . . . . 0.0 109.716 . . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 94.4 m-70 -145.95 124.4 12.39 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 124.019 0.927 . . . . 0.0 109.262 177.049 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 59.2 m80 -83.0 99.46 9.84 Favored 'General case' 0 CA--C 1.538 0.519 0 N-CA-C 107.707 -1.22 . . . . 0.0 107.707 170.97 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 14.9 t-80 -64.94 93.05 0.11 Allowed 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 123.982 0.913 . . . . 0.0 111.574 -171.65 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 31.7 m170 -101.24 71.16 1.36 Allowed 'General case' 0 C--O 1.244 0.789 0 C-N-CA 123.728 0.811 . . . . 0.0 109.305 178.005 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 47.8 t-80 -81.46 118.15 22.47 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 114.767 -1.106 . . . . 0.0 109.901 179.116 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 12.1 m170 -88.24 138.2 31.65 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.517 176.647 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 53.6 p -105.91 32.97 4.01 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 124.511 1.124 . . . . 0.0 109.037 169.113 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 24.5 m -64.17 111.29 2.51 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 124.091 0.957 . . . . 0.0 111.768 -176.886 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -95.99 125.85 8.57 Favored Glycine 0 CA--C 1.529 0.963 0 CA-C-N 115.598 -0.728 . . . . 0.0 111.583 175.981 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 2.0 tmt_? -72.12 -32.64 67.14 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 123.211 0.605 . . . . 0.0 109.625 177.315 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -64.15 93.06 0.09 Allowed 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 123.327 0.651 . . . . 0.0 109.77 175.739 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 8.1 t30 -135.68 73.01 1.45 Allowed 'General case' 0 C--O 1.242 0.674 0 N-CA-C 107.753 -1.203 . . . . 0.0 107.753 177.478 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -154.58 177.16 11.51 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 114.155 -1.384 . . . . 0.0 110.179 -178.755 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 18.6 p90 -55.57 -46.5 77.21 Favored 'General case' 0 CA--C 1.554 1.098 0 C-N-CA 123.827 0.851 . . . . 0.0 111.537 174.408 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 12.8 t80 54.89 26.93 8.37 Favored 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 125.082 1.353 . . . . 0.0 111.771 179.886 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 19.0 mm-40 -91.01 47.41 1.4 Allowed 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 124.497 1.119 . . . . 0.0 110.22 -178.083 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -80.48 65.3 3.89 Favored Glycine 0 C--N 1.345 1.028 0 CA-C-N 115.896 -0.593 . . . . 0.0 112.579 179.483 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 88.8 m-70 -112.31 138.24 49.3 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 124.198 0.999 . . . . 0.0 109.91 -177.711 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 67.4 mtt -123.09 -58.61 1.63 Allowed 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 123.513 0.725 . . . . 0.0 109.257 176.168 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . 62.36 100.24 0.03 OUTLIER 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 124.573 1.149 . . . . 0.0 112.54 173.981 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 75.2 p -147.75 134.49 19.99 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 123.491 0.716 . . . . 0.0 110.19 -178.875 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -177.43 -172.43 41.95 Favored Glycine 0 C--N 1.344 1.008 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.73 178.681 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 23.5 m 57.66 41.38 25.52 Favored 'General case' 0 N--CA 1.484 1.25 0 C-N-CA 123.856 0.862 . . . . 0.0 112.112 177.477 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -92.74 35.93 1.03 Allowed 'General case' 0 N--CA 1.486 1.356 0 CA-C-O 122.283 1.04 . . . . 0.0 110.3 -179.263 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -136.51 107.46 6.68 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 124.036 0.935 . . . . 0.0 108.816 176.445 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -71.71 91.83 1.15 Allowed 'General case' 0 C--O 1.246 0.899 0 CA-C-O 121.595 0.712 . . . . 0.0 109.401 174.878 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 24.9 m -91.59 151.1 3.59 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 CA-C-N 115.069 -0.969 . . . . 0.0 110.468 -178.228 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.536 HG23 ' HB2' ' A' ' 47' ' ' LYS . 30.9 m -112.46 132.97 59.69 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.109 0 C-N-CA 123.435 0.694 . . . . 0.0 109.918 178.371 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.448 ' HA ' ' HD2' ' A' ' 45' ' ' PRO . 76.2 p -148.1 145.85 28.57 Favored 'General case' 0 C--O 1.241 0.635 0 C-N-CA 123.274 0.63 . . . . 0.0 110.336 -178.495 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 43.9 t -114.6 131.22 67.35 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.405 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 172.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -81.55 109.88 16.41 Favored 'General case' 0 CA--C 1.54 0.586 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 173.803 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.483 HD22 ' HB3' ' A' ' 43' ' ' PHE . 4.2 mm? -87.76 168.98 15.2 Favored Pre-proline 0 CA--C 1.557 1.222 0 C-N-CA 123.849 0.86 . . . . 0.0 109.885 -177.065 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -53.68 129.03 31.95 Favored 'Trans proline' 0 C--N 1.397 3.101 0 C-N-CA 122.949 2.433 . . . . 0.0 113.118 -177.173 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -114.98 154.0 47.08 Favored Pre-proline 0 N--CA 1.48 1.031 0 C-N-CA 123.998 0.919 . . . . 0.0 112.466 -167.815 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.782 ' HG2' ' HB2' ' A' ' 39' ' ' TRP . 38.4 Cg_endo -70.96 148.01 56.35 Favored 'Trans proline' 0 C--N 1.377 2.054 0 C-N-CA 122.388 2.059 . . . . 0.0 110.233 166.091 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 33.2 t -64.43 -25.39 67.99 Favored 'General case' 0 N--CA 1.485 1.287 0 C-N-CA 123.595 0.758 . . . . 0.0 112.983 -169.967 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 40.7 t -81.46 -37.24 28.3 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 123.122 0.569 . . . . 0.0 110.766 177.823 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' TRP . . . . . 0.782 ' HB2' ' HG2' ' A' ' 36' ' ' PRO . 20.7 m95 -107.09 -164.99 1.03 Allowed 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 123.603 0.761 . . . . 0.0 110.639 -173.746 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.639 ' HB3' ' HB ' ' A' ' 59' ' ' VAL . 34.1 ttmt -142.7 152.64 42.58 Favored 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 171.248 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.539 ' HZ3' ' HB ' ' A' ' 92' ' ' THR . 16.0 tptm -130.25 127.8 40.32 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 123.66 0.784 . . . . 0.0 109.983 -170.367 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.409 HD23 ' CE1' ' A' ' 44' ' ' TYR . 3.2 tt -134.48 149.72 50.74 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 114.784 -1.098 . . . . 0.0 109.302 179.254 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.483 ' HB3' HD22 ' A' ' 33' ' ' LEU . 32.6 t80 -135.34 136.97 41.95 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 125.317 1.447 . . . . 0.0 108.484 175.653 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . 0.44 ' CG ' ' HB ' ' A' ' 54' ' ' THR . 40.5 m-85 -96.32 106.17 27.29 Favored Pre-proline 0 CA--C 1.55 0.958 0 C-N-CA 122.975 0.51 . . . . 0.0 109.661 172.025 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.448 ' HD2' ' HA ' ' A' ' 30' ' ' SER . 94.8 Cg_endo -79.3 156.22 25.59 Favored 'Trans proline' 0 C--N 1.374 1.883 0 C-N-CA 122.961 2.441 . . . . 0.0 112.383 172.797 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -85.8 105.03 16.02 Favored 'General case' 0 N--CA 1.474 0.767 0 N-CA-C 107.451 -1.315 . . . . 0.0 107.451 173.637 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.536 ' HB2' HG23 ' A' ' 29' ' ' VAL . 33.4 ttpt -55.24 -51.65 65.94 Favored 'General case' 0 N--CA 1.485 1.287 0 C-N-CA 123.438 0.695 . . . . 0.0 111.58 -174.37 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 93.4 t -80.82 -56.14 7.01 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 C-N-CA 123.532 0.733 . . . . 0.0 109.898 176.611 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.444 ' H ' HG22 ' A' ' 51' ' ' VAL . . . 143.19 -50.69 0.68 Allowed Glycine 0 C--N 1.343 0.923 0 CA-C-N 115.265 -0.88 . . . . 0.0 111.316 -178.259 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 20.0 m -82.75 21.05 1.05 Allowed 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 123.721 0.808 . . . . 0.0 111.757 178.584 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.444 HG22 ' H ' ' A' ' 49' ' ' GLY . 12.7 t -77.9 150.01 5.75 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 C-N-CA 123.619 0.767 . . . . 0.0 109.389 -179.053 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.445 ' O ' ' HG2' ' A' ' 53' ' ' LYS . 22.1 tptm -61.76 -35.92 79.53 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 123.373 0.669 . . . . 0.0 110.333 177.079 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.445 ' HG2' ' O ' ' A' ' 52' ' ' LYS . 9.8 ptmm? 60.61 173.39 0.1 Allowed 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 126.306 1.842 . . . . 0.0 112.184 -178.139 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.44 ' HB ' ' CG ' ' A' ' 44' ' ' TYR . 26.1 m -126.83 160.26 31.45 Favored 'General case' 0 CA--C 1.552 1.028 0 N-CA-C 107.039 -1.467 . . . . 0.0 107.039 170.067 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.499 ' HG3' ' O ' ' A' ' 67' ' ' SER . 1.1 pm0 -77.54 -171.24 2.09 Favored 'General case' 0 CA--C 1.551 0.996 0 CA-C-O 121.491 0.662 . . . . 0.0 112.586 -174.075 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 77.6 t -80.62 121.07 33.43 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 CA-C-N 115.151 -0.931 . . . . 0.0 108.54 175.18 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 40.4 t -111.64 118.97 58.84 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.572 0 C-N-CA 123.099 0.56 . . . . 0.0 109.569 -178.465 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.436 ' CZ ' ' HD3' ' A' ' 41' ' ' LYS . 36.1 m-85 -93.15 120.31 33.3 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 123.458 0.703 . . . . 0.0 109.507 171.541 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.639 ' HB ' ' HB3' ' A' ' 40' ' ' LYS . 3.3 t -79.71 126.61 39.3 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.449 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 174.027 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . 0.482 ' HB2' ' H ' ' A' ' 64' ' ' GLU . . . -84.61 148.57 52.21 Favored Pre-proline 0 CA--C 1.541 0.616 0 CA-C-N 114.97 -1.014 . . . . 0.0 110.781 -177.488 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -63.04 -17.36 59.78 Favored 'Trans proline' 0 N--CA 1.494 1.557 0 C-N-CA 123.394 2.729 . . . . 0.0 114.143 -176.705 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 14.1 t -110.83 0.36 17.21 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 123.365 0.666 . . . . 0.0 111.738 -178.878 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 76.35 65.32 2.03 Favored Glycine 0 CA--C 1.533 1.182 0 CA-C-O 121.385 0.436 . . . . 0.0 112.064 -175.976 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.482 ' H ' ' HB2' ' A' ' 60' ' ' ALA . 39.0 tt0 -150.6 72.54 1.09 Allowed 'General case' 0 N--CA 1.474 0.746 0 N-CA-C 106.622 -1.621 . . . . 0.0 106.622 175.244 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 4.6 mp0 -66.99 155.47 38.51 Favored 'General case' 0 N--CA 1.475 0.812 0 CA-C-N 114.756 -1.111 . . . . 0.0 112.094 -165.418 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.438 HG22 ' HB2' ' A' ' 71' ' ' GLN . 48.5 mm -116.87 143.86 26.05 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.508 0 C-N-CA 124.941 1.297 . . . . 0.0 108.965 -176.741 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.499 ' O ' ' HG3' ' A' ' 55' ' ' GLU . 35.9 p -129.37 -2.8 4.95 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 122.93 0.492 . . . . 0.0 112.038 178.533 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 9.6 p30 -151.67 158.81 43.92 Favored 'General case' 0 N--CA 1.486 1.352 0 O-C-N 121.842 -0.536 . . . . 0.0 111.123 176.442 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 55.3 mtp180 -60.61 -31.84 70.99 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 123.89 0.876 . . . . 0.0 112.78 -176.64 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 2.7 tmtp? -60.69 -54.16 48.6 Favored 'General case' 0 N--CA 1.478 0.934 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 178.4 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.438 ' HB2' HG22 ' A' ' 66' ' ' ILE . 45.8 mt-30 -54.86 -40.53 69.77 Favored 'General case' 0 N--CA 1.48 1.045 0 O-C-N 124.12 0.887 . . . . 0.0 111.849 177.867 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.47 ' O ' ' HG ' ' A' ' 76' ' ' LEU . 0.7 OUTLIER -64.74 -53.04 53.41 Favored 'General case' 0 N--CA 1.478 0.949 0 O-C-N 123.699 0.624 . . . . 0.0 110.074 -175.912 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -71.08 -37.23 72.45 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 123.184 0.593 . . . . 0.0 111.692 -172.374 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.98 -26.46 63.16 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 122.245 0.218 . . . . 0.0 111.049 174.653 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 20.0 t80 -65.08 -49.93 68.11 Favored 'General case' 0 N--CA 1.479 0.99 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 175.147 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.47 ' HG ' ' O ' ' A' ' 72' ' ' LEU . 68.3 mt -60.91 -47.29 87.09 Favored 'General case' 0 N--CA 1.479 0.995 0 O-C-N 123.983 0.802 . . . . 0.0 111.936 -173.91 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -69.53 -26.93 64.75 Favored 'General case' 0 CA--C 1.551 1.009 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.873 -177.846 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 59.2 m -89.0 -23.68 22.56 Favored 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 123.024 0.53 . . . . 0.0 111.792 178.177 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 92.8 m-70 -124.72 94.29 44.64 Favored Pre-proline 0 N--CA 1.474 0.731 0 C-N-CA 123.483 0.713 . . . . 0.0 109.959 -173.759 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -68.54 149.66 74.47 Favored 'Trans proline' 0 C--N 1.376 1.992 0 C-N-CA 122.707 2.272 . . . . 0.0 112.448 178.501 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 100.99 -20.08 49.28 Favored Glycine 0 C--N 1.345 1.051 0 CA-C-N 116.167 -0.47 . . . . 0.0 112.723 -178.821 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 40.6 m-80 -77.42 144.42 70.3 Favored Pre-proline 0 CA--C 1.549 0.939 0 C-N-CA 123.132 0.573 . . . . 0.0 110.4 176.527 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -74.8 158.9 42.64 Favored 'Trans proline' 0 C--N 1.374 1.913 0 C-N-CA 122.6 2.2 . . . . 0.0 112.625 177.462 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . 0.413 ' HA ' HD13 ' A' ' 76' ' ' LEU . . . -75.03 153.69 38.33 Favored 'General case' 0 N--CA 1.477 0.89 0 CA-C-N 115.389 -0.823 . . . . 0.0 112.561 -173.045 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.45 ' HB ' HD12 ' A' ' 72' ' ' LEU . 15.9 tt -68.08 -11.64 14.55 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.335 0 C-N-CA 123.899 0.88 . . . . 0.0 111.436 179.954 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -55.68 -31.87 62.78 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 124.226 1.01 . . . . 0.0 112.262 174.138 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -98.08 -15.74 19.86 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 122.988 0.515 . . . . 0.0 111.908 176.477 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -81.27 108.86 15.26 Favored 'General case' 0 N--CA 1.484 1.241 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 177.016 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 10.3 p-10 -97.11 120.62 37.81 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-O 121.395 0.617 . . . . 0.0 110.196 -177.558 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 65.4 m95 -96.72 -9.01 29.92 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 124.053 0.941 . . . . 0.0 109.791 173.762 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 11.0 t -85.75 16.21 4.18 Favored 'General case' 0 CA--C 1.557 1.225 0 C-N-CA 125.581 1.552 . . . . 0.0 111.294 179.665 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' THR . . . . . 0.539 ' HB ' ' HZ3' ' A' ' 41' ' ' LYS . 5.0 t -62.18 -24.8 67.41 Favored 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 124.187 0.995 . . . . 0.0 113.476 -170.172 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 33.4 p -68.41 -23.42 64.64 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 123.967 0.907 . . . . 0.0 111.77 178.333 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 133.59 -159.93 23.83 Favored Glycine 0 C--N 1.34 0.801 0 N-CA-C 110.866 -0.894 . . . . 0.0 110.866 178.631 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 33.5 p . . . . . 0 C--O 1.253 1.244 0 CA-C-O 118.687 -0.673 . . . . 0.0 109.501 176.0 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.416 ' SD ' ' N ' ' A' ' 1' ' ' MET . 3.3 mpp? . . . . . 0 N--CA 1.483 1.205 0 N-CA-C 110.143 -0.317 . . . . 0.0 110.143 . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 43.5 m-70 65.43 -80.6 0.03 OUTLIER 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 124.96 1.304 . . . . 0.0 111.17 -175.718 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 62.2 t-80 57.61 79.69 0.19 Allowed 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 124.308 1.043 . . . . 0.0 110.0 -176.011 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 27.2 t-80 -137.72 131.33 31.18 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 123.798 0.839 . . . . 0.0 110.565 -170.879 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 14.1 m-70 -119.1 126.6 52.02 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 169.152 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 13.6 t-80 -72.97 120.83 19.15 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 123.258 0.623 . . . . 0.0 111.014 -177.775 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 13.4 p80 -151.51 89.56 1.5 Allowed 'General case' 0 CA--C 1.543 0.684 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 170.216 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 47.6 m -79.62 72.92 6.32 Favored 'General case' 0 CA--C 1.538 0.507 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 174.004 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 11.2 m -84.25 79.78 9.42 Favored 'General case' 0 C--O 1.24 0.577 0 CA-C-N 114.678 -1.146 . . . . 0.0 110.698 -169.657 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 52.54 50.24 49.16 Favored Glycine 0 C--N 1.349 1.277 0 O-C-N 124.171 0.92 . . . . 0.0 113.834 177.604 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 27.4 mmt180 -75.8 -1.31 24.53 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 123.445 0.698 . . . . 0.0 112.786 -176.573 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.454 ' HB3' ' HG ' ' A' ' 14' ' ' LEU . 51.4 mt-10 -118.18 -74.76 0.59 Allowed 'General case' 0 CA--C 1.551 0.996 0 C-N-CA 123.095 0.558 . . . . 0.0 110.103 174.487 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 29.0 m-80 59.17 23.67 11.98 Favored 'General case' 0 N--CA 1.494 1.771 0 C-N-CA 124.226 1.011 . . . . 0.0 111.894 -171.344 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.454 ' HG ' ' HB3' ' A' ' 12' ' ' GLU . 1.1 pp -63.69 -42.91 97.94 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 123.482 0.713 . . . . 0.0 112.482 -175.44 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . 0.451 ' N ' HD11 ' A' ' 14' ' ' LEU . 13.1 m-85 42.73 83.22 0.02 OUTLIER 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 124.528 1.131 . . . . 0.0 112.83 -175.696 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 39.4 t80 -79.61 72.34 6.28 Favored 'General case' 0 N--CA 1.479 0.981 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 177.112 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 10.1 pt20 -151.16 106.06 3.29 Favored 'General case' 0 C--O 1.244 0.783 0 C-N-CA 124.328 1.051 . . . . 0.0 108.972 -176.661 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 178.23 154.96 13.23 Favored Glycine 0 C--O 1.244 0.754 0 N-CA-C 110.894 -0.883 . . . . 0.0 110.894 -177.591 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 22.9 t-80 -68.76 117.23 10.2 Favored 'General case' 0 CA--C 1.543 0.674 0 N-CA-C 110.153 -0.314 . . . . 0.0 110.153 -178.622 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 33.2 mmt -95.8 146.07 24.84 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 123.967 0.907 . . . . 0.0 109.075 173.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -154.22 -59.84 0.12 Allowed 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 123.486 0.714 . . . . 0.0 110.596 -177.913 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 33.0 t 66.38 160.72 0.14 Allowed 'General case' 0 N--CA 1.489 1.5 0 C-N-CA 124.705 1.202 . . . . 0.0 111.417 -175.859 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 155.31 85.56 0.05 OUTLIER Glycine 0 C--N 1.345 1.055 0 O-C-N 122.061 -0.4 . . . . 0.0 112.525 178.579 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 23.3 t -133.05 2.61 3.64 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 123.696 0.798 . . . . 0.0 110.829 175.988 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 44.3 tt0 -88.18 131.56 34.68 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 123.218 0.607 . . . . 0.0 109.998 -177.361 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -99.23 176.96 5.36 Favored 'General case' 0 C--O 1.244 0.799 0 C-N-CA 123.749 0.82 . . . . 0.0 110.036 -179.149 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -73.2 94.43 1.97 Allowed 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 123.291 0.636 . . . . 0.0 109.5 179.984 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 33.6 m -92.05 146.34 6.43 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.014 0 C-N-CA 123.957 0.903 . . . . 0.0 110.556 -177.255 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 17.7 m -78.36 108.95 12.46 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.993 0 CA-C-O 121.464 0.65 . . . . 0.0 110.078 178.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 11.0 p -159.87 127.05 4.56 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 124.167 0.987 . . . . 0.0 109.425 -176.083 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 96.7 t -117.92 127.53 75.17 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 C-N-CA 123.885 0.874 . . . . 0.0 108.839 179.406 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.471 ' HA ' ' HA ' ' A' ' 42' ' ' LEU . 2.6 mp0 -87.48 117.0 25.98 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-O 121.206 0.527 . . . . 0.0 110.172 179.609 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.693 ' HB2' ' HZ2' ' A' ' 41' ' ' LYS . 3.3 mm? -94.89 169.57 9.29 Favored Pre-proline 0 N--CA 1.491 1.583 0 C-N-CA 124.635 1.174 . . . . 0.0 110.354 -171.788 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -51.03 137.14 44.86 Favored 'Trans proline' 0 C--N 1.397 3.091 0 C-N-CA 123.195 2.597 . . . . 0.0 113.044 176.241 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -130.56 156.98 78.9 Favored Pre-proline 0 CA--C 1.544 0.725 0 C-N-CA 123.661 0.784 . . . . 0.0 112.417 -164.474 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_exo -54.62 138.07 74.67 Favored 'Trans proline' 0 C--N 1.375 1.947 0 C-N-CA 123.38 2.72 . . . . 0.0 110.786 157.354 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 57.1 p -63.15 -28.84 70.33 Favored 'General case' 0 CA--C 1.55 0.961 0 C-N-CA 123.719 0.808 . . . . 0.0 112.641 -175.146 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 35.3 t -85.16 -14.19 47.74 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 123.362 0.665 . . . . 0.0 111.765 179.356 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 16.3 m95 -122.74 -169.16 1.87 Allowed 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 124.034 0.934 . . . . 0.0 110.186 -178.815 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 28.7 mtmt -140.13 145.67 37.86 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 124.491 1.116 . . . . 0.0 108.462 169.184 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.693 ' HZ2' ' HB2' ' A' ' 33' ' ' LEU . 23.4 tptp -114.66 130.97 56.87 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 124.642 1.177 . . . . 0.0 109.349 -175.961 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.471 ' HA ' ' HA ' ' A' ' 32' ' ' GLU . 6.5 tt -128.36 149.16 50.64 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 124.478 1.111 . . . . 0.0 108.936 175.629 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.503 ' HB2' ' NZ ' ' A' ' 41' ' ' LYS . 25.9 t80 -131.32 139.71 49.61 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 125.06 1.344 . . . . 0.0 108.349 174.917 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . 0.514 ' HB3' ' HB ' ' A' ' 54' ' ' THR . 10.2 m-85 -103.4 98.52 12.56 Favored Pre-proline 0 CA--C 1.552 1.02 0 C-N-CA 122.944 0.498 . . . . 0.0 109.861 173.391 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -77.41 144.0 22.47 Favored 'Trans proline' 0 C--N 1.37 1.669 0 C-N-CA 121.963 1.775 . . . . 0.0 110.231 168.231 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 23.6 t-20 -65.12 -52.55 54.69 Favored 'General case' 0 N--CA 1.478 0.943 0 N-CA-C 108.369 -0.974 . . . . 0.0 108.369 173.311 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -145.17 -60.36 0.35 Allowed 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 125.065 1.346 . . . . 0.0 107.628 170.679 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 89.3 t -131.42 -64.77 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 172.499 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -173.72 -150.97 7.87 Favored Glycine 0 C--N 1.347 1.145 0 CA-C-N 115.24 -0.891 . . . . 0.0 111.567 -178.017 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 33.8 t 65.91 -75.53 0.05 Allowed 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 125.299 1.44 . . . . 0.0 110.823 -176.231 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 26.9 m -61.88 162.62 1.5 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.119 0 C-N-CA 124.059 0.944 . . . . 0.0 112.175 177.242 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 20.0 tptm -69.27 101.74 1.57 Allowed 'General case' 0 CA--C 1.546 0.814 0 CA-C-N 115.305 -0.862 . . . . 0.0 110.91 -172.66 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 50.6 pttt -84.93 166.99 16.33 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 125.165 1.386 . . . . 0.0 110.329 176.983 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.514 ' HB ' ' HB3' ' A' ' 44' ' ' TYR . 65.3 m -84.97 152.0 23.79 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 123.781 0.832 . . . . 0.0 108.948 176.562 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -69.53 177.63 2.84 Favored 'General case' 0 CA--C 1.551 1.018 0 CA-C-O 121.903 0.858 . . . . 0.0 112.246 -174.549 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 15.3 t -82.4 138.77 18.87 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 C-N-CA 124.72 1.208 . . . . 0.0 110.417 -178.865 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.421 ' HB ' HD22 ' A' ' 42' ' ' LEU . 68.7 t -121.21 124.62 72.45 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.772 0 C-N-CA 124.173 0.989 . . . . 0.0 109.531 175.81 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.455 ' CZ ' ' HD3' ' A' ' 41' ' ' LYS . 16.0 m-85 -98.24 123.79 42.5 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 123.356 0.662 . . . . 0.0 109.904 173.179 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 3.4 t -79.17 122.73 34.99 Favored 'Isoleucine or valine' 0 C--O 1.241 0.606 0 C-N-CA 123.47 0.708 . . . . 0.0 109.359 175.936 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -81.45 154.53 71.56 Favored Pre-proline 0 CA--C 1.542 0.651 0 CA-C-N 114.238 -1.346 . . . . 0.0 110.956 -176.266 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_endo -62.17 -27.52 78.72 Favored 'Trans proline' 0 C--N 1.375 1.955 0 C-N-CA 122.759 2.306 . . . . 0.0 112.947 178.939 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 12.4 t -96.89 -7.71 32.69 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 122.72 0.408 . . . . 0.0 111.085 177.309 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 93.99 -1.04 67.42 Favored Glycine 0 C--N 1.353 1.483 0 CA-C-O 119.866 -0.408 . . . . 0.0 113.957 178.816 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -78.79 73.27 5.34 Favored 'General case' 0 N--CA 1.479 0.982 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 174.477 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -67.76 158.43 32.42 Favored 'General case' 0 C--N 1.35 0.594 0 CA-C-N 114.98 -1.009 . . . . 0.0 112.01 -168.777 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 47.3 mm -116.04 125.44 73.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 C-N-CA 124.707 1.203 . . . . 0.0 109.354 -166.879 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 12.3 p -110.93 5.36 20.38 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 123.645 0.778 . . . . 0.0 112.797 -175.184 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 11.2 p30 -163.31 164.56 24.82 Favored 'General case' 0 N--CA 1.486 1.335 0 C-N-CA 122.988 0.515 . . . . 0.0 110.393 172.085 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 19.7 ttp180 -63.67 -34.42 77.82 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 123.683 0.793 . . . . 0.0 112.218 -171.856 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 8.2 tmtm? -60.86 -50.41 73.54 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 123.434 0.694 . . . . 0.0 109.828 179.015 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 75.5 mt-30 -55.84 -34.89 65.82 Favored 'General case' 0 N--CA 1.477 0.917 0 O-C-N 124.288 0.993 . . . . 0.0 111.406 179.123 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.416 ' O ' ' HG ' ' A' ' 76' ' ' LEU . 0.5 OUTLIER -65.33 -54.95 21.44 Favored 'General case' 0 CA--C 1.547 0.858 0 N-CA-C 109.489 -0.559 . . . . 0.0 109.489 179.559 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -59.86 -47.16 86.86 Favored 'General case' 0 N--CA 1.486 1.364 0 C-N-CA 124.19 0.996 . . . . 0.0 111.633 -175.117 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 5.3 pp0? -68.15 -30.77 69.98 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.374 -179.308 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 32.9 t80 -65.83 -45.17 83.22 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 123.248 0.619 . . . . 0.0 109.523 176.732 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.416 ' HG ' ' O ' ' A' ' 72' ' ' LEU . 69.9 mt -63.14 -44.09 96.54 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 123.108 0.563 . . . . 0.0 111.655 -176.115 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.92 -19.39 58.84 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 122.806 0.442 . . . . 0.0 111.414 -179.842 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 46.1 t -91.62 -12.31 34.61 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 123.236 0.615 . . . . 0.0 111.382 174.006 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 57.7 m-70 -133.55 83.51 48.47 Favored Pre-proline 0 CA--C 1.551 1.007 0 C-N-CA 123.462 0.705 . . . . 0.0 109.631 -179.402 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -65.73 128.62 20.35 Favored 'Trans proline' 0 C--N 1.379 2.143 0 C-N-CA 122.802 2.334 . . . . 0.0 112.065 176.691 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 124.01 -22.53 6.75 Favored Glycine 0 C--N 1.342 0.91 0 CA-C-N 115.76 -0.655 . . . . 0.0 111.837 -177.96 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 12.3 m120 -74.25 151.85 87.99 Favored Pre-proline 0 CA--C 1.553 1.072 0 C-N-CA 123.064 0.546 . . . . 0.0 110.785 177.379 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -69.61 160.45 49.7 Favored 'Trans proline' 0 C--N 1.375 1.927 0 C-N-CA 122.73 2.287 . . . . 0.0 112.853 178.887 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -75.82 148.71 38.19 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 123.565 0.746 . . . . 0.0 111.167 -176.299 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 16.1 tt -65.63 -12.53 14.01 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.383 0 C-N-CA 123.729 0.811 . . . . 0.0 112.371 -177.59 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -57.97 -35.46 71.21 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 124.49 1.116 . . . . 0.0 112.215 176.156 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -91.03 -11.88 37.47 Favored 'General case' 0 N--CA 1.485 1.282 0 N-CA-C 112.38 0.511 . . . . 0.0 112.38 177.883 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 4.9 m-85 -76.16 108.55 9.16 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 177.259 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 4.5 t0 -86.97 102.24 14.19 Favored 'General case' 0 CA--C 1.541 0.635 0 CA-C-N 115.995 -0.548 . . . . 0.0 109.964 -173.0 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 82.1 m95 -89.6 -31.94 17.34 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 123.746 0.819 . . . . 0.0 109.99 174.251 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 8.9 t -75.39 -6.49 50.26 Favored 'General case' 0 CA--C 1.557 1.215 0 C-N-CA 124.059 0.944 . . . . 0.0 112.532 -172.373 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 14.9 t -69.16 -7.92 40.77 Favored 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 123.451 0.7 . . . . 0.0 111.803 175.255 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 68.3 p -61.77 -34.36 75.73 Favored 'General case' 0 C--N 1.355 0.846 0 C-N-CA 123.989 0.915 . . . . 0.0 110.667 172.467 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 123.88 127.0 3.15 Favored Glycine 0 C--N 1.348 1.244 0 CA-C-N 115.245 -0.888 . . . . 0.0 111.285 -179.652 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 18.3 p . . . . . 0 C--O 1.25 1.096 0 C-N-CA 123.879 0.872 . . . . 0.0 108.699 177.431 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.472 ' SD ' ' N ' ' A' ' 1' ' ' MET . 1.1 mpt? . . . . . 0 N--CA 1.482 1.148 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 18.7 p80 -156.81 112.17 2.87 Favored 'General case' 0 N--CA 1.479 1.008 0 CA-C-O 121.253 0.549 . . . . 0.0 110.488 178.019 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 98.6 m-70 -132.15 141.46 49.13 Favored 'General case' 0 N--CA 1.475 0.808 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 171.447 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 34.0 m170 -79.1 120.69 24.0 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.825 -171.846 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 30.1 p-80 -104.87 154.75 19.65 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 124.358 1.063 . . . . 0.0 109.278 173.527 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 69.1 m-70 -78.57 150.15 32.85 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 123.244 0.618 . . . . 0.0 110.116 178.149 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 14.0 t-80 -62.95 99.11 0.15 Allowed 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 123.78 0.832 . . . . 0.0 110.833 -175.936 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 16.3 m -84.06 112.21 20.0 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 123.806 0.842 . . . . 0.0 108.953 178.39 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 42.4 p -156.9 138.09 13.7 Favored 'General case' 0 C--O 1.244 0.771 0 C-N-CA 123.386 0.674 . . . . 0.0 110.347 -177.857 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -89.09 148.73 20.35 Favored Glycine 0 C--N 1.344 0.988 0 N-CA-C 110.652 -0.979 . . . . 0.0 110.652 177.203 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 26.3 tpt180 -138.49 -67.95 0.46 Allowed 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 123.71 0.804 . . . . 0.0 109.471 -176.061 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -95.21 78.52 3.49 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 123.068 0.547 . . . . 0.0 109.841 -176.034 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 63.7 t30 -164.18 75.24 0.31 Allowed 'General case' 0 N--CA 1.475 0.793 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 173.118 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -167.32 155.37 9.33 Favored 'General case' 0 N--CA 1.478 0.937 0 CA-C-N 115.084 -0.962 . . . . 0.0 108.908 179.481 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 74.9 m-85 -135.45 -64.35 0.64 Allowed 'General case' 0 N--CA 1.475 0.775 0 C-N-CA 122.971 0.508 . . . . 0.0 110.183 -178.772 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 58.8 t80 64.73 14.44 9.11 Favored 'General case' 0 CA--C 1.565 1.524 0 O-C-N 124.14 0.9 . . . . 0.0 111.14 -179.165 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -128.63 -166.38 1.63 Allowed 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 124.4 1.08 . . . . 0.0 109.835 -176.748 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 88.43 15.16 60.7 Favored Glycine 0 C--N 1.347 1.191 0 CA-C-N 116.402 -0.363 . . . . 0.0 113.695 172.989 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 58.1 t-80 -101.22 117.26 34.64 Favored 'General case' 0 C--O 1.24 0.594 0 N-CA-C 109.419 -0.586 . . . . 0.0 109.419 173.945 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 2.7 mpp? -113.61 128.12 56.32 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 124.235 1.014 . . . . 0.0 108.859 175.833 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -76.49 81.53 3.19 Favored 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 109.125 -0.695 . . . . 0.0 109.125 171.341 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 50.5 m -146.89 143.31 28.45 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 123.702 0.801 . . . . 0.0 110.469 -173.378 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -169.27 40.78 0.21 Allowed Glycine 0 C--N 1.345 1.067 0 N-CA-C 111.547 -0.621 . . . . 0.0 111.547 178.459 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 21.0 m -64.69 131.24 46.35 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 123.802 0.841 . . . . 0.0 110.494 -179.744 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -143.36 79.95 1.66 Allowed 'General case' 0 N--CA 1.47 0.543 0 N-CA-C 108.312 -0.995 . . . . 0.0 108.312 179.884 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -107.05 124.78 50.14 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 124.196 0.998 . . . . 0.0 109.072 -178.507 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 12.5 tp10 -78.38 92.42 4.57 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 123.656 0.783 . . . . 0.0 110.422 -174.317 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 19.0 m -129.11 147.76 33.34 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.028 0 C-N-CA 124.652 1.181 . . . . 0.0 109.881 -178.021 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 21.0 m -85.26 110.97 20.06 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 CA-C-O 121.222 0.534 . . . . 0.0 110.325 178.404 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 58.5 p -140.46 123.74 16.79 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 123.826 0.85 . . . . 0.0 109.49 177.569 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 48.5 t -110.83 124.45 67.64 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 C-N-CA 124.184 0.994 . . . . 0.0 109.464 178.559 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 53.4 mt-10 -80.9 104.08 11.16 Favored 'General case' 0 CA--C 1.545 0.76 0 CA-C-O 121.235 0.54 . . . . 0.0 110.188 176.758 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.431 HD21 ' HB3' ' A' ' 43' ' ' PHE . 3.9 mm? -79.32 163.3 60.16 Favored Pre-proline 0 CA--C 1.564 1.519 0 C-N-CA 124.881 1.272 . . . . 0.0 110.409 177.573 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo -60.04 145.51 98.23 Favored 'Trans proline' 0 C--N 1.391 2.769 0 C-N-CA 122.741 2.294 . . . . 0.0 114.157 -174.467 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . 0.526 ' HB3' ' HB3' ' A' ' 41' ' ' LYS . . . -157.29 163.06 26.19 Favored Pre-proline 0 CA--C 1.542 0.671 0 C-N-CA 124.18 0.992 . . . . 0.0 110.839 -172.2 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_exo -52.73 147.66 30.76 Favored 'Trans proline' 0 C--N 1.379 2.139 0 C-N-CA 123.004 2.469 . . . . 0.0 112.122 164.319 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 37.4 p -71.42 -15.22 62.34 Favored 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 123.519 0.728 . . . . 0.0 111.929 -176.818 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 42.7 t -75.93 -34.85 59.9 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 123.585 0.754 . . . . 0.0 110.19 172.007 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 28.2 m95 -109.83 -169.93 1.56 Allowed 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 123.883 0.873 . . . . 0.0 110.86 -175.515 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.714 ' HB3' ' HB ' ' A' ' 59' ' ' VAL . 1.7 tpmt? -148.35 144.64 27.67 Favored 'General case' 0 CA--C 1.533 0.327 0 CA-C-N 114.939 -1.028 . . . . 0.0 108.266 166.821 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.526 ' HB3' ' HB3' ' A' ' 35' ' ' ALA . 19.6 tptp -112.74 115.48 28.59 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 177.183 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.412 HD22 ' HB ' ' A' ' 57' ' ' VAL . 7.3 tt -111.43 139.78 46.56 Favored 'General case' 0 C--N 1.319 -0.748 0 C-N-CA 124.518 1.127 . . . . 0.0 108.262 174.635 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.431 ' HB3' HD21 ' A' ' 33' ' ' LEU . 38.1 t80 -125.74 135.57 52.21 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 124.619 1.168 . . . . 0.0 107.9 173.286 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 8.6 m-85 -94.24 103.02 9.56 Favored Pre-proline 0 CA--C 1.55 0.969 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 172.812 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -81.99 -163.43 0.22 Allowed 'Trans proline' 0 C--N 1.374 1.905 0 C-N-CA 122.951 2.434 . . . . 0.0 111.792 172.752 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 6.4 p30 -166.81 177.19 6.59 Favored 'General case' 0 CA--C 1.545 0.75 0 C-N-CA 123.842 0.857 . . . . 0.0 110.078 179.444 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 50.9 mtpt -79.03 -51.03 10.14 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 123.434 0.694 . . . . 0.0 112.337 -173.394 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.56 ' HB ' HG23 ' A' ' 51' ' ' VAL . 93.2 t -63.26 -39.39 85.1 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.224 0 C-N-CA 123.117 0.567 . . . . 0.0 111.211 -175.476 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 90.98 -50.7 3.14 Favored Glycine 0 C--N 1.343 0.943 0 CA-C-N 115.764 -0.653 . . . . 0.0 112.408 179.772 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 28.9 m -67.9 -32.81 73.54 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 123.461 0.704 . . . . 0.0 111.934 -179.279 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.56 HG23 ' HB ' ' A' ' 48' ' ' VAL . 24.1 m -77.55 144.13 11.9 Favored 'Isoleucine or valine' 0 C--O 1.239 0.55 0 N-CA-C 109.651 -0.5 . . . . 0.0 109.651 175.283 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -110.12 88.75 2.83 Favored 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 107.625 -1.25 . . . . 0.0 107.625 178.103 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 9.8 tmtt? -67.45 -67.73 0.43 Allowed 'General case' 0 CA--C 1.554 1.101 0 C-N-CA 123.449 0.7 . . . . 0.0 109.97 -171.548 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 85.1 m -129.06 149.32 50.93 Favored 'General case' 0 CA--C 1.545 0.776 0 N-CA-C 108.771 -0.825 . . . . 0.0 108.771 -179.682 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -84.71 -169.02 2.43 Favored 'General case' 0 CA--C 1.554 1.13 0 C-N-CA 123.842 0.857 . . . . 0.0 112.085 -172.473 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 48.1 t -82.58 140.09 16.88 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.594 0 C-N-CA 124.909 1.284 . . . . 0.0 110.578 -179.157 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.412 ' HB ' HD22 ' A' ' 42' ' ' LEU . 81.6 t -123.97 130.69 73.76 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.682 0 C-N-CA 124.079 0.951 . . . . 0.0 109.062 173.022 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 16.2 m-85 -102.03 122.22 43.68 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 123.198 0.599 . . . . 0.0 109.504 171.228 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.714 ' HB ' ' HB3' ' A' ' 40' ' ' LYS . 4.3 t -81.15 130.52 35.72 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 173.122 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -95.06 155.65 38.76 Favored Pre-proline 0 CA--C 1.548 0.87 0 C-N-CA 124.167 0.987 . . . . 0.0 110.754 -176.175 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -66.01 -8.19 19.24 Favored 'Trans proline' 0 C--N 1.38 2.236 0 C-N-CA 123.067 2.511 . . . . 0.0 114.202 -177.259 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 9.6 t -120.98 12.66 11.23 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 123.602 0.761 . . . . 0.0 111.412 -175.174 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 81.03 -22.83 4.79 Favored Glycine 0 C--N 1.353 1.494 0 N-CA-C 114.531 0.572 . . . . 0.0 114.531 179.336 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 49.7 tt0 -72.84 75.0 1.15 Allowed 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 124.551 1.14 . . . . 0.0 109.487 177.626 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -80.97 157.98 25.34 Favored 'General case' 0 N--CA 1.476 0.839 0 CA-C-N 115.287 -0.87 . . . . 0.0 111.707 -168.785 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 42.5 mm -107.9 139.84 28.49 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.755 0 C-N-CA 124.905 1.282 . . . . 0.0 110.379 -173.35 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 16.3 p -108.33 -9.84 15.42 Favored 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 123.584 0.754 . . . . 0.0 112.66 -179.885 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 13.1 p-10 -160.74 162.64 32.53 Favored 'General case' 0 N--CA 1.486 1.337 0 N-CA-C 112.348 0.499 . . . . 0.0 112.348 -168.378 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 3.8 ttm180 -59.92 -41.33 91.49 Favored 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 124.613 1.165 . . . . 0.0 112.17 -170.789 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 7.4 tmtm? -60.91 -54.43 45.12 Favored 'General case' 0 N--CA 1.478 0.929 0 CA-C-N 115.145 -0.934 . . . . 0.0 109.507 -176.622 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.405 ' HA ' ' HG3' ' A' ' 74' ' ' GLN . 87.3 mm-40 -64.2 -25.17 67.95 Favored 'General case' 0 N--CA 1.475 0.797 0 O-C-N 124.03 0.831 . . . . 0.0 111.45 -176.676 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.413 ' O ' ' HG ' ' A' ' 76' ' ' LEU . 0.6 OUTLIER -66.52 -52.67 43.32 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 123.375 0.67 . . . . 0.0 109.224 175.88 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -64.08 -50.54 67.92 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 123.634 0.774 . . . . 0.0 111.363 -175.602 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . 0.405 ' HG3' ' HA ' ' A' ' 71' ' ' GLN . 0.0 OUTLIER -66.16 -23.92 66.55 Favored 'General case' 0 CA--C 1.547 0.861 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.365 179.582 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 38.5 t80 -66.88 -51.79 51.2 Favored 'General case' 0 C--O 1.212 -0.873 0 C-N-CA 122.92 0.488 . . . . 0.0 109.736 171.703 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.413 ' HG ' ' O ' ' A' ' 72' ' ' LEU . 83.1 mt -62.51 -37.78 87.35 Favored 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 123.225 0.61 . . . . 0.0 112.495 -172.105 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.77 -26.57 57.49 Favored 'General case' 0 CA--C 1.553 1.072 0 CA-C-O 120.83 0.347 . . . . 0.0 110.95 178.033 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 41.6 t -83.19 -26.68 30.62 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 123.203 0.601 . . . . 0.0 111.044 175.834 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 53.6 m80 -125.7 89.54 52.24 Favored Pre-proline 0 C--O 1.241 0.613 0 C-N-CA 124.395 1.078 . . . . 0.0 108.594 -173.447 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -68.67 164.85 31.53 Favored 'Trans proline' 0 C--N 1.369 1.62 0 C-N-CA 122.311 2.007 . . . . 0.0 111.666 176.076 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 89.81 -29.46 6.34 Favored Glycine 0 CA--C 1.532 1.123 0 CA-C-N 116.468 -0.333 . . . . 0.0 112.678 -176.049 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 36.1 m-80 -71.73 141.05 84.39 Favored Pre-proline 0 CA--C 1.549 0.932 0 C-N-CA 123.871 0.868 . . . . 0.0 110.778 178.828 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -67.02 163.03 35.51 Favored 'Trans proline' 0 C--N 1.374 1.895 0 C-N-CA 123.114 2.543 . . . . 0.0 112.863 179.959 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -74.7 161.03 30.03 Favored 'General case' 0 N--CA 1.488 1.442 0 C-N-CA 124.017 0.927 . . . . 0.0 112.266 -170.317 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 16.3 tt -78.71 -19.93 13.1 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.253 0 CA-C-O 120.808 0.337 . . . . 0.0 111.158 179.283 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -61.89 -38.17 87.32 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 123.344 0.658 . . . . 0.0 111.777 177.991 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -83.89 -9.75 58.5 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 123.282 0.633 . . . . 0.0 111.51 179.322 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 5.5 m-30 -82.62 129.69 34.99 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 123.397 0.679 . . . . 0.0 110.17 177.769 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . 0.408 ' OD1' ' HB ' ' A' ' 92' ' ' THR . 3.5 t70 -84.57 125.79 32.75 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 123.893 0.877 . . . . 0.0 110.32 177.568 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 86.2 m95 -118.43 -11.56 9.97 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 123.969 0.908 . . . . 0.0 109.439 168.203 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 13.7 t -102.93 13.52 34.15 Favored 'General case' 0 CA--C 1.555 1.15 0 C-N-CA 124.371 1.069 . . . . 0.0 112.571 -163.728 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' THR . . . . . 0.474 HG22 ' HZ1' ' A' ' 41' ' ' LYS . 14.5 t -62.49 -21.08 65.21 Favored 'General case' 0 N--CA 1.49 1.535 0 C-N-CA 122.764 0.426 . . . . 0.0 111.93 -179.549 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 14.7 m -60.62 -17.79 49.17 Favored 'General case' 0 CA--C 1.55 0.947 0 C-N-CA 124.607 1.163 . . . . 0.0 112.31 179.88 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 84.42 -67.52 3.68 Favored Glycine 0 C--N 1.352 1.44 0 N-CA-C 110.458 -1.057 . . . . 0.0 110.458 -178.408 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 29.9 p . . . . . 0 C--O 1.256 1.416 0 C-N-CA 124.408 1.083 . . . . 0.0 109.476 174.337 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 30.4 m . . . . . 0 N--CA 1.479 0.98 0 N-CA-C 111.907 0.336 . . . . 0.0 111.907 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 60.9 p -143.69 129.35 19.21 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 123.526 0.731 . . . . 0.0 109.709 179.021 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 99.4 t -108.32 125.44 65.06 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 C-N-CA 124.337 1.055 . . . . 0.0 108.565 175.651 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -79.87 110.38 15.18 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 176.959 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.491 ' HB2' ' HG3' ' A' ' 41' ' ' LYS . 3.9 mm? -85.8 162.06 48.47 Favored Pre-proline 0 N--CA 1.485 1.29 0 C-N-CA 124.145 0.978 . . . . 0.0 109.399 178.959 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_endo -62.08 155.93 52.98 Favored 'Trans proline' 0 C--N 1.388 2.651 0 C-N-CA 122.628 2.219 . . . . 0.0 113.407 -179.667 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.472 ' HB2' ' CB ' ' A' ' 41' ' ' LYS . . . -161.65 171.2 7.08 Favored Pre-proline 0 N--CA 1.48 1.064 0 C-N-CA 123.741 0.816 . . . . 0.0 111.307 -171.11 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 13.7 Cg_endo -57.02 137.82 83.63 Favored 'Trans proline' 0 C--N 1.384 2.422 0 C-N-CA 122.053 1.835 . . . . 0.0 110.053 158.456 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 24.8 m -67.87 -15.9 63.84 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 123.601 0.76 . . . . 0.0 112.042 -176.383 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 17.8 p -69.15 -39.57 78.74 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 123.956 0.902 . . . . 0.0 110.455 172.646 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 25.5 m95 -105.03 -168.38 1.46 Allowed 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 123.92 0.888 . . . . 0.0 110.179 177.24 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.662 ' HB3' ' HB ' ' A' ' 59' ' ' VAL . 14.2 tppt? -143.77 144.2 31.7 Favored 'General case' 0 C--O 1.234 0.246 0 N-CA-C 107.581 -1.266 . . . . 0.0 107.581 167.93 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.515 ' NZ ' ' HB2' ' A' ' 43' ' ' PHE . 24.6 tptp -108.85 125.4 51.94 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 177.818 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 6.6 tt -122.41 141.76 51.25 Favored 'General case' 0 C--N 1.322 -0.622 0 C-N-CA 124.31 1.044 . . . . 0.0 108.259 174.894 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.515 ' HB2' ' NZ ' ' A' ' 41' ' ' LYS . 29.1 t80 -123.84 136.18 54.22 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 171.184 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 10.5 m-85 -96.03 100.84 7.17 Favored Pre-proline 0 CA--C 1.546 0.811 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 169.363 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 65.8 Cg_endo . . . . . 0 C--N 1.371 1.761 0 C-N-CA 122.329 2.019 . . . . 0.0 111.646 173.485 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.481 1.078 0 CA-C-O 121.409 0.623 . . . . 0.0 111.496 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 42.9 t -82.66 137.36 21.17 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.723 0 C-N-CA 124.841 1.257 . . . . 0.0 110.661 -179.578 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 86.2 t -126.67 125.34 66.85 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.883 0 C-N-CA 124.224 1.01 . . . . 0.0 108.751 173.138 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.483 ' CZ ' ' HD3' ' A' ' 41' ' ' LYS . 14.0 m-85 -94.67 124.0 38.44 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 123.185 0.594 . . . . 0.0 109.65 172.254 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.662 ' HB ' ' HB3' ' A' ' 40' ' ' LYS . 6.0 t -80.88 128.82 38.4 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.522 0 C-N-CA 123.493 0.717 . . . . 0.0 109.681 174.648 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -87.27 153.16 53.61 Favored Pre-proline 0 CA--C 1.543 0.674 0 CA-C-N 115.079 -0.964 . . . . 0.0 110.429 -178.372 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_endo -63.03 -20.84 72.45 Favored 'Trans proline' 0 C--N 1.375 1.958 0 C-N-CA 123.213 2.609 . . . . 0.0 113.514 178.68 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.446 HG23 ' H ' ' A' ' 64' ' ' GLU . 10.5 t -101.83 -4.22 26.67 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 123.837 0.855 . . . . 0.0 111.834 178.956 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 91.31 -9.62 76.97 Favored Glycine 0 C--N 1.352 1.439 0 CA-C-O 119.895 -0.392 . . . . 0.0 113.728 -178.79 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.446 ' H ' HG23 ' A' ' 62' ' ' THR . 34.6 tt0 -76.98 73.42 3.57 Favored 'General case' 0 N--CA 1.486 1.35 0 CA-C-O 122.03 0.919 . . . . 0.0 109.248 178.207 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -72.65 159.82 33.25 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 114.384 -1.28 . . . . 0.0 112.239 -166.954 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.485 HG23 ' HB2' ' A' ' 71' ' ' GLN . 45.8 mm -115.24 123.32 70.71 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.676 0 C-N-CA 125.041 1.337 . . . . 0.0 109.588 -173.412 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 17.4 m -94.18 -22.22 18.57 Favored 'General case' 0 N--CA 1.486 1.331 0 C-N-CA 122.957 0.503 . . . . 0.0 112.096 -176.718 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 7.2 p30 -148.59 155.08 40.63 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 123.032 0.533 . . . . 0.0 110.373 -172.799 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 74.0 ttt-85 -62.4 -31.35 72.02 Favored 'General case' 0 CA--C 1.554 1.117 0 C-N-CA 124.67 1.188 . . . . 0.0 113.682 -166.221 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 1.6 tmtp? -61.85 -46.89 87.48 Favored 'General case' 0 N--CA 1.486 1.355 0 C-N-CA 123.243 0.617 . . . . 0.0 109.627 177.519 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.485 ' HB2' HG23 ' A' ' 66' ' ' ILE . 96.7 mt-30 -61.0 -27.53 68.38 Favored 'General case' 0 N--CA 1.484 1.234 0 CA-C-N 115.646 -0.707 . . . . 0.0 111.599 -178.835 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.427 ' O ' ' HG ' ' A' ' 76' ' ' LEU . 0.6 OUTLIER -67.47 -53.83 25.44 Favored 'General case' 0 N--CA 1.477 0.893 0 O-C-N 123.883 0.739 . . . . 0.0 109.248 179.44 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -60.75 -47.28 87.01 Favored 'General case' 0 N--CA 1.485 1.31 0 C-N-CA 123.621 0.768 . . . . 0.0 111.669 -176.964 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 5.2 pp0? -68.99 -25.33 64.47 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.199 179.516 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 42.2 t80 -67.13 -50.97 59.54 Favored 'General case' 0 N--CA 1.475 0.813 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 174.858 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.427 ' HG ' ' O ' ' A' ' 72' ' ' LEU . 69.7 mt -62.29 -42.13 99.09 Favored 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 123.371 0.669 . . . . 0.0 111.935 -173.267 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -70.18 -26.64 64.0 Favored 'General case' 0 N--CA 1.478 0.965 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.973 178.987 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 48.6 m -92.99 -12.27 31.11 Favored 'General case' 0 N--CA 1.493 1.701 0 C-N-CA 123.34 0.656 . . . . 0.0 111.739 177.463 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 64.8 m80 -135.47 84.19 35.1 Favored Pre-proline 0 N--CA 1.484 1.227 0 C-N-CA 123.965 0.906 . . . . 0.0 109.409 -176.268 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -68.45 147.93 72.2 Favored 'Trans proline' 0 C--N 1.377 2.06 0 C-N-CA 122.608 2.206 . . . . 0.0 111.498 175.818 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 107.12 -31.51 8.08 Favored Glycine 0 C--N 1.341 0.861 0 N-CA-C 111.198 -0.761 . . . . 0.0 111.198 -172.967 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 40.4 m-80 -76.55 136.45 67.82 Favored Pre-proline 0 N--CA 1.48 1.025 0 C-N-CA 123.324 0.65 . . . . 0.0 110.085 177.364 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -66.91 162.38 38.1 Favored 'Trans proline' 0 C--N 1.38 2.195 0 C-N-CA 123.108 2.539 . . . . 0.0 113.141 -176.38 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -75.28 149.65 38.74 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-N 115.021 -0.99 . . . . 0.0 111.895 -172.878 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.4 ' HB ' HD12 ' A' ' 72' ' ' LEU . 15.8 tt -66.29 -11.81 13.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 C-N-CA 124.155 0.982 . . . . 0.0 111.814 -176.986 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -54.26 -41.93 69.36 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 123.95 0.9 . . . . 0.0 111.848 172.685 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -92.79 4.76 53.21 Favored 'General case' 0 N--CA 1.481 1.115 0 N-CA-C 112.089 0.403 . . . . 0.0 112.089 179.783 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -94.76 109.97 21.88 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 123.346 0.658 . . . . 0.0 109.545 176.85 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -84.43 85.96 7.33 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 123.981 0.912 . . . . 0.0 111.292 -176.155 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 93.5 m95 -77.85 -27.07 49.73 Favored 'General case' 0 CA--C 1.547 0.841 0 CA-C-N 115.341 -0.845 . . . . 0.0 109.909 169.179 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 14.7 t . . . . . 0 CA--C 1.557 1.224 0 C-N-CA 124.529 1.132 . . . . 0.0 112.252 -175.582 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 28.1 m . . . . . 0 N--CA 1.48 1.047 0 CA-C-O 120.902 0.382 . . . . 0.0 111.313 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.401 ' HA ' ' HD2' ' A' ' 45' ' ' PRO . 36.6 p -157.64 122.37 4.37 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 124.317 1.047 . . . . 0.0 108.694 177.359 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 65.5 t -103.34 123.97 57.21 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 C-N-CA 123.885 0.874 . . . . 0.0 109.075 -177.121 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -83.38 114.63 21.57 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 123.08 0.552 . . . . 0.0 110.396 177.476 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.472 HD23 ' HB3' ' A' ' 43' ' ' PHE . 4.5 mm? -92.19 168.88 11.92 Favored Pre-proline 0 CA--C 1.562 1.438 0 C-N-CA 124.44 1.096 . . . . 0.0 109.766 -179.712 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -57.37 143.12 94.8 Favored 'Trans proline' 0 C--N 1.39 2.755 0 C-N-CA 122.739 2.293 . . . . 0.0 115.13 -177.967 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.755 ' HB2' ' HB3' ' A' ' 41' ' ' LYS . . . -144.97 167.07 15.57 Favored Pre-proline 0 N--CA 1.484 1.272 0 C-N-CA 124.648 1.179 . . . . 0.0 111.349 -177.501 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.587 ' HG2' ' HB2' ' A' ' 39' ' ' TRP . 31.3 Cg_endo -63.95 162.79 27.69 Favored 'Trans proline' 0 C--N 1.382 2.314 0 C-N-CA 122.645 2.23 . . . . 0.0 111.522 161.22 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 25.2 p -71.93 -24.77 61.68 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 123.52 0.728 . . . . 0.0 112.28 -176.756 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 45.7 m -75.38 -28.64 59.57 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 122.871 0.468 . . . . 0.0 111.319 176.107 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' TRP . . . . . 0.587 ' HB2' ' HG2' ' A' ' 36' ' ' PRO . 36.0 m95 -111.76 175.83 5.27 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 123.692 0.797 . . . . 0.0 110.563 -176.134 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 19.9 mtmt -140.92 128.34 21.2 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 165.5 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.755 ' HB3' ' HB2' ' A' ' 35' ' ' ALA . 13.6 tptm -99.95 126.49 46.12 Favored 'General case' 0 C--N 1.32 -0.679 0 C-N-CA 125.527 1.531 . . . . 0.0 108.502 -174.934 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 6.9 tt -129.07 132.52 47.45 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 114.495 -1.23 . . . . 0.0 107.84 178.867 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.472 ' HB3' HD23 ' A' ' 33' ' ' LEU . 28.9 t80 -110.84 141.93 43.55 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 124.148 0.979 . . . . 0.0 108.785 170.833 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -102.18 99.19 11.9 Favored Pre-proline 0 CA--C 1.55 0.945 0 C-N-CA 123.344 0.658 . . . . 0.0 110.064 174.038 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' PRO . . . . . 0.401 ' HD2' ' HA ' ' A' ' 30' ' ' SER . 83.4 Cg_endo . . . . . 0 C--N 1.377 2.035 0 C-N-CA 122.626 2.217 . . . . 0.0 111.114 171.057 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.243 0.731 0 CA-C-O 121.995 0.903 . . . . 0.0 110.911 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 48.2 t -81.67 138.99 18.62 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.787 0 CA-C-N 114.821 -1.082 . . . . 0.0 111.199 -170.847 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 59.1 t -112.13 115.33 49.53 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.945 0 C-N-CA 124.336 1.055 . . . . 0.0 109.206 174.854 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 45.6 m-85 -100.1 113.41 26.02 Favored 'General case' 0 N--CA 1.481 1.124 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 172.362 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.402 HG23 ' HB3' ' A' ' 65' ' ' GLU . 5.1 p -81.27 131.93 32.74 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 N-CA-C 109.168 -0.679 . . . . 0.0 109.168 179.671 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -92.26 145.62 31.05 Favored Pre-proline 0 CA--C 1.546 0.792 0 C-N-CA 122.814 0.445 . . . . 0.0 112.066 -171.345 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_endo -60.14 -36.42 88.87 Favored 'Trans proline' 0 C--N 1.381 2.285 0 C-N-CA 124.104 3.203 . . . . 0.0 113.724 -177.025 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 6.6 t -77.86 -9.52 59.1 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 122.779 0.432 . . . . 0.0 111.283 -179.368 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 94.57 23.92 19.87 Favored Glycine 0 C--N 1.35 1.342 0 CA-C-N 116.348 -0.387 . . . . 0.0 113.826 179.294 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -112.96 71.31 0.74 Allowed 'General case' 0 N--CA 1.474 0.73 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 178.729 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.402 ' HB3' HG23 ' A' ' 59' ' ' VAL . 0.6 OUTLIER -58.81 145.78 39.5 Favored 'General case' 0 N--CA 1.48 1.032 0 CA-C-N 115.211 -0.904 . . . . 0.0 112.062 -173.299 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.435 HG13 HD22 ' A' ' 72' ' ' LEU . 44.5 mm -111.24 127.26 68.5 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.589 0 C-N-CA 124.301 1.04 . . . . 0.0 110.062 -172.347 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 42.8 p -101.27 -13.58 18.01 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 123.88 0.872 . . . . 0.0 111.754 -178.923 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 11.5 p-10 -160.01 152.2 20.64 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 123.228 0.611 . . . . 0.0 111.045 -167.65 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.547 ' HG3' HD11 ' A' ' 85' ' ' ILE . 72.5 ttt-85 -56.17 -36.09 67.95 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 125.194 1.397 . . . . 0.0 113.357 -171.562 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 7.4 tmtm? -57.57 -49.94 74.74 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 123.885 0.874 . . . . 0.0 110.281 178.868 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.49 ' HA ' ' HG3' ' A' ' 74' ' ' GLN . 86.7 mm-40 -68.1 -24.07 64.99 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 115.14 -0.937 . . . . 0.0 111.733 -175.602 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.438 HD12 ' HB ' ' A' ' 85' ' ' ILE . 0.3 OUTLIER -66.35 -50.46 63.47 Favored 'General case' 0 N--CA 1.477 0.913 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 175.636 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -64.16 -47.99 77.73 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 124.233 1.013 . . . . 0.0 111.211 -176.081 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' GLN . . . . . 0.49 ' HG3' ' HA ' ' A' ' 71' ' ' GLN . 0.0 OUTLIER -68.29 -26.99 65.92 Favored 'General case' 0 CA--C 1.548 0.903 0 CA-C-N 115.802 -0.636 . . . . 0.0 111.427 179.4 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 59.2 t80 -63.66 -52.36 61.05 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 122.943 0.497 . . . . 0.0 110.202 173.854 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 96.6 mt -64.9 -39.24 93.21 Favored 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 123.487 0.715 . . . . 0.0 112.461 -171.902 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -73.42 -21.6 60.43 Favored 'General case' 0 N--CA 1.479 0.982 0 CA-C-N 116.667 -0.242 . . . . 0.0 111.133 178.25 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 46.2 m -99.58 -6.37 27.51 Favored 'General case' 0 N--CA 1.487 1.414 0 C-N-CA 123.093 0.557 . . . . 0.0 112.393 175.309 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 73.8 m80 -141.92 80.88 15.1 Favored Pre-proline 0 N--CA 1.479 1.0 0 C-N-CA 124.022 0.929 . . . . 0.0 108.54 179.147 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -68.31 149.86 75.85 Favored 'Trans proline' 0 C--N 1.375 1.922 0 C-N-CA 122.541 2.16 . . . . 0.0 111.996 178.982 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 103.23 -20.65 42.14 Favored Glycine 0 C--N 1.34 0.795 0 CA-C-N 116.262 -0.426 . . . . 0.0 112.693 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 18.7 m120 -82.42 142.07 46.29 Favored Pre-proline 0 CA--C 1.548 0.893 0 C-N-CA 123.238 0.615 . . . . 0.0 110.555 179.343 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_endo -55.72 145.94 68.67 Favored 'Trans proline' 0 C--N 1.385 2.466 0 C-N-CA 123.428 2.752 . . . . 0.0 113.395 -174.929 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.415 ' O ' ' HG2' ' A' ' 87' ' ' GLU . . . -68.98 160.01 31.69 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 124.156 0.982 . . . . 0.0 112.332 -170.865 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.547 HD11 ' HG3' ' A' ' 69' ' ' ARG . 14.1 tt -73.19 -22.69 19.55 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.966 0 C-N-CA 123.071 0.548 . . . . 0.0 110.8 177.345 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -63.32 -26.69 68.88 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 123.658 0.783 . . . . 0.0 111.863 -179.83 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.415 ' HG2' ' O ' ' A' ' 84' ' ' ALA . 15.0 pt-20 -96.71 -3.17 43.03 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 122.972 0.509 . . . . 0.0 111.567 177.874 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 5.3 m-30 -93.13 120.47 33.46 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 123.524 0.729 . . . . 0.0 109.655 178.188 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 13.8 p-10 -91.59 98.87 11.92 Favored 'General case' 0 N--CA 1.476 0.826 0 CA-C-O 122.042 0.925 . . . . 0.0 111.182 -176.74 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 88.0 m95 -83.19 -25.68 31.56 Favored 'General case' 0 N--CA 1.48 1.063 0 CA-C-N 115.095 -0.957 . . . . 0.0 110.297 171.763 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 14.9 t . . . . . 0 CA--C 1.554 1.123 0 C-N-CA 124.372 1.069 . . . . 0.0 112.485 -173.863 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 17.1 m . . . . . 0 N--CA 1.474 0.745 0 N-CA-C 110.197 -0.297 . . . . 0.0 110.197 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 60.9 p -146.7 113.48 6.07 Favored 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 174.519 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 61.1 t -101.7 131.33 49.8 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 -178.233 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 -84.11 111.66 19.52 Favored 'General case' 0 CA--C 1.536 0.436 0 N-CA-C 108.971 -0.752 . . . . 0.0 108.971 178.521 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.423 HD23 ' HB3' ' A' ' 43' ' ' PHE . 4.1 mm? -91.92 165.13 21.14 Favored Pre-proline 0 CA--C 1.559 1.321 0 C-N-CA 124.704 1.202 . . . . 0.0 109.95 -177.118 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_endo -59.76 143.96 99.53 Favored 'Trans proline' 0 C--N 1.393 2.908 0 C-N-CA 122.927 2.418 . . . . 0.0 113.356 -177.851 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.469 ' HB2' ' HB3' ' A' ' 41' ' ' LYS . . . -138.58 165.22 34.39 Favored Pre-proline 0 N--CA 1.474 0.746 0 C-N-CA 123.972 0.909 . . . . 0.0 111.632 -169.561 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.698 ' HG2' ' HB2' ' A' ' 39' ' ' TRP . 37.4 Cg_endo -65.09 155.61 67.35 Favored 'Trans proline' 0 C--N 1.381 2.253 0 C-N-CA 122.468 2.112 . . . . 0.0 110.8 162.663 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 34.3 t -57.55 -38.49 74.85 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 124.622 1.169 . . . . 0.0 112.895 -171.473 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 11.0 p -77.78 -40.19 41.6 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 123.342 0.657 . . . . 0.0 111.878 -177.582 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' TRP . . . . . 0.698 ' HB2' ' HG2' ' A' ' 36' ' ' PRO . 29.4 m95 -93.26 -174.63 3.59 Favored 'General case' 0 N--CA 1.478 0.944 0 CA-C-O 121.628 0.728 . . . . 0.0 111.336 -178.495 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.705 ' HB3' ' HB ' ' A' ' 59' ' ' VAL . 40.2 ttmt -143.55 144.83 32.12 Favored 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 107.336 -1.357 . . . . 0.0 107.336 173.452 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.469 ' HB3' ' HB2' ' A' ' 35' ' ' ALA . 18.4 tptp -120.23 125.9 49.28 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 124.063 0.945 . . . . 0.0 109.092 -174.511 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.461 HD22 ' HB ' ' A' ' 57' ' ' VAL . 4.3 tt -124.85 149.43 47.49 Favored 'General case' 0 C--O 1.236 0.393 0 C-N-CA 125.127 1.371 . . . . 0.0 108.694 176.648 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.423 ' HB3' HD23 ' A' ' 33' ' ' LEU . 34.3 t80 -135.26 135.58 41.0 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 124.943 1.297 . . . . 0.0 108.27 175.912 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 36.1 m-85 -95.93 103.96 15.05 Favored Pre-proline 0 N--CA 1.48 1.058 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 170.233 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 63.8 Cg_endo . . . . . 0 C--N 1.37 1.669 0 C-N-CA 122.717 2.278 . . . . 0.0 111.397 170.452 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 . . . . . 0 CA--C 1.557 1.217 0 CA-C-O 121.334 0.587 . . . . 0.0 111.492 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 46.7 t -81.72 134.77 26.35 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.668 0 C-N-CA 124.2 1.0 . . . . 0.0 110.416 -176.263 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.461 ' HB ' HD22 ' A' ' 42' ' ' LEU . 96.7 t -120.4 122.65 68.72 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 C-N-CA 124.005 0.922 . . . . 0.0 108.913 177.745 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 24.7 m-85 -97.85 121.15 39.42 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 123.602 0.761 . . . . 0.0 109.864 172.266 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.705 ' HB ' ' HB3' ' A' ' 40' ' ' LYS . 11.0 t -79.43 129.92 36.86 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 172.134 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -84.45 158.42 60.38 Favored Pre-proline 0 CA--C 1.542 0.659 0 CA-C-N 114.904 -1.044 . . . . 0.0 110.912 -175.766 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -63.53 -25.72 69.94 Favored 'Trans proline' 0 C--N 1.374 1.893 0 C-N-CA 123.005 2.47 . . . . 0.0 113.1 176.226 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.457 HG22 ' OH ' ' A' ' 75' ' ' TYR . 14.7 t -97.52 -3.7 39.33 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 123.5 0.72 . . . . 0.0 111.241 177.729 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 93.79 -12.83 68.69 Favored Glycine 0 C--N 1.354 1.577 0 CA-C-O 119.701 -0.5 . . . . 0.0 113.473 179.351 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 44.6 tt0 -73.88 77.63 1.63 Allowed 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 123.903 0.881 . . . . 0.0 109.77 178.862 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -67.41 158.39 31.86 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-N 114.786 -1.097 . . . . 0.0 112.229 -170.006 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.4 HG23 ' HB2' ' A' ' 71' ' ' GLN . 47.7 mm -121.21 131.2 73.6 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.598 0 C-N-CA 125.168 1.387 . . . . 0.0 108.891 -172.201 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 24.3 p -105.86 -17.94 14.21 Favored 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 123.984 0.914 . . . . 0.0 112.141 179.206 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 9.2 p30 -143.64 157.24 44.56 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 122.538 0.335 . . . . 0.0 111.235 -173.284 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 29.7 ttp180 -63.38 -30.62 71.72 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 123.917 0.887 . . . . 0.0 112.342 -171.585 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 5.5 tmtm? -59.89 -54.85 41.39 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 123.793 0.837 . . . . 0.0 109.116 -179.67 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.411 ' HA ' ' HG3' ' A' ' 74' ' ' GLN . 88.3 mm-40 -64.1 -25.55 68.15 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-N 115.006 -0.997 . . . . 0.0 111.597 -177.791 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.407 ' O ' ' HG ' ' A' ' 76' ' ' LEU . 0.4 OUTLIER -66.47 -56.71 9.66 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 123.477 0.711 . . . . 0.0 109.131 176.672 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -58.74 -48.93 79.47 Favored 'General case' 0 N--CA 1.486 1.334 0 C-N-CA 124.393 1.077 . . . . 0.0 111.71 -176.93 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' GLN . . . . . 0.411 ' HG3' ' HA ' ' A' ' 71' ' ' GLN . 0.0 OUTLIER -70.6 -24.24 62.71 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-N 115.472 -0.785 . . . . 0.0 111.538 -177.375 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 75' ' ' TYR . . . . . 0.457 ' OH ' HG22 ' A' ' 62' ' ' THR . 18.9 t80 -68.18 -49.56 60.07 Favored 'General case' 0 N--CA 1.479 0.985 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 172.561 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.407 ' HG ' ' O ' ' A' ' 72' ' ' LEU . 69.0 mt -59.68 -41.36 90.51 Favored 'General case' 0 N--CA 1.485 1.306 0 C-N-CA 123.053 0.541 . . . . 0.0 111.563 -173.17 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 54.9 pttt -73.39 -34.54 65.58 Favored 'General case' 0 N--CA 1.479 1.014 0 O-C-N 123.181 0.301 . . . . 0.0 111.63 -179.729 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 80.9 p -83.02 -17.7 42.4 Favored 'General case' 0 N--CA 1.487 1.423 0 C-N-CA 122.828 0.451 . . . . 0.0 111.582 -178.181 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 75.5 m80 -122.89 102.79 37.59 Favored Pre-proline 0 N--CA 1.48 1.027 0 C-N-CA 123.832 0.853 . . . . 0.0 109.237 -177.465 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -67.68 154.69 72.62 Favored 'Trans proline' 0 C--N 1.378 2.099 0 C-N-CA 122.928 2.418 . . . . 0.0 113.051 -177.785 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 84.04 -9.73 62.58 Favored Glycine 0 C--N 1.349 1.285 0 CA-C-N 115.631 -0.713 . . . . 0.0 114.293 175.243 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 25.0 m-80 -74.65 148.1 85.04 Favored Pre-proline 0 N--CA 1.483 1.211 0 C-N-CA 123.432 0.693 . . . . 0.0 111.178 -178.058 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -68.92 163.99 35.36 Favored 'Trans proline' 0 C--N 1.377 2.068 0 C-N-CA 123.233 2.622 . . . . 0.0 113.176 -177.794 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.485 ' O ' ' HG2' ' A' ' 87' ' ' GLU . . . -71.48 150.74 44.58 Favored 'General case' 0 N--CA 1.476 0.841 0 CA-C-N 115.066 -0.97 . . . . 0.0 111.243 -175.698 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 19.6 tt -72.88 -20.83 19.19 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.111 0 CA-C-O 120.968 0.413 . . . . 0.0 110.877 179.759 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -63.93 -30.13 71.24 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 123.681 0.793 . . . . 0.0 112.377 -179.019 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.485 ' HG2' ' O ' ' A' ' 84' ' ' ALA . 13.4 pt-20 -88.61 -7.49 56.31 Favored 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 123.215 0.606 . . . . 0.0 111.275 178.553 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -83.14 116.48 22.36 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 123.64 0.776 . . . . 0.0 110.365 176.356 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -75.69 128.47 35.27 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 123.86 0.864 . . . . 0.0 110.268 175.662 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 81.1 m95 -119.0 -1.2 11.01 Favored 'General case' 0 CA--C 1.555 1.138 0 C-N-CA 123.28 0.632 . . . . 0.0 110.151 166.325 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 14.2 t . . . . . 0 CA--C 1.565 1.538 0 N-CA-C 113.569 0.952 . . . . 0.0 113.569 -165.992 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 28.8 m . . . . . 0 N--CA 1.483 1.188 0 CA-C-O 121.204 0.526 . . . . 0.0 112.311 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.429 ' HB3' ' CE2' ' A' ' 44' ' ' TYR . 45.7 p -135.41 141.66 45.5 Favored 'General case' 0 C--O 1.241 0.646 0 C-N-CA 124.224 1.01 . . . . 0.0 109.376 -178.258 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 95.7 t -123.99 123.78 67.55 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 C-N-CA 124.266 1.026 . . . . 0.0 108.718 174.881 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -82.36 110.38 17.45 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 123.137 0.575 . . . . 0.0 110.201 176.472 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.517 ' HB2' ' HG3' ' A' ' 41' ' ' LYS . 4.1 mm? -85.38 165.19 37.32 Favored Pre-proline 0 CA--C 1.556 1.19 0 C-N-CA 124.584 1.154 . . . . 0.0 110.084 179.92 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 25.1 Cg_endo -59.88 149.46 83.57 Favored 'Trans proline' 0 C--N 1.389 2.674 0 C-N-CA 122.716 2.277 . . . . 0.0 113.834 179.838 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -149.32 170.29 7.88 Favored Pre-proline 0 CA--C 1.551 0.999 0 C-N-CA 124.32 1.048 . . . . 0.0 110.321 -172.264 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_exo -52.54 157.63 6.9 Favored 'Trans proline' 0 C--N 1.385 2.498 0 C-N-CA 122.946 2.43 . . . . 0.0 112.981 165.133 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 44.9 m -60.04 -29.72 68.71 Favored 'General case' 0 CA--C 1.552 1.021 0 C-N-CA 124.07 0.948 . . . . 0.0 112.233 -179.548 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 37.0 t -84.64 -24.57 29.02 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 123.121 0.568 . . . . 0.0 111.713 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 32.1 m95 -114.25 177.15 4.74 Favored 'General case' 0 N--CA 1.483 1.18 0 CA-C-O 121.467 0.651 . . . . 0.0 112.058 -173.331 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 33.5 mtmt -136.45 145.14 44.88 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 124.712 1.205 . . . . 0.0 108.179 170.093 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.523 ' NZ ' ' HB2' ' A' ' 43' ' ' PHE . 22.4 tptp -114.25 135.25 54.26 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 124.523 1.129 . . . . 0.0 108.707 -178.489 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.468 HD22 ' HB ' ' A' ' 57' ' ' VAL . 5.5 tt -125.95 142.42 51.53 Favored 'General case' 0 C--O 1.238 0.481 0 C-N-CA 124.166 0.986 . . . . 0.0 108.803 176.896 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.523 ' HB2' ' NZ ' ' A' ' 41' ' ' LYS . 65.5 t80 -127.09 144.9 50.92 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 124.884 1.274 . . . . 0.0 108.027 172.807 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' TYR . . . . . 0.429 ' CE2' ' HB3' ' A' ' 30' ' ' SER . 17.8 m-85 -102.44 97.65 9.25 Favored Pre-proline 0 CA--C 1.548 0.868 0 C-N-CA 122.557 0.343 . . . . 0.0 110.12 171.914 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo . . . . . 0 C--N 1.38 2.234 0 C-N-CA 122.945 2.43 . . . . 0.0 112.006 176.029 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 CA--C 1.541 0.631 0 CA-C-O 121.516 0.674 . . . . 0.0 111.671 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.412 ' CG1' ' HE2' ' A' ' 41' ' ' LYS . 31.9 t -81.85 134.29 27.38 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.404 0 CA-C-N 114.891 -1.05 . . . . 0.0 110.052 177.52 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.468 ' HB ' HD22 ' A' ' 42' ' ' LEU . 98.6 t -121.11 130.23 74.88 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 C-N-CA 124.089 0.956 . . . . 0.0 108.928 175.137 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 9.1 m-85 -101.86 119.5 38.88 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 123.297 0.639 . . . . 0.0 109.281 171.376 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.42 ' HA ' ' HG2' ' A' ' 65' ' ' GLU . 14.8 t -78.37 123.81 35.78 Favored 'Isoleucine or valine' 0 C--O 1.239 0.532 0 C-N-CA 123.518 0.727 . . . . 0.0 109.744 176.331 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -82.07 151.98 67.62 Favored Pre-proline 0 CA--C 1.54 0.582 0 CA-C-N 114.335 -1.302 . . . . 0.0 110.873 -175.639 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_endo -60.48 -33.3 94.08 Favored 'Trans proline' 0 C--N 1.374 1.894 0 C-N-CA 123.245 2.63 . . . . 0.0 112.697 177.41 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.496 HG23 ' H ' ' A' ' 64' ' ' GLU . 11.4 t -85.82 -12.82 49.9 Favored 'General case' 0 CA--C 1.545 0.781 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.292 178.207 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 94.57 -1.12 65.98 Favored Glycine 0 C--N 1.357 1.7 0 CA-C-O 120.053 -0.304 . . . . 0.0 113.64 -177.276 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.496 ' H ' HG23 ' A' ' 62' ' ' THR . 33.0 tt0 -78.31 71.87 4.8 Favored 'General case' 0 N--CA 1.48 1.064 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 174.497 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.42 ' HG2' ' HA ' ' A' ' 59' ' ' VAL . 34.1 mt-10 -66.01 148.57 51.59 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-N 114.775 -1.102 . . . . 0.0 111.771 -169.138 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 48.6 mm -115.17 131.11 68.4 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.557 0 C-N-CA 124.44 1.096 . . . . 0.0 110.167 -168.997 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 61.0 p -101.52 -21.12 14.83 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 123.596 0.758 . . . . 0.0 112.482 -178.758 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 7.8 p30 -143.52 159.36 42.57 Favored 'General case' 0 N--CA 1.481 1.111 0 CA-C-O 120.8 0.333 . . . . 0.0 111.802 -172.985 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 55.1 ttt-85 -65.69 -29.29 69.81 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 124.144 0.978 . . . . 0.0 111.968 -171.913 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 7.8 tmtm? -61.18 -54.94 38.0 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 123.352 0.661 . . . . 0.0 109.318 176.782 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 14.2 mm100 -67.5 -20.13 65.41 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-N 115.591 -0.732 . . . . 0.0 111.821 -176.581 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.422 ' O ' ' HG ' ' A' ' 76' ' ' LEU . 0.6 OUTLIER -70.91 -56.45 6.22 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 176.221 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -62.94 -41.83 99.62 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 123.526 0.731 . . . . 0.0 111.191 -176.784 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.47 -28.69 66.31 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 122.684 0.394 . . . . 0.0 110.648 177.467 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 75' ' ' TYR . . . . . 0.426 ' OH ' HG22 ' A' ' 62' ' ' THR . 20.9 t80 -63.06 -49.72 73.41 Favored 'General case' 0 N--CA 1.482 1.128 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 172.789 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.422 ' HG ' ' O ' ' A' ' 72' ' ' LEU . 72.5 mt -61.62 -37.15 82.9 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 123.313 0.645 . . . . 0.0 111.869 -172.341 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.04 -35.71 49.4 Favored 'General case' 0 CA--C 1.548 0.885 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.13 176.847 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 30.0 t -79.03 -16.38 56.94 Favored 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 123.011 0.524 . . . . 0.0 111.541 -179.412 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 76.9 m-70 -129.57 82.81 66.5 Favored Pre-proline 0 CA--C 1.544 0.72 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 178.091 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -64.76 142.26 75.65 Favored 'Trans proline' 0 C--N 1.372 1.803 0 C-N-CA 122.776 2.318 . . . . 0.0 112.543 -178.902 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 105.18 -14.8 47.88 Favored Glycine 0 C--N 1.348 1.246 0 CA-C-N 116.125 -0.489 . . . . 0.0 112.67 -178.024 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 18.4 m-80 -76.62 146.49 76.88 Favored Pre-proline 0 N--CA 1.485 1.316 0 C-N-CA 123.588 0.755 . . . . 0.0 111.526 179.633 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -63.37 158.43 45.07 Favored 'Trans proline' 0 C--N 1.383 2.393 0 C-N-CA 123.019 2.479 . . . . 0.0 113.541 -178.023 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.441 ' O ' ' HG2' ' A' ' 87' ' ' GLU . . . -73.83 144.52 45.47 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-N 114.879 -1.055 . . . . 0.0 111.756 -174.941 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 16.7 tt -67.03 -12.32 14.98 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.311 0 C-N-CA 123.129 0.572 . . . . 0.0 111.657 179.736 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -57.0 -38.86 73.67 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 124.38 1.072 . . . . 0.0 112.297 173.687 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.441 ' HG2' ' O ' ' A' ' 84' ' ' ALA . 11.6 pt-20 -92.76 0.21 57.38 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 123.235 0.614 . . . . 0.0 111.518 -179.569 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -85.26 110.75 19.29 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 123.044 0.537 . . . . 0.0 109.746 177.958 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -83.17 93.78 7.72 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 123.962 0.905 . . . . 0.0 109.941 -178.625 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 78.7 m95 -79.43 -42.45 25.38 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 123.433 0.693 . . . . 0.0 109.996 171.418 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 12.8 t . . . . . 0 CA--C 1.559 1.294 0 C-N-CA 124.4 1.08 . . . . 0.0 112.483 -172.859 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 12.8 m . . . . . 0 CA--C 1.549 0.938 0 CA-C-O 121.697 0.76 . . . . 0.0 110.98 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 15.5 p -145.93 137.32 24.83 Favored 'General case' 0 C--O 1.24 0.597 0 C-N-CA 124.671 1.188 . . . . 0.0 108.74 -178.605 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.407 HG12 HD22 ' A' ' 33' ' ' LEU . 86.3 t -125.62 125.54 68.78 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 C-N-CA 124.048 0.939 . . . . 0.0 108.972 -179.411 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -79.6 104.91 10.52 Favored 'General case' 0 CA--C 1.537 0.473 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 173.546 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.49 HD23 ' HB3' ' A' ' 43' ' ' PHE . 4.4 mm? -80.64 159.95 68.11 Favored Pre-proline 0 CA--C 1.552 1.023 0 C-N-CA 123.611 0.764 . . . . 0.0 109.537 177.068 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_endo -59.85 151.04 74.03 Favored 'Trans proline' 0 C--N 1.381 2.283 0 C-N-CA 122.378 2.052 . . . . 0.0 113.468 -178.016 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -144.81 168.13 12.99 Favored Pre-proline 0 N--CA 1.476 0.848 0 C-N-CA 124.203 1.001 . . . . 0.0 110.979 -168.698 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.537 ' HG2' ' HB2' ' A' ' 39' ' ' TRP . 30.3 Cg_endo -62.93 151.27 85.33 Favored 'Trans proline' 0 C--N 1.381 2.259 0 C-N-CA 122.0 1.8 . . . . 0.0 110.423 160.991 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 57.4 p -64.12 -23.33 67.28 Favored 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 123.528 0.731 . . . . 0.0 111.898 -177.225 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 18.3 m -74.64 -33.6 62.57 Favored 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 123.54 0.736 . . . . 0.0 111.745 178.226 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' TRP . . . . . 0.537 ' HB2' ' HG2' ' A' ' 36' ' ' PRO . 28.4 m95 -117.25 -174.38 2.59 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 123.942 0.897 . . . . 0.0 110.562 -176.866 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 44.8 mtmt -138.74 149.52 45.13 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 124.18 0.992 . . . . 0.0 108.612 168.888 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.559 ' HZ3' ' HB2' ' A' ' 43' ' ' PHE . 24.6 tptp -118.95 127.25 53.3 Favored 'General case' 0 C--N 1.331 -0.206 0 C-N-CA 124.815 1.246 . . . . 0.0 109.311 -175.214 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.416 HD22 ' HB ' ' A' ' 57' ' ' VAL . 4.1 tt -124.28 145.77 49.18 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 124.259 1.024 . . . . 0.0 108.647 174.68 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.559 ' HB2' ' HZ3' ' A' ' 41' ' ' LYS . 48.3 t80 -128.94 142.46 50.93 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 124.994 1.318 . . . . 0.0 108.124 170.934 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 36.5 m-85 -101.1 100.47 13.26 Favored Pre-proline 0 N--CA 1.48 1.058 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 171.243 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 62.2 Cg_endo . . . . . 0 C--N 1.372 1.816 0 C-N-CA 122.736 2.291 . . . . 0.0 111.598 172.499 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 . . . . . 0 CA--C 1.551 0.993 0 CA-C-O 121.731 0.777 . . . . 0.0 111.31 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 11.7 t -81.75 138.04 20.2 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.416 0 C-N-CA 124.581 1.152 . . . . 0.0 110.707 -174.657 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.416 ' HB ' HD22 ' A' ' 42' ' ' LEU . 49.3 t -123.13 116.12 47.66 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.744 0 C-N-CA 123.674 0.79 . . . . 0.0 109.059 171.848 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 15.2 m-85 -86.36 120.64 27.92 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 123.36 0.664 . . . . 0.0 109.585 170.395 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 2.8 t -78.71 127.98 38.63 Favored 'Isoleucine or valine' 0 C--O 1.238 0.494 0 C-N-CA 123.56 0.744 . . . . 0.0 109.039 174.414 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -86.53 153.41 55.79 Favored Pre-proline 0 CA--C 1.539 0.553 0 CA-C-N 114.959 -1.019 . . . . 0.0 110.801 -176.869 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -59.54 -29.88 91.04 Favored 'Trans proline' 0 C--N 1.369 1.613 0 C-N-CA 122.898 2.398 . . . . 0.0 113.076 173.893 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.408 HG23 ' H ' ' A' ' 64' ' ' GLU . 14.5 t -93.32 -3.97 52.51 Favored 'General case' 0 N--CA 1.486 1.343 0 C-N-CA 122.565 0.346 . . . . 0.0 111.522 176.894 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 90.04 -8.71 79.31 Favored Glycine 0 C--N 1.35 1.358 0 CA-C-O 119.576 -0.569 . . . . 0.0 113.996 -179.795 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.408 ' H ' HG23 ' A' ' 62' ' ' THR . 42.8 tt0 -72.63 77.64 1.09 Allowed 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 123.686 0.794 . . . . 0.0 109.306 175.316 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -73.06 158.34 35.57 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-N 115.013 -0.994 . . . . 0.0 111.581 -168.953 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.561 HG23 ' HB2' ' A' ' 71' ' ' GLN . 49.2 mm -122.14 115.42 46.16 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 CA-C-N 114.522 -1.217 . . . . 0.0 109.701 -166.723 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 14.1 p -88.5 -17.57 30.03 Favored 'General case' 0 CA--C 1.553 1.067 0 C-N-CA 123.765 0.826 . . . . 0.0 112.306 179.651 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 5.8 p30 -156.67 157.65 35.57 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 112.133 0.42 . . . . 0.0 112.133 -174.558 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 41.9 mtm105 -56.6 -36.58 69.57 Favored 'General case' 0 N--CA 1.493 1.724 0 C-N-CA 124.35 1.06 . . . . 0.0 113.858 -170.868 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 7.0 tmtm? -54.62 -49.35 70.7 Favored 'General case' 0 N--CA 1.484 1.232 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 179.544 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.561 ' HB2' HG23 ' A' ' 66' ' ' ILE . 91.1 mt-30 -64.06 -35.16 79.84 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 123.693 0.797 . . . . 0.0 111.312 -179.544 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.458 HD12 ' HB ' ' A' ' 85' ' ' ILE . 0.6 OUTLIER -64.68 -51.71 61.06 Favored 'General case' 0 N--CA 1.483 1.178 0 O-C-N 123.739 0.649 . . . . 0.0 109.369 -179.813 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -69.34 -42.16 75.68 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 124.298 1.039 . . . . 0.0 111.599 -173.523 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 1.1 pp0? -66.44 -33.12 75.0 Favored 'General case' 0 N--CA 1.472 0.665 0 O-C-N 123.427 0.454 . . . . 0.0 109.897 176.091 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 12.2 t80 -61.92 -47.1 86.45 Favored 'General case' 0 C--N 1.357 0.909 0 O-C-N 123.656 0.597 . . . . 0.0 109.447 175.41 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.453 ' HG ' ' O ' ' A' ' 72' ' ' LEU . 81.9 mt -62.21 -48.98 77.6 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 123.038 0.535 . . . . 0.0 111.195 -175.738 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.76 -17.61 61.08 Favored 'General case' 0 CA--C 1.551 0.989 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.754 -176.806 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 30.7 t -92.77 -27.7 17.04 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 123.381 0.672 . . . . 0.0 110.781 175.654 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 51.9 m80 -127.72 92.25 43.19 Favored Pre-proline 0 N--CA 1.479 0.979 0 C-N-CA 124.204 1.002 . . . . 0.0 108.735 -174.334 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -64.63 159.79 43.25 Favored 'Trans proline' 0 C--N 1.371 1.756 0 C-N-CA 122.858 2.372 . . . . 0.0 112.551 179.131 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 91.62 -24.35 20.74 Favored Glycine 0 C--N 1.346 1.093 0 CA-C-N 115.989 -0.551 . . . . 0.0 112.971 179.06 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 41.7 m-80 -72.59 132.05 83.91 Favored Pre-proline 0 CA--C 1.546 0.817 0 C-N-CA 123.454 0.702 . . . . 0.0 110.308 177.651 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_endo -60.56 148.49 90.94 Favored 'Trans proline' 0 C--N 1.376 2.0 0 C-N-CA 123.226 2.617 . . . . 0.0 113.017 -176.123 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.406 ' O ' ' HG2' ' A' ' 87' ' ' GLU . . . -68.42 148.44 50.65 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 123.549 0.74 . . . . 0.0 112.088 -175.185 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.458 ' HB ' HD12 ' A' ' 72' ' ' LEU . 15.7 tt -63.49 -13.91 13.66 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.399 0 C-N-CA 124.329 1.052 . . . . 0.0 112.21 -177.459 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -57.76 -38.67 75.82 Favored 'General case' 0 CA--C 1.553 1.074 0 C-N-CA 124.153 0.981 . . . . 0.0 112.213 175.588 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.406 ' HG2' ' O ' ' A' ' 84' ' ' ALA . 11.3 pt-20 -90.55 -10.32 43.93 Favored 'General case' 0 N--CA 1.487 1.404 0 C-N-CA 122.993 0.517 . . . . 0.0 111.947 178.138 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -77.31 115.63 17.24 Favored 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 175.804 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 6.5 t0 -91.38 109.8 21.08 Favored 'General case' 0 CA--C 1.54 0.591 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 -176.122 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 69.8 m95 -96.99 -22.97 16.52 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 123.909 0.884 . . . . 0.0 110.106 176.119 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 12.9 t . . . . . 0 N--CA 1.486 1.329 0 C-N-CA 123.428 0.691 . . . . 0.0 111.718 -174.528 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 15.3 m . . . . . 0 CA--C 1.548 0.884 0 CA-C-O 121.764 0.792 . . . . 0.0 110.345 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 30.8 p -161.99 113.48 1.67 Allowed 'General case' 0 C--O 1.239 0.513 0 C-N-CA 124.52 1.128 . . . . 0.0 108.078 -177.34 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 83.3 t -105.59 124.33 60.53 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.517 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.451 ' HA ' ' HA ' ' A' ' 42' ' ' LEU . 51.6 mt-10 -76.72 113.21 14.12 Favored 'General case' 0 CA--C 1.533 0.317 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 173.761 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.46 HD23 ' HB3' ' A' ' 43' ' ' PHE . 3.7 mm? -87.28 166.4 26.03 Favored Pre-proline 0 CA--C 1.555 1.166 0 C-N-CA 123.69 0.796 . . . . 0.0 109.017 -179.786 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -51.54 134.72 46.9 Favored 'Trans proline' 0 C--N 1.388 2.633 0 C-N-CA 123.012 2.475 . . . . 0.0 113.161 175.854 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.451 ' HB2' ' HB3' ' A' ' 41' ' ' LYS . . . -128.91 158.97 70.89 Favored Pre-proline 0 N--CA 1.477 0.89 0 C-N-CA 125.335 1.454 . . . . 0.0 110.913 -170.648 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.647 ' HG2' ' HB2' ' A' ' 39' ' ' TRP . 58.9 Cg_endo -70.16 177.96 5.32 Favored 'Trans proline' 0 C--N 1.381 2.262 0 C-N-CA 122.686 2.257 . . . . 0.0 111.44 166.057 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 77.2 p -71.22 -47.67 55.96 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 123.694 0.798 . . . . 0.0 112.498 -169.741 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 22.2 m -74.65 -35.61 62.85 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 123.809 0.844 . . . . 0.0 110.884 -175.594 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' TRP . . . . . 0.647 ' HB2' ' HG2' ' A' ' 36' ' ' PRO . 39.7 m95 -100.3 174.3 6.19 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 123.693 0.797 . . . . 0.0 111.28 -175.297 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.785 ' HB3' ' HB ' ' A' ' 59' ' ' VAL . 15.7 tppt? -126.94 148.39 50.06 Favored 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 107.187 -1.412 . . . . 0.0 107.187 169.127 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.451 ' HB3' ' HB2' ' A' ' 35' ' ' ALA . 0.0 OUTLIER -120.97 127.94 52.26 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 107.688 -1.227 . . . . 0.0 107.688 179.41 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.451 ' HA ' ' HA ' ' A' ' 32' ' ' GLU . 4.5 tt -128.55 146.1 50.93 Favored 'General case' 0 C--N 1.324 -0.541 0 C-N-CA 125.29 1.436 . . . . 0.0 107.569 174.033 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.46 ' HB3' HD23 ' A' ' 33' ' ' LEU . 31.6 t80 -126.94 142.92 51.43 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 124.707 1.203 . . . . 0.0 107.923 172.509 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 14.1 m-85 -100.84 99.09 9.52 Favored Pre-proline 0 N--CA 1.488 1.44 0 C-N-CA 123.17 0.588 . . . . 0.0 110.91 174.084 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo . . . . . 0 C--N 1.378 2.108 0 C-N-CA 123.066 2.511 . . . . 0.0 111.999 171.909 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 15.1 pt-20 . . . . . 0 CA--C 1.55 0.959 0 CA-C-O 121.86 0.838 . . . . 0.0 111.431 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 75.4 t -80.28 137.57 21.28 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.76 0 CA-C-N 114.988 -1.005 . . . . 0.0 109.274 179.575 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.424 ' HB ' HD22 ' A' ' 42' ' ' LEU . 87.3 t -117.81 115.2 47.75 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 178.223 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.427 ' CZ ' ' HE3' ' A' ' 41' ' ' LYS . 19.6 m-85 -94.94 115.1 27.03 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 123.657 0.783 . . . . 0.0 109.378 174.635 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.785 ' HB ' ' HB3' ' A' ' 40' ' ' LYS . 2.8 t -79.48 129.84 36.97 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 175.359 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -84.31 153.62 62.54 Favored Pre-proline 0 CA--C 1.54 0.565 0 CA-C-N 114.939 -1.028 . . . . 0.0 111.003 -175.035 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_endo -61.02 -32.72 92.45 Favored 'Trans proline' 0 C--N 1.379 2.147 0 C-N-CA 122.913 2.408 . . . . 0.0 113.101 177.02 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.464 HG23 ' H ' ' A' ' 64' ' ' GLU . 13.2 t -84.49 -6.35 59.37 Favored 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 122.981 0.512 . . . . 0.0 111.627 179.796 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 94.16 -19.87 50.89 Favored Glycine 0 C--N 1.357 1.702 0 CA-C-O 119.686 -0.508 . . . . 0.0 113.179 179.486 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.464 ' H ' HG23 ' A' ' 62' ' ' THR . 42.7 tt0 -69.63 75.74 0.42 Allowed 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 124.299 1.039 . . . . 0.0 109.09 175.608 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -75.36 150.24 38.46 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-O 121.892 0.853 . . . . 0.0 111.548 -166.996 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 39.8 mm -102.27 123.32 55.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 114.047 -1.433 . . . . 0.0 109.555 -175.72 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 24.3 m -105.69 -1.34 24.63 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 123.153 0.581 . . . . 0.0 111.093 -179.404 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 14.5 p-10 -158.01 145.65 18.4 Favored 'General case' 0 C--N 1.353 0.749 0 C-N-CA 123.076 0.55 . . . . 0.0 111.241 -174.062 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.451 ' HG3' HD11 ' A' ' 85' ' ' ILE . 44.1 ttp180 -61.35 -30.61 70.63 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 124.839 1.255 . . . . 0.0 113.864 -166.969 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 6.4 tmtm? -62.28 -49.06 77.16 Favored 'General case' 0 N--CA 1.489 1.508 0 C-N-CA 123.139 0.576 . . . . 0.0 109.554 177.196 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.558 ' HA ' ' HG3' ' A' ' 74' ' ' GLN . 86.4 mm-40 -66.35 -21.61 66.25 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-N 115.406 -0.815 . . . . 0.0 111.515 -176.565 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.456 ' HB3' HD12 ' A' ' 85' ' ' ILE . 0.6 OUTLIER -65.44 -54.95 21.16 Favored 'General case' 0 N--CA 1.477 0.894 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 174.77 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -59.15 -49.74 76.69 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 123.877 0.871 . . . . 0.0 111.031 -176.05 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' GLN . . . . . 0.558 ' HG3' ' HA ' ' A' ' 71' ' ' GLN . 0.0 OUTLIER -67.57 -25.89 66.01 Favored 'General case' 0 CA--C 1.547 0.864 0 CA-C-N 115.414 -0.812 . . . . 0.0 111.369 -177.226 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 34.0 t80 -66.45 -50.43 63.38 Favored 'General case' 0 C--N 1.357 0.897 0 C-N-CA 123.211 0.605 . . . . 0.0 109.592 173.445 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 81.5 mt -58.28 -43.13 87.84 Favored 'General case' 0 N--CA 1.486 1.347 0 O-C-N 123.787 0.679 . . . . 0.0 111.873 -173.679 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 58.3 pttt -68.03 -41.0 82.78 Favored 'General case' 0 N--CA 1.478 0.932 0 O-C-N 123.32 0.387 . . . . 0.0 111.035 -179.354 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 77.4 p -85.52 -10.37 56.11 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 112.012 0.375 . . . . 0.0 112.012 -177.17 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 53.1 m-70 -130.06 84.25 60.95 Favored Pre-proline 0 N--CA 1.482 1.167 0 C-N-CA 124.322 1.049 . . . . 0.0 108.714 177.654 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -67.9 147.29 74.22 Favored 'Trans proline' 0 C--N 1.375 1.924 0 C-N-CA 122.631 2.22 . . . . 0.0 111.786 178.838 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 101.41 -6.43 55.63 Favored Glycine 0 CA--C 1.53 0.995 0 CA-C-N 116.071 -0.513 . . . . 0.0 112.698 -177.192 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 40.2 m-80 -90.68 141.05 26.68 Favored Pre-proline 0 N--CA 1.48 1.062 0 C-N-CA 123.164 0.586 . . . . 0.0 110.595 177.239 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_endo -62.0 149.57 89.79 Favored 'Trans proline' 0 C--N 1.38 2.236 0 C-N-CA 123.384 2.723 . . . . 0.0 112.783 179.091 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -66.28 158.89 27.84 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 124.22 1.008 . . . . 0.0 111.882 -173.162 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.456 HD12 ' HB3' ' A' ' 72' ' ' LEU . 19.3 tt -77.87 -17.58 14.0 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.544 177.485 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -60.7 -34.48 74.42 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 123.8 0.84 . . . . 0.0 111.471 177.089 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -92.81 -11.35 33.91 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 123.492 0.717 . . . . 0.0 110.976 179.65 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 5.8 m-30 -82.01 127.7 33.34 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 123.273 0.629 . . . . 0.0 109.832 176.083 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -92.47 122.18 34.66 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 123.909 0.884 . . . . 0.0 109.785 -178.317 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 77.5 m95 -115.73 6.7 14.48 Favored 'General case' 0 N--CA 1.488 1.471 0 C-N-CA 123.837 0.855 . . . . 0.0 110.729 176.637 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 9.9 t . . . . . 0 CA--C 1.557 1.22 0 C-N-CA 124.815 1.246 . . . . 0.0 110.662 -177.315 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 23.2 m . . . . . 0 CA--C 1.547 0.833 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.469 ' HA ' ' HD2' ' A' ' 45' ' ' PRO . 31.2 p -155.28 129.78 9.08 Favored 'General case' 0 C--O 1.239 0.508 0 CA-C-N 114.97 -1.013 . . . . 0.0 109.09 -173.143 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 65.4 t -114.36 124.89 71.45 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 175.784 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.446 ' HA ' ' HA ' ' A' ' 42' ' ' LEU . 47.1 mt-10 -80.33 110.47 15.79 Favored 'General case' 0 C--O 1.237 0.433 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 177.856 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.523 HD23 ' HB3' ' A' ' 43' ' ' PHE . 4.2 mm? -86.61 160.42 50.54 Favored Pre-proline 0 N--CA 1.476 0.841 0 C-N-CA 123.814 0.846 . . . . 0.0 108.779 -178.775 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 14.0 Cg_endo -51.54 125.68 17.42 Favored 'Trans proline' 0 C--N 1.39 2.735 0 C-N-CA 123.073 2.515 . . . . 0.0 113.101 -172.65 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.46 ' HB2' ' HB3' ' A' ' 41' ' ' LYS . . . -110.51 153.68 43.4 Favored Pre-proline 0 N--CA 1.469 0.483 0 CA-C-N 114.659 -1.155 . . . . 0.0 111.39 -170.876 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.689 ' HG2' ' HB2' ' A' ' 39' ' ' TRP . 56.3 Cg_endo -68.29 153.49 74.24 Favored 'Trans proline' 0 C--N 1.373 1.835 0 C-N-CA 122.584 2.189 . . . . 0.0 109.811 165.561 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 21.0 m -64.23 -29.31 70.42 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 123.468 0.707 . . . . 0.0 112.815 -172.138 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 16.0 m -83.56 -29.26 27.98 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 123.312 0.645 . . . . 0.0 111.609 -176.42 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' TRP . . . . . 0.689 ' HB2' ' HG2' ' A' ' 36' ' ' PRO . 17.5 m95 -114.19 -178.55 3.4 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 123.812 0.845 . . . . 0.0 109.668 -177.283 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.488 ' HB2' ' HB ' ' A' ' 59' ' ' VAL . 0.0 OUTLIER -119.7 165.63 14.26 Favored 'General case' 0 N--CA 1.473 0.713 0 N-CA-C 107.836 -1.172 . . . . 0.0 107.836 164.861 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.46 ' HB3' ' HB2' ' A' ' 35' ' ' ALA . 14.4 tptm -150.73 119.49 6.58 Favored 'General case' 0 C--O 1.238 0.496 0 C-N-CA 124.187 0.995 . . . . 0.0 108.77 -172.776 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.446 ' HA ' ' HA ' ' A' ' 32' ' ' GLU . 2.7 tt -129.1 150.21 50.59 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 113.579 -1.646 . . . . 0.0 108.29 -175.872 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.523 ' HB3' HD23 ' A' ' 33' ' ' LEU . 33.8 t80 -130.24 139.82 50.76 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 124.353 1.061 . . . . 0.0 108.398 170.07 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 22.2 m-85 -96.8 103.11 13.52 Favored Pre-proline 0 CA--C 1.552 1.028 0 C-N-CA 122.849 0.46 . . . . 0.0 109.952 173.696 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' PRO . . . . . 0.469 ' HD2' ' HA ' ' A' ' 30' ' ' SER . 95.3 Cg_endo . . . . . 0 C--N 1.373 1.854 0 C-N-CA 122.526 2.151 . . . . 0.0 111.983 172.61 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 CA--C 1.555 1.162 0 CA-C-O 121.299 0.571 . . . . 0.0 111.713 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 86.9 t -82.95 138.77 18.79 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.885 0 C-N-CA 125.056 1.342 . . . . 0.0 110.529 -178.162 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 61.4 t -121.17 115.39 46.57 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.002 0 C-N-CA 124.039 0.936 . . . . 0.0 109.327 175.423 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 23.8 m-85 -88.8 112.93 23.79 Favored 'General case' 0 N--CA 1.479 1.014 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 170.282 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.488 ' HB ' ' HB2' ' A' ' 40' ' ' LYS . 9.1 t -79.14 133.49 29.83 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 CA-C-O 121.231 0.539 . . . . 0.0 109.907 -179.843 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -86.5 154.15 56.34 Favored Pre-proline 0 CA--C 1.543 0.681 0 CA-C-N 114.567 -1.197 . . . . 0.0 111.785 -172.92 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_endo -61.06 -26.17 82.5 Favored 'Trans proline' 0 C--N 1.377 2.057 0 C-N-CA 123.386 2.724 . . . . 0.0 113.31 173.816 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.533 HG23 ' H ' ' A' ' 64' ' ' GLU . 9.8 t -89.2 -12.27 41.37 Favored 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 122.537 0.335 . . . . 0.0 111.213 176.217 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 95.45 -8.21 68.99 Favored Glycine 0 C--N 1.355 1.607 0 CA-C-O 119.621 -0.544 . . . . 0.0 113.942 -178.164 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.533 ' H ' HG23 ' A' ' 62' ' ' THR . 40.4 tt0 -76.15 78.15 2.97 Favored 'General case' 0 N--CA 1.481 1.092 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 172.47 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -65.34 134.28 53.21 Favored 'General case' 0 CA--C 1.543 0.705 0 CA-C-N 115.325 -0.852 . . . . 0.0 110.781 -173.325 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.635 HG23 ' HB2' ' A' ' 71' ' ' GLN . 44.7 mm -91.69 122.7 43.37 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.659 0 C-N-CA 125.068 1.347 . . . . 0.0 110.114 -175.094 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 6.0 p -94.63 -19.83 20.11 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 123.725 0.81 . . . . 0.0 111.989 177.491 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' ASN . . . . . 0.418 HD21 ' HG3' ' A' ' 71' ' ' GLN . 1.9 p-10 -150.87 150.23 30.64 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 122.959 0.504 . . . . 0.0 111.417 -173.139 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 65.8 mtp85 -55.57 -30.11 60.24 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 125.193 1.397 . . . . 0.0 114.149 -170.922 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 6.4 tmtm? -58.69 -50.61 73.26 Favored 'General case' 0 N--CA 1.48 1.063 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 179.572 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.635 ' HB2' HG23 ' A' ' 66' ' ' ILE . 54.1 mt-30 -63.27 -35.27 79.79 Favored 'General case' 0 N--CA 1.477 0.912 0 O-C-N 124.312 1.008 . . . . 0.0 111.073 -179.766 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.44 ' O ' ' HG ' ' A' ' 76' ' ' LEU . 0.2 OUTLIER -60.52 -52.31 65.73 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 123.482 0.713 . . . . 0.0 109.158 179.004 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -63.1 -50.02 72.16 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 123.839 0.855 . . . . 0.0 111.537 -175.949 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -66.87 -24.98 66.19 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.147 0.579 . . . . 0.0 111.261 -178.459 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 28.8 t80 -69.12 -47.22 65.69 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 123.818 0.847 . . . . 0.0 109.591 175.194 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.453 HD13 ' HA ' ' A' ' 84' ' ' ALA . 92.7 mt -66.01 -44.92 83.36 Favored 'General case' 0 N--CA 1.481 1.09 0 O-C-N 123.822 0.701 . . . . 0.0 111.815 -174.281 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -69.36 -25.89 64.4 Favored 'General case' 0 N--CA 1.48 1.069 0 CA-C-N 116.531 -0.304 . . . . 0.0 110.278 179.106 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 47.0 t -79.71 -29.37 40.68 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 123.046 0.538 . . . . 0.0 111.016 175.117 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 54.6 m80 -132.5 89.43 36.24 Favored Pre-proline 0 CA--C 1.546 0.791 0 C-N-CA 123.548 0.739 . . . . 0.0 109.562 -172.146 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -68.76 151.15 74.55 Favored 'Trans proline' 0 C--N 1.38 2.195 0 C-N-CA 122.664 2.243 . . . . 0.0 112.593 -177.287 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 95.05 -22.85 36.1 Favored Glycine 0 C--N 1.347 1.151 0 CA-C-N 116.141 -0.481 . . . . 0.0 113.052 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 14.7 m120 -68.0 131.52 92.31 Favored Pre-proline 0 N--CA 1.482 1.133 0 CA-C-O 119.102 -0.475 . . . . 0.0 109.821 173.162 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -55.78 141.53 84.69 Favored 'Trans proline' 0 C--N 1.38 2.209 0 C-N-CA 123.133 2.555 . . . . 0.0 112.723 -175.258 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.453 ' HA ' HD13 ' A' ' 76' ' ' LEU . . . -66.53 159.52 27.13 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 123.937 0.895 . . . . 0.0 112.811 -170.675 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.44 ' HB ' HD12 ' A' ' 72' ' ' LEU . 16.3 tt -67.9 -20.72 26.28 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.014 0 C-N-CA 123.863 0.865 . . . . 0.0 110.567 176.26 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -63.68 -36.54 84.17 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 124.457 1.103 . . . . 0.0 112.204 179.741 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -92.35 -1.49 57.01 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 123.442 0.697 . . . . 0.0 111.213 179.086 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 5.3 m-30 -93.82 112.38 24.23 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 123.923 0.889 . . . . 0.0 109.864 178.008 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 11.0 p-10 -86.65 115.06 23.86 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-O 121.494 0.664 . . . . 0.0 110.221 -179.502 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 74.2 m95 -94.12 -20.05 20.25 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 123.588 0.755 . . . . 0.0 109.701 172.822 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 15.1 t . . . . . 0 N--CA 1.484 1.229 0 C-N-CA 125.01 1.324 . . . . 0.0 112.65 -176.734 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 17.1 m . . . . . 0 N--CA 1.479 0.988 0 CA-C-O 121.639 0.733 . . . . 0.0 110.422 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 13.6 p -151.08 113.79 4.69 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 124.561 1.145 . . . . 0.0 108.408 -177.858 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 82.3 t -111.79 122.76 66.73 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 C-N-CA 124.38 1.072 . . . . 0.0 108.843 -176.759 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -79.5 116.74 19.89 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 123.112 0.565 . . . . 0.0 110.109 178.772 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.509 HD23 ' HB3' ' A' ' 43' ' ' PHE . 4.3 mm? -94.27 160.6 31.62 Favored Pre-proline 0 CA--C 1.555 1.167 0 C-N-CA 124.438 1.095 . . . . 0.0 109.128 177.362 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 13.1 Cg_endo -53.7 147.8 38.73 Favored 'Trans proline' 0 C--N 1.391 2.797 0 C-N-CA 123.22 2.613 . . . . 0.0 113.687 -177.974 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.599 ' HB2' ' HB3' ' A' ' 41' ' ' LYS . . . -152.23 167.24 13.61 Favored Pre-proline 0 CA--C 1.538 0.498 0 C-N-CA 123.884 0.874 . . . . 0.0 111.871 -167.92 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_exo -56.1 146.57 69.59 Favored 'Trans proline' 0 C--N 1.38 2.214 0 C-N-CA 122.571 2.181 . . . . 0.0 110.83 158.059 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 61.4 p -66.34 -33.74 76.41 Favored 'General case' 0 CA--C 1.552 1.026 0 C-N-CA 123.149 0.58 . . . . 0.0 110.695 177.451 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 37.1 m -64.79 -41.3 95.93 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 124.686 1.194 . . . . 0.0 111.3 177.136 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' TRP . . . . . 0.427 ' HE1' ' HD2' ' A' ' 83' ' ' PRO . 41.8 m95 -102.04 -166.48 1.29 Allowed 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 123.93 0.892 . . . . 0.0 110.127 178.735 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.493 ' HB3' ' HB ' ' A' ' 59' ' ' VAL . 1.1 tppt? -148.41 154.35 39.79 Favored 'General case' 0 CA--C 1.535 0.38 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 164.468 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.599 ' HB3' ' HB2' ' A' ' 35' ' ' ALA . 17.5 tptm -121.66 122.48 39.7 Favored 'General case' 0 N--CA 1.468 0.444 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 -179.055 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 4.5 tt -124.55 136.93 54.38 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 175.359 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.509 ' HB3' HD23 ' A' ' 33' ' ' LEU . 28.9 t80 -115.62 133.88 55.6 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 125.007 1.323 . . . . 0.0 108.021 172.81 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 13.2 m-85 -94.77 106.75 26.42 Favored Pre-proline 0 CA--C 1.547 0.854 0 C-N-CA 123.284 0.634 . . . . 0.0 109.479 171.66 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo . . . . . 0 C--N 1.37 1.66 0 C-N-CA 122.728 2.286 . . . . 0.0 111.522 169.41 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 CA--C 1.557 1.213 0 CA-C-O 121.136 0.493 . . . . 0.0 111.888 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 64.4 t -83.11 131.08 34.59 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 C-N-CA 124.06 0.944 . . . . 0.0 109.745 176.705 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 61.0 t -121.91 117.81 53.59 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.858 0 C-N-CA 124.052 0.941 . . . . 0.0 109.297 179.448 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 36.1 m-85 -87.18 131.1 34.28 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 123.61 0.764 . . . . 0.0 110.064 169.6 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.541 ' HA ' ' HG3' ' A' ' 65' ' ' GLU . 10.8 t -82.35 129.27 37.75 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 171.045 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -85.26 150.41 54.65 Favored Pre-proline 0 CA--C 1.542 0.672 0 CA-C-N 114.889 -1.051 . . . . 0.0 110.71 179.052 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_endo -61.4 -24.86 79.19 Favored 'Trans proline' 0 CA--C 1.557 1.643 0 C-N-CA 123.543 2.829 . . . . 0.0 111.477 169.715 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 85.2 m -74.53 -35.08 63.13 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 125.296 1.438 . . . . 0.0 112.078 176.193 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 94.2 11.24 57.64 Favored Glycine 0 CA--C 1.534 1.227 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.763 -162.538 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -94.72 70.37 3.49 Favored 'General case' 0 CA--C 1.542 0.641 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 174.938 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.541 ' HG3' ' HA ' ' A' ' 59' ' ' VAL . 0.7 OUTLIER -57.78 129.89 43.95 Favored 'General case' 0 N--CA 1.478 0.943 0 CA-C-N 115.501 -0.772 . . . . 0.0 111.738 -174.599 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.422 HG23 ' HB2' ' A' ' 71' ' ' GLN . 40.2 mm -100.7 128.45 52.8 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 CA-C-N 114.982 -1.008 . . . . 0.0 109.58 -177.906 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 12.2 p -110.27 -0.73 17.61 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 124.064 0.946 . . . . 0.0 111.451 -178.226 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 11.8 p-10 -162.26 149.82 14.11 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 122.757 0.423 . . . . 0.0 111.113 -169.577 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.527 ' HG2' HD11 ' A' ' 85' ' ' ILE . 16.3 mtp180 -52.53 -40.3 62.33 Favored 'General case' 0 N--CA 1.486 1.337 0 C-N-CA 124.346 1.058 . . . . 0.0 112.831 -175.555 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 5.0 tmtm? -53.63 -56.6 15.85 Favored 'General case' 0 N--CA 1.48 1.07 0 O-C-N 124.29 0.993 . . . . 0.0 109.307 -177.857 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.422 ' HB2' HG23 ' A' ' 66' ' ' ILE . 14.8 mm100 -67.18 -25.74 66.29 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 115.485 -0.78 . . . . 0.0 111.814 -175.314 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.453 HD12 ' HB ' ' A' ' 85' ' ' ILE . 0.6 OUTLIER -69.12 -54.68 13.69 Favored 'General case' 0 N--CA 1.482 1.155 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 178.398 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -68.49 -41.15 80.5 Favored 'General case' 0 C--O 1.241 0.642 0 C-N-CA 123.81 0.844 . . . . 0.0 111.005 -171.731 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -68.63 -29.41 67.9 Favored 'General case' 0 C--N 1.355 0.805 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.87 175.484 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 47.1 t80 -64.89 -40.96 95.91 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 122.882 0.473 . . . . 0.0 110.398 174.105 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 79.9 mt -68.07 -37.21 81.01 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 122.974 0.51 . . . . 0.0 111.604 -176.756 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.1 -16.96 36.36 Favored 'General case' 0 N--CA 1.484 1.26 0 C-N-CA 122.772 0.429 . . . . 0.0 111.661 -179.91 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 34.1 t -93.77 -22.0 18.96 Favored 'General case' 0 N--CA 1.492 1.652 0 C-N-CA 123.12 0.568 . . . . 0.0 110.78 174.785 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 54.2 m80 -135.81 79.36 46.18 Favored Pre-proline 0 CA--C 1.547 0.855 0 N-CA-C 107.364 -1.347 . . . . 0.0 107.364 179.95 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_endo -61.92 144.06 96.17 Favored 'Trans proline' 0 C--N 1.376 1.98 0 C-N-CA 123.386 2.724 . . . . 0.0 112.838 -179.113 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 115.21 -33.55 5.24 Favored Glycine 0 C--N 1.344 0.995 0 CA-C-N 116.195 -0.457 . . . . 0.0 112.756 178.136 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 54.0 m-80 -68.17 140.19 93.03 Favored Pre-proline 0 CA--C 1.555 1.142 0 C-N-CA 122.922 0.489 . . . . 0.0 111.323 -177.965 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' PRO . . . . . 0.427 ' HD2' ' HE1' ' A' ' 39' ' ' TRP . 81.9 Cg_exo -46.78 150.58 2.5 Favored 'Trans proline' 0 C--N 1.381 2.262 0 C-N-CA 124.682 3.588 . . . . 0.0 115.194 -178.375 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -71.99 158.17 36.47 Favored 'General case' 0 N--CA 1.484 1.258 0 C-N-CA 124.145 0.978 . . . . 0.0 112.247 -171.608 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.527 HD11 ' HG2' ' A' ' 69' ' ' ARG . 16.8 tt -76.79 -22.15 14.87 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.825 0 N-CA-C 110.253 -0.277 . . . . 0.0 110.253 175.051 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -64.58 -19.38 65.62 Favored 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 123.759 0.824 . . . . 0.0 112.616 178.958 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 -102.54 -14.86 16.61 Favored 'General case' 0 CA--C 1.553 1.076 0 C-N-CA 123.189 0.596 . . . . 0.0 110.85 174.65 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 7.1 m-30 -81.51 113.41 19.54 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 123.659 0.784 . . . . 0.0 110.352 179.612 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -80.59 125.2 29.7 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 123.439 0.696 . . . . 0.0 109.556 177.396 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 64.1 m95 -111.56 -8.25 14.25 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 124.139 0.976 . . . . 0.0 109.623 169.741 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 9.4 t . . . . . 0 CA--C 1.553 1.085 0 C-N-CA 124.111 0.964 . . . . 0.0 112.667 -163.579 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 27.2 m . . . . . 0 CA--C 1.549 0.922 0 CA-C-O 121.398 0.618 . . . . 0.0 110.408 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.402 ' HA ' ' HD2' ' A' ' 45' ' ' PRO . 24.6 p -142.46 118.05 10.38 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 123.974 0.91 . . . . 0.0 108.773 177.41 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 65.7 t -100.31 115.55 41.82 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 -175.144 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -80.61 105.99 12.28 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 123.423 0.689 . . . . 0.0 109.94 -179.367 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.463 HD23 ' HB3' ' A' ' 43' ' ' PHE . 4.5 mm? -83.68 163.94 47.0 Favored Pre-proline 0 N--CA 1.484 1.239 0 C-N-CA 124.281 1.033 . . . . 0.0 109.69 178.933 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -63.2 150.31 88.94 Favored 'Trans proline' 0 C--N 1.385 2.489 0 C-N-CA 122.025 1.817 . . . . 0.0 113.339 -175.407 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -141.8 167.77 15.82 Favored Pre-proline 0 CA--C 1.545 0.759 0 C-N-CA 124.226 1.01 . . . . 0.0 110.255 -173.484 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.401 ' HG2' ' HB2' ' A' ' 39' ' ' TRP . 33.0 Cg_endo -63.5 155.76 60.66 Favored 'Trans proline' 0 C--N 1.383 2.362 0 C-N-CA 121.902 1.735 . . . . 0.0 110.575 162.463 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 21.6 m -61.81 -23.53 66.29 Favored 'General case' 0 N--CA 1.484 1.274 0 C-N-CA 123.586 0.754 . . . . 0.0 111.511 179.205 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 12.6 m -71.24 -38.3 71.96 Favored 'General case' 0 CA--C 1.552 1.033 0 C-N-CA 124.134 0.974 . . . . 0.0 111.841 179.293 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' TRP . . . . . 0.401 ' HB2' ' HG2' ' A' ' 36' ' ' PRO . 26.5 m95 -119.24 -172.44 2.31 Favored 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 124.091 0.957 . . . . 0.0 111.051 -173.885 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 37.3 mtmt -138.7 143.87 39.32 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 124.677 1.191 . . . . 0.0 108.677 168.007 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 17.2 tptm -114.14 118.17 33.27 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 125.631 1.572 . . . . 0.0 108.638 -179.471 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 8.6 tt -120.02 125.96 49.65 Favored 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 175.698 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.463 ' HB3' HD23 ' A' ' 33' ' ' LEU . 87.0 t80 -103.58 134.57 46.7 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 124.441 1.096 . . . . 0.0 108.137 171.663 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' TYR . . . . . 0.419 ' HB2' ' O ' ' A' ' 55' ' ' GLU . 0.6 OUTLIER -100.01 104.52 29.47 Favored Pre-proline 0 CA--C 1.552 1.027 0 N-CA-C 109.392 -0.596 . . . . 0.0 109.392 174.635 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 45' ' ' PRO . . . . . 0.402 ' HD2' ' HA ' ' A' ' 30' ' ' SER . 85.5 Cg_endo . . . . . 0 C--N 1.37 1.71 0 C-N-CA 122.328 2.019 . . . . 0.0 110.431 166.452 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.419 ' O ' ' HB2' ' A' ' 44' ' ' TYR . 0.4 OUTLIER . . . . . 0 N--CA 1.485 1.309 0 CA-C-O 121.394 0.616 . . . . 0.0 112.387 . . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.448 HG22 ' HD1' ' A' ' 43' ' ' PHE . 79.7 t -84.09 132.83 30.6 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.963 0 C-N-CA 124.651 1.18 . . . . 0.0 110.353 179.019 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 98.9 t -122.37 120.93 62.46 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 C-N-CA 123.842 0.857 . . . . 0.0 109.617 173.627 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 15.3 m-85 -90.93 123.96 34.83 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 123.233 0.613 . . . . 0.0 109.378 170.364 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 5.2 t -80.94 124.27 38.5 Favored 'Isoleucine or valine' 0 C--O 1.237 0.431 0 C-N-CA 123.377 0.671 . . . . 0.0 109.317 172.607 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -81.61 153.49 70.68 Favored Pre-proline 0 N--CA 1.468 0.473 0 CA-C-N 114.946 -1.024 . . . . 0.0 110.186 -179.701 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_endo -59.34 -33.19 97.65 Favored 'Trans proline' 0 C--N 1.377 2.073 0 C-N-CA 123.186 2.591 . . . . 0.0 112.787 178.063 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 14.8 t -91.09 -7.22 52.33 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 123.569 0.748 . . . . 0.0 111.551 -179.059 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 93.59 -1.58 69.17 Favored Glycine 0 C--N 1.351 1.365 0 CA-C-O 119.52 -0.6 . . . . 0.0 113.952 179.337 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -80.99 75.04 7.97 Favored 'General case' 0 N--CA 1.481 1.086 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 173.85 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -65.9 145.33 56.06 Favored 'General case' 0 CA--C 1.543 0.686 0 CA-C-N 114.886 -1.052 . . . . 0.0 111.879 -170.392 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.442 HG13 HD22 ' A' ' 72' ' ' LEU . 46.4 mm -101.11 127.31 54.46 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.571 0 C-N-CA 124.39 1.076 . . . . 0.0 109.813 -179.2 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 21.9 p -98.21 -14.5 20.3 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 123.668 0.787 . . . . 0.0 111.896 -177.878 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 13.1 p-10 -155.33 145.02 21.32 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 123.281 0.632 . . . . 0.0 110.543 -167.331 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.521 ' HG3' HD11 ' A' ' 85' ' ' ILE . 69.1 ttt180 -63.38 -26.74 68.89 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 124.459 1.104 . . . . 0.0 113.897 -165.559 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 1.4 tmtp? -66.0 -48.47 71.1 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 176.852 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.439 ' HA ' ' HG3' ' A' ' 74' ' ' GLN . 15.2 mm100 -63.76 -23.94 67.57 Favored 'General case' 0 N--CA 1.477 0.916 0 O-C-N 123.654 0.597 . . . . 0.0 112.034 -177.837 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.451 ' HB3' HD12 ' A' ' 85' ' ' ILE . 0.4 OUTLIER -64.28 -54.03 39.67 Favored 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 175.759 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -63.34 -46.5 86.35 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 123.85 0.86 . . . . 0.0 111.212 -174.02 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' GLN . . . . . 0.439 ' HG3' ' HA ' ' A' ' 71' ' ' GLN . 0.0 OUTLIER -69.97 -25.54 63.67 Favored 'General case' 0 CA--C 1.551 0.989 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.018 -178.851 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 28.1 t80 -65.34 -51.28 61.59 Favored 'General case' 0 C--N 1.358 0.959 0 C-N-CA 123.355 0.662 . . . . 0.0 109.534 173.47 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.409 ' HG ' ' O ' ' A' ' 72' ' ' LEU . 85.0 mt -60.83 -45.37 94.75 Favored 'General case' 0 N--CA 1.488 1.445 0 C-N-CA 123.668 0.787 . . . . 0.0 112.073 -172.621 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 19.0 ptpt -67.22 -32.54 73.65 Favored 'General case' 0 N--CA 1.481 1.122 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.207 178.688 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 34.8 t -85.54 -13.83 47.76 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 123.55 0.74 . . . . 0.0 111.594 -179.312 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 54.9 m80 -136.63 92.38 15.0 Favored Pre-proline 0 N--CA 1.485 1.298 0 C-N-CA 123.62 0.768 . . . . 0.0 109.368 -176.321 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -72.96 154.44 53.05 Favored 'Trans proline' 0 C--N 1.374 1.902 0 C-N-CA 122.7 2.267 . . . . 0.0 112.258 -179.3 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 102.81 -20.9 42.25 Favored Glycine 0 C--N 1.346 1.136 0 CA-C-N 115.893 -0.594 . . . . 0.0 112.205 -174.076 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 21.1 m120 -87.76 137.01 32.03 Favored Pre-proline 0 CA--C 1.553 1.069 0 C-N-CA 124.181 0.992 . . . . 0.0 110.194 179.422 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -72.38 159.43 49.34 Favored 'Trans proline' 0 C--N 1.38 2.234 0 C-N-CA 123.17 2.58 . . . . 0.0 112.908 -176.009 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -68.03 149.69 49.37 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 123.578 0.751 . . . . 0.0 112.138 -174.433 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.521 HD11 ' HG3' ' A' ' 69' ' ' ARG . 15.5 tt -68.05 -11.65 14.54 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.18 0 C-N-CA 123.922 0.889 . . . . 0.0 111.797 -178.928 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -56.92 -31.59 65.08 Favored 'General case' 0 CA--C 1.552 1.027 0 C-N-CA 124.311 1.045 . . . . 0.0 112.218 175.501 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -99.38 3.04 45.75 Favored 'General case' 0 N--CA 1.49 1.538 0 C-N-CA 123.4 0.68 . . . . 0.0 112.274 178.011 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -93.78 113.86 26.0 Favored 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 123.484 0.714 . . . . 0.0 109.386 -179.946 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -78.33 124.92 28.64 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 123.044 0.538 . . . . 0.0 110.454 -179.58 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 86.1 m95 -115.72 -6.55 12.14 Favored 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 123.821 0.848 . . . . 0.0 110.321 171.126 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 9.0 t . . . . . 0 N--CA 1.488 1.454 0 C-N-CA 124.708 1.203 . . . . 0.0 112.307 -166.261 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 31.6 m . . . . . 0 CA--C 1.546 0.795 0 CA-C-O 121.204 0.526 . . . . 0.0 110.05 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 3.8 m -142.96 128.2 18.73 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 123.998 0.919 . . . . 0.0 108.661 -175.619 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.405 HG23 ' HG3' ' A' ' 45' ' ' PRO . 26.2 t -122.4 124.76 71.6 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.935 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 178.75 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.479 ' HA ' ' HA ' ' A' ' 42' ' ' LEU . 48.0 mt-10 -82.31 108.05 15.45 Favored 'General case' 0 C--O 1.237 0.432 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 174.74 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.577 HD23 ' HB3' ' A' ' 43' ' ' PHE . 3.8 mm? -77.89 159.88 75.25 Favored Pre-proline 0 CA--C 1.555 1.167 0 CA-C-N 115.206 -0.907 . . . . 0.0 109.352 178.756 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -53.78 127.0 23.75 Favored 'Trans proline' 0 C--N 1.385 2.475 0 C-N-CA 122.952 2.435 . . . . 0.0 112.693 -174.293 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -113.15 158.1 39.03 Favored Pre-proline 0 N--CA 1.468 0.469 0 C-N-CA 124.063 0.945 . . . . 0.0 111.576 -169.187 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.647 ' HG2' ' HB2' ' A' ' 39' ' ' TRP . 46.6 Cg_endo -68.66 142.88 54.43 Favored 'Trans proline' 0 C--N 1.374 1.871 0 C-N-CA 122.007 1.804 . . . . 0.0 110.046 162.453 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 36.8 m -58.15 -25.38 61.41 Favored 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 124.095 0.958 . . . . 0.0 112.823 -175.007 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 45.8 t -74.61 -41.47 60.36 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 123.175 0.59 . . . . 0.0 110.822 178.185 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' TRP . . . . . 0.647 ' HB2' ' HG2' ' A' ' 36' ' ' PRO . 21.4 m95 -108.2 -167.61 1.26 Allowed 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 123.678 0.791 . . . . 0.0 110.724 -175.418 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.502 ' HB2' ' HB ' ' A' ' 59' ' ' VAL . 8.4 mtmt -137.47 150.32 47.49 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 124.679 1.192 . . . . 0.0 108.099 167.739 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 18.8 tptm -127.59 115.7 19.2 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 124.855 1.262 . . . . 0.0 108.289 -173.194 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.479 ' HA ' ' HA ' ' A' ' 32' ' ' GLU . 3.6 tt -119.26 147.49 44.21 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 124.407 1.083 . . . . 0.0 108.951 178.536 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.577 ' HB3' HD23 ' A' ' 33' ' ' LEU . 45.6 t80 -134.18 140.54 46.6 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 124.844 1.258 . . . . 0.0 108.392 171.734 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' TYR . . . . . 0.405 ' CE1' HD21 ' A' ' 42' ' ' LEU . 33.3 m-85 -97.16 105.57 25.51 Favored Pre-proline 0 CA--C 1.55 0.948 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 173.141 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' PRO . . . . . 0.405 ' HG3' HG23 ' A' ' 31' ' ' VAL . 79.1 Cg_endo . . . . . 0 C--N 1.377 2.036 0 C-N-CA 122.497 2.132 . . . . 0.0 112.719 174.793 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 CA--C 1.55 0.959 0 CA-C-O 121.529 0.68 . . . . 0.0 111.223 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 47.1 t -79.26 138.43 20.02 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.637 0 C-N-CA 123.974 0.909 . . . . 0.0 109.912 -179.735 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 60.5 t -125.46 118.43 52.42 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.663 0 C-N-CA 123.823 0.849 . . . . 0.0 108.824 174.791 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 24.7 m-85 -86.71 126.69 34.73 Favored 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 170.962 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.502 ' HB ' ' HB2' ' A' ' 40' ' ' LYS . 4.6 t -81.72 128.54 38.63 Favored 'Isoleucine or valine' 0 C--O 1.241 0.623 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 170.213 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -84.65 147.91 50.39 Favored Pre-proline 0 C--O 1.242 0.7 0 CA-C-N 115.246 -0.888 . . . . 0.0 110.916 -178.747 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 27.4 Cg_endo -63.18 -23.47 72.89 Favored 'Trans proline' 0 C--N 1.371 1.713 0 C-N-CA 123.112 2.541 . . . . 0.0 112.826 174.569 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.637 HG23 ' H ' ' A' ' 64' ' ' GLU . 12.9 t -91.94 -10.95 37.62 Favored 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 123.059 0.544 . . . . 0.0 111.413 176.308 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 91.99 -8.8 77.67 Favored Glycine 0 C--N 1.355 1.607 0 CA-C-O 120.03 -0.317 . . . . 0.0 113.813 -178.034 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.637 ' H ' HG23 ' A' ' 62' ' ' THR . 9.4 tp10 -76.94 76.68 3.51 Favored 'General case' 0 N--CA 1.486 1.335 0 N-CA-C 108.612 -0.885 . . . . 0.0 108.612 173.137 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -63.76 149.17 47.39 Favored 'General case' 0 C--O 1.241 0.611 0 CA-C-N 115.083 -0.962 . . . . 0.0 111.706 -171.299 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.487 HG23 ' HB2' ' A' ' 71' ' ' GLN . 46.7 mm -115.59 119.96 63.35 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.732 0 CA-C-N 114.638 -1.165 . . . . 0.0 109.309 -174.726 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 14.4 p -106.47 -8.99 16.85 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 123.403 0.681 . . . . 0.0 112.511 -177.0 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 10.9 p30 -144.36 159.26 43.01 Favored 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 122.499 0.32 . . . . 0.0 111.084 175.231 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.513 ' HG3' HD11 ' A' ' 85' ' ' ILE . 50.7 ttt-85 -60.1 -35.85 76.14 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 124.446 1.098 . . . . 0.0 112.349 -173.49 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 1.8 tmtp? -59.91 -51.21 70.66 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 123.255 0.622 . . . . 0.0 109.372 179.189 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.487 ' HB2' HG23 ' A' ' 66' ' ' ILE . 84.1 mm-40 -57.86 -31.49 66.74 Favored 'General case' 0 CA--C 1.55 0.963 0 O-C-N 123.932 0.77 . . . . 0.0 110.949 -179.003 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -67.73 -51.28 51.2 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 123.666 0.786 . . . . 0.0 109.52 178.334 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -61.65 -50.87 70.77 Favored 'General case' 0 N--CA 1.484 1.259 0 C-N-CA 124.087 0.955 . . . . 0.0 111.472 -175.663 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 1.3 pp0? -65.86 -32.2 73.59 Favored 'General case' 0 CA--C 1.544 0.747 0 CA-C-N 115.495 -0.775 . . . . 0.0 111.178 -178.982 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 29.8 t80 -60.64 -51.11 70.77 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 123.334 0.654 . . . . 0.0 110.213 176.1 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.481 HD13 ' HA ' ' A' ' 84' ' ' ALA . 89.0 mt -65.33 -45.21 85.15 Favored 'General case' 0 N--CA 1.479 0.986 0 O-C-N 123.799 0.687 . . . . 0.0 111.994 -172.191 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.28 -20.24 63.05 Favored 'General case' 0 N--CA 1.481 1.094 0 CA-C-O 120.902 0.382 . . . . 0.0 111.211 179.601 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 34.2 t -92.53 -18.78 22.69 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 123.766 0.826 . . . . 0.0 111.574 175.184 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 54.3 m80 -135.2 93.7 16.6 Favored Pre-proline 0 N--CA 1.476 0.86 0 C-N-CA 123.587 0.755 . . . . 0.0 109.663 -174.71 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -71.92 162.71 41.1 Favored 'Trans proline' 0 C--N 1.371 1.732 0 C-N-CA 122.394 2.063 . . . . 0.0 111.804 175.742 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 87.9 -4.06 85.75 Favored Glycine 0 N--CA 1.472 1.05 0 CA-C-N 116.413 -0.358 . . . . 0.0 113.298 -177.51 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 32.0 m-80 -97.43 145.0 28.91 Favored Pre-proline 0 N--CA 1.482 1.171 0 C-N-CA 123.659 0.784 . . . . 0.0 109.991 177.698 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_endo -65.32 144.43 80.45 Favored 'Trans proline' 0 C--N 1.377 2.049 0 C-N-CA 122.561 2.174 . . . . 0.0 111.878 179.286 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.481 ' HA ' HD13 ' A' ' 76' ' ' LEU . . . -70.68 162.03 29.75 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 123.809 0.843 . . . . 0.0 112.305 -171.219 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.513 HD11 ' HG3' ' A' ' 69' ' ' ARG . 17.5 tt -74.29 -15.54 16.45 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.095 0 CA-C-O 120.941 0.401 . . . . 0.0 110.924 179.24 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -60.02 -34.35 73.25 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 124.304 1.042 . . . . 0.0 112.081 175.649 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.449 ' HG2' ' O ' ' A' ' 84' ' ' ALA . 10.2 pt-20 -98.13 -2.65 39.5 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 123.761 0.825 . . . . 0.0 111.172 -178.715 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 3.6 m-30 -90.49 152.48 20.92 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 123.471 0.708 . . . . 0.0 110.144 176.055 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -120.3 122.74 41.5 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 123.464 0.706 . . . . 0.0 109.943 178.167 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 88.9 m95 -111.64 -2.0 15.54 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 123.798 0.839 . . . . 0.0 110.512 172.075 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 12.5 t . . . . . 0 N--CA 1.479 0.983 0 C-N-CA 123.639 0.776 . . . . 0.0 112.145 -168.252 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 19.2 m . . . . . 0 CA--C 1.555 1.162 0 CA-C-O 121.898 0.856 . . . . 0.0 109.815 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 39.9 p -171.91 141.22 1.34 Allowed 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 125.202 1.401 . . . . 0.0 107.948 -177.972 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.479 HG23 ' HG3' ' A' ' 45' ' ' PRO . 59.9 t -117.92 126.51 74.9 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 -178.972 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -84.97 105.13 15.5 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 123.58 0.752 . . . . 0.0 108.982 176.512 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.501 HD23 ' HB3' ' A' ' 43' ' ' PHE . 4.4 mm? -82.56 163.54 51.48 Favored Pre-proline 0 N--CA 1.48 1.057 0 C-N-CA 123.82 0.848 . . . . 0.0 110.192 -178.564 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -57.25 137.16 80.45 Favored 'Trans proline' 0 C--N 1.39 2.759 0 C-N-CA 122.683 2.255 . . . . 0.0 112.797 -179.536 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.571 ' HB2' ' HB3' ' A' ' 41' ' ' LYS . . . -123.48 161.72 44.19 Favored Pre-proline 0 N--CA 1.476 0.86 0 C-N-CA 124.298 1.039 . . . . 0.0 111.742 -172.766 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.704 ' HG2' ' HB2' ' A' ' 39' ' ' TRP . 31.6 Cg_endo -63.72 146.36 92.07 Favored 'Trans proline' 0 C--N 1.375 1.926 0 C-N-CA 122.551 2.167 . . . . 0.0 109.669 159.028 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 18.5 m -59.04 -37.95 78.18 Favored 'General case' 0 N--CA 1.489 1.477 0 C-N-CA 124.179 0.992 . . . . 0.0 112.838 -169.734 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 48.5 m -69.81 -35.05 74.51 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 123.574 0.75 . . . . 0.0 111.528 -179.907 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' TRP . . . . . 0.704 ' HB2' ' HG2' ' A' ' 36' ' ' PRO . 33.3 m95 -104.6 -179.89 4.08 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 123.782 0.833 . . . . 0.0 110.566 -175.678 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.36 152.42 51.44 Favored 'General case' 0 N--CA 1.476 0.844 0 N-CA-C 107.556 -1.276 . . . . 0.0 107.556 173.743 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.571 ' HB3' ' HB2' ' A' ' 35' ' ' ALA . 18.2 tptm -132.53 117.8 18.45 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 123.922 0.889 . . . . 0.0 109.812 -171.717 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 2.3 tt -122.24 144.7 48.82 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 124.762 1.225 . . . . 0.0 108.604 174.459 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.501 ' HB3' HD23 ' A' ' 33' ' ' LEU . 47.6 t80 -128.1 147.64 50.54 Favored 'General case' 0 C--O 1.238 0.482 0 C-N-CA 124.701 1.201 . . . . 0.0 108.98 171.405 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 18.2 m-85 -102.18 100.97 16.78 Favored Pre-proline 0 CA--C 1.551 0.994 0 C-N-CA 123.651 0.781 . . . . 0.0 110.147 171.895 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' PRO . . . . . 0.479 ' HG3' HG23 ' A' ' 31' ' ' VAL . 30.9 Cg_endo . . . . . 0 C--N 1.373 1.852 0 C-N-CA 123.435 2.756 . . . . 0.0 113.342 175.993 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 . . . . . 0 CA--C 1.549 0.939 0 CA-C-O 122.547 1.165 . . . . 0.0 112.16 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 20.5 t -80.52 145.88 8.41 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.668 0 CA-C-N 113.764 -1.562 . . . . 0.0 110.519 -174.512 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 49.1 t -121.77 116.55 49.72 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.804 0 C-N-CA 123.969 0.908 . . . . 0.0 109.007 172.219 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 33.9 m-85 -90.3 132.79 35.36 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 123.618 0.767 . . . . 0.0 110.255 171.424 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.414 ' HA ' ' HG2' ' A' ' 65' ' ' GLU . 14.8 t -85.59 132.19 32.49 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 168.477 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -87.4 153.7 53.6 Favored Pre-proline 0 C--O 1.244 0.772 0 CA-C-N 115.317 -0.856 . . . . 0.0 110.638 179.739 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_endo -69.43 -3.02 10.94 Favored 'Trans proline' 0 C--N 1.376 1.974 0 C-N-CA 122.865 2.377 . . . . 0.0 113.062 177.667 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.564 HG23 ' H ' ' A' ' 64' ' ' GLU . 12.3 t -115.62 -7.97 12.13 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 124.129 0.972 . . . . 0.0 111.401 -179.902 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 94.16 -15.2 63.72 Favored Glycine 0 C--N 1.358 1.783 0 CA-C-O 119.695 -0.503 . . . . 0.0 113.791 -179.547 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.564 ' H ' HG23 ' A' ' 62' ' ' THR . 42.9 tt0 -78.4 80.12 4.81 Favored 'General case' 0 N--CA 1.484 1.265 0 CA-C-O 121.67 0.748 . . . . 0.0 109.335 173.394 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.414 ' HG2' ' HA ' ' A' ' 59' ' ' VAL . 28.3 mt-10 -69.73 156.46 38.96 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 124.43 1.092 . . . . 0.0 111.73 -170.224 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 41.0 mm -111.19 122.51 65.78 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.613 0 C-N-CA 123.855 0.862 . . . . 0.0 109.481 178.138 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 61.6 p -99.65 -11.45 20.91 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 123.481 0.712 . . . . 0.0 112.506 -177.817 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 12.1 p30 -153.94 150.54 28.43 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 122.598 0.359 . . . . 0.0 111.315 -177.804 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.455 ' HG3' HD11 ' A' ' 85' ' ' ILE . 41.5 ttm105 -54.98 -32.4 61.64 Favored 'General case' 0 N--CA 1.491 1.588 0 C-N-CA 125.369 1.468 . . . . 0.0 114.143 -168.196 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -60.05 -54.37 46.83 Favored 'General case' 0 N--CA 1.487 1.404 0 C-N-CA 123.356 0.662 . . . . 0.0 109.648 -179.798 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.474 ' O ' ' HB2' ' A' ' 75' ' ' TYR . 90.1 mm-40 -64.2 -20.97 66.38 Favored 'General case' 0 N--CA 1.476 0.841 0 CA-C-N 115.347 -0.842 . . . . 0.0 111.778 -176.564 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.44 ' O ' ' HG ' ' A' ' 76' ' ' LEU . 0.9 OUTLIER -69.85 -52.97 20.43 Favored 'General case' 0 N--CA 1.481 1.091 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 175.697 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -58.0 -54.42 47.11 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 123.971 0.908 . . . . 0.0 111.766 -178.752 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' GLN . . . . . 0.442 ' HG3' ' HA ' ' A' ' 71' ' ' GLN . 0.0 OUTLIER -67.5 -24.29 65.56 Favored 'General case' 0 CA--C 1.551 0.993 0 CA-C-N 115.455 -0.793 . . . . 0.0 111.077 -177.685 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 75' ' ' TYR . . . . . 0.474 ' HB2' ' O ' ' A' ' 71' ' ' GLN . 35.6 t80 -65.94 -55.27 17.71 Favored 'General case' 0 C--N 1.36 1.032 0 C-N-CA 123.097 0.559 . . . . 0.0 109.706 174.383 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.44 ' HG ' ' O ' ' A' ' 72' ' ' LEU . 71.2 mt -59.96 -39.47 85.71 Favored 'General case' 0 N--CA 1.489 1.514 0 C-N-CA 123.436 0.694 . . . . 0.0 111.855 -172.629 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.95 -14.35 58.66 Favored 'General case' 0 N--CA 1.484 1.269 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.824 -179.517 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 37.5 t -102.02 -9.6 20.47 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 123.621 0.768 . . . . 0.0 111.198 172.697 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 86.5 m-70 -137.45 87.23 18.05 Favored Pre-proline 0 N--CA 1.481 1.083 0 C-N-CA 124.189 0.995 . . . . 0.0 109.363 -177.132 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 63.2 Cg_endo -71.35 141.65 39.4 Favored 'Trans proline' 0 C--N 1.374 1.874 0 C-N-CA 122.403 2.069 . . . . 0.0 111.126 174.993 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 116.58 -20.24 12.24 Favored Glycine 0 N--CA 1.471 1.032 0 N-CA-C 111.695 -0.562 . . . . 0.0 111.695 -174.245 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 39.4 m-80 -91.67 140.51 25.17 Favored Pre-proline 0 CA--C 1.548 0.892 0 C-N-CA 123.435 0.694 . . . . 0.0 109.717 177.351 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -70.07 159.42 53.24 Favored 'Trans proline' 0 C--N 1.377 2.045 0 C-N-CA 122.845 2.363 . . . . 0.0 112.983 -178.65 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -70.0 154.55 41.81 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 123.949 0.9 . . . . 0.0 112.477 -173.432 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.455 HD11 ' HG3' ' A' ' 69' ' ' ARG . 16.2 tt -66.82 -12.01 14.34 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.209 0 C-N-CA 124.171 0.988 . . . . 0.0 111.686 -179.227 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -52.89 -39.8 62.99 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 124.505 1.122 . . . . 0.0 112.05 174.977 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -94.4 -8.14 39.57 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 123.526 0.73 . . . . 0.0 112.044 178.902 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -86.56 110.86 20.09 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 123.444 0.698 . . . . 0.0 109.314 176.39 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -87.63 126.56 35.02 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 123.683 0.793 . . . . 0.0 109.882 -178.744 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 85.2 m95 -118.29 -3.96 10.96 Favored 'General case' 0 CA--C 1.555 1.173 0 C-N-CA 125.126 1.37 . . . . 0.0 110.106 172.456 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 15.1 t . . . . . 0 N--CA 1.482 1.145 0 C-N-CA 124.025 0.93 . . . . 0.0 112.18 -168.046 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 15.3 m . . . . . 0 CA--C 1.545 0.774 0 CA-C-O 121.221 0.534 . . . . 0.0 109.854 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 50.1 p -152.99 123.83 7.37 Favored 'General case' 0 C--O 1.239 0.541 0 C-N-CA 123.934 0.893 . . . . 0.0 108.804 178.249 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 48.6 t -103.15 119.83 52.17 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 -178.582 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.441 ' HA ' ' HA ' ' A' ' 42' ' ' LEU . 37.4 mt-10 -79.11 117.07 19.81 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.011 177.166 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.442 HD23 ' HB3' ' A' ' 43' ' ' PHE . 3.0 mm? -92.0 164.1 24.83 Favored Pre-proline 0 N--CA 1.483 1.195 0 C-N-CA 124.26 1.024 . . . . 0.0 109.6 -178.033 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -53.46 140.15 64.4 Favored 'Trans proline' 0 C--N 1.394 2.968 0 C-N-CA 123.127 2.551 . . . . 0.0 114.027 179.927 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.768 ' HB2' ' HB3' ' A' ' 41' ' ' LYS . . . -140.19 156.84 69.9 Favored Pre-proline 0 N--CA 1.472 0.672 0 C-N-CA 124.419 1.087 . . . . 0.0 111.473 -170.068 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -58.41 140.73 95.68 Favored 'Trans proline' 0 C--N 1.372 1.784 0 C-N-CA 122.798 2.332 . . . . 0.0 110.504 155.269 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 70.5 p -63.51 -28.15 69.75 Favored 'General case' 0 N--CA 1.487 1.422 0 C-N-CA 122.993 0.517 . . . . 0.0 111.884 -177.007 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 31.8 m -67.24 -40.03 86.24 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 123.282 0.633 . . . . 0.0 110.612 176.911 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 33.8 m95 -100.46 -179.46 4.11 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 123.743 0.817 . . . . 0.0 110.25 179.266 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.5 150.51 52.15 Favored 'General case' 0 N--CA 1.469 0.482 0 N-CA-C 106.768 -1.568 . . . . 0.0 106.768 169.893 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.768 ' HB3' ' HB2' ' A' ' 35' ' ' ALA . 15.2 tptm -133.0 128.96 37.52 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.676 0.751 . . . . 0.0 108.998 -174.493 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.441 ' HA ' ' HA ' ' A' ' 32' ' ' GLU . 3.3 tt -135.37 151.32 50.37 Favored 'General case' 0 C--O 1.241 0.607 0 CA-C-N 114.001 -1.454 . . . . 0.0 108.62 -177.146 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.442 ' HB3' HD23 ' A' ' 33' ' ' LEU . 32.9 t80 -133.61 137.84 45.65 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.782 1.233 . . . . 0.0 108.267 173.735 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 44' ' ' TYR . . . . . 0.434 ' CE1' HD21 ' A' ' 42' ' ' LEU . 38.5 m-85 -100.59 103.53 24.7 Favored Pre-proline 0 N--CA 1.484 1.231 0 C-N-CA 122.692 0.397 . . . . 0.0 111.025 175.544 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 65.0 Cg_endo . . . . . 0 C--N 1.371 1.727 0 C-N-CA 122.421 2.081 . . . . 0.0 110.994 166.676 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 4.0 pm0 . . . . . 0 CA--C 1.555 1.164 0 CA-C-O 121.694 0.759 . . . . 0.0 111.674 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 75.2 t -83.02 141.87 14.33 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.695 0 C-N-CA 124.33 1.052 . . . . 0.0 110.241 -177.317 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 57.7 t -123.56 124.01 68.6 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 C-N-CA 123.737 0.815 . . . . 0.0 109.555 179.594 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 29.6 m-85 -101.83 113.68 27.09 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 123.582 0.753 . . . . 0.0 109.27 171.774 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 3.4 t -79.1 130.45 36.11 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 C-N-CA 123.323 0.649 . . . . 0.0 109.587 175.939 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -84.18 154.47 63.48 Favored Pre-proline 0 CA--C 1.541 0.622 0 CA-C-N 115.022 -0.99 . . . . 0.0 111.593 -175.796 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 26.5 Cg_endo -60.42 -33.6 93.95 Favored 'Trans proline' 0 C--N 1.377 2.071 0 C-N-CA 123.251 2.634 . . . . 0.0 113.179 177.226 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 14.8 t -85.47 -2.49 58.18 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 123.027 0.531 . . . . 0.0 111.602 179.256 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 94.21 -18.01 57.71 Favored Glycine 0 C--N 1.35 1.308 0 CA-C-O 119.635 -0.536 . . . . 0.0 113.682 178.978 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -72.46 76.82 1.04 Allowed 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 123.983 0.913 . . . . 0.0 109.638 178.198 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -65.57 157.86 28.64 Favored 'General case' 0 N--CA 1.477 0.881 0 CA-C-N 115.024 -0.989 . . . . 0.0 111.682 -172.744 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 47.4 mm -118.44 122.52 69.72 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.445 0 CA-C-N 114.83 -1.077 . . . . 0.0 109.386 -170.741 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 7.6 p -93.82 -21.26 19.39 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 123.932 0.893 . . . . 0.0 112.403 -178.44 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 2.4 p-10 -153.95 165.95 34.52 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 122.674 0.39 . . . . 0.0 111.393 -172.401 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 34.8 ttp180 -58.91 -41.93 88.45 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 124.314 1.046 . . . . 0.0 111.954 -171.059 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 5.0 tmtm? -55.99 -51.6 67.15 Favored 'General case' 0 N--CA 1.486 1.335 0 C-N-CA 123.821 0.848 . . . . 0.0 109.76 -179.52 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 77.5 mt-30 -60.3 -31.63 70.44 Favored 'General case' 0 N--CA 1.476 0.839 0 O-C-N 124.144 0.903 . . . . 0.0 111.422 -178.729 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -67.62 -50.42 58.19 Favored 'General case' 0 N--CA 1.481 1.12 0 N-CA-C 109.338 -0.615 . . . . 0.0 109.338 177.898 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -62.8 -51.0 68.77 Favored 'General case' 0 C--O 1.242 0.693 0 CA-C-N 115.236 -0.893 . . . . 0.0 111.225 -174.897 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -66.36 -29.42 69.6 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 122.556 0.343 . . . . 0.0 111.223 179.799 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 43.7 t80 -62.53 -54.68 36.28 Favored 'General case' 0 C--N 1.357 0.913 0 C-N-CA 122.946 0.498 . . . . 0.0 109.824 176.06 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 67.1 mt -60.71 -44.5 96.5 Favored 'General case' 0 N--CA 1.481 1.095 0 O-C-N 123.579 0.549 . . . . 0.0 111.847 -173.143 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -69.1 -25.04 64.21 Favored 'General case' 0 N--CA 1.48 1.037 0 CA-C-N 116.589 -0.278 . . . . 0.0 111.402 -177.813 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 100.0 p -98.47 -12.4 21.36 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 122.91 0.484 . . . . 0.0 111.811 178.715 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 90.4 m-70 -130.84 91.02 38.15 Favored Pre-proline 0 N--CA 1.476 0.841 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 179.673 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_endo -67.01 166.04 24.26 Favored 'Trans proline' 0 C--N 1.372 1.783 0 C-N-CA 122.412 2.075 . . . . 0.0 112.071 175.661 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 90.81 -17.22 55.98 Favored Glycine 0 C--N 1.347 1.15 0 CA-C-N 116.565 -0.289 . . . . 0.0 113.259 -179.776 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 40.2 m-80 -84.16 144.64 44.42 Favored Pre-proline 0 CA--C 1.547 0.856 0 C-N-CA 123.652 0.781 . . . . 0.0 111.269 -178.013 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_exo -56.18 152.01 40.28 Favored 'Trans proline' 0 C--N 1.378 2.081 0 C-N-CA 123.875 3.05 . . . . 0.0 112.794 170.97 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -77.04 161.56 28.22 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 123.526 0.73 . . . . 0.0 112.207 -173.997 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 16.9 tt -72.93 -23.45 20.38 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.222 0 C-N-CA 123.347 0.659 . . . . 0.0 111.488 -178.71 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -65.13 -31.58 72.85 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 123.308 0.643 . . . . 0.0 111.854 -177.728 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -90.52 0.2 57.42 Favored 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 123.432 0.693 . . . . 0.0 111.247 177.106 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 6.0 m-30 -92.74 111.42 23.02 Favored 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 123.499 0.72 . . . . 0.0 109.248 177.149 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -84.0 88.79 7.17 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 123.559 0.744 . . . . 0.0 110.618 -175.872 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 89.5 m95 -76.19 -17.69 59.42 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 122.695 0.398 . . . . 0.0 110.902 173.171 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 14.5 t . . . . . 0 N--CA 1.488 1.425 0 C-N-CA 125.623 1.569 . . . . 0.0 111.979 177.697 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 34.7 m . . . . . 0 CA--C 1.551 1.019 0 CA-C-O 121.444 0.64 . . . . 0.0 110.435 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 56.2 p -134.71 124.29 25.04 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 124.013 0.925 . . . . 0.0 109.87 -176.064 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 95.4 t -109.55 116.61 52.6 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.448 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 174.372 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.494 ' HA ' ' HA ' ' A' ' 42' ' ' LEU . 44.0 mt-10 -77.27 125.3 29.1 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 123.257 0.623 . . . . 0.0 110.387 177.455 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -100.64 169.03 8.4 Favored Pre-proline 0 CA--C 1.559 1.304 0 C-N-CA 124.613 1.165 . . . . 0.0 109.316 -177.144 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -54.94 126.44 22.54 Favored 'Trans proline' 0 C--N 1.395 3.005 0 C-N-CA 122.99 2.46 . . . . 0.0 113.147 -177.745 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.46 ' HB2' ' HB3' ' A' ' 41' ' ' LYS . . . -114.9 156.83 44.57 Favored Pre-proline 0 N--CA 1.48 1.069 0 C-N-CA 124.374 1.069 . . . . 0.0 111.88 -171.697 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.592 ' HG2' ' HB2' ' A' ' 39' ' ' TRP . 72.6 Cg_endo -73.25 171.07 18.38 Favored 'Trans proline' 0 C--N 1.372 1.806 0 C-N-CA 122.544 2.163 . . . . 0.0 111.13 166.727 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 43.6 p -66.57 -46.13 77.02 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 123.421 0.689 . . . . 0.0 111.803 -176.937 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' SER . . . . . 0.444 ' HB2' ' HD1' ' A' ' 39' ' ' TRP . 9.8 m -72.68 -40.74 66.02 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-N 115.174 -0.921 . . . . 0.0 111.78 -174.187 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 39' ' ' TRP . . . . . 0.592 ' HB2' ' HG2' ' A' ' 36' ' ' PRO . 18.4 m95 -105.02 -173.86 2.4 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 123.535 0.734 . . . . 0.0 110.989 -175.273 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -130.28 158.02 40.93 Favored 'General case' 0 C--O 1.239 0.537 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 172.222 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.46 ' HB3' ' HB2' ' A' ' 35' ' ' ALA . 16.7 tptm -136.88 126.64 25.56 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.741 0.782 . . . . 0.0 109.135 -174.973 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.494 ' HA ' ' HA ' ' A' ' 32' ' ' GLU . 3.3 tt -136.05 151.97 50.41 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 113.653 -1.612 . . . . 0.0 108.195 -177.613 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 31.5 t80 -132.89 140.26 47.8 Favored 'General case' 0 C--O 1.235 0.309 0 C-N-CA 124.154 0.982 . . . . 0.0 108.491 171.405 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 25.3 m-85 -102.7 99.53 13.74 Favored Pre-proline 0 CA--C 1.547 0.833 0 C-N-CA 122.933 0.493 . . . . 0.0 109.687 174.654 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_endo . . . . . 0 C--N 1.368 1.603 0 C-N-CA 122.765 2.31 . . . . 0.0 111.705 173.942 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 CA--C 1.557 1.235 0 CA-C-O 121.325 0.583 . . . . 0.0 111.631 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 87.5 t -82.1 144.66 9.91 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.77 0 C-N-CA 124.848 1.259 . . . . 0.0 110.353 -179.104 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 60.7 t -126.82 129.16 71.41 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.068 0 C-N-CA 124.325 1.05 . . . . 0.0 109.333 177.545 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.404 ' CZ ' ' HD3' ' A' ' 41' ' ' LYS . 31.2 m-85 -105.84 114.98 29.46 Favored 'General case' 0 N--CA 1.477 0.879 0 N-CA-C 108.752 -0.832 . . . . 0.0 108.752 170.622 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 6.9 t -80.14 133.91 28.61 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 C-N-CA 123.073 0.549 . . . . 0.0 109.764 178.11 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -85.94 155.57 58.25 Favored Pre-proline 0 CA--C 1.542 0.64 0 CA-C-N 115.166 -0.925 . . . . 0.0 111.4 -176.337 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -69.79 7.49 0.99 Allowed 'Trans proline' 0 N--CA 1.504 2.131 0 C-N-CA 123.258 2.639 . . . . 0.0 114.702 -179.016 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.524 HG23 ' H ' ' A' ' 64' ' ' GLU . 9.0 t -128.93 -7.1 4.97 Favored 'General case' 0 N--CA 1.484 1.26 0 C-N-CA 123.484 0.714 . . . . 0.0 111.263 -176.478 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 95.57 -11.03 68.82 Favored Glycine 0 C--N 1.351 1.382 0 CA-C-O 119.572 -0.571 . . . . 0.0 114.497 -176.687 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.524 ' H ' HG23 ' A' ' 62' ' ' THR . 44.3 tt0 -79.76 73.22 6.5 Favored 'General case' 0 N--CA 1.483 1.204 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 172.932 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -69.73 158.04 36.16 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-N 114.823 -1.08 . . . . 0.0 111.568 -171.298 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.435 HD12 ' HB3' ' A' ' 71' ' ' GLN . 44.7 mm -113.95 120.31 63.41 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 CA-C-N 115.157 -0.929 . . . . 0.0 109.757 -173.741 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 77.4 p -93.06 -24.33 18.34 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 123.691 0.797 . . . . 0.0 111.762 -177.147 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 8.9 p30 -141.23 157.8 44.75 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 122.775 0.43 . . . . 0.0 111.325 -175.42 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 70.1 ttt180 -62.92 -27.33 69.3 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 124.524 1.13 . . . . 0.0 112.562 -173.391 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 6.5 tmtm? -65.51 -50.37 65.52 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 123.316 0.646 . . . . 0.0 109.298 176.483 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.435 ' HB3' HD12 ' A' ' 66' ' ' ILE . 46.9 mt-30 -55.82 -31.37 62.63 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 123.942 0.897 . . . . 0.0 111.562 179.463 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.429 ' O ' ' HG ' ' A' ' 76' ' ' LEU . 0.2 OUTLIER -64.7 -51.77 60.72 Favored 'General case' 0 CA--C 1.551 1.017 0 O-C-N 123.613 0.571 . . . . 0.0 109.722 178.801 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -59.99 -50.4 73.88 Favored 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 122.859 0.464 . . . . 0.0 111.504 -178.116 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.2 -25.54 66.18 Favored 'General case' 0 CA--C 1.543 0.694 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.385 -177.033 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 22.1 t80 -65.64 -49.51 68.4 Favored 'General case' 0 C--N 1.351 0.662 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 171.794 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.429 ' HG ' ' O ' ' A' ' 72' ' ' LEU . 80.2 mt -66.42 -39.4 88.94 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 123.135 0.574 . . . . 0.0 112.404 -172.24 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.02 -24.3 61.53 Favored 'General case' 0 N--CA 1.481 1.117 0 CA-C-O 120.817 0.342 . . . . 0.0 110.753 178.094 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 43.8 t -85.21 -27.57 26.01 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 123.409 0.684 . . . . 0.0 111.131 175.536 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 59.9 m80 -132.61 88.48 38.51 Favored Pre-proline 0 N--CA 1.475 0.781 0 C-N-CA 123.694 0.798 . . . . 0.0 109.511 -172.44 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -70.02 160.17 50.6 Favored 'Trans proline' 0 C--N 1.373 1.856 0 C-N-CA 122.468 2.112 . . . . 0.0 111.341 177.011 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 95.46 -32.78 5.95 Favored Glycine 0 CA--C 1.532 1.119 0 N-CA-C 112.353 -0.299 . . . . 0.0 112.353 -176.799 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 32.2 m-80 -65.49 143.72 98.75 Favored Pre-proline 0 CA--C 1.551 0.998 0 C-N-CA 123.593 0.757 . . . . 0.0 110.698 176.66 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' PRO . . . . . 0.418 ' HB2' ' CE2' ' A' ' 88' ' ' PHE . 42.5 Cg_exo -53.98 157.12 11.22 Favored 'Trans proline' 0 C--N 1.375 1.944 0 C-N-CA 123.809 3.006 . . . . 0.0 113.587 -179.008 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -68.78 152.37 45.41 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 123.983 0.913 . . . . 0.0 111.412 -177.603 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.413 HD12 ' HB3' ' A' ' 72' ' ' LEU . 12.8 tt -75.11 -21.61 16.63 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.17 0 CA-C-O 120.744 0.307 . . . . 0.0 110.288 175.08 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -58.85 -40.07 83.2 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 124.246 1.018 . . . . 0.0 112.078 178.011 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -84.48 -8.89 58.79 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 123.474 0.71 . . . . 0.0 111.587 179.583 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 88' ' ' PHE . . . . . 0.418 ' CE2' ' HB2' ' A' ' 83' ' ' PRO . 4.4 m-30 -84.45 112.93 20.81 Favored 'General case' 0 N--CA 1.476 0.835 0 CA-C-O 121.652 0.739 . . . . 0.0 109.778 177.483 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 19.4 p-10 -93.12 88.52 6.11 Favored 'General case' 0 CA--C 1.543 0.703 0 CA-C-N 114.451 -1.25 . . . . 0.0 111.191 -171.166 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 76.0 m95 -76.23 -21.89 55.84 Favored 'General case' 0 N--CA 1.485 1.309 0 CA-C-N 115.441 -0.799 . . . . 0.0 110.51 173.406 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 10.7 t . . . . . 0 CA--C 1.556 1.209 0 C-N-CA 125.652 1.581 . . . . 0.0 111.775 -178.761 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 14.9 m . . . . . 0 N--CA 1.475 0.821 0 CA-C-O 121.703 0.763 . . . . 0.0 111.347 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 3.8 p -144.44 118.12 9.22 Favored 'General case' 0 C--O 1.239 0.515 0 C-N-CA 124.305 1.042 . . . . 0.0 109.304 -179.507 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 90.4 t -101.65 130.98 50.43 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.483 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 179.268 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -81.89 107.17 14.39 Favored 'General case' 0 C--O 1.238 0.474 0 C-N-CA 123.09 0.556 . . . . 0.0 109.873 175.084 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.541 HD23 ' HB3' ' A' ' 43' ' ' PHE . 4.3 mm? -83.31 161.06 58.27 Favored Pre-proline 0 CA--C 1.553 1.064 0 C-N-CA 124.324 1.049 . . . . 0.0 109.742 -179.836 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -53.37 136.46 63.15 Favored 'Trans proline' 0 C--N 1.388 2.645 0 C-N-CA 122.988 2.459 . . . . 0.0 113.178 -179.149 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -121.18 163.39 30.31 Favored Pre-proline 0 N--CA 1.481 1.086 0 C-N-CA 124.361 1.065 . . . . 0.0 112.961 -164.142 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.623 ' HG2' ' HB2' ' A' ' 39' ' ' TRP . 40.9 Cg_endo -67.72 156.96 63.94 Favored 'Trans proline' 0 C--N 1.381 2.27 0 C-N-CA 122.52 2.147 . . . . 0.0 110.587 161.324 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 55.2 p -62.36 -39.04 91.85 Favored 'General case' 0 N--CA 1.486 1.354 0 N-CA-C 113.874 1.064 . . . . 0.0 113.874 -166.725 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 15.0 p -89.21 -21.6 23.18 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 112.375 0.509 . . . . 0.0 112.375 -174.952 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' TRP . . . . . 0.623 ' HB2' ' HG2' ' A' ' 36' ' ' PRO . 16.3 m95 -109.97 174.37 5.89 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-O 121.758 0.79 . . . . 0.0 110.469 179.463 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.452 ' HB2' ' HB ' ' A' ' 59' ' ' VAL . 0.0 OUTLIER -117.54 158.14 25.09 Favored 'General case' 0 C--O 1.24 0.559 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 170.371 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.406 ' HD3' ' CZ ' ' A' ' 58' ' ' PHE . 16.8 tptm -130.33 122.14 27.34 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 124.445 1.098 . . . . 0.0 108.133 -176.862 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.498 HD22 ' HB ' ' A' ' 57' ' ' VAL . 4.7 tt -125.19 150.31 47.1 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 124.743 1.217 . . . . 0.0 108.668 177.443 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.541 ' HB3' HD23 ' A' ' 33' ' ' LEU . 36.2 t80 -136.78 145.33 44.42 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 125.053 1.341 . . . . 0.0 108.347 174.064 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 16.4 m-85 -102.14 96.75 7.35 Favored Pre-proline 0 CA--C 1.555 1.17 0 C-N-CA 123.113 0.565 . . . . 0.0 110.114 174.33 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo . . . . . 0 C--N 1.374 1.906 0 C-N-CA 122.734 2.289 . . . . 0.0 111.806 175.437 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 . . . . . 0 CA--C 1.552 1.049 0 CA-C-O 121.419 0.628 . . . . 0.0 111.168 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 48.9 t -81.33 138.67 19.21 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.661 0 C-N-CA 124.145 0.978 . . . . 0.0 110.435 -176.723 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.498 ' HB ' HD22 ' A' ' 42' ' ' LEU . 87.2 t -123.5 115.82 46.5 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.952 0 C-N-CA 124.738 1.215 . . . . 0.0 108.512 176.213 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.406 ' CZ ' ' HD3' ' A' ' 41' ' ' LYS . 15.9 m-85 -91.99 118.39 30.73 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 123.465 0.706 . . . . 0.0 109.873 177.227 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.452 ' HB ' ' HB2' ' A' ' 40' ' ' LYS . 3.3 t -80.2 131.17 34.71 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 C-N-CA 123.439 0.696 . . . . 0.0 110.712 179.914 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -88.35 158.95 48.36 Favored Pre-proline 0 N--CA 1.476 0.834 0 C-N-CA 124.276 1.031 . . . . 0.0 111.677 -173.905 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -68.29 -19.18 44.33 Favored 'Trans proline' 0 C--N 1.38 2.223 0 C-N-CA 122.878 2.386 . . . . 0.0 113.191 178.305 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.565 HG23 ' H ' ' A' ' 64' ' ' GLU . 14.8 t -88.09 -11.31 47.47 Favored 'General case' 0 CA--C 1.55 0.957 0 C-N-CA 123.327 0.651 . . . . 0.0 111.198 175.934 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 96.36 -25.64 25.03 Favored Glycine 0 C--N 1.355 1.605 0 C-N-CA 122.601 0.143 . . . . 0.0 113.206 -177.609 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.565 ' H ' HG23 ' A' ' 62' ' ' THR . 37.7 tt0 -72.74 83.94 1.18 Allowed 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 124.08 0.952 . . . . 0.0 109.717 174.326 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.43 159.14 24.92 Favored 'General case' 0 N--CA 1.473 0.707 0 CA-C-N 114.878 -1.055 . . . . 0.0 112.072 -177.027 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.463 HG23 ' HB2' ' A' ' 71' ' ' GLN . 35.1 mm -102.44 127.53 55.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 C-N-CA 125.33 1.452 . . . . 0.0 109.08 177.522 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 29.9 m -97.59 -30.03 13.09 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 122.774 0.43 . . . . 0.0 111.504 -174.5 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 8.1 p30 -135.08 159.43 41.54 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 123.038 0.535 . . . . 0.0 110.47 -179.068 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 32.3 ttm180 -64.79 -30.43 71.43 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 124.271 1.028 . . . . 0.0 113.155 -168.45 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 6.2 tmtm? -63.73 -47.73 79.89 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 123.384 0.674 . . . . 0.0 109.449 176.341 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.463 ' HB2' HG23 ' A' ' 66' ' ' ILE . 23.3 mt-30 -55.27 -32.76 62.62 Favored 'General case' 0 N--CA 1.49 1.547 0 C-N-CA 123.679 0.792 . . . . 0.0 111.598 179.341 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.475 ' O ' ' HG ' ' A' ' 76' ' ' LEU . 0.4 OUTLIER -61.22 -52.94 62.68 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 123.125 0.57 . . . . 0.0 109.56 -179.276 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -67.85 -42.91 80.64 Favored 'General case' 0 C--O 1.248 0.992 0 C-N-CA 123.781 0.832 . . . . 0.0 111.691 -174.372 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.36 -22.65 61.87 Favored 'General case' 0 N--CA 1.478 0.971 0 CA-C-N 116.779 -0.192 . . . . 0.0 111.094 179.263 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 39.7 t80 -70.36 -42.83 71.3 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 122.969 0.508 . . . . 0.0 109.822 172.214 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.475 ' HG ' ' O ' ' A' ' 72' ' ' LEU . 80.1 mt -64.19 -33.83 76.7 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 123.166 0.586 . . . . 0.0 111.739 -175.991 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 14.3 ptpt -79.98 -32.61 39.79 Favored 'General case' 0 N--CA 1.482 1.171 0 N-CA-C 111.607 0.225 . . . . 0.0 111.607 175.06 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 40.9 t -71.28 -29.91 65.64 Favored 'General case' 0 N--CA 1.485 1.302 0 CA-C-O 121.427 0.632 . . . . 0.0 110.955 178.737 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 42.1 m80 -143.01 86.08 9.47 Favored Pre-proline 0 C--O 1.24 0.563 0 C-N-CA 124.677 1.191 . . . . 0.0 108.423 -178.267 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -67.58 163.01 36.66 Favored 'Trans proline' 0 C--N 1.378 2.09 0 C-N-CA 122.652 2.235 . . . . 0.0 111.704 173.516 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 101.82 -31.21 8.95 Favored Glycine 0 C--N 1.342 0.889 0 N-CA-C 111.283 -0.727 . . . . 0.0 111.283 -173.658 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 37.0 m-80 -66.79 144.52 98.62 Favored Pre-proline 0 CA--C 1.553 1.08 0 C-N-CA 123.535 0.734 . . . . 0.0 110.606 174.464 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -63.77 154.25 70.64 Favored 'Trans proline' 0 C--N 1.373 1.862 0 C-N-CA 123.067 2.511 . . . . 0.0 112.984 -176.097 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.49 ' O ' ' HG2' ' A' ' 87' ' ' GLU . . . -71.02 146.41 49.38 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 114.6 -1.182 . . . . 0.0 111.396 -174.745 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 17.1 tt -64.81 -14.41 16.24 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.258 0 C-N-CA 123.637 0.775 . . . . 0.0 111.739 -179.274 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -53.76 -40.26 66.05 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 124.205 1.002 . . . . 0.0 112.576 175.325 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.49 ' HG2' ' O ' ' A' ' 84' ' ' ALA . 10.6 pt-20 -86.32 -17.81 33.59 Favored 'General case' 0 N--CA 1.486 1.35 0 C-N-CA 123.306 0.643 . . . . 0.0 111.429 178.619 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -77.31 109.04 10.88 Favored 'General case' 0 N--CA 1.478 0.959 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 177.92 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -94.83 121.01 35.98 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-O 121.311 0.577 . . . . 0.0 109.725 -177.71 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 49.6 m95 -103.38 -3.7 25.14 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 123.857 0.863 . . . . 0.0 109.446 174.981 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 14.8 t . . . . . 0 CA--C 1.55 0.976 0 C-N-CA 125.118 1.367 . . . . 0.0 112.14 -176.041 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 27.1 m . . . . . 0 CA--C 1.542 0.642 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 39.2 p -157.33 118.65 3.65 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 123.943 0.897 . . . . 0.0 108.891 -177.929 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 48.1 t -106.06 125.71 61.61 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 C-N-CA 123.879 0.872 . . . . 0.0 109.056 -177.514 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.461 ' HA ' ' HA ' ' A' ' 42' ' ' LEU . 45.6 mt-10 -79.66 101.54 8.43 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 123.068 0.547 . . . . 0.0 110.092 178.942 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -81.21 152.77 71.33 Favored Pre-proline 0 CA--C 1.559 1.298 0 C-N-CA 124.379 1.071 . . . . 0.0 110.773 -176.178 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -62.84 137.74 64.7 Favored 'Trans proline' 0 C--N 1.384 2.401 0 C-N-CA 123.073 2.515 . . . . 0.0 114.085 -177.718 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -146.07 169.98 8.71 Favored Pre-proline 0 CA--C 1.557 1.218 0 C-N-CA 124.276 1.03 . . . . 0.0 108.933 -178.541 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -51.25 145.26 27.45 Favored 'Trans proline' 0 C--N 1.392 2.848 0 C-N-CA 122.691 2.26 . . . . 0.0 112.168 173.894 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 49.2 m -64.01 -20.04 65.62 Favored 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 113.164 0.802 . . . . 0.0 113.164 -171.717 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 33.4 m -72.23 -40.23 67.93 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 123.197 0.599 . . . . 0.0 110.16 174.581 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 25.6 m95 -104.83 -168.3 1.46 Allowed 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 123.958 0.903 . . . . 0.0 110.038 179.449 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.525 ' HB3' ' HB ' ' A' ' 59' ' ' VAL . 40.7 ttmt -156.41 170.78 21.51 Favored 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 106.565 -1.643 . . . . 0.0 106.565 171.584 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.716 ' HD2' HG11 ' A' ' 56' ' ' VAL . 21.3 pttm -151.34 154.06 35.97 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-O 121.845 0.831 . . . . 0.0 110.904 171.434 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.461 ' HA ' ' HA ' ' A' ' 32' ' ' GLU . 0.8 OUTLIER -127.0 130.76 50.66 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 113.348 -1.751 . . . . 0.0 107.726 178.433 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 28.7 t80 -101.39 141.04 34.85 Favored 'General case' 0 CA--C 1.542 0.647 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 170.728 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' TYR . . . . . 0.403 ' CE1' HD21 ' A' ' 42' ' ' LEU . 11.6 m-85 -99.37 100.14 9.86 Favored Pre-proline 0 N--CA 1.481 1.111 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 171.487 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo . . . . . 0 C--N 1.365 1.413 0 C-N-CA 122.411 2.074 . . . . 0.0 112.43 175.489 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 . . . . . 0 CA--C 1.549 0.905 0 CA-C-O 122.11 0.957 . . . . 0.0 112.133 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.716 HG11 ' HD2' ' A' ' 41' ' ' LYS . 51.0 t -82.35 147.42 6.04 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.771 0 CA-C-N 114.799 -1.091 . . . . 0.0 111.376 -168.896 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 65.8 t -124.52 116.5 47.73 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.693 0 C-N-CA 125.074 1.35 . . . . 0.0 107.681 175.276 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 36.7 m-85 -87.25 123.77 32.61 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 123.486 0.714 . . . . 0.0 110.982 -179.146 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.525 ' HB ' ' HB3' ' A' ' 40' ' ' LYS . 6.8 t -81.16 130.28 36.12 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.411 0 C-N-CA 123.677 0.791 . . . . 0.0 110.141 175.534 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -85.59 157.21 58.5 Favored Pre-proline 0 N--CA 1.475 0.794 0 O-C-N 124.157 0.911 . . . . 0.0 111.211 -178.618 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -63.7 -22.49 69.82 Favored 'Trans proline' 0 C--N 1.382 2.314 0 C-N-CA 122.934 2.423 . . . . 0.0 112.703 176.491 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.626 HG23 ' H ' ' A' ' 64' ' ' GLU . 12.1 t -91.53 -12.17 35.25 Favored 'General case' 0 CA--C 1.549 0.924 0 C-N-CA 123.822 0.849 . . . . 0.0 111.181 178.957 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 95.23 -11.73 68.81 Favored Glycine 0 C--N 1.349 1.283 0 CA-C-O 119.769 -0.462 . . . . 0.0 113.559 -177.591 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.626 ' H ' HG23 ' A' ' 62' ' ' THR . 36.4 tt0 -77.97 78.14 4.47 Favored 'General case' 0 N--CA 1.481 1.121 0 CA-C-N 117.576 0.688 . . . . 0.0 109.341 174.334 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -67.96 139.22 56.38 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-N 115.119 -0.946 . . . . 0.0 111.028 -174.075 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 36.8 mm -94.77 130.92 42.92 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.663 0 C-N-CA 124.484 1.114 . . . . 0.0 109.883 -179.927 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 6.0 p -96.59 -11.65 25.06 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 123.784 0.834 . . . . 0.0 112.414 -175.375 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 11.1 p-10 -153.53 151.32 29.67 Favored 'General case' 0 N--CA 1.48 1.052 0 N-CA-C 111.941 0.349 . . . . 0.0 111.941 -168.044 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 30.1 ttm180 -59.06 -39.55 82.42 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 124.759 1.224 . . . . 0.0 112.817 -168.582 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 4.3 tmtm? -59.71 -54.4 46.79 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 123.419 0.688 . . . . 0.0 109.923 -177.743 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.425 ' HA ' ' HG3' ' A' ' 74' ' ' GLN . 87.4 mm-40 -66.2 -22.32 66.34 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-N 115.032 -0.985 . . . . 0.0 111.309 -175.674 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.495 ' O ' ' HG ' ' A' ' 76' ' ' LEU . 0.8 OUTLIER -66.47 -56.36 11.3 Favored 'General case' 0 CA--C 1.544 0.742 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 174.318 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -57.41 -50.24 73.62 Favored 'General case' 0 N--CA 1.486 1.355 0 C-N-CA 124.404 1.082 . . . . 0.0 111.473 -176.314 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' GLN . . . . . 0.425 ' HG3' ' HA ' ' A' ' 71' ' ' GLN . 0.0 OUTLIER -70.31 -25.04 63.13 Favored 'General case' 0 CA--C 1.545 0.768 0 CA-C-N 115.4 -0.818 . . . . 0.0 111.608 -177.903 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 45.5 t80 -66.44 -45.99 77.96 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 122.75 0.42 . . . . 0.0 109.907 174.503 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.495 ' HG ' ' O ' ' A' ' 72' ' ' LEU . 52.4 mt -62.58 -45.23 93.86 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 123.033 0.533 . . . . 0.0 110.913 -175.36 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.11 -24.16 59.41 Favored 'General case' 0 CA--C 1.551 0.983 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.589 -179.835 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 46.3 t -78.19 -27.68 47.95 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 122.857 0.463 . . . . 0.0 110.806 174.949 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 59.0 m80 -127.4 84.89 62.22 Favored Pre-proline 0 N--CA 1.472 0.671 0 C-N-CA 123.401 0.681 . . . . 0.0 109.751 -175.435 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -62.8 122.18 10.38 Favored 'Trans proline' 0 C--N 1.372 1.788 0 C-N-CA 122.953 2.435 . . . . 0.0 111.709 177.431 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 133.23 -30.56 3.02 Favored Glycine 0 C--N 1.342 0.888 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.795 -174.042 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 40.2 m-80 -72.5 137.13 80.73 Favored Pre-proline 0 N--CA 1.476 0.864 0 C-N-CA 123.468 0.707 . . . . 0.0 110.456 177.109 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -62.88 154.25 67.67 Favored 'Trans proline' 0 C--N 1.375 1.971 0 C-N-CA 123.111 2.541 . . . . 0.0 112.777 -179.138 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.498 ' O ' ' HG2' ' A' ' 87' ' ' GLU . . . -73.96 148.07 42.46 Favored 'General case' 0 N--CA 1.476 0.842 0 CA-C-N 115.313 -0.858 . . . . 0.0 111.866 -173.674 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 17.3 tt -65.44 -11.72 12.5 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.194 0 C-N-CA 124.087 0.955 . . . . 0.0 112.366 -176.629 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -57.23 -38.66 74.13 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 123.678 0.791 . . . . 0.0 112.08 174.044 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.498 ' HG2' ' O ' ' A' ' 84' ' ' ALA . 12.6 pt-20 -90.81 -3.98 56.98 Favored 'General case' 0 N--CA 1.487 1.414 0 C-N-CA 123.14 0.576 . . . . 0.0 111.769 178.31 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -87.81 107.82 18.85 Favored 'General case' 0 N--CA 1.477 0.911 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 176.709 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 14.5 p-10 -93.48 88.0 5.76 Favored 'General case' 0 CA--C 1.547 0.842 0 CA-C-O 122.21 1.005 . . . . 0.0 111.174 -172.405 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 82.2 m95 -69.25 -26.15 64.63 Favored 'General case' 0 N--CA 1.481 1.111 0 CA-C-N 115.064 -0.971 . . . . 0.0 110.202 170.216 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 12.5 t . . . . . 0 CA--C 1.556 1.184 0 C-N-CA 125.196 1.398 . . . . 0.0 112.64 -175.443 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 13.8 m . . . . . 0 N--CA 1.472 0.656 0 CA-C-O 120.566 0.222 . . . . 0.0 110.686 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 54.7 p -142.82 114.06 7.79 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 123.53 0.732 . . . . 0.0 109.5 178.604 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 62.1 t -101.85 127.81 54.95 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 C-N-CA 124.16 0.984 . . . . 0.0 108.959 179.565 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 53.3 mt-10 -83.02 106.79 15.13 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-O 121.011 0.434 . . . . 0.0 109.987 178.517 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.479 HD23 ' HB3' ' A' ' 43' ' ' PHE . 3.6 mm? -82.7 164.26 47.84 Favored Pre-proline 0 CA--C 1.559 1.325 0 C-N-CA 124.619 1.167 . . . . 0.0 109.877 178.938 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -49.89 143.42 23.75 Favored 'Trans proline' 0 C--N 1.393 2.891 0 C-N-CA 123.334 2.689 . . . . 0.0 114.097 -175.914 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -146.03 155.49 51.24 Favored Pre-proline 0 CA--C 1.542 0.673 0 C-N-CA 123.633 0.773 . . . . 0.0 111.255 -167.396 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_exo -58.51 149.82 72.71 Favored 'Trans proline' 0 C--N 1.381 2.255 0 C-N-CA 123.158 2.572 . . . . 0.0 110.598 163.525 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 20.7 p -58.66 -42.66 88.92 Favored 'General case' 0 CA--C 1.551 1.019 0 C-N-CA 123.72 0.808 . . . . 0.0 111.914 -176.241 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 26.6 t -67.49 -33.65 75.54 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 123.768 0.827 . . . . 0.0 111.452 -179.966 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 21.7 m95 -105.45 -176.12 2.99 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 123.469 0.707 . . . . 0.0 111.211 -177.095 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 45.3 mtmt -137.98 149.16 45.87 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 114.926 -1.034 . . . . 0.0 108.51 162.881 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.737 ' HZ3' ' HB2' ' A' ' 43' ' ' PHE . 19.6 tptp -117.13 121.12 40.37 Favored 'General case' 0 N--CA 1.464 0.265 0 C-N-CA 124.899 1.28 . . . . 0.0 107.552 178.487 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.49 HD22 ' HB ' ' A' ' 57' ' ' VAL . 5.7 tt -119.19 143.92 46.98 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 124.171 0.988 . . . . 0.0 108.968 177.932 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.737 ' HB2' ' HZ3' ' A' ' 41' ' ' LYS . 24.3 t80 -130.63 128.14 40.37 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 125.293 1.437 . . . . 0.0 107.822 174.881 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 24.8 m-85 -86.63 111.55 40.47 Favored Pre-proline 0 CA--C 1.55 0.979 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 169.456 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo . . . . . 0 C--N 1.372 1.769 0 C-N-CA 122.427 2.085 . . . . 0.0 111.034 165.724 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 CA--C 1.557 1.232 0 CA-C-O 121.226 0.536 . . . . 0.0 111.524 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 37.5 t -80.51 130.87 35.25 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.625 0 C-N-CA 123.917 0.887 . . . . 0.0 110.038 -179.581 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.49 ' HB ' HD22 ' A' ' 42' ' ' LEU . 38.3 t -122.92 120.7 61.34 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.695 0 C-N-CA 123.525 0.73 . . . . 0.0 109.503 179.589 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.48 ' CZ ' ' HD3' ' A' ' 41' ' ' LYS . 27.0 m-85 -92.87 118.38 31.06 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 123.231 0.612 . . . . 0.0 109.947 174.1 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 2.0 t -78.43 123.82 35.87 Favored 'Isoleucine or valine' 0 C--O 1.239 0.509 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 177.049 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.485 ' HB3' ' H ' ' A' ' 64' ' ' GLU . . . -88.72 147.4 39.2 Favored Pre-proline 0 CA--C 1.544 0.734 0 CA-C-N 114.796 -1.093 . . . . 0.0 111.087 -175.478 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_endo -61.9 -30.69 84.19 Favored 'Trans proline' 0 C--N 1.369 1.636 0 C-N-CA 123.871 3.047 . . . . 0.0 114.064 -179.437 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 5.7 t -87.05 -1.46 57.9 Favored 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 122.242 0.217 . . . . 0.0 111.013 179.328 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 77.97 61.72 2.48 Favored Glycine 0 C--N 1.353 1.516 0 N-CA-C 112.011 -0.436 . . . . 0.0 112.011 -177.072 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.485 ' H ' ' HB3' ' A' ' 60' ' ' ALA . 40.8 tt0 -151.02 70.65 0.99 Allowed 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 107.999 -1.112 . . . . 0.0 107.999 179.318 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -65.4 158.15 27.43 Favored 'General case' 0 CA--C 1.544 0.74 0 CA-C-N 115.203 -0.908 . . . . 0.0 112.237 -171.885 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.584 HG23 ' HB2' ' A' ' 71' ' ' GLN . 44.4 mm -121.8 110.12 26.56 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 CA-C-N 115.169 -0.923 . . . . 0.0 110.484 -163.21 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 11.1 p -83.94 -17.08 41.85 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 123.249 0.62 . . . . 0.0 112.265 178.954 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 2.2 p-10 -157.26 152.52 26.19 Favored 'General case' 0 N--CA 1.476 0.854 0 N-CA-C 111.779 0.289 . . . . 0.0 111.779 -174.943 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 85.2 mtt180 -55.43 -31.76 62.15 Favored 'General case' 0 N--CA 1.493 1.686 0 C-N-CA 124.743 1.217 . . . . 0.0 114.215 -169.784 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 1.8 tmtp? -54.88 -53.92 49.18 Favored 'General case' 0 N--CA 1.486 1.371 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 177.861 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.584 ' HB2' HG23 ' A' ' 66' ' ' ILE . 84.3 mt-30 -61.68 -34.27 75.45 Favored 'General case' 0 N--CA 1.475 0.797 0 CA-C-N 114.741 -1.118 . . . . 0.0 111.126 -177.239 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.446 HD22 HG13 ' A' ' 66' ' ' ILE . 0.6 OUTLIER -60.74 -53.3 59.02 Favored 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 123.65 0.78 . . . . 0.0 109.755 179.153 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -68.41 -49.52 59.42 Favored 'General case' 0 C--O 1.238 0.491 0 CA-C-N 114.976 -1.011 . . . . 0.0 111.326 -172.782 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.5 -24.2 67.72 Favored 'General case' 0 C--N 1.356 0.865 0 O-C-N 123.635 0.584 . . . . 0.0 110.935 178.981 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 36.8 t80 -67.29 -50.62 59.59 Favored 'General case' 0 C--N 1.356 0.849 0 C-N-CA 123.224 0.61 . . . . 0.0 109.488 173.058 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.463 HD13 ' HA ' ' A' ' 84' ' ' ALA . 85.0 mt -61.84 -45.22 94.74 Favored 'General case' 0 N--CA 1.487 1.401 0 C-N-CA 123.337 0.655 . . . . 0.0 111.243 -174.4 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.06 -7.23 56.66 Favored 'General case' 0 CA--C 1.555 1.166 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.972 179.229 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 43.4 t -96.42 -22.99 16.81 Favored 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 123.744 0.818 . . . . 0.0 111.039 168.535 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 74.4 m80 -132.56 95.73 19.87 Favored Pre-proline 0 N--CA 1.476 0.871 0 C-N-CA 124.053 0.941 . . . . 0.0 109.43 -172.387 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -75.18 153.07 40.66 Favored 'Trans proline' 0 C--N 1.37 1.687 0 C-N-CA 122.382 2.055 . . . . 0.0 111.857 177.442 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 87.95 7.32 74.36 Favored Glycine 0 C--N 1.345 1.074 0 CA-C-N 115.975 -0.557 . . . . 0.0 112.686 -174.426 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 25.2 m-80 -103.69 127.33 29.71 Favored Pre-proline 0 N--CA 1.479 0.982 0 C-N-CA 123.801 0.84 . . . . 0.0 110.026 177.447 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -54.45 143.53 66.26 Favored 'Trans proline' 0 C--N 1.38 2.197 0 C-N-CA 123.606 2.871 . . . . 0.0 113.13 -178.058 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.463 ' HA ' HD13 ' A' ' 76' ' ' LEU . . . -71.16 159.1 35.28 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 123.649 0.78 . . . . 0.0 112.206 -172.283 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.431 ' HB ' HD12 ' A' ' 72' ' ' LEU . 15.1 tt -67.64 -16.21 20.76 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.218 0 C-N-CA 123.698 0.799 . . . . 0.0 111.385 -179.536 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -61.02 -29.91 69.99 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 124.351 1.061 . . . . 0.0 112.937 179.229 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.429 ' HG3' ' HD2' ' A' ' 88' ' ' PHE . 10.0 pt-20 -97.57 -8.05 29.9 Favored 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 122.728 0.411 . . . . 0.0 111.327 177.271 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 88' ' ' PHE . . . . . 0.429 ' HD2' ' HG3' ' A' ' 87' ' ' GLU . 4.3 m-30 -85.23 116.38 23.55 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 123.423 0.689 . . . . 0.0 110.344 -176.471 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -94.37 124.79 38.61 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 123.114 0.566 . . . . 0.0 110.97 -174.721 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 52.3 m95 -110.36 -20.68 12.53 Favored 'General case' 0 CA--C 1.551 0.989 0 C-N-CA 124.451 1.101 . . . . 0.0 109.632 176.889 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 11.3 t . . . . . 0 N--CA 1.489 1.507 0 C-N-CA 123.767 0.827 . . . . 0.0 112.298 -172.501 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 16.7 m . . . . . 0 N--CA 1.478 0.967 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 23.7 p -162.68 118.15 1.84 Allowed 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 122.915 0.486 . . . . 0.0 110.7 -171.685 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 63.1 t -105.77 133.4 50.23 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 C-N-CA 124.372 1.069 . . . . 0.0 108.533 176.835 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -83.37 113.49 20.77 Favored 'General case' 0 CA--C 1.539 0.523 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 176.148 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.543 HD23 ' HB3' ' A' ' 43' ' ' PHE . 3.8 mm? -89.88 165.13 25.9 Favored Pre-proline 0 CA--C 1.556 1.208 0 C-N-CA 124.337 1.055 . . . . 0.0 110.088 -179.797 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -56.72 142.74 91.48 Favored 'Trans proline' 0 C--N 1.394 2.941 0 C-N-CA 122.92 2.414 . . . . 0.0 113.113 179.192 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.523 ' HB2' ' HB3' ' A' ' 41' ' ' LYS . . . -136.24 166.04 31.0 Favored Pre-proline 0 CA--C 1.539 0.537 0 C-N-CA 124.216 1.007 . . . . 0.0 111.098 -169.091 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 81.5 Cg_exo -52.58 164.32 1.48 Allowed 'Trans proline' 0 C--N 1.376 2.011 0 C-N-CA 123.161 2.574 . . . . 0.0 112.538 160.8 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 66.0 p -63.95 -39.92 95.26 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 123.535 0.734 . . . . 0.0 111.748 -176.251 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 22.0 m -82.1 -37.8 25.78 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 123.641 0.776 . . . . 0.0 111.554 -177.612 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 45.0 m95 -97.17 158.12 15.6 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 123.369 0.668 . . . . 0.0 111.059 -173.389 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.54 ' HB2' ' HB ' ' A' ' 59' ' ' VAL . 0.1 OUTLIER -111.86 152.63 27.72 Favored 'General case' 0 C--O 1.236 0.352 0 N-CA-C 107.906 -1.146 . . . . 0.0 107.906 168.632 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.523 ' HB3' ' HB2' ' A' ' 35' ' ' ALA . 17.1 tptm -126.74 119.13 26.17 Favored 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 -175.309 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 4.8 tt -115.1 144.91 42.92 Favored 'General case' 0 C--N 1.322 -0.599 0 C-N-CA 124.726 1.21 . . . . 0.0 108.638 174.322 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.543 ' HB3' HD23 ' A' ' 33' ' ' LEU . 27.6 t80 -131.21 128.75 40.59 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 125.31 1.444 . . . . 0.0 108.436 174.975 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 39.0 m-85 -87.74 105.46 8.95 Favored Pre-proline 0 CA--C 1.554 1.132 0 N-CA-C 108.782 -0.822 . . . . 0.0 108.782 170.649 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo . . . . . 0 C--N 1.37 1.684 0 C-N-CA 122.735 2.29 . . . . 0.0 112.173 173.28 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.482 1.137 0 N-CA-C 112.9 0.704 . . . . 0.0 112.9 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 64.9 t -82.86 140.82 15.78 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.847 0 C-N-CA 124.455 1.102 . . . . 0.0 111.519 -170.648 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 63.2 t -122.23 128.61 75.56 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.9 0 C-N-CA 124.052 0.941 . . . . 0.0 108.97 176.819 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 13.3 m-85 -102.05 123.02 45.22 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 123.282 0.633 . . . . 0.0 109.563 171.583 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.54 ' HB ' ' HB2' ' A' ' 40' ' ' LYS . 2.3 t -79.58 129.47 37.51 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.611 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 174.456 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -83.85 154.61 64.67 Favored Pre-proline 0 CA--C 1.539 0.556 0 CA-C-N 114.901 -1.045 . . . . 0.0 111.446 -176.368 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -62.14 -22.86 74.92 Favored 'Trans proline' 0 C--N 1.379 2.164 0 C-N-CA 123.153 2.568 . . . . 0.0 113.447 177.251 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.423 HG22 ' OH ' ' A' ' 75' ' ' TYR . 12.1 t -99.86 -7.23 25.59 Favored 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 123.027 0.531 . . . . 0.0 111.86 177.798 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 94.16 -4.17 70.54 Favored Glycine 0 CA--C 1.531 1.043 0 CA-C-O 119.849 -0.417 . . . . 0.0 113.859 -179.386 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.407 ' H ' HG23 ' A' ' 62' ' ' THR . 36.2 tt0 -78.97 75.76 5.47 Favored 'General case' 0 N--CA 1.482 1.127 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 174.801 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -67.48 157.77 33.47 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-O 121.979 0.895 . . . . 0.0 111.596 -168.833 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.535 HG23 ' HB2' ' A' ' 71' ' ' GLN . 42.7 mm -116.61 120.15 64.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 C-N-CA 125.141 1.376 . . . . 0.0 108.876 -171.016 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 18.5 p -89.19 -19.94 24.82 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 123.315 0.646 . . . . 0.0 112.349 -176.665 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 2.0 p-10 -157.95 165.33 35.42 Favored 'General case' 0 N--CA 1.481 1.109 0 CA-C-O 120.968 0.413 . . . . 0.0 111.651 -174.919 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 20.3 ttm180 -57.51 -42.17 82.25 Favored 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 125.211 1.404 . . . . 0.0 113.101 -167.702 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 8.6 tmtm? -54.27 -49.92 68.45 Favored 'General case' 0 N--CA 1.487 1.378 0 C-N-CA 123.953 0.901 . . . . 0.0 110.527 -179.702 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.535 ' HB2' HG23 ' A' ' 66' ' ' ILE . 80.5 mt-30 -61.96 -32.74 73.2 Favored 'General case' 0 N--CA 1.475 0.802 0 CA-C-N 114.765 -1.107 . . . . 0.0 111.254 -179.136 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.417 ' O ' ' HG ' ' A' ' 76' ' ' LEU . 0.5 OUTLIER -65.82 -50.88 63.05 Favored 'General case' 0 CA--C 1.551 1.004 0 C-N-CA 123.466 0.707 . . . . 0.0 109.283 179.043 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -66.29 -43.98 84.81 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 124.155 0.982 . . . . 0.0 111.81 -174.705 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -68.24 -26.69 65.81 Favored 'General case' 0 N--CA 1.482 1.144 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.799 177.872 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 75' ' ' TYR . . . . . 0.423 ' OH ' HG22 ' A' ' 62' ' ' THR . 19.7 t80 -69.55 -47.09 64.83 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 123.374 0.67 . . . . 0.0 109.914 176.106 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.417 ' HG ' ' O ' ' A' ' 72' ' ' LEU . 74.8 mt -69.89 -28.43 65.62 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 113.03 0.752 . . . . 0.0 113.03 -172.631 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 66.0 pttt -75.51 -36.2 60.61 Favored 'General case' 0 N--CA 1.476 0.846 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 173.485 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 34.2 t -73.97 -20.36 60.37 Favored 'General case' 0 N--CA 1.485 1.292 0 C-N-CA 123.593 0.757 . . . . 0.0 111.125 176.206 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 58.3 m80 -137.25 76.14 44.83 Favored Pre-proline 0 CA--C 1.548 0.867 0 C-N-CA 124.394 1.077 . . . . 0.0 108.354 -177.29 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -67.64 -16.75 47.35 Favored 'Trans proline' 0 C--N 1.381 2.253 0 C-N-CA 123.032 2.488 . . . . 0.0 113.155 -178.269 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -70.84 -14.75 73.28 Favored Glycine 0 C--N 1.347 1.161 0 CA-C-N 116.046 -0.525 . . . . 0.0 112.928 175.108 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 16.1 m120 -94.29 146.08 30.9 Favored Pre-proline 0 CA--C 1.547 0.845 0 C-N-CA 123.959 0.904 . . . . 0.0 110.214 176.108 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -68.97 159.94 51.89 Favored 'Trans proline' 0 C--N 1.378 2.104 0 C-N-CA 123.05 2.5 . . . . 0.0 113.752 -170.808 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -71.5 148.93 46.28 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 124.295 1.038 . . . . 0.0 112.166 -174.474 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 17.8 tt -68.08 -11.62 14.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 C-N-CA 123.778 0.831 . . . . 0.0 111.457 -179.068 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -58.7 -28.96 66.28 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 124.458 1.103 . . . . 0.0 112.797 174.263 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -100.69 -8.26 23.01 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 122.947 0.499 . . . . 0.0 111.515 176.666 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -80.42 110.02 15.48 Favored 'General case' 0 N--CA 1.48 1.03 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 177.768 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -78.43 119.81 22.27 Favored 'General case' 0 CA--C 1.537 0.45 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 175.509 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 76.2 m95 -109.13 -7.79 15.26 Favored 'General case' 0 CA--C 1.55 0.972 0 C-N-CA 124.215 1.006 . . . . 0.0 109.451 168.081 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 15.0 t . . . . . 0 CA--C 1.558 1.267 0 C-N-CA 124.28 1.032 . . . . 0.0 112.598 -164.286 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 30.9 m . . . . . 0 N--CA 1.481 1.109 0 N-CA-C 109.918 -0.401 . . . . 0.0 109.918 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.472 ' HA ' ' HD2' ' A' ' 45' ' ' PRO . 76.2 p -148.1 145.85 28.57 Favored 'General case' 0 C--O 1.241 0.635 0 C-N-CA 123.274 0.63 . . . . 0.0 110.336 -178.495 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 43.9 t -114.6 131.22 67.35 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.405 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 172.992 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -81.55 109.88 16.41 Favored 'General case' 0 CA--C 1.54 0.586 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 173.803 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.512 HD23 ' HB3' ' A' ' 43' ' ' PHE . 4.2 mm? -87.76 168.98 15.2 Favored Pre-proline 0 CA--C 1.557 1.222 0 C-N-CA 123.849 0.86 . . . . 0.0 109.885 -177.065 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -53.68 129.03 31.95 Favored 'Trans proline' 0 C--N 1.397 3.101 0 C-N-CA 122.949 2.433 . . . . 0.0 113.118 -177.173 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -114.98 154.0 47.08 Favored Pre-proline 0 N--CA 1.48 1.031 0 C-N-CA 123.998 0.919 . . . . 0.0 112.466 -167.815 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.804 ' HG2' ' HB2' ' A' ' 39' ' ' TRP . 38.4 Cg_endo -70.96 148.01 56.35 Favored 'Trans proline' 0 C--N 1.377 2.054 0 C-N-CA 122.388 2.059 . . . . 0.0 110.233 166.091 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 33.2 t -64.43 -25.39 67.99 Favored 'General case' 0 N--CA 1.485 1.287 0 C-N-CA 123.595 0.758 . . . . 0.0 112.983 -169.967 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 40.7 t -81.46 -37.24 28.3 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 123.122 0.569 . . . . 0.0 110.766 177.823 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' TRP . . . . . 0.804 ' HB2' ' HG2' ' A' ' 36' ' ' PRO . 20.7 m95 -107.09 -164.99 1.03 Allowed 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 123.603 0.761 . . . . 0.0 110.639 -173.746 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.659 ' HB3' ' HB ' ' A' ' 59' ' ' VAL . 34.1 ttmt -142.7 152.64 42.58 Favored 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 171.248 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.443 ' HD3' ' CZ ' ' A' ' 58' ' ' PHE . 16.0 tptm -130.25 127.8 40.32 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 123.66 0.784 . . . . 0.0 109.983 -170.367 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.435 HD21 ' CE1' ' A' ' 44' ' ' TYR . 3.2 tt -134.48 149.72 50.74 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 114.784 -1.098 . . . . 0.0 109.302 179.254 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.512 ' HB3' HD23 ' A' ' 33' ' ' LEU . 32.6 t80 -135.34 136.97 41.95 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 125.317 1.447 . . . . 0.0 108.484 175.653 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 44' ' ' TYR . . . . . 0.435 ' CE1' HD21 ' A' ' 42' ' ' LEU . 40.5 m-85 -96.32 106.17 27.29 Favored Pre-proline 0 CA--C 1.55 0.958 0 C-N-CA 122.975 0.51 . . . . 0.0 109.661 172.025 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 45' ' ' PRO . . . . . 0.472 ' HD2' ' HA ' ' A' ' 30' ' ' SER . 94.8 Cg_endo . . . . . 0 C--N 1.374 1.883 0 C-N-CA 122.961 2.441 . . . . 0.0 112.383 172.797 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.511 ' HG3' ' O ' ' A' ' 67' ' ' SER . 1.1 pm0 . . . . . 0 CA--C 1.551 0.996 0 CA-C-O 121.491 0.662 . . . . 0.0 112.586 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 77.6 t -80.62 121.07 33.43 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 CA-C-N 115.151 -0.931 . . . . 0.0 108.54 175.18 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 40.4 t -111.64 118.97 58.84 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.572 0 C-N-CA 123.099 0.56 . . . . 0.0 109.569 -178.465 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.443 ' CZ ' ' HD3' ' A' ' 41' ' ' LYS . 36.1 m-85 -93.15 120.31 33.3 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 123.458 0.703 . . . . 0.0 109.507 171.541 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.659 ' HB ' ' HB3' ' A' ' 40' ' ' LYS . 3.3 t -79.71 126.61 39.3 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.449 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 174.027 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.581 ' HB3' ' H ' ' A' ' 64' ' ' GLU . . . -84.61 148.57 52.21 Favored Pre-proline 0 CA--C 1.541 0.616 0 CA-C-N 114.97 -1.014 . . . . 0.0 110.781 -177.488 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -63.04 -17.36 59.78 Favored 'Trans proline' 0 N--CA 1.494 1.557 0 C-N-CA 123.394 2.729 . . . . 0.0 114.143 -176.705 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 14.1 t -110.83 0.36 17.21 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 123.365 0.666 . . . . 0.0 111.738 -178.878 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 76.35 65.32 2.03 Favored Glycine 0 CA--C 1.533 1.182 0 CA-C-O 121.385 0.436 . . . . 0.0 112.064 -175.976 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.581 ' H ' ' HB3' ' A' ' 60' ' ' ALA . 39.0 tt0 -150.6 72.54 1.09 Allowed 'General case' 0 N--CA 1.474 0.746 0 N-CA-C 106.622 -1.621 . . . . 0.0 106.622 175.244 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 4.6 mp0 -66.99 155.47 38.51 Favored 'General case' 0 N--CA 1.475 0.812 0 CA-C-N 114.756 -1.111 . . . . 0.0 112.094 -165.418 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.463 HG23 ' HB2' ' A' ' 71' ' ' GLN . 48.5 mm -116.87 143.86 26.05 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.508 0 C-N-CA 124.941 1.297 . . . . 0.0 108.965 -176.741 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.511 ' O ' ' HG3' ' A' ' 55' ' ' GLU . 35.9 p -129.37 -2.8 4.95 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 122.93 0.492 . . . . 0.0 112.038 178.533 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 9.6 p30 -151.67 158.81 43.92 Favored 'General case' 0 N--CA 1.486 1.352 0 O-C-N 121.842 -0.536 . . . . 0.0 111.123 176.442 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 55.3 mtp180 -60.61 -31.84 70.99 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 123.89 0.876 . . . . 0.0 112.78 -176.64 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 2.7 tmtp? -60.69 -54.16 48.6 Favored 'General case' 0 N--CA 1.478 0.934 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 178.4 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.463 ' HB2' HG23 ' A' ' 66' ' ' ILE . 45.8 mt-30 -54.86 -40.53 69.77 Favored 'General case' 0 N--CA 1.48 1.045 0 O-C-N 124.12 0.887 . . . . 0.0 111.849 177.867 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.486 HD12 ' HB ' ' A' ' 85' ' ' ILE . 0.7 OUTLIER -64.74 -53.04 53.41 Favored 'General case' 0 N--CA 1.478 0.949 0 O-C-N 123.699 0.624 . . . . 0.0 110.074 -175.912 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -71.08 -37.23 72.45 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 123.184 0.593 . . . . 0.0 111.692 -172.374 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.98 -26.46 63.16 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 122.245 0.218 . . . . 0.0 111.049 174.653 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 20.0 t80 -65.08 -49.93 68.11 Favored 'General case' 0 N--CA 1.479 0.99 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 175.147 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.478 ' HG ' ' O ' ' A' ' 72' ' ' LEU . 68.3 mt -60.91 -47.29 87.09 Favored 'General case' 0 N--CA 1.479 0.995 0 O-C-N 123.983 0.802 . . . . 0.0 111.936 -173.91 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -69.53 -26.93 64.75 Favored 'General case' 0 CA--C 1.551 1.009 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.873 -177.846 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 59.2 m -89.0 -23.68 22.56 Favored 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 123.024 0.53 . . . . 0.0 111.792 178.177 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 92.8 m-70 -124.72 94.29 44.64 Favored Pre-proline 0 N--CA 1.474 0.731 0 C-N-CA 123.483 0.713 . . . . 0.0 109.959 -173.759 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -68.54 149.66 74.47 Favored 'Trans proline' 0 C--N 1.376 1.992 0 C-N-CA 122.707 2.272 . . . . 0.0 112.448 178.501 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 100.99 -20.08 49.28 Favored Glycine 0 C--N 1.345 1.051 0 CA-C-N 116.167 -0.47 . . . . 0.0 112.723 -178.821 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 40.6 m-80 -77.42 144.42 70.3 Favored Pre-proline 0 CA--C 1.549 0.939 0 C-N-CA 123.132 0.573 . . . . 0.0 110.4 176.527 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -74.8 158.9 42.64 Favored 'Trans proline' 0 C--N 1.374 1.913 0 C-N-CA 122.6 2.2 . . . . 0.0 112.625 177.462 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.432 ' HA ' HD13 ' A' ' 76' ' ' LEU . . . -75.03 153.69 38.33 Favored 'General case' 0 N--CA 1.477 0.89 0 CA-C-N 115.389 -0.823 . . . . 0.0 112.561 -173.045 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.486 ' HB ' HD12 ' A' ' 72' ' ' LEU . 15.9 tt -68.08 -11.64 14.55 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.335 0 C-N-CA 123.899 0.88 . . . . 0.0 111.436 179.954 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -55.68 -31.87 62.78 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 124.226 1.01 . . . . 0.0 112.262 174.138 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -98.08 -15.74 19.86 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 122.988 0.515 . . . . 0.0 111.908 176.477 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -81.27 108.86 15.26 Favored 'General case' 0 N--CA 1.484 1.241 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 177.016 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 10.3 p-10 -97.11 120.62 37.81 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-O 121.395 0.617 . . . . 0.0 110.196 -177.558 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 65.4 m95 -96.72 -9.01 29.92 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 124.053 0.941 . . . . 0.0 109.791 173.762 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 11.0 t . . . . . 0 CA--C 1.557 1.225 0 C-N-CA 125.581 1.552 . . . . 0.0 111.294 179.665 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 17.7 m . . . . . 0 CA--C 1.551 0.993 0 CA-C-O 121.464 0.65 . . . . 0.0 110.078 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 11.0 p -159.87 127.05 4.56 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 124.167 0.987 . . . . 0.0 109.425 -176.083 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 96.7 t -117.92 127.53 75.17 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 C-N-CA 123.885 0.874 . . . . 0.0 108.839 179.406 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.475 ' HA ' ' HA ' ' A' ' 42' ' ' LEU . 2.6 mp0 -87.48 117.0 25.98 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-O 121.206 0.527 . . . . 0.0 110.172 179.609 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.499 HD23 ' HB3' ' A' ' 43' ' ' PHE . 3.3 mm? -94.89 169.57 9.29 Favored Pre-proline 0 N--CA 1.491 1.583 0 C-N-CA 124.635 1.174 . . . . 0.0 110.354 -171.788 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -51.03 137.14 44.86 Favored 'Trans proline' 0 C--N 1.397 3.091 0 C-N-CA 123.195 2.597 . . . . 0.0 113.044 176.241 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -130.56 156.98 78.9 Favored Pre-proline 0 CA--C 1.544 0.725 0 C-N-CA 123.661 0.784 . . . . 0.0 112.417 -164.474 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_exo -54.62 138.07 74.67 Favored 'Trans proline' 0 C--N 1.375 1.947 0 C-N-CA 123.38 2.72 . . . . 0.0 110.786 157.354 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 57.1 p -63.15 -28.84 70.33 Favored 'General case' 0 CA--C 1.55 0.961 0 C-N-CA 123.719 0.808 . . . . 0.0 112.641 -175.146 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 35.3 t -85.16 -14.19 47.74 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 123.362 0.665 . . . . 0.0 111.765 179.356 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 16.3 m95 -122.74 -169.16 1.87 Allowed 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 124.034 0.934 . . . . 0.0 110.186 -178.815 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 28.7 mtmt -140.13 145.67 37.86 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 124.491 1.116 . . . . 0.0 108.462 169.184 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.513 ' NZ ' ' HB2' ' A' ' 43' ' ' PHE . 23.4 tptp -114.66 130.97 56.87 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 124.642 1.177 . . . . 0.0 109.349 -175.961 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.475 ' HA ' ' HA ' ' A' ' 32' ' ' GLU . 6.5 tt -128.36 149.16 50.64 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 124.478 1.111 . . . . 0.0 108.936 175.629 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.513 ' HB2' ' NZ ' ' A' ' 41' ' ' LYS . 25.9 t80 -131.32 139.71 49.61 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 125.06 1.344 . . . . 0.0 108.349 174.917 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 10.2 m-85 -103.4 98.52 12.56 Favored Pre-proline 0 CA--C 1.552 1.02 0 C-N-CA 122.944 0.498 . . . . 0.0 109.861 173.391 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo . . . . . 0 C--N 1.37 1.669 0 C-N-CA 121.963 1.775 . . . . 0.0 110.231 168.231 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 CA--C 1.551 1.018 0 CA-C-O 121.903 0.858 . . . . 0.0 112.246 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 15.3 t -82.4 138.77 18.87 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 C-N-CA 124.72 1.208 . . . . 0.0 110.417 -178.865 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.444 ' HB ' HD22 ' A' ' 42' ' ' LEU . 68.7 t -121.21 124.62 72.45 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.772 0 C-N-CA 124.173 0.989 . . . . 0.0 109.531 175.81 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.467 ' CZ ' ' HD3' ' A' ' 41' ' ' LYS . 16.0 m-85 -98.24 123.79 42.5 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 123.356 0.662 . . . . 0.0 109.904 173.179 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 3.4 t -79.17 122.73 34.99 Favored 'Isoleucine or valine' 0 C--O 1.241 0.606 0 C-N-CA 123.47 0.708 . . . . 0.0 109.359 175.936 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -81.45 154.53 71.56 Favored Pre-proline 0 CA--C 1.542 0.651 0 CA-C-N 114.238 -1.346 . . . . 0.0 110.956 -176.266 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_endo -62.17 -27.52 78.72 Favored 'Trans proline' 0 C--N 1.375 1.955 0 C-N-CA 122.759 2.306 . . . . 0.0 112.947 178.939 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.403 HG22 ' OH ' ' A' ' 75' ' ' TYR . 12.4 t -96.89 -7.71 32.69 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 122.72 0.408 . . . . 0.0 111.085 177.309 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 93.99 -1.04 67.42 Favored Glycine 0 C--N 1.353 1.483 0 CA-C-O 119.866 -0.408 . . . . 0.0 113.957 178.816 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -78.79 73.27 5.34 Favored 'General case' 0 N--CA 1.479 0.982 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 174.477 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -67.76 158.43 32.42 Favored 'General case' 0 C--N 1.35 0.594 0 CA-C-N 114.98 -1.009 . . . . 0.0 112.01 -168.777 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 47.3 mm -116.04 125.44 73.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 C-N-CA 124.707 1.203 . . . . 0.0 109.354 -166.879 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 12.3 p -110.93 5.36 20.38 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 123.645 0.778 . . . . 0.0 112.797 -175.184 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 11.2 p30 -163.31 164.56 24.82 Favored 'General case' 0 N--CA 1.486 1.335 0 C-N-CA 122.988 0.515 . . . . 0.0 110.393 172.085 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 19.7 ttp180 -63.67 -34.42 77.82 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 123.683 0.793 . . . . 0.0 112.218 -171.856 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 8.2 tmtm? -60.86 -50.41 73.54 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 123.434 0.694 . . . . 0.0 109.828 179.015 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 75.5 mt-30 -55.84 -34.89 65.82 Favored 'General case' 0 N--CA 1.477 0.917 0 O-C-N 124.288 0.993 . . . . 0.0 111.406 179.123 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.424 ' O ' ' HG ' ' A' ' 76' ' ' LEU . 0.5 OUTLIER -65.33 -54.95 21.44 Favored 'General case' 0 CA--C 1.547 0.858 0 N-CA-C 109.489 -0.559 . . . . 0.0 109.489 179.559 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -59.86 -47.16 86.86 Favored 'General case' 0 N--CA 1.486 1.364 0 C-N-CA 124.19 0.996 . . . . 0.0 111.633 -175.117 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 5.3 pp0? -68.15 -30.77 69.98 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.374 -179.308 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' TYR . . . . . 0.403 ' OH ' HG22 ' A' ' 62' ' ' THR . 32.9 t80 -65.83 -45.17 83.22 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 123.248 0.619 . . . . 0.0 109.523 176.732 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.424 ' HG ' ' O ' ' A' ' 72' ' ' LEU . 69.9 mt -63.14 -44.09 96.54 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 123.108 0.563 . . . . 0.0 111.655 -176.115 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.92 -19.39 58.84 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 122.806 0.442 . . . . 0.0 111.414 -179.842 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 46.1 t -91.62 -12.31 34.61 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 123.236 0.615 . . . . 0.0 111.382 174.006 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 57.7 m-70 -133.55 83.51 48.47 Favored Pre-proline 0 CA--C 1.551 1.007 0 C-N-CA 123.462 0.705 . . . . 0.0 109.631 -179.402 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -65.73 128.62 20.35 Favored 'Trans proline' 0 C--N 1.379 2.143 0 C-N-CA 122.802 2.334 . . . . 0.0 112.065 176.691 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 124.01 -22.53 6.75 Favored Glycine 0 C--N 1.342 0.91 0 CA-C-N 115.76 -0.655 . . . . 0.0 111.837 -177.96 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 83.4 m-20 -74.25 151.85 87.99 Favored Pre-proline 0 CA--C 1.553 1.072 0 C-N-CA 123.064 0.546 . . . . 0.0 110.785 177.379 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -69.61 160.45 49.7 Favored 'Trans proline' 0 C--N 1.375 1.927 0 C-N-CA 122.73 2.287 . . . . 0.0 112.853 178.887 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -75.82 148.71 38.19 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 123.565 0.746 . . . . 0.0 111.167 -176.299 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 16.1 tt -65.63 -12.53 14.01 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.383 0 C-N-CA 123.729 0.811 . . . . 0.0 112.371 -177.59 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -57.97 -35.46 71.21 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 124.49 1.116 . . . . 0.0 112.215 176.156 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -91.03 -11.88 37.47 Favored 'General case' 0 N--CA 1.485 1.282 0 N-CA-C 112.38 0.511 . . . . 0.0 112.38 177.883 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 4.9 m-85 -76.16 108.55 9.16 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 177.259 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 4.5 t0 -86.97 102.24 14.19 Favored 'General case' 0 CA--C 1.541 0.635 0 CA-C-N 115.995 -0.548 . . . . 0.0 109.964 -173.0 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 82.1 m95 -89.6 -31.94 17.34 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 123.746 0.819 . . . . 0.0 109.99 174.251 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 8.9 t . . . . . 0 CA--C 1.557 1.215 0 C-N-CA 124.059 0.944 . . . . 0.0 112.532 -172.373 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 21.0 m . . . . . 0 N--CA 1.476 0.836 0 CA-C-O 121.222 0.534 . . . . 0.0 110.325 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 58.5 p -140.46 123.74 16.79 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 123.826 0.85 . . . . 0.0 109.49 177.569 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 48.5 t -110.83 124.45 67.64 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 C-N-CA 124.184 0.994 . . . . 0.0 109.464 178.559 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 53.4 mt-10 -80.9 104.08 11.16 Favored 'General case' 0 CA--C 1.545 0.76 0 CA-C-O 121.235 0.54 . . . . 0.0 110.188 176.758 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.459 HD23 ' HB3' ' A' ' 43' ' ' PHE . 3.9 mm? -79.32 163.3 60.16 Favored Pre-proline 0 CA--C 1.564 1.519 0 C-N-CA 124.881 1.272 . . . . 0.0 110.409 177.573 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo -60.04 145.51 98.23 Favored 'Trans proline' 0 C--N 1.391 2.769 0 C-N-CA 122.741 2.294 . . . . 0.0 114.157 -174.467 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.536 ' HB2' ' HB3' ' A' ' 41' ' ' LYS . . . -157.29 163.06 26.19 Favored Pre-proline 0 CA--C 1.542 0.671 0 C-N-CA 124.18 0.992 . . . . 0.0 110.839 -172.2 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_exo -52.73 147.66 30.76 Favored 'Trans proline' 0 C--N 1.379 2.139 0 C-N-CA 123.004 2.469 . . . . 0.0 112.122 164.319 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 37.4 p -71.42 -15.22 62.34 Favored 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 123.519 0.728 . . . . 0.0 111.929 -176.818 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 42.7 t -75.93 -34.85 59.9 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 123.585 0.754 . . . . 0.0 110.19 172.007 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 28.2 m95 -109.83 -169.93 1.56 Allowed 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 123.883 0.873 . . . . 0.0 110.86 -175.515 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.733 ' HB3' ' HB ' ' A' ' 59' ' ' VAL . 1.7 tpmt? -148.35 144.64 27.67 Favored 'General case' 0 CA--C 1.533 0.327 0 CA-C-N 114.939 -1.028 . . . . 0.0 108.266 166.821 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.536 ' HB3' ' HB2' ' A' ' 35' ' ' ALA . 19.6 tptp -112.74 115.48 28.59 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 177.183 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.426 HD22 ' HB ' ' A' ' 57' ' ' VAL . 7.3 tt -111.43 139.78 46.56 Favored 'General case' 0 C--N 1.319 -0.748 0 C-N-CA 124.518 1.127 . . . . 0.0 108.262 174.635 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.459 ' HB3' HD23 ' A' ' 33' ' ' LEU . 38.1 t80 -125.74 135.57 52.21 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 124.619 1.168 . . . . 0.0 107.9 173.286 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 8.6 m-85 -94.24 103.02 9.56 Favored Pre-proline 0 CA--C 1.55 0.969 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 172.812 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo . . . . . 0 C--N 1.374 1.905 0 C-N-CA 122.951 2.434 . . . . 0.0 111.792 172.752 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 CA--C 1.554 1.13 0 CA-C-O 121.657 0.741 . . . . 0.0 112.085 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 48.1 t -82.58 140.09 16.88 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.594 0 C-N-CA 124.909 1.284 . . . . 0.0 110.578 -179.157 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.426 ' HB ' HD22 ' A' ' 42' ' ' LEU . 81.6 t -123.97 130.69 73.76 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.682 0 C-N-CA 124.079 0.951 . . . . 0.0 109.062 173.022 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 16.2 m-85 -102.03 122.22 43.68 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 123.198 0.599 . . . . 0.0 109.504 171.228 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.733 ' HB ' ' HB3' ' A' ' 40' ' ' LYS . 4.3 t -81.15 130.52 35.72 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 173.122 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -95.06 155.65 38.76 Favored Pre-proline 0 CA--C 1.548 0.87 0 C-N-CA 124.167 0.987 . . . . 0.0 110.754 -176.175 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -66.01 -8.19 19.24 Favored 'Trans proline' 0 C--N 1.38 2.236 0 C-N-CA 123.067 2.511 . . . . 0.0 114.202 -177.259 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 9.6 t -120.98 12.66 11.23 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 123.602 0.761 . . . . 0.0 111.412 -175.174 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 81.03 -22.83 4.79 Favored Glycine 0 C--N 1.353 1.494 0 N-CA-C 114.531 0.572 . . . . 0.0 114.531 179.336 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 49.7 tt0 -72.84 75.0 1.15 Allowed 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 124.551 1.14 . . . . 0.0 109.487 177.626 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -80.97 157.98 25.34 Favored 'General case' 0 N--CA 1.476 0.839 0 CA-C-N 115.287 -0.87 . . . . 0.0 111.707 -168.785 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 42.5 mm -107.9 139.84 28.49 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.755 0 C-N-CA 124.905 1.282 . . . . 0.0 110.379 -173.35 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 16.3 p -108.33 -9.84 15.42 Favored 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 123.584 0.754 . . . . 0.0 112.66 -179.885 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 13.1 p-10 -160.74 162.64 32.53 Favored 'General case' 0 N--CA 1.486 1.337 0 N-CA-C 112.348 0.499 . . . . 0.0 112.348 -168.378 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 3.8 ttm180 -59.92 -41.33 91.49 Favored 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 124.613 1.165 . . . . 0.0 112.17 -170.789 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 7.4 tmtm? -60.91 -54.43 45.12 Favored 'General case' 0 N--CA 1.478 0.929 0 CA-C-N 115.145 -0.934 . . . . 0.0 109.507 -176.622 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.415 ' HA ' ' HG3' ' A' ' 74' ' ' GLN . 87.3 mm-40 -64.2 -25.17 67.95 Favored 'General case' 0 N--CA 1.475 0.797 0 O-C-N 124.03 0.831 . . . . 0.0 111.45 -176.676 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.418 ' O ' ' HG ' ' A' ' 76' ' ' LEU . 0.6 OUTLIER -66.52 -52.67 43.32 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 123.375 0.67 . . . . 0.0 109.224 175.88 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -64.08 -50.54 67.92 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 123.634 0.774 . . . . 0.0 111.363 -175.602 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 74' ' ' GLN . . . . . 0.415 ' HG3' ' HA ' ' A' ' 71' ' ' GLN . 0.0 OUTLIER -66.16 -23.92 66.55 Favored 'General case' 0 CA--C 1.547 0.861 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.365 179.582 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 38.5 t80 -66.88 -51.79 51.2 Favored 'General case' 0 C--O 1.212 -0.873 0 C-N-CA 122.92 0.488 . . . . 0.0 109.736 171.703 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.418 ' HG ' ' O ' ' A' ' 72' ' ' LEU . 83.1 mt -62.51 -37.78 87.35 Favored 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 123.225 0.61 . . . . 0.0 112.495 -172.105 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.77 -26.57 57.49 Favored 'General case' 0 CA--C 1.553 1.072 0 CA-C-O 120.83 0.347 . . . . 0.0 110.95 178.033 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 41.6 t -83.19 -26.68 30.62 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 123.203 0.601 . . . . 0.0 111.044 175.834 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 53.6 m80 -125.7 89.54 52.24 Favored Pre-proline 0 C--O 1.241 0.613 0 C-N-CA 124.395 1.078 . . . . 0.0 108.594 -173.447 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -68.67 164.85 31.53 Favored 'Trans proline' 0 C--N 1.369 1.62 0 C-N-CA 122.311 2.007 . . . . 0.0 111.666 176.076 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 89.81 -29.46 6.34 Favored Glycine 0 CA--C 1.532 1.123 0 CA-C-N 116.468 -0.333 . . . . 0.0 112.678 -176.049 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 36.1 m-80 -71.73 141.05 84.39 Favored Pre-proline 0 CA--C 1.549 0.932 0 C-N-CA 123.871 0.868 . . . . 0.0 110.778 178.828 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -67.02 163.03 35.51 Favored 'Trans proline' 0 C--N 1.374 1.895 0 C-N-CA 123.114 2.543 . . . . 0.0 112.863 179.959 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -74.7 161.03 30.03 Favored 'General case' 0 N--CA 1.488 1.442 0 C-N-CA 124.017 0.927 . . . . 0.0 112.266 -170.317 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 16.3 tt -78.71 -19.93 13.1 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.253 0 CA-C-O 120.808 0.337 . . . . 0.0 111.158 179.283 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -61.89 -38.17 87.32 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 123.344 0.658 . . . . 0.0 111.777 177.991 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -83.89 -9.75 58.5 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 123.282 0.633 . . . . 0.0 111.51 179.322 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 5.5 m-30 -82.62 129.69 34.99 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 123.397 0.679 . . . . 0.0 110.17 177.769 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -84.57 125.79 32.75 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 123.893 0.877 . . . . 0.0 110.32 177.568 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 86.2 m95 -118.43 -11.56 9.97 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 123.969 0.908 . . . . 0.0 109.439 168.203 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 13.7 t . . . . . 0 CA--C 1.555 1.15 0 C-N-CA 124.371 1.069 . . . . 0.0 112.571 -163.728 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.2 mpt? . . . . . 0 N--CA 1.478 0.938 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 35.2 m170 -129.6 -55.91 1.15 Allowed 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 123.802 0.841 . . . . 0.0 109.704 178.094 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 20.3 m-70 61.31 84.44 0.13 Allowed 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 124.453 1.101 . . . . 0.0 111.251 -176.221 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 9.9 t-160 -106.1 119.28 38.8 Favored 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 179.122 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 51.3 t-80 -109.39 143.3 39.14 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 123.95 0.9 . . . . 0.0 110.149 -174.839 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 37.1 m170 -130.1 174.0 10.21 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 124.436 1.094 . . . . 0.0 110.204 175.934 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 56.3 p-80 -158.54 125.94 5.0 Favored 'General case' 0 CA--C 1.545 0.767 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 169.78 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 38.8 p -157.12 118.47 3.7 Favored 'General case' 0 C--O 1.238 0.467 0 C-N-CA 124.058 0.943 . . . . 0.0 109.096 179.077 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 26.0 m -87.95 -0.94 57.64 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 123.071 0.549 . . . . 0.0 111.036 178.757 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 106.63 -89.37 0.59 Allowed Glycine 0 C--N 1.348 1.203 0 CA-C-N 115.869 -0.605 . . . . 0.0 112.499 178.011 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 14.8 mmt85 -87.86 158.27 18.76 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 123.54 0.736 . . . . 0.0 110.972 -175.07 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.428 ' HG2' HD12 ' A' ' 14' ' ' LEU . 31.2 tt0 -130.99 77.04 1.76 Allowed 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 124.14 0.976 . . . . 0.0 108.421 176.279 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 28.0 t-20 -95.1 107.23 19.29 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-N 115.603 -0.726 . . . . 0.0 109.895 -179.685 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.428 HD12 ' HG2' ' A' ' 12' ' ' GLU . 0.0 OUTLIER -157.09 151.02 24.66 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 124.352 1.061 . . . . 0.0 108.802 -179.477 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 70.2 m-85 -132.13 109.48 10.0 Favored 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 123.239 0.615 . . . . 0.0 110.562 -172.793 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 59.7 t80 -96.85 38.05 1.25 Allowed 'General case' 0 CA--C 1.555 1.145 0 CA-C-O 122.598 1.189 . . . . 0.0 108.44 170.614 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 64.8 mm-40 -98.14 21.22 11.14 Favored 'General case' 0 N--CA 1.477 0.876 0 CA-C-N 115.347 -0.842 . . . . 0.0 111.341 -169.907 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -80.19 19.22 6.93 Favored Glycine 0 C--N 1.348 1.219 0 CA-C-N 116.302 -0.408 . . . . 0.0 114.068 -179.453 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 48.6 m-70 -109.49 119.79 40.53 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 123.838 0.855 . . . . 0.0 108.79 175.777 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 27.1 ptt? -75.83 -16.68 60.04 Favored 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 123.358 0.663 . . . . 0.0 111.075 175.374 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . 65.81 179.59 0.2 Allowed 'General case' 0 C--N 1.362 1.11 0 C-N-CA 125.315 1.446 . . . . 0.0 111.786 -177.367 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 16.9 t 61.01 -152.3 0.39 Allowed 'General case' 0 CA--C 1.56 1.336 0 C-N-CA 124.309 1.044 . . . . 0.0 111.057 178.219 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 99.55 8.06 52.89 Favored Glycine 0 C--N 1.35 1.317 0 N-CA-C 112.436 -0.266 . . . . 0.0 112.436 -179.107 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 13.8 m -93.26 166.12 12.47 Favored 'General case' 0 C--O 1.245 0.86 0 C-N-CA 123.755 0.822 . . . . 0.0 109.661 174.641 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -69.9 109.44 4.47 Favored 'General case' 0 N--CA 1.473 0.694 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 175.491 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -81.29 162.16 23.6 Favored 'General case' 0 CA--C 1.55 0.957 0 C-N-CA 123.349 0.66 . . . . 0.0 109.464 178.368 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 67.78 42.46 1.96 Allowed 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 124.63 1.172 . . . . 0.0 109.992 -179.607 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 5.7 m -98.97 126.18 52.25 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.08 0 CA-C-N 114.616 -1.174 . . . . 0.0 109.019 172.534 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 30.4 m -71.68 135.11 28.63 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.98 0 C-N-CA 123.722 0.809 . . . . 0.0 111.907 -172.376 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 60.9 p -143.69 129.35 19.21 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 123.526 0.731 . . . . 0.0 109.709 179.021 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 99.4 t -108.32 125.44 65.06 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 C-N-CA 124.337 1.055 . . . . 0.0 108.565 175.651 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -79.87 110.38 15.18 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 176.959 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.491 ' HB2' ' HG3' ' A' ' 41' ' ' LYS . 3.9 mm? -85.8 162.06 48.47 Favored Pre-proline 0 N--CA 1.485 1.29 0 C-N-CA 124.145 0.978 . . . . 0.0 109.399 178.959 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_endo -62.08 155.93 52.98 Favored 'Trans proline' 0 C--N 1.388 2.651 0 C-N-CA 122.628 2.219 . . . . 0.0 113.407 -179.667 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.472 ' HB2' ' CB ' ' A' ' 41' ' ' LYS . . . -161.65 171.2 7.08 Favored Pre-proline 0 N--CA 1.48 1.064 0 C-N-CA 123.741 0.816 . . . . 0.0 111.307 -171.11 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 13.7 Cg_endo -57.02 137.82 83.63 Favored 'Trans proline' 0 C--N 1.384 2.422 0 C-N-CA 122.053 1.835 . . . . 0.0 110.053 158.456 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 24.8 m -67.87 -15.9 63.84 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 123.601 0.76 . . . . 0.0 112.042 -176.383 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 17.8 p -69.15 -39.57 78.74 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 123.956 0.902 . . . . 0.0 110.455 172.646 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 25.5 m95 -105.03 -168.38 1.46 Allowed 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 123.92 0.888 . . . . 0.0 110.179 177.24 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.662 ' HB3' ' HB ' ' A' ' 59' ' ' VAL . 14.2 tppt? -143.77 144.2 31.7 Favored 'General case' 0 C--O 1.234 0.246 0 N-CA-C 107.581 -1.266 . . . . 0.0 107.581 167.93 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.515 ' NZ ' ' HB2' ' A' ' 43' ' ' PHE . 24.6 tptp -108.85 125.4 51.94 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 177.818 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 6.6 tt -122.41 141.76 51.25 Favored 'General case' 0 C--N 1.322 -0.622 0 C-N-CA 124.31 1.044 . . . . 0.0 108.259 174.894 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.515 ' HB2' ' NZ ' ' A' ' 41' ' ' LYS . 29.1 t80 -123.84 136.18 54.22 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 171.184 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' TYR . . . . . 0.529 ' HB3' ' HB ' ' A' ' 54' ' ' THR . 10.5 m-85 -96.03 100.84 7.17 Favored Pre-proline 0 CA--C 1.546 0.811 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 169.363 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 65.8 Cg_endo -80.65 -178.71 4.62 Favored 'Trans proline' 0 C--N 1.371 1.761 0 C-N-CA 122.329 2.019 . . . . 0.0 111.646 173.485 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 12.0 t-20 -153.35 -84.39 0.07 Allowed 'General case' 0 CA--C 1.538 0.494 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 172.536 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 67.0 mttm -135.65 -79.08 0.43 Allowed 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 123.255 0.622 . . . . 0.0 109.609 179.802 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 59.5 t -128.38 -72.34 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.055 0 N-CA-C 109.287 -0.634 . . . . 0.0 109.287 -178.329 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -171.97 -39.45 0.03 OUTLIER Glycine 0 C--N 1.354 1.568 0 C-N-CA 121.702 -0.285 . . . . 0.0 112.724 -176.918 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 50.0 m -80.83 60.04 3.94 Favored 'General case' 0 N--CA 1.486 1.325 0 C-N-CA 123.769 0.827 . . . . 0.0 110.381 176.956 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.405 HG23 ' HB2' ' A' ' 53' ' ' LYS . 9.5 m -143.53 -173.09 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.934 0 C-N-CA 125.384 1.474 . . . . 0.0 108.835 -176.899 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -59.34 -60.84 3.21 Favored 'General case' 0 N--CA 1.478 0.954 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 173.266 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.405 ' HB2' HG23 ' A' ' 51' ' ' VAL . 77.1 tttt 64.04 151.0 0.04 OUTLIER 'General case' 0 CA--C 1.558 1.285 0 C-N-CA 124.448 1.099 . . . . 0.0 112.906 173.096 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.529 ' HB ' ' HB3' ' A' ' 44' ' ' TYR . 8.3 m -132.31 158.71 41.18 Favored 'General case' 0 CA--C 1.554 1.125 0 N-CA-C 107.66 -1.237 . . . . 0.0 107.66 169.635 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -92.56 -168.19 1.91 Allowed 'General case' 0 N--CA 1.481 1.078 0 CA-C-O 121.409 0.623 . . . . 0.0 111.496 -174.86 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 42.9 t -82.66 137.36 21.17 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.723 0 C-N-CA 124.841 1.257 . . . . 0.0 110.661 -179.578 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 86.2 t -126.67 125.34 66.85 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.883 0 C-N-CA 124.224 1.01 . . . . 0.0 108.751 173.138 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.483 ' CZ ' ' HD3' ' A' ' 41' ' ' LYS . 14.0 m-85 -94.67 124.0 38.44 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 123.185 0.594 . . . . 0.0 109.65 172.254 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.662 ' HB ' ' HB3' ' A' ' 40' ' ' LYS . 6.0 t -80.88 128.82 38.4 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.522 0 C-N-CA 123.493 0.717 . . . . 0.0 109.681 174.648 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -87.27 153.16 53.61 Favored Pre-proline 0 CA--C 1.543 0.674 0 CA-C-N 115.079 -0.964 . . . . 0.0 110.429 -178.372 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_endo -63.03 -20.84 72.45 Favored 'Trans proline' 0 C--N 1.375 1.958 0 C-N-CA 123.213 2.609 . . . . 0.0 113.514 178.68 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.446 HG23 ' H ' ' A' ' 64' ' ' GLU . 10.5 t -101.83 -4.22 26.67 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 123.837 0.855 . . . . 0.0 111.834 178.956 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 91.31 -9.62 76.97 Favored Glycine 0 C--N 1.352 1.439 0 CA-C-O 119.895 -0.392 . . . . 0.0 113.728 -178.79 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.446 ' H ' HG23 ' A' ' 62' ' ' THR . 34.6 tt0 -76.98 73.42 3.57 Favored 'General case' 0 N--CA 1.486 1.35 0 CA-C-O 122.03 0.919 . . . . 0.0 109.248 178.207 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -72.65 159.82 33.25 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 114.384 -1.28 . . . . 0.0 112.239 -166.954 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.485 HG23 ' HB2' ' A' ' 71' ' ' GLN . 45.8 mm -115.24 123.32 70.71 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.676 0 C-N-CA 125.041 1.337 . . . . 0.0 109.588 -173.412 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 17.4 m -94.18 -22.22 18.57 Favored 'General case' 0 N--CA 1.486 1.331 0 C-N-CA 122.957 0.503 . . . . 0.0 112.096 -176.718 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 7.2 p30 -148.59 155.08 40.63 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 123.032 0.533 . . . . 0.0 110.373 -172.799 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 74.0 ttt-85 -62.4 -31.35 72.02 Favored 'General case' 0 CA--C 1.554 1.117 0 C-N-CA 124.67 1.188 . . . . 0.0 113.682 -166.221 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 1.6 tmtp? -61.85 -46.89 87.48 Favored 'General case' 0 N--CA 1.486 1.355 0 C-N-CA 123.243 0.617 . . . . 0.0 109.627 177.519 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.485 ' HB2' HG23 ' A' ' 66' ' ' ILE . 96.7 mt-30 -61.0 -27.53 68.38 Favored 'General case' 0 N--CA 1.484 1.234 0 CA-C-N 115.646 -0.707 . . . . 0.0 111.599 -178.835 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.427 ' O ' ' HG ' ' A' ' 76' ' ' LEU . 0.6 OUTLIER -67.47 -53.83 25.44 Favored 'General case' 0 N--CA 1.477 0.893 0 O-C-N 123.883 0.739 . . . . 0.0 109.248 179.44 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -60.75 -47.28 87.01 Favored 'General case' 0 N--CA 1.485 1.31 0 C-N-CA 123.621 0.768 . . . . 0.0 111.669 -176.964 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 5.2 pp0? -68.99 -25.33 64.47 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.199 179.516 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 42.2 t80 -67.13 -50.97 59.54 Favored 'General case' 0 N--CA 1.475 0.813 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 174.858 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.427 ' HG ' ' O ' ' A' ' 72' ' ' LEU . 69.7 mt -62.29 -42.13 99.09 Favored 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 123.371 0.669 . . . . 0.0 111.935 -173.267 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -70.18 -26.64 64.0 Favored 'General case' 0 N--CA 1.478 0.965 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.973 178.987 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 48.6 m -92.99 -12.27 31.11 Favored 'General case' 0 N--CA 1.493 1.701 0 C-N-CA 123.34 0.656 . . . . 0.0 111.739 177.463 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 64.8 m80 -135.47 84.19 35.1 Favored Pre-proline 0 N--CA 1.484 1.227 0 C-N-CA 123.965 0.906 . . . . 0.0 109.409 -176.268 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -68.45 147.93 72.2 Favored 'Trans proline' 0 C--N 1.377 2.06 0 C-N-CA 122.608 2.206 . . . . 0.0 111.498 175.818 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 107.12 -31.51 8.08 Favored Glycine 0 C--N 1.341 0.861 0 N-CA-C 111.198 -0.761 . . . . 0.0 111.198 -172.967 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 40.4 m-80 -76.55 136.45 67.82 Favored Pre-proline 0 N--CA 1.48 1.025 0 C-N-CA 123.324 0.65 . . . . 0.0 110.085 177.364 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -66.91 162.38 38.1 Favored 'Trans proline' 0 C--N 1.38 2.195 0 C-N-CA 123.108 2.539 . . . . 0.0 113.141 -176.38 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -75.28 149.65 38.74 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-N 115.021 -0.99 . . . . 0.0 111.895 -172.878 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.4 ' HB ' HD12 ' A' ' 72' ' ' LEU . 15.8 tt -66.29 -11.81 13.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 C-N-CA 124.155 0.982 . . . . 0.0 111.814 -176.986 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -54.26 -41.93 69.36 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 123.95 0.9 . . . . 0.0 111.848 172.685 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -92.79 4.76 53.21 Favored 'General case' 0 N--CA 1.481 1.115 0 N-CA-C 112.089 0.403 . . . . 0.0 112.089 179.783 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -94.76 109.97 21.88 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 123.346 0.658 . . . . 0.0 109.545 176.85 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -84.43 85.96 7.33 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 123.981 0.912 . . . . 0.0 111.292 -176.155 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 93.5 m95 -77.85 -27.07 49.73 Favored 'General case' 0 CA--C 1.547 0.841 0 CA-C-N 115.341 -0.845 . . . . 0.0 109.909 169.179 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 14.7 t -86.58 11.52 12.57 Favored 'General case' 0 CA--C 1.557 1.224 0 C-N-CA 124.529 1.132 . . . . 0.0 112.252 -175.582 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 12.8 t -63.18 -24.97 68.13 Favored 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 123.346 0.658 . . . . 0.0 111.68 176.477 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 12.9 p -83.75 -30.58 26.55 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 124.453 1.101 . . . . 0.0 111.354 -179.521 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -106.28 -126.69 5.7 Favored Glycine 0 C--N 1.35 1.361 0 N-CA-C 111.773 -0.531 . . . . 0.0 111.773 -178.511 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 30.4 p . . . . . 0 C--O 1.25 1.092 0 C-N-CA 124.044 0.938 . . . . 0.0 109.611 -179.079 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 48.5 ttm . . . . . 0 N--CA 1.477 0.913 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 8.1 p80 -147.09 145.8 29.74 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 123.141 0.577 . . . . 0.0 109.985 -178.792 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 53.9 t-80 -153.9 -50.44 0.09 Allowed 'General case' 0 N--CA 1.47 0.529 0 N-CA-C 107.75 -1.204 . . . . 0.0 107.75 172.035 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 74.2 m-70 69.73 153.68 0.11 Allowed 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 124.775 1.23 . . . . 0.0 112.361 174.137 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 21.5 m80 -152.09 140.62 20.68 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 124.805 1.242 . . . . 0.0 109.382 177.01 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 17.3 m-70 -83.35 90.09 7.11 Favored 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 171.053 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 25.9 t-80 -80.28 113.22 18.29 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 115.303 -0.862 . . . . 0.0 109.876 179.551 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 33.4 t -85.31 179.67 7.14 Favored 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 123.729 0.811 . . . . 0.0 109.753 172.629 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 49.1 m -130.58 132.65 45.65 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 123.357 0.663 . . . . 0.0 110.035 -179.629 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -72.72 143.25 33.47 Favored Glycine 0 C--N 1.348 1.236 0 O-C-N 123.549 0.531 . . . . 0.0 112.805 -179.259 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 24.4 mmt85 -92.0 112.24 24.1 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 123.721 0.808 . . . . 0.0 109.444 -177.078 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -78.0 83.82 4.29 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 123.262 0.625 . . . . 0.0 109.832 179.873 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 6.7 t30 -86.81 78.55 9.05 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.644 -172.794 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -171.14 154.67 4.12 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 124.537 1.135 . . . . 0.0 109.484 171.538 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 6.3 p90 -75.93 94.89 3.44 Favored 'General case' 0 CA--C 1.546 0.811 0 CA-C-O 121.696 0.76 . . . . 0.0 109.404 175.067 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 16.2 t80 -89.47 23.05 2.71 Favored 'General case' 0 N--CA 1.484 1.267 0 CA-C-O 121.216 0.532 . . . . 0.0 110.738 -177.661 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 19.3 pt20 -66.81 -36.21 81.84 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 123.652 0.781 . . . . 0.0 111.221 174.636 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 75.89 153.45 4.42 Favored Glycine 0 C--N 1.352 1.445 0 CA-C-N 116.081 -0.509 . . . . 0.0 113.084 -175.063 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 14.6 t60 -104.94 128.94 53.41 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 175.445 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 26.6 ttt -146.29 119.32 8.79 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 123.397 0.679 . . . . 0.0 109.866 177.809 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -77.26 127.27 32.32 Favored 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 171.381 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 22.7 t -152.31 170.87 19.0 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 122.906 0.482 . . . . 0.0 110.851 -177.094 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 85.8 -79.35 1.88 Allowed Glycine 0 C--N 1.349 1.284 0 CA-C-N 116.046 -0.524 . . . . 0.0 111.935 -178.921 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 27.1 m -71.5 -28.56 64.0 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 123.49 0.716 . . . . 0.0 111.743 -178.267 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -78.47 86.43 4.5 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 123.008 0.523 . . . . 0.0 110.42 -178.439 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 59.58 -87.49 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 124.759 1.224 . . . . 0.0 111.895 175.628 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER 55.03 69.98 0.67 Allowed 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 125.081 1.352 . . . . 0.0 109.989 -178.74 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 22.0 m -107.68 160.48 6.82 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.052 0 C-N-CA 124.188 0.995 . . . . 0.0 110.993 -173.99 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 28.1 m -83.91 147.9 5.4 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.047 0 C-N-CA 122.959 0.503 . . . . 0.0 111.313 -179.458 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.401 ' HA ' ' HD2' ' A' ' 45' ' ' PRO . 36.6 p -157.64 122.37 4.37 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 124.317 1.047 . . . . 0.0 108.694 177.359 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 65.5 t -103.34 123.97 57.21 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 C-N-CA 123.885 0.874 . . . . 0.0 109.075 -177.121 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -83.38 114.63 21.57 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 123.08 0.552 . . . . 0.0 110.396 177.476 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.472 HD23 ' HB3' ' A' ' 43' ' ' PHE . 4.5 mm? -92.19 168.88 11.92 Favored Pre-proline 0 CA--C 1.562 1.438 0 C-N-CA 124.44 1.096 . . . . 0.0 109.766 -179.712 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -57.37 143.12 94.8 Favored 'Trans proline' 0 C--N 1.39 2.755 0 C-N-CA 122.739 2.293 . . . . 0.0 115.13 -177.967 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.755 ' HB2' ' HB3' ' A' ' 41' ' ' LYS . . . -144.97 167.07 15.57 Favored Pre-proline 0 N--CA 1.484 1.272 0 C-N-CA 124.648 1.179 . . . . 0.0 111.349 -177.501 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.587 ' HG2' ' HB2' ' A' ' 39' ' ' TRP . 31.3 Cg_endo -63.95 162.79 27.69 Favored 'Trans proline' 0 C--N 1.382 2.314 0 C-N-CA 122.645 2.23 . . . . 0.0 111.522 161.22 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 25.2 p -71.93 -24.77 61.68 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 123.52 0.728 . . . . 0.0 112.28 -176.756 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 45.7 m -75.38 -28.64 59.57 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 122.871 0.468 . . . . 0.0 111.319 176.107 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' TRP . . . . . 0.587 ' HB2' ' HG2' ' A' ' 36' ' ' PRO . 36.0 m95 -111.76 175.83 5.27 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 123.692 0.797 . . . . 0.0 110.563 -176.134 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 19.9 mtmt -140.92 128.34 21.2 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 165.5 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.755 ' HB3' ' HB2' ' A' ' 35' ' ' ALA . 13.6 tptm -99.95 126.49 46.12 Favored 'General case' 0 C--N 1.32 -0.679 0 C-N-CA 125.527 1.531 . . . . 0.0 108.502 -174.934 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 6.9 tt -129.07 132.52 47.45 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 114.495 -1.23 . . . . 0.0 107.84 178.867 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.472 ' HB3' HD23 ' A' ' 33' ' ' LEU . 28.9 t80 -110.84 141.93 43.55 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 124.148 0.979 . . . . 0.0 108.785 170.833 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -102.18 99.19 11.9 Favored Pre-proline 0 CA--C 1.55 0.945 0 C-N-CA 123.344 0.658 . . . . 0.0 110.064 174.038 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.401 ' HD2' ' HA ' ' A' ' 30' ' ' SER . 83.4 Cg_endo -79.83 141.54 15.25 Favored 'Trans proline' 0 C--N 1.377 2.035 0 C-N-CA 122.626 2.217 . . . . 0.0 111.114 171.057 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' ASN . . . . . 0.531 HD22 ' HB3' ' A' ' 53' ' ' LYS . 9.0 p30 -85.69 162.2 18.87 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 110.077 -0.342 . . . . 0.0 110.077 176.938 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 93.1 mttt -65.01 -40.37 94.81 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 123.679 0.792 . . . . 0.0 112.115 -172.347 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.434 ' HB ' HG22 ' A' ' 51' ' ' VAL . 53.2 t -72.93 -34.42 46.15 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.195 0 C-N-CA 123.589 0.756 . . . . 0.0 110.724 179.421 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 92.6 -50.71 2.63 Favored Glycine 0 CA--C 1.532 1.137 0 CA-C-N 115.392 -0.822 . . . . 0.0 112.47 -172.575 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 38.3 m -79.34 -27.76 42.03 Favored 'General case' 0 N--CA 1.479 0.986 0 N-CA-C 113.395 0.887 . . . . 0.0 113.395 -171.642 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.434 HG22 ' HB ' ' A' ' 48' ' ' VAL . 25.2 m -88.85 -167.26 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 N-CA-C 112.335 0.494 . . . . 0.0 112.335 -170.894 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 94.9 mttt -56.96 138.86 53.56 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 124.172 0.989 . . . . 0.0 111.898 179.176 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.537 ' HE3' ' H ' ' A' ' 53' ' ' LYS . 0.0 OUTLIER -140.17 154.84 47.08 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 124.126 0.97 . . . . 0.0 108.818 179.213 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 50.6 m -71.94 138.97 48.46 Favored 'General case' 0 C--O 1.243 0.752 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 171.901 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -69.07 -172.97 0.45 Allowed 'General case' 0 C--O 1.243 0.731 0 CA-C-O 121.995 0.903 . . . . 0.0 110.911 179.273 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 48.2 t -81.67 138.99 18.62 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.787 0 CA-C-N 114.821 -1.082 . . . . 0.0 111.199 -170.847 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 59.1 t -112.13 115.33 49.53 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.945 0 C-N-CA 124.336 1.055 . . . . 0.0 109.206 174.854 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 45.6 m-85 -100.1 113.41 26.02 Favored 'General case' 0 N--CA 1.481 1.124 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 172.362 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.402 HG23 ' HB3' ' A' ' 65' ' ' GLU . 5.1 p -81.27 131.93 32.74 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 N-CA-C 109.168 -0.679 . . . . 0.0 109.168 179.671 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -92.26 145.62 31.05 Favored Pre-proline 0 CA--C 1.546 0.792 0 C-N-CA 122.814 0.445 . . . . 0.0 112.066 -171.345 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_endo -60.14 -36.42 88.87 Favored 'Trans proline' 0 C--N 1.381 2.285 0 C-N-CA 124.104 3.203 . . . . 0.0 113.724 -177.025 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 6.6 t -77.86 -9.52 59.1 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 122.779 0.432 . . . . 0.0 111.283 -179.368 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 94.57 23.92 19.87 Favored Glycine 0 C--N 1.35 1.342 0 CA-C-N 116.348 -0.387 . . . . 0.0 113.826 179.294 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -112.96 71.31 0.74 Allowed 'General case' 0 N--CA 1.474 0.73 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 178.729 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.402 ' HB3' HG23 ' A' ' 59' ' ' VAL . 0.6 OUTLIER -58.81 145.78 39.5 Favored 'General case' 0 N--CA 1.48 1.032 0 CA-C-N 115.211 -0.904 . . . . 0.0 112.062 -173.299 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.435 HG13 HD22 ' A' ' 72' ' ' LEU . 44.5 mm -111.24 127.26 68.5 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.589 0 C-N-CA 124.301 1.04 . . . . 0.0 110.062 -172.347 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 42.8 p -101.27 -13.58 18.01 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 123.88 0.872 . . . . 0.0 111.754 -178.923 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 11.5 p-10 -160.01 152.2 20.64 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 123.228 0.611 . . . . 0.0 111.045 -167.65 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.547 ' HG3' HD11 ' A' ' 85' ' ' ILE . 72.5 ttt-85 -56.17 -36.09 67.95 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 125.194 1.397 . . . . 0.0 113.357 -171.562 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 7.4 tmtm? -57.57 -49.94 74.74 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 123.885 0.874 . . . . 0.0 110.281 178.868 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.49 ' HA ' ' HG3' ' A' ' 74' ' ' GLN . 86.7 mm-40 -68.1 -24.07 64.99 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 115.14 -0.937 . . . . 0.0 111.733 -175.602 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.438 HD12 ' HB ' ' A' ' 85' ' ' ILE . 0.3 OUTLIER -66.35 -50.46 63.47 Favored 'General case' 0 N--CA 1.477 0.913 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 175.636 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -64.16 -47.99 77.73 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 124.233 1.013 . . . . 0.0 111.211 -176.081 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' GLN . . . . . 0.49 ' HG3' ' HA ' ' A' ' 71' ' ' GLN . 0.0 OUTLIER -68.29 -26.99 65.92 Favored 'General case' 0 CA--C 1.548 0.903 0 CA-C-N 115.802 -0.636 . . . . 0.0 111.427 179.4 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 59.2 t80 -63.66 -52.36 61.05 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 122.943 0.497 . . . . 0.0 110.202 173.854 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 96.6 mt -64.9 -39.24 93.21 Favored 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 123.487 0.715 . . . . 0.0 112.461 -171.902 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -73.42 -21.6 60.43 Favored 'General case' 0 N--CA 1.479 0.982 0 CA-C-N 116.667 -0.242 . . . . 0.0 111.133 178.25 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 46.2 m -99.58 -6.37 27.51 Favored 'General case' 0 N--CA 1.487 1.414 0 C-N-CA 123.093 0.557 . . . . 0.0 112.393 175.309 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 73.8 m80 -141.92 80.88 15.1 Favored Pre-proline 0 N--CA 1.479 1.0 0 C-N-CA 124.022 0.929 . . . . 0.0 108.54 179.147 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -68.31 149.86 75.85 Favored 'Trans proline' 0 C--N 1.375 1.922 0 C-N-CA 122.541 2.16 . . . . 0.0 111.996 178.982 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 103.23 -20.65 42.14 Favored Glycine 0 C--N 1.34 0.795 0 CA-C-N 116.262 -0.426 . . . . 0.0 112.693 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 18.7 m120 -82.42 142.07 46.29 Favored Pre-proline 0 CA--C 1.548 0.893 0 C-N-CA 123.238 0.615 . . . . 0.0 110.555 179.343 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_endo -55.72 145.94 68.67 Favored 'Trans proline' 0 C--N 1.385 2.466 0 C-N-CA 123.428 2.752 . . . . 0.0 113.395 -174.929 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.415 ' O ' ' HG2' ' A' ' 87' ' ' GLU . . . -68.98 160.01 31.69 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 124.156 0.982 . . . . 0.0 112.332 -170.865 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.547 HD11 ' HG3' ' A' ' 69' ' ' ARG . 14.1 tt -73.19 -22.69 19.55 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.966 0 C-N-CA 123.071 0.548 . . . . 0.0 110.8 177.345 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -63.32 -26.69 68.88 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 123.658 0.783 . . . . 0.0 111.863 -179.83 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.415 ' HG2' ' O ' ' A' ' 84' ' ' ALA . 15.0 pt-20 -96.71 -3.17 43.03 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 122.972 0.509 . . . . 0.0 111.567 177.874 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 5.3 m-30 -93.13 120.47 33.46 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 123.524 0.729 . . . . 0.0 109.655 178.188 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 13.8 p-10 -91.59 98.87 11.92 Favored 'General case' 0 N--CA 1.476 0.826 0 CA-C-O 122.042 0.925 . . . . 0.0 111.182 -176.74 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 88.0 m95 -83.19 -25.68 31.56 Favored 'General case' 0 N--CA 1.48 1.063 0 CA-C-N 115.095 -0.957 . . . . 0.0 110.297 171.763 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 14.9 t -82.22 13.35 3.55 Favored 'General case' 0 CA--C 1.554 1.123 0 C-N-CA 124.372 1.069 . . . . 0.0 112.485 -173.863 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 15.0 t -62.73 -24.12 67.52 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 122.726 0.41 . . . . 0.0 111.269 174.807 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 27.1 p -82.4 -41.94 19.26 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 123.871 0.869 . . . . 0.0 110.362 172.782 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -89.45 58.92 3.79 Favored Glycine 0 C--N 1.347 1.189 0 CA-C-N 115.496 -0.774 . . . . 0.0 112.916 -176.508 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 3.7 t . . . . . 0 CA--C 1.56 1.341 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 173.891 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.1 tpt . . . . . 0 N--CA 1.488 1.463 0 N-CA-C 110.31 -0.256 . . . . 0.0 110.31 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 42.5 m80 -86.06 82.98 7.88 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 123.535 0.734 . . . . 0.0 109.724 -179.274 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 22.4 t-160 -136.06 -66.73 0.54 Allowed 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 123.126 0.57 . . . . 0.0 109.657 -179.942 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 10.0 p-80 -86.7 56.93 4.22 Favored 'General case' 0 N--CA 1.486 1.334 0 CA-C-O 121.808 0.814 . . . . 0.0 110.267 177.384 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 56.1 t-80 -164.27 154.39 14.56 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 108.312 -0.996 . . . . 0.0 108.312 -175.694 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 31.6 t60 -56.4 114.81 2.16 Favored 'General case' 0 N--CA 1.486 1.368 0 C-N-CA 123.219 0.607 . . . . 0.0 110.192 176.908 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -59.79 133.12 55.8 Favored 'General case' 0 CA--C 1.548 0.89 0 O-C-N 124.236 0.96 . . . . 0.0 111.113 -175.676 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 13.9 m -65.87 -26.05 67.46 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 124.463 1.105 . . . . 0.0 112.489 -172.904 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 34.4 t -71.24 -27.38 63.42 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 123.027 0.531 . . . . 0.0 110.824 176.69 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -92.68 26.76 12.76 Favored Glycine 0 C--N 1.346 1.117 0 CA-C-N 116.024 -0.534 . . . . 0.0 112.851 178.423 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 77.9 ttt180 -71.24 -38.0 71.97 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 123.387 0.675 . . . . 0.0 110.603 178.018 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -70.83 92.94 0.93 Allowed 'General case' 0 CA--C 1.545 0.777 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 -178.761 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 12.3 m120 -110.47 89.82 3.14 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 123.795 0.838 . . . . 0.0 108.806 179.277 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 1.1 pp -162.78 -47.89 0.04 OUTLIER 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 124.624 1.17 . . . . 0.0 108.624 -179.052 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 74.6 m-85 -143.92 -71.27 0.29 Allowed 'General case' 0 C--O 1.237 0.415 0 C-N-CA 124.729 1.212 . . . . 0.0 108.083 171.394 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 49.7 t80 57.11 30.18 17.84 Favored 'General case' 0 CA--C 1.556 1.184 0 C-N-CA 124.482 1.113 . . . . 0.0 111.028 -178.897 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 81.4 mm-40 -86.62 176.18 7.92 Favored 'General case' 0 N--CA 1.476 0.873 0 CA-C-N 114.96 -1.018 . . . . 0.0 110.769 -174.255 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -108.79 160.52 13.6 Favored Glycine 0 C--O 1.24 0.504 0 N-CA-C 111.003 -0.839 . . . . 0.0 111.003 171.367 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 23.2 p80 -69.91 122.04 18.52 Favored 'General case' 0 N--CA 1.484 1.261 0 CA-C-N 117.416 0.608 . . . . 0.0 109.555 178.168 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 46.1 ttm 62.85 95.26 0.04 OUTLIER 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 124.684 1.194 . . . . 0.0 111.174 -179.564 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -63.39 105.84 0.81 Allowed 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 123.796 0.838 . . . . 0.0 111.505 -175.264 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 21.1 t -155.84 143.05 19.22 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 124.189 0.995 . . . . 0.0 108.993 179.082 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 130.76 -5.52 5.8 Favored Glycine 0 N--CA 1.472 1.06 0 CA-C-O 119.358 -0.69 . . . . 0.0 113.159 -179.655 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 22.0 t 68.7 107.75 0.05 Allowed 'General case' 0 CA--C 1.553 1.076 0 C-N-CA 125.387 1.475 . . . . 0.0 110.815 -179.766 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -66.93 118.16 10.01 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 124.183 0.993 . . . . 0.0 111.812 -173.235 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 63.8 mm-40 55.81 34.02 22.64 Favored 'General case' 0 N--CA 1.489 1.5 0 C-N-CA 124.381 1.072 . . . . 0.0 112.507 174.727 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -66.92 99.81 0.67 Allowed 'General case' 0 C--N 1.355 0.815 0 CA-C-O 121.007 0.432 . . . . 0.0 110.328 -177.229 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 35.8 m -108.75 167.72 3.94 Favored 'Isoleucine or valine' 0 C--O 1.241 0.639 0 C-N-CA 124.239 1.016 . . . . 0.0 109.599 176.74 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 17.1 m -98.73 132.79 43.27 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 C-N-CA 123.365 0.666 . . . . 0.0 110.197 177.827 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 60.9 p -146.7 113.48 6.07 Favored 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 174.519 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 61.1 t -101.7 131.33 49.8 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 -178.233 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 -84.11 111.66 19.52 Favored 'General case' 0 CA--C 1.536 0.436 0 N-CA-C 108.971 -0.752 . . . . 0.0 108.971 178.521 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.489 ' HG ' HG21 ' A' ' 92' ' ' THR . 4.1 mm? -91.92 165.13 21.14 Favored Pre-proline 0 CA--C 1.559 1.321 0 C-N-CA 124.704 1.202 . . . . 0.0 109.95 -177.118 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_endo -59.76 143.96 99.53 Favored 'Trans proline' 0 C--N 1.393 2.908 0 C-N-CA 122.927 2.418 . . . . 0.0 113.356 -177.851 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.469 ' HB2' ' HB3' ' A' ' 41' ' ' LYS . . . -138.58 165.22 34.39 Favored Pre-proline 0 N--CA 1.474 0.746 0 C-N-CA 123.972 0.909 . . . . 0.0 111.632 -169.561 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.698 ' HG2' ' HB2' ' A' ' 39' ' ' TRP . 37.4 Cg_endo -65.09 155.61 67.35 Favored 'Trans proline' 0 C--N 1.381 2.253 0 C-N-CA 122.468 2.112 . . . . 0.0 110.8 162.663 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 34.3 t -57.55 -38.49 74.85 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 124.622 1.169 . . . . 0.0 112.895 -171.473 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 11.0 p -77.78 -40.19 41.6 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 123.342 0.657 . . . . 0.0 111.878 -177.582 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' TRP . . . . . 0.698 ' HB2' ' HG2' ' A' ' 36' ' ' PRO . 29.4 m95 -93.26 -174.63 3.59 Favored 'General case' 0 N--CA 1.478 0.944 0 CA-C-O 121.628 0.728 . . . . 0.0 111.336 -178.495 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.705 ' HB3' ' HB ' ' A' ' 59' ' ' VAL . 40.2 ttmt -143.55 144.83 32.12 Favored 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 107.336 -1.357 . . . . 0.0 107.336 173.452 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.469 ' HB3' ' HB2' ' A' ' 35' ' ' ALA . 18.4 tptp -120.23 125.9 49.28 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 124.063 0.945 . . . . 0.0 109.092 -174.511 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.461 HD22 ' HB ' ' A' ' 57' ' ' VAL . 4.3 tt -124.85 149.43 47.49 Favored 'General case' 0 C--O 1.236 0.393 0 C-N-CA 125.127 1.371 . . . . 0.0 108.694 176.648 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.423 ' HB3' HD23 ' A' ' 33' ' ' LEU . 34.3 t80 -135.26 135.58 41.0 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 124.943 1.297 . . . . 0.0 108.27 175.912 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 36.1 m-85 -95.93 103.96 15.05 Favored Pre-proline 0 N--CA 1.48 1.058 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 170.233 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 63.8 Cg_endo -83.4 -162.06 0.16 Allowed 'Trans proline' 0 C--N 1.37 1.669 0 C-N-CA 122.717 2.278 . . . . 0.0 111.397 170.452 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' ASN . . . . . 0.543 ' HB3' ' HA ' ' A' ' 51' ' ' VAL . 7.4 p30 -115.47 172.58 7.01 Favored 'General case' 0 N--CA 1.472 0.64 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 169.798 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 38.7 ttpt -111.25 -60.91 1.77 Allowed 'General case' 0 CA--C 1.539 0.543 0 N-CA-C 108.374 -0.973 . . . . 0.0 108.374 175.866 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 60.3 t -131.13 -63.68 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 N-CA-C 107.999 -1.111 . . . . 0.0 107.999 172.251 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -95.91 166.97 25.14 Favored Glycine 0 C--N 1.345 1.076 0 CA-C-N 115.272 -0.876 . . . . 0.0 112.66 179.581 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 25.6 m 58.33 69.82 0.7 Allowed 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 124.917 1.287 . . . . 0.0 111.6 179.05 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.543 ' HA ' ' HB3' ' A' ' 46' ' ' ASN . 33.5 m -72.59 142.88 14.59 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 CA-C-N 115.599 -0.728 . . . . 0.0 109.752 175.628 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 8.4 mtpm? 58.19 54.77 5.56 Favored 'General case' 0 N--CA 1.48 1.025 0 C-N-CA 123.863 0.865 . . . . 0.0 109.291 -169.758 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 7.1 tmtt? -55.9 -59.04 5.45 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 124.479 1.112 . . . . 0.0 109.667 -173.486 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 33.6 m -134.47 157.2 47.09 Favored 'General case' 0 CA--C 1.548 0.904 0 C-N-CA 124.614 1.165 . . . . 0.0 107.911 169.529 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -75.6 -169.52 1.06 Allowed 'General case' 0 CA--C 1.557 1.217 0 C-N-CA 123.478 0.711 . . . . 0.0 111.492 178.844 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 46.7 t -81.72 134.77 26.35 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.668 0 C-N-CA 124.2 1.0 . . . . 0.0 110.416 -176.263 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.461 ' HB ' HD22 ' A' ' 42' ' ' LEU . 96.7 t -120.4 122.65 68.72 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 C-N-CA 124.005 0.922 . . . . 0.0 108.913 177.745 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 24.7 m-85 -97.85 121.15 39.42 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 123.602 0.761 . . . . 0.0 109.864 172.266 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.705 ' HB ' ' HB3' ' A' ' 40' ' ' LYS . 11.0 t -79.43 129.92 36.86 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 172.134 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -84.45 158.42 60.38 Favored Pre-proline 0 CA--C 1.542 0.659 0 CA-C-N 114.904 -1.044 . . . . 0.0 110.912 -175.766 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -63.53 -25.72 69.94 Favored 'Trans proline' 0 C--N 1.374 1.893 0 C-N-CA 123.005 2.47 . . . . 0.0 113.1 176.226 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.457 HG22 ' OH ' ' A' ' 75' ' ' TYR . 14.7 t -97.52 -3.7 39.33 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 123.5 0.72 . . . . 0.0 111.241 177.729 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 93.79 -12.83 68.69 Favored Glycine 0 C--N 1.354 1.577 0 CA-C-O 119.701 -0.5 . . . . 0.0 113.473 179.351 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 44.6 tt0 -73.88 77.63 1.63 Allowed 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 123.903 0.881 . . . . 0.0 109.77 178.862 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -67.41 158.39 31.86 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-N 114.786 -1.097 . . . . 0.0 112.229 -170.006 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.4 HG23 ' HB2' ' A' ' 71' ' ' GLN . 47.7 mm -121.21 131.2 73.6 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.598 0 C-N-CA 125.168 1.387 . . . . 0.0 108.891 -172.201 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 24.3 p -105.86 -17.94 14.21 Favored 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 123.984 0.914 . . . . 0.0 112.141 179.206 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 9.2 p30 -143.64 157.24 44.56 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 122.538 0.335 . . . . 0.0 111.235 -173.284 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 29.7 ttp180 -63.38 -30.62 71.72 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 123.917 0.887 . . . . 0.0 112.342 -171.585 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 5.5 tmtm? -59.89 -54.85 41.39 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 123.793 0.837 . . . . 0.0 109.116 -179.67 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.411 ' HA ' ' HG3' ' A' ' 74' ' ' GLN . 88.3 mm-40 -64.1 -25.55 68.15 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-N 115.006 -0.997 . . . . 0.0 111.597 -177.791 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.407 ' O ' ' HG ' ' A' ' 76' ' ' LEU . 0.4 OUTLIER -66.47 -56.71 9.66 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 123.477 0.711 . . . . 0.0 109.131 176.672 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -58.74 -48.93 79.47 Favored 'General case' 0 N--CA 1.486 1.334 0 C-N-CA 124.393 1.077 . . . . 0.0 111.71 -176.93 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' GLN . . . . . 0.411 ' HG3' ' HA ' ' A' ' 71' ' ' GLN . 0.0 OUTLIER -70.6 -24.24 62.71 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-N 115.472 -0.785 . . . . 0.0 111.538 -177.375 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 75' ' ' TYR . . . . . 0.457 ' OH ' HG22 ' A' ' 62' ' ' THR . 18.9 t80 -68.18 -49.56 60.07 Favored 'General case' 0 N--CA 1.479 0.985 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 172.561 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.407 ' HG ' ' O ' ' A' ' 72' ' ' LEU . 69.0 mt -59.68 -41.36 90.51 Favored 'General case' 0 N--CA 1.485 1.306 0 C-N-CA 123.053 0.541 . . . . 0.0 111.563 -173.17 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 54.9 pttt -73.39 -34.54 65.58 Favored 'General case' 0 N--CA 1.479 1.014 0 O-C-N 123.181 0.301 . . . . 0.0 111.63 -179.729 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 80.9 p -83.02 -17.7 42.4 Favored 'General case' 0 N--CA 1.487 1.423 0 C-N-CA 122.828 0.451 . . . . 0.0 111.582 -178.181 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 75.5 m80 -122.89 102.79 37.59 Favored Pre-proline 0 N--CA 1.48 1.027 0 C-N-CA 123.832 0.853 . . . . 0.0 109.237 -177.465 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -67.68 154.69 72.62 Favored 'Trans proline' 0 C--N 1.378 2.099 0 C-N-CA 122.928 2.418 . . . . 0.0 113.051 -177.785 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 84.04 -9.73 62.58 Favored Glycine 0 C--N 1.349 1.285 0 CA-C-N 115.631 -0.713 . . . . 0.0 114.293 175.243 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 25.0 m-80 -74.65 148.1 85.04 Favored Pre-proline 0 N--CA 1.483 1.211 0 C-N-CA 123.432 0.693 . . . . 0.0 111.178 -178.058 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -68.92 163.99 35.36 Favored 'Trans proline' 0 C--N 1.377 2.068 0 C-N-CA 123.233 2.622 . . . . 0.0 113.176 -177.794 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.485 ' O ' ' HG2' ' A' ' 87' ' ' GLU . . . -71.48 150.74 44.58 Favored 'General case' 0 N--CA 1.476 0.841 0 CA-C-N 115.066 -0.97 . . . . 0.0 111.243 -175.698 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 19.6 tt -72.88 -20.83 19.19 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.111 0 CA-C-O 120.968 0.413 . . . . 0.0 110.877 179.759 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -63.93 -30.13 71.24 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 123.681 0.793 . . . . 0.0 112.377 -179.019 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.485 ' HG2' ' O ' ' A' ' 84' ' ' ALA . 13.4 pt-20 -88.61 -7.49 56.31 Favored 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 123.215 0.606 . . . . 0.0 111.275 178.553 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -83.14 116.48 22.36 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 123.64 0.776 . . . . 0.0 110.365 176.356 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -75.69 128.47 35.27 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 123.86 0.864 . . . . 0.0 110.268 175.662 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 81.1 m95 -119.0 -1.2 11.01 Favored 'General case' 0 CA--C 1.555 1.138 0 C-N-CA 123.28 0.632 . . . . 0.0 110.151 166.325 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 14.2 t -112.39 12.67 20.17 Favored 'General case' 0 CA--C 1.565 1.538 0 N-CA-C 113.569 0.952 . . . . 0.0 113.569 -165.992 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.489 HG21 ' HG ' ' A' ' 33' ' ' LEU . 15.1 t -63.28 -14.35 48.55 Favored 'General case' 0 N--CA 1.502 2.171 0 N-CA-C 113.515 0.931 . . . . 0.0 113.515 -174.342 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 32.4 p -61.44 -26.42 67.86 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 123.629 0.772 . . . . 0.0 111.803 178.093 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 110.03 91.53 2.12 Favored Glycine 0 C--N 1.344 1.007 0 N-CA-C 111.487 -0.645 . . . . 0.0 111.487 177.777 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 8.9 t . . . . . 0 CA--C 1.565 1.536 0 C-N-CA 123.688 0.795 . . . . 0.0 111.064 179.325 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.2 mmt . . . . . 0 N--CA 1.472 0.674 0 CA-C-O 120.714 0.293 . . . . 0.0 110.49 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 33.1 p80 -76.48 17.36 0.39 Allowed 'General case' 0 N--CA 1.486 1.35 0 N-CA-C 112.968 0.729 . . . . 0.0 112.968 -177.69 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 39.0 t60 -138.61 147.06 42.51 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 124.573 1.149 . . . . 0.0 108.204 171.747 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 54.9 m80 -130.86 147.9 52.56 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 123.102 0.561 . . . . 0.0 109.748 177.022 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 61.6 t-80 -96.59 153.53 17.8 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 124.03 0.932 . . . . 0.0 110.353 -175.261 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 30.0 m-70 -57.69 146.13 32.0 Favored 'General case' 0 N--CA 1.486 1.356 0 C-N-CA 123.483 0.713 . . . . 0.0 111.179 176.451 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 47.6 p-80 -154.74 143.28 20.62 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 123.88 0.872 . . . . 0.0 109.255 -178.119 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 22.5 p -72.53 -61.24 1.87 Allowed 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 175.808 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 73.8 m -160.41 -45.23 0.05 OUTLIER 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 124.563 1.145 . . . . 0.0 109.661 177.329 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 81.18 -152.29 32.54 Favored Glycine 0 C--N 1.346 1.122 0 CA-C-N 115.016 -0.993 . . . . 0.0 111.891 -175.943 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 76.1 ttt180 -151.42 110.59 3.92 Favored 'General case' 0 CA--C 1.538 0.481 0 N-CA-C 108.682 -0.858 . . . . 0.0 108.682 -179.882 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 3.3 tm-20 -145.79 97.79 3.02 Favored 'General case' 0 N--CA 1.472 0.672 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 -178.94 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 23.7 m-80 -149.8 85.18 1.42 Allowed 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 124.342 1.057 . . . . 0.0 108.209 177.583 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -137.9 141.21 40.65 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 123.421 0.688 . . . . 0.0 109.708 173.457 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 9.2 p90 -59.37 -36.56 75.98 Favored 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 123.42 0.688 . . . . 0.0 111.362 179.481 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 54.4 t80 66.62 -1.88 1.2 Allowed 'General case' 0 N--CA 1.489 1.485 0 C-N-CA 125.333 1.453 . . . . 0.0 113.282 173.558 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 15.4 mm100 -76.53 83.44 3.22 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 123.591 0.757 . . . . 0.0 109.377 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -148.96 127.16 2.43 Favored Glycine 0 C--N 1.339 0.747 0 N-CA-C 110.834 -0.906 . . . . 0.0 110.834 -178.443 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 68.5 m80 -84.46 118.84 24.53 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 123.834 0.854 . . . . 0.0 110.133 -177.74 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 21.0 ptt? -139.62 100.9 4.08 Favored 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 124.412 1.085 . . . . 0.0 108.83 -178.752 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -161.93 170.15 19.91 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.861 -174.634 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 38.1 t -150.94 134.07 16.04 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 123.621 0.769 . . . . 0.0 109.12 175.575 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -98.01 -1.94 58.31 Favored Glycine 0 C--N 1.348 1.225 0 O-C-N 123.353 0.408 . . . . 0.0 113.535 -178.851 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 52.8 p -64.72 111.31 2.71 Favored 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 123.136 0.574 . . . . 0.0 110.601 -177.811 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -155.14 121.74 5.35 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 123.056 0.543 . . . . 0.0 109.834 -174.794 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -167.69 114.81 0.74 Allowed 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 123.893 0.877 . . . . 0.0 108.648 176.384 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -78.24 103.69 8.34 Favored 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 177.046 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.415 HG23 ' HE2' ' A' ' 44' ' ' TYR . 24.1 m -71.42 140.51 18.1 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.959 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.82 178.167 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 28.8 m -63.86 122.86 15.55 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.188 0 C-N-CA 123.182 0.593 . . . . 0.0 112.311 -171.468 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.429 ' HB3' ' CE2' ' A' ' 44' ' ' TYR . 45.7 p -135.41 141.66 45.5 Favored 'General case' 0 C--O 1.241 0.646 0 C-N-CA 124.224 1.01 . . . . 0.0 109.376 -178.258 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 95.7 t -123.99 123.78 67.55 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 C-N-CA 124.266 1.026 . . . . 0.0 108.718 174.881 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -82.36 110.38 17.45 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 123.137 0.575 . . . . 0.0 110.201 176.472 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.517 ' HB2' ' HG3' ' A' ' 41' ' ' LYS . 4.1 mm? -85.38 165.19 37.32 Favored Pre-proline 0 CA--C 1.556 1.19 0 C-N-CA 124.584 1.154 . . . . 0.0 110.084 179.92 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 25.1 Cg_endo -59.88 149.46 83.57 Favored 'Trans proline' 0 C--N 1.389 2.674 0 C-N-CA 122.716 2.277 . . . . 0.0 113.834 179.838 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -149.32 170.29 7.88 Favored Pre-proline 0 CA--C 1.551 0.999 0 C-N-CA 124.32 1.048 . . . . 0.0 110.321 -172.264 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_exo -52.54 157.63 6.9 Favored 'Trans proline' 0 C--N 1.385 2.498 0 C-N-CA 122.946 2.43 . . . . 0.0 112.981 165.133 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 44.9 m -60.04 -29.72 68.71 Favored 'General case' 0 CA--C 1.552 1.021 0 C-N-CA 124.07 0.948 . . . . 0.0 112.233 -179.548 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 37.0 t -84.64 -24.57 29.02 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 123.121 0.568 . . . . 0.0 111.713 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 32.1 m95 -114.25 177.15 4.74 Favored 'General case' 0 N--CA 1.483 1.18 0 CA-C-O 121.467 0.651 . . . . 0.0 112.058 -173.331 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 33.5 mtmt -136.45 145.14 44.88 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 124.712 1.205 . . . . 0.0 108.179 170.093 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.523 ' NZ ' ' HB2' ' A' ' 43' ' ' PHE . 22.4 tptp -114.25 135.25 54.26 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 124.523 1.129 . . . . 0.0 108.707 -178.489 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.468 HD22 ' HB ' ' A' ' 57' ' ' VAL . 5.5 tt -125.95 142.42 51.53 Favored 'General case' 0 C--O 1.238 0.481 0 C-N-CA 124.166 0.986 . . . . 0.0 108.803 176.896 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.523 ' HB2' ' NZ ' ' A' ' 41' ' ' LYS . 65.5 t80 -127.09 144.9 50.92 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 124.884 1.274 . . . . 0.0 108.027 172.807 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' TYR . . . . . 0.429 ' CE2' ' HB3' ' A' ' 30' ' ' SER . 17.8 m-85 -102.44 97.65 9.25 Favored Pre-proline 0 CA--C 1.548 0.868 0 C-N-CA 122.557 0.343 . . . . 0.0 110.12 171.914 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -82.49 89.23 1.19 Allowed 'Trans proline' 0 C--N 1.38 2.234 0 C-N-CA 122.945 2.43 . . . . 0.0 112.006 176.029 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' ASN . . . . . 0.41 ' ND2' ' HA ' ' A' ' 53' ' ' LYS . 23.6 m120 -74.07 105.93 5.52 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 115.033 -0.985 . . . . 0.0 109.764 179.27 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.534 ' HE2' ' HA ' ' A' ' 47' ' ' LYS . 11.9 mmpt? -64.38 -38.39 90.86 Favored 'General case' 0 CA--C 1.543 0.694 0 CA-C-N 114.528 -1.215 . . . . 0.0 111.639 -174.819 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.534 HG12 ' H ' ' A' ' 50' ' ' SER . 71.4 t -122.15 131.6 72.81 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 N-CA-C 107.445 -1.317 . . . . 0.0 107.445 171.08 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -67.98 -16.03 67.93 Favored Glycine 0 CA--C 1.535 1.293 0 N-CA-C 114.087 0.395 . . . . 0.0 114.087 -177.649 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' SER . . . . . 0.534 ' H ' HG12 ' A' ' 48' ' ' VAL . 25.6 m -73.45 -17.25 61.26 Favored 'General case' 0 CA--C 1.552 1.037 0 C-N-CA 123.531 0.732 . . . . 0.0 112.416 -179.738 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.486 HG22 ' O ' ' A' ' 48' ' ' VAL . 5.8 m -83.23 -175.77 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 C-N-CA 122.597 0.359 . . . . 0.0 110.796 -179.02 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 12.6 mptt -66.93 88.65 0.15 Allowed 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 123.134 0.574 . . . . 0.0 110.248 -179.39 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.556 ' H ' ' HD3' ' A' ' 53' ' ' LYS . 0.2 OUTLIER -77.5 120.81 23.0 Favored 'General case' 0 C--N 1.349 0.562 0 CA-C-N 115.595 -0.73 . . . . 0.0 109.897 -178.608 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 1.1 p -129.93 165.49 21.98 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 123.578 0.751 . . . . 0.0 109.852 -176.977 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -98.1 -167.11 1.46 Allowed 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 123.965 0.906 . . . . 0.0 111.671 -167.416 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.412 ' CG1' ' HE2' ' A' ' 41' ' ' LYS . 31.9 t -81.85 134.29 27.38 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.404 0 CA-C-N 114.891 -1.05 . . . . 0.0 110.052 177.52 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.468 ' HB ' HD22 ' A' ' 42' ' ' LEU . 98.6 t -121.11 130.23 74.88 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 C-N-CA 124.089 0.956 . . . . 0.0 108.928 175.137 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 9.1 m-85 -101.86 119.5 38.88 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 123.297 0.639 . . . . 0.0 109.281 171.376 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.42 ' HA ' ' HG2' ' A' ' 65' ' ' GLU . 14.8 t -78.37 123.81 35.78 Favored 'Isoleucine or valine' 0 C--O 1.239 0.532 0 C-N-CA 123.518 0.727 . . . . 0.0 109.744 176.331 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -82.07 151.98 67.62 Favored Pre-proline 0 CA--C 1.54 0.582 0 CA-C-N 114.335 -1.302 . . . . 0.0 110.873 -175.639 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_endo -60.48 -33.3 94.08 Favored 'Trans proline' 0 C--N 1.374 1.894 0 C-N-CA 123.245 2.63 . . . . 0.0 112.697 177.41 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.496 HG23 ' H ' ' A' ' 64' ' ' GLU . 11.4 t -85.82 -12.82 49.9 Favored 'General case' 0 CA--C 1.545 0.781 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.292 178.207 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 94.57 -1.12 65.98 Favored Glycine 0 C--N 1.357 1.7 0 CA-C-O 120.053 -0.304 . . . . 0.0 113.64 -177.276 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.496 ' H ' HG23 ' A' ' 62' ' ' THR . 33.0 tt0 -78.31 71.87 4.8 Favored 'General case' 0 N--CA 1.48 1.064 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 174.497 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.42 ' HG2' ' HA ' ' A' ' 59' ' ' VAL . 34.1 mt-10 -66.01 148.57 51.59 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-N 114.775 -1.102 . . . . 0.0 111.771 -169.138 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 48.6 mm -115.17 131.11 68.4 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.557 0 C-N-CA 124.44 1.096 . . . . 0.0 110.167 -168.997 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 61.0 p -101.52 -21.12 14.83 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 123.596 0.758 . . . . 0.0 112.482 -178.758 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 7.8 p30 -143.52 159.36 42.57 Favored 'General case' 0 N--CA 1.481 1.111 0 CA-C-O 120.8 0.333 . . . . 0.0 111.802 -172.985 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 55.1 ttt-85 -65.69 -29.29 69.81 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 124.144 0.978 . . . . 0.0 111.968 -171.913 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 7.8 tmtm? -61.18 -54.94 38.0 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 123.352 0.661 . . . . 0.0 109.318 176.782 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 14.2 mm100 -67.5 -20.13 65.41 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-N 115.591 -0.732 . . . . 0.0 111.821 -176.581 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.422 ' O ' ' HG ' ' A' ' 76' ' ' LEU . 0.6 OUTLIER -70.91 -56.45 6.22 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 176.221 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -62.94 -41.83 99.62 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 123.526 0.731 . . . . 0.0 111.191 -176.784 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.47 -28.69 66.31 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 122.684 0.394 . . . . 0.0 110.648 177.467 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' TYR . . . . . 0.426 ' OH ' HG22 ' A' ' 62' ' ' THR . 20.9 t80 -63.06 -49.72 73.41 Favored 'General case' 0 N--CA 1.482 1.128 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 172.789 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.422 ' HG ' ' O ' ' A' ' 72' ' ' LEU . 72.5 mt -61.62 -37.15 82.9 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 123.313 0.645 . . . . 0.0 111.869 -172.341 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.04 -35.71 49.4 Favored 'General case' 0 CA--C 1.548 0.885 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.13 176.847 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 30.0 t -79.03 -16.38 56.94 Favored 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 123.011 0.524 . . . . 0.0 111.541 -179.412 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 76.9 m-70 -129.57 82.81 66.5 Favored Pre-proline 0 CA--C 1.544 0.72 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 178.091 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -64.76 142.26 75.65 Favored 'Trans proline' 0 C--N 1.372 1.803 0 C-N-CA 122.776 2.318 . . . . 0.0 112.543 -178.902 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 105.18 -14.8 47.88 Favored Glycine 0 C--N 1.348 1.246 0 CA-C-N 116.125 -0.489 . . . . 0.0 112.67 -178.024 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 18.4 m-80 -76.62 146.49 76.88 Favored Pre-proline 0 N--CA 1.485 1.316 0 C-N-CA 123.588 0.755 . . . . 0.0 111.526 179.633 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -63.37 158.43 45.07 Favored 'Trans proline' 0 C--N 1.383 2.393 0 C-N-CA 123.019 2.479 . . . . 0.0 113.541 -178.023 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.441 ' O ' ' HG2' ' A' ' 87' ' ' GLU . . . -73.83 144.52 45.47 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-N 114.879 -1.055 . . . . 0.0 111.756 -174.941 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 16.7 tt -67.03 -12.32 14.98 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.311 0 C-N-CA 123.129 0.572 . . . . 0.0 111.657 179.736 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -57.0 -38.86 73.67 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 124.38 1.072 . . . . 0.0 112.297 173.687 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.441 ' HG2' ' O ' ' A' ' 84' ' ' ALA . 11.6 pt-20 -92.76 0.21 57.38 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 123.235 0.614 . . . . 0.0 111.518 -179.569 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -85.26 110.75 19.29 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 123.044 0.537 . . . . 0.0 109.746 177.958 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -83.17 93.78 7.72 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 123.962 0.905 . . . . 0.0 109.941 -178.625 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 78.7 m95 -79.43 -42.45 25.38 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 123.433 0.693 . . . . 0.0 109.996 171.418 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 12.8 t -82.05 13.84 3.16 Favored 'General case' 0 CA--C 1.559 1.294 0 C-N-CA 124.4 1.08 . . . . 0.0 112.483 -172.859 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 11.4 t -80.12 51.82 1.44 Allowed 'General case' 0 CA--C 1.561 1.397 0 CA-C-O 122.119 0.961 . . . . 0.0 110.716 172.79 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 14.9 p -58.59 105.55 0.31 Allowed 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 123.95 0.9 . . . . 0.0 110.771 179.597 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -59.37 105.73 0.78 Allowed Glycine 0 C--N 1.349 1.305 0 O-C-N 123.791 0.682 . . . . 0.0 112.316 179.022 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 34.5 p . . . . . 0 C--O 1.251 1.167 0 C-N-CA 124.398 1.079 . . . . 0.0 109.101 179.439 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.36 0 CA-C-O 120.835 0.35 . . . . 0.0 110.663 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 17.0 p80 -133.71 104.32 6.28 Favored 'General case' 0 C--O 1.246 0.921 0 N-CA-C 107.147 -1.427 . . . . 0.0 107.147 172.806 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 38.3 m80 64.03 -175.62 0.16 Allowed 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 123.903 0.881 . . . . 0.0 110.941 -171.229 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 95.8 m-70 -141.54 162.36 35.68 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 123.201 0.6 . . . . 0.0 111.328 -179.327 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 30.9 m-70 -97.95 148.37 23.53 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 114.836 -1.074 . . . . 0.0 110.173 176.913 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 8.6 p-80 -142.49 31.49 1.5 Allowed 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 124.044 0.938 . . . . 0.0 109.36 175.507 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 16.8 t60 -61.25 136.34 58.02 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 124.331 1.052 . . . . 0.0 110.572 -176.881 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 48.1 m -63.92 97.93 0.18 Allowed 'General case' 0 CA--C 1.547 0.828 0 O-C-N 123.636 0.585 . . . . 0.0 110.39 178.473 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 62.7 m -140.63 160.34 40.23 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-N 115.199 -0.909 . . . . 0.0 110.884 -173.273 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 108.64 141.03 9.36 Favored Glycine 0 C--N 1.349 1.265 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.578 -177.91 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -80.96 124.23 28.97 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 123.143 0.577 . . . . 0.0 109.72 179.792 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -150.29 155.49 39.78 Favored 'General case' 0 CA--C 1.552 1.026 0 N-CA-C 106.732 -1.581 . . . . 0.0 106.732 179.226 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 64.3 t30 70.75 19.77 5.83 Favored 'General case' 0 N--CA 1.499 1.985 0 C-N-CA 124.126 0.97 . . . . 0.0 109.435 -169.977 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 2.5 pp -68.44 -43.8 76.29 Favored 'General case' 0 N--CA 1.478 0.944 0 CA-C-N 114.547 -1.206 . . . . 0.0 110.971 -178.97 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 76.3 m-85 -141.95 -84.73 0.18 Allowed 'General case' 0 CA--C 1.54 0.587 0 N-CA-C 106.948 -1.501 . . . . 0.0 106.948 171.327 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 54.5 t80 50.95 35.49 12.7 Favored 'General case' 0 CA--C 1.559 1.32 0 C-N-CA 124.374 1.07 . . . . 0.0 111.478 177.264 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 28.1 mm-40 -68.17 -59.69 3.04 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 124.578 1.151 . . . . 0.0 110.919 -176.969 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 137.85 81.63 0.1 OUTLIER Glycine 0 C--N 1.347 1.152 0 N-CA-C 111.785 -0.526 . . . . 0.0 111.785 179.089 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 39.0 p-80 -68.55 127.44 33.01 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 123.2 0.6 . . . . 0.0 110.077 176.044 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -100.81 121.04 41.02 Favored 'General case' 0 N--CA 1.473 0.721 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 173.097 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -79.88 -77.18 0.19 Allowed 'General case' 0 CA--C 1.545 0.785 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 178.843 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 28.5 t 179.95 164.32 1.13 Allowed 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 124.434 1.094 . . . . 0.0 109.025 179.122 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -167.0 -159.33 12.39 Favored Glycine 0 C--N 1.341 0.81 0 N-CA-C 111.569 -0.613 . . . . 0.0 111.569 -179.715 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 41.4 m -95.19 83.49 3.9 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 123.439 0.696 . . . . 0.0 110.098 179.183 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 11.6 tp10 -130.73 120.06 23.27 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 124.0 0.92 . . . . 0.0 109.874 177.83 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 4.5 mp0 -93.11 97.14 10.48 Favored 'General case' 0 C--O 1.242 0.678 0 N-CA-C 109.063 -0.718 . . . . 0.0 109.063 -178.227 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -79.88 78.47 6.48 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-O 121.654 0.74 . . . . 0.0 109.39 178.599 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 27.4 m -95.56 175.99 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 CA-C-N 115.008 -0.996 . . . . 0.0 110.984 -176.504 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.523 HG11 ' HG2' ' A' ' 47' ' ' LYS . 12.8 m -67.8 112.47 2.97 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.938 0 CA-C-N 115.359 -0.837 . . . . 0.0 110.98 178.539 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 15.5 p -145.93 137.32 24.83 Favored 'General case' 0 C--O 1.24 0.597 0 C-N-CA 124.671 1.188 . . . . 0.0 108.74 -178.605 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.407 HG12 HD22 ' A' ' 33' ' ' LEU . 86.3 t -125.62 125.54 68.78 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 C-N-CA 124.048 0.939 . . . . 0.0 108.972 -179.411 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -79.6 104.91 10.52 Favored 'General case' 0 CA--C 1.537 0.473 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 173.546 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.49 HD23 ' HB3' ' A' ' 43' ' ' PHE . 4.4 mm? -80.64 159.95 68.11 Favored Pre-proline 0 CA--C 1.552 1.023 0 C-N-CA 123.611 0.764 . . . . 0.0 109.537 177.068 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_endo -59.85 151.04 74.03 Favored 'Trans proline' 0 C--N 1.381 2.283 0 C-N-CA 122.378 2.052 . . . . 0.0 113.468 -178.016 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -144.81 168.13 12.99 Favored Pre-proline 0 N--CA 1.476 0.848 0 C-N-CA 124.203 1.001 . . . . 0.0 110.979 -168.698 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.537 ' HG2' ' HB2' ' A' ' 39' ' ' TRP . 30.3 Cg_endo -62.93 151.27 85.33 Favored 'Trans proline' 0 C--N 1.381 2.259 0 C-N-CA 122.0 1.8 . . . . 0.0 110.423 160.991 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 57.4 p -64.12 -23.33 67.28 Favored 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 123.528 0.731 . . . . 0.0 111.898 -177.225 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 18.3 m -74.64 -33.6 62.57 Favored 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 123.54 0.736 . . . . 0.0 111.745 178.226 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' TRP . . . . . 0.537 ' HB2' ' HG2' ' A' ' 36' ' ' PRO . 28.4 m95 -117.25 -174.38 2.59 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 123.942 0.897 . . . . 0.0 110.562 -176.866 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 44.8 mtmt -138.74 149.52 45.13 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 124.18 0.992 . . . . 0.0 108.612 168.888 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.559 ' HZ3' ' HB2' ' A' ' 43' ' ' PHE . 24.6 tptp -118.95 127.25 53.3 Favored 'General case' 0 C--N 1.331 -0.206 0 C-N-CA 124.815 1.246 . . . . 0.0 109.311 -175.214 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.416 HD22 ' HB ' ' A' ' 57' ' ' VAL . 4.1 tt -124.28 145.77 49.18 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 124.259 1.024 . . . . 0.0 108.647 174.68 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.559 ' HB2' ' HZ3' ' A' ' 41' ' ' LYS . 48.3 t80 -128.94 142.46 50.93 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 124.994 1.318 . . . . 0.0 108.124 170.934 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 36.5 m-85 -101.1 100.47 13.26 Favored Pre-proline 0 N--CA 1.48 1.058 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 171.243 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 62.2 Cg_endo -84.24 156.9 12.89 Favored 'Trans proline' 0 C--N 1.372 1.816 0 C-N-CA 122.736 2.291 . . . . 0.0 111.598 172.499 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 46.6 t-20 -83.76 152.07 24.87 Favored 'General case' 0 CA--C 1.545 0.768 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 171.22 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.523 ' HG2' HG11 ' A' ' 29' ' ' VAL . 96.4 mttt -62.19 -23.99 66.94 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 122.987 0.515 . . . . 0.0 111.435 179.007 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 65.3 t -60.52 -46.25 95.75 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.75 0 C-N-CA 123.127 0.571 . . . . 0.0 110.156 172.915 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 100.79 159.33 27.65 Favored Glycine 0 C--N 1.341 0.852 0 CA-C-N 115.496 -0.774 . . . . 0.0 111.387 -174.824 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' SER . . . . . 0.494 ' HA ' ' HA ' ' A' ' 95' ' ' THR . 32.6 t 71.74 -66.22 0.31 Allowed 'General case' 0 N--CA 1.49 1.574 0 C-N-CA 125.644 1.577 . . . . 0.0 110.823 -176.94 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 34.0 m -68.47 148.31 11.85 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.75 0 CA-C-N 115.227 -0.897 . . . . 0.0 111.769 177.875 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 21.9 ptmt -79.0 158.06 28.0 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-N 114.196 -1.366 . . . . 0.0 111.157 179.301 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 12.9 tmtt? -102.38 -53.81 2.82 Favored 'General case' 0 N--CA 1.477 0.915 0 N-CA-C 106.626 -1.62 . . . . 0.0 106.626 169.442 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 26.4 m -132.04 162.11 31.57 Favored 'General case' 0 CA--C 1.55 0.946 0 N-CA-C 106.59 -1.633 . . . . 0.0 106.59 173.766 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -72.42 -171.01 0.72 Allowed 'General case' 0 CA--C 1.551 0.993 0 CA-C-O 121.731 0.777 . . . . 0.0 111.31 179.217 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 11.7 t -81.75 138.04 20.2 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.416 0 C-N-CA 124.581 1.152 . . . . 0.0 110.707 -174.657 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.416 ' HB ' HD22 ' A' ' 42' ' ' LEU . 49.3 t -123.13 116.12 47.66 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.744 0 C-N-CA 123.674 0.79 . . . . 0.0 109.059 171.848 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 15.2 m-85 -86.36 120.64 27.92 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 123.36 0.664 . . . . 0.0 109.585 170.395 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 2.8 t -78.71 127.98 38.63 Favored 'Isoleucine or valine' 0 C--O 1.238 0.494 0 C-N-CA 123.56 0.744 . . . . 0.0 109.039 174.414 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -86.53 153.41 55.79 Favored Pre-proline 0 CA--C 1.539 0.553 0 CA-C-N 114.959 -1.019 . . . . 0.0 110.801 -176.869 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -59.54 -29.88 91.04 Favored 'Trans proline' 0 C--N 1.369 1.613 0 C-N-CA 122.898 2.398 . . . . 0.0 113.076 173.893 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.408 HG23 ' H ' ' A' ' 64' ' ' GLU . 14.5 t -93.32 -3.97 52.51 Favored 'General case' 0 N--CA 1.486 1.343 0 C-N-CA 122.565 0.346 . . . . 0.0 111.522 176.894 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 90.04 -8.71 79.31 Favored Glycine 0 C--N 1.35 1.358 0 CA-C-O 119.576 -0.569 . . . . 0.0 113.996 -179.795 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.408 ' H ' HG23 ' A' ' 62' ' ' THR . 42.8 tt0 -72.63 77.64 1.09 Allowed 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 123.686 0.794 . . . . 0.0 109.306 175.316 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -73.06 158.34 35.57 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-N 115.013 -0.994 . . . . 0.0 111.581 -168.953 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.561 HG23 ' HB2' ' A' ' 71' ' ' GLN . 49.2 mm -122.14 115.42 46.16 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 CA-C-N 114.522 -1.217 . . . . 0.0 109.701 -166.723 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 14.1 p -88.5 -17.57 30.03 Favored 'General case' 0 CA--C 1.553 1.067 0 C-N-CA 123.765 0.826 . . . . 0.0 112.306 179.651 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 5.8 p30 -156.67 157.65 35.57 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 112.133 0.42 . . . . 0.0 112.133 -174.558 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 41.9 mtm105 -56.6 -36.58 69.57 Favored 'General case' 0 N--CA 1.493 1.724 0 C-N-CA 124.35 1.06 . . . . 0.0 113.858 -170.868 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 7.0 tmtm? -54.62 -49.35 70.7 Favored 'General case' 0 N--CA 1.484 1.232 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 179.544 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.561 ' HB2' HG23 ' A' ' 66' ' ' ILE . 91.1 mt-30 -64.06 -35.16 79.84 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 123.693 0.797 . . . . 0.0 111.312 -179.544 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.458 HD12 ' HB ' ' A' ' 85' ' ' ILE . 0.6 OUTLIER -64.68 -51.71 61.06 Favored 'General case' 0 N--CA 1.483 1.178 0 O-C-N 123.739 0.649 . . . . 0.0 109.369 -179.813 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -69.34 -42.16 75.68 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 124.298 1.039 . . . . 0.0 111.599 -173.523 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 1.1 pp0? -66.44 -33.12 75.0 Favored 'General case' 0 N--CA 1.472 0.665 0 O-C-N 123.427 0.454 . . . . 0.0 109.897 176.091 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 12.2 t80 -61.92 -47.1 86.45 Favored 'General case' 0 C--N 1.357 0.909 0 O-C-N 123.656 0.597 . . . . 0.0 109.447 175.41 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.453 ' HG ' ' O ' ' A' ' 72' ' ' LEU . 81.9 mt -62.21 -48.98 77.6 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 123.038 0.535 . . . . 0.0 111.195 -175.738 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.76 -17.61 61.08 Favored 'General case' 0 CA--C 1.551 0.989 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.754 -176.806 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 30.7 t -92.77 -27.7 17.04 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 123.381 0.672 . . . . 0.0 110.781 175.654 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 51.9 m80 -127.72 92.25 43.19 Favored Pre-proline 0 N--CA 1.479 0.979 0 C-N-CA 124.204 1.002 . . . . 0.0 108.735 -174.334 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -64.63 159.79 43.25 Favored 'Trans proline' 0 C--N 1.371 1.756 0 C-N-CA 122.858 2.372 . . . . 0.0 112.551 179.131 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 91.62 -24.35 20.74 Favored Glycine 0 C--N 1.346 1.093 0 CA-C-N 115.989 -0.551 . . . . 0.0 112.971 179.06 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 41.7 m-80 -72.59 132.05 83.91 Favored Pre-proline 0 CA--C 1.546 0.817 0 C-N-CA 123.454 0.702 . . . . 0.0 110.308 177.651 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_endo -60.56 148.49 90.94 Favored 'Trans proline' 0 C--N 1.376 2.0 0 C-N-CA 123.226 2.617 . . . . 0.0 113.017 -176.123 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.406 ' O ' ' HG2' ' A' ' 87' ' ' GLU . . . -68.42 148.44 50.65 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 123.549 0.74 . . . . 0.0 112.088 -175.185 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.458 ' HB ' HD12 ' A' ' 72' ' ' LEU . 15.7 tt -63.49 -13.91 13.66 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.399 0 C-N-CA 124.329 1.052 . . . . 0.0 112.21 -177.459 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -57.76 -38.67 75.82 Favored 'General case' 0 CA--C 1.553 1.074 0 C-N-CA 124.153 0.981 . . . . 0.0 112.213 175.588 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.406 ' HG2' ' O ' ' A' ' 84' ' ' ALA . 11.3 pt-20 -90.55 -10.32 43.93 Favored 'General case' 0 N--CA 1.487 1.404 0 C-N-CA 122.993 0.517 . . . . 0.0 111.947 178.138 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -77.31 115.63 17.24 Favored 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 175.804 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 6.5 t0 -91.38 109.8 21.08 Favored 'General case' 0 CA--C 1.54 0.591 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 -176.122 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 69.8 m95 -96.99 -22.97 16.52 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 123.909 0.884 . . . . 0.0 110.106 176.119 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 12.9 t -88.16 7.81 29.98 Favored 'General case' 0 N--CA 1.486 1.329 0 C-N-CA 123.428 0.691 . . . . 0.0 111.718 -174.528 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 9.4 t -81.11 51.35 1.57 Allowed 'General case' 0 CA--C 1.56 1.344 0 CA-C-O 122.28 1.038 . . . . 0.0 111.431 175.79 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 46.4 m -74.13 101.84 4.06 Favored 'General case' 0 CA--C 1.545 0.751 0 CA-C-N 115.323 -0.853 . . . . 0.0 109.84 174.112 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -64.86 125.11 29.94 Favored Glycine 0 C--N 1.351 1.389 0 CA-C-N 115.684 -0.689 . . . . 0.0 112.918 -177.545 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' THR . . . . . 0.494 ' HA ' ' HA ' ' A' ' 50' ' ' SER . 96.3 m . . . . . 0 CA--C 1.552 1.047 0 CA-C-O 118.595 -0.716 . . . . 0.0 110.563 177.327 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.6 ptp . . . . . 0 N--CA 1.493 1.698 0 CA-C-O 120.611 0.243 . . . . 0.0 110.761 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 85.3 t60 -155.85 103.27 2.23 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 123.125 0.57 . . . . 0.0 109.67 178.002 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 15.1 t-80 -155.52 -39.82 0.08 Allowed 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 124.785 1.234 . . . . 0.0 108.022 169.587 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 29.1 t-80 -77.8 90.89 4.07 Favored 'General case' 0 CA--C 1.547 0.845 0 N-CA-C 109.333 -0.618 . . . . 0.0 109.333 171.11 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 42.5 t-80 -111.83 90.62 3.39 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 124.259 1.024 . . . . 0.0 108.305 175.497 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 76.9 t60 -164.38 112.76 1.12 Allowed 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 -177.089 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 48.6 m170 -103.12 119.22 38.46 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 123.415 0.686 . . . . 0.0 109.538 176.409 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 38.0 m -143.22 92.9 2.43 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 124.215 1.006 . . . . 0.0 108.666 173.19 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 50.3 m -141.01 113.36 8.02 Favored 'General case' 0 C--O 1.241 0.609 0 C-N-CA 124.002 0.921 . . . . 0.0 108.735 178.827 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -164.5 -171.89 31.31 Favored Glycine 0 C--N 1.339 0.724 0 O-C-N 123.664 0.602 . . . . 0.0 111.936 179.207 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 66.6 mtt-85 -123.72 117.86 25.9 Favored 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 177.981 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -72.66 78.35 1.09 Allowed 'General case' 0 N--CA 1.476 0.825 0 CA-C-O 121.698 0.761 . . . . 0.0 109.839 178.204 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 51.8 t-20 -132.19 92.56 3.12 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 107.654 -1.239 . . . . 0.0 107.654 -179.121 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -146.58 174.17 11.66 Favored 'General case' 0 C--O 1.244 0.775 0 CA-C-N 114.899 -1.046 . . . . 0.0 109.239 178.042 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 25.2 p90 -65.95 108.63 2.25 Favored 'General case' 0 CA--C 1.553 1.081 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 173.001 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 51.2 p90 -91.18 -16.92 26.92 Favored 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 123.466 0.706 . . . . 0.0 110.613 177.284 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 86.0 mm-40 56.42 80.86 0.14 Allowed 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 125.202 1.401 . . . . 0.0 111.839 178.646 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -85.19 62.65 4.48 Favored Glycine 0 C--N 1.348 1.212 0 CA-C-N 115.662 -0.699 . . . . 0.0 112.38 -179.573 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 5.8 p-80 -83.07 123.99 30.02 Favored 'General case' 0 CA--C 1.548 0.896 0 C-N-CA 124.067 0.947 . . . . 0.0 109.867 -179.926 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 69.17 -67.42 0.22 Allowed 'General case' 0 N--CA 1.489 1.485 0 C-N-CA 125.624 1.57 . . . . 0.0 110.594 -177.858 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -68.17 139.36 56.1 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 123.227 0.611 . . . . 0.0 110.253 172.305 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 22.8 t 68.21 25.32 7.29 Favored 'General case' 0 CA--C 1.556 1.174 0 C-N-CA 124.619 1.168 . . . . 0.0 111.436 -178.794 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -157.06 -71.4 0.01 OUTLIER Glycine 0 C--N 1.35 1.355 0 N-CA-C 111.15 -0.78 . . . . 0.0 111.15 176.019 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 47.7 t 58.7 68.58 0.81 Allowed 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 124.872 1.269 . . . . 0.0 110.485 179.274 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 -87.21 52.17 2.44 Favored 'General case' 0 CA--C 1.546 0.815 0 CA-C-N 115.219 -0.901 . . . . 0.0 108.849 177.105 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 58.31 -171.27 0.11 Allowed 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 124.393 1.077 . . . . 0.0 111.933 -170.401 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -132.56 86.79 2.35 Favored 'General case' 0 C--O 1.237 0.41 0 N-CA-C 106.617 -1.624 . . . . 0.0 106.617 170.073 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 33.6 m -64.51 152.48 8.54 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 CA-C-N 115.135 -0.938 . . . . 0.0 111.088 -177.508 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 15.3 m -63.42 104.81 0.41 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.884 0 CA-C-O 121.764 0.792 . . . . 0.0 110.345 -179.039 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 30.8 p -161.99 113.48 1.67 Allowed 'General case' 0 C--O 1.239 0.513 0 C-N-CA 124.52 1.128 . . . . 0.0 108.078 -177.34 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 83.3 t -105.59 124.33 60.53 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.517 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.451 ' HA ' ' HA ' ' A' ' 42' ' ' LEU . 51.6 mt-10 -76.72 113.21 14.12 Favored 'General case' 0 CA--C 1.533 0.317 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 173.761 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.46 HD23 ' HB3' ' A' ' 43' ' ' PHE . 3.7 mm? -87.28 166.4 26.03 Favored Pre-proline 0 CA--C 1.555 1.166 0 C-N-CA 123.69 0.796 . . . . 0.0 109.017 -179.786 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -51.54 134.72 46.9 Favored 'Trans proline' 0 C--N 1.388 2.633 0 C-N-CA 123.012 2.475 . . . . 0.0 113.161 175.854 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.451 ' HB2' ' HB3' ' A' ' 41' ' ' LYS . . . -128.91 158.97 70.89 Favored Pre-proline 0 N--CA 1.477 0.89 0 C-N-CA 125.335 1.454 . . . . 0.0 110.913 -170.648 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.647 ' HG2' ' HB2' ' A' ' 39' ' ' TRP . 58.9 Cg_endo -70.16 177.96 5.32 Favored 'Trans proline' 0 C--N 1.381 2.262 0 C-N-CA 122.686 2.257 . . . . 0.0 111.44 166.057 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 77.2 p -71.22 -47.67 55.96 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 123.694 0.798 . . . . 0.0 112.498 -169.741 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 22.2 m -74.65 -35.61 62.85 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 123.809 0.844 . . . . 0.0 110.884 -175.594 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' TRP . . . . . 0.647 ' HB2' ' HG2' ' A' ' 36' ' ' PRO . 39.7 m95 -100.3 174.3 6.19 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 123.693 0.797 . . . . 0.0 111.28 -175.297 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.785 ' HB3' ' HB ' ' A' ' 59' ' ' VAL . 15.7 tppt? -126.94 148.39 50.06 Favored 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 107.187 -1.412 . . . . 0.0 107.187 169.127 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.451 ' HB3' ' HB2' ' A' ' 35' ' ' ALA . 0.0 OUTLIER -120.97 127.94 52.26 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 107.688 -1.227 . . . . 0.0 107.688 179.41 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.451 ' HA ' ' HA ' ' A' ' 32' ' ' GLU . 4.5 tt -128.55 146.1 50.93 Favored 'General case' 0 C--N 1.324 -0.541 0 C-N-CA 125.29 1.436 . . . . 0.0 107.569 174.033 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.46 ' HB3' HD23 ' A' ' 33' ' ' LEU . 31.6 t80 -126.94 142.92 51.43 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 124.707 1.203 . . . . 0.0 107.923 172.509 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 14.1 m-85 -100.84 99.09 9.52 Favored Pre-proline 0 N--CA 1.488 1.44 0 C-N-CA 123.17 0.588 . . . . 0.0 110.91 174.084 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -82.36 89.41 1.18 Allowed 'Trans proline' 0 C--N 1.378 2.108 0 C-N-CA 123.066 2.511 . . . . 0.0 111.999 171.909 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 45.8 t-20 -71.09 147.91 48.01 Favored 'General case' 0 N--CA 1.479 0.979 0 CA-C-N 115.815 -0.63 . . . . 0.0 109.536 178.969 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 31.1 mmmt -51.07 -54.35 25.64 Favored 'General case' 0 N--CA 1.48 1.025 0 C-N-CA 124.485 1.114 . . . . 0.0 111.618 176.973 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 65.7 t -105.12 128.79 58.68 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 -179.704 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.41 ' HA2' ' HD3' ' A' ' 53' ' ' LYS . . . -78.34 -30.33 50.27 Favored Glycine 0 CA--C 1.53 1.011 0 CA-C-N 116.309 -0.405 . . . . 0.0 112.757 178.847 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 29.7 m -69.71 -24.44 63.56 Favored 'General case' 0 CA--C 1.551 0.994 0 C-N-CA 123.851 0.861 . . . . 0.0 112.464 -177.956 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 27.5 m -86.75 -169.82 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.408 0 C-N-CA 122.787 0.435 . . . . 0.0 109.942 175.607 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 19.0 ptpt -65.41 77.33 0.06 Allowed 'General case' 0 CA--C 1.558 1.251 0 C-N-CA 123.735 0.814 . . . . 0.0 112.534 178.09 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.41 ' HD3' ' HA2' ' A' ' 49' ' ' GLY . 23.6 pttm -78.24 104.43 8.82 Favored 'General case' 0 C--N 1.346 0.446 0 N-CA-C 107.449 -1.315 . . . . 0.0 107.449 171.295 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 20.1 m -61.18 139.35 58.14 Favored 'General case' 0 CA--C 1.543 0.701 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.605 -176.866 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 15.1 pt-20 -73.37 -165.92 0.29 Allowed 'General case' 0 CA--C 1.55 0.959 0 CA-C-O 121.86 0.838 . . . . 0.0 111.431 -174.236 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 75.4 t -80.28 137.57 21.28 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.76 0 CA-C-N 114.988 -1.005 . . . . 0.0 109.274 179.575 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.424 ' HB ' HD22 ' A' ' 42' ' ' LEU . 87.3 t -117.81 115.2 47.75 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 178.223 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.427 ' CZ ' ' HE3' ' A' ' 41' ' ' LYS . 19.6 m-85 -94.94 115.1 27.03 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 123.657 0.783 . . . . 0.0 109.378 174.635 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.785 ' HB ' ' HB3' ' A' ' 40' ' ' LYS . 2.8 t -79.48 129.84 36.97 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 175.359 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -84.31 153.62 62.54 Favored Pre-proline 0 CA--C 1.54 0.565 0 CA-C-N 114.939 -1.028 . . . . 0.0 111.003 -175.035 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_endo -61.02 -32.72 92.45 Favored 'Trans proline' 0 C--N 1.379 2.147 0 C-N-CA 122.913 2.408 . . . . 0.0 113.101 177.02 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.464 HG23 ' H ' ' A' ' 64' ' ' GLU . 13.2 t -84.49 -6.35 59.37 Favored 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 122.981 0.512 . . . . 0.0 111.627 179.796 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 94.16 -19.87 50.89 Favored Glycine 0 C--N 1.357 1.702 0 CA-C-O 119.686 -0.508 . . . . 0.0 113.179 179.486 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.464 ' H ' HG23 ' A' ' 62' ' ' THR . 42.7 tt0 -69.63 75.74 0.42 Allowed 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 124.299 1.039 . . . . 0.0 109.09 175.608 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -75.36 150.24 38.46 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-O 121.892 0.853 . . . . 0.0 111.548 -166.996 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 39.8 mm -102.27 123.32 55.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 114.047 -1.433 . . . . 0.0 109.555 -175.72 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 24.3 m -105.69 -1.34 24.63 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 123.153 0.581 . . . . 0.0 111.093 -179.404 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 14.5 p-10 -158.01 145.65 18.4 Favored 'General case' 0 C--N 1.353 0.749 0 C-N-CA 123.076 0.55 . . . . 0.0 111.241 -174.062 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.451 ' HG3' HD11 ' A' ' 85' ' ' ILE . 44.1 ttp180 -61.35 -30.61 70.63 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 124.839 1.255 . . . . 0.0 113.864 -166.969 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 6.4 tmtm? -62.28 -49.06 77.16 Favored 'General case' 0 N--CA 1.489 1.508 0 C-N-CA 123.139 0.576 . . . . 0.0 109.554 177.196 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.558 ' HA ' ' HG3' ' A' ' 74' ' ' GLN . 86.4 mm-40 -66.35 -21.61 66.25 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-N 115.406 -0.815 . . . . 0.0 111.515 -176.565 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.456 ' HB3' HD12 ' A' ' 85' ' ' ILE . 0.6 OUTLIER -65.44 -54.95 21.16 Favored 'General case' 0 N--CA 1.477 0.894 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 174.77 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -59.15 -49.74 76.69 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 123.877 0.871 . . . . 0.0 111.031 -176.05 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' GLN . . . . . 0.558 ' HG3' ' HA ' ' A' ' 71' ' ' GLN . 0.0 OUTLIER -67.57 -25.89 66.01 Favored 'General case' 0 CA--C 1.547 0.864 0 CA-C-N 115.414 -0.812 . . . . 0.0 111.369 -177.226 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 34.0 t80 -66.45 -50.43 63.38 Favored 'General case' 0 C--N 1.357 0.897 0 C-N-CA 123.211 0.605 . . . . 0.0 109.592 173.445 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 81.5 mt -58.28 -43.13 87.84 Favored 'General case' 0 N--CA 1.486 1.347 0 O-C-N 123.787 0.679 . . . . 0.0 111.873 -173.679 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 58.3 pttt -68.03 -41.0 82.78 Favored 'General case' 0 N--CA 1.478 0.932 0 O-C-N 123.32 0.387 . . . . 0.0 111.035 -179.354 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 77.4 p -85.52 -10.37 56.11 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 112.012 0.375 . . . . 0.0 112.012 -177.17 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 53.1 m-70 -130.06 84.25 60.95 Favored Pre-proline 0 N--CA 1.482 1.167 0 C-N-CA 124.322 1.049 . . . . 0.0 108.714 177.654 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -67.9 147.29 74.22 Favored 'Trans proline' 0 C--N 1.375 1.924 0 C-N-CA 122.631 2.22 . . . . 0.0 111.786 178.838 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 101.41 -6.43 55.63 Favored Glycine 0 CA--C 1.53 0.995 0 CA-C-N 116.071 -0.513 . . . . 0.0 112.698 -177.192 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 40.2 m-80 -90.68 141.05 26.68 Favored Pre-proline 0 N--CA 1.48 1.062 0 C-N-CA 123.164 0.586 . . . . 0.0 110.595 177.239 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_endo -62.0 149.57 89.79 Favored 'Trans proline' 0 C--N 1.38 2.236 0 C-N-CA 123.384 2.723 . . . . 0.0 112.783 179.091 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -66.28 158.89 27.84 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 124.22 1.008 . . . . 0.0 111.882 -173.162 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.456 HD12 ' HB3' ' A' ' 72' ' ' LEU . 19.3 tt -77.87 -17.58 14.0 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.544 177.485 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -60.7 -34.48 74.42 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 123.8 0.84 . . . . 0.0 111.471 177.089 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -92.81 -11.35 33.91 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 123.492 0.717 . . . . 0.0 110.976 179.65 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 5.8 m-30 -82.01 127.7 33.34 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 123.273 0.629 . . . . 0.0 109.832 176.083 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -92.47 122.18 34.66 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 123.909 0.884 . . . . 0.0 109.785 -178.317 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 77.5 m95 -115.73 6.7 14.48 Favored 'General case' 0 N--CA 1.488 1.471 0 C-N-CA 123.837 0.855 . . . . 0.0 110.729 176.637 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 9.9 t -108.55 17.41 22.05 Favored 'General case' 0 CA--C 1.557 1.22 0 C-N-CA 124.815 1.246 . . . . 0.0 110.662 -177.315 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 9.9 t -77.88 31.72 0.17 Allowed 'General case' 0 CA--C 1.563 1.452 0 C-N-CA 124.205 1.002 . . . . 0.0 113.027 -176.153 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 22.0 t -89.24 15.21 9.32 Favored 'General case' 0 CA--C 1.552 1.029 0 C-N-CA 124.096 0.958 . . . . 0.0 111.028 178.541 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 82.8 100.51 0.49 Allowed Glycine 0 C--N 1.354 1.541 0 N-CA-C 109.672 -1.371 . . . . 0.0 109.672 -168.518 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 37.8 p . . . . . 0 CA--C 1.558 1.263 0 C-N-CA 123.862 0.865 . . . . 0.0 111.219 -173.626 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 83.3 mtp . . . . . 0 N--CA 1.481 1.111 0 N-CA-C 110.329 -0.249 . . . . 0.0 110.329 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 20.5 t60 -110.41 23.6 14.05 Favored 'General case' 0 CA--C 1.554 1.099 0 C-N-CA 123.962 0.905 . . . . 0.0 108.774 175.47 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 27.5 t60 -56.0 -36.14 67.57 Favored 'General case' 0 N--CA 1.488 1.426 0 C-N-CA 124.121 0.969 . . . . 0.0 111.247 -177.308 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 65.9 t-80 -76.26 86.05 3.07 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.143 174.204 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 19.0 p-80 -106.52 130.61 54.27 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 115.714 -0.676 . . . . 0.0 109.916 179.237 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 58.0 t-80 -148.85 99.64 3.0 Favored 'General case' 0 N--CA 1.466 0.325 0 N-CA-C 108.663 -0.865 . . . . 0.0 108.663 174.447 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 64.3 t-80 -155.11 81.5 1.07 Allowed 'General case' 0 CA--C 1.545 0.767 0 N-CA-C 108.358 -0.979 . . . . 0.0 108.358 176.856 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 20.4 p -107.78 98.99 8.5 Favored 'General case' 0 CA--C 1.545 0.784 0 CA-C-N 115.363 -0.835 . . . . 0.0 109.92 179.934 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 25.9 p -89.81 100.67 13.43 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 123.148 0.579 . . . . 0.0 109.634 176.316 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -133.39 -152.77 6.93 Favored Glycine 0 C--N 1.349 1.294 0 N-CA-C 111.334 -0.706 . . . . 0.0 111.334 178.467 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 30.0 tpt180 -130.79 -57.72 1.04 Allowed 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 123.438 0.695 . . . . 0.0 109.359 179.141 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 69.08 160.68 0.19 Allowed 'General case' 0 CA--C 1.564 1.505 0 C-N-CA 125.09 1.356 . . . . 0.0 111.727 179.57 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 32.3 m-80 72.05 96.84 0.07 Allowed 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 125.488 1.515 . . . . 0.0 111.317 175.392 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -93.22 133.09 36.78 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 122.984 0.514 . . . . 0.0 110.146 176.535 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 5.1 p90 -98.26 -51.5 3.97 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 124.506 1.123 . . . . 0.0 109.08 177.676 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 47.4 t80 49.7 87.7 0.03 OUTLIER 'General case' 0 CA--C 1.559 1.313 0 C-N-CA 124.844 1.258 . . . . 0.0 112.314 177.267 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 11.1 pt20 -159.3 164.73 34.61 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 123.523 0.729 . . . . 0.0 111.097 -174.9 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 121.13 156.6 9.84 Favored Glycine 0 C--N 1.349 1.302 0 CA-C-N 115.843 -0.617 . . . . 0.0 113.127 176.169 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 30.0 p80 -81.79 135.58 35.45 Favored 'General case' 0 N--CA 1.476 0.845 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 174.956 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 51.2 ttm -162.0 -48.54 0.04 OUTLIER 'General case' 0 C--O 1.243 0.732 0 C-N-CA 123.389 0.676 . . . . 0.0 109.85 -173.001 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . 63.93 -88.48 0.03 OUTLIER 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 124.978 1.311 . . . . 0.0 110.199 -173.454 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 23.0 t 53.8 25.07 4.86 Favored 'General case' 0 C--N 1.369 1.443 0 C-N-CA 124.238 1.015 . . . . 0.0 112.271 176.173 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -90.72 26.64 10.29 Favored Glycine 0 C--N 1.35 1.346 0 C-N-CA 123.537 0.589 . . . . 0.0 114.012 -169.596 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 59.3 m -148.08 -46.61 0.16 Allowed 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 124.236 1.014 . . . . 0.0 109.008 177.183 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -129.43 143.58 50.9 Favored 'General case' 0 C--N 1.348 0.541 0 C-N-CA 123.905 0.882 . . . . 0.0 109.272 175.02 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -81.96 150.98 27.39 Favored 'General case' 0 C--O 1.241 0.645 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 174.132 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 31.9 mt-10 -63.85 100.43 0.3 Allowed 'General case' 0 CA--C 1.55 0.946 0 C-N-CA 123.394 0.678 . . . . 0.0 110.888 -172.445 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 32.6 m -68.04 129.12 32.39 Favored 'Isoleucine or valine' 0 C--O 1.245 0.867 0 C-N-CA 123.489 0.715 . . . . 0.0 110.904 -175.771 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 23.2 m -75.21 106.69 5.16 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.833 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 176.678 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.469 ' HA ' ' HD2' ' A' ' 45' ' ' PRO . 31.2 p -155.28 129.78 9.08 Favored 'General case' 0 C--O 1.239 0.508 0 CA-C-N 114.97 -1.013 . . . . 0.0 109.09 -173.143 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 65.4 t -114.36 124.89 71.45 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 175.784 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.446 ' HA ' ' HA ' ' A' ' 42' ' ' LEU . 47.1 mt-10 -80.33 110.47 15.79 Favored 'General case' 0 C--O 1.237 0.433 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 177.856 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.523 HD23 ' HB3' ' A' ' 43' ' ' PHE . 4.2 mm? -86.61 160.42 50.54 Favored Pre-proline 0 N--CA 1.476 0.841 0 C-N-CA 123.814 0.846 . . . . 0.0 108.779 -178.775 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 14.0 Cg_endo -51.54 125.68 17.42 Favored 'Trans proline' 0 C--N 1.39 2.735 0 C-N-CA 123.073 2.515 . . . . 0.0 113.101 -172.65 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.46 ' HB2' ' HB3' ' A' ' 41' ' ' LYS . . . -110.51 153.68 43.4 Favored Pre-proline 0 N--CA 1.469 0.483 0 CA-C-N 114.659 -1.155 . . . . 0.0 111.39 -170.876 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.689 ' HG2' ' HB2' ' A' ' 39' ' ' TRP . 56.3 Cg_endo -68.29 153.49 74.24 Favored 'Trans proline' 0 C--N 1.373 1.835 0 C-N-CA 122.584 2.189 . . . . 0.0 109.811 165.561 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 21.0 m -64.23 -29.31 70.42 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 123.468 0.707 . . . . 0.0 112.815 -172.138 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 16.0 m -83.56 -29.26 27.98 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 123.312 0.645 . . . . 0.0 111.609 -176.42 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' TRP . . . . . 0.689 ' HB2' ' HG2' ' A' ' 36' ' ' PRO . 17.5 m95 -114.19 -178.55 3.4 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 123.812 0.845 . . . . 0.0 109.668 -177.283 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.488 ' HB2' ' HB ' ' A' ' 59' ' ' VAL . 0.0 OUTLIER -119.7 165.63 14.26 Favored 'General case' 0 N--CA 1.473 0.713 0 N-CA-C 107.836 -1.172 . . . . 0.0 107.836 164.861 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.46 ' HB3' ' HB2' ' A' ' 35' ' ' ALA . 14.4 tptm -150.73 119.49 6.58 Favored 'General case' 0 C--O 1.238 0.496 0 C-N-CA 124.187 0.995 . . . . 0.0 108.77 -172.776 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.446 ' HA ' ' HA ' ' A' ' 32' ' ' GLU . 2.7 tt -129.1 150.21 50.59 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 113.579 -1.646 . . . . 0.0 108.29 -175.872 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.523 ' HB3' HD23 ' A' ' 33' ' ' LEU . 33.8 t80 -130.24 139.82 50.76 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 124.353 1.061 . . . . 0.0 108.398 170.07 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 22.2 m-85 -96.8 103.11 13.52 Favored Pre-proline 0 CA--C 1.552 1.028 0 C-N-CA 122.849 0.46 . . . . 0.0 109.952 173.696 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.469 ' HD2' ' HA ' ' A' ' 30' ' ' SER . 95.3 Cg_endo -76.28 154.25 36.46 Favored 'Trans proline' 0 C--N 1.373 1.854 0 C-N-CA 122.526 2.151 . . . . 0.0 111.983 172.61 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -80.17 -15.33 57.29 Favored 'General case' 0 CA--C 1.555 1.165 0 C-N-CA 123.686 0.794 . . . . 0.0 109.312 174.98 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 84.8 tttt 68.97 34.25 3.21 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 125.674 1.59 . . . . 0.0 108.579 -174.189 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 60.1 t -129.76 -44.13 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 CA-C-N 114.39 -1.277 . . . . 0.0 108.192 179.364 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 96.93 146.65 21.38 Favored Glycine 0 C--N 1.351 1.378 0 CA-C-N 115.111 -0.95 . . . . 0.0 110.818 -171.786 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 30.0 t 73.7 -68.05 0.24 Allowed 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 125.33 1.452 . . . . 0.0 111.641 179.803 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 15.6 m -64.46 130.63 29.72 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.921 0 C-N-CA 123.568 0.747 . . . . 0.0 111.446 177.885 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 46.1 mtmt -101.44 114.71 28.96 Favored 'General case' 0 N--CA 1.472 0.651 0 N-CA-C 108.925 -0.768 . . . . 0.0 108.925 178.39 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -72.13 -51.22 22.4 Favored 'General case' 0 N--CA 1.475 0.812 0 CA-C-O 122.064 0.935 . . . . 0.0 108.784 171.396 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 58.7 m -133.04 156.74 46.81 Favored 'General case' 0 CA--C 1.553 1.061 0 CA-C-N 114.369 -1.287 . . . . 0.0 108.768 176.242 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -90.26 -166.86 1.69 Allowed 'General case' 0 CA--C 1.555 1.162 0 C-N-CA 124.14 0.976 . . . . 0.0 111.713 -174.929 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 86.9 t -82.95 138.77 18.79 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.885 0 C-N-CA 125.056 1.342 . . . . 0.0 110.529 -178.162 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 61.4 t -121.17 115.39 46.57 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.002 0 C-N-CA 124.039 0.936 . . . . 0.0 109.327 175.423 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 23.8 m-85 -88.8 112.93 23.79 Favored 'General case' 0 N--CA 1.479 1.014 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 170.282 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.488 ' HB ' ' HB2' ' A' ' 40' ' ' LYS . 9.1 t -79.14 133.49 29.83 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 CA-C-O 121.231 0.539 . . . . 0.0 109.907 -179.843 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -86.5 154.15 56.34 Favored Pre-proline 0 CA--C 1.543 0.681 0 CA-C-N 114.567 -1.197 . . . . 0.0 111.785 -172.92 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_endo -61.06 -26.17 82.5 Favored 'Trans proline' 0 C--N 1.377 2.057 0 C-N-CA 123.386 2.724 . . . . 0.0 113.31 173.816 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.533 HG23 ' H ' ' A' ' 64' ' ' GLU . 9.8 t -89.2 -12.27 41.37 Favored 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 122.537 0.335 . . . . 0.0 111.213 176.217 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 95.45 -8.21 68.99 Favored Glycine 0 C--N 1.355 1.607 0 CA-C-O 119.621 -0.544 . . . . 0.0 113.942 -178.164 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.533 ' H ' HG23 ' A' ' 62' ' ' THR . 40.4 tt0 -76.15 78.15 2.97 Favored 'General case' 0 N--CA 1.481 1.092 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 172.47 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -65.34 134.28 53.21 Favored 'General case' 0 CA--C 1.543 0.705 0 CA-C-N 115.325 -0.852 . . . . 0.0 110.781 -173.325 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.635 HG23 ' HB2' ' A' ' 71' ' ' GLN . 44.7 mm -91.69 122.7 43.37 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.659 0 C-N-CA 125.068 1.347 . . . . 0.0 110.114 -175.094 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 6.0 p -94.63 -19.83 20.11 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 123.725 0.81 . . . . 0.0 111.989 177.491 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' ASN . . . . . 0.418 HD21 ' HG3' ' A' ' 71' ' ' GLN . 1.9 p-10 -150.87 150.23 30.64 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 122.959 0.504 . . . . 0.0 111.417 -173.139 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 65.8 mtp85 -55.57 -30.11 60.24 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 125.193 1.397 . . . . 0.0 114.149 -170.922 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 6.4 tmtm? -58.69 -50.61 73.26 Favored 'General case' 0 N--CA 1.48 1.063 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 179.572 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.635 ' HB2' HG23 ' A' ' 66' ' ' ILE . 54.1 mt-30 -63.27 -35.27 79.79 Favored 'General case' 0 N--CA 1.477 0.912 0 O-C-N 124.312 1.008 . . . . 0.0 111.073 -179.766 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.44 ' O ' ' HG ' ' A' ' 76' ' ' LEU . 0.2 OUTLIER -60.52 -52.31 65.73 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 123.482 0.713 . . . . 0.0 109.158 179.004 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -63.1 -50.02 72.16 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 123.839 0.855 . . . . 0.0 111.537 -175.949 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -66.87 -24.98 66.19 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.147 0.579 . . . . 0.0 111.261 -178.459 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 28.8 t80 -69.12 -47.22 65.69 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 123.818 0.847 . . . . 0.0 109.591 175.194 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.453 HD13 ' HA ' ' A' ' 84' ' ' ALA . 92.7 mt -66.01 -44.92 83.36 Favored 'General case' 0 N--CA 1.481 1.09 0 O-C-N 123.822 0.701 . . . . 0.0 111.815 -174.281 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -69.36 -25.89 64.4 Favored 'General case' 0 N--CA 1.48 1.069 0 CA-C-N 116.531 -0.304 . . . . 0.0 110.278 179.106 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 47.0 t -79.71 -29.37 40.68 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 123.046 0.538 . . . . 0.0 111.016 175.117 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 54.6 m80 -132.5 89.43 36.24 Favored Pre-proline 0 CA--C 1.546 0.791 0 C-N-CA 123.548 0.739 . . . . 0.0 109.562 -172.146 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -68.76 151.15 74.55 Favored 'Trans proline' 0 C--N 1.38 2.195 0 C-N-CA 122.664 2.243 . . . . 0.0 112.593 -177.287 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 95.05 -22.85 36.1 Favored Glycine 0 C--N 1.347 1.151 0 CA-C-N 116.141 -0.481 . . . . 0.0 113.052 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 14.7 m120 -68.0 131.52 92.31 Favored Pre-proline 0 N--CA 1.482 1.133 0 CA-C-O 119.102 -0.475 . . . . 0.0 109.821 173.162 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -55.78 141.53 84.69 Favored 'Trans proline' 0 C--N 1.38 2.209 0 C-N-CA 123.133 2.555 . . . . 0.0 112.723 -175.258 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.453 ' HA ' HD13 ' A' ' 76' ' ' LEU . . . -66.53 159.52 27.13 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 123.937 0.895 . . . . 0.0 112.811 -170.675 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.44 ' HB ' HD12 ' A' ' 72' ' ' LEU . 16.3 tt -67.9 -20.72 26.28 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.014 0 C-N-CA 123.863 0.865 . . . . 0.0 110.567 176.26 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -63.68 -36.54 84.17 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 124.457 1.103 . . . . 0.0 112.204 179.741 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -92.35 -1.49 57.01 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 123.442 0.697 . . . . 0.0 111.213 179.086 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 5.3 m-30 -93.82 112.38 24.23 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 123.923 0.889 . . . . 0.0 109.864 178.008 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 11.0 p-10 -86.65 115.06 23.86 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-O 121.494 0.664 . . . . 0.0 110.221 -179.502 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 74.2 m95 -94.12 -20.05 20.25 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 123.588 0.755 . . . . 0.0 109.701 172.822 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 15.1 t -73.82 7.0 2.79 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 125.01 1.324 . . . . 0.0 112.65 -176.734 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.456 HG21 ' HE2' ' A' ' 41' ' ' LYS . 2.7 t -64.11 -18.34 64.31 Favored 'General case' 0 CA--C 1.553 1.063 0 C-N-CA 123.276 0.63 . . . . 0.0 111.81 177.206 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 16.8 p -61.55 -30.26 70.54 Favored 'General case' 0 CA--C 1.549 0.929 0 C-N-CA 124.207 1.003 . . . . 0.0 111.167 174.593 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 136.06 -147.94 19.44 Favored Glycine 0 C--N 1.343 0.939 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.627 175.226 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 4.3 t . . . . . 0 C--O 1.251 1.134 0 C-N-CA 124.011 0.924 . . . . 0.0 109.168 175.363 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.3 mpt? . . . . . 0 N--CA 1.475 0.795 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 38.6 m170 -86.6 114.54 23.41 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 123.447 0.699 . . . . 0.0 109.462 176.213 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 61.0 m80 -75.37 -29.07 59.75 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 124.395 1.078 . . . . 0.0 111.632 -177.961 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 11.4 m-70 68.64 115.24 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.693 0 C-N-CA 124.861 1.264 . . . . 0.0 112.23 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 36.6 m80 -120.45 137.39 54.36 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 123.672 0.789 . . . . 0.0 109.283 173.498 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 40.2 t60 -155.56 81.33 1.03 Allowed 'General case' 0 CA--C 1.542 0.638 0 N-CA-C 107.373 -1.343 . . . . 0.0 107.373 173.202 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 18.1 p-80 -82.56 136.98 34.7 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 123.857 0.863 . . . . 0.0 110.263 -178.403 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 20.1 m -82.84 -63.56 1.34 Allowed 'General case' 0 C--O 1.243 0.713 0 C-N-CA 122.974 0.51 . . . . 0.0 109.977 178.136 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 23.5 m 57.15 39.96 28.57 Favored 'General case' 0 CA--C 1.552 1.033 0 C-N-CA 124.13 0.972 . . . . 0.0 111.218 178.117 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -66.06 -23.35 71.23 Favored Glycine 0 C--N 1.357 1.698 0 CA-C-N 115.555 -0.748 . . . . 0.0 113.751 -175.437 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 26.1 mtm180 -99.73 142.05 31.73 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 123.394 0.678 . . . . 0.0 110.272 174.679 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -70.77 -56.64 5.91 Favored 'General case' 0 CA--C 1.539 0.557 0 O-C-N 124.241 0.963 . . . . 0.0 109.436 172.058 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 65.4 t30 58.64 18.84 6.18 Favored 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 125.281 1.432 . . . . 0.0 112.118 175.651 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.431 HD12 ' HB2' ' A' ' 15' ' ' TYR . 3.9 pp -80.66 -46.18 16.02 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 123.099 0.56 . . . . 0.0 111.173 -173.76 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.431 ' HB2' HD12 ' A' ' 14' ' ' LEU . 33.1 m-85 -153.65 -80.6 0.09 Allowed 'General case' 0 N--CA 1.483 1.175 0 C-N-CA 124.336 1.054 . . . . 0.0 108.404 178.833 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 76.9 t80 47.59 77.61 0.09 Allowed 'General case' 0 CA--C 1.552 1.043 0 C-N-CA 125.498 1.519 . . . . 0.0 112.105 -178.388 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -123.94 -61.24 1.38 Allowed 'General case' 0 N--CA 1.479 1.002 0 N-CA-C 107.742 -1.207 . . . . 0.0 107.742 178.218 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 117.25 117.17 2.88 Favored Glycine 0 C--N 1.352 1.442 0 CA-C-N 115.155 -0.929 . . . . 0.0 111.486 179.354 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 18.6 p80 -85.06 132.24 34.35 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 122.919 0.488 . . . . 0.0 110.122 -179.338 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 22.5 ptp -83.67 -31.91 25.88 Favored 'General case' 0 N--CA 1.474 0.768 0 CA-C-N 115.846 -0.616 . . . . 0.0 111.302 -177.845 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . 52.33 93.44 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.379 0 C-N-CA 124.825 1.25 . . . . 0.0 112.52 177.302 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 28.3 m -60.88 -49.97 75.3 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 122.872 0.469 . . . . 0.0 111.183 -175.875 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 63.48 -95.62 0.15 Allowed Glycine 0 C--N 1.353 1.484 0 CA-C-N 115.483 -0.78 . . . . 0.0 111.486 -178.401 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 22.7 t -169.61 -179.39 3.35 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 124.628 1.171 . . . . 0.0 108.223 175.253 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 28.3 tt0 -145.42 29.13 1.16 Allowed 'General case' 0 N--CA 1.483 1.185 0 CA-C-O 121.956 0.884 . . . . 0.0 109.721 175.133 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -78.4 118.77 20.89 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 115.047 -0.979 . . . . 0.0 110.4 -179.53 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -91.48 30.04 1.38 Allowed 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 124.491 1.117 . . . . 0.0 110.8 -179.824 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 33.6 m -73.51 157.71 6.28 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.789 0 C-N-CA 124.784 1.234 . . . . 0.0 110.766 -177.955 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 17.1 m -68.36 109.27 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.988 0 CA-C-O 121.639 0.733 . . . . 0.0 110.422 -178.604 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 13.6 p -151.08 113.79 4.69 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 124.561 1.145 . . . . 0.0 108.408 -177.858 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 82.3 t -111.79 122.76 66.73 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 C-N-CA 124.38 1.072 . . . . 0.0 108.843 -176.759 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -79.5 116.74 19.89 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 123.112 0.565 . . . . 0.0 110.109 178.772 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.509 HD23 ' HB3' ' A' ' 43' ' ' PHE . 4.3 mm? -94.27 160.6 31.62 Favored Pre-proline 0 CA--C 1.555 1.167 0 C-N-CA 124.438 1.095 . . . . 0.0 109.128 177.362 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 13.1 Cg_endo -53.7 147.8 38.73 Favored 'Trans proline' 0 C--N 1.391 2.797 0 C-N-CA 123.22 2.613 . . . . 0.0 113.687 -177.974 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.599 ' HB2' ' HB3' ' A' ' 41' ' ' LYS . . . -152.23 167.24 13.61 Favored Pre-proline 0 CA--C 1.538 0.498 0 C-N-CA 123.884 0.874 . . . . 0.0 111.871 -167.92 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_exo -56.1 146.57 69.59 Favored 'Trans proline' 0 C--N 1.38 2.214 0 C-N-CA 122.571 2.181 . . . . 0.0 110.83 158.059 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 61.4 p -66.34 -33.74 76.41 Favored 'General case' 0 CA--C 1.552 1.026 0 C-N-CA 123.149 0.58 . . . . 0.0 110.695 177.451 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 37.1 m -64.79 -41.3 95.93 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 124.686 1.194 . . . . 0.0 111.3 177.136 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' TRP . . . . . 0.427 ' HE1' ' HD2' ' A' ' 83' ' ' PRO . 41.8 m95 -102.04 -166.48 1.29 Allowed 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 123.93 0.892 . . . . 0.0 110.127 178.735 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.493 ' HB3' ' HB ' ' A' ' 59' ' ' VAL . 1.1 tppt? -148.41 154.35 39.79 Favored 'General case' 0 CA--C 1.535 0.38 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 164.468 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.599 ' HB3' ' HB2' ' A' ' 35' ' ' ALA . 17.5 tptm -121.66 122.48 39.7 Favored 'General case' 0 N--CA 1.468 0.444 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 -179.055 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 4.5 tt -124.55 136.93 54.38 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 175.359 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.509 ' HB3' HD23 ' A' ' 33' ' ' LEU . 28.9 t80 -115.62 133.88 55.6 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 125.007 1.323 . . . . 0.0 108.021 172.81 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 13.2 m-85 -94.77 106.75 26.42 Favored Pre-proline 0 CA--C 1.547 0.854 0 C-N-CA 123.284 0.634 . . . . 0.0 109.479 171.66 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -82.72 -161.26 0.14 Allowed 'Trans proline' 0 C--N 1.37 1.66 0 C-N-CA 122.728 2.286 . . . . 0.0 111.522 169.41 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 34.7 t30 -155.82 -82.35 0.07 Allowed 'General case' 0 CA--C 1.544 0.735 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 172.59 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 58.7 tttp 176.64 -54.91 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 125.162 1.385 . . . . 0.0 107.759 -178.327 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 63.5 t -121.96 137.04 56.87 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.759 0 C-N-CA 124.104 0.962 . . . . 0.0 108.604 173.541 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -87.41 29.61 5.2 Favored Glycine 0 C--N 1.348 1.243 0 N-CA-C 113.958 0.343 . . . . 0.0 113.958 -177.454 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 44.7 m -106.97 7.44 29.92 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 123.707 0.803 . . . . 0.0 111.263 178.617 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 31.3 m -100.03 -172.01 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.055 0 C-N-CA 124.166 0.986 . . . . 0.0 109.836 178.507 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 80.9 tttt -63.77 -58.44 6.85 Favored 'General case' 0 CA--C 1.549 0.939 0 N-CA-C 109.581 -0.526 . . . . 0.0 109.581 170.133 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 28.8 ttpt 66.63 164.73 0.2 Allowed 'General case' 0 N--CA 1.486 1.368 0 C-N-CA 125.207 1.403 . . . . 0.0 110.326 -174.653 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 16.5 m -110.33 151.35 27.53 Favored 'General case' 0 CA--C 1.545 0.772 0 N-CA-C 108.134 -1.062 . . . . 0.0 108.134 173.281 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -83.45 -170.13 2.9 Favored 'General case' 0 CA--C 1.557 1.213 0 C-N-CA 123.826 0.85 . . . . 0.0 111.888 -172.186 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 64.4 t -83.11 131.08 34.59 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 C-N-CA 124.06 0.944 . . . . 0.0 109.745 176.705 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 61.0 t -121.91 117.81 53.59 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.858 0 C-N-CA 124.052 0.941 . . . . 0.0 109.297 179.448 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 36.1 m-85 -87.18 131.1 34.28 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 123.61 0.764 . . . . 0.0 110.064 169.6 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.541 ' HA ' ' HG3' ' A' ' 65' ' ' GLU . 10.8 t -82.35 129.27 37.75 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 171.045 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -85.26 150.41 54.65 Favored Pre-proline 0 CA--C 1.542 0.672 0 CA-C-N 114.889 -1.051 . . . . 0.0 110.71 179.052 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_endo -61.4 -24.86 79.19 Favored 'Trans proline' 0 CA--C 1.557 1.643 0 C-N-CA 123.543 2.829 . . . . 0.0 111.477 169.715 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 85.2 m -74.53 -35.08 63.13 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 125.296 1.438 . . . . 0.0 112.078 176.193 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 94.2 11.24 57.64 Favored Glycine 0 CA--C 1.534 1.227 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.763 -162.538 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -94.72 70.37 3.49 Favored 'General case' 0 CA--C 1.542 0.641 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 174.938 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.541 ' HG3' ' HA ' ' A' ' 59' ' ' VAL . 0.7 OUTLIER -57.78 129.89 43.95 Favored 'General case' 0 N--CA 1.478 0.943 0 CA-C-N 115.501 -0.772 . . . . 0.0 111.738 -174.599 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.422 HG23 ' HB2' ' A' ' 71' ' ' GLN . 40.2 mm -100.7 128.45 52.8 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 CA-C-N 114.982 -1.008 . . . . 0.0 109.58 -177.906 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 12.2 p -110.27 -0.73 17.61 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 124.064 0.946 . . . . 0.0 111.451 -178.226 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 11.8 p-10 -162.26 149.82 14.11 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 122.757 0.423 . . . . 0.0 111.113 -169.577 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.527 ' HG2' HD11 ' A' ' 85' ' ' ILE . 16.3 mtp180 -52.53 -40.3 62.33 Favored 'General case' 0 N--CA 1.486 1.337 0 C-N-CA 124.346 1.058 . . . . 0.0 112.831 -175.555 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 5.0 tmtm? -53.63 -56.6 15.85 Favored 'General case' 0 N--CA 1.48 1.07 0 O-C-N 124.29 0.993 . . . . 0.0 109.307 -177.857 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.422 ' HB2' HG23 ' A' ' 66' ' ' ILE . 14.8 mm100 -67.18 -25.74 66.29 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 115.485 -0.78 . . . . 0.0 111.814 -175.314 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.453 HD12 ' HB ' ' A' ' 85' ' ' ILE . 0.6 OUTLIER -69.12 -54.68 13.69 Favored 'General case' 0 N--CA 1.482 1.155 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 178.398 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -68.49 -41.15 80.5 Favored 'General case' 0 C--O 1.241 0.642 0 C-N-CA 123.81 0.844 . . . . 0.0 111.005 -171.731 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -68.63 -29.41 67.9 Favored 'General case' 0 C--N 1.355 0.805 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.87 175.484 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 47.1 t80 -64.89 -40.96 95.91 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 122.882 0.473 . . . . 0.0 110.398 174.105 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 79.9 mt -68.07 -37.21 81.01 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 122.974 0.51 . . . . 0.0 111.604 -176.756 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.1 -16.96 36.36 Favored 'General case' 0 N--CA 1.484 1.26 0 C-N-CA 122.772 0.429 . . . . 0.0 111.661 -179.91 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 34.1 t -93.77 -22.0 18.96 Favored 'General case' 0 N--CA 1.492 1.652 0 C-N-CA 123.12 0.568 . . . . 0.0 110.78 174.785 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 54.2 m80 -135.81 79.36 46.18 Favored Pre-proline 0 CA--C 1.547 0.855 0 N-CA-C 107.364 -1.347 . . . . 0.0 107.364 179.95 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_endo -61.92 144.06 96.17 Favored 'Trans proline' 0 C--N 1.376 1.98 0 C-N-CA 123.386 2.724 . . . . 0.0 112.838 -179.113 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 115.21 -33.55 5.24 Favored Glycine 0 C--N 1.344 0.995 0 CA-C-N 116.195 -0.457 . . . . 0.0 112.756 178.136 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 54.0 m-80 -68.17 140.19 93.03 Favored Pre-proline 0 CA--C 1.555 1.142 0 C-N-CA 122.922 0.489 . . . . 0.0 111.323 -177.965 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.427 ' HD2' ' HE1' ' A' ' 39' ' ' TRP . 81.9 Cg_exo -46.78 150.58 2.5 Favored 'Trans proline' 0 C--N 1.381 2.262 0 C-N-CA 124.682 3.588 . . . . 0.0 115.194 -178.375 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -71.99 158.17 36.47 Favored 'General case' 0 N--CA 1.484 1.258 0 C-N-CA 124.145 0.978 . . . . 0.0 112.247 -171.608 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.527 HD11 ' HG2' ' A' ' 69' ' ' ARG . 16.8 tt -76.79 -22.15 14.87 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.825 0 N-CA-C 110.253 -0.277 . . . . 0.0 110.253 175.051 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -64.58 -19.38 65.62 Favored 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 123.759 0.824 . . . . 0.0 112.616 178.958 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 -102.54 -14.86 16.61 Favored 'General case' 0 CA--C 1.553 1.076 0 C-N-CA 123.189 0.596 . . . . 0.0 110.85 174.65 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 7.1 m-30 -81.51 113.41 19.54 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 123.659 0.784 . . . . 0.0 110.352 179.612 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -80.59 125.2 29.7 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 123.439 0.696 . . . . 0.0 109.556 177.396 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 64.1 m95 -111.56 -8.25 14.25 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 124.139 0.976 . . . . 0.0 109.623 169.741 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 9.4 t -107.65 15.56 24.57 Favored 'General case' 0 CA--C 1.553 1.085 0 C-N-CA 124.111 0.964 . . . . 0.0 112.667 -163.579 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 13.2 t -62.42 -16.7 56.52 Favored 'General case' 0 N--CA 1.496 1.861 0 C-N-CA 122.987 0.515 . . . . 0.0 111.452 175.766 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 15.7 t -60.47 -24.52 65.32 Favored 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 124.139 0.976 . . . . 0.0 112.251 177.965 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -139.8 -65.87 0.04 OUTLIER Glycine 0 C--N 1.347 1.192 0 N-CA-C 112.48 -0.248 . . . . 0.0 112.48 -178.203 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 2.7 t . . . . . 0 CA--C 1.562 1.411 0 C-N-CA 123.319 0.648 . . . . 0.0 110.728 -170.735 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 63.4 mtt . . . . . 0 N--CA 1.475 0.798 0 N-CA-C 109.832 -0.433 . . . . 0.0 109.832 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -176.15 92.21 0.05 OUTLIER 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 124.822 1.249 . . . . 0.0 109.257 168.19 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 55.5 t60 -72.46 87.72 1.19 Allowed 'General case' 0 CA--C 1.54 0.589 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 174.264 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 20.2 t60 -132.04 125.77 32.27 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 123.477 0.711 . . . . 0.0 109.854 -173.392 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 55.0 m80 -126.25 133.87 51.34 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 123.763 0.825 . . . . 0.0 108.776 174.607 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 6.0 t60 -132.09 112.28 12.19 Favored 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 107.937 -1.135 . . . . 0.0 107.937 177.715 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 81.1 m-70 -114.58 153.34 30.27 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 123.753 0.821 . . . . 0.0 109.22 174.274 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 24.9 t -157.37 164.49 37.5 Favored 'General case' 0 C--O 1.242 0.659 0 C-N-CA 123.236 0.614 . . . . 0.0 110.303 -174.416 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 32.4 p -79.76 -29.08 40.37 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 124.017 0.927 . . . . 0.0 111.173 -179.667 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 77.39 29.42 55.99 Favored Glycine 0 C--N 1.351 1.364 0 CA-C-N 116.002 -0.545 . . . . 0.0 112.224 -177.802 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 36.0 mmt180 -68.59 134.05 49.4 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 123.812 0.845 . . . . 0.0 111.62 -177.824 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -120.86 135.5 55.16 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 124.605 1.162 . . . . 0.0 109.482 -177.13 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 58.7 t30 -153.89 124.05 6.92 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 123.872 0.869 . . . . 0.0 108.724 174.58 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -146.08 179.64 7.35 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 124.626 1.17 . . . . 0.0 109.537 -179.094 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 40.0 p90 -81.83 127.79 33.36 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 122.795 0.438 . . . . 0.0 110.554 178.678 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 38.6 p90 -104.9 7.26 34.23 Favored 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 124.095 0.958 . . . . 0.0 111.078 -179.304 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 12.6 pt20 -61.16 147.31 44.53 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 124.142 0.977 . . . . 0.0 111.477 179.071 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -179.43 72.29 0.07 OUTLIER Glycine 0 C--N 1.342 0.882 0 CA-C-N 115.991 -0.549 . . . . 0.0 111.983 -179.299 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 34.3 m170 -103.65 126.87 51.07 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 123.312 0.645 . . . . 0.0 110.182 175.853 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 54.5 ttm -152.25 113.18 4.2 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 123.081 0.552 . . . . 0.0 110.384 177.144 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -147.55 101.86 3.39 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 107.742 -1.206 . . . . 0.0 107.742 173.876 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 65.4 p -159.3 172.23 18.38 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 123.008 0.523 . . . . 0.0 111.157 -173.445 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 95.3 137.82 9.27 Favored Glycine 0 C--N 1.348 1.247 0 CA-C-N 115.534 -0.757 . . . . 0.0 112.177 177.498 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 50.8 p -82.79 162.68 21.61 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 123.176 0.59 . . . . 0.0 110.515 174.684 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -79.17 71.93 5.7 Favored 'General case' 0 N--CA 1.477 0.904 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 176.041 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -138.34 99.54 3.88 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 123.963 0.905 . . . . 0.0 108.82 179.662 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -81.0 83.55 6.68 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 123.563 0.745 . . . . 0.0 109.127 175.652 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 2.8 m -136.03 145.61 30.73 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.874 0 C-N-CA 124.831 1.253 . . . . 0.0 109.391 -179.293 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 27.2 m -80.29 128.53 38.57 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.922 0 CA-C-O 121.398 0.618 . . . . 0.0 110.408 179.448 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.402 ' HA ' ' HD2' ' A' ' 45' ' ' PRO . 24.6 p -142.46 118.05 10.38 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 123.974 0.91 . . . . 0.0 108.773 177.41 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 65.7 t -100.31 115.55 41.82 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 -175.144 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -80.61 105.99 12.28 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 123.423 0.689 . . . . 0.0 109.94 -179.367 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.463 HD23 ' HB3' ' A' ' 43' ' ' PHE . 4.5 mm? -83.68 163.94 47.0 Favored Pre-proline 0 N--CA 1.484 1.239 0 C-N-CA 124.281 1.033 . . . . 0.0 109.69 178.933 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -63.2 150.31 88.94 Favored 'Trans proline' 0 C--N 1.385 2.489 0 C-N-CA 122.025 1.817 . . . . 0.0 113.339 -175.407 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -141.8 167.77 15.82 Favored Pre-proline 0 CA--C 1.545 0.759 0 C-N-CA 124.226 1.01 . . . . 0.0 110.255 -173.484 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.401 ' HG2' ' HB2' ' A' ' 39' ' ' TRP . 33.0 Cg_endo -63.5 155.76 60.66 Favored 'Trans proline' 0 C--N 1.383 2.362 0 C-N-CA 121.902 1.735 . . . . 0.0 110.575 162.463 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 21.6 m -61.81 -23.53 66.29 Favored 'General case' 0 N--CA 1.484 1.274 0 C-N-CA 123.586 0.754 . . . . 0.0 111.511 179.205 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 12.6 m -71.24 -38.3 71.96 Favored 'General case' 0 CA--C 1.552 1.033 0 C-N-CA 124.134 0.974 . . . . 0.0 111.841 179.293 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' TRP . . . . . 0.401 ' HB2' ' HG2' ' A' ' 36' ' ' PRO . 26.5 m95 -119.24 -172.44 2.31 Favored 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 124.091 0.957 . . . . 0.0 111.051 -173.885 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 37.3 mtmt -138.7 143.87 39.32 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 124.677 1.191 . . . . 0.0 108.677 168.007 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 17.2 tptm -114.14 118.17 33.27 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 125.631 1.572 . . . . 0.0 108.638 -179.471 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 8.6 tt -120.02 125.96 49.65 Favored 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 175.698 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.463 ' HB3' HD23 ' A' ' 33' ' ' LEU . 87.0 t80 -103.58 134.57 46.7 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 124.441 1.096 . . . . 0.0 108.137 171.663 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' TYR . . . . . 0.419 ' HB2' ' O ' ' A' ' 55' ' ' GLU . 0.6 OUTLIER -100.01 104.52 29.47 Favored Pre-proline 0 CA--C 1.552 1.027 0 N-CA-C 109.392 -0.596 . . . . 0.0 109.392 174.635 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.402 ' HD2' ' HA ' ' A' ' 30' ' ' SER . 85.5 Cg_endo -79.38 158.89 26.02 Favored 'Trans proline' 0 C--N 1.37 1.71 0 C-N-CA 122.328 2.019 . . . . 0.0 110.431 166.452 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 24.5 t-20 -121.49 -84.45 0.66 Allowed 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 -178.828 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -137.77 -93.44 0.21 Allowed 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 123.605 0.762 . . . . 0.0 109.413 179.252 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 85.6 t -142.47 -60.39 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 N-CA-C 107.874 -1.158 . . . . 0.0 107.874 179.432 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -173.03 178.05 45.2 Favored Glycine 0 C--N 1.353 1.482 0 CA-C-N 115.796 -0.638 . . . . 0.0 112.76 -178.311 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 27.2 m 60.41 33.52 20.69 Favored 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 124.859 1.264 . . . . 0.0 111.107 -174.402 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 17.5 m -129.04 170.52 18.45 Favored 'Isoleucine or valine' 0 C--O 1.242 0.69 0 C-N-CA 124.555 1.142 . . . . 0.0 110.124 -174.738 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 60.3 pttt -65.23 -41.61 94.2 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 123.881 0.873 . . . . 0.0 110.164 174.926 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 66.14 141.85 0.03 OUTLIER 'General case' 0 C--N 1.372 1.582 0 C-N-CA 125.063 1.345 . . . . 0.0 111.851 175.71 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 6.1 p -110.65 153.54 25.07 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 123.969 0.908 . . . . 0.0 111.026 -177.991 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.419 ' O ' ' HB2' ' A' ' 44' ' ' TYR . 0.4 OUTLIER -102.69 -178.09 3.57 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 125.019 1.328 . . . . 0.0 112.387 -166.87 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.448 HG22 ' HD1' ' A' ' 43' ' ' PHE . 79.7 t -84.09 132.83 30.6 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.963 0 C-N-CA 124.651 1.18 . . . . 0.0 110.353 179.019 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 98.9 t -122.37 120.93 62.46 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 C-N-CA 123.842 0.857 . . . . 0.0 109.617 173.627 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 15.3 m-85 -90.93 123.96 34.83 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 123.233 0.613 . . . . 0.0 109.378 170.364 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 5.2 t -80.94 124.27 38.5 Favored 'Isoleucine or valine' 0 C--O 1.237 0.431 0 C-N-CA 123.377 0.671 . . . . 0.0 109.317 172.607 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -81.61 153.49 70.68 Favored Pre-proline 0 N--CA 1.468 0.473 0 CA-C-N 114.946 -1.024 . . . . 0.0 110.186 -179.701 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_endo -59.34 -33.19 97.65 Favored 'Trans proline' 0 C--N 1.377 2.073 0 C-N-CA 123.186 2.591 . . . . 0.0 112.787 178.063 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 14.8 t -91.09 -7.22 52.33 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 123.569 0.748 . . . . 0.0 111.551 -179.059 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 93.59 -1.58 69.17 Favored Glycine 0 C--N 1.351 1.365 0 CA-C-O 119.52 -0.6 . . . . 0.0 113.952 179.337 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -80.99 75.04 7.97 Favored 'General case' 0 N--CA 1.481 1.086 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 173.85 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -65.9 145.33 56.06 Favored 'General case' 0 CA--C 1.543 0.686 0 CA-C-N 114.886 -1.052 . . . . 0.0 111.879 -170.392 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.442 HG13 HD22 ' A' ' 72' ' ' LEU . 46.4 mm -101.11 127.31 54.46 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.571 0 C-N-CA 124.39 1.076 . . . . 0.0 109.813 -179.2 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 21.9 p -98.21 -14.5 20.3 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 123.668 0.787 . . . . 0.0 111.896 -177.878 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 13.1 p-10 -155.33 145.02 21.32 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 123.281 0.632 . . . . 0.0 110.543 -167.331 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.521 ' HG3' HD11 ' A' ' 85' ' ' ILE . 69.1 ttt180 -63.38 -26.74 68.89 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 124.459 1.104 . . . . 0.0 113.897 -165.559 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 1.4 tmtp? -66.0 -48.47 71.1 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 176.852 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.439 ' HA ' ' HG3' ' A' ' 74' ' ' GLN . 15.2 mm100 -63.76 -23.94 67.57 Favored 'General case' 0 N--CA 1.477 0.916 0 O-C-N 123.654 0.597 . . . . 0.0 112.034 -177.837 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.451 ' HB3' HD12 ' A' ' 85' ' ' ILE . 0.4 OUTLIER -64.28 -54.03 39.67 Favored 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 175.759 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -63.34 -46.5 86.35 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 123.85 0.86 . . . . 0.0 111.212 -174.02 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' GLN . . . . . 0.439 ' HG3' ' HA ' ' A' ' 71' ' ' GLN . 0.0 OUTLIER -69.97 -25.54 63.67 Favored 'General case' 0 CA--C 1.551 0.989 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.018 -178.851 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 28.1 t80 -65.34 -51.28 61.59 Favored 'General case' 0 C--N 1.358 0.959 0 C-N-CA 123.355 0.662 . . . . 0.0 109.534 173.47 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.409 ' HG ' ' O ' ' A' ' 72' ' ' LEU . 85.0 mt -60.83 -45.37 94.75 Favored 'General case' 0 N--CA 1.488 1.445 0 C-N-CA 123.668 0.787 . . . . 0.0 112.073 -172.621 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 19.0 ptpt -67.22 -32.54 73.65 Favored 'General case' 0 N--CA 1.481 1.122 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.207 178.688 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 34.8 t -85.54 -13.83 47.76 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 123.55 0.74 . . . . 0.0 111.594 -179.312 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 54.9 m80 -136.63 92.38 15.0 Favored Pre-proline 0 N--CA 1.485 1.298 0 C-N-CA 123.62 0.768 . . . . 0.0 109.368 -176.321 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -72.96 154.44 53.05 Favored 'Trans proline' 0 C--N 1.374 1.902 0 C-N-CA 122.7 2.267 . . . . 0.0 112.258 -179.3 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 102.81 -20.9 42.25 Favored Glycine 0 C--N 1.346 1.136 0 CA-C-N 115.893 -0.594 . . . . 0.0 112.205 -174.076 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 21.1 m120 -87.76 137.01 32.03 Favored Pre-proline 0 CA--C 1.553 1.069 0 C-N-CA 124.181 0.992 . . . . 0.0 110.194 179.422 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -72.38 159.43 49.34 Favored 'Trans proline' 0 C--N 1.38 2.234 0 C-N-CA 123.17 2.58 . . . . 0.0 112.908 -176.009 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -68.03 149.69 49.37 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 123.578 0.751 . . . . 0.0 112.138 -174.433 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.521 HD11 ' HG3' ' A' ' 69' ' ' ARG . 15.5 tt -68.05 -11.65 14.54 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.18 0 C-N-CA 123.922 0.889 . . . . 0.0 111.797 -178.928 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -56.92 -31.59 65.08 Favored 'General case' 0 CA--C 1.552 1.027 0 C-N-CA 124.311 1.045 . . . . 0.0 112.218 175.501 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -99.38 3.04 45.75 Favored 'General case' 0 N--CA 1.49 1.538 0 C-N-CA 123.4 0.68 . . . . 0.0 112.274 178.011 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -93.78 113.86 26.0 Favored 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 123.484 0.714 . . . . 0.0 109.386 -179.946 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -78.33 124.92 28.64 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 123.044 0.538 . . . . 0.0 110.454 -179.58 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 86.1 m95 -115.72 -6.55 12.14 Favored 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 123.821 0.848 . . . . 0.0 110.321 171.126 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 9.0 t -104.47 14.6 29.75 Favored 'General case' 0 N--CA 1.488 1.454 0 C-N-CA 124.708 1.203 . . . . 0.0 112.307 -166.261 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 12.9 t -65.7 -7.47 15.68 Favored 'General case' 0 N--CA 1.491 1.625 0 N-CA-C 113.571 0.952 . . . . 0.0 113.571 -176.718 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 15.7 m -45.9 100.52 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 125.382 1.473 . . . . 0.0 112.548 -175.676 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 95.79 -115.42 5.15 Favored Glycine 0 C--N 1.349 1.285 0 N-CA-C 110.981 -0.848 . . . . 0.0 110.981 -173.614 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 19.2 p . . . . . 0 N--CA 1.484 1.245 0 C-N-CA 124.133 0.973 . . . . 0.0 109.518 178.297 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.3 mpt? . . . . . 0 N--CA 1.479 1.021 0 N-CA-C 110.319 -0.252 . . . . 0.0 110.319 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 59.2 t-80 -132.05 75.42 1.64 Allowed 'General case' 0 N--CA 1.474 0.767 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 174.893 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 72.2 m-70 -132.88 156.71 46.71 Favored 'General case' 0 N--CA 1.482 1.162 0 CA-C-N 115.19 -0.914 . . . . 0.0 110.226 -179.689 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 73.1 m80 -105.5 130.97 53.45 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 123.672 0.789 . . . . 0.0 110.172 178.537 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 69.6 m-70 -134.32 150.14 50.94 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 124.539 1.135 . . . . 0.0 109.017 177.384 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 59.2 t-80 59.76 71.95 0.55 Allowed 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 124.432 1.093 . . . . 0.0 110.597 -178.349 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 9.4 t-160 -86.35 101.82 13.44 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-N 116.002 -0.545 . . . . 0.0 109.595 -179.629 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 17.1 m -67.69 106.85 2.35 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 123.709 0.804 . . . . 0.0 110.056 177.175 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 48.9 m -140.12 157.53 45.48 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 123.894 0.878 . . . . 0.0 110.317 -177.599 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -157.01 104.42 0.25 Allowed Glycine 0 C--N 1.344 1.027 0 CA-C-N 116.375 -0.375 . . . . 0.0 112.667 179.46 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 33.6 mmt180 -128.46 94.49 3.89 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 123.959 0.904 . . . . 0.0 109.483 179.446 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -118.11 104.71 11.1 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 124.639 1.176 . . . . 0.0 108.597 175.009 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 48.6 t-20 -146.93 127.0 13.7 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 123.659 0.784 . . . . 0.0 109.314 179.098 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -165.69 -179.0 5.12 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 124.605 1.162 . . . . 0.0 109.193 178.582 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 4.9 p90 -99.05 103.83 15.81 Favored 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 170.91 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 69.9 t80 -83.24 83.87 7.7 Favored 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 179.196 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 10.3 pt20 -163.2 151.3 13.64 Favored 'General case' 0 C--O 1.248 0.996 0 CA-C-N 115.459 -0.791 . . . . 0.0 109.315 -179.607 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -141.9 83.28 0.22 Allowed Glycine 0 C--N 1.341 0.825 0 N-CA-C 111.068 -0.813 . . . . 0.0 111.068 -178.287 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 58.6 m170 -70.99 138.07 49.63 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 123.446 0.698 . . . . 0.0 110.553 -178.742 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 19.6 ptp -108.08 102.88 12.0 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 123.502 0.721 . . . . 0.0 109.35 177.795 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -149.24 143.08 25.66 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 123.912 0.885 . . . . 0.0 109.872 -177.969 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 37.9 m -133.44 100.41 4.81 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 123.853 0.861 . . . . 0.0 109.168 179.667 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -150.16 -99.54 0.2 Allowed Glycine 0 C--N 1.347 1.191 0 N-CA-C 111.878 -0.489 . . . . 0.0 111.878 -179.901 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 55.8 p -169.57 165.45 10.26 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 124.249 1.019 . . . . 0.0 109.801 179.301 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -142.92 80.27 1.68 Allowed 'General case' 0 N--CA 1.479 0.983 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 178.117 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -124.22 85.87 2.48 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 123.436 0.694 . . . . 0.0 109.39 -177.999 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 11.7 tp10 -92.47 98.16 11.29 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-N 115.304 -0.862 . . . . 0.0 109.429 178.337 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 27.4 m -81.33 138.2 20.0 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.043 0 C-N-CA 122.93 0.492 . . . . 0.0 110.035 177.589 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 31.6 m -69.24 125.13 26.56 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.795 0 CA-C-O 121.204 0.526 . . . . 0.0 110.05 -179.894 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 3.8 m -142.96 128.2 18.73 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 123.998 0.919 . . . . 0.0 108.661 -175.619 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.405 HG23 ' HG3' ' A' ' 45' ' ' PRO . 26.2 t -122.4 124.76 71.6 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.935 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 178.75 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.479 ' HA ' ' HA ' ' A' ' 42' ' ' LEU . 48.0 mt-10 -82.31 108.05 15.45 Favored 'General case' 0 C--O 1.237 0.432 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 174.74 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.577 HD23 ' HB3' ' A' ' 43' ' ' PHE . 3.8 mm? -77.89 159.88 75.25 Favored Pre-proline 0 CA--C 1.555 1.167 0 CA-C-N 115.206 -0.907 . . . . 0.0 109.352 178.756 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -53.78 127.0 23.75 Favored 'Trans proline' 0 C--N 1.385 2.475 0 C-N-CA 122.952 2.435 . . . . 0.0 112.693 -174.293 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -113.15 158.1 39.03 Favored Pre-proline 0 N--CA 1.468 0.469 0 C-N-CA 124.063 0.945 . . . . 0.0 111.576 -169.187 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.647 ' HG2' ' HB2' ' A' ' 39' ' ' TRP . 46.6 Cg_endo -68.66 142.88 54.43 Favored 'Trans proline' 0 C--N 1.374 1.871 0 C-N-CA 122.007 1.804 . . . . 0.0 110.046 162.453 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 36.8 m -58.15 -25.38 61.41 Favored 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 124.095 0.958 . . . . 0.0 112.823 -175.007 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 45.8 t -74.61 -41.47 60.36 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 123.175 0.59 . . . . 0.0 110.822 178.185 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' TRP . . . . . 0.647 ' HB2' ' HG2' ' A' ' 36' ' ' PRO . 21.4 m95 -108.2 -167.61 1.26 Allowed 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 123.678 0.791 . . . . 0.0 110.724 -175.418 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.502 ' HB2' ' HB ' ' A' ' 59' ' ' VAL . 8.4 mtmt -137.47 150.32 47.49 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 124.679 1.192 . . . . 0.0 108.099 167.739 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 18.8 tptm -127.59 115.7 19.2 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 124.855 1.262 . . . . 0.0 108.289 -173.194 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.479 ' HA ' ' HA ' ' A' ' 32' ' ' GLU . 3.6 tt -119.26 147.49 44.21 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 124.407 1.083 . . . . 0.0 108.951 178.536 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.577 ' HB3' HD23 ' A' ' 33' ' ' LEU . 45.6 t80 -134.18 140.54 46.6 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 124.844 1.258 . . . . 0.0 108.392 171.734 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' TYR . . . . . 0.405 ' CE1' HD21 ' A' ' 42' ' ' LEU . 33.3 m-85 -97.16 105.57 25.51 Favored Pre-proline 0 CA--C 1.55 0.948 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 173.141 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.405 ' HG3' HG23 ' A' ' 31' ' ' VAL . 79.1 Cg_endo -73.99 151.56 45.05 Favored 'Trans proline' 0 C--N 1.377 2.036 0 C-N-CA 122.497 2.132 . . . . 0.0 112.719 174.793 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 17.1 p-10 -90.8 129.0 36.91 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.077 174.578 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 58.0 tptt -57.85 -52.97 63.28 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 124.423 1.089 . . . . 0.0 110.681 -178.99 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 42.3 t -96.81 151.03 4.21 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 C-N-CA 124.282 1.033 . . . . 0.0 108.522 174.722 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -71.74 165.7 53.6 Favored Glycine 0 CA--C 1.543 1.814 0 CA-C-O 120.249 -0.195 . . . . 0.0 112.881 177.214 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 16.6 m 76.02 -47.35 0.56 Allowed 'General case' 0 N--CA 1.498 1.935 0 C-N-CA 126.157 1.783 . . . . 0.0 113.185 176.833 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 22.4 m -62.61 134.63 27.78 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.113 0 C-N-CA 123.623 0.769 . . . . 0.0 112.261 -178.4 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 57.4 mtpt -86.74 109.29 19.13 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 123.338 0.655 . . . . 0.0 110.646 -178.833 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.53 ' HE3' ' HA ' ' A' ' 53' ' ' LYS . 0.1 OUTLIER -93.61 -177.26 4.33 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 123.556 0.742 . . . . 0.0 109.979 171.806 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 23.9 m -55.86 142.69 34.25 Favored 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 124.013 0.925 . . . . 0.0 111.153 -178.329 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -77.33 -165.67 0.62 Allowed 'General case' 0 CA--C 1.55 0.959 0 C-N-CA 123.883 0.873 . . . . 0.0 111.223 -176.493 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 47.1 t -79.26 138.43 20.02 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.637 0 C-N-CA 123.974 0.909 . . . . 0.0 109.912 -179.735 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 60.5 t -125.46 118.43 52.42 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.663 0 C-N-CA 123.823 0.849 . . . . 0.0 108.824 174.791 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 24.7 m-85 -86.71 126.69 34.73 Favored 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 170.962 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.502 ' HB ' ' HB2' ' A' ' 40' ' ' LYS . 4.6 t -81.72 128.54 38.63 Favored 'Isoleucine or valine' 0 C--O 1.241 0.623 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 170.213 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -84.65 147.91 50.39 Favored Pre-proline 0 C--O 1.242 0.7 0 CA-C-N 115.246 -0.888 . . . . 0.0 110.916 -178.747 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 27.4 Cg_endo -63.18 -23.47 72.89 Favored 'Trans proline' 0 C--N 1.371 1.713 0 C-N-CA 123.112 2.541 . . . . 0.0 112.826 174.569 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.637 HG23 ' H ' ' A' ' 64' ' ' GLU . 12.9 t -91.94 -10.95 37.62 Favored 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 123.059 0.544 . . . . 0.0 111.413 176.308 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 91.99 -8.8 77.67 Favored Glycine 0 C--N 1.355 1.607 0 CA-C-O 120.03 -0.317 . . . . 0.0 113.813 -178.034 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.637 ' H ' HG23 ' A' ' 62' ' ' THR . 9.4 tp10 -76.94 76.68 3.51 Favored 'General case' 0 N--CA 1.486 1.335 0 N-CA-C 108.612 -0.885 . . . . 0.0 108.612 173.137 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -63.76 149.17 47.39 Favored 'General case' 0 C--O 1.241 0.611 0 CA-C-N 115.083 -0.962 . . . . 0.0 111.706 -171.299 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.487 HG23 ' HB2' ' A' ' 71' ' ' GLN . 46.7 mm -115.59 119.96 63.35 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.732 0 CA-C-N 114.638 -1.165 . . . . 0.0 109.309 -174.726 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 14.4 p -106.47 -8.99 16.85 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 123.403 0.681 . . . . 0.0 112.511 -177.0 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 10.9 p30 -144.36 159.26 43.01 Favored 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 122.499 0.32 . . . . 0.0 111.084 175.231 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.513 ' HG3' HD11 ' A' ' 85' ' ' ILE . 50.7 ttt-85 -60.1 -35.85 76.14 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 124.446 1.098 . . . . 0.0 112.349 -173.49 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 1.8 tmtp? -59.91 -51.21 70.66 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 123.255 0.622 . . . . 0.0 109.372 179.189 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.487 ' HB2' HG23 ' A' ' 66' ' ' ILE . 84.1 mm-40 -57.86 -31.49 66.74 Favored 'General case' 0 CA--C 1.55 0.963 0 O-C-N 123.932 0.77 . . . . 0.0 110.949 -179.003 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -67.73 -51.28 51.2 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 123.666 0.786 . . . . 0.0 109.52 178.334 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -61.65 -50.87 70.77 Favored 'General case' 0 N--CA 1.484 1.259 0 C-N-CA 124.087 0.955 . . . . 0.0 111.472 -175.663 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 1.3 pp0? -65.86 -32.2 73.59 Favored 'General case' 0 CA--C 1.544 0.747 0 CA-C-N 115.495 -0.775 . . . . 0.0 111.178 -178.982 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 29.8 t80 -60.64 -51.11 70.77 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 123.334 0.654 . . . . 0.0 110.213 176.1 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.481 HD13 ' HA ' ' A' ' 84' ' ' ALA . 89.0 mt -65.33 -45.21 85.15 Favored 'General case' 0 N--CA 1.479 0.986 0 O-C-N 123.799 0.687 . . . . 0.0 111.994 -172.191 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.28 -20.24 63.05 Favored 'General case' 0 N--CA 1.481 1.094 0 CA-C-O 120.902 0.382 . . . . 0.0 111.211 179.601 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 34.2 t -92.53 -18.78 22.69 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 123.766 0.826 . . . . 0.0 111.574 175.184 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 54.3 m80 -135.2 93.7 16.6 Favored Pre-proline 0 N--CA 1.476 0.86 0 C-N-CA 123.587 0.755 . . . . 0.0 109.663 -174.71 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -71.92 162.71 41.1 Favored 'Trans proline' 0 C--N 1.371 1.732 0 C-N-CA 122.394 2.063 . . . . 0.0 111.804 175.742 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 87.9 -4.06 85.75 Favored Glycine 0 N--CA 1.472 1.05 0 CA-C-N 116.413 -0.358 . . . . 0.0 113.298 -177.51 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 32.0 m-80 -97.43 145.0 28.91 Favored Pre-proline 0 N--CA 1.482 1.171 0 C-N-CA 123.659 0.784 . . . . 0.0 109.991 177.698 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_endo -65.32 144.43 80.45 Favored 'Trans proline' 0 C--N 1.377 2.049 0 C-N-CA 122.561 2.174 . . . . 0.0 111.878 179.286 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.481 ' HA ' HD13 ' A' ' 76' ' ' LEU . . . -70.68 162.03 29.75 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 123.809 0.843 . . . . 0.0 112.305 -171.219 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.513 HD11 ' HG3' ' A' ' 69' ' ' ARG . 17.5 tt -74.29 -15.54 16.45 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.095 0 CA-C-O 120.941 0.401 . . . . 0.0 110.924 179.24 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -60.02 -34.35 73.25 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 124.304 1.042 . . . . 0.0 112.081 175.649 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.449 ' HG2' ' O ' ' A' ' 84' ' ' ALA . 10.2 pt-20 -98.13 -2.65 39.5 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 123.761 0.825 . . . . 0.0 111.172 -178.715 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 3.6 m-30 -90.49 152.48 20.92 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 123.471 0.708 . . . . 0.0 110.144 176.055 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -120.3 122.74 41.5 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 123.464 0.706 . . . . 0.0 109.943 178.167 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 88.9 m95 -111.64 -2.0 15.54 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 123.798 0.839 . . . . 0.0 110.512 172.075 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 12.5 t -107.54 15.83 24.39 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 123.639 0.776 . . . . 0.0 112.145 -168.252 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 15.4 t -62.05 -20.12 63.63 Favored 'General case' 0 N--CA 1.492 1.64 0 C-N-CA 123.077 0.551 . . . . 0.0 111.734 -179.908 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 15.3 p -72.55 79.88 1.07 Allowed 'General case' 0 CA--C 1.553 1.064 0 C-N-CA 123.835 0.854 . . . . 0.0 110.455 176.776 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -91.76 123.22 7.11 Favored Glycine 0 C--N 1.346 1.123 0 CA-C-N 115.519 -0.764 . . . . 0.0 111.212 176.091 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 31.8 p . . . . . 0 C--O 1.252 1.212 0 C-N-CA 123.505 0.722 . . . . 0.0 110.27 179.198 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.3 mpt? . . . . . 0 N--CA 1.48 1.051 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 35.5 t-80 -170.59 135.45 1.17 Allowed 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 124.416 1.086 . . . . 0.0 108.375 -179.38 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 13.8 t60 -87.11 75.3 9.47 Favored 'General case' 0 N--CA 1.479 0.981 0 CA-C-O 120.953 0.406 . . . . 0.0 109.961 -176.97 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 63.6 m170 53.52 -91.97 0.03 OUTLIER 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 125.496 1.518 . . . . 0.0 112.367 -179.505 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 3.2 p80 174.0 147.79 0.07 Allowed 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 125.35 1.46 . . . . 0.0 108.608 -176.831 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 92.4 m-70 -139.02 112.48 8.22 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 123.627 0.771 . . . . 0.0 109.252 179.831 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 62.3 m80 -144.98 135.11 23.94 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 124.457 1.103 . . . . 0.0 110.05 177.816 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 37.7 t -85.08 129.54 34.78 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 124.326 1.051 . . . . 0.0 109.753 -179.849 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 25.5 p -84.78 88.89 7.42 Favored 'General case' 0 CA--C 1.551 0.99 0 C-N-CA 123.841 0.856 . . . . 0.0 110.745 -176.709 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -103.07 161.2 16.51 Favored Glycine 0 C--N 1.347 1.15 0 CA-C-N 115.173 -0.921 . . . . 0.0 111.802 176.646 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 2.4 mpt_? -115.05 154.31 29.1 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 123.773 0.829 . . . . 0.0 109.617 -175.418 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -100.93 -63.35 1.14 Allowed 'General case' 0 N--CA 1.476 0.845 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 168.586 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 7.9 t30 56.53 83.93 0.09 Allowed 'General case' 0 C--N 1.357 0.906 0 C-N-CA 125.129 1.372 . . . . 0.0 112.144 179.88 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -118.17 128.48 54.76 Favored 'General case' 0 N--CA 1.477 0.915 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 170.111 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 27.8 p90 -94.61 -54.13 3.62 Favored 'General case' 0 C--O 1.239 0.502 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 171.285 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 41.7 t80 51.22 25.96 2.71 Favored 'General case' 0 CA--C 1.566 1.568 0 C-N-CA 125.467 1.507 . . . . 0.0 112.034 177.691 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 14.2 pt20 -100.03 147.32 25.74 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 124.119 0.968 . . . . 0.0 110.102 -175.902 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -171.03 133.47 2.78 Favored Glycine 0 C--N 1.338 0.688 0 N-CA-C 111.466 -0.654 . . . . 0.0 111.466 -177.998 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 50.3 p-80 -86.54 124.3 32.69 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 123.456 0.702 . . . . 0.0 109.157 178.917 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 3.9 mmt -133.41 122.04 23.14 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 123.59 0.756 . . . . 0.0 109.703 -179.735 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -109.28 -19.24 13.37 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 123.798 0.839 . . . . 0.0 111.017 177.565 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 44.2 m -80.49 126.56 31.37 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 123.464 0.706 . . . . 0.0 110.217 179.254 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -73.74 -48.31 17.52 Favored Glycine 0 C--N 1.344 1.026 0 O-C-N 123.669 0.605 . . . . 0.0 111.982 178.921 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 56.0 p -80.68 79.69 7.28 Favored 'General case' 0 C--O 1.247 0.928 0 C-N-CA 123.519 0.727 . . . . 0.0 109.795 174.643 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -86.46 111.33 20.44 Favored 'General case' 0 C--O 1.239 0.505 0 CA-C-N 115.2 -0.909 . . . . 0.0 108.879 179.557 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 -102.07 33.38 3.08 Favored 'General case' 0 CA--C 1.552 1.049 0 C-N-CA 123.838 0.855 . . . . 0.0 110.724 -177.577 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 16.4 mm-40 -78.65 81.55 4.96 Favored 'General case' 0 N--CA 1.479 0.989 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 172.398 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 27.5 m -101.14 174.95 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 CA-C-N 114.166 -1.379 . . . . 0.0 110.558 -175.144 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 19.2 m -71.11 104.74 1.44 Allowed 'Isoleucine or valine' 0 CA--C 1.555 1.162 0 CA-C-O 121.898 0.856 . . . . 0.0 109.815 175.657 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 39.9 p -171.91 141.22 1.34 Allowed 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 125.202 1.401 . . . . 0.0 107.948 -177.972 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.479 HG23 ' HG3' ' A' ' 45' ' ' PRO . 59.9 t -117.92 126.51 74.9 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 -178.972 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -84.97 105.13 15.5 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 123.58 0.752 . . . . 0.0 108.982 176.512 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.501 HD23 ' HB3' ' A' ' 43' ' ' PHE . 4.4 mm? -82.56 163.54 51.48 Favored Pre-proline 0 N--CA 1.48 1.057 0 C-N-CA 123.82 0.848 . . . . 0.0 110.192 -178.564 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -57.25 137.16 80.45 Favored 'Trans proline' 0 C--N 1.39 2.759 0 C-N-CA 122.683 2.255 . . . . 0.0 112.797 -179.536 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.571 ' HB2' ' HB3' ' A' ' 41' ' ' LYS . . . -123.48 161.72 44.19 Favored Pre-proline 0 N--CA 1.476 0.86 0 C-N-CA 124.298 1.039 . . . . 0.0 111.742 -172.766 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.704 ' HG2' ' HB2' ' A' ' 39' ' ' TRP . 31.6 Cg_endo -63.72 146.36 92.07 Favored 'Trans proline' 0 C--N 1.375 1.926 0 C-N-CA 122.551 2.167 . . . . 0.0 109.669 159.028 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 18.5 m -59.04 -37.95 78.18 Favored 'General case' 0 N--CA 1.489 1.477 0 C-N-CA 124.179 0.992 . . . . 0.0 112.838 -169.734 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 48.5 m -69.81 -35.05 74.51 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 123.574 0.75 . . . . 0.0 111.528 -179.907 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' TRP . . . . . 0.704 ' HB2' ' HG2' ' A' ' 36' ' ' PRO . 33.3 m95 -104.6 -179.89 4.08 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 123.782 0.833 . . . . 0.0 110.566 -175.678 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.36 152.42 51.44 Favored 'General case' 0 N--CA 1.476 0.844 0 N-CA-C 107.556 -1.276 . . . . 0.0 107.556 173.743 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.571 ' HB3' ' HB2' ' A' ' 35' ' ' ALA . 18.2 tptm -132.53 117.8 18.45 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 123.922 0.889 . . . . 0.0 109.812 -171.717 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 2.3 tt -122.24 144.7 48.82 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 124.762 1.225 . . . . 0.0 108.604 174.459 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.501 ' HB3' HD23 ' A' ' 33' ' ' LEU . 47.6 t80 -128.1 147.64 50.54 Favored 'General case' 0 C--O 1.238 0.482 0 C-N-CA 124.701 1.201 . . . . 0.0 108.98 171.405 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 18.2 m-85 -102.18 100.97 16.78 Favored Pre-proline 0 CA--C 1.551 0.994 0 C-N-CA 123.651 0.781 . . . . 0.0 110.147 171.895 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.479 ' HG3' HG23 ' A' ' 31' ' ' VAL . 30.9 Cg_endo -86.71 -174.65 1.46 Allowed 'Trans proline' 0 C--N 1.373 1.852 0 C-N-CA 123.435 2.756 . . . . 0.0 113.342 175.993 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' ASN . . . . . 0.63 ' HB2' ' HA ' ' A' ' 51' ' ' VAL . 3.9 p-10 -127.44 148.02 50.29 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 124.283 1.033 . . . . 0.0 108.765 174.251 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 73.0 mmtt -127.21 97.47 4.93 Favored 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 123.372 0.669 . . . . 0.0 111.461 -172.456 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 32.6 t 43.55 84.25 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 C-N-CA 126.179 1.792 . . . . 0.0 113.48 169.545 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 87.17 -46.54 3.54 Favored Glycine 0 C--N 1.341 0.828 0 CA-C-N 116.28 -0.418 . . . . 0.0 112.492 -177.986 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 49.4 m -71.19 81.52 0.71 Allowed 'General case' 0 C--N 1.359 0.984 0 CA-C-O 121.656 0.741 . . . . 0.0 109.999 175.122 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.63 ' HA ' ' HB2' ' A' ' 46' ' ' ASN . 16.4 m -94.87 115.85 34.75 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.613 0 CA-C-N 114.965 -1.016 . . . . 0.0 110.238 -178.235 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 44.5 tptt -155.7 30.54 0.37 Allowed 'General case' 0 CA--C 1.549 0.917 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 177.9 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -63.95 135.07 56.19 Favored 'General case' 0 C--N 1.354 0.796 0 CA-C-N 114.928 -1.033 . . . . 0.0 110.063 -178.549 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 24.9 m -130.82 162.49 29.47 Favored 'General case' 0 C--O 1.241 0.633 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 -177.097 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -60.4 172.95 0.75 Allowed 'General case' 0 CA--C 1.549 0.939 0 CA-C-O 122.547 1.165 . . . . 0.0 112.16 176.363 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 20.5 t -80.52 145.88 8.41 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.668 0 CA-C-N 113.764 -1.562 . . . . 0.0 110.519 -174.512 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 49.1 t -121.77 116.55 49.72 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.804 0 C-N-CA 123.969 0.908 . . . . 0.0 109.007 172.219 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 33.9 m-85 -90.3 132.79 35.36 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 123.618 0.767 . . . . 0.0 110.255 171.424 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.414 ' HA ' ' HG2' ' A' ' 65' ' ' GLU . 14.8 t -85.59 132.19 32.49 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 168.477 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -87.4 153.7 53.6 Favored Pre-proline 0 C--O 1.244 0.772 0 CA-C-N 115.317 -0.856 . . . . 0.0 110.638 179.739 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_endo -69.43 -3.02 10.94 Favored 'Trans proline' 0 C--N 1.376 1.974 0 C-N-CA 122.865 2.377 . . . . 0.0 113.062 177.667 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.564 HG23 ' H ' ' A' ' 64' ' ' GLU . 12.3 t -115.62 -7.97 12.13 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 124.129 0.972 . . . . 0.0 111.401 -179.902 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 94.16 -15.2 63.72 Favored Glycine 0 C--N 1.358 1.783 0 CA-C-O 119.695 -0.503 . . . . 0.0 113.791 -179.547 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.564 ' H ' HG23 ' A' ' 62' ' ' THR . 42.9 tt0 -78.4 80.12 4.81 Favored 'General case' 0 N--CA 1.484 1.265 0 CA-C-O 121.67 0.748 . . . . 0.0 109.335 173.394 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.414 ' HG2' ' HA ' ' A' ' 59' ' ' VAL . 28.3 mt-10 -69.73 156.46 38.96 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 124.43 1.092 . . . . 0.0 111.73 -170.224 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 41.0 mm -111.19 122.51 65.78 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.613 0 C-N-CA 123.855 0.862 . . . . 0.0 109.481 178.138 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 61.6 p -99.65 -11.45 20.91 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 123.481 0.712 . . . . 0.0 112.506 -177.817 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 12.1 p30 -153.94 150.54 28.43 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 122.598 0.359 . . . . 0.0 111.315 -177.804 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.455 ' HG3' HD11 ' A' ' 85' ' ' ILE . 41.5 ttm105 -54.98 -32.4 61.64 Favored 'General case' 0 N--CA 1.491 1.588 0 C-N-CA 125.369 1.468 . . . . 0.0 114.143 -168.196 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -60.05 -54.37 46.83 Favored 'General case' 0 N--CA 1.487 1.404 0 C-N-CA 123.356 0.662 . . . . 0.0 109.648 -179.798 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.474 ' O ' ' HB2' ' A' ' 75' ' ' TYR . 90.1 mm-40 -64.2 -20.97 66.38 Favored 'General case' 0 N--CA 1.476 0.841 0 CA-C-N 115.347 -0.842 . . . . 0.0 111.778 -176.564 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.44 ' O ' ' HG ' ' A' ' 76' ' ' LEU . 0.9 OUTLIER -69.85 -52.97 20.43 Favored 'General case' 0 N--CA 1.481 1.091 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 175.697 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -58.0 -54.42 47.11 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 123.971 0.908 . . . . 0.0 111.766 -178.752 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' GLN . . . . . 0.442 ' HG3' ' HA ' ' A' ' 71' ' ' GLN . 0.0 OUTLIER -67.5 -24.29 65.56 Favored 'General case' 0 CA--C 1.551 0.993 0 CA-C-N 115.455 -0.793 . . . . 0.0 111.077 -177.685 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 75' ' ' TYR . . . . . 0.474 ' HB2' ' O ' ' A' ' 71' ' ' GLN . 35.6 t80 -65.94 -55.27 17.71 Favored 'General case' 0 C--N 1.36 1.032 0 C-N-CA 123.097 0.559 . . . . 0.0 109.706 174.383 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.44 ' HG ' ' O ' ' A' ' 72' ' ' LEU . 71.2 mt -59.96 -39.47 85.71 Favored 'General case' 0 N--CA 1.489 1.514 0 C-N-CA 123.436 0.694 . . . . 0.0 111.855 -172.629 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.95 -14.35 58.66 Favored 'General case' 0 N--CA 1.484 1.269 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.824 -179.517 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 37.5 t -102.02 -9.6 20.47 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 123.621 0.768 . . . . 0.0 111.198 172.697 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 86.5 m-70 -137.45 87.23 18.05 Favored Pre-proline 0 N--CA 1.481 1.083 0 C-N-CA 124.189 0.995 . . . . 0.0 109.363 -177.132 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 63.2 Cg_endo -71.35 141.65 39.4 Favored 'Trans proline' 0 C--N 1.374 1.874 0 C-N-CA 122.403 2.069 . . . . 0.0 111.126 174.993 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 116.58 -20.24 12.24 Favored Glycine 0 N--CA 1.471 1.032 0 N-CA-C 111.695 -0.562 . . . . 0.0 111.695 -174.245 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 39.4 m-80 -91.67 140.51 25.17 Favored Pre-proline 0 CA--C 1.548 0.892 0 C-N-CA 123.435 0.694 . . . . 0.0 109.717 177.351 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -70.07 159.42 53.24 Favored 'Trans proline' 0 C--N 1.377 2.045 0 C-N-CA 122.845 2.363 . . . . 0.0 112.983 -178.65 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -70.0 154.55 41.81 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 123.949 0.9 . . . . 0.0 112.477 -173.432 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.455 HD11 ' HG3' ' A' ' 69' ' ' ARG . 16.2 tt -66.82 -12.01 14.34 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.209 0 C-N-CA 124.171 0.988 . . . . 0.0 111.686 -179.227 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -52.89 -39.8 62.99 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 124.505 1.122 . . . . 0.0 112.05 174.977 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -94.4 -8.14 39.57 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 123.526 0.73 . . . . 0.0 112.044 178.902 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -86.56 110.86 20.09 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 123.444 0.698 . . . . 0.0 109.314 176.39 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -87.63 126.56 35.02 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 123.683 0.793 . . . . 0.0 109.882 -178.744 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 85.2 m95 -118.29 -3.96 10.96 Favored 'General case' 0 CA--C 1.555 1.173 0 C-N-CA 125.126 1.37 . . . . 0.0 110.106 172.456 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 15.1 t -108.62 14.13 24.73 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 124.025 0.93 . . . . 0.0 112.18 -168.046 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 9.4 t -62.39 -15.31 48.12 Favored 'General case' 0 N--CA 1.493 1.709 0 C-N-CA 123.0 0.52 . . . . 0.0 112.248 178.617 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 10.4 p -57.93 -12.47 3.26 Favored 'General case' 0 CA--C 1.554 1.107 0 C-N-CA 125.549 1.539 . . . . 0.0 113.693 176.469 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -167.99 158.27 30.97 Favored Glycine 0 C--N 1.338 0.675 0 N-CA-C 111.551 -0.62 . . . . 0.0 111.551 173.63 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 12.4 t . . . . . 0 CA--C 1.559 1.293 0 C-N-CA 122.915 0.486 . . . . 0.0 110.089 177.619 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.5 mpp? . . . . . 0 N--CA 1.478 0.944 0 N-CA-C 109.519 -0.548 . . . . 0.0 109.519 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 22.4 m-70 -102.94 113.64 27.27 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 173.854 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 7.8 p-80 -68.35 -31.49 70.93 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 123.383 0.673 . . . . 0.0 112.115 -178.503 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 71.4 m-70 63.15 163.69 0.11 Allowed 'General case' 0 N--CA 1.493 1.684 0 C-N-CA 124.863 1.265 . . . . 0.0 111.679 -175.034 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 16.1 m170 -148.7 90.73 1.8 Allowed 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 123.859 0.864 . . . . 0.0 109.068 174.854 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 54.9 t-80 -80.03 86.2 5.53 Favored 'General case' 0 C--O 1.242 0.672 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 176.876 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 8.4 p80 -97.42 114.26 26.07 Favored 'General case' 0 C--O 1.242 0.658 0 CA-C-N 115.163 -0.926 . . . . 0.0 109.181 176.807 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 49.9 m -141.8 82.25 1.8 Allowed 'General case' 0 C--O 1.24 0.575 0 C-N-CA 123.628 0.771 . . . . 0.0 109.808 -179.528 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 47.9 p -156.78 133.98 10.51 Favored 'General case' 0 C--O 1.24 0.554 0 CA-C-N 114.825 -1.08 . . . . 0.0 108.959 -177.999 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 150.04 52.67 0.02 OUTLIER Glycine 0 C--N 1.346 1.125 0 N-CA-C 112.574 -0.21 . . . . 0.0 112.574 178.331 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 97.9 mtt180 -92.35 146.52 23.63 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 123.432 0.693 . . . . 0.0 109.665 175.411 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 13.3 tp10 -76.94 -64.9 1.02 Allowed 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 123.301 0.64 . . . . 0.0 109.693 178.316 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 4.6 m-20 59.45 21.12 9.52 Favored 'General case' 0 N--CA 1.493 1.694 0 C-N-CA 124.659 1.184 . . . . 0.0 112.65 176.85 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -84.66 116.7 23.34 Favored 'General case' 0 CA--C 1.536 0.414 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 -176.738 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.421 ' HD2' ' HG2' ' A' ' 17' ' ' GLN . 19.5 p90 -110.44 -52.43 2.78 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 123.571 0.748 . . . . 0.0 110.646 178.332 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 45.1 t80 40.28 79.51 0.03 OUTLIER 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 125.761 1.624 . . . . 0.0 111.606 -171.651 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' GLN . . . . . 0.421 ' HG2' ' HD2' ' A' ' 15' ' ' TYR . 14.0 pt20 -135.85 -12.66 1.97 Allowed 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 123.239 0.616 . . . . 0.0 111.411 -173.502 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -85.65 52.31 4.58 Favored Glycine 0 C--N 1.351 1.403 0 CA-C-O 120.413 -0.104 . . . . 0.0 113.307 -175.842 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 23.9 p80 -84.69 116.82 23.42 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-O 121.309 0.576 . . . . 0.0 109.588 178.834 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 64.0 mtt -104.57 -65.58 1.02 Allowed 'General case' 0 C--O 1.242 0.672 0 N-CA-C 108.277 -1.009 . . . . 0.0 108.277 178.026 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . 51.12 33.65 9.68 Favored 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 124.213 1.005 . . . . 0.0 111.959 175.965 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 66.5 p -70.96 79.9 0.65 Allowed 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 124.342 1.057 . . . . 0.0 111.786 -167.351 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 81.04 -50.45 4.17 Favored Glycine 0 C--N 1.348 1.219 0 CA-C-N 115.408 -0.815 . . . . 0.0 113.278 -179.175 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 23.0 t 58.7 31.73 21.45 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 124.342 1.057 . . . . 0.0 109.438 -166.499 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -107.5 94.47 5.1 Favored 'General case' 0 C--O 1.241 0.625 0 C-N-CA 125.127 1.371 . . . . 0.0 108.578 -176.021 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 69.0 134.56 0.03 OUTLIER 'General case' 0 CA--C 1.55 0.978 0 C-N-CA 125.194 1.398 . . . . 0.0 111.97 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -150.4 103.84 3.18 Favored 'General case' 0 CA--C 1.542 0.666 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 178.177 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 25.2 m -95.36 176.54 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.982 0 C-N-CA 123.53 0.732 . . . . 0.0 110.469 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.488 HG11 ' HG3' ' A' ' 47' ' ' LYS . 15.3 m -87.17 125.62 40.98 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.774 0 CA-C-N 115.767 -0.651 . . . . 0.0 109.854 170.798 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 50.1 p -152.99 123.83 7.37 Favored 'General case' 0 C--O 1.239 0.541 0 C-N-CA 123.934 0.893 . . . . 0.0 108.804 178.249 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 48.6 t -103.15 119.83 52.17 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 -178.582 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.441 ' HA ' ' HA ' ' A' ' 42' ' ' LEU . 37.4 mt-10 -79.11 117.07 19.81 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.011 177.166 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.442 HD23 ' HB3' ' A' ' 43' ' ' PHE . 3.0 mm? -92.0 164.1 24.83 Favored Pre-proline 0 N--CA 1.483 1.195 0 C-N-CA 124.26 1.024 . . . . 0.0 109.6 -178.033 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -53.46 140.15 64.4 Favored 'Trans proline' 0 C--N 1.394 2.968 0 C-N-CA 123.127 2.551 . . . . 0.0 114.027 179.927 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.768 ' HB2' ' HB3' ' A' ' 41' ' ' LYS . . . -140.19 156.84 69.9 Favored Pre-proline 0 N--CA 1.472 0.672 0 C-N-CA 124.419 1.087 . . . . 0.0 111.473 -170.068 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -58.41 140.73 95.68 Favored 'Trans proline' 0 C--N 1.372 1.784 0 C-N-CA 122.798 2.332 . . . . 0.0 110.504 155.269 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 70.5 p -63.51 -28.15 69.75 Favored 'General case' 0 N--CA 1.487 1.422 0 C-N-CA 122.993 0.517 . . . . 0.0 111.884 -177.007 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 31.8 m -67.24 -40.03 86.24 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 123.282 0.633 . . . . 0.0 110.612 176.911 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 33.8 m95 -100.46 -179.46 4.11 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 123.743 0.817 . . . . 0.0 110.25 179.266 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.5 150.51 52.15 Favored 'General case' 0 N--CA 1.469 0.482 0 N-CA-C 106.768 -1.568 . . . . 0.0 106.768 169.893 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.768 ' HB3' ' HB2' ' A' ' 35' ' ' ALA . 15.2 tptm -133.0 128.96 37.52 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.676 0.751 . . . . 0.0 108.998 -174.493 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.441 ' HA ' ' HA ' ' A' ' 32' ' ' GLU . 3.3 tt -135.37 151.32 50.37 Favored 'General case' 0 C--O 1.241 0.607 0 CA-C-N 114.001 -1.454 . . . . 0.0 108.62 -177.146 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.442 ' HB3' HD23 ' A' ' 33' ' ' LEU . 32.9 t80 -133.61 137.84 45.65 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.782 1.233 . . . . 0.0 108.267 173.735 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' TYR . . . . . 0.434 ' CE1' HD21 ' A' ' 42' ' ' LEU . 38.5 m-85 -100.59 103.53 24.7 Favored Pre-proline 0 N--CA 1.484 1.231 0 C-N-CA 122.692 0.397 . . . . 0.0 111.025 175.544 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.675 ' HA ' ' HA ' ' A' ' 52' ' ' LYS . 65.0 Cg_endo -83.64 168.17 12.83 Favored 'Trans proline' 0 C--N 1.371 1.727 0 C-N-CA 122.421 2.081 . . . . 0.0 110.994 166.676 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' ASN . . . . . 0.476 ' HA ' ' HB2' ' A' ' 53' ' ' LYS . 48.3 t-20 -68.43 -44.3 75.25 Favored 'General case' 0 N--CA 1.478 0.929 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 169.787 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.535 ' HG2' HG23 ' A' ' 48' ' ' VAL . 36.8 ttpt 177.86 -75.3 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.618 0 O-C-N 125.229 1.581 . . . . 0.0 108.339 166.753 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.535 HG23 ' HG2' ' A' ' 47' ' ' LYS . 51.9 t -127.58 156.09 39.17 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.301 0 C-N-CA 124.317 1.047 . . . . 0.0 109.11 -177.592 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 105.59 7.98 35.83 Favored Glycine 0 C--N 1.349 1.303 0 C-N-CA 123.078 0.37 . . . . 0.0 112.339 -177.865 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 26.8 m 69.43 -3.83 1.5 Allowed 'General case' 0 N--CA 1.495 1.804 0 C-N-CA 125.593 1.557 . . . . 0.0 112.592 -177.816 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 26.6 m -74.53 140.0 18.29 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.454 0 C-N-CA 123.825 0.85 . . . . 0.0 110.526 -175.67 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.675 ' HA ' ' HA ' ' A' ' 45' ' ' PRO . 16.7 ptpt -93.6 160.97 14.54 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-N 115.636 -0.711 . . . . 0.0 111.089 178.407 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.476 ' HB2' ' HA ' ' A' ' 46' ' ' ASN . 88.3 tttt -121.13 -41.8 2.51 Favored 'General case' 0 N--CA 1.479 0.978 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 178.74 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.411 ' HB ' ' HB2' ' A' ' 44' ' ' TYR . 17.9 m -130.94 161.83 31.04 Favored 'General case' 0 CA--C 1.544 0.732 0 CA-C-N 114.529 -1.214 . . . . 0.0 108.008 176.391 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 4.0 pm0 -69.94 -177.97 1.45 Allowed 'General case' 0 CA--C 1.555 1.164 0 C-N-CA 123.658 0.783 . . . . 0.0 111.674 179.102 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 75.2 t -83.02 141.87 14.33 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.695 0 C-N-CA 124.33 1.052 . . . . 0.0 110.241 -177.317 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 57.7 t -123.56 124.01 68.6 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 C-N-CA 123.737 0.815 . . . . 0.0 109.555 179.594 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 29.6 m-85 -101.83 113.68 27.09 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 123.582 0.753 . . . . 0.0 109.27 171.774 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 3.4 t -79.1 130.45 36.11 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 C-N-CA 123.323 0.649 . . . . 0.0 109.587 175.939 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -84.18 154.47 63.48 Favored Pre-proline 0 CA--C 1.541 0.622 0 CA-C-N 115.022 -0.99 . . . . 0.0 111.593 -175.796 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 26.5 Cg_endo -60.42 -33.6 93.95 Favored 'Trans proline' 0 C--N 1.377 2.071 0 C-N-CA 123.251 2.634 . . . . 0.0 113.179 177.226 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 14.8 t -85.47 -2.49 58.18 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 123.027 0.531 . . . . 0.0 111.602 179.256 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 94.21 -18.01 57.71 Favored Glycine 0 C--N 1.35 1.308 0 CA-C-O 119.635 -0.536 . . . . 0.0 113.682 178.978 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -72.46 76.82 1.04 Allowed 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 123.983 0.913 . . . . 0.0 109.638 178.198 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -65.57 157.86 28.64 Favored 'General case' 0 N--CA 1.477 0.881 0 CA-C-N 115.024 -0.989 . . . . 0.0 111.682 -172.744 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 47.4 mm -118.44 122.52 69.72 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.445 0 CA-C-N 114.83 -1.077 . . . . 0.0 109.386 -170.741 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 7.6 p -93.82 -21.26 19.39 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 123.932 0.893 . . . . 0.0 112.403 -178.44 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 2.4 p-10 -153.95 165.95 34.52 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 122.674 0.39 . . . . 0.0 111.393 -172.401 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 34.8 ttp180 -58.91 -41.93 88.45 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 124.314 1.046 . . . . 0.0 111.954 -171.059 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 5.0 tmtm? -55.99 -51.6 67.15 Favored 'General case' 0 N--CA 1.486 1.335 0 C-N-CA 123.821 0.848 . . . . 0.0 109.76 -179.52 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 77.5 mt-30 -60.3 -31.63 70.44 Favored 'General case' 0 N--CA 1.476 0.839 0 O-C-N 124.144 0.903 . . . . 0.0 111.422 -178.729 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -67.62 -50.42 58.19 Favored 'General case' 0 N--CA 1.481 1.12 0 N-CA-C 109.338 -0.615 . . . . 0.0 109.338 177.898 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -62.8 -51.0 68.77 Favored 'General case' 0 C--O 1.242 0.693 0 CA-C-N 115.236 -0.893 . . . . 0.0 111.225 -174.897 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -66.36 -29.42 69.6 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 122.556 0.343 . . . . 0.0 111.223 179.799 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 43.7 t80 -62.53 -54.68 36.28 Favored 'General case' 0 C--N 1.357 0.913 0 C-N-CA 122.946 0.498 . . . . 0.0 109.824 176.06 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 67.1 mt -60.71 -44.5 96.5 Favored 'General case' 0 N--CA 1.481 1.095 0 O-C-N 123.579 0.549 . . . . 0.0 111.847 -173.143 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -69.1 -25.04 64.21 Favored 'General case' 0 N--CA 1.48 1.037 0 CA-C-N 116.589 -0.278 . . . . 0.0 111.402 -177.813 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 100.0 p -98.47 -12.4 21.36 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 122.91 0.484 . . . . 0.0 111.811 178.715 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 90.4 m-70 -130.84 91.02 38.15 Favored Pre-proline 0 N--CA 1.476 0.841 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 179.673 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_endo -67.01 166.04 24.26 Favored 'Trans proline' 0 C--N 1.372 1.783 0 C-N-CA 122.412 2.075 . . . . 0.0 112.071 175.661 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 90.81 -17.22 55.98 Favored Glycine 0 C--N 1.347 1.15 0 CA-C-N 116.565 -0.289 . . . . 0.0 113.259 -179.776 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 40.2 m-80 -84.16 144.64 44.42 Favored Pre-proline 0 CA--C 1.547 0.856 0 C-N-CA 123.652 0.781 . . . . 0.0 111.269 -178.013 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_exo -56.18 152.01 40.28 Favored 'Trans proline' 0 C--N 1.378 2.081 0 C-N-CA 123.875 3.05 . . . . 0.0 112.794 170.97 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -77.04 161.56 28.22 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 123.526 0.73 . . . . 0.0 112.207 -173.997 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 16.9 tt -72.93 -23.45 20.38 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.222 0 C-N-CA 123.347 0.659 . . . . 0.0 111.488 -178.71 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -65.13 -31.58 72.85 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 123.308 0.643 . . . . 0.0 111.854 -177.728 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -90.52 0.2 57.42 Favored 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 123.432 0.693 . . . . 0.0 111.247 177.106 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 6.0 m-30 -92.74 111.42 23.02 Favored 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 123.499 0.72 . . . . 0.0 109.248 177.149 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -84.0 88.79 7.17 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 123.559 0.744 . . . . 0.0 110.618 -175.872 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 89.5 m95 -76.19 -17.69 59.42 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 122.695 0.398 . . . . 0.0 110.902 173.171 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 14.5 t -81.49 16.5 1.67 Allowed 'General case' 0 N--CA 1.488 1.425 0 C-N-CA 125.623 1.569 . . . . 0.0 111.979 177.697 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 4.8 t -62.68 -12.32 22.81 Favored 'General case' 0 CA--C 1.559 1.321 0 N-CA-C 114.965 1.469 . . . . 0.0 114.965 -163.073 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 50.2 m -67.78 90.28 0.28 Allowed 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 123.118 0.567 . . . . 0.0 110.26 177.338 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 66.57 -102.32 0.74 Allowed Glycine 0 C--N 1.349 1.303 0 N-CA-C 111.18 -0.768 . . . . 0.0 111.18 -172.891 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 8.5 t . . . . . 0 CA--C 1.553 1.06 0 C-N-CA 123.541 0.736 . . . . 0.0 109.864 175.605 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.8 mmt . . . . . 0 N--CA 1.481 1.093 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 33.9 t-80 -171.67 99.92 0.18 Allowed 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 124.299 1.04 . . . . 0.0 109.476 -178.609 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 38.4 m170 -123.5 141.81 51.63 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 123.655 0.782 . . . . 0.0 110.138 174.442 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 73.2 m80 -91.96 80.76 5.15 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 123.415 0.686 . . . . 0.0 109.515 -179.946 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 8.3 p80 -83.81 119.95 25.46 Favored 'General case' 0 N--CA 1.475 0.823 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 176.522 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 59.4 t-80 -148.43 142.26 25.71 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 123.915 0.886 . . . . 0.0 108.837 -178.947 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 45.1 m80 -65.11 121.67 15.26 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 122.761 0.424 . . . . 0.0 110.188 177.505 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 28.7 m -58.19 -39.68 79.56 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 123.658 0.783 . . . . 0.0 110.719 179.01 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 23.2 t 59.48 19.19 7.6 Favored 'General case' 0 CA--C 1.557 1.224 0 C-N-CA 124.701 1.2 . . . . 0.0 112.645 169.399 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -161.0 76.64 0.18 Allowed Glycine 0 C--N 1.343 0.942 0 N-CA-C 112.063 -0.415 . . . . 0.0 112.063 -175.78 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 53.8 ttp180 -86.35 98.04 10.76 Favored 'General case' 0 CA--C 1.541 0.623 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 173.293 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -85.54 74.18 10.35 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 123.53 0.732 . . . . 0.0 109.944 -176.035 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 89.0 m-20 -149.75 116.01 5.75 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 125.371 1.468 . . . . 0.0 108.536 -179.24 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -158.86 146.84 17.98 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 122.859 0.464 . . . . 0.0 110.242 171.65 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 22.1 m-85 -132.25 98.88 4.52 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-O 121.984 0.897 . . . . 0.0 109.045 169.484 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 25.5 p90 -81.61 10.12 6.52 Favored 'General case' 0 CA--C 1.55 0.971 0 CA-C-N 113.958 -1.474 . . . . 0.0 111.469 -178.878 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 8.0 mm100 -70.77 128.13 34.98 Favored 'General case' 0 C--O 1.241 0.648 0 C-N-CA 124.297 1.039 . . . . 0.0 109.839 -178.659 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -158.68 171.5 35.4 Favored Glycine 0 C--O 1.242 0.638 0 N-CA-C 111.51 -0.636 . . . . 0.0 111.51 176.52 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 52.5 m-70 -89.38 117.25 28.18 Favored 'General case' 0 N--CA 1.466 0.374 0 C-N-CA 122.749 0.42 . . . . 0.0 110.031 -175.852 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 25.8 mmt -81.22 -14.9 57.04 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 123.621 0.768 . . . . 0.0 110.827 174.036 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . 66.82 -169.96 0.2 Allowed 'General case' 0 C--N 1.355 0.814 0 C-N-CA 124.669 1.188 . . . . 0.0 111.186 -179.052 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 29.0 t -162.16 170.82 18.44 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 123.109 0.563 . . . . 0.0 110.177 179.893 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -89.92 37.05 3.4 Favored Glycine 0 C--N 1.344 1.012 0 CA-C-N 115.994 -0.548 . . . . 0.0 112.304 172.996 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 26.1 m -87.12 40.32 0.91 Allowed 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 124.213 1.005 . . . . 0.0 110.006 -178.502 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -116.41 -170.51 1.83 Allowed 'General case' 0 C--O 1.242 0.663 0 C-N-CA 124.686 1.194 . . . . 0.0 109.858 -174.125 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -151.89 141.99 22.23 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 122.947 0.499 . . . . 0.0 109.908 -179.063 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -69.67 107.16 3.33 Favored 'General case' 0 C--N 1.349 0.556 0 C-N-CA 123.323 0.649 . . . . 0.0 109.292 176.232 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 15.5 m -127.5 141.04 47.44 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 C-N-CA 123.821 0.848 . . . . 0.0 109.398 -178.754 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 34.7 m -76.71 110.62 12.45 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.019 0 CA-C-O 121.444 0.64 . . . . 0.0 110.435 -177.05 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 56.2 p -134.71 124.29 25.04 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 124.013 0.925 . . . . 0.0 109.87 -176.064 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 95.4 t -109.55 116.61 52.6 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.448 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 174.372 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.494 ' HA ' ' HA ' ' A' ' 42' ' ' LEU . 44.0 mt-10 -77.27 125.3 29.1 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 123.257 0.623 . . . . 0.0 110.387 177.455 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -100.64 169.03 8.4 Favored Pre-proline 0 CA--C 1.559 1.304 0 C-N-CA 124.613 1.165 . . . . 0.0 109.316 -177.144 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -54.94 126.44 22.54 Favored 'Trans proline' 0 C--N 1.395 3.005 0 C-N-CA 122.99 2.46 . . . . 0.0 113.147 -177.745 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.46 ' HB2' ' HB3' ' A' ' 41' ' ' LYS . . . -114.9 156.83 44.57 Favored Pre-proline 0 N--CA 1.48 1.069 0 C-N-CA 124.374 1.069 . . . . 0.0 111.88 -171.697 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.592 ' HG2' ' HB2' ' A' ' 39' ' ' TRP . 72.6 Cg_endo -73.25 171.07 18.38 Favored 'Trans proline' 0 C--N 1.372 1.806 0 C-N-CA 122.544 2.163 . . . . 0.0 111.13 166.727 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 43.6 p -66.57 -46.13 77.02 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 123.421 0.689 . . . . 0.0 111.803 -176.937 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.444 ' HB2' ' HD1' ' A' ' 39' ' ' TRP . 9.8 m -72.68 -40.74 66.02 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-N 115.174 -0.921 . . . . 0.0 111.78 -174.187 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' TRP . . . . . 0.592 ' HB2' ' HG2' ' A' ' 36' ' ' PRO . 18.4 m95 -105.02 -173.86 2.4 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 123.535 0.734 . . . . 0.0 110.989 -175.273 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -130.28 158.02 40.93 Favored 'General case' 0 C--O 1.239 0.537 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 172.222 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.46 ' HB3' ' HB2' ' A' ' 35' ' ' ALA . 16.7 tptm -136.88 126.64 25.56 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.741 0.782 . . . . 0.0 109.135 -174.973 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.494 ' HA ' ' HA ' ' A' ' 32' ' ' GLU . 3.3 tt -136.05 151.97 50.41 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 113.653 -1.612 . . . . 0.0 108.195 -177.613 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 31.5 t80 -132.89 140.26 47.8 Favored 'General case' 0 C--O 1.235 0.309 0 C-N-CA 124.154 0.982 . . . . 0.0 108.491 171.405 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' TYR . . . . . 0.434 ' CB ' ' HB ' ' A' ' 54' ' ' THR . 25.3 m-85 -102.7 99.53 13.74 Favored Pre-proline 0 CA--C 1.547 0.833 0 C-N-CA 122.933 0.493 . . . . 0.0 109.687 174.654 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_endo -83.38 177.38 6.49 Favored 'Trans proline' 0 C--N 1.368 1.603 0 C-N-CA 122.765 2.31 . . . . 0.0 111.705 173.942 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' ASN . . . . . 0.409 ' HB3' ' HB2' ' A' ' 53' ' ' LYS . 8.8 p30 -87.24 172.12 10.12 Favored 'General case' 0 C--O 1.243 0.724 0 CA-C-N 115.949 -0.569 . . . . 0.0 109.676 170.661 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 5.1 tmtt? -76.52 -74.29 0.24 Allowed 'General case' 0 CA--C 1.553 1.075 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 173.894 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 59.9 t -141.66 109.97 2.43 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.213 0 N-CA-C 108.088 -1.079 . . . . 0.0 108.088 172.75 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 174.87 163.86 28.72 Favored Glycine 0 C--N 1.344 1.003 0 O-C-N 123.28 0.362 . . . . 0.0 112.677 176.776 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 69.4 p -90.36 40.44 1.01 Allowed 'General case' 0 CA--C 1.551 1.019 0 C-N-CA 123.738 0.815 . . . . 0.0 110.408 178.231 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 30.8 m -117.21 162.97 14.77 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 C-N-CA 124.217 1.007 . . . . 0.0 109.636 -178.687 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 39.7 ttmt -81.47 -32.62 32.45 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 123.355 0.662 . . . . 0.0 109.339 174.008 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.409 ' HB2' ' HB3' ' A' ' 46' ' ' ASN . 14.8 tmtt? 71.33 -78.79 0.04 OUTLIER 'General case' 0 CA--C 1.553 1.065 0 C-N-CA 125.068 1.347 . . . . 0.0 109.716 -176.274 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.434 ' HB ' ' CB ' ' A' ' 44' ' ' TYR . 72.7 m -135.39 160.1 39.5 Favored 'General case' 0 CA--C 1.552 1.029 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 174.073 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -87.44 -169.82 2.77 Favored 'General case' 0 CA--C 1.557 1.235 0 CA-C-O 121.325 0.583 . . . . 0.0 111.631 -178.398 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 87.5 t -82.1 144.66 9.91 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.77 0 C-N-CA 124.848 1.259 . . . . 0.0 110.353 -179.104 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 60.7 t -126.82 129.16 71.41 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.068 0 C-N-CA 124.325 1.05 . . . . 0.0 109.333 177.545 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.404 ' CZ ' ' HD3' ' A' ' 41' ' ' LYS . 31.2 m-85 -105.84 114.98 29.46 Favored 'General case' 0 N--CA 1.477 0.879 0 N-CA-C 108.752 -0.832 . . . . 0.0 108.752 170.622 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 6.9 t -80.14 133.91 28.61 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 C-N-CA 123.073 0.549 . . . . 0.0 109.764 178.11 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -85.94 155.57 58.25 Favored Pre-proline 0 CA--C 1.542 0.64 0 CA-C-N 115.166 -0.925 . . . . 0.0 111.4 -176.337 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -69.79 7.49 0.99 Allowed 'Trans proline' 0 N--CA 1.504 2.131 0 C-N-CA 123.258 2.639 . . . . 0.0 114.702 -179.016 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.524 HG23 ' H ' ' A' ' 64' ' ' GLU . 9.0 t -128.93 -7.1 4.97 Favored 'General case' 0 N--CA 1.484 1.26 0 C-N-CA 123.484 0.714 . . . . 0.0 111.263 -176.478 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 95.57 -11.03 68.82 Favored Glycine 0 C--N 1.351 1.382 0 CA-C-O 119.572 -0.571 . . . . 0.0 114.497 -176.687 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.524 ' H ' HG23 ' A' ' 62' ' ' THR . 44.3 tt0 -79.76 73.22 6.5 Favored 'General case' 0 N--CA 1.483 1.204 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 172.932 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -69.73 158.04 36.16 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-N 114.823 -1.08 . . . . 0.0 111.568 -171.298 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.435 HD12 ' HB3' ' A' ' 71' ' ' GLN . 44.7 mm -113.95 120.31 63.41 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 CA-C-N 115.157 -0.929 . . . . 0.0 109.757 -173.741 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 77.4 p -93.06 -24.33 18.34 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 123.691 0.797 . . . . 0.0 111.762 -177.147 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 8.9 p30 -141.23 157.8 44.75 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 122.775 0.43 . . . . 0.0 111.325 -175.42 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 70.1 ttt180 -62.92 -27.33 69.3 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 124.524 1.13 . . . . 0.0 112.562 -173.391 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 6.5 tmtm? -65.51 -50.37 65.52 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 123.316 0.646 . . . . 0.0 109.298 176.483 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.435 ' HB3' HD12 ' A' ' 66' ' ' ILE . 46.9 mt-30 -55.82 -31.37 62.63 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 123.942 0.897 . . . . 0.0 111.562 179.463 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.429 ' O ' ' HG ' ' A' ' 76' ' ' LEU . 0.2 OUTLIER -64.7 -51.77 60.72 Favored 'General case' 0 CA--C 1.551 1.017 0 O-C-N 123.613 0.571 . . . . 0.0 109.722 178.801 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -59.99 -50.4 73.88 Favored 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 122.859 0.464 . . . . 0.0 111.504 -178.116 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.2 -25.54 66.18 Favored 'General case' 0 CA--C 1.543 0.694 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.385 -177.033 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 22.1 t80 -65.64 -49.51 68.4 Favored 'General case' 0 C--N 1.351 0.662 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 171.794 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.429 ' HG ' ' O ' ' A' ' 72' ' ' LEU . 80.2 mt -66.42 -39.4 88.94 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 123.135 0.574 . . . . 0.0 112.404 -172.24 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.02 -24.3 61.53 Favored 'General case' 0 N--CA 1.481 1.117 0 CA-C-O 120.817 0.342 . . . . 0.0 110.753 178.094 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 43.8 t -85.21 -27.57 26.01 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 123.409 0.684 . . . . 0.0 111.131 175.536 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 59.9 m80 -132.61 88.48 38.51 Favored Pre-proline 0 N--CA 1.475 0.781 0 C-N-CA 123.694 0.798 . . . . 0.0 109.511 -172.44 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -70.02 160.17 50.6 Favored 'Trans proline' 0 C--N 1.373 1.856 0 C-N-CA 122.468 2.112 . . . . 0.0 111.341 177.011 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 95.46 -32.78 5.95 Favored Glycine 0 CA--C 1.532 1.119 0 N-CA-C 112.353 -0.299 . . . . 0.0 112.353 -176.799 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 32.2 m-80 -65.49 143.72 98.75 Favored Pre-proline 0 CA--C 1.551 0.998 0 C-N-CA 123.593 0.757 . . . . 0.0 110.698 176.66 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.418 ' HB2' ' CE2' ' A' ' 88' ' ' PHE . 42.5 Cg_exo -53.98 157.12 11.22 Favored 'Trans proline' 0 C--N 1.375 1.944 0 C-N-CA 123.809 3.006 . . . . 0.0 113.587 -179.008 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -68.78 152.37 45.41 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 123.983 0.913 . . . . 0.0 111.412 -177.603 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.413 HD12 ' HB3' ' A' ' 72' ' ' LEU . 12.8 tt -75.11 -21.61 16.63 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.17 0 CA-C-O 120.744 0.307 . . . . 0.0 110.288 175.08 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -58.85 -40.07 83.2 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 124.246 1.018 . . . . 0.0 112.078 178.011 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -84.48 -8.89 58.79 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 123.474 0.71 . . . . 0.0 111.587 179.583 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.418 ' CE2' ' HB2' ' A' ' 83' ' ' PRO . 4.4 m-30 -84.45 112.93 20.81 Favored 'General case' 0 N--CA 1.476 0.835 0 CA-C-O 121.652 0.739 . . . . 0.0 109.778 177.483 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 19.4 p-10 -93.12 88.52 6.11 Favored 'General case' 0 CA--C 1.543 0.703 0 CA-C-N 114.451 -1.25 . . . . 0.0 111.191 -171.166 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 76.0 m95 -76.23 -21.89 55.84 Favored 'General case' 0 N--CA 1.485 1.309 0 CA-C-N 115.441 -0.799 . . . . 0.0 110.51 173.406 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 10.7 t -86.27 16.01 4.78 Favored 'General case' 0 CA--C 1.556 1.209 0 C-N-CA 125.652 1.581 . . . . 0.0 111.775 -178.761 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 9.9 t -59.3 -39.28 82.53 Favored 'General case' 0 CA--C 1.551 0.983 0 C-N-CA 124.336 1.054 . . . . 0.0 113.77 -166.259 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 65.6 m -158.4 125.89 5.06 Favored 'General case' 0 C--O 1.241 0.621 0 C-N-CA 123.867 0.867 . . . . 0.0 109.576 -176.982 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -80.78 73.39 2.56 Favored Glycine 0 C--N 1.346 1.101 0 N-CA-C 109.959 -1.256 . . . . 0.0 109.959 167.889 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 74.9 p . . . . . 0 CA--C 1.56 1.346 0 C-N-CA 125.725 1.61 . . . . 0.0 111.766 -168.567 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.482 ' SD ' ' N ' ' A' ' 1' ' ' MET . 0.9 OUTLIER . . . . . 0 N--CA 1.488 1.447 0 N-CA-C 110.4 -0.222 . . . . 0.0 110.4 . . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 31.7 m170 -75.18 -43.8 50.16 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 123.517 0.727 . . . . 0.0 111.249 -178.216 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 58.0 t-80 -78.7 88.11 4.6 Favored 'General case' 0 N--CA 1.475 0.815 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 178.314 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 97.0 m-70 -62.11 127.86 33.37 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-N 115.229 -0.896 . . . . 0.0 111.242 -174.767 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 44.3 m-70 -68.21 -21.01 64.88 Favored 'General case' 0 N--CA 1.48 1.067 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.586 175.563 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 65.5 m80 -79.83 120.66 24.38 Favored 'General case' 0 CA--C 1.537 0.455 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 166.285 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 7.1 t-160 -94.18 20.14 8.42 Favored 'General case' 0 CA--C 1.557 1.25 0 C-N-CA 123.365 0.666 . . . . 0.0 109.846 175.638 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 46.7 m -67.58 102.41 1.16 Allowed 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 124.181 0.992 . . . . 0.0 110.51 175.376 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 45.1 t -162.55 -42.31 0.04 OUTLIER 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 123.804 0.842 . . . . 0.0 109.638 -178.272 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 82.09 21.63 60.63 Favored Glycine 0 C--N 1.352 1.446 0 CA-C-N 115.525 -0.762 . . . . 0.0 112.46 -176.816 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 74.7 mtm180 66.28 127.51 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 C-N-CA 125.282 1.433 . . . . 0.0 112.275 -179.239 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -72.93 88.59 1.37 Allowed 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 172.747 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 8.0 t30 -136.27 -34.0 0.8 Allowed 'General case' 0 N--CA 1.472 0.659 0 CA-C-N 115.156 -0.929 . . . . 0.0 109.315 -177.805 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 3.3 mm? 63.66 -170.08 0.19 Allowed 'General case' 0 C--N 1.362 1.143 0 C-N-CA 124.44 1.096 . . . . 0.0 111.131 -177.59 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 20.4 p90 -142.68 -48.61 0.34 Allowed 'General case' 0 C--O 1.241 0.632 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 171.892 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 52.9 t80 46.18 61.82 2.55 Favored 'General case' 0 CA--C 1.554 1.108 0 C-N-CA 125.444 1.497 . . . . 0.0 111.342 -179.53 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 11.4 pt20 -136.6 111.74 9.03 Favored 'General case' 0 C--O 1.243 0.719 0 CA-C-N 114.86 -1.064 . . . . 0.0 108.49 -178.558 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 88.29 166.22 42.09 Favored Glycine 0 CA--C 1.532 1.099 0 CA-C-N 115.437 -0.801 . . . . 0.0 111.732 -169.51 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 12.6 m170 -78.87 112.9 16.5 Favored 'General case' 0 N--CA 1.476 0.852 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 179.888 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 68.5 mtt -149.55 142.87 25.19 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 124.751 1.22 . . . . 0.0 108.371 -179.417 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . 60.07 37.94 20.81 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 124.122 0.969 . . . . 0.0 109.93 -167.858 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 16.5 m -63.12 -24.51 67.93 Favored 'General case' 0 N--CA 1.481 1.088 0 CA-C-N 114.101 -1.409 . . . . 0.0 112.568 -175.881 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -81.76 60.06 4.79 Favored Glycine 0 C--N 1.343 0.963 0 CA-C-N 115.58 -0.736 . . . . 0.0 112.054 176.398 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 25.3 m -80.39 90.43 5.61 Favored 'General case' 0 C--O 1.24 0.58 0 C-N-CA 123.983 0.913 . . . . 0.0 109.779 -179.233 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -109.88 81.99 1.52 Allowed 'General case' 0 CA--C 1.54 0.579 0 N-CA-C 107.66 -1.237 . . . . 0.0 107.66 -178.387 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 66.06 9.22 6.05 Favored 'General case' 0 N--CA 1.488 1.462 0 C-N-CA 125.266 1.426 . . . . 0.0 113.049 -178.179 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 48.3 65.15 1.4 Allowed 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 125.649 1.579 . . . . 0.0 112.459 176.942 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 15.5 m -68.91 128.75 32.88 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.877 0 CA-C-N 115.213 -0.903 . . . . 0.0 110.875 178.839 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.48 HG11 ' HG2' ' A' ' 47' ' ' LYS . 14.9 m -69.92 111.91 4.26 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 CA-C-O 121.703 0.763 . . . . 0.0 111.347 -175.671 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 3.8 p -144.44 118.12 9.22 Favored 'General case' 0 C--O 1.239 0.515 0 C-N-CA 124.305 1.042 . . . . 0.0 109.304 -179.507 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 90.4 t -101.65 130.98 50.43 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.483 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 179.268 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -81.89 107.17 14.39 Favored 'General case' 0 C--O 1.238 0.474 0 C-N-CA 123.09 0.556 . . . . 0.0 109.873 175.084 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.541 HD23 ' HB3' ' A' ' 43' ' ' PHE . 4.3 mm? -83.31 161.06 58.27 Favored Pre-proline 0 CA--C 1.553 1.064 0 C-N-CA 124.324 1.049 . . . . 0.0 109.742 -179.836 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -53.37 136.46 63.15 Favored 'Trans proline' 0 C--N 1.388 2.645 0 C-N-CA 122.988 2.459 . . . . 0.0 113.178 -179.149 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -121.18 163.39 30.31 Favored Pre-proline 0 N--CA 1.481 1.086 0 C-N-CA 124.361 1.065 . . . . 0.0 112.961 -164.142 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.623 ' HG2' ' HB2' ' A' ' 39' ' ' TRP . 40.9 Cg_endo -67.72 156.96 63.94 Favored 'Trans proline' 0 C--N 1.381 2.27 0 C-N-CA 122.52 2.147 . . . . 0.0 110.587 161.324 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 55.2 p -62.36 -39.04 91.85 Favored 'General case' 0 N--CA 1.486 1.354 0 N-CA-C 113.874 1.064 . . . . 0.0 113.874 -166.725 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 15.0 p -89.21 -21.6 23.18 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 112.375 0.509 . . . . 0.0 112.375 -174.952 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' TRP . . . . . 0.623 ' HB2' ' HG2' ' A' ' 36' ' ' PRO . 16.3 m95 -109.97 174.37 5.89 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-O 121.758 0.79 . . . . 0.0 110.469 179.463 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.452 ' HB2' ' HB ' ' A' ' 59' ' ' VAL . 0.0 OUTLIER -117.54 158.14 25.09 Favored 'General case' 0 C--O 1.24 0.559 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 170.371 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.406 ' HD3' ' CZ ' ' A' ' 58' ' ' PHE . 16.8 tptm -130.33 122.14 27.34 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 124.445 1.098 . . . . 0.0 108.133 -176.862 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.498 HD22 ' HB ' ' A' ' 57' ' ' VAL . 4.7 tt -125.19 150.31 47.1 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 124.743 1.217 . . . . 0.0 108.668 177.443 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.541 ' HB3' HD23 ' A' ' 33' ' ' LEU . 36.2 t80 -136.78 145.33 44.42 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 125.053 1.341 . . . . 0.0 108.347 174.064 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 16.4 m-85 -102.14 96.75 7.35 Favored Pre-proline 0 CA--C 1.555 1.17 0 C-N-CA 123.113 0.565 . . . . 0.0 110.114 174.33 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -82.72 163.49 16.26 Favored 'Trans proline' 0 C--N 1.374 1.906 0 C-N-CA 122.734 2.289 . . . . 0.0 111.806 175.437 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -81.79 147.95 29.14 Favored 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 170.363 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.48 ' HG2' HG11 ' A' ' 29' ' ' VAL . 96.5 mttt -62.73 -40.27 96.68 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 123.413 0.685 . . . . 0.0 111.706 -176.693 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 41.7 t -80.78 -36.34 15.48 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.958 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 173.548 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 104.25 -160.49 15.85 Favored Glycine 0 C--N 1.346 1.122 0 CA-C-N 115.225 -0.898 . . . . 0.0 112.316 -178.572 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 57.1 m 67.34 -71.56 0.1 Allowed 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 125.486 1.514 . . . . 0.0 111.769 -179.36 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 34.2 m -75.1 170.5 1.47 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.794 0 C-N-CA 123.553 0.741 . . . . 0.0 110.576 174.935 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 4.8 ttmp? -108.61 135.32 50.06 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 123.997 0.919 . . . . 0.0 110.031 -175.36 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -78.18 -71.18 0.44 Allowed 'General case' 0 CA--C 1.55 0.953 0 N-CA-C 107.195 -1.409 . . . . 0.0 107.195 174.086 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 15.8 m -133.73 162.12 32.84 Favored 'General case' 0 CA--C 1.547 0.864 0 N-CA-C 106.947 -1.501 . . . . 0.0 106.947 173.607 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -73.01 -168.03 0.45 Allowed 'General case' 0 CA--C 1.552 1.049 0 CA-C-O 121.419 0.628 . . . . 0.0 111.168 178.783 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 48.9 t -81.33 138.67 19.21 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.661 0 C-N-CA 124.145 0.978 . . . . 0.0 110.435 -176.723 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.498 ' HB ' HD22 ' A' ' 42' ' ' LEU . 87.2 t -123.5 115.82 46.5 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.952 0 C-N-CA 124.738 1.215 . . . . 0.0 108.512 176.213 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.406 ' CZ ' ' HD3' ' A' ' 41' ' ' LYS . 15.9 m-85 -91.99 118.39 30.73 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 123.465 0.706 . . . . 0.0 109.873 177.227 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.452 ' HB ' ' HB2' ' A' ' 40' ' ' LYS . 3.3 t -80.2 131.17 34.71 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 C-N-CA 123.439 0.696 . . . . 0.0 110.712 179.914 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -88.35 158.95 48.36 Favored Pre-proline 0 N--CA 1.476 0.834 0 C-N-CA 124.276 1.031 . . . . 0.0 111.677 -173.905 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -68.29 -19.18 44.33 Favored 'Trans proline' 0 C--N 1.38 2.223 0 C-N-CA 122.878 2.386 . . . . 0.0 113.191 178.305 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.565 HG23 ' H ' ' A' ' 64' ' ' GLU . 14.8 t -88.09 -11.31 47.47 Favored 'General case' 0 CA--C 1.55 0.957 0 C-N-CA 123.327 0.651 . . . . 0.0 111.198 175.934 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 96.36 -25.64 25.03 Favored Glycine 0 C--N 1.355 1.605 0 C-N-CA 122.601 0.143 . . . . 0.0 113.206 -177.609 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.565 ' H ' HG23 ' A' ' 62' ' ' THR . 37.7 tt0 -72.74 83.94 1.18 Allowed 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 124.08 0.952 . . . . 0.0 109.717 174.326 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.43 159.14 24.92 Favored 'General case' 0 N--CA 1.473 0.707 0 CA-C-N 114.878 -1.055 . . . . 0.0 112.072 -177.027 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.463 HG23 ' HB2' ' A' ' 71' ' ' GLN . 35.1 mm -102.44 127.53 55.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 C-N-CA 125.33 1.452 . . . . 0.0 109.08 177.522 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 29.9 m -97.59 -30.03 13.09 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 122.774 0.43 . . . . 0.0 111.504 -174.5 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 8.1 p30 -135.08 159.43 41.54 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 123.038 0.535 . . . . 0.0 110.47 -179.068 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 32.3 ttm180 -64.79 -30.43 71.43 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 124.271 1.028 . . . . 0.0 113.155 -168.45 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 6.2 tmtm? -63.73 -47.73 79.89 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 123.384 0.674 . . . . 0.0 109.449 176.341 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.463 ' HB2' HG23 ' A' ' 66' ' ' ILE . 23.3 mt-30 -55.27 -32.76 62.62 Favored 'General case' 0 N--CA 1.49 1.547 0 C-N-CA 123.679 0.792 . . . . 0.0 111.598 179.341 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.475 ' O ' ' HG ' ' A' ' 76' ' ' LEU . 0.4 OUTLIER -61.22 -52.94 62.68 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 123.125 0.57 . . . . 0.0 109.56 -179.276 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -67.85 -42.91 80.64 Favored 'General case' 0 C--O 1.248 0.992 0 C-N-CA 123.781 0.832 . . . . 0.0 111.691 -174.372 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.36 -22.65 61.87 Favored 'General case' 0 N--CA 1.478 0.971 0 CA-C-N 116.779 -0.192 . . . . 0.0 111.094 179.263 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 39.7 t80 -70.36 -42.83 71.3 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 122.969 0.508 . . . . 0.0 109.822 172.214 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.475 ' HG ' ' O ' ' A' ' 72' ' ' LEU . 80.1 mt -64.19 -33.83 76.7 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 123.166 0.586 . . . . 0.0 111.739 -175.991 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 14.3 ptpt -79.98 -32.61 39.79 Favored 'General case' 0 N--CA 1.482 1.171 0 N-CA-C 111.607 0.225 . . . . 0.0 111.607 175.06 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 40.9 t -71.28 -29.91 65.64 Favored 'General case' 0 N--CA 1.485 1.302 0 CA-C-O 121.427 0.632 . . . . 0.0 110.955 178.737 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 42.1 m80 -143.01 86.08 9.47 Favored Pre-proline 0 C--O 1.24 0.563 0 C-N-CA 124.677 1.191 . . . . 0.0 108.423 -178.267 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -67.58 163.01 36.66 Favored 'Trans proline' 0 C--N 1.378 2.09 0 C-N-CA 122.652 2.235 . . . . 0.0 111.704 173.516 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 101.82 -31.21 8.95 Favored Glycine 0 C--N 1.342 0.889 0 N-CA-C 111.283 -0.727 . . . . 0.0 111.283 -173.658 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 37.0 m-80 -66.79 144.52 98.62 Favored Pre-proline 0 CA--C 1.553 1.08 0 C-N-CA 123.535 0.734 . . . . 0.0 110.606 174.464 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -63.77 154.25 70.64 Favored 'Trans proline' 0 C--N 1.373 1.862 0 C-N-CA 123.067 2.511 . . . . 0.0 112.984 -176.097 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.49 ' O ' ' HG2' ' A' ' 87' ' ' GLU . . . -71.02 146.41 49.38 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 114.6 -1.182 . . . . 0.0 111.396 -174.745 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 17.1 tt -64.81 -14.41 16.24 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.258 0 C-N-CA 123.637 0.775 . . . . 0.0 111.739 -179.274 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -53.76 -40.26 66.05 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 124.205 1.002 . . . . 0.0 112.576 175.325 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.49 ' HG2' ' O ' ' A' ' 84' ' ' ALA . 10.6 pt-20 -86.32 -17.81 33.59 Favored 'General case' 0 N--CA 1.486 1.35 0 C-N-CA 123.306 0.643 . . . . 0.0 111.429 178.619 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -77.31 109.04 10.88 Favored 'General case' 0 N--CA 1.478 0.959 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 177.92 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -94.83 121.01 35.98 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-O 121.311 0.577 . . . . 0.0 109.725 -177.71 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 49.6 m95 -103.38 -3.7 25.14 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 123.857 0.863 . . . . 0.0 109.446 174.981 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 14.8 t -91.03 13.42 16.79 Favored 'General case' 0 CA--C 1.55 0.976 0 C-N-CA 125.118 1.367 . . . . 0.0 112.14 -176.041 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 7.1 t -62.36 -16.96 57.65 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 123.722 0.809 . . . . 0.0 112.577 -175.801 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 10.1 m -72.85 86.69 1.28 Allowed 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 123.324 0.65 . . . . 0.0 109.794 177.541 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -81.01 68.11 3.49 Favored Glycine 0 C--N 1.351 1.371 0 N-CA-C 111.068 -0.813 . . . . 0.0 111.068 175.624 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 1.8 t . . . . . 0 CA--C 1.559 1.301 0 C-N-CA 124.37 1.068 . . . . 0.0 110.95 -173.122 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.407 ' SD ' ' N ' ' A' ' 1' ' ' MET . 0.9 OUTLIER . . . . . 0 N--CA 1.482 1.146 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 . . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 62.4 t-80 -72.18 -48.81 40.45 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 123.443 0.697 . . . . 0.0 111.501 -173.914 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 8.9 p80 -112.2 132.64 54.79 Favored 'General case' 0 N--CA 1.48 1.038 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 178.978 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 49.0 t-80 -102.91 138.49 39.72 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 123.703 0.801 . . . . 0.0 111.759 -172.551 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 32.3 m170 -131.18 172.27 12.33 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 124.64 1.176 . . . . 0.0 109.456 169.627 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 46.4 m80 -93.42 93.36 8.1 Favored 'General case' 0 N--CA 1.469 0.483 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 170.295 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 53.3 t-80 -66.43 99.02 0.53 Allowed 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 123.271 0.628 . . . . 0.0 110.017 179.461 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 19.6 m 63.43 19.76 11.87 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 124.491 1.116 . . . . 0.0 112.128 175.509 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 41.2 p -124.35 163.48 21.63 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 123.794 0.838 . . . . 0.0 110.164 -178.357 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -129.75 -141.28 4.98 Favored Glycine 0 C--N 1.335 0.501 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.761 -178.667 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 26.5 mmm180 59.83 32.9 21.53 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 124.889 1.275 . . . . 0.0 111.597 -179.566 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -79.14 -8.99 59.43 Favored 'General case' 0 CA--C 1.554 1.13 0 C-N-CA 124.105 0.962 . . . . 0.0 110.191 175.869 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 24.8 p-10 -79.79 79.3 6.32 Favored 'General case' 0 CA--C 1.557 1.239 0 CA-C-O 122.105 0.955 . . . . 0.0 110.726 176.342 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -141.55 -176.39 4.73 Favored 'General case' 0 N--CA 1.478 0.943 0 CA-C-N 115.467 -0.788 . . . . 0.0 109.605 173.521 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 4.1 p90 -75.69 65.98 1.94 Allowed 'General case' 0 CA--C 1.561 1.398 0 CA-C-O 122.335 1.064 . . . . 0.0 110.762 175.56 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 58.7 t80 -81.15 77.46 8.04 Favored 'General case' 0 CA--C 1.543 0.704 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 177.56 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 9.0 pt20 -135.05 -47.0 0.72 Allowed 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 115.131 -0.94 . . . . 0.0 110.279 -171.688 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -111.78 42.76 1.87 Allowed Glycine 0 C--N 1.346 1.106 0 N-CA-C 111.904 -0.478 . . . . 0.0 111.904 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 31.9 t60 -78.56 117.41 19.72 Favored 'General case' 0 CA--C 1.542 0.658 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 176.24 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 39.8 tpp -135.97 148.06 48.3 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 123.569 0.747 . . . . 0.0 109.947 -178.147 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -144.01 18.82 1.78 Allowed 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 123.095 0.558 . . . . 0.0 111.675 -174.498 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 19.4 m 60.39 97.42 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 C-N-CA 124.632 1.173 . . . . 0.0 111.398 -176.687 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 103.26 -178.31 25.42 Favored Glycine 0 C--N 1.342 0.864 0 N-CA-C 110.707 -0.957 . . . . 0.0 110.707 -167.433 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 32.9 t 76.7 -32.98 0.2 Allowed 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 124.932 1.293 . . . . 0.0 113.332 176.005 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -56.25 102.96 0.09 Allowed 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 124.12 0.968 . . . . 0.0 111.43 -177.363 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 47.76 26.3 0.86 Allowed 'General case' 0 N--CA 1.497 1.885 0 C-N-CA 126.427 1.891 . . . . 0.0 112.746 -177.88 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -73.43 118.4 16.34 Favored 'General case' 0 C--O 1.24 0.566 0 CA-C-N 115.223 -0.899 . . . . 0.0 110.441 -170.96 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 34.6 m -77.91 154.63 5.24 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 C-N-CA 124.36 1.064 . . . . 0.0 110.899 -177.764 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 27.1 m -89.34 130.97 37.8 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.642 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 174.631 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 39.2 p -157.33 118.65 3.65 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 123.943 0.897 . . . . 0.0 108.891 -177.929 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 48.1 t -106.06 125.71 61.61 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 C-N-CA 123.879 0.872 . . . . 0.0 109.056 -177.514 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.461 ' HA ' ' HA ' ' A' ' 42' ' ' LEU . 45.6 mt-10 -79.66 101.54 8.43 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 123.068 0.547 . . . . 0.0 110.092 178.942 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -81.21 152.77 71.33 Favored Pre-proline 0 CA--C 1.559 1.298 0 C-N-CA 124.379 1.071 . . . . 0.0 110.773 -176.178 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -62.84 137.74 64.7 Favored 'Trans proline' 0 C--N 1.384 2.401 0 C-N-CA 123.073 2.515 . . . . 0.0 114.085 -177.718 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -146.07 169.98 8.71 Favored Pre-proline 0 CA--C 1.557 1.218 0 C-N-CA 124.276 1.03 . . . . 0.0 108.933 -178.541 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -51.25 145.26 27.45 Favored 'Trans proline' 0 C--N 1.392 2.848 0 C-N-CA 122.691 2.26 . . . . 0.0 112.168 173.894 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 49.2 m -64.01 -20.04 65.62 Favored 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 113.164 0.802 . . . . 0.0 113.164 -171.717 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 33.4 m -72.23 -40.23 67.93 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 123.197 0.599 . . . . 0.0 110.16 174.581 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 25.6 m95 -104.83 -168.3 1.46 Allowed 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 123.958 0.903 . . . . 0.0 110.038 179.449 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.525 ' HB3' ' HB ' ' A' ' 59' ' ' VAL . 40.7 ttmt -156.41 170.78 21.51 Favored 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 106.565 -1.643 . . . . 0.0 106.565 171.584 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.716 ' HD2' HG11 ' A' ' 56' ' ' VAL . 21.3 pttm -151.34 154.06 35.97 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-O 121.845 0.831 . . . . 0.0 110.904 171.434 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.461 ' HA ' ' HA ' ' A' ' 32' ' ' GLU . 0.8 OUTLIER -127.0 130.76 50.66 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 113.348 -1.751 . . . . 0.0 107.726 178.433 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 28.7 t80 -101.39 141.04 34.85 Favored 'General case' 0 CA--C 1.542 0.647 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 170.728 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' TYR . . . . . 0.403 ' CE1' HD21 ' A' ' 42' ' ' LEU . 11.6 m-85 -99.37 100.14 9.86 Favored Pre-proline 0 N--CA 1.481 1.111 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 171.487 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -79.49 168.17 20.17 Favored 'Trans proline' 0 C--N 1.365 1.413 0 C-N-CA 122.411 2.074 . . . . 0.0 112.43 175.489 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' ASN . . . . . 0.494 ' HB2' ' HB ' ' A' ' 51' ' ' VAL . 30.1 p30 -86.95 156.7 19.69 Favored 'General case' 0 C--O 1.241 0.605 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 168.447 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -77.88 -87.3 0.05 Allowed 'General case' 0 N--CA 1.475 0.782 0 CA-C-O 119.33 -0.367 . . . . 0.0 111.2 -175.314 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 57.9 t -134.37 142.43 40.82 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.382 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 -179.789 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 85.34 -112.12 3.63 Favored Glycine 0 C--N 1.348 1.195 0 N-CA-C 111.43 -0.668 . . . . 0.0 111.43 -177.077 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 28.3 t -145.08 79.12 1.58 Allowed 'General case' 0 C--O 1.24 0.574 0 CA-C-O 121.784 0.802 . . . . 0.0 109.14 175.881 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.494 ' HB ' ' HB2' ' A' ' 46' ' ' ASN . 21.5 t -85.66 158.28 3.36 Favored 'Isoleucine or valine' 0 C--O 1.246 0.889 0 N-CA-C 107.555 -1.276 . . . . 0.0 107.555 170.099 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.602 ' HD3' ' H ' ' A' ' 52' ' ' LYS . 0.0 OUTLIER -68.08 109.25 3.42 Favored 'General case' 0 CA--C 1.553 1.082 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 174.933 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 25.3 pttm -79.87 139.42 37.16 Favored 'General case' 0 C--N 1.353 0.748 0 N-CA-C 107.896 -1.15 . . . . 0.0 107.896 172.818 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 96.3 m -102.74 141.39 35.62 Favored 'General case' 0 CA--C 1.538 0.489 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 177.673 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -61.28 177.98 0.32 Allowed 'General case' 0 CA--C 1.549 0.905 0 CA-C-O 122.11 0.957 . . . . 0.0 112.133 179.267 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.716 HG11 ' HD2' ' A' ' 41' ' ' LYS . 51.0 t -82.35 147.42 6.04 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.771 0 CA-C-N 114.799 -1.091 . . . . 0.0 111.376 -168.896 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 65.8 t -124.52 116.5 47.73 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.693 0 C-N-CA 125.074 1.35 . . . . 0.0 107.681 175.276 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 36.7 m-85 -87.25 123.77 32.61 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 123.486 0.714 . . . . 0.0 110.982 -179.146 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.525 ' HB ' ' HB3' ' A' ' 40' ' ' LYS . 6.8 t -81.16 130.28 36.12 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.411 0 C-N-CA 123.677 0.791 . . . . 0.0 110.141 175.534 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -85.59 157.21 58.5 Favored Pre-proline 0 N--CA 1.475 0.794 0 O-C-N 124.157 0.911 . . . . 0.0 111.211 -178.618 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -63.7 -22.49 69.82 Favored 'Trans proline' 0 C--N 1.382 2.314 0 C-N-CA 122.934 2.423 . . . . 0.0 112.703 176.491 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.626 HG23 ' H ' ' A' ' 64' ' ' GLU . 12.1 t -91.53 -12.17 35.25 Favored 'General case' 0 CA--C 1.549 0.924 0 C-N-CA 123.822 0.849 . . . . 0.0 111.181 178.957 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 95.23 -11.73 68.81 Favored Glycine 0 C--N 1.349 1.283 0 CA-C-O 119.769 -0.462 . . . . 0.0 113.559 -177.591 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.626 ' H ' HG23 ' A' ' 62' ' ' THR . 36.4 tt0 -77.97 78.14 4.47 Favored 'General case' 0 N--CA 1.481 1.121 0 CA-C-N 117.576 0.688 . . . . 0.0 109.341 174.334 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -67.96 139.22 56.38 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-N 115.119 -0.946 . . . . 0.0 111.028 -174.075 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 36.8 mm -94.77 130.92 42.92 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.663 0 C-N-CA 124.484 1.114 . . . . 0.0 109.883 -179.927 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 6.0 p -96.59 -11.65 25.06 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 123.784 0.834 . . . . 0.0 112.414 -175.375 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 11.1 p-10 -153.53 151.32 29.67 Favored 'General case' 0 N--CA 1.48 1.052 0 N-CA-C 111.941 0.349 . . . . 0.0 111.941 -168.044 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 30.1 ttm180 -59.06 -39.55 82.42 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 124.759 1.224 . . . . 0.0 112.817 -168.582 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 4.3 tmtm? -59.71 -54.4 46.79 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 123.419 0.688 . . . . 0.0 109.923 -177.743 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.425 ' HA ' ' HG3' ' A' ' 74' ' ' GLN . 87.4 mm-40 -66.2 -22.32 66.34 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-N 115.032 -0.985 . . . . 0.0 111.309 -175.674 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.495 ' O ' ' HG ' ' A' ' 76' ' ' LEU . 0.8 OUTLIER -66.47 -56.36 11.3 Favored 'General case' 0 CA--C 1.544 0.742 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 174.318 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -57.41 -50.24 73.62 Favored 'General case' 0 N--CA 1.486 1.355 0 C-N-CA 124.404 1.082 . . . . 0.0 111.473 -176.314 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' GLN . . . . . 0.425 ' HG3' ' HA ' ' A' ' 71' ' ' GLN . 0.0 OUTLIER -70.31 -25.04 63.13 Favored 'General case' 0 CA--C 1.545 0.768 0 CA-C-N 115.4 -0.818 . . . . 0.0 111.608 -177.903 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 45.5 t80 -66.44 -45.99 77.96 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 122.75 0.42 . . . . 0.0 109.907 174.503 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.495 ' HG ' ' O ' ' A' ' 72' ' ' LEU . 52.4 mt -62.58 -45.23 93.86 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 123.033 0.533 . . . . 0.0 110.913 -175.36 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.11 -24.16 59.41 Favored 'General case' 0 CA--C 1.551 0.983 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.589 -179.835 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 46.3 t -78.19 -27.68 47.95 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 122.857 0.463 . . . . 0.0 110.806 174.949 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 59.0 m80 -127.4 84.89 62.22 Favored Pre-proline 0 N--CA 1.472 0.671 0 C-N-CA 123.401 0.681 . . . . 0.0 109.751 -175.435 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -62.8 122.18 10.38 Favored 'Trans proline' 0 C--N 1.372 1.788 0 C-N-CA 122.953 2.435 . . . . 0.0 111.709 177.431 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 133.23 -30.56 3.02 Favored Glycine 0 C--N 1.342 0.888 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.795 -174.042 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 40.2 m-80 -72.5 137.13 80.73 Favored Pre-proline 0 N--CA 1.476 0.864 0 C-N-CA 123.468 0.707 . . . . 0.0 110.456 177.109 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -62.88 154.25 67.67 Favored 'Trans proline' 0 C--N 1.375 1.971 0 C-N-CA 123.111 2.541 . . . . 0.0 112.777 -179.138 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.498 ' O ' ' HG2' ' A' ' 87' ' ' GLU . . . -73.96 148.07 42.46 Favored 'General case' 0 N--CA 1.476 0.842 0 CA-C-N 115.313 -0.858 . . . . 0.0 111.866 -173.674 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 17.3 tt -65.44 -11.72 12.5 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.194 0 C-N-CA 124.087 0.955 . . . . 0.0 112.366 -176.629 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -57.23 -38.66 74.13 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 123.678 0.791 . . . . 0.0 112.08 174.044 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.498 ' HG2' ' O ' ' A' ' 84' ' ' ALA . 12.6 pt-20 -90.81 -3.98 56.98 Favored 'General case' 0 N--CA 1.487 1.414 0 C-N-CA 123.14 0.576 . . . . 0.0 111.769 178.31 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -87.81 107.82 18.85 Favored 'General case' 0 N--CA 1.477 0.911 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 176.709 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 14.5 p-10 -93.48 88.0 5.76 Favored 'General case' 0 CA--C 1.547 0.842 0 CA-C-O 122.21 1.005 . . . . 0.0 111.174 -172.405 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 82.2 m95 -69.25 -26.15 64.63 Favored 'General case' 0 N--CA 1.481 1.111 0 CA-C-N 115.064 -0.971 . . . . 0.0 110.202 170.216 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 12.5 t -78.98 8.87 4.92 Favored 'General case' 0 CA--C 1.556 1.184 0 C-N-CA 125.196 1.398 . . . . 0.0 112.64 -175.443 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 14.1 t -63.0 -25.26 68.3 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 123.058 0.543 . . . . 0.0 111.13 176.482 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 21.3 p -68.4 99.29 0.93 Allowed 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 123.795 0.838 . . . . 0.0 109.676 175.062 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -69.81 136.29 27.33 Favored Glycine 0 C--N 1.348 1.199 0 CA-C-N 116.04 -0.527 . . . . 0.0 112.076 178.376 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 39.6 p . . . . . 0 CA--C 1.554 1.113 0 C-N-CA 123.863 0.865 . . . . 0.0 110.553 -178.683 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 52.8 ttp . . . . . 0 N--CA 1.481 1.106 0 N-CA-C 108.952 -0.758 . . . . 0.0 108.952 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 3.2 p80 -131.78 124.97 30.77 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 122.997 0.519 . . . . 0.0 109.968 -176.58 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 96.5 m-70 -128.93 95.0 3.97 Favored 'General case' 0 N--CA 1.472 0.651 0 N-CA-C 108.512 -0.922 . . . . 0.0 108.512 174.666 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 13.2 m-70 -89.42 45.09 1.25 Allowed 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 124.502 1.121 . . . . 0.0 110.891 -176.127 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 26.5 m170 -141.5 170.41 15.78 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 124.523 1.129 . . . . 0.0 109.547 175.456 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 26.9 p80 -69.5 168.13 15.25 Favored 'General case' 0 N--CA 1.483 1.202 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.641 -179.477 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 31.7 m170 -68.47 121.15 15.74 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.356 -179.084 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 28.0 t -146.08 176.99 9.3 Favored 'General case' 0 C--O 1.244 0.78 0 C-N-CA 124.084 0.953 . . . . 0.0 108.956 -179.037 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 32.8 t -76.58 70.02 3.07 Favored 'General case' 0 CA--C 1.555 1.157 0 C-N-CA 123.489 0.716 . . . . 0.0 109.752 177.495 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -97.39 76.89 0.65 Allowed Glycine 0 C--N 1.354 1.569 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.843 -175.092 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 6.8 mpt_? -81.1 -30.74 34.55 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 124.011 0.925 . . . . 0.0 110.047 179.658 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -77.21 -159.96 0.15 Allowed 'General case' 0 CA--C 1.558 1.286 0 C-N-CA 124.223 1.009 . . . . 0.0 111.023 178.652 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 33.3 m-80 72.18 69.63 0.14 Allowed 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 125.062 1.345 . . . . 0.0 109.86 -174.997 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -153.5 -166.77 2.5 Favored 'General case' 0 CA--C 1.548 0.874 0 CA-C-N 114.003 -1.453 . . . . 0.0 109.564 -179.956 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -145.85 95.51 2.65 Favored 'General case' 0 CA--C 1.55 0.966 0 C-N-CA 123.415 0.686 . . . . 0.0 109.741 -172.735 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 64.3 t80 -80.78 98.52 7.82 Favored 'General case' 0 N--CA 1.475 0.815 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 176.772 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 16.8 pt20 -160.18 178.59 9.5 Favored 'General case' 0 C--O 1.243 0.754 0 CA-C-N 115.115 -0.948 . . . . 0.0 109.594 -178.173 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -97.7 -134.88 8.46 Favored Glycine 0 C--N 1.343 0.937 0 N-CA-C 111.517 -0.633 . . . . 0.0 111.517 173.159 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 13.2 p-80 -89.31 150.38 22.62 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 123.818 0.847 . . . . 0.0 111.121 -179.293 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 63.7 mtt -144.47 109.42 5.02 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 124.285 1.034 . . . . 0.0 108.758 172.887 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -84.28 158.19 21.3 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 122.812 0.445 . . . . 0.0 110.103 177.107 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 78.8 p -80.92 -165.65 0.95 Allowed 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 123.394 0.678 . . . . 0.0 109.591 173.065 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -174.71 168.63 41.36 Favored Glycine 0 C--N 1.341 0.834 0 C-N-CA 121.219 -0.515 . . . . 0.0 112.589 177.614 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 22.7 t 64.54 -173.06 0.17 Allowed 'General case' 0 CA--C 1.556 1.182 0 C-N-CA 124.776 1.23 . . . . 0.0 111.536 177.303 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.415 ' HG2' ' H ' ' A' ' 26' ' ' GLU . 22.7 tt0 -153.55 -179.81 8.13 Favored 'General case' 0 CA--C 1.549 0.94 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 173.568 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.415 ' H ' ' HG2' ' A' ' 25' ' ' GLU . 40.4 tt0 -51.47 139.74 19.32 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 123.565 0.746 . . . . 0.0 111.685 175.063 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -72.39 86.42 1.13 Allowed 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 123.507 0.723 . . . . 0.0 110.111 -176.834 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 13.9 m -80.67 107.3 12.88 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.675 0 CA-C-O 121.858 0.837 . . . . 0.0 108.996 173.722 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 13.8 m -91.05 122.8 42.82 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 CA-C-N 114.823 -1.081 . . . . 0.0 110.686 -170.622 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 54.7 p -142.82 114.06 7.79 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 123.53 0.732 . . . . 0.0 109.5 178.604 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 62.1 t -101.85 127.81 54.95 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 C-N-CA 124.16 0.984 . . . . 0.0 108.959 179.565 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 53.3 mt-10 -83.02 106.79 15.13 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-O 121.011 0.434 . . . . 0.0 109.987 178.517 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.479 HD23 ' HB3' ' A' ' 43' ' ' PHE . 3.6 mm? -82.7 164.26 47.84 Favored Pre-proline 0 CA--C 1.559 1.325 0 C-N-CA 124.619 1.167 . . . . 0.0 109.877 178.938 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -49.89 143.42 23.75 Favored 'Trans proline' 0 C--N 1.393 2.891 0 C-N-CA 123.334 2.689 . . . . 0.0 114.097 -175.914 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -146.03 155.49 51.24 Favored Pre-proline 0 CA--C 1.542 0.673 0 C-N-CA 123.633 0.773 . . . . 0.0 111.255 -167.396 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_exo -58.51 149.82 72.71 Favored 'Trans proline' 0 C--N 1.381 2.255 0 C-N-CA 123.158 2.572 . . . . 0.0 110.598 163.525 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 20.7 p -58.66 -42.66 88.92 Favored 'General case' 0 CA--C 1.551 1.019 0 C-N-CA 123.72 0.808 . . . . 0.0 111.914 -176.241 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 26.6 t -67.49 -33.65 75.54 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 123.768 0.827 . . . . 0.0 111.452 -179.966 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 21.7 m95 -105.45 -176.12 2.99 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 123.469 0.707 . . . . 0.0 111.211 -177.095 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 45.3 mtmt -137.98 149.16 45.87 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 114.926 -1.034 . . . . 0.0 108.51 162.881 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.702 ' HZ1' ' HB2' ' A' ' 43' ' ' PHE . 19.6 tptp -117.13 121.12 40.37 Favored 'General case' 0 N--CA 1.464 0.265 0 C-N-CA 124.899 1.28 . . . . 0.0 107.552 178.487 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.49 HD22 ' HB ' ' A' ' 57' ' ' VAL . 5.7 tt -119.19 143.92 46.98 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 124.171 0.988 . . . . 0.0 108.968 177.932 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.702 ' HB2' ' HZ1' ' A' ' 41' ' ' LYS . 24.3 t80 -130.63 128.14 40.37 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 125.293 1.437 . . . . 0.0 107.822 174.881 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 44' ' ' TYR . . . . . 0.499 ' CG ' ' HB ' ' A' ' 54' ' ' THR . 24.8 m-85 -86.63 111.55 40.47 Favored Pre-proline 0 CA--C 1.55 0.979 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 169.456 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -76.65 -170.48 0.9 Allowed 'Trans proline' 0 C--N 1.372 1.769 0 C-N-CA 122.427 2.085 . . . . 0.0 111.034 165.724 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' ASN . . . . . 0.534 ' HB2' ' HB ' ' A' ' 51' ' ' VAL . 7.6 p30 -123.07 -175.12 3.1 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 123.756 0.822 . . . . 0.0 109.774 179.626 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.423 ' H ' HG21 ' A' ' 51' ' ' VAL . 45.2 mmtm -85.0 -78.27 0.26 Allowed 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 110.017 -0.364 . . . . 0.0 110.017 172.821 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 44.7 t -130.61 75.71 0.48 Allowed 'Isoleucine or valine' 0 CA--C 1.553 1.074 0 C-N-CA 123.375 0.67 . . . . 0.0 109.948 -173.874 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 70.57 -78.68 0.46 Allowed Glycine 0 N--CA 1.476 1.326 0 N-CA-C 115.67 1.028 . . . . 0.0 115.67 169.851 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 26.7 p -82.77 43.17 0.82 Allowed 'General case' 0 CA--C 1.552 1.033 0 C-N-CA 125.196 1.398 . . . . 0.0 112.607 -170.022 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.534 ' HB ' ' HB2' ' A' ' 46' ' ' ASN . 16.9 t -102.93 153.41 5.59 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 C-N-CA 123.736 0.815 . . . . 0.0 109.094 179.679 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -65.61 -53.0 47.7 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 123.531 0.732 . . . . 0.0 110.742 -179.625 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 15.5 pttp 51.94 -168.7 0.04 OUTLIER 'General case' 0 CA--C 1.559 1.301 0 C-N-CA 126.143 1.777 . . . . 0.0 112.094 -177.893 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.499 ' HB ' ' CG ' ' A' ' 44' ' ' TYR . 51.4 m -122.31 159.66 26.96 Favored 'General case' 0 CA--C 1.55 0.976 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 175.628 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -78.83 -167.09 1.02 Allowed 'General case' 0 CA--C 1.557 1.232 0 C-N-CA 123.123 0.569 . . . . 0.0 111.524 179.525 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 37.5 t -80.51 130.87 35.25 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.625 0 C-N-CA 123.917 0.887 . . . . 0.0 110.038 -179.581 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.49 ' HB ' HD22 ' A' ' 42' ' ' LEU . 38.3 t -122.92 120.7 61.34 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.695 0 C-N-CA 123.525 0.73 . . . . 0.0 109.503 179.589 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.48 ' CZ ' ' HD3' ' A' ' 41' ' ' LYS . 27.0 m-85 -92.87 118.38 31.06 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 123.231 0.612 . . . . 0.0 109.947 174.1 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 2.0 t -78.43 123.82 35.87 Favored 'Isoleucine or valine' 0 C--O 1.239 0.509 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 177.049 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.485 ' HB3' ' H ' ' A' ' 64' ' ' GLU . . . -88.72 147.4 39.2 Favored Pre-proline 0 CA--C 1.544 0.734 0 CA-C-N 114.796 -1.093 . . . . 0.0 111.087 -175.478 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_endo -61.9 -30.69 84.19 Favored 'Trans proline' 0 C--N 1.369 1.636 0 C-N-CA 123.871 3.047 . . . . 0.0 114.064 -179.437 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 5.7 t -87.05 -1.46 57.9 Favored 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 122.242 0.217 . . . . 0.0 111.013 179.328 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 77.97 61.72 2.48 Favored Glycine 0 C--N 1.353 1.516 0 N-CA-C 112.011 -0.436 . . . . 0.0 112.011 -177.072 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.485 ' H ' ' HB3' ' A' ' 60' ' ' ALA . 40.8 tt0 -151.02 70.65 0.99 Allowed 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 107.999 -1.112 . . . . 0.0 107.999 179.318 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -65.4 158.15 27.43 Favored 'General case' 0 CA--C 1.544 0.74 0 CA-C-N 115.203 -0.908 . . . . 0.0 112.237 -171.885 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.584 HG23 ' HB2' ' A' ' 71' ' ' GLN . 44.4 mm -121.8 110.12 26.56 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 CA-C-N 115.169 -0.923 . . . . 0.0 110.484 -163.21 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 11.1 p -83.94 -17.08 41.85 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 123.249 0.62 . . . . 0.0 112.265 178.954 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 2.2 p-10 -157.26 152.52 26.19 Favored 'General case' 0 N--CA 1.476 0.854 0 N-CA-C 111.779 0.289 . . . . 0.0 111.779 -174.943 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 85.2 mtt180 -55.43 -31.76 62.15 Favored 'General case' 0 N--CA 1.493 1.686 0 C-N-CA 124.743 1.217 . . . . 0.0 114.215 -169.784 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 1.8 tmtp? -54.88 -53.92 49.18 Favored 'General case' 0 N--CA 1.486 1.371 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 177.861 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.584 ' HB2' HG23 ' A' ' 66' ' ' ILE . 84.3 mt-30 -61.68 -34.27 75.45 Favored 'General case' 0 N--CA 1.475 0.797 0 CA-C-N 114.741 -1.118 . . . . 0.0 111.126 -177.239 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.446 HD22 HG13 ' A' ' 66' ' ' ILE . 0.6 OUTLIER -60.74 -53.3 59.02 Favored 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 123.65 0.78 . . . . 0.0 109.755 179.153 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -68.41 -49.52 59.42 Favored 'General case' 0 C--O 1.238 0.491 0 CA-C-N 114.976 -1.011 . . . . 0.0 111.326 -172.782 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.5 -24.2 67.72 Favored 'General case' 0 C--N 1.356 0.865 0 O-C-N 123.635 0.584 . . . . 0.0 110.935 178.981 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 36.8 t80 -67.29 -50.62 59.59 Favored 'General case' 0 C--N 1.356 0.849 0 C-N-CA 123.224 0.61 . . . . 0.0 109.488 173.058 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.463 HD13 ' HA ' ' A' ' 84' ' ' ALA . 85.0 mt -61.84 -45.22 94.74 Favored 'General case' 0 N--CA 1.487 1.401 0 C-N-CA 123.337 0.655 . . . . 0.0 111.243 -174.4 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.06 -7.23 56.66 Favored 'General case' 0 CA--C 1.555 1.166 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.972 179.229 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 43.4 t -96.42 -22.99 16.81 Favored 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 123.744 0.818 . . . . 0.0 111.039 168.535 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 74.4 m80 -132.56 95.73 19.87 Favored Pre-proline 0 N--CA 1.476 0.871 0 C-N-CA 124.053 0.941 . . . . 0.0 109.43 -172.387 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -75.18 153.07 40.66 Favored 'Trans proline' 0 C--N 1.37 1.687 0 C-N-CA 122.382 2.055 . . . . 0.0 111.857 177.442 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 87.95 7.32 74.36 Favored Glycine 0 C--N 1.345 1.074 0 CA-C-N 115.975 -0.557 . . . . 0.0 112.686 -174.426 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 25.2 m-80 -103.69 127.33 29.71 Favored Pre-proline 0 N--CA 1.479 0.982 0 C-N-CA 123.801 0.84 . . . . 0.0 110.026 177.447 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -54.45 143.53 66.26 Favored 'Trans proline' 0 C--N 1.38 2.197 0 C-N-CA 123.606 2.871 . . . . 0.0 113.13 -178.058 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.463 ' HA ' HD13 ' A' ' 76' ' ' LEU . . . -71.16 159.1 35.28 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 123.649 0.78 . . . . 0.0 112.206 -172.283 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.431 ' HB ' HD12 ' A' ' 72' ' ' LEU . 15.1 tt -67.64 -16.21 20.76 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.218 0 C-N-CA 123.698 0.799 . . . . 0.0 111.385 -179.536 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -61.02 -29.91 69.99 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 124.351 1.061 . . . . 0.0 112.937 179.229 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.429 ' HG3' ' HD2' ' A' ' 88' ' ' PHE . 10.0 pt-20 -97.57 -8.05 29.9 Favored 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 122.728 0.411 . . . . 0.0 111.327 177.271 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.429 ' HD2' ' HG3' ' A' ' 87' ' ' GLU . 4.3 m-30 -85.23 116.38 23.55 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 123.423 0.689 . . . . 0.0 110.344 -176.471 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -94.37 124.79 38.61 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 123.114 0.566 . . . . 0.0 110.97 -174.721 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 52.3 m95 -110.36 -20.68 12.53 Favored 'General case' 0 CA--C 1.551 0.989 0 C-N-CA 124.451 1.101 . . . . 0.0 109.632 176.889 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 11.3 t -80.86 5.46 15.99 Favored 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 123.767 0.827 . . . . 0.0 112.298 -172.501 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.445 HG21 ' NZ ' ' A' ' 41' ' ' LYS . 13.9 t -61.74 -21.42 64.51 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 123.251 0.621 . . . . 0.0 111.394 176.318 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 6.2 m -65.07 -27.28 68.67 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 124.977 1.311 . . . . 0.0 111.741 177.24 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 118.97 165.16 13.07 Favored Glycine 0 C--N 1.342 0.88 0 N-CA-C 110.632 -0.987 . . . . 0.0 110.632 -172.553 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 1.2 t . . . . . 0 C--O 1.252 1.194 0 CA-C-O 118.252 -0.88 . . . . 0.0 109.267 -179.088 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.482 1.142 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 65.3 m80 -98.09 -35.42 10.42 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 123.573 0.749 . . . . 0.0 111.276 -176.894 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 36.6 m80 66.39 104.75 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 C-N-CA 125.31 1.444 . . . . 0.0 111.578 -176.526 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 76.7 m80 -105.42 119.71 39.78 Favored 'General case' 0 N--CA 1.472 0.674 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 173.543 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 31.4 m-70 -104.19 65.28 0.79 Allowed 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 123.678 0.791 . . . . 0.0 109.86 -176.545 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 29.7 m80 -139.13 102.5 4.53 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 123.641 0.776 . . . . 0.0 110.669 -179.908 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 10.5 p-80 -146.12 39.52 1.11 Allowed 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 125.158 1.383 . . . . 0.0 108.212 172.293 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 7.3 m -77.09 -4.25 43.41 Favored 'General case' 0 N--CA 1.479 0.992 0 CA-C-N 114.672 -1.149 . . . . 0.0 112.667 -173.405 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 32.3 m -74.52 113.42 11.75 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 123.312 0.645 . . . . 0.0 110.903 -177.502 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -153.32 54.89 0.44 Allowed Glycine 0 C--N 1.342 0.87 0 N-CA-C 111.354 -0.698 . . . . 0.0 111.354 -179.061 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 46.3 mtm180 -98.99 11.96 37.42 Favored 'General case' 0 N--CA 1.484 1.225 0 C-N-CA 123.964 0.905 . . . . 0.0 110.961 -178.567 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 44.3 tt0 -60.88 107.18 0.67 Allowed 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 123.639 0.776 . . . . 0.0 110.364 -177.812 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 32.4 t30 -128.2 96.83 4.57 Favored 'General case' 0 C--O 1.239 0.51 0 C-N-CA 124.031 0.932 . . . . 0.0 109.415 -174.697 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -110.18 135.32 51.14 Favored 'General case' 0 C--O 1.241 0.613 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 168.511 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 21.1 p90 -91.3 -36.58 13.79 Favored 'General case' 0 CA--C 1.537 0.474 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 169.502 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 35.0 t80 46.57 58.53 4.55 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 126.13 1.772 . . . . 0.0 111.764 173.534 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 13.8 pt20 -150.76 162.31 40.98 Favored 'General case' 0 C--O 1.241 0.613 0 CA-C-N 115.107 -0.952 . . . . 0.0 110.032 -176.998 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -170.3 174.53 44.34 Favored Glycine 0 C--O 1.24 0.53 0 CA-C-N 114.889 -1.05 . . . . 0.0 111.093 178.752 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 28.2 p-80 -88.55 137.57 32.21 Favored 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 109.781 -0.452 . . . . 0.0 109.781 177.726 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 25.7 mmt -118.38 102.12 8.7 Favored 'General case' 0 N--CA 1.477 0.912 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 -179.929 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -71.12 98.75 1.73 Allowed 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 123.471 0.709 . . . . 0.0 110.205 -179.522 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 20.7 m -133.53 68.77 1.49 Allowed 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 124.206 1.002 . . . . 0.0 108.604 179.833 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -90.3 -122.37 2.42 Favored Glycine 0 C--N 1.349 1.293 0 CA-C-N 115.397 -0.82 . . . . 0.0 111.539 175.861 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 60.0 p -87.38 27.09 1.12 Allowed 'General case' 0 CA--C 1.553 1.07 0 C-N-CA 123.61 0.764 . . . . 0.0 111.808 179.074 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -65.32 128.84 37.49 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 123.446 0.698 . . . . 0.0 111.051 179.175 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -88.4 143.05 27.23 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 123.767 0.827 . . . . 0.0 110.073 -179.525 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -84.93 83.45 8.05 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 123.403 0.681 . . . . 0.0 110.139 -175.435 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 32.8 m -99.33 128.69 50.79 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.959 0 C-N-CA 123.185 0.594 . . . . 0.0 109.399 175.867 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 16.7 m -73.74 105.48 3.07 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 178.888 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 23.7 p -162.68 118.15 1.84 Allowed 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 122.915 0.486 . . . . 0.0 110.7 -171.685 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 63.1 t -105.77 133.4 50.23 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 C-N-CA 124.372 1.069 . . . . 0.0 108.533 176.835 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -83.37 113.49 20.77 Favored 'General case' 0 CA--C 1.539 0.523 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 176.148 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.543 HD23 ' HB3' ' A' ' 43' ' ' PHE . 3.8 mm? -89.88 165.13 25.9 Favored Pre-proline 0 CA--C 1.556 1.208 0 C-N-CA 124.337 1.055 . . . . 0.0 110.088 -179.797 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -56.72 142.74 91.48 Favored 'Trans proline' 0 C--N 1.394 2.941 0 C-N-CA 122.92 2.414 . . . . 0.0 113.113 179.192 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.523 ' HB2' ' HB3' ' A' ' 41' ' ' LYS . . . -136.24 166.04 31.0 Favored Pre-proline 0 CA--C 1.539 0.537 0 C-N-CA 124.216 1.007 . . . . 0.0 111.098 -169.091 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 81.5 Cg_exo -52.58 164.32 1.48 Allowed 'Trans proline' 0 C--N 1.376 2.011 0 C-N-CA 123.161 2.574 . . . . 0.0 112.538 160.8 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 66.0 p -63.95 -39.92 95.26 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 123.535 0.734 . . . . 0.0 111.748 -176.251 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 22.0 m -82.1 -37.8 25.78 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 123.641 0.776 . . . . 0.0 111.554 -177.612 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 45.0 m95 -97.17 158.12 15.6 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 123.369 0.668 . . . . 0.0 111.059 -173.389 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.54 ' HB2' ' HB ' ' A' ' 59' ' ' VAL . 0.1 OUTLIER -111.86 152.63 27.72 Favored 'General case' 0 C--O 1.236 0.352 0 N-CA-C 107.906 -1.146 . . . . 0.0 107.906 168.632 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.523 ' HB3' ' HB2' ' A' ' 35' ' ' ALA . 17.1 tptm -126.74 119.13 26.17 Favored 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 -175.309 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 4.8 tt -115.1 144.91 42.92 Favored 'General case' 0 C--N 1.322 -0.599 0 C-N-CA 124.726 1.21 . . . . 0.0 108.638 174.322 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.543 ' HB3' HD23 ' A' ' 33' ' ' LEU . 27.6 t80 -131.21 128.75 40.59 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 125.31 1.444 . . . . 0.0 108.436 174.975 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 39.0 m-85 -87.74 105.46 8.95 Favored Pre-proline 0 CA--C 1.554 1.132 0 N-CA-C 108.782 -0.822 . . . . 0.0 108.782 170.649 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -78.82 158.36 27.76 Favored 'Trans proline' 0 C--N 1.37 1.684 0 C-N-CA 122.735 2.29 . . . . 0.0 112.173 173.28 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' ASN . . . . . 0.472 ' HB2' ' HB3' ' A' ' 53' ' ' LYS . 24.6 t-20 -99.21 154.55 18.06 Favored 'General case' 0 N--CA 1.477 0.899 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 173.561 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 51.2 mtpt -57.03 -39.52 74.96 Favored 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 123.747 0.819 . . . . 0.0 111.673 -178.758 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 58.5 t -116.56 85.7 0.87 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.834 0 C-N-CA 124.139 0.976 . . . . 0.0 108.522 174.779 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 68.5 -101.55 0.78 Allowed Glycine 0 C--N 1.345 1.081 0 CA-C-N 115.772 -0.649 . . . . 0.0 113.786 175.926 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 48.7 m -127.77 -58.92 1.22 Allowed 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 123.412 0.685 . . . . 0.0 110.998 -174.227 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 46.2 t 50.83 -89.56 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 C-N-CA 124.758 1.223 . . . . 0.0 112.255 179.191 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -140.85 41.09 1.83 Allowed 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 124.45 1.1 . . . . 0.0 108.905 -177.982 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.487 ' HE3' ' HB3' ' A' ' 93' ' ' SER . 24.0 pttm -58.34 153.55 15.29 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 124.599 1.16 . . . . 0.0 112.041 -176.793 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 26.0 m -66.9 140.0 57.75 Favored 'General case' 0 CA--C 1.555 1.171 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 169.917 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -74.56 -178.31 3.52 Favored 'General case' 0 N--CA 1.482 1.137 0 N-CA-C 112.9 0.704 . . . . 0.0 112.9 -171.762 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 64.9 t -82.86 140.82 15.78 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.847 0 C-N-CA 124.455 1.102 . . . . 0.0 111.519 -170.648 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 63.2 t -122.23 128.61 75.56 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.9 0 C-N-CA 124.052 0.941 . . . . 0.0 108.97 176.819 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 13.3 m-85 -102.05 123.02 45.22 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 123.282 0.633 . . . . 0.0 109.563 171.583 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.54 ' HB ' ' HB2' ' A' ' 40' ' ' LYS . 2.3 t -79.58 129.47 37.51 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.611 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 174.456 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -83.85 154.61 64.67 Favored Pre-proline 0 CA--C 1.539 0.556 0 CA-C-N 114.901 -1.045 . . . . 0.0 111.446 -176.368 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -62.14 -22.86 74.92 Favored 'Trans proline' 0 C--N 1.379 2.164 0 C-N-CA 123.153 2.568 . . . . 0.0 113.447 177.251 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.423 HG22 ' OH ' ' A' ' 75' ' ' TYR . 12.1 t -99.86 -7.23 25.59 Favored 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 123.027 0.531 . . . . 0.0 111.86 177.798 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 94.16 -4.17 70.54 Favored Glycine 0 CA--C 1.531 1.043 0 CA-C-O 119.849 -0.417 . . . . 0.0 113.859 -179.386 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.407 ' H ' HG23 ' A' ' 62' ' ' THR . 36.2 tt0 -78.97 75.76 5.47 Favored 'General case' 0 N--CA 1.482 1.127 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 174.801 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -67.48 157.77 33.47 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-O 121.979 0.895 . . . . 0.0 111.596 -168.833 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.535 HG23 ' HB2' ' A' ' 71' ' ' GLN . 42.7 mm -116.61 120.15 64.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 C-N-CA 125.141 1.376 . . . . 0.0 108.876 -171.016 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 18.5 p -89.19 -19.94 24.82 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 123.315 0.646 . . . . 0.0 112.349 -176.665 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 2.0 p-10 -157.95 165.33 35.42 Favored 'General case' 0 N--CA 1.481 1.109 0 CA-C-O 120.968 0.413 . . . . 0.0 111.651 -174.919 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 20.3 ttm180 -57.51 -42.17 82.25 Favored 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 125.211 1.404 . . . . 0.0 113.101 -167.702 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 8.6 tmtm? -54.27 -49.92 68.45 Favored 'General case' 0 N--CA 1.487 1.378 0 C-N-CA 123.953 0.901 . . . . 0.0 110.527 -179.702 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.535 ' HB2' HG23 ' A' ' 66' ' ' ILE . 80.5 mt-30 -61.96 -32.74 73.2 Favored 'General case' 0 N--CA 1.475 0.802 0 CA-C-N 114.765 -1.107 . . . . 0.0 111.254 -179.136 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.417 ' O ' ' HG ' ' A' ' 76' ' ' LEU . 0.5 OUTLIER -65.82 -50.88 63.05 Favored 'General case' 0 CA--C 1.551 1.004 0 C-N-CA 123.466 0.707 . . . . 0.0 109.283 179.043 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -66.29 -43.98 84.81 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 124.155 0.982 . . . . 0.0 111.81 -174.705 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -68.24 -26.69 65.81 Favored 'General case' 0 N--CA 1.482 1.144 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.799 177.872 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 75' ' ' TYR . . . . . 0.423 ' OH ' HG22 ' A' ' 62' ' ' THR . 19.7 t80 -69.55 -47.09 64.83 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 123.374 0.67 . . . . 0.0 109.914 176.106 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.417 ' HG ' ' O ' ' A' ' 72' ' ' LEU . 74.8 mt -69.89 -28.43 65.62 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 113.03 0.752 . . . . 0.0 113.03 -172.631 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 66.0 pttt -75.51 -36.2 60.61 Favored 'General case' 0 N--CA 1.476 0.846 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 173.485 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 34.2 t -73.97 -20.36 60.37 Favored 'General case' 0 N--CA 1.485 1.292 0 C-N-CA 123.593 0.757 . . . . 0.0 111.125 176.206 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 58.3 m80 -137.25 76.14 44.83 Favored Pre-proline 0 CA--C 1.548 0.867 0 C-N-CA 124.394 1.077 . . . . 0.0 108.354 -177.29 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -67.64 -16.75 47.35 Favored 'Trans proline' 0 C--N 1.381 2.253 0 C-N-CA 123.032 2.488 . . . . 0.0 113.155 -178.269 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -70.84 -14.75 73.28 Favored Glycine 0 C--N 1.347 1.161 0 CA-C-N 116.046 -0.525 . . . . 0.0 112.928 175.108 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 16.1 m120 -94.29 146.08 30.9 Favored Pre-proline 0 CA--C 1.547 0.845 0 C-N-CA 123.959 0.904 . . . . 0.0 110.214 176.108 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -68.97 159.94 51.89 Favored 'Trans proline' 0 C--N 1.378 2.104 0 C-N-CA 123.05 2.5 . . . . 0.0 113.752 -170.808 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -71.5 148.93 46.28 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 124.295 1.038 . . . . 0.0 112.166 -174.474 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 17.8 tt -68.08 -11.62 14.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 C-N-CA 123.778 0.831 . . . . 0.0 111.457 -179.068 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -58.7 -28.96 66.28 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 124.458 1.103 . . . . 0.0 112.797 174.263 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -100.69 -8.26 23.01 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 122.947 0.499 . . . . 0.0 111.515 176.666 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -80.42 110.02 15.48 Favored 'General case' 0 N--CA 1.48 1.03 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 177.768 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -78.43 119.81 22.27 Favored 'General case' 0 CA--C 1.537 0.45 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 175.509 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 76.2 m95 -109.13 -7.79 15.26 Favored 'General case' 0 CA--C 1.55 0.972 0 C-N-CA 124.215 1.006 . . . . 0.0 109.451 168.081 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 15.0 t -107.08 14.3 26.48 Favored 'General case' 0 CA--C 1.558 1.267 0 C-N-CA 124.28 1.032 . . . . 0.0 112.598 -164.286 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 14.6 t -61.32 -25.35 67.08 Favored 'General case' 0 N--CA 1.499 1.981 0 CA-C-O 121.393 0.616 . . . . 0.0 110.463 173.644 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' SER . . . . . 0.487 ' HB3' ' HE3' ' A' ' 53' ' ' LYS . 7.4 m -61.44 -30.37 70.54 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 125.529 1.532 . . . . 0.0 112.065 -179.838 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 71.0 -90.7 0.42 Allowed Glycine 0 C--N 1.345 1.057 0 N-CA-C 109.571 -1.412 . . . . 0.0 109.571 -167.121 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 18.1 p . . . . . 0 C--O 1.252 1.234 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 165.655 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.555 1.145 0 CA-C-O 121.936 0.874 . . . . 0.0 109.716 . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 94.4 m-70 -145.95 124.4 12.39 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 124.019 0.927 . . . . 0.0 109.262 177.049 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 59.2 m80 -83.0 99.46 9.84 Favored 'General case' 0 CA--C 1.538 0.519 0 N-CA-C 107.707 -1.22 . . . . 0.0 107.707 170.97 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 14.9 t-80 -64.94 93.05 0.11 Allowed 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 123.982 0.913 . . . . 0.0 111.574 -171.65 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 31.7 m170 -101.24 71.16 1.36 Allowed 'General case' 0 C--O 1.244 0.789 0 C-N-CA 123.728 0.811 . . . . 0.0 109.305 178.005 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 47.8 t-80 -81.46 118.15 22.47 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 114.767 -1.106 . . . . 0.0 109.901 179.116 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 12.1 m170 -88.24 138.2 31.65 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.517 176.647 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 53.6 p -105.91 32.97 4.01 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 124.511 1.124 . . . . 0.0 109.037 169.113 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 24.5 m -64.17 111.29 2.51 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 124.091 0.957 . . . . 0.0 111.768 -176.886 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -95.99 125.85 8.57 Favored Glycine 0 CA--C 1.529 0.963 0 CA-C-N 115.598 -0.728 . . . . 0.0 111.583 175.981 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 2.0 tmt_? -72.12 -32.64 67.14 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 123.211 0.605 . . . . 0.0 109.625 177.315 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -64.15 93.06 0.09 Allowed 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 123.327 0.651 . . . . 0.0 109.77 175.739 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 8.1 t30 -135.68 73.01 1.45 Allowed 'General case' 0 C--O 1.242 0.674 0 N-CA-C 107.753 -1.203 . . . . 0.0 107.753 177.478 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -154.58 177.16 11.51 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 114.155 -1.384 . . . . 0.0 110.179 -178.755 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 18.6 p90 -55.57 -46.5 77.21 Favored 'General case' 0 CA--C 1.554 1.098 0 C-N-CA 123.827 0.851 . . . . 0.0 111.537 174.408 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 12.8 t80 54.89 26.93 8.37 Favored 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 125.082 1.353 . . . . 0.0 111.771 179.886 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 19.0 mm-40 -91.01 47.41 1.4 Allowed 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 124.497 1.119 . . . . 0.0 110.22 -178.083 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -80.48 65.3 3.89 Favored Glycine 0 C--N 1.345 1.028 0 CA-C-N 115.896 -0.593 . . . . 0.0 112.579 179.483 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 88.8 m-70 -112.31 138.24 49.3 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 124.198 0.999 . . . . 0.0 109.91 -177.711 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 67.4 mtt -123.09 -58.61 1.63 Allowed 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 123.513 0.725 . . . . 0.0 109.257 176.168 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . 62.36 100.24 0.03 OUTLIER 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 124.573 1.149 . . . . 0.0 112.54 173.981 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 75.2 p -147.75 134.49 19.99 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 123.491 0.716 . . . . 0.0 110.19 -178.875 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -177.43 -172.43 41.95 Favored Glycine 0 C--N 1.344 1.008 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.73 178.681 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 23.5 m 57.66 41.38 25.52 Favored 'General case' 0 N--CA 1.484 1.25 0 C-N-CA 123.856 0.862 . . . . 0.0 112.112 177.477 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -92.74 35.93 1.03 Allowed 'General case' 0 N--CA 1.486 1.356 0 CA-C-O 122.283 1.04 . . . . 0.0 110.3 -179.263 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -136.51 107.46 6.68 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 124.036 0.935 . . . . 0.0 108.816 176.445 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -71.71 91.83 1.15 Allowed 'General case' 0 C--O 1.246 0.899 0 CA-C-O 121.595 0.712 . . . . 0.0 109.401 174.878 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 24.9 m -91.59 151.1 3.59 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 CA-C-N 115.069 -0.969 . . . . 0.0 110.468 -178.228 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.532 HG21 ' HB2' ' A' ' 47' ' ' LYS . 30.9 m -112.46 132.97 59.69 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.109 0 C-N-CA 123.435 0.694 . . . . 0.0 109.918 178.371 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.472 ' HA ' ' HD2' ' A' ' 45' ' ' PRO . 76.2 p -148.1 145.85 28.57 Favored 'General case' 0 C--O 1.241 0.635 0 C-N-CA 123.274 0.63 . . . . 0.0 110.336 -178.495 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 43.9 t -114.6 131.22 67.35 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.405 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 172.992 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -81.55 109.88 16.41 Favored 'General case' 0 CA--C 1.54 0.586 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 173.803 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.512 HD23 ' HB3' ' A' ' 43' ' ' PHE . 4.2 mm? -87.76 168.98 15.2 Favored Pre-proline 0 CA--C 1.557 1.222 0 C-N-CA 123.849 0.86 . . . . 0.0 109.885 -177.065 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -53.68 129.03 31.95 Favored 'Trans proline' 0 C--N 1.397 3.101 0 C-N-CA 122.949 2.433 . . . . 0.0 113.118 -177.173 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -114.98 154.0 47.08 Favored Pre-proline 0 N--CA 1.48 1.031 0 C-N-CA 123.998 0.919 . . . . 0.0 112.466 -167.815 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.804 ' HG2' ' HB2' ' A' ' 39' ' ' TRP . 38.4 Cg_endo -70.96 148.01 56.35 Favored 'Trans proline' 0 C--N 1.377 2.054 0 C-N-CA 122.388 2.059 . . . . 0.0 110.233 166.091 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 33.2 t -64.43 -25.39 67.99 Favored 'General case' 0 N--CA 1.485 1.287 0 C-N-CA 123.595 0.758 . . . . 0.0 112.983 -169.967 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 40.7 t -81.46 -37.24 28.3 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 123.122 0.569 . . . . 0.0 110.766 177.823 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' TRP . . . . . 0.804 ' HB2' ' HG2' ' A' ' 36' ' ' PRO . 20.7 m95 -107.09 -164.99 1.03 Allowed 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 123.603 0.761 . . . . 0.0 110.639 -173.746 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.659 ' HB3' ' HB ' ' A' ' 59' ' ' VAL . 34.1 ttmt -142.7 152.64 42.58 Favored 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 171.248 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.443 ' HD3' ' CZ ' ' A' ' 58' ' ' PHE . 16.0 tptm -130.25 127.8 40.32 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 123.66 0.784 . . . . 0.0 109.983 -170.367 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.435 HD21 ' CE1' ' A' ' 44' ' ' TYR . 3.2 tt -134.48 149.72 50.74 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 114.784 -1.098 . . . . 0.0 109.302 179.254 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.512 ' HB3' HD23 ' A' ' 33' ' ' LEU . 32.6 t80 -135.34 136.97 41.95 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 125.317 1.447 . . . . 0.0 108.484 175.653 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 44' ' ' TYR . . . . . 0.441 ' CG ' ' HB ' ' A' ' 54' ' ' THR . 40.5 m-85 -96.32 106.17 27.29 Favored Pre-proline 0 CA--C 1.55 0.958 0 C-N-CA 122.975 0.51 . . . . 0.0 109.661 172.025 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.472 ' HD2' ' HA ' ' A' ' 30' ' ' SER . 94.8 Cg_endo -79.3 156.22 25.59 Favored 'Trans proline' 0 C--N 1.374 1.883 0 C-N-CA 122.961 2.441 . . . . 0.0 112.383 172.797 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -85.8 105.03 16.02 Favored 'General case' 0 N--CA 1.474 0.767 0 N-CA-C 107.451 -1.315 . . . . 0.0 107.451 173.637 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.532 ' HB2' HG21 ' A' ' 29' ' ' VAL . 33.4 ttpt -55.24 -51.65 65.94 Favored 'General case' 0 N--CA 1.485 1.287 0 C-N-CA 123.438 0.695 . . . . 0.0 111.58 -174.37 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 93.4 t -80.82 -56.14 7.01 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 C-N-CA 123.532 0.733 . . . . 0.0 109.898 176.611 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.5 ' H ' HG23 ' A' ' 51' ' ' VAL . . . 143.19 -50.69 0.68 Allowed Glycine 0 C--N 1.343 0.923 0 CA-C-N 115.265 -0.88 . . . . 0.0 111.316 -178.259 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 20.0 m -82.75 21.05 1.05 Allowed 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 123.721 0.808 . . . . 0.0 111.757 178.584 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.5 HG23 ' H ' ' A' ' 49' ' ' GLY . 12.7 t -77.9 150.01 5.75 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 C-N-CA 123.619 0.767 . . . . 0.0 109.389 -179.053 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.45 ' O ' ' HG2' ' A' ' 53' ' ' LYS . 22.1 tptm -61.76 -35.92 79.53 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 123.373 0.669 . . . . 0.0 110.333 177.079 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.5 ' H ' HG12 ' A' ' 51' ' ' VAL . 9.8 ptmm? 60.61 173.39 0.1 Allowed 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 126.306 1.842 . . . . 0.0 112.184 -178.139 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.441 ' HB ' ' CG ' ' A' ' 44' ' ' TYR . 26.1 m -126.83 160.26 31.45 Favored 'General case' 0 CA--C 1.552 1.028 0 N-CA-C 107.039 -1.467 . . . . 0.0 107.039 170.067 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.511 ' HG3' ' O ' ' A' ' 67' ' ' SER . 1.1 pm0 -77.54 -171.24 2.09 Favored 'General case' 0 CA--C 1.551 0.996 0 CA-C-O 121.491 0.662 . . . . 0.0 112.586 -174.075 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 77.6 t -80.62 121.07 33.43 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 CA-C-N 115.151 -0.931 . . . . 0.0 108.54 175.18 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 40.4 t -111.64 118.97 58.84 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.572 0 C-N-CA 123.099 0.56 . . . . 0.0 109.569 -178.465 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.443 ' CZ ' ' HD3' ' A' ' 41' ' ' LYS . 36.1 m-85 -93.15 120.31 33.3 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 123.458 0.703 . . . . 0.0 109.507 171.541 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.659 ' HB ' ' HB3' ' A' ' 40' ' ' LYS . 3.3 t -79.71 126.61 39.3 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.449 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 174.027 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.581 ' HB3' ' H ' ' A' ' 64' ' ' GLU . . . -84.61 148.57 52.21 Favored Pre-proline 0 CA--C 1.541 0.616 0 CA-C-N 114.97 -1.014 . . . . 0.0 110.781 -177.488 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -63.04 -17.36 59.78 Favored 'Trans proline' 0 N--CA 1.494 1.557 0 C-N-CA 123.394 2.729 . . . . 0.0 114.143 -176.705 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 14.1 t -110.83 0.36 17.21 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 123.365 0.666 . . . . 0.0 111.738 -178.878 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 76.35 65.32 2.03 Favored Glycine 0 CA--C 1.533 1.182 0 CA-C-O 121.385 0.436 . . . . 0.0 112.064 -175.976 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.581 ' H ' ' HB3' ' A' ' 60' ' ' ALA . 39.0 tt0 -150.6 72.54 1.09 Allowed 'General case' 0 N--CA 1.474 0.746 0 N-CA-C 106.622 -1.621 . . . . 0.0 106.622 175.244 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 4.6 mp0 -66.99 155.47 38.51 Favored 'General case' 0 N--CA 1.475 0.812 0 CA-C-N 114.756 -1.111 . . . . 0.0 112.094 -165.418 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.463 HG23 ' HB2' ' A' ' 71' ' ' GLN . 48.5 mm -116.87 143.86 26.05 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.508 0 C-N-CA 124.941 1.297 . . . . 0.0 108.965 -176.741 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.511 ' O ' ' HG3' ' A' ' 55' ' ' GLU . 35.9 p -129.37 -2.8 4.95 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 122.93 0.492 . . . . 0.0 112.038 178.533 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 9.6 p30 -151.67 158.81 43.92 Favored 'General case' 0 N--CA 1.486 1.352 0 O-C-N 121.842 -0.536 . . . . 0.0 111.123 176.442 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 55.3 mtp180 -60.61 -31.84 70.99 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 123.89 0.876 . . . . 0.0 112.78 -176.64 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 2.7 tmtp? -60.69 -54.16 48.6 Favored 'General case' 0 N--CA 1.478 0.934 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 178.4 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.463 ' HB2' HG23 ' A' ' 66' ' ' ILE . 45.8 mt-30 -54.86 -40.53 69.77 Favored 'General case' 0 N--CA 1.48 1.045 0 O-C-N 124.12 0.887 . . . . 0.0 111.849 177.867 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.486 HD12 ' HB ' ' A' ' 85' ' ' ILE . 0.7 OUTLIER -64.74 -53.04 53.41 Favored 'General case' 0 N--CA 1.478 0.949 0 O-C-N 123.699 0.624 . . . . 0.0 110.074 -175.912 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -71.08 -37.23 72.45 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 123.184 0.593 . . . . 0.0 111.692 -172.374 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.98 -26.46 63.16 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 122.245 0.218 . . . . 0.0 111.049 174.653 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 20.0 t80 -65.08 -49.93 68.11 Favored 'General case' 0 N--CA 1.479 0.99 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 175.147 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.478 ' HG ' ' O ' ' A' ' 72' ' ' LEU . 68.3 mt -60.91 -47.29 87.09 Favored 'General case' 0 N--CA 1.479 0.995 0 O-C-N 123.983 0.802 . . . . 0.0 111.936 -173.91 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -69.53 -26.93 64.75 Favored 'General case' 0 CA--C 1.551 1.009 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.873 -177.846 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 59.2 m -89.0 -23.68 22.56 Favored 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 123.024 0.53 . . . . 0.0 111.792 178.177 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 92.8 m-70 -124.72 94.29 44.64 Favored Pre-proline 0 N--CA 1.474 0.731 0 C-N-CA 123.483 0.713 . . . . 0.0 109.959 -173.759 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -68.54 149.66 74.47 Favored 'Trans proline' 0 C--N 1.376 1.992 0 C-N-CA 122.707 2.272 . . . . 0.0 112.448 178.501 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 100.99 -20.08 49.28 Favored Glycine 0 C--N 1.345 1.051 0 CA-C-N 116.167 -0.47 . . . . 0.0 112.723 -178.821 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 40.6 m-80 -77.42 144.42 70.3 Favored Pre-proline 0 CA--C 1.549 0.939 0 C-N-CA 123.132 0.573 . . . . 0.0 110.4 176.527 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -74.8 158.9 42.64 Favored 'Trans proline' 0 C--N 1.374 1.913 0 C-N-CA 122.6 2.2 . . . . 0.0 112.625 177.462 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.432 ' HA ' HD13 ' A' ' 76' ' ' LEU . . . -75.03 153.69 38.33 Favored 'General case' 0 N--CA 1.477 0.89 0 CA-C-N 115.389 -0.823 . . . . 0.0 112.561 -173.045 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.486 ' HB ' HD12 ' A' ' 72' ' ' LEU . 15.9 tt -68.08 -11.64 14.55 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.335 0 C-N-CA 123.899 0.88 . . . . 0.0 111.436 179.954 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -55.68 -31.87 62.78 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 124.226 1.01 . . . . 0.0 112.262 174.138 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -98.08 -15.74 19.86 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 122.988 0.515 . . . . 0.0 111.908 176.477 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -81.27 108.86 15.26 Favored 'General case' 0 N--CA 1.484 1.241 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 177.016 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 10.3 p-10 -97.11 120.62 37.81 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-O 121.395 0.617 . . . . 0.0 110.196 -177.558 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 65.4 m95 -96.72 -9.01 29.92 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 124.053 0.941 . . . . 0.0 109.791 173.762 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 11.0 t -85.75 16.21 4.18 Favored 'General case' 0 CA--C 1.557 1.225 0 C-N-CA 125.581 1.552 . . . . 0.0 111.294 179.665 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 5.0 t -62.18 -24.8 67.41 Favored 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 124.187 0.995 . . . . 0.0 113.476 -170.172 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 33.4 p -68.41 -23.42 64.64 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 123.967 0.907 . . . . 0.0 111.77 178.333 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 133.59 -159.93 23.83 Favored Glycine 0 C--N 1.34 0.801 0 N-CA-C 110.866 -0.894 . . . . 0.0 110.866 178.631 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 33.5 p . . . . . 0 C--O 1.253 1.244 0 CA-C-O 118.687 -0.673 . . . . 0.0 109.501 176.0 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.3 mpp? . . . . . 0 N--CA 1.483 1.205 0 N-CA-C 110.143 -0.317 . . . . 0.0 110.143 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 43.5 m-70 65.43 -80.6 0.03 OUTLIER 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 124.96 1.304 . . . . 0.0 111.17 -175.718 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 62.2 t-80 57.61 79.69 0.19 Allowed 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 124.308 1.043 . . . . 0.0 110.0 -176.011 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 27.2 t-80 -137.72 131.33 31.18 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 123.798 0.839 . . . . 0.0 110.565 -170.879 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 14.1 m-70 -119.1 126.6 52.02 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 169.152 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 13.6 t-80 -72.97 120.83 19.15 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 123.258 0.623 . . . . 0.0 111.014 -177.775 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 13.4 p80 -151.51 89.56 1.5 Allowed 'General case' 0 CA--C 1.543 0.684 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 170.216 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 47.6 m -79.62 72.92 6.32 Favored 'General case' 0 CA--C 1.538 0.507 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 174.004 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 11.2 m -84.25 79.78 9.42 Favored 'General case' 0 C--O 1.24 0.577 0 CA-C-N 114.678 -1.146 . . . . 0.0 110.698 -169.657 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 52.54 50.24 49.16 Favored Glycine 0 C--N 1.349 1.277 0 O-C-N 124.171 0.92 . . . . 0.0 113.834 177.604 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 27.4 mmt180 -75.8 -1.31 24.53 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 123.445 0.698 . . . . 0.0 112.786 -176.573 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.45 ' HB3' ' HG ' ' A' ' 14' ' ' LEU . 51.4 mt-10 -118.18 -74.76 0.59 Allowed 'General case' 0 CA--C 1.551 0.996 0 C-N-CA 123.095 0.558 . . . . 0.0 110.103 174.487 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 29.0 m-80 59.17 23.67 11.98 Favored 'General case' 0 N--CA 1.494 1.771 0 C-N-CA 124.226 1.011 . . . . 0.0 111.894 -171.344 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.499 HD12 ' H ' ' A' ' 15' ' ' TYR . 1.1 pp -63.69 -42.91 97.94 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 123.482 0.713 . . . . 0.0 112.482 -175.44 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.499 ' H ' HD12 ' A' ' 14' ' ' LEU . 13.1 m-85 42.73 83.22 0.02 OUTLIER 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 124.528 1.131 . . . . 0.0 112.83 -175.696 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 39.4 t80 -79.61 72.34 6.28 Favored 'General case' 0 N--CA 1.479 0.981 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 177.112 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 10.1 pt20 -151.16 106.06 3.29 Favored 'General case' 0 C--O 1.244 0.783 0 C-N-CA 124.328 1.051 . . . . 0.0 108.972 -176.661 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 178.23 154.96 13.23 Favored Glycine 0 C--O 1.244 0.754 0 N-CA-C 110.894 -0.883 . . . . 0.0 110.894 -177.591 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 22.9 t-80 -68.76 117.23 10.2 Favored 'General case' 0 CA--C 1.543 0.674 0 N-CA-C 110.153 -0.314 . . . . 0.0 110.153 -178.622 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 33.2 mmt -95.8 146.07 24.84 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 123.967 0.907 . . . . 0.0 109.075 173.99 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -154.22 -59.84 0.12 Allowed 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 123.486 0.714 . . . . 0.0 110.596 -177.913 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 33.0 t 66.38 160.72 0.14 Allowed 'General case' 0 N--CA 1.489 1.5 0 C-N-CA 124.705 1.202 . . . . 0.0 111.417 -175.859 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 155.31 85.56 0.05 OUTLIER Glycine 0 C--N 1.345 1.055 0 O-C-N 122.061 -0.4 . . . . 0.0 112.525 178.579 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 23.3 t -133.05 2.61 3.64 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 123.696 0.798 . . . . 0.0 110.829 175.988 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 44.3 tt0 -88.18 131.56 34.68 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 123.218 0.607 . . . . 0.0 109.998 -177.361 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -99.23 176.96 5.36 Favored 'General case' 0 C--O 1.244 0.799 0 C-N-CA 123.749 0.82 . . . . 0.0 110.036 -179.149 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -73.2 94.43 1.97 Allowed 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 123.291 0.636 . . . . 0.0 109.5 179.984 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 33.6 m -92.05 146.34 6.43 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.014 0 C-N-CA 123.957 0.903 . . . . 0.0 110.556 -177.255 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 17.7 m -78.36 108.95 12.46 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.993 0 CA-C-O 121.464 0.65 . . . . 0.0 110.078 178.985 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 11.0 p -159.87 127.05 4.56 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 124.167 0.987 . . . . 0.0 109.425 -176.083 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 96.7 t -117.92 127.53 75.17 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 C-N-CA 123.885 0.874 . . . . 0.0 108.839 179.406 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.475 ' HA ' ' HA ' ' A' ' 42' ' ' LEU . 2.6 mp0 -87.48 117.0 25.98 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-O 121.206 0.527 . . . . 0.0 110.172 179.609 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.499 HD23 ' HB3' ' A' ' 43' ' ' PHE . 3.3 mm? -94.89 169.57 9.29 Favored Pre-proline 0 N--CA 1.491 1.583 0 C-N-CA 124.635 1.174 . . . . 0.0 110.354 -171.788 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -51.03 137.14 44.86 Favored 'Trans proline' 0 C--N 1.397 3.091 0 C-N-CA 123.195 2.597 . . . . 0.0 113.044 176.241 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -130.56 156.98 78.9 Favored Pre-proline 0 CA--C 1.544 0.725 0 C-N-CA 123.661 0.784 . . . . 0.0 112.417 -164.474 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_exo -54.62 138.07 74.67 Favored 'Trans proline' 0 C--N 1.375 1.947 0 C-N-CA 123.38 2.72 . . . . 0.0 110.786 157.354 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 57.1 p -63.15 -28.84 70.33 Favored 'General case' 0 CA--C 1.55 0.961 0 C-N-CA 123.719 0.808 . . . . 0.0 112.641 -175.146 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 35.3 t -85.16 -14.19 47.74 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 123.362 0.665 . . . . 0.0 111.765 179.356 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 16.3 m95 -122.74 -169.16 1.87 Allowed 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 124.034 0.934 . . . . 0.0 110.186 -178.815 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 28.7 mtmt -140.13 145.67 37.86 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 124.491 1.116 . . . . 0.0 108.462 169.184 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.513 ' NZ ' ' HB2' ' A' ' 43' ' ' PHE . 23.4 tptp -114.66 130.97 56.87 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 124.642 1.177 . . . . 0.0 109.349 -175.961 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.475 ' HA ' ' HA ' ' A' ' 32' ' ' GLU . 6.5 tt -128.36 149.16 50.64 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 124.478 1.111 . . . . 0.0 108.936 175.629 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.513 ' HB2' ' NZ ' ' A' ' 41' ' ' LYS . 25.9 t80 -131.32 139.71 49.61 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 125.06 1.344 . . . . 0.0 108.349 174.917 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 44' ' ' TYR . . . . . 0.512 ' HB3' ' HB ' ' A' ' 54' ' ' THR . 10.2 m-85 -103.4 98.52 12.56 Favored Pre-proline 0 CA--C 1.552 1.02 0 C-N-CA 122.944 0.498 . . . . 0.0 109.861 173.391 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -77.41 144.0 22.47 Favored 'Trans proline' 0 C--N 1.37 1.669 0 C-N-CA 121.963 1.775 . . . . 0.0 110.231 168.231 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 23.6 t-20 -65.12 -52.55 54.69 Favored 'General case' 0 N--CA 1.478 0.943 0 N-CA-C 108.369 -0.974 . . . . 0.0 108.369 173.311 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -145.17 -60.36 0.35 Allowed 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 125.065 1.346 . . . . 0.0 107.628 170.679 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 89.3 t -131.42 -64.77 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 172.499 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -173.72 -150.97 7.87 Favored Glycine 0 C--N 1.347 1.145 0 CA-C-N 115.24 -0.891 . . . . 0.0 111.567 -178.017 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 33.8 t 65.91 -75.53 0.05 Allowed 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 125.299 1.44 . . . . 0.0 110.823 -176.231 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 26.9 m -61.88 162.62 1.5 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.119 0 C-N-CA 124.059 0.944 . . . . 0.0 112.175 177.242 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 20.0 tptm -69.27 101.74 1.57 Allowed 'General case' 0 CA--C 1.546 0.814 0 CA-C-N 115.305 -0.862 . . . . 0.0 110.91 -172.66 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 50.6 pttt -84.93 166.99 16.33 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 125.165 1.386 . . . . 0.0 110.329 176.983 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.512 ' HB ' ' HB3' ' A' ' 44' ' ' TYR . 65.3 m -84.97 152.0 23.79 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 123.781 0.832 . . . . 0.0 108.948 176.562 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -69.53 177.63 2.84 Favored 'General case' 0 CA--C 1.551 1.018 0 CA-C-O 121.903 0.858 . . . . 0.0 112.246 -174.549 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 15.3 t -82.4 138.77 18.87 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 C-N-CA 124.72 1.208 . . . . 0.0 110.417 -178.865 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.444 ' HB ' HD22 ' A' ' 42' ' ' LEU . 68.7 t -121.21 124.62 72.45 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.772 0 C-N-CA 124.173 0.989 . . . . 0.0 109.531 175.81 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.467 ' CZ ' ' HD3' ' A' ' 41' ' ' LYS . 16.0 m-85 -98.24 123.79 42.5 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 123.356 0.662 . . . . 0.0 109.904 173.179 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 3.4 t -79.17 122.73 34.99 Favored 'Isoleucine or valine' 0 C--O 1.241 0.606 0 C-N-CA 123.47 0.708 . . . . 0.0 109.359 175.936 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -81.45 154.53 71.56 Favored Pre-proline 0 CA--C 1.542 0.651 0 CA-C-N 114.238 -1.346 . . . . 0.0 110.956 -176.266 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_endo -62.17 -27.52 78.72 Favored 'Trans proline' 0 C--N 1.375 1.955 0 C-N-CA 122.759 2.306 . . . . 0.0 112.947 178.939 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.403 HG22 ' OH ' ' A' ' 75' ' ' TYR . 12.4 t -96.89 -7.71 32.69 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 122.72 0.408 . . . . 0.0 111.085 177.309 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 93.99 -1.04 67.42 Favored Glycine 0 C--N 1.353 1.483 0 CA-C-O 119.866 -0.408 . . . . 0.0 113.957 178.816 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -78.79 73.27 5.34 Favored 'General case' 0 N--CA 1.479 0.982 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 174.477 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -67.76 158.43 32.42 Favored 'General case' 0 C--N 1.35 0.594 0 CA-C-N 114.98 -1.009 . . . . 0.0 112.01 -168.777 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 47.3 mm -116.04 125.44 73.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 C-N-CA 124.707 1.203 . . . . 0.0 109.354 -166.879 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 12.3 p -110.93 5.36 20.38 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 123.645 0.778 . . . . 0.0 112.797 -175.184 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 11.2 p30 -163.31 164.56 24.82 Favored 'General case' 0 N--CA 1.486 1.335 0 C-N-CA 122.988 0.515 . . . . 0.0 110.393 172.085 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 19.7 ttp180 -63.67 -34.42 77.82 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 123.683 0.793 . . . . 0.0 112.218 -171.856 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 8.2 tmtm? -60.86 -50.41 73.54 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 123.434 0.694 . . . . 0.0 109.828 179.015 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 75.5 mt-30 -55.84 -34.89 65.82 Favored 'General case' 0 N--CA 1.477 0.917 0 O-C-N 124.288 0.993 . . . . 0.0 111.406 179.123 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.424 ' O ' ' HG ' ' A' ' 76' ' ' LEU . 0.5 OUTLIER -65.33 -54.95 21.44 Favored 'General case' 0 CA--C 1.547 0.858 0 N-CA-C 109.489 -0.559 . . . . 0.0 109.489 179.559 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -59.86 -47.16 86.86 Favored 'General case' 0 N--CA 1.486 1.364 0 C-N-CA 124.19 0.996 . . . . 0.0 111.633 -175.117 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 5.3 pp0? -68.15 -30.77 69.98 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.374 -179.308 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' TYR . . . . . 0.403 ' OH ' HG22 ' A' ' 62' ' ' THR . 32.9 t80 -65.83 -45.17 83.22 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 123.248 0.619 . . . . 0.0 109.523 176.732 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.424 ' HG ' ' O ' ' A' ' 72' ' ' LEU . 69.9 mt -63.14 -44.09 96.54 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 123.108 0.563 . . . . 0.0 111.655 -176.115 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.92 -19.39 58.84 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 122.806 0.442 . . . . 0.0 111.414 -179.842 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 46.1 t -91.62 -12.31 34.61 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 123.236 0.615 . . . . 0.0 111.382 174.006 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 57.7 m-70 -133.55 83.51 48.47 Favored Pre-proline 0 CA--C 1.551 1.007 0 C-N-CA 123.462 0.705 . . . . 0.0 109.631 -179.402 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -65.73 128.62 20.35 Favored 'Trans proline' 0 C--N 1.379 2.143 0 C-N-CA 122.802 2.334 . . . . 0.0 112.065 176.691 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 124.01 -22.53 6.75 Favored Glycine 0 C--N 1.342 0.91 0 CA-C-N 115.76 -0.655 . . . . 0.0 111.837 -177.96 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 83.4 m-20 -74.25 151.85 87.99 Favored Pre-proline 0 CA--C 1.553 1.072 0 C-N-CA 123.064 0.546 . . . . 0.0 110.785 177.379 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -69.61 160.45 49.7 Favored 'Trans proline' 0 C--N 1.375 1.927 0 C-N-CA 122.73 2.287 . . . . 0.0 112.853 178.887 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -75.82 148.71 38.19 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 123.565 0.746 . . . . 0.0 111.167 -176.299 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 16.1 tt -65.63 -12.53 14.01 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.383 0 C-N-CA 123.729 0.811 . . . . 0.0 112.371 -177.59 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -57.97 -35.46 71.21 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 124.49 1.116 . . . . 0.0 112.215 176.156 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -91.03 -11.88 37.47 Favored 'General case' 0 N--CA 1.485 1.282 0 N-CA-C 112.38 0.511 . . . . 0.0 112.38 177.883 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 4.9 m-85 -76.16 108.55 9.16 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 177.259 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 4.5 t0 -86.97 102.24 14.19 Favored 'General case' 0 CA--C 1.541 0.635 0 CA-C-N 115.995 -0.548 . . . . 0.0 109.964 -173.0 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 82.1 m95 -89.6 -31.94 17.34 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 123.746 0.819 . . . . 0.0 109.99 174.251 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 8.9 t -75.39 -6.49 50.26 Favored 'General case' 0 CA--C 1.557 1.215 0 C-N-CA 124.059 0.944 . . . . 0.0 112.532 -172.373 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 14.9 t -69.16 -7.92 40.77 Favored 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 123.451 0.7 . . . . 0.0 111.803 175.255 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 68.3 p -61.77 -34.36 75.73 Favored 'General case' 0 C--N 1.355 0.846 0 C-N-CA 123.989 0.915 . . . . 0.0 110.667 172.467 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 123.88 127.0 3.15 Favored Glycine 0 C--N 1.348 1.244 0 CA-C-N 115.245 -0.888 . . . . 0.0 111.285 -179.652 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 18.3 p . . . . . 0 C--O 1.25 1.096 0 C-N-CA 123.879 0.872 . . . . 0.0 108.699 177.431 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.1 mpt? . . . . . 0 N--CA 1.482 1.148 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 18.7 p80 -156.81 112.17 2.87 Favored 'General case' 0 N--CA 1.479 1.008 0 CA-C-O 121.253 0.549 . . . . 0.0 110.488 178.019 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 98.6 m-70 -132.15 141.46 49.13 Favored 'General case' 0 N--CA 1.475 0.808 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 171.447 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 34.0 m170 -79.1 120.69 24.0 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.825 -171.846 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 30.1 p-80 -104.87 154.75 19.65 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 124.358 1.063 . . . . 0.0 109.278 173.527 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 69.1 m-70 -78.57 150.15 32.85 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 123.244 0.618 . . . . 0.0 110.116 178.149 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 14.0 t-80 -62.95 99.11 0.15 Allowed 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 123.78 0.832 . . . . 0.0 110.833 -175.936 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 16.3 m -84.06 112.21 20.0 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 123.806 0.842 . . . . 0.0 108.953 178.39 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 42.4 p -156.9 138.09 13.7 Favored 'General case' 0 C--O 1.244 0.771 0 C-N-CA 123.386 0.674 . . . . 0.0 110.347 -177.857 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -89.09 148.73 20.35 Favored Glycine 0 C--N 1.344 0.988 0 N-CA-C 110.652 -0.979 . . . . 0.0 110.652 177.203 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 26.3 tpt180 -138.49 -67.95 0.46 Allowed 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 123.71 0.804 . . . . 0.0 109.471 -176.061 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -95.21 78.52 3.49 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 123.068 0.547 . . . . 0.0 109.841 -176.034 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 63.7 t30 -164.18 75.24 0.31 Allowed 'General case' 0 N--CA 1.475 0.793 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 173.118 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -167.32 155.37 9.33 Favored 'General case' 0 N--CA 1.478 0.937 0 CA-C-N 115.084 -0.962 . . . . 0.0 108.908 179.481 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 74.9 m-85 -135.45 -64.35 0.64 Allowed 'General case' 0 N--CA 1.475 0.775 0 C-N-CA 122.971 0.508 . . . . 0.0 110.183 -178.772 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 58.8 t80 64.73 14.44 9.11 Favored 'General case' 0 CA--C 1.565 1.524 0 O-C-N 124.14 0.9 . . . . 0.0 111.14 -179.165 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -128.63 -166.38 1.63 Allowed 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 124.4 1.08 . . . . 0.0 109.835 -176.748 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 88.43 15.16 60.7 Favored Glycine 0 C--N 1.347 1.191 0 CA-C-N 116.402 -0.363 . . . . 0.0 113.695 172.989 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 58.1 t-80 -101.22 117.26 34.64 Favored 'General case' 0 C--O 1.24 0.594 0 N-CA-C 109.419 -0.586 . . . . 0.0 109.419 173.945 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 2.7 mpp? -113.61 128.12 56.32 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 124.235 1.014 . . . . 0.0 108.859 175.833 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -76.49 81.53 3.19 Favored 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 109.125 -0.695 . . . . 0.0 109.125 171.341 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 50.5 m -146.89 143.31 28.45 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 123.702 0.801 . . . . 0.0 110.469 -173.378 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -169.27 40.78 0.21 Allowed Glycine 0 C--N 1.345 1.067 0 N-CA-C 111.547 -0.621 . . . . 0.0 111.547 178.459 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 21.0 m -64.69 131.24 46.35 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 123.802 0.841 . . . . 0.0 110.494 -179.744 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -143.36 79.95 1.66 Allowed 'General case' 0 N--CA 1.47 0.543 0 N-CA-C 108.312 -0.995 . . . . 0.0 108.312 179.884 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -107.05 124.78 50.14 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 124.196 0.998 . . . . 0.0 109.072 -178.507 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 12.5 tp10 -78.38 92.42 4.57 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 123.656 0.783 . . . . 0.0 110.422 -174.317 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 19.0 m -129.11 147.76 33.34 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.028 0 C-N-CA 124.652 1.181 . . . . 0.0 109.881 -178.021 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 21.0 m -85.26 110.97 20.06 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 CA-C-O 121.222 0.534 . . . . 0.0 110.325 178.404 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 58.5 p -140.46 123.74 16.79 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 123.826 0.85 . . . . 0.0 109.49 177.569 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 48.5 t -110.83 124.45 67.64 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 C-N-CA 124.184 0.994 . . . . 0.0 109.464 178.559 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 53.4 mt-10 -80.9 104.08 11.16 Favored 'General case' 0 CA--C 1.545 0.76 0 CA-C-O 121.235 0.54 . . . . 0.0 110.188 176.758 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.459 HD23 ' HB3' ' A' ' 43' ' ' PHE . 3.9 mm? -79.32 163.3 60.16 Favored Pre-proline 0 CA--C 1.564 1.519 0 C-N-CA 124.881 1.272 . . . . 0.0 110.409 177.573 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo -60.04 145.51 98.23 Favored 'Trans proline' 0 C--N 1.391 2.769 0 C-N-CA 122.741 2.294 . . . . 0.0 114.157 -174.467 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.536 ' HB2' ' HB3' ' A' ' 41' ' ' LYS . . . -157.29 163.06 26.19 Favored Pre-proline 0 CA--C 1.542 0.671 0 C-N-CA 124.18 0.992 . . . . 0.0 110.839 -172.2 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_exo -52.73 147.66 30.76 Favored 'Trans proline' 0 C--N 1.379 2.139 0 C-N-CA 123.004 2.469 . . . . 0.0 112.122 164.319 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 37.4 p -71.42 -15.22 62.34 Favored 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 123.519 0.728 . . . . 0.0 111.929 -176.818 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 42.7 t -75.93 -34.85 59.9 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 123.585 0.754 . . . . 0.0 110.19 172.007 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 28.2 m95 -109.83 -169.93 1.56 Allowed 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 123.883 0.873 . . . . 0.0 110.86 -175.515 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.733 ' HB3' ' HB ' ' A' ' 59' ' ' VAL . 1.7 tpmt? -148.35 144.64 27.67 Favored 'General case' 0 CA--C 1.533 0.327 0 CA-C-N 114.939 -1.028 . . . . 0.0 108.266 166.821 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.536 ' HB3' ' HB2' ' A' ' 35' ' ' ALA . 19.6 tptp -112.74 115.48 28.59 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 177.183 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.426 HD22 ' HB ' ' A' ' 57' ' ' VAL . 7.3 tt -111.43 139.78 46.56 Favored 'General case' 0 C--N 1.319 -0.748 0 C-N-CA 124.518 1.127 . . . . 0.0 108.262 174.635 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.459 ' HB3' HD23 ' A' ' 33' ' ' LEU . 38.1 t80 -125.74 135.57 52.21 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 124.619 1.168 . . . . 0.0 107.9 173.286 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 8.6 m-85 -94.24 103.02 9.56 Favored Pre-proline 0 CA--C 1.55 0.969 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 172.812 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -81.99 -163.43 0.22 Allowed 'Trans proline' 0 C--N 1.374 1.905 0 C-N-CA 122.951 2.434 . . . . 0.0 111.792 172.752 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 6.4 p30 -166.81 177.19 6.59 Favored 'General case' 0 CA--C 1.545 0.75 0 C-N-CA 123.842 0.857 . . . . 0.0 110.078 179.444 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 50.9 mtpt -79.03 -51.03 10.14 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 123.434 0.694 . . . . 0.0 112.337 -173.394 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.567 ' HB ' HG22 ' A' ' 51' ' ' VAL . 93.2 t -63.26 -39.39 85.1 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.224 0 C-N-CA 123.117 0.567 . . . . 0.0 111.211 -175.476 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 90.98 -50.7 3.14 Favored Glycine 0 C--N 1.343 0.943 0 CA-C-N 115.764 -0.653 . . . . 0.0 112.408 179.772 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 28.9 m -67.9 -32.81 73.54 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 123.461 0.704 . . . . 0.0 111.934 -179.279 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.567 HG22 ' HB ' ' A' ' 48' ' ' VAL . 24.1 m -77.55 144.13 11.9 Favored 'Isoleucine or valine' 0 C--O 1.239 0.55 0 N-CA-C 109.651 -0.5 . . . . 0.0 109.651 175.283 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -110.12 88.75 2.83 Favored 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 107.625 -1.25 . . . . 0.0 107.625 178.103 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 9.8 tmtt? -67.45 -67.73 0.43 Allowed 'General case' 0 CA--C 1.554 1.101 0 C-N-CA 123.449 0.7 . . . . 0.0 109.97 -171.548 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 85.1 m -129.06 149.32 50.93 Favored 'General case' 0 CA--C 1.545 0.776 0 N-CA-C 108.771 -0.825 . . . . 0.0 108.771 -179.682 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -84.71 -169.02 2.43 Favored 'General case' 0 CA--C 1.554 1.13 0 C-N-CA 123.842 0.857 . . . . 0.0 112.085 -172.473 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 48.1 t -82.58 140.09 16.88 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.594 0 C-N-CA 124.909 1.284 . . . . 0.0 110.578 -179.157 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.426 ' HB ' HD22 ' A' ' 42' ' ' LEU . 81.6 t -123.97 130.69 73.76 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.682 0 C-N-CA 124.079 0.951 . . . . 0.0 109.062 173.022 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 16.2 m-85 -102.03 122.22 43.68 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 123.198 0.599 . . . . 0.0 109.504 171.228 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.733 ' HB ' ' HB3' ' A' ' 40' ' ' LYS . 4.3 t -81.15 130.52 35.72 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 173.122 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -95.06 155.65 38.76 Favored Pre-proline 0 CA--C 1.548 0.87 0 C-N-CA 124.167 0.987 . . . . 0.0 110.754 -176.175 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -66.01 -8.19 19.24 Favored 'Trans proline' 0 C--N 1.38 2.236 0 C-N-CA 123.067 2.511 . . . . 0.0 114.202 -177.259 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 9.6 t -120.98 12.66 11.23 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 123.602 0.761 . . . . 0.0 111.412 -175.174 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 81.03 -22.83 4.79 Favored Glycine 0 C--N 1.353 1.494 0 N-CA-C 114.531 0.572 . . . . 0.0 114.531 179.336 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 49.7 tt0 -72.84 75.0 1.15 Allowed 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 124.551 1.14 . . . . 0.0 109.487 177.626 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -80.97 157.98 25.34 Favored 'General case' 0 N--CA 1.476 0.839 0 CA-C-N 115.287 -0.87 . . . . 0.0 111.707 -168.785 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 42.5 mm -107.9 139.84 28.49 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.755 0 C-N-CA 124.905 1.282 . . . . 0.0 110.379 -173.35 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 16.3 p -108.33 -9.84 15.42 Favored 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 123.584 0.754 . . . . 0.0 112.66 -179.885 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 13.1 p-10 -160.74 162.64 32.53 Favored 'General case' 0 N--CA 1.486 1.337 0 N-CA-C 112.348 0.499 . . . . 0.0 112.348 -168.378 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 3.8 ttm180 -59.92 -41.33 91.49 Favored 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 124.613 1.165 . . . . 0.0 112.17 -170.789 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 7.4 tmtm? -60.91 -54.43 45.12 Favored 'General case' 0 N--CA 1.478 0.929 0 CA-C-N 115.145 -0.934 . . . . 0.0 109.507 -176.622 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.415 ' HA ' ' HG3' ' A' ' 74' ' ' GLN . 87.3 mm-40 -64.2 -25.17 67.95 Favored 'General case' 0 N--CA 1.475 0.797 0 O-C-N 124.03 0.831 . . . . 0.0 111.45 -176.676 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.418 ' O ' ' HG ' ' A' ' 76' ' ' LEU . 0.6 OUTLIER -66.52 -52.67 43.32 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 123.375 0.67 . . . . 0.0 109.224 175.88 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -64.08 -50.54 67.92 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 123.634 0.774 . . . . 0.0 111.363 -175.602 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' GLN . . . . . 0.415 ' HG3' ' HA ' ' A' ' 71' ' ' GLN . 0.0 OUTLIER -66.16 -23.92 66.55 Favored 'General case' 0 CA--C 1.547 0.861 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.365 179.582 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 38.5 t80 -66.88 -51.79 51.2 Favored 'General case' 0 C--O 1.212 -0.873 0 C-N-CA 122.92 0.488 . . . . 0.0 109.736 171.703 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.418 ' HG ' ' O ' ' A' ' 72' ' ' LEU . 83.1 mt -62.51 -37.78 87.35 Favored 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 123.225 0.61 . . . . 0.0 112.495 -172.105 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.77 -26.57 57.49 Favored 'General case' 0 CA--C 1.553 1.072 0 CA-C-O 120.83 0.347 . . . . 0.0 110.95 178.033 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 41.6 t -83.19 -26.68 30.62 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 123.203 0.601 . . . . 0.0 111.044 175.834 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 53.6 m80 -125.7 89.54 52.24 Favored Pre-proline 0 C--O 1.241 0.613 0 C-N-CA 124.395 1.078 . . . . 0.0 108.594 -173.447 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -68.67 164.85 31.53 Favored 'Trans proline' 0 C--N 1.369 1.62 0 C-N-CA 122.311 2.007 . . . . 0.0 111.666 176.076 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 89.81 -29.46 6.34 Favored Glycine 0 CA--C 1.532 1.123 0 CA-C-N 116.468 -0.333 . . . . 0.0 112.678 -176.049 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 36.1 m-80 -71.73 141.05 84.39 Favored Pre-proline 0 CA--C 1.549 0.932 0 C-N-CA 123.871 0.868 . . . . 0.0 110.778 178.828 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -67.02 163.03 35.51 Favored 'Trans proline' 0 C--N 1.374 1.895 0 C-N-CA 123.114 2.543 . . . . 0.0 112.863 179.959 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -74.7 161.03 30.03 Favored 'General case' 0 N--CA 1.488 1.442 0 C-N-CA 124.017 0.927 . . . . 0.0 112.266 -170.317 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 16.3 tt -78.71 -19.93 13.1 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.253 0 CA-C-O 120.808 0.337 . . . . 0.0 111.158 179.283 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -61.89 -38.17 87.32 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 123.344 0.658 . . . . 0.0 111.777 177.991 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -83.89 -9.75 58.5 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 123.282 0.633 . . . . 0.0 111.51 179.322 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 5.5 m-30 -82.62 129.69 34.99 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 123.397 0.679 . . . . 0.0 110.17 177.769 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' ASP . . . . . 0.429 ' OD1' ' HB ' ' A' ' 92' ' ' THR . 3.5 t70 -84.57 125.79 32.75 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 123.893 0.877 . . . . 0.0 110.32 177.568 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 86.2 m95 -118.43 -11.56 9.97 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 123.969 0.908 . . . . 0.0 109.439 168.203 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 13.7 t -102.93 13.52 34.15 Favored 'General case' 0 CA--C 1.555 1.15 0 C-N-CA 124.371 1.069 . . . . 0.0 112.571 -163.728 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.431 HG21 ' HG ' ' A' ' 33' ' ' LEU . 14.5 t -62.49 -21.08 65.21 Favored 'General case' 0 N--CA 1.49 1.535 0 C-N-CA 122.764 0.426 . . . . 0.0 111.93 -179.549 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 14.7 m -60.62 -17.79 49.17 Favored 'General case' 0 CA--C 1.55 0.947 0 C-N-CA 124.607 1.163 . . . . 0.0 112.31 179.88 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 84.42 -67.52 3.68 Favored Glycine 0 C--N 1.352 1.44 0 N-CA-C 110.458 -1.057 . . . . 0.0 110.458 -178.408 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 29.9 p . . . . . 0 C--O 1.256 1.416 0 C-N-CA 124.408 1.083 . . . . 0.0 109.476 174.337 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 30.4 m . . . . . 0 N--CA 1.479 0.98 0 N-CA-C 111.907 0.336 . . . . 0.0 111.907 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 60.9 p -143.69 129.35 19.21 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 123.526 0.731 . . . . 0.0 109.709 179.021 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 99.4 t -108.32 125.44 65.06 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 C-N-CA 124.337 1.055 . . . . 0.0 108.565 175.651 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -79.87 110.38 15.18 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 176.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.491 ' HB2' ' HG3' ' A' ' 41' ' ' LYS . 3.9 mm? -85.8 162.06 48.47 Favored Pre-proline 0 N--CA 1.485 1.29 0 C-N-CA 124.145 0.978 . . . . 0.0 109.399 178.959 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_endo -62.08 155.93 52.98 Favored 'Trans proline' 0 C--N 1.388 2.651 0 C-N-CA 122.628 2.219 . . . . 0.0 113.407 -179.667 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.472 ' HB2' ' CB ' ' A' ' 41' ' ' LYS . . . -161.65 171.2 7.08 Favored Pre-proline 0 N--CA 1.48 1.064 0 C-N-CA 123.741 0.816 . . . . 0.0 111.307 -171.11 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 13.7 Cg_endo -57.02 137.82 83.63 Favored 'Trans proline' 0 C--N 1.384 2.422 0 C-N-CA 122.053 1.835 . . . . 0.0 110.053 158.456 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 24.8 m -67.87 -15.9 63.84 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 123.601 0.76 . . . . 0.0 112.042 -176.383 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 17.8 p -69.15 -39.57 78.74 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 123.956 0.902 . . . . 0.0 110.455 172.646 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 25.5 m95 -105.03 -168.38 1.46 Allowed 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 123.92 0.888 . . . . 0.0 110.179 177.24 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.662 ' HB3' ' HB ' ' A' ' 59' ' ' VAL . 14.2 tppt? -143.77 144.2 31.7 Favored 'General case' 0 C--O 1.234 0.246 0 N-CA-C 107.581 -1.266 . . . . 0.0 107.581 167.93 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.515 ' NZ ' ' HB2' ' A' ' 43' ' ' PHE . 24.6 tptp -108.85 125.4 51.94 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 177.818 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 6.6 tt -122.41 141.76 51.25 Favored 'General case' 0 C--N 1.322 -0.622 0 C-N-CA 124.31 1.044 . . . . 0.0 108.259 174.894 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.515 ' HB2' ' NZ ' ' A' ' 41' ' ' LYS . 29.1 t80 -123.84 136.18 54.22 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 171.184 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 10.5 m-85 -96.03 100.84 7.17 Favored Pre-proline 0 CA--C 1.546 0.811 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 169.363 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 65.8 Cg_endo . . . . . 0 C--N 1.371 1.761 0 C-N-CA 122.329 2.019 . . . . 0.0 111.646 173.485 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.481 1.078 0 CA-C-O 121.409 0.623 . . . . 0.0 111.496 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 42.9 t -82.66 137.36 21.17 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.723 0 C-N-CA 124.841 1.257 . . . . 0.0 110.661 -179.578 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 86.2 t -126.67 125.34 66.85 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.883 0 C-N-CA 124.224 1.01 . . . . 0.0 108.751 173.138 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.483 ' CZ ' ' HD3' ' A' ' 41' ' ' LYS . 14.0 m-85 -94.67 124.0 38.44 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 123.185 0.594 . . . . 0.0 109.65 172.254 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.662 ' HB ' ' HB3' ' A' ' 40' ' ' LYS . 6.0 t -80.88 128.82 38.4 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.522 0 C-N-CA 123.493 0.717 . . . . 0.0 109.681 174.648 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -87.27 153.16 53.61 Favored Pre-proline 0 CA--C 1.543 0.674 0 CA-C-N 115.079 -0.964 . . . . 0.0 110.429 -178.372 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_endo -63.03 -20.84 72.45 Favored 'Trans proline' 0 C--N 1.375 1.958 0 C-N-CA 123.213 2.609 . . . . 0.0 113.514 178.68 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.446 HG23 ' H ' ' A' ' 64' ' ' GLU . 10.5 t -101.83 -4.22 26.67 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 123.837 0.855 . . . . 0.0 111.834 178.956 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 91.31 -9.62 76.97 Favored Glycine 0 C--N 1.352 1.439 0 CA-C-O 119.895 -0.392 . . . . 0.0 113.728 -178.79 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.446 ' H ' HG23 ' A' ' 62' ' ' THR . 34.6 tt0 -76.98 73.42 3.57 Favored 'General case' 0 N--CA 1.486 1.35 0 CA-C-O 122.03 0.919 . . . . 0.0 109.248 178.207 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -72.65 159.82 33.25 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 114.384 -1.28 . . . . 0.0 112.239 -166.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.485 HG23 ' HB2' ' A' ' 71' ' ' GLN . 45.8 mm -115.24 123.32 70.71 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.676 0 C-N-CA 125.041 1.337 . . . . 0.0 109.588 -173.412 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 17.4 m -94.18 -22.22 18.57 Favored 'General case' 0 N--CA 1.486 1.331 0 C-N-CA 122.957 0.503 . . . . 0.0 112.096 -176.718 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 3.2 p-10 -148.59 155.08 40.63 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 123.032 0.533 . . . . 0.0 110.373 -172.799 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 74.0 ttt-85 -62.4 -31.35 72.02 Favored 'General case' 0 CA--C 1.554 1.117 0 C-N-CA 124.67 1.188 . . . . 0.0 113.682 -166.221 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 1.6 tmtp? -61.85 -46.89 87.48 Favored 'General case' 0 N--CA 1.486 1.355 0 C-N-CA 123.243 0.617 . . . . 0.0 109.627 177.519 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.485 ' HB2' HG23 ' A' ' 66' ' ' ILE . 96.7 mt-30 -61.0 -27.53 68.38 Favored 'General case' 0 N--CA 1.484 1.234 0 CA-C-N 115.646 -0.707 . . . . 0.0 111.599 -178.835 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.427 ' O ' ' HG ' ' A' ' 76' ' ' LEU . 0.6 OUTLIER -67.47 -53.83 25.44 Favored 'General case' 0 N--CA 1.477 0.893 0 O-C-N 123.883 0.739 . . . . 0.0 109.248 179.44 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -60.75 -47.28 87.01 Favored 'General case' 0 N--CA 1.485 1.31 0 C-N-CA 123.621 0.768 . . . . 0.0 111.669 -176.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 5.2 pp0? -68.99 -25.33 64.47 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.199 179.516 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 42.2 t80 -67.13 -50.97 59.54 Favored 'General case' 0 N--CA 1.475 0.813 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 174.858 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.427 ' HG ' ' O ' ' A' ' 72' ' ' LEU . 69.7 mt -62.29 -42.13 99.09 Favored 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 123.371 0.669 . . . . 0.0 111.935 -173.267 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -70.18 -26.64 64.0 Favored 'General case' 0 N--CA 1.478 0.965 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.973 178.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 48.6 m -92.99 -12.27 31.11 Favored 'General case' 0 N--CA 1.493 1.701 0 C-N-CA 123.34 0.656 . . . . 0.0 111.739 177.463 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 64.8 m80 -135.47 84.19 35.1 Favored Pre-proline 0 N--CA 1.484 1.227 0 C-N-CA 123.965 0.906 . . . . 0.0 109.409 -176.268 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -68.45 147.93 72.2 Favored 'Trans proline' 0 C--N 1.377 2.06 0 C-N-CA 122.608 2.206 . . . . 0.0 111.498 175.818 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 107.12 -31.51 8.08 Favored Glycine 0 C--N 1.341 0.861 0 N-CA-C 111.198 -0.761 . . . . 0.0 111.198 -172.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 40.4 m-80 -76.55 136.45 67.82 Favored Pre-proline 0 N--CA 1.48 1.025 0 C-N-CA 123.324 0.65 . . . . 0.0 110.085 177.364 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -66.91 162.38 38.1 Favored 'Trans proline' 0 C--N 1.38 2.195 0 C-N-CA 123.108 2.539 . . . . 0.0 113.141 -176.38 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -75.28 149.65 38.74 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-N 115.021 -0.99 . . . . 0.0 111.895 -172.878 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.4 ' HB ' HD12 ' A' ' 72' ' ' LEU . 15.8 tt -66.29 -11.81 13.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 C-N-CA 124.155 0.982 . . . . 0.0 111.814 -176.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -54.26 -41.93 69.36 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 123.95 0.9 . . . . 0.0 111.848 172.685 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -92.79 4.76 53.21 Favored 'General case' 0 N--CA 1.481 1.115 0 N-CA-C 112.089 0.403 . . . . 0.0 112.089 179.783 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -94.76 109.97 21.88 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 123.346 0.658 . . . . 0.0 109.545 176.85 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -84.43 85.96 7.33 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 123.981 0.912 . . . . 0.0 111.292 -176.155 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 93.5 m95 -77.85 -27.07 49.73 Favored 'General case' 0 CA--C 1.547 0.841 0 CA-C-N 115.341 -0.845 . . . . 0.0 109.909 169.179 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 14.7 t . . . . . 0 CA--C 1.557 1.224 0 C-N-CA 124.529 1.132 . . . . 0.0 112.252 -175.582 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 28.1 m . . . . . 0 N--CA 1.48 1.047 0 CA-C-O 120.902 0.382 . . . . 0.0 111.313 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.401 ' HA ' ' HD2' ' A' ' 45' ' ' PRO . 36.6 p -157.64 122.37 4.37 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 124.317 1.047 . . . . 0.0 108.694 177.359 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 65.5 t -103.34 123.97 57.21 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 C-N-CA 123.885 0.874 . . . . 0.0 109.075 -177.121 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -83.38 114.63 21.57 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 123.08 0.552 . . . . 0.0 110.396 177.476 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.472 HD23 ' HB3' ' A' ' 43' ' ' PHE . 4.5 mm? -92.19 168.88 11.92 Favored Pre-proline 0 CA--C 1.562 1.438 0 C-N-CA 124.44 1.096 . . . . 0.0 109.766 -179.712 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -57.37 143.12 94.8 Favored 'Trans proline' 0 C--N 1.39 2.755 0 C-N-CA 122.739 2.293 . . . . 0.0 115.13 -177.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.755 ' HB2' ' HB3' ' A' ' 41' ' ' LYS . . . -144.97 167.07 15.57 Favored Pre-proline 0 N--CA 1.484 1.272 0 C-N-CA 124.648 1.179 . . . . 0.0 111.349 -177.501 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.587 ' HG2' ' HB2' ' A' ' 39' ' ' TRP . 31.3 Cg_endo -63.95 162.79 27.69 Favored 'Trans proline' 0 C--N 1.382 2.314 0 C-N-CA 122.645 2.23 . . . . 0.0 111.522 161.22 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 25.2 p -71.93 -24.77 61.68 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 123.52 0.728 . . . . 0.0 112.28 -176.756 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 45.7 m -75.38 -28.64 59.57 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 122.871 0.468 . . . . 0.0 111.319 176.107 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' TRP . . . . . 0.587 ' HB2' ' HG2' ' A' ' 36' ' ' PRO . 36.0 m95 -111.76 175.83 5.27 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 123.692 0.797 . . . . 0.0 110.563 -176.134 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 19.9 mtmt -140.92 128.34 21.2 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 165.5 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.755 ' HB3' ' HB2' ' A' ' 35' ' ' ALA . 13.6 tptm -99.95 126.49 46.12 Favored 'General case' 0 C--N 1.32 -0.679 0 C-N-CA 125.527 1.531 . . . . 0.0 108.502 -174.934 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 6.9 tt -129.07 132.52 47.45 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 114.495 -1.23 . . . . 0.0 107.84 178.867 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.472 ' HB3' HD23 ' A' ' 33' ' ' LEU . 28.9 t80 -110.84 141.93 43.55 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 124.148 0.979 . . . . 0.0 108.785 170.833 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -102.18 99.19 11.9 Favored Pre-proline 0 CA--C 1.55 0.945 0 C-N-CA 123.344 0.658 . . . . 0.0 110.064 174.038 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . 0.401 ' HD2' ' HA ' ' A' ' 30' ' ' SER . 83.4 Cg_endo . . . . . 0 C--N 1.377 2.035 0 C-N-CA 122.626 2.217 . . . . 0.0 111.114 171.057 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.243 0.731 0 CA-C-O 121.995 0.903 . . . . 0.0 110.911 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 48.2 t -81.67 138.99 18.62 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.787 0 CA-C-N 114.821 -1.082 . . . . 0.0 111.199 -170.847 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 59.1 t -112.13 115.33 49.53 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.945 0 C-N-CA 124.336 1.055 . . . . 0.0 109.206 174.854 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 45.6 m-85 -100.1 113.41 26.02 Favored 'General case' 0 N--CA 1.481 1.124 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 172.362 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.402 HG23 ' HB3' ' A' ' 65' ' ' GLU . 5.1 p -81.27 131.93 32.74 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 N-CA-C 109.168 -0.679 . . . . 0.0 109.168 179.671 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -92.26 145.62 31.05 Favored Pre-proline 0 CA--C 1.546 0.792 0 C-N-CA 122.814 0.445 . . . . 0.0 112.066 -171.345 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_endo -60.14 -36.42 88.87 Favored 'Trans proline' 0 C--N 1.381 2.285 0 C-N-CA 124.104 3.203 . . . . 0.0 113.724 -177.025 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 6.6 t -77.86 -9.52 59.1 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 122.779 0.432 . . . . 0.0 111.283 -179.368 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 94.57 23.92 19.87 Favored Glycine 0 C--N 1.35 1.342 0 CA-C-N 116.348 -0.387 . . . . 0.0 113.826 179.294 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -112.96 71.31 0.74 Allowed 'General case' 0 N--CA 1.474 0.73 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 178.729 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.402 ' HB3' HG23 ' A' ' 59' ' ' VAL . 0.6 OUTLIER -58.81 145.78 39.5 Favored 'General case' 0 N--CA 1.48 1.032 0 CA-C-N 115.211 -0.904 . . . . 0.0 112.062 -173.299 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.435 HG13 HD22 ' A' ' 72' ' ' LEU . 44.5 mm -111.24 127.26 68.5 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.589 0 C-N-CA 124.301 1.04 . . . . 0.0 110.062 -172.347 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 42.8 p -101.27 -13.58 18.01 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 123.88 0.872 . . . . 0.0 111.754 -178.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 11.5 p-10 -160.01 152.2 20.64 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 123.228 0.611 . . . . 0.0 111.045 -167.65 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.547 ' HG3' HD11 ' A' ' 85' ' ' ILE . 72.5 ttt-85 -56.17 -36.09 67.95 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 125.194 1.397 . . . . 0.0 113.357 -171.562 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 7.4 tmtm? -57.57 -49.94 74.74 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 123.885 0.874 . . . . 0.0 110.281 178.868 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.49 ' HA ' ' HG3' ' A' ' 74' ' ' GLN . 86.7 mm-40 -68.1 -24.07 64.99 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 115.14 -0.937 . . . . 0.0 111.733 -175.602 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.438 HD12 ' HB ' ' A' ' 85' ' ' ILE . 0.3 OUTLIER -66.35 -50.46 63.47 Favored 'General case' 0 N--CA 1.477 0.913 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 175.636 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -64.16 -47.99 77.73 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 124.233 1.013 . . . . 0.0 111.211 -176.081 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . 0.49 ' HG3' ' HA ' ' A' ' 71' ' ' GLN . 0.0 OUTLIER -68.29 -26.99 65.92 Favored 'General case' 0 CA--C 1.548 0.903 0 CA-C-N 115.802 -0.636 . . . . 0.0 111.427 179.4 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 59.2 t80 -63.66 -52.36 61.05 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 122.943 0.497 . . . . 0.0 110.202 173.854 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 96.6 mt -64.9 -39.24 93.21 Favored 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 123.487 0.715 . . . . 0.0 112.461 -171.902 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -73.42 -21.6 60.43 Favored 'General case' 0 N--CA 1.479 0.982 0 CA-C-N 116.667 -0.242 . . . . 0.0 111.133 178.25 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 46.2 m -99.58 -6.37 27.51 Favored 'General case' 0 N--CA 1.487 1.414 0 C-N-CA 123.093 0.557 . . . . 0.0 112.393 175.309 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 73.8 m80 -141.92 80.88 15.1 Favored Pre-proline 0 N--CA 1.479 1.0 0 C-N-CA 124.022 0.929 . . . . 0.0 108.54 179.147 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -68.31 149.86 75.85 Favored 'Trans proline' 0 C--N 1.375 1.922 0 C-N-CA 122.541 2.16 . . . . 0.0 111.996 178.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 103.23 -20.65 42.14 Favored Glycine 0 C--N 1.34 0.795 0 CA-C-N 116.262 -0.426 . . . . 0.0 112.693 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 18.7 m120 -82.42 142.07 46.29 Favored Pre-proline 0 CA--C 1.548 0.893 0 C-N-CA 123.238 0.615 . . . . 0.0 110.555 179.343 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_endo -55.72 145.94 68.67 Favored 'Trans proline' 0 C--N 1.385 2.466 0 C-N-CA 123.428 2.752 . . . . 0.0 113.395 -174.929 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.415 ' O ' ' HG2' ' A' ' 87' ' ' GLU . . . -68.98 160.01 31.69 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 124.156 0.982 . . . . 0.0 112.332 -170.865 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.547 HD11 ' HG3' ' A' ' 69' ' ' ARG . 14.1 tt -73.19 -22.69 19.55 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.966 0 C-N-CA 123.071 0.548 . . . . 0.0 110.8 177.345 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -63.32 -26.69 68.88 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 123.658 0.783 . . . . 0.0 111.863 -179.83 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.415 ' HG2' ' O ' ' A' ' 84' ' ' ALA . 15.0 pt-20 -96.71 -3.17 43.03 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 122.972 0.509 . . . . 0.0 111.567 177.874 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 5.3 m-30 -93.13 120.47 33.46 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 123.524 0.729 . . . . 0.0 109.655 178.188 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 13.8 p-10 -91.59 98.87 11.92 Favored 'General case' 0 N--CA 1.476 0.826 0 CA-C-O 122.042 0.925 . . . . 0.0 111.182 -176.74 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 88.0 m95 -83.19 -25.68 31.56 Favored 'General case' 0 N--CA 1.48 1.063 0 CA-C-N 115.095 -0.957 . . . . 0.0 110.297 171.763 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 14.9 t . . . . . 0 CA--C 1.554 1.123 0 C-N-CA 124.372 1.069 . . . . 0.0 112.485 -173.863 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 17.1 m . . . . . 0 N--CA 1.474 0.745 0 N-CA-C 110.197 -0.297 . . . . 0.0 110.197 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 60.9 p -146.7 113.48 6.07 Favored 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 174.519 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 61.1 t -101.7 131.33 49.8 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 -178.233 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 -84.11 111.66 19.52 Favored 'General case' 0 CA--C 1.536 0.436 0 N-CA-C 108.971 -0.752 . . . . 0.0 108.971 178.521 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.423 HD23 ' HB3' ' A' ' 43' ' ' PHE . 4.1 mm? -91.92 165.13 21.14 Favored Pre-proline 0 CA--C 1.559 1.321 0 C-N-CA 124.704 1.202 . . . . 0.0 109.95 -177.118 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_endo -59.76 143.96 99.53 Favored 'Trans proline' 0 C--N 1.393 2.908 0 C-N-CA 122.927 2.418 . . . . 0.0 113.356 -177.851 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.469 ' HB2' ' HB3' ' A' ' 41' ' ' LYS . . . -138.58 165.22 34.39 Favored Pre-proline 0 N--CA 1.474 0.746 0 C-N-CA 123.972 0.909 . . . . 0.0 111.632 -169.561 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.698 ' HG2' ' HB2' ' A' ' 39' ' ' TRP . 37.4 Cg_endo -65.09 155.61 67.35 Favored 'Trans proline' 0 C--N 1.381 2.253 0 C-N-CA 122.468 2.112 . . . . 0.0 110.8 162.663 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 34.3 t -57.55 -38.49 74.85 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 124.622 1.169 . . . . 0.0 112.895 -171.473 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 11.0 p -77.78 -40.19 41.6 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 123.342 0.657 . . . . 0.0 111.878 -177.582 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' TRP . . . . . 0.698 ' HB2' ' HG2' ' A' ' 36' ' ' PRO . 29.4 m95 -93.26 -174.63 3.59 Favored 'General case' 0 N--CA 1.478 0.944 0 CA-C-O 121.628 0.728 . . . . 0.0 111.336 -178.495 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.705 ' HB3' ' HB ' ' A' ' 59' ' ' VAL . 40.2 ttmt -143.55 144.83 32.12 Favored 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 107.336 -1.357 . . . . 0.0 107.336 173.452 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.469 ' HB3' ' HB2' ' A' ' 35' ' ' ALA . 18.4 tptp -120.23 125.9 49.28 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 124.063 0.945 . . . . 0.0 109.092 -174.511 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.461 HD22 ' HB ' ' A' ' 57' ' ' VAL . 4.3 tt -124.85 149.43 47.49 Favored 'General case' 0 C--O 1.236 0.393 0 C-N-CA 125.127 1.371 . . . . 0.0 108.694 176.648 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.423 ' HB3' HD23 ' A' ' 33' ' ' LEU . 34.3 t80 -135.26 135.58 41.0 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 124.943 1.297 . . . . 0.0 108.27 175.912 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 36.1 m-85 -95.93 103.96 15.05 Favored Pre-proline 0 N--CA 1.48 1.058 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 170.233 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 63.8 Cg_endo . . . . . 0 C--N 1.37 1.669 0 C-N-CA 122.717 2.278 . . . . 0.0 111.397 170.452 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 . . . . . 0 CA--C 1.557 1.217 0 CA-C-O 121.334 0.587 . . . . 0.0 111.492 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 46.7 t -81.72 134.77 26.35 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.668 0 C-N-CA 124.2 1.0 . . . . 0.0 110.416 -176.263 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.461 ' HB ' HD22 ' A' ' 42' ' ' LEU . 96.7 t -120.4 122.65 68.72 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 C-N-CA 124.005 0.922 . . . . 0.0 108.913 177.745 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 24.7 m-85 -97.85 121.15 39.42 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 123.602 0.761 . . . . 0.0 109.864 172.266 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.705 ' HB ' ' HB3' ' A' ' 40' ' ' LYS . 11.0 t -79.43 129.92 36.86 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 172.134 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -84.45 158.42 60.38 Favored Pre-proline 0 CA--C 1.542 0.659 0 CA-C-N 114.904 -1.044 . . . . 0.0 110.912 -175.766 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -63.53 -25.72 69.94 Favored 'Trans proline' 0 C--N 1.374 1.893 0 C-N-CA 123.005 2.47 . . . . 0.0 113.1 176.226 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.457 HG22 ' OH ' ' A' ' 75' ' ' TYR . 14.7 t -97.52 -3.7 39.33 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 123.5 0.72 . . . . 0.0 111.241 177.729 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 93.79 -12.83 68.69 Favored Glycine 0 C--N 1.354 1.577 0 CA-C-O 119.701 -0.5 . . . . 0.0 113.473 179.351 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 44.6 tt0 -73.88 77.63 1.63 Allowed 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 123.903 0.881 . . . . 0.0 109.77 178.862 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -67.41 158.39 31.86 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-N 114.786 -1.097 . . . . 0.0 112.229 -170.006 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.4 HG23 ' HB2' ' A' ' 71' ' ' GLN . 47.7 mm -121.21 131.2 73.6 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.598 0 C-N-CA 125.168 1.387 . . . . 0.0 108.891 -172.201 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 24.3 p -105.86 -17.94 14.21 Favored 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 123.984 0.914 . . . . 0.0 112.141 179.206 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 9.2 p30 -143.64 157.24 44.56 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 122.538 0.335 . . . . 0.0 111.235 -173.284 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 29.7 ttp180 -63.38 -30.62 71.72 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 123.917 0.887 . . . . 0.0 112.342 -171.585 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 5.5 tmtm? -59.89 -54.85 41.39 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 123.793 0.837 . . . . 0.0 109.116 -179.67 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.411 ' HA ' ' HG3' ' A' ' 74' ' ' GLN . 88.3 mm-40 -64.1 -25.55 68.15 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-N 115.006 -0.997 . . . . 0.0 111.597 -177.791 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.407 ' O ' ' HG ' ' A' ' 76' ' ' LEU . 0.4 OUTLIER -66.47 -56.71 9.66 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 123.477 0.711 . . . . 0.0 109.131 176.672 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -58.74 -48.93 79.47 Favored 'General case' 0 N--CA 1.486 1.334 0 C-N-CA 124.393 1.077 . . . . 0.0 111.71 -176.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . 0.411 ' HG3' ' HA ' ' A' ' 71' ' ' GLN . 0.0 OUTLIER -70.6 -24.24 62.71 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-N 115.472 -0.785 . . . . 0.0 111.538 -177.375 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . 0.457 ' OH ' HG22 ' A' ' 62' ' ' THR . 18.9 t80 -68.18 -49.56 60.07 Favored 'General case' 0 N--CA 1.479 0.985 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 172.561 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.407 ' HG ' ' O ' ' A' ' 72' ' ' LEU . 69.0 mt -59.68 -41.36 90.51 Favored 'General case' 0 N--CA 1.485 1.306 0 C-N-CA 123.053 0.541 . . . . 0.0 111.563 -173.17 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 54.9 pttt -73.39 -34.54 65.58 Favored 'General case' 0 N--CA 1.479 1.014 0 O-C-N 123.181 0.301 . . . . 0.0 111.63 -179.729 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 80.9 p -83.02 -17.7 42.4 Favored 'General case' 0 N--CA 1.487 1.423 0 C-N-CA 122.828 0.451 . . . . 0.0 111.582 -178.181 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 75.5 m80 -122.89 102.79 37.59 Favored Pre-proline 0 N--CA 1.48 1.027 0 C-N-CA 123.832 0.853 . . . . 0.0 109.237 -177.465 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -67.68 154.69 72.62 Favored 'Trans proline' 0 C--N 1.378 2.099 0 C-N-CA 122.928 2.418 . . . . 0.0 113.051 -177.785 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 84.04 -9.73 62.58 Favored Glycine 0 C--N 1.349 1.285 0 CA-C-N 115.631 -0.713 . . . . 0.0 114.293 175.243 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 25.0 m-80 -74.65 148.1 85.04 Favored Pre-proline 0 N--CA 1.483 1.211 0 C-N-CA 123.432 0.693 . . . . 0.0 111.178 -178.058 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -68.92 163.99 35.36 Favored 'Trans proline' 0 C--N 1.377 2.068 0 C-N-CA 123.233 2.622 . . . . 0.0 113.176 -177.794 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.485 ' O ' ' HG2' ' A' ' 87' ' ' GLU . . . -71.48 150.74 44.58 Favored 'General case' 0 N--CA 1.476 0.841 0 CA-C-N 115.066 -0.97 . . . . 0.0 111.243 -175.698 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 19.6 tt -72.88 -20.83 19.19 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.111 0 CA-C-O 120.968 0.413 . . . . 0.0 110.877 179.759 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -63.93 -30.13 71.24 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 123.681 0.793 . . . . 0.0 112.377 -179.019 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.485 ' HG2' ' O ' ' A' ' 84' ' ' ALA . 13.4 pt-20 -88.61 -7.49 56.31 Favored 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 123.215 0.606 . . . . 0.0 111.275 178.553 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -83.14 116.48 22.36 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 123.64 0.776 . . . . 0.0 110.365 176.356 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -75.69 128.47 35.27 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 123.86 0.864 . . . . 0.0 110.268 175.662 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 81.1 m95 -119.0 -1.2 11.01 Favored 'General case' 0 CA--C 1.555 1.138 0 C-N-CA 123.28 0.632 . . . . 0.0 110.151 166.325 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 14.2 t . . . . . 0 CA--C 1.565 1.538 0 N-CA-C 113.569 0.952 . . . . 0.0 113.569 -165.992 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 28.8 m . . . . . 0 N--CA 1.483 1.188 0 CA-C-O 121.204 0.526 . . . . 0.0 112.311 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.429 ' HB3' ' CE2' ' A' ' 44' ' ' TYR . 45.7 p -135.41 141.66 45.5 Favored 'General case' 0 C--O 1.241 0.646 0 C-N-CA 124.224 1.01 . . . . 0.0 109.376 -178.258 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 95.7 t -123.99 123.78 67.55 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 C-N-CA 124.266 1.026 . . . . 0.0 108.718 174.881 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -82.36 110.38 17.45 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 123.137 0.575 . . . . 0.0 110.201 176.472 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.517 ' HB2' ' HG3' ' A' ' 41' ' ' LYS . 4.1 mm? -85.38 165.19 37.32 Favored Pre-proline 0 CA--C 1.556 1.19 0 C-N-CA 124.584 1.154 . . . . 0.0 110.084 179.92 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 25.1 Cg_endo -59.88 149.46 83.57 Favored 'Trans proline' 0 C--N 1.389 2.674 0 C-N-CA 122.716 2.277 . . . . 0.0 113.834 179.838 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -149.32 170.29 7.88 Favored Pre-proline 0 CA--C 1.551 0.999 0 C-N-CA 124.32 1.048 . . . . 0.0 110.321 -172.264 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_exo -52.54 157.63 6.9 Favored 'Trans proline' 0 C--N 1.385 2.498 0 C-N-CA 122.946 2.43 . . . . 0.0 112.981 165.133 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 44.9 m -60.04 -29.72 68.71 Favored 'General case' 0 CA--C 1.552 1.021 0 C-N-CA 124.07 0.948 . . . . 0.0 112.233 -179.548 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 37.0 t -84.64 -24.57 29.02 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 123.121 0.568 . . . . 0.0 111.713 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 32.1 m95 -114.25 177.15 4.74 Favored 'General case' 0 N--CA 1.483 1.18 0 CA-C-O 121.467 0.651 . . . . 0.0 112.058 -173.331 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 33.5 mtmt -136.45 145.14 44.88 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 124.712 1.205 . . . . 0.0 108.179 170.093 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.523 ' NZ ' ' HB2' ' A' ' 43' ' ' PHE . 22.4 tptp -114.25 135.25 54.26 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 124.523 1.129 . . . . 0.0 108.707 -178.489 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.468 HD22 ' HB ' ' A' ' 57' ' ' VAL . 5.5 tt -125.95 142.42 51.53 Favored 'General case' 0 C--O 1.238 0.481 0 C-N-CA 124.166 0.986 . . . . 0.0 108.803 176.896 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.523 ' HB2' ' NZ ' ' A' ' 41' ' ' LYS . 65.5 t80 -127.09 144.9 50.92 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 124.884 1.274 . . . . 0.0 108.027 172.807 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . 0.429 ' CE2' ' HB3' ' A' ' 30' ' ' SER . 17.8 m-85 -102.44 97.65 9.25 Favored Pre-proline 0 CA--C 1.548 0.868 0 C-N-CA 122.557 0.343 . . . . 0.0 110.12 171.914 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo . . . . . 0 C--N 1.38 2.234 0 C-N-CA 122.945 2.43 . . . . 0.0 112.006 176.029 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 CA--C 1.541 0.631 0 CA-C-O 121.516 0.674 . . . . 0.0 111.671 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.412 ' CG1' ' HE2' ' A' ' 41' ' ' LYS . 31.9 t -81.85 134.29 27.38 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.404 0 CA-C-N 114.891 -1.05 . . . . 0.0 110.052 177.52 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.468 ' HB ' HD22 ' A' ' 42' ' ' LEU . 98.6 t -121.11 130.23 74.88 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 C-N-CA 124.089 0.956 . . . . 0.0 108.928 175.137 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 9.1 m-85 -101.86 119.5 38.88 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 123.297 0.639 . . . . 0.0 109.281 171.376 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.42 ' HA ' ' HG2' ' A' ' 65' ' ' GLU . 14.8 t -78.37 123.81 35.78 Favored 'Isoleucine or valine' 0 C--O 1.239 0.532 0 C-N-CA 123.518 0.727 . . . . 0.0 109.744 176.331 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -82.07 151.98 67.62 Favored Pre-proline 0 CA--C 1.54 0.582 0 CA-C-N 114.335 -1.302 . . . . 0.0 110.873 -175.639 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_endo -60.48 -33.3 94.08 Favored 'Trans proline' 0 C--N 1.374 1.894 0 C-N-CA 123.245 2.63 . . . . 0.0 112.697 177.41 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.496 HG23 ' H ' ' A' ' 64' ' ' GLU . 11.4 t -85.82 -12.82 49.9 Favored 'General case' 0 CA--C 1.545 0.781 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.292 178.207 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 94.57 -1.12 65.98 Favored Glycine 0 C--N 1.357 1.7 0 CA-C-O 120.053 -0.304 . . . . 0.0 113.64 -177.276 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.496 ' H ' HG23 ' A' ' 62' ' ' THR . 33.0 tt0 -78.31 71.87 4.8 Favored 'General case' 0 N--CA 1.48 1.064 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 174.497 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.42 ' HG2' ' HA ' ' A' ' 59' ' ' VAL . 34.1 mt-10 -66.01 148.57 51.59 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-N 114.775 -1.102 . . . . 0.0 111.771 -169.138 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 48.6 mm -115.17 131.11 68.4 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.557 0 C-N-CA 124.44 1.096 . . . . 0.0 110.167 -168.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 61.0 p -101.52 -21.12 14.83 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 123.596 0.758 . . . . 0.0 112.482 -178.758 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 7.8 p30 -143.52 159.36 42.57 Favored 'General case' 0 N--CA 1.481 1.111 0 CA-C-O 120.8 0.333 . . . . 0.0 111.802 -172.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 55.1 ttt-85 -65.69 -29.29 69.81 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 124.144 0.978 . . . . 0.0 111.968 -171.913 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 7.8 tmtm? -61.18 -54.94 38.0 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 123.352 0.661 . . . . 0.0 109.318 176.782 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 14.2 mm100 -67.5 -20.13 65.41 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-N 115.591 -0.732 . . . . 0.0 111.821 -176.581 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.422 ' O ' ' HG ' ' A' ' 76' ' ' LEU . 0.6 OUTLIER -70.91 -56.45 6.22 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 176.221 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -62.94 -41.83 99.62 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 123.526 0.731 . . . . 0.0 111.191 -176.784 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.47 -28.69 66.31 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 122.684 0.394 . . . . 0.0 110.648 177.467 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . 0.426 ' OH ' HG22 ' A' ' 62' ' ' THR . 20.9 t80 -63.06 -49.72 73.41 Favored 'General case' 0 N--CA 1.482 1.128 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 172.789 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.422 ' HG ' ' O ' ' A' ' 72' ' ' LEU . 72.5 mt -61.62 -37.15 82.9 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 123.313 0.645 . . . . 0.0 111.869 -172.341 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.04 -35.71 49.4 Favored 'General case' 0 CA--C 1.548 0.885 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.13 176.847 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 30.0 t -79.03 -16.38 56.94 Favored 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 123.011 0.524 . . . . 0.0 111.541 -179.412 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 76.9 m-70 -129.57 82.81 66.5 Favored Pre-proline 0 CA--C 1.544 0.72 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 178.091 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -64.76 142.26 75.65 Favored 'Trans proline' 0 C--N 1.372 1.803 0 C-N-CA 122.776 2.318 . . . . 0.0 112.543 -178.902 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 105.18 -14.8 47.88 Favored Glycine 0 C--N 1.348 1.246 0 CA-C-N 116.125 -0.489 . . . . 0.0 112.67 -178.024 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 18.4 m-80 -76.62 146.49 76.88 Favored Pre-proline 0 N--CA 1.485 1.316 0 C-N-CA 123.588 0.755 . . . . 0.0 111.526 179.633 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -63.37 158.43 45.07 Favored 'Trans proline' 0 C--N 1.383 2.393 0 C-N-CA 123.019 2.479 . . . . 0.0 113.541 -178.023 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.441 ' O ' ' HG2' ' A' ' 87' ' ' GLU . . . -73.83 144.52 45.47 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-N 114.879 -1.055 . . . . 0.0 111.756 -174.941 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 16.7 tt -67.03 -12.32 14.98 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.311 0 C-N-CA 123.129 0.572 . . . . 0.0 111.657 179.736 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -57.0 -38.86 73.67 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 124.38 1.072 . . . . 0.0 112.297 173.687 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.441 ' HG2' ' O ' ' A' ' 84' ' ' ALA . 11.6 pt-20 -92.76 0.21 57.38 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 123.235 0.614 . . . . 0.0 111.518 -179.569 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -85.26 110.75 19.29 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 123.044 0.537 . . . . 0.0 109.746 177.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -83.17 93.78 7.72 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 123.962 0.905 . . . . 0.0 109.941 -178.625 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 78.7 m95 -79.43 -42.45 25.38 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 123.433 0.693 . . . . 0.0 109.996 171.418 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 12.8 t . . . . . 0 CA--C 1.559 1.294 0 C-N-CA 124.4 1.08 . . . . 0.0 112.483 -172.859 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 12.8 m . . . . . 0 CA--C 1.549 0.938 0 CA-C-O 121.697 0.76 . . . . 0.0 110.98 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 15.5 p -145.93 137.32 24.83 Favored 'General case' 0 C--O 1.24 0.597 0 C-N-CA 124.671 1.188 . . . . 0.0 108.74 -178.605 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.407 HG12 HD22 ' A' ' 33' ' ' LEU . 86.3 t -125.62 125.54 68.78 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 C-N-CA 124.048 0.939 . . . . 0.0 108.972 -179.411 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -79.6 104.91 10.52 Favored 'General case' 0 CA--C 1.537 0.473 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 173.546 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.49 HD23 ' HB3' ' A' ' 43' ' ' PHE . 4.4 mm? -80.64 159.95 68.11 Favored Pre-proline 0 CA--C 1.552 1.023 0 C-N-CA 123.611 0.764 . . . . 0.0 109.537 177.068 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_endo -59.85 151.04 74.03 Favored 'Trans proline' 0 C--N 1.381 2.283 0 C-N-CA 122.378 2.052 . . . . 0.0 113.468 -178.016 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -144.81 168.13 12.99 Favored Pre-proline 0 N--CA 1.476 0.848 0 C-N-CA 124.203 1.001 . . . . 0.0 110.979 -168.698 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.537 ' HG2' ' HB2' ' A' ' 39' ' ' TRP . 30.3 Cg_endo -62.93 151.27 85.33 Favored 'Trans proline' 0 C--N 1.381 2.259 0 C-N-CA 122.0 1.8 . . . . 0.0 110.423 160.991 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 57.4 p -64.12 -23.33 67.28 Favored 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 123.528 0.731 . . . . 0.0 111.898 -177.225 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 18.3 m -74.64 -33.6 62.57 Favored 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 123.54 0.736 . . . . 0.0 111.745 178.226 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' TRP . . . . . 0.537 ' HB2' ' HG2' ' A' ' 36' ' ' PRO . 28.4 m95 -117.25 -174.38 2.59 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 123.942 0.897 . . . . 0.0 110.562 -176.866 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 44.8 mtmt -138.74 149.52 45.13 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 124.18 0.992 . . . . 0.0 108.612 168.888 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.559 ' HZ3' ' HB2' ' A' ' 43' ' ' PHE . 24.6 tptp -118.95 127.25 53.3 Favored 'General case' 0 C--N 1.331 -0.206 0 C-N-CA 124.815 1.246 . . . . 0.0 109.311 -175.214 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.416 HD22 ' HB ' ' A' ' 57' ' ' VAL . 4.1 tt -124.28 145.77 49.18 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 124.259 1.024 . . . . 0.0 108.647 174.68 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.559 ' HB2' ' HZ3' ' A' ' 41' ' ' LYS . 48.3 t80 -128.94 142.46 50.93 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 124.994 1.318 . . . . 0.0 108.124 170.934 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 36.5 m-85 -101.1 100.47 13.26 Favored Pre-proline 0 N--CA 1.48 1.058 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 171.243 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 62.2 Cg_endo . . . . . 0 C--N 1.372 1.816 0 C-N-CA 122.736 2.291 . . . . 0.0 111.598 172.499 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 . . . . . 0 CA--C 1.551 0.993 0 CA-C-O 121.731 0.777 . . . . 0.0 111.31 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 11.7 t -81.75 138.04 20.2 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.416 0 C-N-CA 124.581 1.152 . . . . 0.0 110.707 -174.657 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.416 ' HB ' HD22 ' A' ' 42' ' ' LEU . 49.3 t -123.13 116.12 47.66 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.744 0 C-N-CA 123.674 0.79 . . . . 0.0 109.059 171.848 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 15.2 m-85 -86.36 120.64 27.92 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 123.36 0.664 . . . . 0.0 109.585 170.395 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 2.8 t -78.71 127.98 38.63 Favored 'Isoleucine or valine' 0 C--O 1.238 0.494 0 C-N-CA 123.56 0.744 . . . . 0.0 109.039 174.414 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -86.53 153.41 55.79 Favored Pre-proline 0 CA--C 1.539 0.553 0 CA-C-N 114.959 -1.019 . . . . 0.0 110.801 -176.869 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -59.54 -29.88 91.04 Favored 'Trans proline' 0 C--N 1.369 1.613 0 C-N-CA 122.898 2.398 . . . . 0.0 113.076 173.893 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.408 HG23 ' H ' ' A' ' 64' ' ' GLU . 14.5 t -93.32 -3.97 52.51 Favored 'General case' 0 N--CA 1.486 1.343 0 C-N-CA 122.565 0.346 . . . . 0.0 111.522 176.894 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 90.04 -8.71 79.31 Favored Glycine 0 C--N 1.35 1.358 0 CA-C-O 119.576 -0.569 . . . . 0.0 113.996 -179.795 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.408 ' H ' HG23 ' A' ' 62' ' ' THR . 42.8 tt0 -72.63 77.64 1.09 Allowed 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 123.686 0.794 . . . . 0.0 109.306 175.316 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -73.06 158.34 35.57 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-N 115.013 -0.994 . . . . 0.0 111.581 -168.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.561 HG23 ' HB2' ' A' ' 71' ' ' GLN . 49.2 mm -122.14 115.42 46.16 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 CA-C-N 114.522 -1.217 . . . . 0.0 109.701 -166.723 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 14.1 p -88.5 -17.57 30.03 Favored 'General case' 0 CA--C 1.553 1.067 0 C-N-CA 123.765 0.826 . . . . 0.0 112.306 179.651 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 2.0 p-10 -156.67 157.65 35.57 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 112.133 0.42 . . . . 0.0 112.133 -174.558 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 41.9 mtm105 -56.6 -36.58 69.57 Favored 'General case' 0 N--CA 1.493 1.724 0 C-N-CA 124.35 1.06 . . . . 0.0 113.858 -170.868 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 7.0 tmtm? -54.62 -49.35 70.7 Favored 'General case' 0 N--CA 1.484 1.232 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 179.544 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.561 ' HB2' HG23 ' A' ' 66' ' ' ILE . 91.1 mt-30 -64.06 -35.16 79.84 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 123.693 0.797 . . . . 0.0 111.312 -179.544 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.458 HD12 ' HB ' ' A' ' 85' ' ' ILE . 0.6 OUTLIER -64.68 -51.71 61.06 Favored 'General case' 0 N--CA 1.483 1.178 0 O-C-N 123.739 0.649 . . . . 0.0 109.369 -179.813 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -69.34 -42.16 75.68 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 124.298 1.039 . . . . 0.0 111.599 -173.523 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 1.1 pp0? -66.44 -33.12 75.0 Favored 'General case' 0 N--CA 1.472 0.665 0 O-C-N 123.427 0.454 . . . . 0.0 109.897 176.091 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 12.2 t80 -61.92 -47.1 86.45 Favored 'General case' 0 C--N 1.357 0.909 0 O-C-N 123.656 0.597 . . . . 0.0 109.447 175.41 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.453 ' HG ' ' O ' ' A' ' 72' ' ' LEU . 81.9 mt -62.21 -48.98 77.6 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 123.038 0.535 . . . . 0.0 111.195 -175.738 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.76 -17.61 61.08 Favored 'General case' 0 CA--C 1.551 0.989 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.754 -176.806 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 30.7 t -92.77 -27.7 17.04 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 123.381 0.672 . . . . 0.0 110.781 175.654 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 51.9 m80 -127.72 92.25 43.19 Favored Pre-proline 0 N--CA 1.479 0.979 0 C-N-CA 124.204 1.002 . . . . 0.0 108.735 -174.334 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -64.63 159.79 43.25 Favored 'Trans proline' 0 C--N 1.371 1.756 0 C-N-CA 122.858 2.372 . . . . 0.0 112.551 179.131 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 91.62 -24.35 20.74 Favored Glycine 0 C--N 1.346 1.093 0 CA-C-N 115.989 -0.551 . . . . 0.0 112.971 179.06 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 41.7 m-80 -72.59 132.05 83.91 Favored Pre-proline 0 CA--C 1.546 0.817 0 C-N-CA 123.454 0.702 . . . . 0.0 110.308 177.651 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_endo -60.56 148.49 90.94 Favored 'Trans proline' 0 C--N 1.376 2.0 0 C-N-CA 123.226 2.617 . . . . 0.0 113.017 -176.123 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.406 ' O ' ' HG2' ' A' ' 87' ' ' GLU . . . -68.42 148.44 50.65 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 123.549 0.74 . . . . 0.0 112.088 -175.185 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.458 ' HB ' HD12 ' A' ' 72' ' ' LEU . 15.7 tt -63.49 -13.91 13.66 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.399 0 C-N-CA 124.329 1.052 . . . . 0.0 112.21 -177.459 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -57.76 -38.67 75.82 Favored 'General case' 0 CA--C 1.553 1.074 0 C-N-CA 124.153 0.981 . . . . 0.0 112.213 175.588 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.406 ' HG2' ' O ' ' A' ' 84' ' ' ALA . 11.3 pt-20 -90.55 -10.32 43.93 Favored 'General case' 0 N--CA 1.487 1.404 0 C-N-CA 122.993 0.517 . . . . 0.0 111.947 178.138 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -77.31 115.63 17.24 Favored 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 175.804 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 6.5 t0 -91.38 109.8 21.08 Favored 'General case' 0 CA--C 1.54 0.591 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 -176.122 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 69.8 m95 -96.99 -22.97 16.52 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 123.909 0.884 . . . . 0.0 110.106 176.119 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 12.9 t . . . . . 0 N--CA 1.486 1.329 0 C-N-CA 123.428 0.691 . . . . 0.0 111.718 -174.528 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 15.3 m . . . . . 0 CA--C 1.548 0.884 0 CA-C-O 121.764 0.792 . . . . 0.0 110.345 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 30.8 p -161.99 113.48 1.67 Allowed 'General case' 0 C--O 1.239 0.513 0 C-N-CA 124.52 1.128 . . . . 0.0 108.078 -177.34 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 83.3 t -105.59 124.33 60.53 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.517 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.451 ' HA ' ' HA ' ' A' ' 42' ' ' LEU . 51.6 mt-10 -76.72 113.21 14.12 Favored 'General case' 0 CA--C 1.533 0.317 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 173.761 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.46 HD23 ' HB3' ' A' ' 43' ' ' PHE . 3.7 mm? -87.28 166.4 26.03 Favored Pre-proline 0 CA--C 1.555 1.166 0 C-N-CA 123.69 0.796 . . . . 0.0 109.017 -179.786 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -51.54 134.72 46.9 Favored 'Trans proline' 0 C--N 1.388 2.633 0 C-N-CA 123.012 2.475 . . . . 0.0 113.161 175.854 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.451 ' HB2' ' HB3' ' A' ' 41' ' ' LYS . . . -128.91 158.97 70.89 Favored Pre-proline 0 N--CA 1.477 0.89 0 C-N-CA 125.335 1.454 . . . . 0.0 110.913 -170.648 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.647 ' HG2' ' HB2' ' A' ' 39' ' ' TRP . 58.9 Cg_endo -70.16 177.96 5.32 Favored 'Trans proline' 0 C--N 1.381 2.262 0 C-N-CA 122.686 2.257 . . . . 0.0 111.44 166.057 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 77.2 p -71.22 -47.67 55.96 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 123.694 0.798 . . . . 0.0 112.498 -169.741 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 22.2 m -74.65 -35.61 62.85 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 123.809 0.844 . . . . 0.0 110.884 -175.594 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' TRP . . . . . 0.647 ' HB2' ' HG2' ' A' ' 36' ' ' PRO . 39.7 m95 -100.3 174.3 6.19 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 123.693 0.797 . . . . 0.0 111.28 -175.297 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.785 ' HB3' ' HB ' ' A' ' 59' ' ' VAL . 15.7 tppt? -126.94 148.39 50.06 Favored 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 107.187 -1.412 . . . . 0.0 107.187 169.127 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.451 ' HB3' ' HB2' ' A' ' 35' ' ' ALA . 0.0 OUTLIER -120.97 127.94 52.26 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 107.688 -1.227 . . . . 0.0 107.688 179.41 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.451 ' HA ' ' HA ' ' A' ' 32' ' ' GLU . 4.5 tt -128.55 146.1 50.93 Favored 'General case' 0 C--N 1.324 -0.541 0 C-N-CA 125.29 1.436 . . . . 0.0 107.569 174.033 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.46 ' HB3' HD23 ' A' ' 33' ' ' LEU . 31.6 t80 -126.94 142.92 51.43 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 124.707 1.203 . . . . 0.0 107.923 172.509 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 14.1 m-85 -100.84 99.09 9.52 Favored Pre-proline 0 N--CA 1.488 1.44 0 C-N-CA 123.17 0.588 . . . . 0.0 110.91 174.084 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo . . . . . 0 C--N 1.378 2.108 0 C-N-CA 123.066 2.511 . . . . 0.0 111.999 171.909 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 15.1 pt-20 . . . . . 0 CA--C 1.55 0.959 0 CA-C-O 121.86 0.838 . . . . 0.0 111.431 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 75.4 t -80.28 137.57 21.28 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.76 0 CA-C-N 114.988 -1.005 . . . . 0.0 109.274 179.575 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.424 ' HB ' HD22 ' A' ' 42' ' ' LEU . 87.3 t -117.81 115.2 47.75 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 178.223 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.427 ' CZ ' ' HE3' ' A' ' 41' ' ' LYS . 19.6 m-85 -94.94 115.1 27.03 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 123.657 0.783 . . . . 0.0 109.378 174.635 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.785 ' HB ' ' HB3' ' A' ' 40' ' ' LYS . 2.8 t -79.48 129.84 36.97 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 175.359 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -84.31 153.62 62.54 Favored Pre-proline 0 CA--C 1.54 0.565 0 CA-C-N 114.939 -1.028 . . . . 0.0 111.003 -175.035 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_endo -61.02 -32.72 92.45 Favored 'Trans proline' 0 C--N 1.379 2.147 0 C-N-CA 122.913 2.408 . . . . 0.0 113.101 177.02 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.464 HG23 ' H ' ' A' ' 64' ' ' GLU . 13.2 t -84.49 -6.35 59.37 Favored 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 122.981 0.512 . . . . 0.0 111.627 179.796 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 94.16 -19.87 50.89 Favored Glycine 0 C--N 1.357 1.702 0 CA-C-O 119.686 -0.508 . . . . 0.0 113.179 179.486 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.464 ' H ' HG23 ' A' ' 62' ' ' THR . 42.7 tt0 -69.63 75.74 0.42 Allowed 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 124.299 1.039 . . . . 0.0 109.09 175.608 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -75.36 150.24 38.46 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-O 121.892 0.853 . . . . 0.0 111.548 -166.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 39.8 mm -102.27 123.32 55.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 114.047 -1.433 . . . . 0.0 109.555 -175.72 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 24.3 m -105.69 -1.34 24.63 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 123.153 0.581 . . . . 0.0 111.093 -179.404 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 14.5 p-10 -158.01 145.65 18.4 Favored 'General case' 0 C--N 1.353 0.749 0 C-N-CA 123.076 0.55 . . . . 0.0 111.241 -174.062 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.451 ' HG3' HD11 ' A' ' 85' ' ' ILE . 44.1 ttp180 -61.35 -30.61 70.63 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 124.839 1.255 . . . . 0.0 113.864 -166.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 6.4 tmtm? -62.28 -49.06 77.16 Favored 'General case' 0 N--CA 1.489 1.508 0 C-N-CA 123.139 0.576 . . . . 0.0 109.554 177.196 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.558 ' HA ' ' HG3' ' A' ' 74' ' ' GLN . 86.4 mm-40 -66.35 -21.61 66.25 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-N 115.406 -0.815 . . . . 0.0 111.515 -176.565 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.456 ' HB3' HD12 ' A' ' 85' ' ' ILE . 0.6 OUTLIER -65.44 -54.95 21.16 Favored 'General case' 0 N--CA 1.477 0.894 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 174.77 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -59.15 -49.74 76.69 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 123.877 0.871 . . . . 0.0 111.031 -176.05 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . 0.558 ' HG3' ' HA ' ' A' ' 71' ' ' GLN . 0.0 OUTLIER -67.57 -25.89 66.01 Favored 'General case' 0 CA--C 1.547 0.864 0 CA-C-N 115.414 -0.812 . . . . 0.0 111.369 -177.226 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 34.0 t80 -66.45 -50.43 63.38 Favored 'General case' 0 C--N 1.357 0.897 0 C-N-CA 123.211 0.605 . . . . 0.0 109.592 173.445 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 81.5 mt -58.28 -43.13 87.84 Favored 'General case' 0 N--CA 1.486 1.347 0 O-C-N 123.787 0.679 . . . . 0.0 111.873 -173.679 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 58.3 pttt -68.03 -41.0 82.78 Favored 'General case' 0 N--CA 1.478 0.932 0 O-C-N 123.32 0.387 . . . . 0.0 111.035 -179.354 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 77.4 p -85.52 -10.37 56.11 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 112.012 0.375 . . . . 0.0 112.012 -177.17 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 53.1 m-70 -130.06 84.25 60.95 Favored Pre-proline 0 N--CA 1.482 1.167 0 C-N-CA 124.322 1.049 . . . . 0.0 108.714 177.654 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -67.9 147.29 74.22 Favored 'Trans proline' 0 C--N 1.375 1.924 0 C-N-CA 122.631 2.22 . . . . 0.0 111.786 178.838 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 101.41 -6.43 55.63 Favored Glycine 0 CA--C 1.53 0.995 0 CA-C-N 116.071 -0.513 . . . . 0.0 112.698 -177.192 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 40.2 m-80 -90.68 141.05 26.68 Favored Pre-proline 0 N--CA 1.48 1.062 0 C-N-CA 123.164 0.586 . . . . 0.0 110.595 177.239 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_endo -62.0 149.57 89.79 Favored 'Trans proline' 0 C--N 1.38 2.236 0 C-N-CA 123.384 2.723 . . . . 0.0 112.783 179.091 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -66.28 158.89 27.84 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 124.22 1.008 . . . . 0.0 111.882 -173.162 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.456 HD12 ' HB3' ' A' ' 72' ' ' LEU . 19.3 tt -77.87 -17.58 14.0 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.544 177.485 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -60.7 -34.48 74.42 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 123.8 0.84 . . . . 0.0 111.471 177.089 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -92.81 -11.35 33.91 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 123.492 0.717 . . . . 0.0 110.976 179.65 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 5.8 m-30 -82.01 127.7 33.34 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 123.273 0.629 . . . . 0.0 109.832 176.083 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -92.47 122.18 34.66 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 123.909 0.884 . . . . 0.0 109.785 -178.317 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 77.5 m95 -115.73 6.7 14.48 Favored 'General case' 0 N--CA 1.488 1.471 0 C-N-CA 123.837 0.855 . . . . 0.0 110.729 176.637 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 9.9 t . . . . . 0 CA--C 1.557 1.22 0 C-N-CA 124.815 1.246 . . . . 0.0 110.662 -177.315 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 23.2 m . . . . . 0 CA--C 1.547 0.833 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.469 ' HA ' ' HD2' ' A' ' 45' ' ' PRO . 31.2 p -155.28 129.78 9.08 Favored 'General case' 0 C--O 1.239 0.508 0 CA-C-N 114.97 -1.013 . . . . 0.0 109.09 -173.143 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 65.4 t -114.36 124.89 71.45 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 175.784 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.446 ' HA ' ' HA ' ' A' ' 42' ' ' LEU . 47.1 mt-10 -80.33 110.47 15.79 Favored 'General case' 0 C--O 1.237 0.433 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 177.856 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.523 HD23 ' HB3' ' A' ' 43' ' ' PHE . 4.2 mm? -86.61 160.42 50.54 Favored Pre-proline 0 N--CA 1.476 0.841 0 C-N-CA 123.814 0.846 . . . . 0.0 108.779 -178.775 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 14.0 Cg_endo -51.54 125.68 17.42 Favored 'Trans proline' 0 C--N 1.39 2.735 0 C-N-CA 123.073 2.515 . . . . 0.0 113.101 -172.65 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.46 ' HB2' ' HB3' ' A' ' 41' ' ' LYS . . . -110.51 153.68 43.4 Favored Pre-proline 0 N--CA 1.469 0.483 0 CA-C-N 114.659 -1.155 . . . . 0.0 111.39 -170.876 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.689 ' HG2' ' HB2' ' A' ' 39' ' ' TRP . 56.3 Cg_endo -68.29 153.49 74.24 Favored 'Trans proline' 0 C--N 1.373 1.835 0 C-N-CA 122.584 2.189 . . . . 0.0 109.811 165.561 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 21.0 m -64.23 -29.31 70.42 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 123.468 0.707 . . . . 0.0 112.815 -172.138 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 16.0 m -83.56 -29.26 27.98 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 123.312 0.645 . . . . 0.0 111.609 -176.42 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' TRP . . . . . 0.689 ' HB2' ' HG2' ' A' ' 36' ' ' PRO . 17.5 m95 -114.19 -178.55 3.4 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 123.812 0.845 . . . . 0.0 109.668 -177.283 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.488 ' HB2' ' HB ' ' A' ' 59' ' ' VAL . 0.0 OUTLIER -119.7 165.63 14.26 Favored 'General case' 0 N--CA 1.473 0.713 0 N-CA-C 107.836 -1.172 . . . . 0.0 107.836 164.861 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.46 ' HB3' ' HB2' ' A' ' 35' ' ' ALA . 14.4 tptm -150.73 119.49 6.58 Favored 'General case' 0 C--O 1.238 0.496 0 C-N-CA 124.187 0.995 . . . . 0.0 108.77 -172.776 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.446 ' HA ' ' HA ' ' A' ' 32' ' ' GLU . 2.7 tt -129.1 150.21 50.59 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 113.579 -1.646 . . . . 0.0 108.29 -175.872 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.523 ' HB3' HD23 ' A' ' 33' ' ' LEU . 33.8 t80 -130.24 139.82 50.76 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 124.353 1.061 . . . . 0.0 108.398 170.07 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 22.2 m-85 -96.8 103.11 13.52 Favored Pre-proline 0 CA--C 1.552 1.028 0 C-N-CA 122.849 0.46 . . . . 0.0 109.952 173.696 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . 0.469 ' HD2' ' HA ' ' A' ' 30' ' ' SER . 95.3 Cg_endo . . . . . 0 C--N 1.373 1.854 0 C-N-CA 122.526 2.151 . . . . 0.0 111.983 172.61 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 CA--C 1.555 1.162 0 CA-C-O 121.299 0.571 . . . . 0.0 111.713 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 86.9 t -82.95 138.77 18.79 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.885 0 C-N-CA 125.056 1.342 . . . . 0.0 110.529 -178.162 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 61.4 t -121.17 115.39 46.57 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.002 0 C-N-CA 124.039 0.936 . . . . 0.0 109.327 175.423 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 23.8 m-85 -88.8 112.93 23.79 Favored 'General case' 0 N--CA 1.479 1.014 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 170.282 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.488 ' HB ' ' HB2' ' A' ' 40' ' ' LYS . 9.1 t -79.14 133.49 29.83 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 CA-C-O 121.231 0.539 . . . . 0.0 109.907 -179.843 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -86.5 154.15 56.34 Favored Pre-proline 0 CA--C 1.543 0.681 0 CA-C-N 114.567 -1.197 . . . . 0.0 111.785 -172.92 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_endo -61.06 -26.17 82.5 Favored 'Trans proline' 0 C--N 1.377 2.057 0 C-N-CA 123.386 2.724 . . . . 0.0 113.31 173.816 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.533 HG23 ' H ' ' A' ' 64' ' ' GLU . 9.8 t -89.2 -12.27 41.37 Favored 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 122.537 0.335 . . . . 0.0 111.213 176.217 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 95.45 -8.21 68.99 Favored Glycine 0 C--N 1.355 1.607 0 CA-C-O 119.621 -0.544 . . . . 0.0 113.942 -178.164 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.533 ' H ' HG23 ' A' ' 62' ' ' THR . 40.4 tt0 -76.15 78.15 2.97 Favored 'General case' 0 N--CA 1.481 1.092 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 172.47 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -65.34 134.28 53.21 Favored 'General case' 0 CA--C 1.543 0.705 0 CA-C-N 115.325 -0.852 . . . . 0.0 110.781 -173.325 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.635 HG23 ' HB2' ' A' ' 71' ' ' GLN . 44.7 mm -91.69 122.7 43.37 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.659 0 C-N-CA 125.068 1.347 . . . . 0.0 110.114 -175.094 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 6.0 p -94.63 -19.83 20.11 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 123.725 0.81 . . . . 0.0 111.989 177.491 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . 0.418 HD21 ' HG3' ' A' ' 71' ' ' GLN . 1.9 p-10 -150.87 150.23 30.64 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 122.959 0.504 . . . . 0.0 111.417 -173.139 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 65.8 mtp85 -55.57 -30.11 60.24 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 125.193 1.397 . . . . 0.0 114.149 -170.922 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 6.4 tmtm? -58.69 -50.61 73.26 Favored 'General case' 0 N--CA 1.48 1.063 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 179.572 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.635 ' HB2' HG23 ' A' ' 66' ' ' ILE . 54.1 mt-30 -63.27 -35.27 79.79 Favored 'General case' 0 N--CA 1.477 0.912 0 O-C-N 124.312 1.008 . . . . 0.0 111.073 -179.766 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.44 ' O ' ' HG ' ' A' ' 76' ' ' LEU . 0.2 OUTLIER -60.52 -52.31 65.73 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 123.482 0.713 . . . . 0.0 109.158 179.004 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -63.1 -50.02 72.16 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 123.839 0.855 . . . . 0.0 111.537 -175.949 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -66.87 -24.98 66.19 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.147 0.579 . . . . 0.0 111.261 -178.459 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 28.8 t80 -69.12 -47.22 65.69 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 123.818 0.847 . . . . 0.0 109.591 175.194 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.453 HD13 ' HA ' ' A' ' 84' ' ' ALA . 92.7 mt -66.01 -44.92 83.36 Favored 'General case' 0 N--CA 1.481 1.09 0 O-C-N 123.822 0.701 . . . . 0.0 111.815 -174.281 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -69.36 -25.89 64.4 Favored 'General case' 0 N--CA 1.48 1.069 0 CA-C-N 116.531 -0.304 . . . . 0.0 110.278 179.106 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 47.0 t -79.71 -29.37 40.68 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 123.046 0.538 . . . . 0.0 111.016 175.117 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 54.6 m80 -132.5 89.43 36.24 Favored Pre-proline 0 CA--C 1.546 0.791 0 C-N-CA 123.548 0.739 . . . . 0.0 109.562 -172.146 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -68.76 151.15 74.55 Favored 'Trans proline' 0 C--N 1.38 2.195 0 C-N-CA 122.664 2.243 . . . . 0.0 112.593 -177.287 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 95.05 -22.85 36.1 Favored Glycine 0 C--N 1.347 1.151 0 CA-C-N 116.141 -0.481 . . . . 0.0 113.052 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 14.7 m120 -68.0 131.52 92.31 Favored Pre-proline 0 N--CA 1.482 1.133 0 CA-C-O 119.102 -0.475 . . . . 0.0 109.821 173.162 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -55.78 141.53 84.69 Favored 'Trans proline' 0 C--N 1.38 2.209 0 C-N-CA 123.133 2.555 . . . . 0.0 112.723 -175.258 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.453 ' HA ' HD13 ' A' ' 76' ' ' LEU . . . -66.53 159.52 27.13 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 123.937 0.895 . . . . 0.0 112.811 -170.675 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.44 ' HB ' HD12 ' A' ' 72' ' ' LEU . 16.3 tt -67.9 -20.72 26.28 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.014 0 C-N-CA 123.863 0.865 . . . . 0.0 110.567 176.26 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -63.68 -36.54 84.17 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 124.457 1.103 . . . . 0.0 112.204 179.741 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -92.35 -1.49 57.01 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 123.442 0.697 . . . . 0.0 111.213 179.086 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 5.3 m-30 -93.82 112.38 24.23 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 123.923 0.889 . . . . 0.0 109.864 178.008 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 11.0 p-10 -86.65 115.06 23.86 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-O 121.494 0.664 . . . . 0.0 110.221 -179.502 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 74.2 m95 -94.12 -20.05 20.25 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 123.588 0.755 . . . . 0.0 109.701 172.822 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 15.1 t . . . . . 0 N--CA 1.484 1.229 0 C-N-CA 125.01 1.324 . . . . 0.0 112.65 -176.734 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 17.1 m . . . . . 0 N--CA 1.479 0.988 0 CA-C-O 121.639 0.733 . . . . 0.0 110.422 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 13.6 p -151.08 113.79 4.69 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 124.561 1.145 . . . . 0.0 108.408 -177.858 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 82.3 t -111.79 122.76 66.73 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 C-N-CA 124.38 1.072 . . . . 0.0 108.843 -176.759 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -79.5 116.74 19.89 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 123.112 0.565 . . . . 0.0 110.109 178.772 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.509 HD23 ' HB3' ' A' ' 43' ' ' PHE . 4.3 mm? -94.27 160.6 31.62 Favored Pre-proline 0 CA--C 1.555 1.167 0 C-N-CA 124.438 1.095 . . . . 0.0 109.128 177.362 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 13.1 Cg_endo -53.7 147.8 38.73 Favored 'Trans proline' 0 C--N 1.391 2.797 0 C-N-CA 123.22 2.613 . . . . 0.0 113.687 -177.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.599 ' HB2' ' HB3' ' A' ' 41' ' ' LYS . . . -152.23 167.24 13.61 Favored Pre-proline 0 CA--C 1.538 0.498 0 C-N-CA 123.884 0.874 . . . . 0.0 111.871 -167.92 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_exo -56.1 146.57 69.59 Favored 'Trans proline' 0 C--N 1.38 2.214 0 C-N-CA 122.571 2.181 . . . . 0.0 110.83 158.059 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 61.4 p -66.34 -33.74 76.41 Favored 'General case' 0 CA--C 1.552 1.026 0 C-N-CA 123.149 0.58 . . . . 0.0 110.695 177.451 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 37.1 m -64.79 -41.3 95.93 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 124.686 1.194 . . . . 0.0 111.3 177.136 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' TRP . . . . . 0.427 ' HE1' ' HD2' ' A' ' 83' ' ' PRO . 41.8 m95 -102.04 -166.48 1.29 Allowed 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 123.93 0.892 . . . . 0.0 110.127 178.735 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.493 ' HB3' ' HB ' ' A' ' 59' ' ' VAL . 1.1 tppt? -148.41 154.35 39.79 Favored 'General case' 0 CA--C 1.535 0.38 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 164.468 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.599 ' HB3' ' HB2' ' A' ' 35' ' ' ALA . 17.5 tptm -121.66 122.48 39.7 Favored 'General case' 0 N--CA 1.468 0.444 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 -179.055 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 4.5 tt -124.55 136.93 54.38 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 175.359 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.509 ' HB3' HD23 ' A' ' 33' ' ' LEU . 28.9 t80 -115.62 133.88 55.6 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 125.007 1.323 . . . . 0.0 108.021 172.81 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 13.2 m-85 -94.77 106.75 26.42 Favored Pre-proline 0 CA--C 1.547 0.854 0 C-N-CA 123.284 0.634 . . . . 0.0 109.479 171.66 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo . . . . . 0 C--N 1.37 1.66 0 C-N-CA 122.728 2.286 . . . . 0.0 111.522 169.41 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 CA--C 1.557 1.213 0 CA-C-O 121.136 0.493 . . . . 0.0 111.888 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 64.4 t -83.11 131.08 34.59 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 C-N-CA 124.06 0.944 . . . . 0.0 109.745 176.705 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 61.0 t -121.91 117.81 53.59 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.858 0 C-N-CA 124.052 0.941 . . . . 0.0 109.297 179.448 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 36.1 m-85 -87.18 131.1 34.28 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 123.61 0.764 . . . . 0.0 110.064 169.6 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.541 ' HA ' ' HG3' ' A' ' 65' ' ' GLU . 10.8 t -82.35 129.27 37.75 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 171.045 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -85.26 150.41 54.65 Favored Pre-proline 0 CA--C 1.542 0.672 0 CA-C-N 114.889 -1.051 . . . . 0.0 110.71 179.052 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_endo -61.4 -24.86 79.19 Favored 'Trans proline' 0 CA--C 1.557 1.643 0 C-N-CA 123.543 2.829 . . . . 0.0 111.477 169.715 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 85.2 m -74.53 -35.08 63.13 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 125.296 1.438 . . . . 0.0 112.078 176.193 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 94.2 11.24 57.64 Favored Glycine 0 CA--C 1.534 1.227 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.763 -162.538 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -94.72 70.37 3.49 Favored 'General case' 0 CA--C 1.542 0.641 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 174.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.541 ' HG3' ' HA ' ' A' ' 59' ' ' VAL . 0.7 OUTLIER -57.78 129.89 43.95 Favored 'General case' 0 N--CA 1.478 0.943 0 CA-C-N 115.501 -0.772 . . . . 0.0 111.738 -174.599 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.422 HG23 ' HB2' ' A' ' 71' ' ' GLN . 40.2 mm -100.7 128.45 52.8 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 CA-C-N 114.982 -1.008 . . . . 0.0 109.58 -177.906 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 12.2 p -110.27 -0.73 17.61 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 124.064 0.946 . . . . 0.0 111.451 -178.226 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 11.8 p-10 -162.26 149.82 14.11 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 122.757 0.423 . . . . 0.0 111.113 -169.577 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.527 ' HG2' HD11 ' A' ' 85' ' ' ILE . 16.3 mtp180 -52.53 -40.3 62.33 Favored 'General case' 0 N--CA 1.486 1.337 0 C-N-CA 124.346 1.058 . . . . 0.0 112.831 -175.555 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 5.0 tmtm? -53.63 -56.6 15.85 Favored 'General case' 0 N--CA 1.48 1.07 0 O-C-N 124.29 0.993 . . . . 0.0 109.307 -177.857 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.422 ' HB2' HG23 ' A' ' 66' ' ' ILE . 14.8 mm100 -67.18 -25.74 66.29 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 115.485 -0.78 . . . . 0.0 111.814 -175.314 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.453 HD12 ' HB ' ' A' ' 85' ' ' ILE . 0.6 OUTLIER -69.12 -54.68 13.69 Favored 'General case' 0 N--CA 1.482 1.155 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 178.398 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -68.49 -41.15 80.5 Favored 'General case' 0 C--O 1.241 0.642 0 C-N-CA 123.81 0.844 . . . . 0.0 111.005 -171.731 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -68.63 -29.41 67.9 Favored 'General case' 0 C--N 1.355 0.805 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.87 175.484 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 47.1 t80 -64.89 -40.96 95.91 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 122.882 0.473 . . . . 0.0 110.398 174.105 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 79.9 mt -68.07 -37.21 81.01 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 122.974 0.51 . . . . 0.0 111.604 -176.756 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.1 -16.96 36.36 Favored 'General case' 0 N--CA 1.484 1.26 0 C-N-CA 122.772 0.429 . . . . 0.0 111.661 -179.91 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 34.1 t -93.77 -22.0 18.96 Favored 'General case' 0 N--CA 1.492 1.652 0 C-N-CA 123.12 0.568 . . . . 0.0 110.78 174.785 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 54.2 m80 -135.81 79.36 46.18 Favored Pre-proline 0 CA--C 1.547 0.855 0 N-CA-C 107.364 -1.347 . . . . 0.0 107.364 179.95 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_endo -61.92 144.06 96.17 Favored 'Trans proline' 0 C--N 1.376 1.98 0 C-N-CA 123.386 2.724 . . . . 0.0 112.838 -179.113 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 115.21 -33.55 5.24 Favored Glycine 0 C--N 1.344 0.995 0 CA-C-N 116.195 -0.457 . . . . 0.0 112.756 178.136 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 54.0 m-80 -68.17 140.19 93.03 Favored Pre-proline 0 CA--C 1.555 1.142 0 C-N-CA 122.922 0.489 . . . . 0.0 111.323 -177.965 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . 0.427 ' HD2' ' HE1' ' A' ' 39' ' ' TRP . 81.9 Cg_exo -46.78 150.58 2.5 Favored 'Trans proline' 0 C--N 1.381 2.262 0 C-N-CA 124.682 3.588 . . . . 0.0 115.194 -178.375 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -71.99 158.17 36.47 Favored 'General case' 0 N--CA 1.484 1.258 0 C-N-CA 124.145 0.978 . . . . 0.0 112.247 -171.608 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.527 HD11 ' HG2' ' A' ' 69' ' ' ARG . 16.8 tt -76.79 -22.15 14.87 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.825 0 N-CA-C 110.253 -0.277 . . . . 0.0 110.253 175.051 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -64.58 -19.38 65.62 Favored 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 123.759 0.824 . . . . 0.0 112.616 178.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 -102.54 -14.86 16.61 Favored 'General case' 0 CA--C 1.553 1.076 0 C-N-CA 123.189 0.596 . . . . 0.0 110.85 174.65 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 7.1 m-30 -81.51 113.41 19.54 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 123.659 0.784 . . . . 0.0 110.352 179.612 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -80.59 125.2 29.7 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 123.439 0.696 . . . . 0.0 109.556 177.396 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 64.1 m95 -111.56 -8.25 14.25 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 124.139 0.976 . . . . 0.0 109.623 169.741 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 9.4 t . . . . . 0 CA--C 1.553 1.085 0 C-N-CA 124.111 0.964 . . . . 0.0 112.667 -163.579 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 27.2 m . . . . . 0 CA--C 1.549 0.922 0 CA-C-O 121.398 0.618 . . . . 0.0 110.408 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.402 ' HA ' ' HD2' ' A' ' 45' ' ' PRO . 24.6 p -142.46 118.05 10.38 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 123.974 0.91 . . . . 0.0 108.773 177.41 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 65.7 t -100.31 115.55 41.82 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 -175.144 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -80.61 105.99 12.28 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 123.423 0.689 . . . . 0.0 109.94 -179.367 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.463 HD23 ' HB3' ' A' ' 43' ' ' PHE . 4.5 mm? -83.68 163.94 47.0 Favored Pre-proline 0 N--CA 1.484 1.239 0 C-N-CA 124.281 1.033 . . . . 0.0 109.69 178.933 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -63.2 150.31 88.94 Favored 'Trans proline' 0 C--N 1.385 2.489 0 C-N-CA 122.025 1.817 . . . . 0.0 113.339 -175.407 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -141.8 167.77 15.82 Favored Pre-proline 0 CA--C 1.545 0.759 0 C-N-CA 124.226 1.01 . . . . 0.0 110.255 -173.484 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.401 ' HG2' ' HB2' ' A' ' 39' ' ' TRP . 33.0 Cg_endo -63.5 155.76 60.66 Favored 'Trans proline' 0 C--N 1.383 2.362 0 C-N-CA 121.902 1.735 . . . . 0.0 110.575 162.463 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 21.6 m -61.81 -23.53 66.29 Favored 'General case' 0 N--CA 1.484 1.274 0 C-N-CA 123.586 0.754 . . . . 0.0 111.511 179.205 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 12.6 m -71.24 -38.3 71.96 Favored 'General case' 0 CA--C 1.552 1.033 0 C-N-CA 124.134 0.974 . . . . 0.0 111.841 179.293 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' TRP . . . . . 0.401 ' HB2' ' HG2' ' A' ' 36' ' ' PRO . 26.5 m95 -119.24 -172.44 2.31 Favored 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 124.091 0.957 . . . . 0.0 111.051 -173.885 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 37.3 mtmt -138.7 143.87 39.32 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 124.677 1.191 . . . . 0.0 108.677 168.007 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 17.2 tptm -114.14 118.17 33.27 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 125.631 1.572 . . . . 0.0 108.638 -179.471 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 8.6 tt -120.02 125.96 49.65 Favored 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 175.698 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.463 ' HB3' HD23 ' A' ' 33' ' ' LEU . 87.0 t80 -103.58 134.57 46.7 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 124.441 1.096 . . . . 0.0 108.137 171.663 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . 0.419 ' HB2' ' O ' ' A' ' 55' ' ' GLU . 0.6 OUTLIER -100.01 104.52 29.47 Favored Pre-proline 0 CA--C 1.552 1.027 0 N-CA-C 109.392 -0.596 . . . . 0.0 109.392 174.635 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . 0.402 ' HD2' ' HA ' ' A' ' 30' ' ' SER . 85.5 Cg_endo . . . . . 0 C--N 1.37 1.71 0 C-N-CA 122.328 2.019 . . . . 0.0 110.431 166.452 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.419 ' O ' ' HB2' ' A' ' 44' ' ' TYR . 0.4 OUTLIER . . . . . 0 N--CA 1.485 1.309 0 CA-C-O 121.394 0.616 . . . . 0.0 112.387 . . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.448 HG22 ' HD1' ' A' ' 43' ' ' PHE . 79.7 t -84.09 132.83 30.6 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.963 0 C-N-CA 124.651 1.18 . . . . 0.0 110.353 179.019 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 98.9 t -122.37 120.93 62.46 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 C-N-CA 123.842 0.857 . . . . 0.0 109.617 173.627 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 15.3 m-85 -90.93 123.96 34.83 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 123.233 0.613 . . . . 0.0 109.378 170.364 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 5.2 t -80.94 124.27 38.5 Favored 'Isoleucine or valine' 0 C--O 1.237 0.431 0 C-N-CA 123.377 0.671 . . . . 0.0 109.317 172.607 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -81.61 153.49 70.68 Favored Pre-proline 0 N--CA 1.468 0.473 0 CA-C-N 114.946 -1.024 . . . . 0.0 110.186 -179.701 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_endo -59.34 -33.19 97.65 Favored 'Trans proline' 0 C--N 1.377 2.073 0 C-N-CA 123.186 2.591 . . . . 0.0 112.787 178.063 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 14.8 t -91.09 -7.22 52.33 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 123.569 0.748 . . . . 0.0 111.551 -179.059 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 93.59 -1.58 69.17 Favored Glycine 0 C--N 1.351 1.365 0 CA-C-O 119.52 -0.6 . . . . 0.0 113.952 179.337 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -80.99 75.04 7.97 Favored 'General case' 0 N--CA 1.481 1.086 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 173.85 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -65.9 145.33 56.06 Favored 'General case' 0 CA--C 1.543 0.686 0 CA-C-N 114.886 -1.052 . . . . 0.0 111.879 -170.392 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.442 HG13 HD22 ' A' ' 72' ' ' LEU . 46.4 mm -101.11 127.31 54.46 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.571 0 C-N-CA 124.39 1.076 . . . . 0.0 109.813 -179.2 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 21.9 p -98.21 -14.5 20.3 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 123.668 0.787 . . . . 0.0 111.896 -177.878 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 13.1 p-10 -155.33 145.02 21.32 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 123.281 0.632 . . . . 0.0 110.543 -167.331 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.521 ' HG3' HD11 ' A' ' 85' ' ' ILE . 69.1 ttt180 -63.38 -26.74 68.89 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 124.459 1.104 . . . . 0.0 113.897 -165.559 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 1.4 tmtp? -66.0 -48.47 71.1 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 176.852 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.439 ' HA ' ' HG3' ' A' ' 74' ' ' GLN . 15.2 mm100 -63.76 -23.94 67.57 Favored 'General case' 0 N--CA 1.477 0.916 0 O-C-N 123.654 0.597 . . . . 0.0 112.034 -177.837 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.451 ' HB3' HD12 ' A' ' 85' ' ' ILE . 0.4 OUTLIER -64.28 -54.03 39.67 Favored 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 175.759 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -63.34 -46.5 86.35 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 123.85 0.86 . . . . 0.0 111.212 -174.02 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . 0.439 ' HG3' ' HA ' ' A' ' 71' ' ' GLN . 0.0 OUTLIER -69.97 -25.54 63.67 Favored 'General case' 0 CA--C 1.551 0.989 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.018 -178.851 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 28.1 t80 -65.34 -51.28 61.59 Favored 'General case' 0 C--N 1.358 0.959 0 C-N-CA 123.355 0.662 . . . . 0.0 109.534 173.47 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.409 ' HG ' ' O ' ' A' ' 72' ' ' LEU . 85.0 mt -60.83 -45.37 94.75 Favored 'General case' 0 N--CA 1.488 1.445 0 C-N-CA 123.668 0.787 . . . . 0.0 112.073 -172.621 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 19.0 ptpt -67.22 -32.54 73.65 Favored 'General case' 0 N--CA 1.481 1.122 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.207 178.688 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 34.8 t -85.54 -13.83 47.76 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 123.55 0.74 . . . . 0.0 111.594 -179.312 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 54.9 m80 -136.63 92.38 15.0 Favored Pre-proline 0 N--CA 1.485 1.298 0 C-N-CA 123.62 0.768 . . . . 0.0 109.368 -176.321 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -72.96 154.44 53.05 Favored 'Trans proline' 0 C--N 1.374 1.902 0 C-N-CA 122.7 2.267 . . . . 0.0 112.258 -179.3 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 102.81 -20.9 42.25 Favored Glycine 0 C--N 1.346 1.136 0 CA-C-N 115.893 -0.594 . . . . 0.0 112.205 -174.076 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 21.1 m120 -87.76 137.01 32.03 Favored Pre-proline 0 CA--C 1.553 1.069 0 C-N-CA 124.181 0.992 . . . . 0.0 110.194 179.422 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -72.38 159.43 49.34 Favored 'Trans proline' 0 C--N 1.38 2.234 0 C-N-CA 123.17 2.58 . . . . 0.0 112.908 -176.009 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -68.03 149.69 49.37 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 123.578 0.751 . . . . 0.0 112.138 -174.433 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.521 HD11 ' HG3' ' A' ' 69' ' ' ARG . 15.5 tt -68.05 -11.65 14.54 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.18 0 C-N-CA 123.922 0.889 . . . . 0.0 111.797 -178.928 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -56.92 -31.59 65.08 Favored 'General case' 0 CA--C 1.552 1.027 0 C-N-CA 124.311 1.045 . . . . 0.0 112.218 175.501 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -99.38 3.04 45.75 Favored 'General case' 0 N--CA 1.49 1.538 0 C-N-CA 123.4 0.68 . . . . 0.0 112.274 178.011 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -93.78 113.86 26.0 Favored 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 123.484 0.714 . . . . 0.0 109.386 -179.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -78.33 124.92 28.64 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 123.044 0.538 . . . . 0.0 110.454 -179.58 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 86.1 m95 -115.72 -6.55 12.14 Favored 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 123.821 0.848 . . . . 0.0 110.321 171.126 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 9.0 t . . . . . 0 N--CA 1.488 1.454 0 C-N-CA 124.708 1.203 . . . . 0.0 112.307 -166.261 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 31.6 m . . . . . 0 CA--C 1.546 0.795 0 CA-C-O 121.204 0.526 . . . . 0.0 110.05 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 3.8 m -142.96 128.2 18.73 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 123.998 0.919 . . . . 0.0 108.661 -175.619 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.405 HG23 ' HG3' ' A' ' 45' ' ' PRO . 26.2 t -122.4 124.76 71.6 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.935 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 178.75 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.479 ' HA ' ' HA ' ' A' ' 42' ' ' LEU . 48.0 mt-10 -82.31 108.05 15.45 Favored 'General case' 0 C--O 1.237 0.432 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 174.74 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.577 HD23 ' HB3' ' A' ' 43' ' ' PHE . 3.8 mm? -77.89 159.88 75.25 Favored Pre-proline 0 CA--C 1.555 1.167 0 CA-C-N 115.206 -0.907 . . . . 0.0 109.352 178.756 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -53.78 127.0 23.75 Favored 'Trans proline' 0 C--N 1.385 2.475 0 C-N-CA 122.952 2.435 . . . . 0.0 112.693 -174.293 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -113.15 158.1 39.03 Favored Pre-proline 0 N--CA 1.468 0.469 0 C-N-CA 124.063 0.945 . . . . 0.0 111.576 -169.187 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.647 ' HG2' ' HB2' ' A' ' 39' ' ' TRP . 46.6 Cg_endo -68.66 142.88 54.43 Favored 'Trans proline' 0 C--N 1.374 1.871 0 C-N-CA 122.007 1.804 . . . . 0.0 110.046 162.453 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 36.8 m -58.15 -25.38 61.41 Favored 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 124.095 0.958 . . . . 0.0 112.823 -175.007 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 45.8 t -74.61 -41.47 60.36 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 123.175 0.59 . . . . 0.0 110.822 178.185 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' TRP . . . . . 0.647 ' HB2' ' HG2' ' A' ' 36' ' ' PRO . 21.4 m95 -108.2 -167.61 1.26 Allowed 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 123.678 0.791 . . . . 0.0 110.724 -175.418 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.502 ' HB2' ' HB ' ' A' ' 59' ' ' VAL . 8.4 mtmt -137.47 150.32 47.49 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 124.679 1.192 . . . . 0.0 108.099 167.739 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 18.8 tptm -127.59 115.7 19.2 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 124.855 1.262 . . . . 0.0 108.289 -173.194 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.479 ' HA ' ' HA ' ' A' ' 32' ' ' GLU . 3.6 tt -119.26 147.49 44.21 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 124.407 1.083 . . . . 0.0 108.951 178.536 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.577 ' HB3' HD23 ' A' ' 33' ' ' LEU . 45.6 t80 -134.18 140.54 46.6 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 124.844 1.258 . . . . 0.0 108.392 171.734 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . 0.405 ' CE1' HD21 ' A' ' 42' ' ' LEU . 33.3 m-85 -97.16 105.57 25.51 Favored Pre-proline 0 CA--C 1.55 0.948 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 173.141 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . 0.405 ' HG3' HG23 ' A' ' 31' ' ' VAL . 79.1 Cg_endo . . . . . 0 C--N 1.377 2.036 0 C-N-CA 122.497 2.132 . . . . 0.0 112.719 174.793 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 CA--C 1.55 0.959 0 CA-C-O 121.529 0.68 . . . . 0.0 111.223 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 47.1 t -79.26 138.43 20.02 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.637 0 C-N-CA 123.974 0.909 . . . . 0.0 109.912 -179.735 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 60.5 t -125.46 118.43 52.42 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.663 0 C-N-CA 123.823 0.849 . . . . 0.0 108.824 174.791 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 24.7 m-85 -86.71 126.69 34.73 Favored 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 170.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.502 ' HB ' ' HB2' ' A' ' 40' ' ' LYS . 4.6 t -81.72 128.54 38.63 Favored 'Isoleucine or valine' 0 C--O 1.241 0.623 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 170.213 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -84.65 147.91 50.39 Favored Pre-proline 0 C--O 1.242 0.7 0 CA-C-N 115.246 -0.888 . . . . 0.0 110.916 -178.747 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 27.4 Cg_endo -63.18 -23.47 72.89 Favored 'Trans proline' 0 C--N 1.371 1.713 0 C-N-CA 123.112 2.541 . . . . 0.0 112.826 174.569 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.637 HG23 ' H ' ' A' ' 64' ' ' GLU . 12.9 t -91.94 -10.95 37.62 Favored 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 123.059 0.544 . . . . 0.0 111.413 176.308 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 91.99 -8.8 77.67 Favored Glycine 0 C--N 1.355 1.607 0 CA-C-O 120.03 -0.317 . . . . 0.0 113.813 -178.034 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.637 ' H ' HG23 ' A' ' 62' ' ' THR . 9.4 tp10 -76.94 76.68 3.51 Favored 'General case' 0 N--CA 1.486 1.335 0 N-CA-C 108.612 -0.885 . . . . 0.0 108.612 173.137 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -63.76 149.17 47.39 Favored 'General case' 0 C--O 1.241 0.611 0 CA-C-N 115.083 -0.962 . . . . 0.0 111.706 -171.299 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.487 HG23 ' HB2' ' A' ' 71' ' ' GLN . 46.7 mm -115.59 119.96 63.35 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.732 0 CA-C-N 114.638 -1.165 . . . . 0.0 109.309 -174.726 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 14.4 p -106.47 -8.99 16.85 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 123.403 0.681 . . . . 0.0 112.511 -177.0 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 10.9 p30 -144.36 159.26 43.01 Favored 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 122.499 0.32 . . . . 0.0 111.084 175.231 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.513 ' HG3' HD11 ' A' ' 85' ' ' ILE . 50.7 ttt-85 -60.1 -35.85 76.14 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 124.446 1.098 . . . . 0.0 112.349 -173.49 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 1.8 tmtp? -59.91 -51.21 70.66 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 123.255 0.622 . . . . 0.0 109.372 179.189 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.487 ' HB2' HG23 ' A' ' 66' ' ' ILE . 84.1 mm-40 -57.86 -31.49 66.74 Favored 'General case' 0 CA--C 1.55 0.963 0 O-C-N 123.932 0.77 . . . . 0.0 110.949 -179.003 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -67.73 -51.28 51.2 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 123.666 0.786 . . . . 0.0 109.52 178.334 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -61.65 -50.87 70.77 Favored 'General case' 0 N--CA 1.484 1.259 0 C-N-CA 124.087 0.955 . . . . 0.0 111.472 -175.663 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 1.3 pp0? -65.86 -32.2 73.59 Favored 'General case' 0 CA--C 1.544 0.747 0 CA-C-N 115.495 -0.775 . . . . 0.0 111.178 -178.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 29.8 t80 -60.64 -51.11 70.77 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 123.334 0.654 . . . . 0.0 110.213 176.1 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.481 HD13 ' HA ' ' A' ' 84' ' ' ALA . 89.0 mt -65.33 -45.21 85.15 Favored 'General case' 0 N--CA 1.479 0.986 0 O-C-N 123.799 0.687 . . . . 0.0 111.994 -172.191 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.28 -20.24 63.05 Favored 'General case' 0 N--CA 1.481 1.094 0 CA-C-O 120.902 0.382 . . . . 0.0 111.211 179.601 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 34.2 t -92.53 -18.78 22.69 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 123.766 0.826 . . . . 0.0 111.574 175.184 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 54.3 m80 -135.2 93.7 16.6 Favored Pre-proline 0 N--CA 1.476 0.86 0 C-N-CA 123.587 0.755 . . . . 0.0 109.663 -174.71 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -71.92 162.71 41.1 Favored 'Trans proline' 0 C--N 1.371 1.732 0 C-N-CA 122.394 2.063 . . . . 0.0 111.804 175.742 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 87.9 -4.06 85.75 Favored Glycine 0 N--CA 1.472 1.05 0 CA-C-N 116.413 -0.358 . . . . 0.0 113.298 -177.51 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 32.0 m-80 -97.43 145.0 28.91 Favored Pre-proline 0 N--CA 1.482 1.171 0 C-N-CA 123.659 0.784 . . . . 0.0 109.991 177.698 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_endo -65.32 144.43 80.45 Favored 'Trans proline' 0 C--N 1.377 2.049 0 C-N-CA 122.561 2.174 . . . . 0.0 111.878 179.286 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.481 ' HA ' HD13 ' A' ' 76' ' ' LEU . . . -70.68 162.03 29.75 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 123.809 0.843 . . . . 0.0 112.305 -171.219 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.513 HD11 ' HG3' ' A' ' 69' ' ' ARG . 17.5 tt -74.29 -15.54 16.45 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.095 0 CA-C-O 120.941 0.401 . . . . 0.0 110.924 179.24 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -60.02 -34.35 73.25 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 124.304 1.042 . . . . 0.0 112.081 175.649 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.449 ' HG2' ' O ' ' A' ' 84' ' ' ALA . 10.2 pt-20 -98.13 -2.65 39.5 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 123.761 0.825 . . . . 0.0 111.172 -178.715 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 3.6 m-30 -90.49 152.48 20.92 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 123.471 0.708 . . . . 0.0 110.144 176.055 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -120.3 122.74 41.5 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 123.464 0.706 . . . . 0.0 109.943 178.167 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 88.9 m95 -111.64 -2.0 15.54 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 123.798 0.839 . . . . 0.0 110.512 172.075 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 12.5 t . . . . . 0 N--CA 1.479 0.983 0 C-N-CA 123.639 0.776 . . . . 0.0 112.145 -168.252 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 19.2 m . . . . . 0 CA--C 1.555 1.162 0 CA-C-O 121.898 0.856 . . . . 0.0 109.815 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 39.9 p -171.91 141.22 1.34 Allowed 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 125.202 1.401 . . . . 0.0 107.948 -177.972 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.479 HG23 ' HG3' ' A' ' 45' ' ' PRO . 59.9 t -117.92 126.51 74.9 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 -178.972 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -84.97 105.13 15.5 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 123.58 0.752 . . . . 0.0 108.982 176.512 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.501 HD23 ' HB3' ' A' ' 43' ' ' PHE . 4.4 mm? -82.56 163.54 51.48 Favored Pre-proline 0 N--CA 1.48 1.057 0 C-N-CA 123.82 0.848 . . . . 0.0 110.192 -178.564 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -57.25 137.16 80.45 Favored 'Trans proline' 0 C--N 1.39 2.759 0 C-N-CA 122.683 2.255 . . . . 0.0 112.797 -179.536 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.571 ' HB2' ' HB3' ' A' ' 41' ' ' LYS . . . -123.48 161.72 44.19 Favored Pre-proline 0 N--CA 1.476 0.86 0 C-N-CA 124.298 1.039 . . . . 0.0 111.742 -172.766 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.704 ' HG2' ' HB2' ' A' ' 39' ' ' TRP . 31.6 Cg_endo -63.72 146.36 92.07 Favored 'Trans proline' 0 C--N 1.375 1.926 0 C-N-CA 122.551 2.167 . . . . 0.0 109.669 159.028 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 18.5 m -59.04 -37.95 78.18 Favored 'General case' 0 N--CA 1.489 1.477 0 C-N-CA 124.179 0.992 . . . . 0.0 112.838 -169.734 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 48.5 m -69.81 -35.05 74.51 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 123.574 0.75 . . . . 0.0 111.528 -179.907 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' TRP . . . . . 0.704 ' HB2' ' HG2' ' A' ' 36' ' ' PRO . 33.3 m95 -104.6 -179.89 4.08 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 123.782 0.833 . . . . 0.0 110.566 -175.678 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.36 152.42 51.44 Favored 'General case' 0 N--CA 1.476 0.844 0 N-CA-C 107.556 -1.276 . . . . 0.0 107.556 173.743 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.571 ' HB3' ' HB2' ' A' ' 35' ' ' ALA . 18.2 tptm -132.53 117.8 18.45 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 123.922 0.889 . . . . 0.0 109.812 -171.717 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 2.3 tt -122.24 144.7 48.82 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 124.762 1.225 . . . . 0.0 108.604 174.459 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.501 ' HB3' HD23 ' A' ' 33' ' ' LEU . 47.6 t80 -128.1 147.64 50.54 Favored 'General case' 0 C--O 1.238 0.482 0 C-N-CA 124.701 1.201 . . . . 0.0 108.98 171.405 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 18.2 m-85 -102.18 100.97 16.78 Favored Pre-proline 0 CA--C 1.551 0.994 0 C-N-CA 123.651 0.781 . . . . 0.0 110.147 171.895 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . 0.479 ' HG3' HG23 ' A' ' 31' ' ' VAL . 30.9 Cg_endo . . . . . 0 C--N 1.373 1.852 0 C-N-CA 123.435 2.756 . . . . 0.0 113.342 175.993 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 . . . . . 0 CA--C 1.549 0.939 0 CA-C-O 122.547 1.165 . . . . 0.0 112.16 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 20.5 t -80.52 145.88 8.41 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.668 0 CA-C-N 113.764 -1.562 . . . . 0.0 110.519 -174.512 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 49.1 t -121.77 116.55 49.72 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.804 0 C-N-CA 123.969 0.908 . . . . 0.0 109.007 172.219 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 33.9 m-85 -90.3 132.79 35.36 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 123.618 0.767 . . . . 0.0 110.255 171.424 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.414 ' HA ' ' HG2' ' A' ' 65' ' ' GLU . 14.8 t -85.59 132.19 32.49 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 168.477 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -87.4 153.7 53.6 Favored Pre-proline 0 C--O 1.244 0.772 0 CA-C-N 115.317 -0.856 . . . . 0.0 110.638 179.739 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_endo -69.43 -3.02 10.94 Favored 'Trans proline' 0 C--N 1.376 1.974 0 C-N-CA 122.865 2.377 . . . . 0.0 113.062 177.667 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.564 HG23 ' H ' ' A' ' 64' ' ' GLU . 12.3 t -115.62 -7.97 12.13 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 124.129 0.972 . . . . 0.0 111.401 -179.902 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 94.16 -15.2 63.72 Favored Glycine 0 C--N 1.358 1.783 0 CA-C-O 119.695 -0.503 . . . . 0.0 113.791 -179.547 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.564 ' H ' HG23 ' A' ' 62' ' ' THR . 42.9 tt0 -78.4 80.12 4.81 Favored 'General case' 0 N--CA 1.484 1.265 0 CA-C-O 121.67 0.748 . . . . 0.0 109.335 173.394 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.414 ' HG2' ' HA ' ' A' ' 59' ' ' VAL . 28.3 mt-10 -69.73 156.46 38.96 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 124.43 1.092 . . . . 0.0 111.73 -170.224 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 41.0 mm -111.19 122.51 65.78 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.613 0 C-N-CA 123.855 0.862 . . . . 0.0 109.481 178.138 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 61.6 p -99.65 -11.45 20.91 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 123.481 0.712 . . . . 0.0 112.506 -177.817 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -153.94 150.54 28.43 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 122.598 0.359 . . . . 0.0 111.315 -177.804 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.455 ' HG3' HD11 ' A' ' 85' ' ' ILE . 41.5 ttm105 -54.98 -32.4 61.64 Favored 'General case' 0 N--CA 1.491 1.588 0 C-N-CA 125.369 1.468 . . . . 0.0 114.143 -168.196 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -60.05 -54.37 46.83 Favored 'General case' 0 N--CA 1.487 1.404 0 C-N-CA 123.356 0.662 . . . . 0.0 109.648 -179.798 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.474 ' O ' ' HB2' ' A' ' 75' ' ' TYR . 90.1 mm-40 -64.2 -20.97 66.38 Favored 'General case' 0 N--CA 1.476 0.841 0 CA-C-N 115.347 -0.842 . . . . 0.0 111.778 -176.564 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.44 ' O ' ' HG ' ' A' ' 76' ' ' LEU . 0.9 OUTLIER -69.85 -52.97 20.43 Favored 'General case' 0 N--CA 1.481 1.091 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 175.697 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -58.0 -54.42 47.11 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 123.971 0.908 . . . . 0.0 111.766 -178.752 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . 0.442 ' HG3' ' HA ' ' A' ' 71' ' ' GLN . 0.0 OUTLIER -67.5 -24.29 65.56 Favored 'General case' 0 CA--C 1.551 0.993 0 CA-C-N 115.455 -0.793 . . . . 0.0 111.077 -177.685 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . 0.474 ' HB2' ' O ' ' A' ' 71' ' ' GLN . 35.6 t80 -65.94 -55.27 17.71 Favored 'General case' 0 C--N 1.36 1.032 0 C-N-CA 123.097 0.559 . . . . 0.0 109.706 174.383 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.44 ' HG ' ' O ' ' A' ' 72' ' ' LEU . 71.2 mt -59.96 -39.47 85.71 Favored 'General case' 0 N--CA 1.489 1.514 0 C-N-CA 123.436 0.694 . . . . 0.0 111.855 -172.629 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.95 -14.35 58.66 Favored 'General case' 0 N--CA 1.484 1.269 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.824 -179.517 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 37.5 t -102.02 -9.6 20.47 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 123.621 0.768 . . . . 0.0 111.198 172.697 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 86.5 m-70 -137.45 87.23 18.05 Favored Pre-proline 0 N--CA 1.481 1.083 0 C-N-CA 124.189 0.995 . . . . 0.0 109.363 -177.132 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 63.2 Cg_endo -71.35 141.65 39.4 Favored 'Trans proline' 0 C--N 1.374 1.874 0 C-N-CA 122.403 2.069 . . . . 0.0 111.126 174.993 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 116.58 -20.24 12.24 Favored Glycine 0 N--CA 1.471 1.032 0 N-CA-C 111.695 -0.562 . . . . 0.0 111.695 -174.245 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 39.4 m-80 -91.67 140.51 25.17 Favored Pre-proline 0 CA--C 1.548 0.892 0 C-N-CA 123.435 0.694 . . . . 0.0 109.717 177.351 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -70.07 159.42 53.24 Favored 'Trans proline' 0 C--N 1.377 2.045 0 C-N-CA 122.845 2.363 . . . . 0.0 112.983 -178.65 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -70.0 154.55 41.81 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 123.949 0.9 . . . . 0.0 112.477 -173.432 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.455 HD11 ' HG3' ' A' ' 69' ' ' ARG . 16.2 tt -66.82 -12.01 14.34 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.209 0 C-N-CA 124.171 0.988 . . . . 0.0 111.686 -179.227 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -52.89 -39.8 62.99 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 124.505 1.122 . . . . 0.0 112.05 174.977 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -94.4 -8.14 39.57 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 123.526 0.73 . . . . 0.0 112.044 178.902 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -86.56 110.86 20.09 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 123.444 0.698 . . . . 0.0 109.314 176.39 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -87.63 126.56 35.02 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 123.683 0.793 . . . . 0.0 109.882 -178.744 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 85.2 m95 -118.29 -3.96 10.96 Favored 'General case' 0 CA--C 1.555 1.173 0 C-N-CA 125.126 1.37 . . . . 0.0 110.106 172.456 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 15.1 t . . . . . 0 N--CA 1.482 1.145 0 C-N-CA 124.025 0.93 . . . . 0.0 112.18 -168.046 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 15.3 m . . . . . 0 CA--C 1.545 0.774 0 CA-C-O 121.221 0.534 . . . . 0.0 109.854 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 50.1 p -152.99 123.83 7.37 Favored 'General case' 0 C--O 1.239 0.541 0 C-N-CA 123.934 0.893 . . . . 0.0 108.804 178.249 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 48.6 t -103.15 119.83 52.17 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 -178.582 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.441 ' HA ' ' HA ' ' A' ' 42' ' ' LEU . 37.4 mt-10 -79.11 117.07 19.81 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.011 177.166 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.442 HD23 ' HB3' ' A' ' 43' ' ' PHE . 3.0 mm? -92.0 164.1 24.83 Favored Pre-proline 0 N--CA 1.483 1.195 0 C-N-CA 124.26 1.024 . . . . 0.0 109.6 -178.033 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -53.46 140.15 64.4 Favored 'Trans proline' 0 C--N 1.394 2.968 0 C-N-CA 123.127 2.551 . . . . 0.0 114.027 179.927 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.768 ' HB2' ' HB3' ' A' ' 41' ' ' LYS . . . -140.19 156.84 69.9 Favored Pre-proline 0 N--CA 1.472 0.672 0 C-N-CA 124.419 1.087 . . . . 0.0 111.473 -170.068 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -58.41 140.73 95.68 Favored 'Trans proline' 0 C--N 1.372 1.784 0 C-N-CA 122.798 2.332 . . . . 0.0 110.504 155.269 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 70.5 p -63.51 -28.15 69.75 Favored 'General case' 0 N--CA 1.487 1.422 0 C-N-CA 122.993 0.517 . . . . 0.0 111.884 -177.007 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 31.8 m -67.24 -40.03 86.24 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 123.282 0.633 . . . . 0.0 110.612 176.911 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 33.8 m95 -100.46 -179.46 4.11 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 123.743 0.817 . . . . 0.0 110.25 179.266 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.5 150.51 52.15 Favored 'General case' 0 N--CA 1.469 0.482 0 N-CA-C 106.768 -1.568 . . . . 0.0 106.768 169.893 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.768 ' HB3' ' HB2' ' A' ' 35' ' ' ALA . 15.2 tptm -133.0 128.96 37.52 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.676 0.751 . . . . 0.0 108.998 -174.493 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.441 ' HA ' ' HA ' ' A' ' 32' ' ' GLU . 3.3 tt -135.37 151.32 50.37 Favored 'General case' 0 C--O 1.241 0.607 0 CA-C-N 114.001 -1.454 . . . . 0.0 108.62 -177.146 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.442 ' HB3' HD23 ' A' ' 33' ' ' LEU . 32.9 t80 -133.61 137.84 45.65 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.782 1.233 . . . . 0.0 108.267 173.735 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . 0.434 ' CE1' HD21 ' A' ' 42' ' ' LEU . 38.5 m-85 -100.59 103.53 24.7 Favored Pre-proline 0 N--CA 1.484 1.231 0 C-N-CA 122.692 0.397 . . . . 0.0 111.025 175.544 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 65.0 Cg_endo . . . . . 0 C--N 1.371 1.727 0 C-N-CA 122.421 2.081 . . . . 0.0 110.994 166.676 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 4.0 pm0 . . . . . 0 CA--C 1.555 1.164 0 CA-C-O 121.694 0.759 . . . . 0.0 111.674 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 75.2 t -83.02 141.87 14.33 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.695 0 C-N-CA 124.33 1.052 . . . . 0.0 110.241 -177.317 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 57.7 t -123.56 124.01 68.6 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 C-N-CA 123.737 0.815 . . . . 0.0 109.555 179.594 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 29.6 m-85 -101.83 113.68 27.09 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 123.582 0.753 . . . . 0.0 109.27 171.774 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 3.4 t -79.1 130.45 36.11 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 C-N-CA 123.323 0.649 . . . . 0.0 109.587 175.939 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -84.18 154.47 63.48 Favored Pre-proline 0 CA--C 1.541 0.622 0 CA-C-N 115.022 -0.99 . . . . 0.0 111.593 -175.796 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 26.5 Cg_endo -60.42 -33.6 93.95 Favored 'Trans proline' 0 C--N 1.377 2.071 0 C-N-CA 123.251 2.634 . . . . 0.0 113.179 177.226 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 14.8 t -85.47 -2.49 58.18 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 123.027 0.531 . . . . 0.0 111.602 179.256 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 94.21 -18.01 57.71 Favored Glycine 0 C--N 1.35 1.308 0 CA-C-O 119.635 -0.536 . . . . 0.0 113.682 178.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -72.46 76.82 1.04 Allowed 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 123.983 0.913 . . . . 0.0 109.638 178.198 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -65.57 157.86 28.64 Favored 'General case' 0 N--CA 1.477 0.881 0 CA-C-N 115.024 -0.989 . . . . 0.0 111.682 -172.744 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 47.4 mm -118.44 122.52 69.72 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.445 0 CA-C-N 114.83 -1.077 . . . . 0.0 109.386 -170.741 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 7.6 p -93.82 -21.26 19.39 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 123.932 0.893 . . . . 0.0 112.403 -178.44 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 2.4 p-10 -153.95 165.95 34.52 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 122.674 0.39 . . . . 0.0 111.393 -172.401 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 34.8 ttp180 -58.91 -41.93 88.45 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 124.314 1.046 . . . . 0.0 111.954 -171.059 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 5.0 tmtm? -55.99 -51.6 67.15 Favored 'General case' 0 N--CA 1.486 1.335 0 C-N-CA 123.821 0.848 . . . . 0.0 109.76 -179.52 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 77.5 mt-30 -60.3 -31.63 70.44 Favored 'General case' 0 N--CA 1.476 0.839 0 O-C-N 124.144 0.903 . . . . 0.0 111.422 -178.729 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -67.62 -50.42 58.19 Favored 'General case' 0 N--CA 1.481 1.12 0 N-CA-C 109.338 -0.615 . . . . 0.0 109.338 177.898 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -62.8 -51.0 68.77 Favored 'General case' 0 C--O 1.242 0.693 0 CA-C-N 115.236 -0.893 . . . . 0.0 111.225 -174.897 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -66.36 -29.42 69.6 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 122.556 0.343 . . . . 0.0 111.223 179.799 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 43.7 t80 -62.53 -54.68 36.28 Favored 'General case' 0 C--N 1.357 0.913 0 C-N-CA 122.946 0.498 . . . . 0.0 109.824 176.06 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 67.1 mt -60.71 -44.5 96.5 Favored 'General case' 0 N--CA 1.481 1.095 0 O-C-N 123.579 0.549 . . . . 0.0 111.847 -173.143 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -69.1 -25.04 64.21 Favored 'General case' 0 N--CA 1.48 1.037 0 CA-C-N 116.589 -0.278 . . . . 0.0 111.402 -177.813 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 100.0 p -98.47 -12.4 21.36 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 122.91 0.484 . . . . 0.0 111.811 178.715 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 90.4 m-70 -130.84 91.02 38.15 Favored Pre-proline 0 N--CA 1.476 0.841 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 179.673 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_endo -67.01 166.04 24.26 Favored 'Trans proline' 0 C--N 1.372 1.783 0 C-N-CA 122.412 2.075 . . . . 0.0 112.071 175.661 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 90.81 -17.22 55.98 Favored Glycine 0 C--N 1.347 1.15 0 CA-C-N 116.565 -0.289 . . . . 0.0 113.259 -179.776 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 40.2 m-80 -84.16 144.64 44.42 Favored Pre-proline 0 CA--C 1.547 0.856 0 C-N-CA 123.652 0.781 . . . . 0.0 111.269 -178.013 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_exo -56.18 152.01 40.28 Favored 'Trans proline' 0 C--N 1.378 2.081 0 C-N-CA 123.875 3.05 . . . . 0.0 112.794 170.97 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -77.04 161.56 28.22 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 123.526 0.73 . . . . 0.0 112.207 -173.997 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 16.9 tt -72.93 -23.45 20.38 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.222 0 C-N-CA 123.347 0.659 . . . . 0.0 111.488 -178.71 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -65.13 -31.58 72.85 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 123.308 0.643 . . . . 0.0 111.854 -177.728 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -90.52 0.2 57.42 Favored 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 123.432 0.693 . . . . 0.0 111.247 177.106 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 6.0 m-30 -92.74 111.42 23.02 Favored 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 123.499 0.72 . . . . 0.0 109.248 177.149 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -84.0 88.79 7.17 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 123.559 0.744 . . . . 0.0 110.618 -175.872 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 89.5 m95 -76.19 -17.69 59.42 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 122.695 0.398 . . . . 0.0 110.902 173.171 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 14.5 t . . . . . 0 N--CA 1.488 1.425 0 C-N-CA 125.623 1.569 . . . . 0.0 111.979 177.697 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 34.7 m . . . . . 0 CA--C 1.551 1.019 0 CA-C-O 121.444 0.64 . . . . 0.0 110.435 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 56.2 p -134.71 124.29 25.04 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 124.013 0.925 . . . . 0.0 109.87 -176.064 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 95.4 t -109.55 116.61 52.6 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.448 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 174.372 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.494 ' HA ' ' HA ' ' A' ' 42' ' ' LEU . 44.0 mt-10 -77.27 125.3 29.1 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 123.257 0.623 . . . . 0.0 110.387 177.455 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -100.64 169.03 8.4 Favored Pre-proline 0 CA--C 1.559 1.304 0 C-N-CA 124.613 1.165 . . . . 0.0 109.316 -177.144 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -54.94 126.44 22.54 Favored 'Trans proline' 0 C--N 1.395 3.005 0 C-N-CA 122.99 2.46 . . . . 0.0 113.147 -177.745 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.46 ' HB2' ' HB3' ' A' ' 41' ' ' LYS . . . -114.9 156.83 44.57 Favored Pre-proline 0 N--CA 1.48 1.069 0 C-N-CA 124.374 1.069 . . . . 0.0 111.88 -171.697 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.592 ' HG2' ' HB2' ' A' ' 39' ' ' TRP . 72.6 Cg_endo -73.25 171.07 18.38 Favored 'Trans proline' 0 C--N 1.372 1.806 0 C-N-CA 122.544 2.163 . . . . 0.0 111.13 166.727 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 43.6 p -66.57 -46.13 77.02 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 123.421 0.689 . . . . 0.0 111.803 -176.937 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . 0.444 ' HB2' ' HD1' ' A' ' 39' ' ' TRP . 9.8 m -72.68 -40.74 66.02 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-N 115.174 -0.921 . . . . 0.0 111.78 -174.187 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' TRP . . . . . 0.592 ' HB2' ' HG2' ' A' ' 36' ' ' PRO . 18.4 m95 -105.02 -173.86 2.4 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 123.535 0.734 . . . . 0.0 110.989 -175.273 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -130.28 158.02 40.93 Favored 'General case' 0 C--O 1.239 0.537 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 172.222 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.46 ' HB3' ' HB2' ' A' ' 35' ' ' ALA . 16.7 tptm -136.88 126.64 25.56 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.741 0.782 . . . . 0.0 109.135 -174.973 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.494 ' HA ' ' HA ' ' A' ' 32' ' ' GLU . 3.3 tt -136.05 151.97 50.41 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 113.653 -1.612 . . . . 0.0 108.195 -177.613 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 31.5 t80 -132.89 140.26 47.8 Favored 'General case' 0 C--O 1.235 0.309 0 C-N-CA 124.154 0.982 . . . . 0.0 108.491 171.405 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 25.3 m-85 -102.7 99.53 13.74 Favored Pre-proline 0 CA--C 1.547 0.833 0 C-N-CA 122.933 0.493 . . . . 0.0 109.687 174.654 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_endo . . . . . 0 C--N 1.368 1.603 0 C-N-CA 122.765 2.31 . . . . 0.0 111.705 173.942 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 CA--C 1.557 1.235 0 CA-C-O 121.325 0.583 . . . . 0.0 111.631 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 87.5 t -82.1 144.66 9.91 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.77 0 C-N-CA 124.848 1.259 . . . . 0.0 110.353 -179.104 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 60.7 t -126.82 129.16 71.41 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.068 0 C-N-CA 124.325 1.05 . . . . 0.0 109.333 177.545 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.404 ' CZ ' ' HD3' ' A' ' 41' ' ' LYS . 31.2 m-85 -105.84 114.98 29.46 Favored 'General case' 0 N--CA 1.477 0.879 0 N-CA-C 108.752 -0.832 . . . . 0.0 108.752 170.622 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 6.9 t -80.14 133.91 28.61 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 C-N-CA 123.073 0.549 . . . . 0.0 109.764 178.11 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -85.94 155.57 58.25 Favored Pre-proline 0 CA--C 1.542 0.64 0 CA-C-N 115.166 -0.925 . . . . 0.0 111.4 -176.337 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -69.79 7.49 0.99 Allowed 'Trans proline' 0 N--CA 1.504 2.131 0 C-N-CA 123.258 2.639 . . . . 0.0 114.702 -179.016 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.524 HG23 ' H ' ' A' ' 64' ' ' GLU . 9.0 t -128.93 -7.1 4.97 Favored 'General case' 0 N--CA 1.484 1.26 0 C-N-CA 123.484 0.714 . . . . 0.0 111.263 -176.478 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 95.57 -11.03 68.82 Favored Glycine 0 C--N 1.351 1.382 0 CA-C-O 119.572 -0.571 . . . . 0.0 114.497 -176.687 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.524 ' H ' HG23 ' A' ' 62' ' ' THR . 44.3 tt0 -79.76 73.22 6.5 Favored 'General case' 0 N--CA 1.483 1.204 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 172.932 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -69.73 158.04 36.16 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-N 114.823 -1.08 . . . . 0.0 111.568 -171.298 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.435 HD12 ' HB3' ' A' ' 71' ' ' GLN . 44.7 mm -113.95 120.31 63.41 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 CA-C-N 115.157 -0.929 . . . . 0.0 109.757 -173.741 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 77.4 p -93.06 -24.33 18.34 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 123.691 0.797 . . . . 0.0 111.762 -177.147 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 8.9 p30 -141.23 157.8 44.75 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 122.775 0.43 . . . . 0.0 111.325 -175.42 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 70.1 ttt180 -62.92 -27.33 69.3 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 124.524 1.13 . . . . 0.0 112.562 -173.391 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 6.5 tmtm? -65.51 -50.37 65.52 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 123.316 0.646 . . . . 0.0 109.298 176.483 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.435 ' HB3' HD12 ' A' ' 66' ' ' ILE . 46.9 mt-30 -55.82 -31.37 62.63 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 123.942 0.897 . . . . 0.0 111.562 179.463 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.429 ' O ' ' HG ' ' A' ' 76' ' ' LEU . 0.2 OUTLIER -64.7 -51.77 60.72 Favored 'General case' 0 CA--C 1.551 1.017 0 O-C-N 123.613 0.571 . . . . 0.0 109.722 178.801 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -59.99 -50.4 73.88 Favored 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 122.859 0.464 . . . . 0.0 111.504 -178.116 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.2 -25.54 66.18 Favored 'General case' 0 CA--C 1.543 0.694 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.385 -177.033 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 22.1 t80 -65.64 -49.51 68.4 Favored 'General case' 0 C--N 1.351 0.662 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 171.794 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.429 ' HG ' ' O ' ' A' ' 72' ' ' LEU . 80.2 mt -66.42 -39.4 88.94 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 123.135 0.574 . . . . 0.0 112.404 -172.24 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.02 -24.3 61.53 Favored 'General case' 0 N--CA 1.481 1.117 0 CA-C-O 120.817 0.342 . . . . 0.0 110.753 178.094 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 43.8 t -85.21 -27.57 26.01 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 123.409 0.684 . . . . 0.0 111.131 175.536 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 59.9 m80 -132.61 88.48 38.51 Favored Pre-proline 0 N--CA 1.475 0.781 0 C-N-CA 123.694 0.798 . . . . 0.0 109.511 -172.44 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -70.02 160.17 50.6 Favored 'Trans proline' 0 C--N 1.373 1.856 0 C-N-CA 122.468 2.112 . . . . 0.0 111.341 177.011 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 95.46 -32.78 5.95 Favored Glycine 0 CA--C 1.532 1.119 0 N-CA-C 112.353 -0.299 . . . . 0.0 112.353 -176.799 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 32.2 m-80 -65.49 143.72 98.75 Favored Pre-proline 0 CA--C 1.551 0.998 0 C-N-CA 123.593 0.757 . . . . 0.0 110.698 176.66 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . 0.418 ' HB2' ' CE2' ' A' ' 88' ' ' PHE . 42.5 Cg_exo -53.98 157.12 11.22 Favored 'Trans proline' 0 C--N 1.375 1.944 0 C-N-CA 123.809 3.006 . . . . 0.0 113.587 -179.008 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -68.78 152.37 45.41 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 123.983 0.913 . . . . 0.0 111.412 -177.603 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.413 HD12 ' HB3' ' A' ' 72' ' ' LEU . 12.8 tt -75.11 -21.61 16.63 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.17 0 CA-C-O 120.744 0.307 . . . . 0.0 110.288 175.08 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -58.85 -40.07 83.2 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 124.246 1.018 . . . . 0.0 112.078 178.011 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -84.48 -8.89 58.79 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 123.474 0.71 . . . . 0.0 111.587 179.583 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . 0.418 ' CE2' ' HB2' ' A' ' 83' ' ' PRO . 4.4 m-30 -84.45 112.93 20.81 Favored 'General case' 0 N--CA 1.476 0.835 0 CA-C-O 121.652 0.739 . . . . 0.0 109.778 177.483 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 19.4 p-10 -93.12 88.52 6.11 Favored 'General case' 0 CA--C 1.543 0.703 0 CA-C-N 114.451 -1.25 . . . . 0.0 111.191 -171.166 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 76.0 m95 -76.23 -21.89 55.84 Favored 'General case' 0 N--CA 1.485 1.309 0 CA-C-N 115.441 -0.799 . . . . 0.0 110.51 173.406 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 10.7 t . . . . . 0 CA--C 1.556 1.209 0 C-N-CA 125.652 1.581 . . . . 0.0 111.775 -178.761 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 14.9 m . . . . . 0 N--CA 1.475 0.821 0 CA-C-O 121.703 0.763 . . . . 0.0 111.347 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 3.8 p -144.44 118.12 9.22 Favored 'General case' 0 C--O 1.239 0.515 0 C-N-CA 124.305 1.042 . . . . 0.0 109.304 -179.507 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 90.4 t -101.65 130.98 50.43 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.483 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 179.268 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -81.89 107.17 14.39 Favored 'General case' 0 C--O 1.238 0.474 0 C-N-CA 123.09 0.556 . . . . 0.0 109.873 175.084 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.541 HD23 ' HB3' ' A' ' 43' ' ' PHE . 4.3 mm? -83.31 161.06 58.27 Favored Pre-proline 0 CA--C 1.553 1.064 0 C-N-CA 124.324 1.049 . . . . 0.0 109.742 -179.836 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -53.37 136.46 63.15 Favored 'Trans proline' 0 C--N 1.388 2.645 0 C-N-CA 122.988 2.459 . . . . 0.0 113.178 -179.149 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -121.18 163.39 30.31 Favored Pre-proline 0 N--CA 1.481 1.086 0 C-N-CA 124.361 1.065 . . . . 0.0 112.961 -164.142 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.623 ' HG2' ' HB2' ' A' ' 39' ' ' TRP . 40.9 Cg_endo -67.72 156.96 63.94 Favored 'Trans proline' 0 C--N 1.381 2.27 0 C-N-CA 122.52 2.147 . . . . 0.0 110.587 161.324 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 55.2 p -62.36 -39.04 91.85 Favored 'General case' 0 N--CA 1.486 1.354 0 N-CA-C 113.874 1.064 . . . . 0.0 113.874 -166.725 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 15.0 p -89.21 -21.6 23.18 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 112.375 0.509 . . . . 0.0 112.375 -174.952 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' TRP . . . . . 0.623 ' HB2' ' HG2' ' A' ' 36' ' ' PRO . 16.3 m95 -109.97 174.37 5.89 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-O 121.758 0.79 . . . . 0.0 110.469 179.463 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.452 ' HB2' ' HB ' ' A' ' 59' ' ' VAL . 0.0 OUTLIER -117.54 158.14 25.09 Favored 'General case' 0 C--O 1.24 0.559 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 170.371 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.406 ' HD3' ' CZ ' ' A' ' 58' ' ' PHE . 16.8 tptm -130.33 122.14 27.34 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 124.445 1.098 . . . . 0.0 108.133 -176.862 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.498 HD22 ' HB ' ' A' ' 57' ' ' VAL . 4.7 tt -125.19 150.31 47.1 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 124.743 1.217 . . . . 0.0 108.668 177.443 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.541 ' HB3' HD23 ' A' ' 33' ' ' LEU . 36.2 t80 -136.78 145.33 44.42 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 125.053 1.341 . . . . 0.0 108.347 174.064 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 16.4 m-85 -102.14 96.75 7.35 Favored Pre-proline 0 CA--C 1.555 1.17 0 C-N-CA 123.113 0.565 . . . . 0.0 110.114 174.33 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo . . . . . 0 C--N 1.374 1.906 0 C-N-CA 122.734 2.289 . . . . 0.0 111.806 175.437 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 . . . . . 0 CA--C 1.552 1.049 0 CA-C-O 121.419 0.628 . . . . 0.0 111.168 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 48.9 t -81.33 138.67 19.21 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.661 0 C-N-CA 124.145 0.978 . . . . 0.0 110.435 -176.723 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.498 ' HB ' HD22 ' A' ' 42' ' ' LEU . 87.2 t -123.5 115.82 46.5 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.952 0 C-N-CA 124.738 1.215 . . . . 0.0 108.512 176.213 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.406 ' CZ ' ' HD3' ' A' ' 41' ' ' LYS . 15.9 m-85 -91.99 118.39 30.73 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 123.465 0.706 . . . . 0.0 109.873 177.227 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.452 ' HB ' ' HB2' ' A' ' 40' ' ' LYS . 3.3 t -80.2 131.17 34.71 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 C-N-CA 123.439 0.696 . . . . 0.0 110.712 179.914 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -88.35 158.95 48.36 Favored Pre-proline 0 N--CA 1.476 0.834 0 C-N-CA 124.276 1.031 . . . . 0.0 111.677 -173.905 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -68.29 -19.18 44.33 Favored 'Trans proline' 0 C--N 1.38 2.223 0 C-N-CA 122.878 2.386 . . . . 0.0 113.191 178.305 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.565 HG23 ' H ' ' A' ' 64' ' ' GLU . 14.8 t -88.09 -11.31 47.47 Favored 'General case' 0 CA--C 1.55 0.957 0 C-N-CA 123.327 0.651 . . . . 0.0 111.198 175.934 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 96.36 -25.64 25.03 Favored Glycine 0 C--N 1.355 1.605 0 C-N-CA 122.601 0.143 . . . . 0.0 113.206 -177.609 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.565 ' H ' HG23 ' A' ' 62' ' ' THR . 37.7 tt0 -72.74 83.94 1.18 Allowed 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 124.08 0.952 . . . . 0.0 109.717 174.326 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.43 159.14 24.92 Favored 'General case' 0 N--CA 1.473 0.707 0 CA-C-N 114.878 -1.055 . . . . 0.0 112.072 -177.027 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.463 HG23 ' HB2' ' A' ' 71' ' ' GLN . 35.1 mm -102.44 127.53 55.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 C-N-CA 125.33 1.452 . . . . 0.0 109.08 177.522 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 29.9 m -97.59 -30.03 13.09 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 122.774 0.43 . . . . 0.0 111.504 -174.5 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 2.8 p-10 -135.08 159.43 41.54 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 123.038 0.535 . . . . 0.0 110.47 -179.068 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 32.3 ttm180 -64.79 -30.43 71.43 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 124.271 1.028 . . . . 0.0 113.155 -168.45 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 6.2 tmtm? -63.73 -47.73 79.89 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 123.384 0.674 . . . . 0.0 109.449 176.341 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.463 ' HB2' HG23 ' A' ' 66' ' ' ILE . 68.0 mt-30 -55.27 -32.76 62.62 Favored 'General case' 0 N--CA 1.49 1.547 0 C-N-CA 123.679 0.792 . . . . 0.0 111.598 179.341 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.475 ' O ' ' HG ' ' A' ' 76' ' ' LEU . 0.4 OUTLIER -61.22 -52.94 62.68 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 123.125 0.57 . . . . 0.0 109.56 -179.276 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -67.85 -42.91 80.64 Favored 'General case' 0 C--O 1.248 0.992 0 C-N-CA 123.781 0.832 . . . . 0.0 111.691 -174.372 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.36 -22.65 61.87 Favored 'General case' 0 N--CA 1.478 0.971 0 CA-C-N 116.779 -0.192 . . . . 0.0 111.094 179.263 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 39.7 t80 -70.36 -42.83 71.3 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 122.969 0.508 . . . . 0.0 109.822 172.214 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.475 ' HG ' ' O ' ' A' ' 72' ' ' LEU . 80.1 mt -64.19 -33.83 76.7 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 123.166 0.586 . . . . 0.0 111.739 -175.991 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 14.3 ptpt -79.98 -32.61 39.79 Favored 'General case' 0 N--CA 1.482 1.171 0 N-CA-C 111.607 0.225 . . . . 0.0 111.607 175.06 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 40.9 t -71.28 -29.91 65.64 Favored 'General case' 0 N--CA 1.485 1.302 0 CA-C-O 121.427 0.632 . . . . 0.0 110.955 178.737 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 42.1 m80 -143.01 86.08 9.47 Favored Pre-proline 0 C--O 1.24 0.563 0 C-N-CA 124.677 1.191 . . . . 0.0 108.423 -178.267 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -67.58 163.01 36.66 Favored 'Trans proline' 0 C--N 1.378 2.09 0 C-N-CA 122.652 2.235 . . . . 0.0 111.704 173.516 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 101.82 -31.21 8.95 Favored Glycine 0 C--N 1.342 0.889 0 N-CA-C 111.283 -0.727 . . . . 0.0 111.283 -173.658 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 37.0 m-80 -66.79 144.52 98.62 Favored Pre-proline 0 CA--C 1.553 1.08 0 C-N-CA 123.535 0.734 . . . . 0.0 110.606 174.464 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -63.77 154.25 70.64 Favored 'Trans proline' 0 C--N 1.373 1.862 0 C-N-CA 123.067 2.511 . . . . 0.0 112.984 -176.097 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.49 ' O ' ' HG2' ' A' ' 87' ' ' GLU . . . -71.02 146.41 49.38 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 114.6 -1.182 . . . . 0.0 111.396 -174.745 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 17.1 tt -64.81 -14.41 16.24 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.258 0 C-N-CA 123.637 0.775 . . . . 0.0 111.739 -179.274 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -53.76 -40.26 66.05 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 124.205 1.002 . . . . 0.0 112.576 175.325 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.49 ' HG2' ' O ' ' A' ' 84' ' ' ALA . 10.6 pt-20 -86.32 -17.81 33.59 Favored 'General case' 0 N--CA 1.486 1.35 0 C-N-CA 123.306 0.643 . . . . 0.0 111.429 178.619 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -77.31 109.04 10.88 Favored 'General case' 0 N--CA 1.478 0.959 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 177.92 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -94.83 121.01 35.98 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-O 121.311 0.577 . . . . 0.0 109.725 -177.71 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 49.6 m95 -103.38 -3.7 25.14 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 123.857 0.863 . . . . 0.0 109.446 174.981 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 14.8 t . . . . . 0 CA--C 1.55 0.976 0 C-N-CA 125.118 1.367 . . . . 0.0 112.14 -176.041 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 27.1 m . . . . . 0 CA--C 1.542 0.642 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 39.2 p -157.33 118.65 3.65 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 123.943 0.897 . . . . 0.0 108.891 -177.929 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 48.1 t -106.06 125.71 61.61 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 C-N-CA 123.879 0.872 . . . . 0.0 109.056 -177.514 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.461 ' HA ' ' HA ' ' A' ' 42' ' ' LEU . 45.6 mt-10 -79.66 101.54 8.43 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 123.068 0.547 . . . . 0.0 110.092 178.942 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -81.21 152.77 71.33 Favored Pre-proline 0 CA--C 1.559 1.298 0 C-N-CA 124.379 1.071 . . . . 0.0 110.773 -176.178 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -62.84 137.74 64.7 Favored 'Trans proline' 0 C--N 1.384 2.401 0 C-N-CA 123.073 2.515 . . . . 0.0 114.085 -177.718 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -146.07 169.98 8.71 Favored Pre-proline 0 CA--C 1.557 1.218 0 C-N-CA 124.276 1.03 . . . . 0.0 108.933 -178.541 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -51.25 145.26 27.45 Favored 'Trans proline' 0 C--N 1.392 2.848 0 C-N-CA 122.691 2.26 . . . . 0.0 112.168 173.894 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 49.2 m -64.01 -20.04 65.62 Favored 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 113.164 0.802 . . . . 0.0 113.164 -171.717 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 33.4 m -72.23 -40.23 67.93 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 123.197 0.599 . . . . 0.0 110.16 174.581 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 25.6 m95 -104.83 -168.3 1.46 Allowed 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 123.958 0.903 . . . . 0.0 110.038 179.449 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.525 ' HB3' ' HB ' ' A' ' 59' ' ' VAL . 40.7 ttmt -156.41 170.78 21.51 Favored 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 106.565 -1.643 . . . . 0.0 106.565 171.584 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.716 ' HD2' HG11 ' A' ' 56' ' ' VAL . 21.3 pttm -151.34 154.06 35.97 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-O 121.845 0.831 . . . . 0.0 110.904 171.434 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.461 ' HA ' ' HA ' ' A' ' 32' ' ' GLU . 0.8 OUTLIER -127.0 130.76 50.66 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 113.348 -1.751 . . . . 0.0 107.726 178.433 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 28.7 t80 -101.39 141.04 34.85 Favored 'General case' 0 CA--C 1.542 0.647 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 170.728 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . 0.403 ' CE1' HD21 ' A' ' 42' ' ' LEU . 11.6 m-85 -99.37 100.14 9.86 Favored Pre-proline 0 N--CA 1.481 1.111 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 171.487 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo . . . . . 0 C--N 1.365 1.413 0 C-N-CA 122.411 2.074 . . . . 0.0 112.43 175.489 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 . . . . . 0 CA--C 1.549 0.905 0 CA-C-O 122.11 0.957 . . . . 0.0 112.133 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.716 HG11 ' HD2' ' A' ' 41' ' ' LYS . 51.0 t -82.35 147.42 6.04 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.771 0 CA-C-N 114.799 -1.091 . . . . 0.0 111.376 -168.896 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 65.8 t -124.52 116.5 47.73 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.693 0 C-N-CA 125.074 1.35 . . . . 0.0 107.681 175.276 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 36.7 m-85 -87.25 123.77 32.61 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 123.486 0.714 . . . . 0.0 110.982 -179.146 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.525 ' HB ' ' HB3' ' A' ' 40' ' ' LYS . 6.8 t -81.16 130.28 36.12 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.411 0 C-N-CA 123.677 0.791 . . . . 0.0 110.141 175.534 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -85.59 157.21 58.5 Favored Pre-proline 0 N--CA 1.475 0.794 0 O-C-N 124.157 0.911 . . . . 0.0 111.211 -178.618 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -63.7 -22.49 69.82 Favored 'Trans proline' 0 C--N 1.382 2.314 0 C-N-CA 122.934 2.423 . . . . 0.0 112.703 176.491 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.626 HG23 ' H ' ' A' ' 64' ' ' GLU . 12.1 t -91.53 -12.17 35.25 Favored 'General case' 0 CA--C 1.549 0.924 0 C-N-CA 123.822 0.849 . . . . 0.0 111.181 178.957 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 95.23 -11.73 68.81 Favored Glycine 0 C--N 1.349 1.283 0 CA-C-O 119.769 -0.462 . . . . 0.0 113.559 -177.591 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.626 ' H ' HG23 ' A' ' 62' ' ' THR . 36.4 tt0 -77.97 78.14 4.47 Favored 'General case' 0 N--CA 1.481 1.121 0 CA-C-N 117.576 0.688 . . . . 0.0 109.341 174.334 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -67.96 139.22 56.38 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-N 115.119 -0.946 . . . . 0.0 111.028 -174.075 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 36.8 mm -94.77 130.92 42.92 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.663 0 C-N-CA 124.484 1.114 . . . . 0.0 109.883 -179.927 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 6.0 p -96.59 -11.65 25.06 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 123.784 0.834 . . . . 0.0 112.414 -175.375 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 11.1 p-10 -153.53 151.32 29.67 Favored 'General case' 0 N--CA 1.48 1.052 0 N-CA-C 111.941 0.349 . . . . 0.0 111.941 -168.044 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 30.1 ttm180 -59.06 -39.55 82.42 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 124.759 1.224 . . . . 0.0 112.817 -168.582 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 4.3 tmtm? -59.71 -54.4 46.79 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 123.419 0.688 . . . . 0.0 109.923 -177.743 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.425 ' HA ' ' HG3' ' A' ' 74' ' ' GLN . 87.4 mm-40 -66.2 -22.32 66.34 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-N 115.032 -0.985 . . . . 0.0 111.309 -175.674 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.495 ' O ' ' HG ' ' A' ' 76' ' ' LEU . 0.8 OUTLIER -66.47 -56.36 11.3 Favored 'General case' 0 CA--C 1.544 0.742 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 174.318 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -57.41 -50.24 73.62 Favored 'General case' 0 N--CA 1.486 1.355 0 C-N-CA 124.404 1.082 . . . . 0.0 111.473 -176.314 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . 0.425 ' HG3' ' HA ' ' A' ' 71' ' ' GLN . 0.0 OUTLIER -70.31 -25.04 63.13 Favored 'General case' 0 CA--C 1.545 0.768 0 CA-C-N 115.4 -0.818 . . . . 0.0 111.608 -177.903 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 45.5 t80 -66.44 -45.99 77.96 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 122.75 0.42 . . . . 0.0 109.907 174.503 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.495 ' HG ' ' O ' ' A' ' 72' ' ' LEU . 52.4 mt -62.58 -45.23 93.86 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 123.033 0.533 . . . . 0.0 110.913 -175.36 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.11 -24.16 59.41 Favored 'General case' 0 CA--C 1.551 0.983 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.589 -179.835 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 46.3 t -78.19 -27.68 47.95 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 122.857 0.463 . . . . 0.0 110.806 174.949 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 59.0 m80 -127.4 84.89 62.22 Favored Pre-proline 0 N--CA 1.472 0.671 0 C-N-CA 123.401 0.681 . . . . 0.0 109.751 -175.435 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -62.8 122.18 10.38 Favored 'Trans proline' 0 C--N 1.372 1.788 0 C-N-CA 122.953 2.435 . . . . 0.0 111.709 177.431 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 133.23 -30.56 3.02 Favored Glycine 0 C--N 1.342 0.888 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.795 -174.042 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 40.2 m-80 -72.5 137.13 80.73 Favored Pre-proline 0 N--CA 1.476 0.864 0 C-N-CA 123.468 0.707 . . . . 0.0 110.456 177.109 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -62.88 154.25 67.67 Favored 'Trans proline' 0 C--N 1.375 1.971 0 C-N-CA 123.111 2.541 . . . . 0.0 112.777 -179.138 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.498 ' O ' ' HG2' ' A' ' 87' ' ' GLU . . . -73.96 148.07 42.46 Favored 'General case' 0 N--CA 1.476 0.842 0 CA-C-N 115.313 -0.858 . . . . 0.0 111.866 -173.674 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 17.3 tt -65.44 -11.72 12.5 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.194 0 C-N-CA 124.087 0.955 . . . . 0.0 112.366 -176.629 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -57.23 -38.66 74.13 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 123.678 0.791 . . . . 0.0 112.08 174.044 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.498 ' HG2' ' O ' ' A' ' 84' ' ' ALA . 12.6 pt-20 -90.81 -3.98 56.98 Favored 'General case' 0 N--CA 1.487 1.414 0 C-N-CA 123.14 0.576 . . . . 0.0 111.769 178.31 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -87.81 107.82 18.85 Favored 'General case' 0 N--CA 1.477 0.911 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 176.709 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 14.5 p-10 -93.48 88.0 5.76 Favored 'General case' 0 CA--C 1.547 0.842 0 CA-C-O 122.21 1.005 . . . . 0.0 111.174 -172.405 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 82.2 m95 -69.25 -26.15 64.63 Favored 'General case' 0 N--CA 1.481 1.111 0 CA-C-N 115.064 -0.971 . . . . 0.0 110.202 170.216 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 12.5 t . . . . . 0 CA--C 1.556 1.184 0 C-N-CA 125.196 1.398 . . . . 0.0 112.64 -175.443 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 13.8 m . . . . . 0 N--CA 1.472 0.656 0 CA-C-O 120.566 0.222 . . . . 0.0 110.686 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 54.7 p -142.82 114.06 7.79 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 123.53 0.732 . . . . 0.0 109.5 178.604 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 62.1 t -101.85 127.81 54.95 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 C-N-CA 124.16 0.984 . . . . 0.0 108.959 179.565 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 53.3 mt-10 -83.02 106.79 15.13 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-O 121.011 0.434 . . . . 0.0 109.987 178.517 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.479 HD23 ' HB3' ' A' ' 43' ' ' PHE . 3.6 mm? -82.7 164.26 47.84 Favored Pre-proline 0 CA--C 1.559 1.325 0 C-N-CA 124.619 1.167 . . . . 0.0 109.877 178.938 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -49.89 143.42 23.75 Favored 'Trans proline' 0 C--N 1.393 2.891 0 C-N-CA 123.334 2.689 . . . . 0.0 114.097 -175.914 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -146.03 155.49 51.24 Favored Pre-proline 0 CA--C 1.542 0.673 0 C-N-CA 123.633 0.773 . . . . 0.0 111.255 -167.396 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_exo -58.51 149.82 72.71 Favored 'Trans proline' 0 C--N 1.381 2.255 0 C-N-CA 123.158 2.572 . . . . 0.0 110.598 163.525 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 20.7 p -58.66 -42.66 88.92 Favored 'General case' 0 CA--C 1.551 1.019 0 C-N-CA 123.72 0.808 . . . . 0.0 111.914 -176.241 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 26.6 t -67.49 -33.65 75.54 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 123.768 0.827 . . . . 0.0 111.452 -179.966 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 21.7 m95 -105.45 -176.12 2.99 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 123.469 0.707 . . . . 0.0 111.211 -177.095 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 45.3 mtmt -137.98 149.16 45.87 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 114.926 -1.034 . . . . 0.0 108.51 162.881 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.737 ' HZ3' ' HB2' ' A' ' 43' ' ' PHE . 19.6 tptp -117.13 121.12 40.37 Favored 'General case' 0 N--CA 1.464 0.265 0 C-N-CA 124.899 1.28 . . . . 0.0 107.552 178.487 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.49 HD22 ' HB ' ' A' ' 57' ' ' VAL . 5.7 tt -119.19 143.92 46.98 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 124.171 0.988 . . . . 0.0 108.968 177.932 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.737 ' HB2' ' HZ3' ' A' ' 41' ' ' LYS . 24.3 t80 -130.63 128.14 40.37 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 125.293 1.437 . . . . 0.0 107.822 174.881 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 24.8 m-85 -86.63 111.55 40.47 Favored Pre-proline 0 CA--C 1.55 0.979 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 169.456 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo . . . . . 0 C--N 1.372 1.769 0 C-N-CA 122.427 2.085 . . . . 0.0 111.034 165.724 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 CA--C 1.557 1.232 0 CA-C-O 121.226 0.536 . . . . 0.0 111.524 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 37.5 t -80.51 130.87 35.25 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.625 0 C-N-CA 123.917 0.887 . . . . 0.0 110.038 -179.581 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.49 ' HB ' HD22 ' A' ' 42' ' ' LEU . 38.3 t -122.92 120.7 61.34 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.695 0 C-N-CA 123.525 0.73 . . . . 0.0 109.503 179.589 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.48 ' CZ ' ' HD3' ' A' ' 41' ' ' LYS . 27.0 m-85 -92.87 118.38 31.06 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 123.231 0.612 . . . . 0.0 109.947 174.1 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 2.0 t -78.43 123.82 35.87 Favored 'Isoleucine or valine' 0 C--O 1.239 0.509 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 177.049 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.485 ' HB3' ' H ' ' A' ' 64' ' ' GLU . . . -88.72 147.4 39.2 Favored Pre-proline 0 CA--C 1.544 0.734 0 CA-C-N 114.796 -1.093 . . . . 0.0 111.087 -175.478 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_endo -61.9 -30.69 84.19 Favored 'Trans proline' 0 C--N 1.369 1.636 0 C-N-CA 123.871 3.047 . . . . 0.0 114.064 -179.437 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 5.7 t -87.05 -1.46 57.9 Favored 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 122.242 0.217 . . . . 0.0 111.013 179.328 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 77.97 61.72 2.48 Favored Glycine 0 C--N 1.353 1.516 0 N-CA-C 112.011 -0.436 . . . . 0.0 112.011 -177.072 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.485 ' H ' ' HB3' ' A' ' 60' ' ' ALA . 40.8 tt0 -151.02 70.65 0.99 Allowed 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 107.999 -1.112 . . . . 0.0 107.999 179.318 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -65.4 158.15 27.43 Favored 'General case' 0 CA--C 1.544 0.74 0 CA-C-N 115.203 -0.908 . . . . 0.0 112.237 -171.885 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.584 HG23 ' HB2' ' A' ' 71' ' ' GLN . 44.4 mm -121.8 110.12 26.56 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 CA-C-N 115.169 -0.923 . . . . 0.0 110.484 -163.21 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 11.1 p -83.94 -17.08 41.85 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 123.249 0.62 . . . . 0.0 112.265 178.954 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 2.2 p-10 -157.26 152.52 26.19 Favored 'General case' 0 N--CA 1.476 0.854 0 N-CA-C 111.779 0.289 . . . . 0.0 111.779 -174.943 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 85.2 mtt180 -55.43 -31.76 62.15 Favored 'General case' 0 N--CA 1.493 1.686 0 C-N-CA 124.743 1.217 . . . . 0.0 114.215 -169.784 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 1.8 tmtp? -54.88 -53.92 49.18 Favored 'General case' 0 N--CA 1.486 1.371 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 177.861 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.584 ' HB2' HG23 ' A' ' 66' ' ' ILE . 84.3 mt-30 -61.68 -34.27 75.45 Favored 'General case' 0 N--CA 1.475 0.797 0 CA-C-N 114.741 -1.118 . . . . 0.0 111.126 -177.239 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.446 HD22 HG13 ' A' ' 66' ' ' ILE . 0.6 OUTLIER -60.74 -53.3 59.02 Favored 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 123.65 0.78 . . . . 0.0 109.755 179.153 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -68.41 -49.52 59.42 Favored 'General case' 0 C--O 1.238 0.491 0 CA-C-N 114.976 -1.011 . . . . 0.0 111.326 -172.782 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -63.5 -24.2 67.72 Favored 'General case' 0 C--N 1.356 0.865 0 O-C-N 123.635 0.584 . . . . 0.0 110.935 178.981 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 36.8 t80 -67.29 -50.62 59.59 Favored 'General case' 0 C--N 1.356 0.849 0 C-N-CA 123.224 0.61 . . . . 0.0 109.488 173.058 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.463 HD13 ' HA ' ' A' ' 84' ' ' ALA . 85.0 mt -61.84 -45.22 94.74 Favored 'General case' 0 N--CA 1.487 1.401 0 C-N-CA 123.337 0.655 . . . . 0.0 111.243 -174.4 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.06 -7.23 56.66 Favored 'General case' 0 CA--C 1.555 1.166 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.972 179.229 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 43.4 t -96.42 -22.99 16.81 Favored 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 123.744 0.818 . . . . 0.0 111.039 168.535 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 74.4 m80 -132.56 95.73 19.87 Favored Pre-proline 0 N--CA 1.476 0.871 0 C-N-CA 124.053 0.941 . . . . 0.0 109.43 -172.387 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -75.18 153.07 40.66 Favored 'Trans proline' 0 C--N 1.37 1.687 0 C-N-CA 122.382 2.055 . . . . 0.0 111.857 177.442 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 87.95 7.32 74.36 Favored Glycine 0 C--N 1.345 1.074 0 CA-C-N 115.975 -0.557 . . . . 0.0 112.686 -174.426 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 25.2 m-80 -103.69 127.33 29.71 Favored Pre-proline 0 N--CA 1.479 0.982 0 C-N-CA 123.801 0.84 . . . . 0.0 110.026 177.447 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -54.45 143.53 66.26 Favored 'Trans proline' 0 C--N 1.38 2.197 0 C-N-CA 123.606 2.871 . . . . 0.0 113.13 -178.058 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.463 ' HA ' HD13 ' A' ' 76' ' ' LEU . . . -71.16 159.1 35.28 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 123.649 0.78 . . . . 0.0 112.206 -172.283 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.431 ' HB ' HD12 ' A' ' 72' ' ' LEU . 15.1 tt -67.64 -16.21 20.76 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.218 0 C-N-CA 123.698 0.799 . . . . 0.0 111.385 -179.536 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -61.02 -29.91 69.99 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 124.351 1.061 . . . . 0.0 112.937 179.229 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.429 ' HG3' ' HD2' ' A' ' 88' ' ' PHE . 10.0 pt-20 -97.57 -8.05 29.9 Favored 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 122.728 0.411 . . . . 0.0 111.327 177.271 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . 0.429 ' HD2' ' HG3' ' A' ' 87' ' ' GLU . 4.3 m-30 -85.23 116.38 23.55 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 123.423 0.689 . . . . 0.0 110.344 -176.471 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -94.37 124.79 38.61 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 123.114 0.566 . . . . 0.0 110.97 -174.721 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 52.3 m95 -110.36 -20.68 12.53 Favored 'General case' 0 CA--C 1.551 0.989 0 C-N-CA 124.451 1.101 . . . . 0.0 109.632 176.889 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 11.3 t . . . . . 0 N--CA 1.489 1.507 0 C-N-CA 123.767 0.827 . . . . 0.0 112.298 -172.501 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 16.7 m . . . . . 0 N--CA 1.478 0.967 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 23.7 p -162.68 118.15 1.84 Allowed 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 122.915 0.486 . . . . 0.0 110.7 -171.685 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 63.1 t -105.77 133.4 50.23 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 C-N-CA 124.372 1.069 . . . . 0.0 108.533 176.835 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -83.37 113.49 20.77 Favored 'General case' 0 CA--C 1.539 0.523 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 176.148 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.543 HD23 ' HB3' ' A' ' 43' ' ' PHE . 3.8 mm? -89.88 165.13 25.9 Favored Pre-proline 0 CA--C 1.556 1.208 0 C-N-CA 124.337 1.055 . . . . 0.0 110.088 -179.797 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -56.72 142.74 91.48 Favored 'Trans proline' 0 C--N 1.394 2.941 0 C-N-CA 122.92 2.414 . . . . 0.0 113.113 179.192 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.523 ' HB2' ' HB3' ' A' ' 41' ' ' LYS . . . -136.24 166.04 31.0 Favored Pre-proline 0 CA--C 1.539 0.537 0 C-N-CA 124.216 1.007 . . . . 0.0 111.098 -169.091 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 81.5 Cg_exo -52.58 164.32 1.48 Allowed 'Trans proline' 0 C--N 1.376 2.011 0 C-N-CA 123.161 2.574 . . . . 0.0 112.538 160.8 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 66.0 p -63.95 -39.92 95.26 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 123.535 0.734 . . . . 0.0 111.748 -176.251 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 22.0 m -82.1 -37.8 25.78 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 123.641 0.776 . . . . 0.0 111.554 -177.612 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 45.0 m95 -97.17 158.12 15.6 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 123.369 0.668 . . . . 0.0 111.059 -173.389 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.54 ' HB2' ' HB ' ' A' ' 59' ' ' VAL . 0.1 OUTLIER -111.86 152.63 27.72 Favored 'General case' 0 C--O 1.236 0.352 0 N-CA-C 107.906 -1.146 . . . . 0.0 107.906 168.632 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.523 ' HB3' ' HB2' ' A' ' 35' ' ' ALA . 17.1 tptm -126.74 119.13 26.17 Favored 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 -175.309 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 4.8 tt -115.1 144.91 42.92 Favored 'General case' 0 C--N 1.322 -0.599 0 C-N-CA 124.726 1.21 . . . . 0.0 108.638 174.322 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.543 ' HB3' HD23 ' A' ' 33' ' ' LEU . 27.6 t80 -131.21 128.75 40.59 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 125.31 1.444 . . . . 0.0 108.436 174.975 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 39.0 m-85 -87.74 105.46 8.95 Favored Pre-proline 0 CA--C 1.554 1.132 0 N-CA-C 108.782 -0.822 . . . . 0.0 108.782 170.649 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo . . . . . 0 C--N 1.37 1.684 0 C-N-CA 122.735 2.29 . . . . 0.0 112.173 173.28 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.482 1.137 0 N-CA-C 112.9 0.704 . . . . 0.0 112.9 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 64.9 t -82.86 140.82 15.78 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.847 0 C-N-CA 124.455 1.102 . . . . 0.0 111.519 -170.648 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 63.2 t -122.23 128.61 75.56 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.9 0 C-N-CA 124.052 0.941 . . . . 0.0 108.97 176.819 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 13.3 m-85 -102.05 123.02 45.22 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 123.282 0.633 . . . . 0.0 109.563 171.583 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.54 ' HB ' ' HB2' ' A' ' 40' ' ' LYS . 2.3 t -79.58 129.47 37.51 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.611 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 174.456 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -83.85 154.61 64.67 Favored Pre-proline 0 CA--C 1.539 0.556 0 CA-C-N 114.901 -1.045 . . . . 0.0 111.446 -176.368 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -62.14 -22.86 74.92 Favored 'Trans proline' 0 C--N 1.379 2.164 0 C-N-CA 123.153 2.568 . . . . 0.0 113.447 177.251 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.423 HG22 ' OH ' ' A' ' 75' ' ' TYR . 12.1 t -99.86 -7.23 25.59 Favored 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 123.027 0.531 . . . . 0.0 111.86 177.798 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 94.16 -4.17 70.54 Favored Glycine 0 CA--C 1.531 1.043 0 CA-C-O 119.849 -0.417 . . . . 0.0 113.859 -179.386 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.407 ' H ' HG23 ' A' ' 62' ' ' THR . 36.2 tt0 -78.97 75.76 5.47 Favored 'General case' 0 N--CA 1.482 1.127 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 174.801 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -67.48 157.77 33.47 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-O 121.979 0.895 . . . . 0.0 111.596 -168.833 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.535 HG23 ' HB2' ' A' ' 71' ' ' GLN . 42.7 mm -116.61 120.15 64.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 C-N-CA 125.141 1.376 . . . . 0.0 108.876 -171.016 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 18.5 p -89.19 -19.94 24.82 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 123.315 0.646 . . . . 0.0 112.349 -176.665 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 2.0 p-10 -157.95 165.33 35.42 Favored 'General case' 0 N--CA 1.481 1.109 0 CA-C-O 120.968 0.413 . . . . 0.0 111.651 -174.919 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 20.3 ttm180 -57.51 -42.17 82.25 Favored 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 125.211 1.404 . . . . 0.0 113.101 -167.702 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 8.6 tmtm? -54.27 -49.92 68.45 Favored 'General case' 0 N--CA 1.487 1.378 0 C-N-CA 123.953 0.901 . . . . 0.0 110.527 -179.702 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.535 ' HB2' HG23 ' A' ' 66' ' ' ILE . 80.5 mt-30 -61.96 -32.74 73.2 Favored 'General case' 0 N--CA 1.475 0.802 0 CA-C-N 114.765 -1.107 . . . . 0.0 111.254 -179.136 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.417 ' O ' ' HG ' ' A' ' 76' ' ' LEU . 0.5 OUTLIER -65.82 -50.88 63.05 Favored 'General case' 0 CA--C 1.551 1.004 0 C-N-CA 123.466 0.707 . . . . 0.0 109.283 179.043 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -66.29 -43.98 84.81 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 124.155 0.982 . . . . 0.0 111.81 -174.705 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -68.24 -26.69 65.81 Favored 'General case' 0 N--CA 1.482 1.144 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.799 177.872 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . 0.423 ' OH ' HG22 ' A' ' 62' ' ' THR . 19.7 t80 -69.55 -47.09 64.83 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 123.374 0.67 . . . . 0.0 109.914 176.106 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.417 ' HG ' ' O ' ' A' ' 72' ' ' LEU . 74.8 mt -69.89 -28.43 65.62 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 113.03 0.752 . . . . 0.0 113.03 -172.631 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 66.0 pttt -75.51 -36.2 60.61 Favored 'General case' 0 N--CA 1.476 0.846 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 173.485 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 34.2 t -73.97 -20.36 60.37 Favored 'General case' 0 N--CA 1.485 1.292 0 C-N-CA 123.593 0.757 . . . . 0.0 111.125 176.206 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 58.3 m80 -137.25 76.14 44.83 Favored Pre-proline 0 CA--C 1.548 0.867 0 C-N-CA 124.394 1.077 . . . . 0.0 108.354 -177.29 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -67.64 -16.75 47.35 Favored 'Trans proline' 0 C--N 1.381 2.253 0 C-N-CA 123.032 2.488 . . . . 0.0 113.155 -178.269 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -70.84 -14.75 73.28 Favored Glycine 0 C--N 1.347 1.161 0 CA-C-N 116.046 -0.525 . . . . 0.0 112.928 175.108 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 16.1 m120 -94.29 146.08 30.9 Favored Pre-proline 0 CA--C 1.547 0.845 0 C-N-CA 123.959 0.904 . . . . 0.0 110.214 176.108 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -68.97 159.94 51.89 Favored 'Trans proline' 0 C--N 1.378 2.104 0 C-N-CA 123.05 2.5 . . . . 0.0 113.752 -170.808 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -71.5 148.93 46.28 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 124.295 1.038 . . . . 0.0 112.166 -174.474 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 17.8 tt -68.08 -11.62 14.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 C-N-CA 123.778 0.831 . . . . 0.0 111.457 -179.068 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -58.7 -28.96 66.28 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 124.458 1.103 . . . . 0.0 112.797 174.263 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -100.69 -8.26 23.01 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 122.947 0.499 . . . . 0.0 111.515 176.666 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -80.42 110.02 15.48 Favored 'General case' 0 N--CA 1.48 1.03 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 177.768 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -78.43 119.81 22.27 Favored 'General case' 0 CA--C 1.537 0.45 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 175.509 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 76.2 m95 -109.13 -7.79 15.26 Favored 'General case' 0 CA--C 1.55 0.972 0 C-N-CA 124.215 1.006 . . . . 0.0 109.451 168.081 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 15.0 t . . . . . 0 CA--C 1.558 1.267 0 C-N-CA 124.28 1.032 . . . . 0.0 112.598 -164.286 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 30.9 m . . . . . 0 N--CA 1.481 1.109 0 N-CA-C 109.918 -0.401 . . . . 0.0 109.918 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.472 ' HA ' ' HD2' ' A' ' 45' ' ' PRO . 76.2 p -148.1 145.85 28.57 Favored 'General case' 0 C--O 1.241 0.635 0 C-N-CA 123.274 0.63 . . . . 0.0 110.336 -178.495 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 43.9 t -114.6 131.22 67.35 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.405 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 172.992 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -81.55 109.88 16.41 Favored 'General case' 0 CA--C 1.54 0.586 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 173.803 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.512 HD23 ' HB3' ' A' ' 43' ' ' PHE . 4.2 mm? -87.76 168.98 15.2 Favored Pre-proline 0 CA--C 1.557 1.222 0 C-N-CA 123.849 0.86 . . . . 0.0 109.885 -177.065 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -53.68 129.03 31.95 Favored 'Trans proline' 0 C--N 1.397 3.101 0 C-N-CA 122.949 2.433 . . . . 0.0 113.118 -177.173 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -114.98 154.0 47.08 Favored Pre-proline 0 N--CA 1.48 1.031 0 C-N-CA 123.998 0.919 . . . . 0.0 112.466 -167.815 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.804 ' HG2' ' HB2' ' A' ' 39' ' ' TRP . 38.4 Cg_endo -70.96 148.01 56.35 Favored 'Trans proline' 0 C--N 1.377 2.054 0 C-N-CA 122.388 2.059 . . . . 0.0 110.233 166.091 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 33.2 t -64.43 -25.39 67.99 Favored 'General case' 0 N--CA 1.485 1.287 0 C-N-CA 123.595 0.758 . . . . 0.0 112.983 -169.967 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 40.7 t -81.46 -37.24 28.3 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 123.122 0.569 . . . . 0.0 110.766 177.823 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' TRP . . . . . 0.804 ' HB2' ' HG2' ' A' ' 36' ' ' PRO . 20.7 m95 -107.09 -164.99 1.03 Allowed 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 123.603 0.761 . . . . 0.0 110.639 -173.746 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.659 ' HB3' ' HB ' ' A' ' 59' ' ' VAL . 34.1 ttmt -142.7 152.64 42.58 Favored 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 171.248 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.443 ' HD3' ' CZ ' ' A' ' 58' ' ' PHE . 16.0 tptm -130.25 127.8 40.32 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 123.66 0.784 . . . . 0.0 109.983 -170.367 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.435 HD21 ' CE1' ' A' ' 44' ' ' TYR . 3.2 tt -134.48 149.72 50.74 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 114.784 -1.098 . . . . 0.0 109.302 179.254 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.512 ' HB3' HD23 ' A' ' 33' ' ' LEU . 32.6 t80 -135.34 136.97 41.95 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 125.317 1.447 . . . . 0.0 108.484 175.653 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . 0.435 ' CE1' HD21 ' A' ' 42' ' ' LEU . 40.5 m-85 -96.32 106.17 27.29 Favored Pre-proline 0 CA--C 1.55 0.958 0 C-N-CA 122.975 0.51 . . . . 0.0 109.661 172.025 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . 0.472 ' HD2' ' HA ' ' A' ' 30' ' ' SER . 94.8 Cg_endo . . . . . 0 C--N 1.374 1.883 0 C-N-CA 122.961 2.441 . . . . 0.0 112.383 172.797 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.511 ' HG3' ' O ' ' A' ' 67' ' ' SER . 1.1 pm0 . . . . . 0 CA--C 1.551 0.996 0 CA-C-O 121.491 0.662 . . . . 0.0 112.586 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 77.6 t -80.62 121.07 33.43 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 CA-C-N 115.151 -0.931 . . . . 0.0 108.54 175.18 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 40.4 t -111.64 118.97 58.84 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.572 0 C-N-CA 123.099 0.56 . . . . 0.0 109.569 -178.465 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.443 ' CZ ' ' HD3' ' A' ' 41' ' ' LYS . 36.1 m-85 -93.15 120.31 33.3 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 123.458 0.703 . . . . 0.0 109.507 171.541 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.659 ' HB ' ' HB3' ' A' ' 40' ' ' LYS . 3.3 t -79.71 126.61 39.3 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.449 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 174.027 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.581 ' HB3' ' H ' ' A' ' 64' ' ' GLU . . . -84.61 148.57 52.21 Favored Pre-proline 0 CA--C 1.541 0.616 0 CA-C-N 114.97 -1.014 . . . . 0.0 110.781 -177.488 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -63.04 -17.36 59.78 Favored 'Trans proline' 0 N--CA 1.494 1.557 0 C-N-CA 123.394 2.729 . . . . 0.0 114.143 -176.705 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 14.1 t -110.83 0.36 17.21 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 123.365 0.666 . . . . 0.0 111.738 -178.878 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 76.35 65.32 2.03 Favored Glycine 0 CA--C 1.533 1.182 0 CA-C-O 121.385 0.436 . . . . 0.0 112.064 -175.976 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.581 ' H ' ' HB3' ' A' ' 60' ' ' ALA . 39.0 tt0 -150.6 72.54 1.09 Allowed 'General case' 0 N--CA 1.474 0.746 0 N-CA-C 106.622 -1.621 . . . . 0.0 106.622 175.244 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 4.6 mp0 -66.99 155.47 38.51 Favored 'General case' 0 N--CA 1.475 0.812 0 CA-C-N 114.756 -1.111 . . . . 0.0 112.094 -165.418 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.463 HG23 ' HB2' ' A' ' 71' ' ' GLN . 48.5 mm -116.87 143.86 26.05 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.508 0 C-N-CA 124.941 1.297 . . . . 0.0 108.965 -176.741 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.511 ' O ' ' HG3' ' A' ' 55' ' ' GLU . 35.9 p -129.37 -2.8 4.95 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 122.93 0.492 . . . . 0.0 112.038 178.533 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 9.6 p30 -151.67 158.81 43.92 Favored 'General case' 0 N--CA 1.486 1.352 0 O-C-N 121.842 -0.536 . . . . 0.0 111.123 176.442 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 55.3 mtp180 -60.61 -31.84 70.99 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 123.89 0.876 . . . . 0.0 112.78 -176.64 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 2.7 tmtp? -60.69 -54.16 48.6 Favored 'General case' 0 N--CA 1.478 0.934 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 178.4 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.463 ' HB2' HG23 ' A' ' 66' ' ' ILE . 45.8 mt-30 -54.86 -40.53 69.77 Favored 'General case' 0 N--CA 1.48 1.045 0 O-C-N 124.12 0.887 . . . . 0.0 111.849 177.867 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.486 HD12 ' HB ' ' A' ' 85' ' ' ILE . 0.7 OUTLIER -64.74 -53.04 53.41 Favored 'General case' 0 N--CA 1.478 0.949 0 O-C-N 123.699 0.624 . . . . 0.0 110.074 -175.912 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -71.08 -37.23 72.45 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 123.184 0.593 . . . . 0.0 111.692 -172.374 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.98 -26.46 63.16 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 122.245 0.218 . . . . 0.0 111.049 174.653 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 20.0 t80 -65.08 -49.93 68.11 Favored 'General case' 0 N--CA 1.479 0.99 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 175.147 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.478 ' HG ' ' O ' ' A' ' 72' ' ' LEU . 68.3 mt -60.91 -47.29 87.09 Favored 'General case' 0 N--CA 1.479 0.995 0 O-C-N 123.983 0.802 . . . . 0.0 111.936 -173.91 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -69.53 -26.93 64.75 Favored 'General case' 0 CA--C 1.551 1.009 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.873 -177.846 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 59.2 m -89.0 -23.68 22.56 Favored 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 123.024 0.53 . . . . 0.0 111.792 178.177 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 92.8 m-70 -124.72 94.29 44.64 Favored Pre-proline 0 N--CA 1.474 0.731 0 C-N-CA 123.483 0.713 . . . . 0.0 109.959 -173.759 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -68.54 149.66 74.47 Favored 'Trans proline' 0 C--N 1.376 1.992 0 C-N-CA 122.707 2.272 . . . . 0.0 112.448 178.501 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 100.99 -20.08 49.28 Favored Glycine 0 C--N 1.345 1.051 0 CA-C-N 116.167 -0.47 . . . . 0.0 112.723 -178.821 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 40.6 m-80 -77.42 144.42 70.3 Favored Pre-proline 0 CA--C 1.549 0.939 0 C-N-CA 123.132 0.573 . . . . 0.0 110.4 176.527 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -74.8 158.9 42.64 Favored 'Trans proline' 0 C--N 1.374 1.913 0 C-N-CA 122.6 2.2 . . . . 0.0 112.625 177.462 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.432 ' HA ' HD13 ' A' ' 76' ' ' LEU . . . -75.03 153.69 38.33 Favored 'General case' 0 N--CA 1.477 0.89 0 CA-C-N 115.389 -0.823 . . . . 0.0 112.561 -173.045 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.486 ' HB ' HD12 ' A' ' 72' ' ' LEU . 15.9 tt -68.08 -11.64 14.55 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.335 0 C-N-CA 123.899 0.88 . . . . 0.0 111.436 179.954 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -55.68 -31.87 62.78 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 124.226 1.01 . . . . 0.0 112.262 174.138 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -98.08 -15.74 19.86 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 122.988 0.515 . . . . 0.0 111.908 176.477 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -81.27 108.86 15.26 Favored 'General case' 0 N--CA 1.484 1.241 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 177.016 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 10.3 p-10 -97.11 120.62 37.81 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-O 121.395 0.617 . . . . 0.0 110.196 -177.558 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 65.4 m95 -96.72 -9.01 29.92 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 124.053 0.941 . . . . 0.0 109.791 173.762 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 11.0 t . . . . . 0 CA--C 1.557 1.225 0 C-N-CA 125.581 1.552 . . . . 0.0 111.294 179.665 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 17.7 m . . . . . 0 CA--C 1.551 0.993 0 CA-C-O 121.464 0.65 . . . . 0.0 110.078 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 11.0 p -159.87 127.05 4.56 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 124.167 0.987 . . . . 0.0 109.425 -176.083 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 96.7 t -117.92 127.53 75.17 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 C-N-CA 123.885 0.874 . . . . 0.0 108.839 179.406 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.475 ' HA ' ' HA ' ' A' ' 42' ' ' LEU . 2.6 mp0 -87.48 117.0 25.98 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-O 121.206 0.527 . . . . 0.0 110.172 179.609 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.499 HD23 ' HB3' ' A' ' 43' ' ' PHE . 3.3 mm? -94.89 169.57 9.29 Favored Pre-proline 0 N--CA 1.491 1.583 0 C-N-CA 124.635 1.174 . . . . 0.0 110.354 -171.788 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -51.03 137.14 44.86 Favored 'Trans proline' 0 C--N 1.397 3.091 0 C-N-CA 123.195 2.597 . . . . 0.0 113.044 176.241 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -130.56 156.98 78.9 Favored Pre-proline 0 CA--C 1.544 0.725 0 C-N-CA 123.661 0.784 . . . . 0.0 112.417 -164.474 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_exo -54.62 138.07 74.67 Favored 'Trans proline' 0 C--N 1.375 1.947 0 C-N-CA 123.38 2.72 . . . . 0.0 110.786 157.354 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 57.1 p -63.15 -28.84 70.33 Favored 'General case' 0 CA--C 1.55 0.961 0 C-N-CA 123.719 0.808 . . . . 0.0 112.641 -175.146 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 35.3 t -85.16 -14.19 47.74 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 123.362 0.665 . . . . 0.0 111.765 179.356 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 16.3 m95 -122.74 -169.16 1.87 Allowed 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 124.034 0.934 . . . . 0.0 110.186 -178.815 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 28.7 mtmt -140.13 145.67 37.86 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 124.491 1.116 . . . . 0.0 108.462 169.184 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.513 ' NZ ' ' HB2' ' A' ' 43' ' ' PHE . 23.4 tptp -114.66 130.97 56.87 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 124.642 1.177 . . . . 0.0 109.349 -175.961 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.475 ' HA ' ' HA ' ' A' ' 32' ' ' GLU . 6.5 tt -128.36 149.16 50.64 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 124.478 1.111 . . . . 0.0 108.936 175.629 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.513 ' HB2' ' NZ ' ' A' ' 41' ' ' LYS . 25.9 t80 -131.32 139.71 49.61 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 125.06 1.344 . . . . 0.0 108.349 174.917 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 10.2 m-85 -103.4 98.52 12.56 Favored Pre-proline 0 CA--C 1.552 1.02 0 C-N-CA 122.944 0.498 . . . . 0.0 109.861 173.391 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo . . . . . 0 C--N 1.37 1.669 0 C-N-CA 121.963 1.775 . . . . 0.0 110.231 168.231 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 CA--C 1.551 1.018 0 CA-C-O 121.903 0.858 . . . . 0.0 112.246 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 15.3 t -82.4 138.77 18.87 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 C-N-CA 124.72 1.208 . . . . 0.0 110.417 -178.865 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.444 ' HB ' HD22 ' A' ' 42' ' ' LEU . 68.7 t -121.21 124.62 72.45 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.772 0 C-N-CA 124.173 0.989 . . . . 0.0 109.531 175.81 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.467 ' CZ ' ' HD3' ' A' ' 41' ' ' LYS . 16.0 m-85 -98.24 123.79 42.5 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 123.356 0.662 . . . . 0.0 109.904 173.179 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 3.4 t -79.17 122.73 34.99 Favored 'Isoleucine or valine' 0 C--O 1.241 0.606 0 C-N-CA 123.47 0.708 . . . . 0.0 109.359 175.936 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -81.45 154.53 71.56 Favored Pre-proline 0 CA--C 1.542 0.651 0 CA-C-N 114.238 -1.346 . . . . 0.0 110.956 -176.266 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_endo -62.17 -27.52 78.72 Favored 'Trans proline' 0 C--N 1.375 1.955 0 C-N-CA 122.759 2.306 . . . . 0.0 112.947 178.939 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.403 HG22 ' OH ' ' A' ' 75' ' ' TYR . 12.4 t -96.89 -7.71 32.69 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 122.72 0.408 . . . . 0.0 111.085 177.309 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 93.99 -1.04 67.42 Favored Glycine 0 C--N 1.353 1.483 0 CA-C-O 119.866 -0.408 . . . . 0.0 113.957 178.816 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -78.79 73.27 5.34 Favored 'General case' 0 N--CA 1.479 0.982 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 174.477 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -67.76 158.43 32.42 Favored 'General case' 0 C--N 1.35 0.594 0 CA-C-N 114.98 -1.009 . . . . 0.0 112.01 -168.777 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 47.3 mm -116.04 125.44 73.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 C-N-CA 124.707 1.203 . . . . 0.0 109.354 -166.879 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 12.3 p -110.93 5.36 20.38 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 123.645 0.778 . . . . 0.0 112.797 -175.184 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 11.2 p30 -163.31 164.56 24.82 Favored 'General case' 0 N--CA 1.486 1.335 0 C-N-CA 122.988 0.515 . . . . 0.0 110.393 172.085 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 19.7 ttp180 -63.67 -34.42 77.82 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 123.683 0.793 . . . . 0.0 112.218 -171.856 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 8.2 tmtm? -60.86 -50.41 73.54 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 123.434 0.694 . . . . 0.0 109.828 179.015 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 75.5 mt-30 -55.84 -34.89 65.82 Favored 'General case' 0 N--CA 1.477 0.917 0 O-C-N 124.288 0.993 . . . . 0.0 111.406 179.123 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.424 ' O ' ' HG ' ' A' ' 76' ' ' LEU . 0.5 OUTLIER -65.33 -54.95 21.44 Favored 'General case' 0 CA--C 1.547 0.858 0 N-CA-C 109.489 -0.559 . . . . 0.0 109.489 179.559 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -59.86 -47.16 86.86 Favored 'General case' 0 N--CA 1.486 1.364 0 C-N-CA 124.19 0.996 . . . . 0.0 111.633 -175.117 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 5.3 pp0? -68.15 -30.77 69.98 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.374 -179.308 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . 0.403 ' OH ' HG22 ' A' ' 62' ' ' THR . 32.9 t80 -65.83 -45.17 83.22 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 123.248 0.619 . . . . 0.0 109.523 176.732 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.424 ' HG ' ' O ' ' A' ' 72' ' ' LEU . 69.9 mt -63.14 -44.09 96.54 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 123.108 0.563 . . . . 0.0 111.655 -176.115 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.92 -19.39 58.84 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 122.806 0.442 . . . . 0.0 111.414 -179.842 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 46.1 t -91.62 -12.31 34.61 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 123.236 0.615 . . . . 0.0 111.382 174.006 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 57.7 m-70 -133.55 83.51 48.47 Favored Pre-proline 0 CA--C 1.551 1.007 0 C-N-CA 123.462 0.705 . . . . 0.0 109.631 -179.402 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -65.73 128.62 20.35 Favored 'Trans proline' 0 C--N 1.379 2.143 0 C-N-CA 122.802 2.334 . . . . 0.0 112.065 176.691 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 124.01 -22.53 6.75 Favored Glycine 0 C--N 1.342 0.91 0 CA-C-N 115.76 -0.655 . . . . 0.0 111.837 -177.96 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 12.3 m120 -74.25 151.85 87.99 Favored Pre-proline 0 CA--C 1.553 1.072 0 C-N-CA 123.064 0.546 . . . . 0.0 110.785 177.379 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -69.61 160.45 49.7 Favored 'Trans proline' 0 C--N 1.375 1.927 0 C-N-CA 122.73 2.287 . . . . 0.0 112.853 178.887 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -75.82 148.71 38.19 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 123.565 0.746 . . . . 0.0 111.167 -176.299 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 16.1 tt -65.63 -12.53 14.01 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.383 0 C-N-CA 123.729 0.811 . . . . 0.0 112.371 -177.59 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -57.97 -35.46 71.21 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 124.49 1.116 . . . . 0.0 112.215 176.156 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -91.03 -11.88 37.47 Favored 'General case' 0 N--CA 1.485 1.282 0 N-CA-C 112.38 0.511 . . . . 0.0 112.38 177.883 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 4.9 m-85 -76.16 108.55 9.16 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 177.259 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 4.5 t0 -86.97 102.24 14.19 Favored 'General case' 0 CA--C 1.541 0.635 0 CA-C-N 115.995 -0.548 . . . . 0.0 109.964 -173.0 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 82.1 m95 -89.6 -31.94 17.34 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 123.746 0.819 . . . . 0.0 109.99 174.251 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 8.9 t . . . . . 0 CA--C 1.557 1.215 0 C-N-CA 124.059 0.944 . . . . 0.0 112.532 -172.373 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 21.0 m . . . . . 0 N--CA 1.476 0.836 0 CA-C-O 121.222 0.534 . . . . 0.0 110.325 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 58.5 p -140.46 123.74 16.79 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 123.826 0.85 . . . . 0.0 109.49 177.569 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 48.5 t -110.83 124.45 67.64 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 C-N-CA 124.184 0.994 . . . . 0.0 109.464 178.559 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 53.4 mt-10 -80.9 104.08 11.16 Favored 'General case' 0 CA--C 1.545 0.76 0 CA-C-O 121.235 0.54 . . . . 0.0 110.188 176.758 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.459 HD23 ' HB3' ' A' ' 43' ' ' PHE . 3.9 mm? -79.32 163.3 60.16 Favored Pre-proline 0 CA--C 1.564 1.519 0 C-N-CA 124.881 1.272 . . . . 0.0 110.409 177.573 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo -60.04 145.51 98.23 Favored 'Trans proline' 0 C--N 1.391 2.769 0 C-N-CA 122.741 2.294 . . . . 0.0 114.157 -174.467 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.536 ' HB2' ' HB3' ' A' ' 41' ' ' LYS . . . -157.29 163.06 26.19 Favored Pre-proline 0 CA--C 1.542 0.671 0 C-N-CA 124.18 0.992 . . . . 0.0 110.839 -172.2 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_exo -52.73 147.66 30.76 Favored 'Trans proline' 0 C--N 1.379 2.139 0 C-N-CA 123.004 2.469 . . . . 0.0 112.122 164.319 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 37.4 p -71.42 -15.22 62.34 Favored 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 123.519 0.728 . . . . 0.0 111.929 -176.818 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 42.7 t -75.93 -34.85 59.9 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 123.585 0.754 . . . . 0.0 110.19 172.007 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 28.2 m95 -109.83 -169.93 1.56 Allowed 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 123.883 0.873 . . . . 0.0 110.86 -175.515 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.733 ' HB3' ' HB ' ' A' ' 59' ' ' VAL . 1.7 tpmt? -148.35 144.64 27.67 Favored 'General case' 0 CA--C 1.533 0.327 0 CA-C-N 114.939 -1.028 . . . . 0.0 108.266 166.821 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.536 ' HB3' ' HB2' ' A' ' 35' ' ' ALA . 19.6 tptp -112.74 115.48 28.59 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 177.183 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.426 HD22 ' HB ' ' A' ' 57' ' ' VAL . 7.3 tt -111.43 139.78 46.56 Favored 'General case' 0 C--N 1.319 -0.748 0 C-N-CA 124.518 1.127 . . . . 0.0 108.262 174.635 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.459 ' HB3' HD23 ' A' ' 33' ' ' LEU . 38.1 t80 -125.74 135.57 52.21 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 124.619 1.168 . . . . 0.0 107.9 173.286 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 8.6 m-85 -94.24 103.02 9.56 Favored Pre-proline 0 CA--C 1.55 0.969 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 172.812 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo . . . . . 0 C--N 1.374 1.905 0 C-N-CA 122.951 2.434 . . . . 0.0 111.792 172.752 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 CA--C 1.554 1.13 0 CA-C-O 121.657 0.741 . . . . 0.0 112.085 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 48.1 t -82.58 140.09 16.88 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.594 0 C-N-CA 124.909 1.284 . . . . 0.0 110.578 -179.157 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.426 ' HB ' HD22 ' A' ' 42' ' ' LEU . 81.6 t -123.97 130.69 73.76 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.682 0 C-N-CA 124.079 0.951 . . . . 0.0 109.062 173.022 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 16.2 m-85 -102.03 122.22 43.68 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 123.198 0.599 . . . . 0.0 109.504 171.228 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.733 ' HB ' ' HB3' ' A' ' 40' ' ' LYS . 4.3 t -81.15 130.52 35.72 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 173.122 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -95.06 155.65 38.76 Favored Pre-proline 0 CA--C 1.548 0.87 0 C-N-CA 124.167 0.987 . . . . 0.0 110.754 -176.175 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -66.01 -8.19 19.24 Favored 'Trans proline' 0 C--N 1.38 2.236 0 C-N-CA 123.067 2.511 . . . . 0.0 114.202 -177.259 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 9.6 t -120.98 12.66 11.23 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 123.602 0.761 . . . . 0.0 111.412 -175.174 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 81.03 -22.83 4.79 Favored Glycine 0 C--N 1.353 1.494 0 N-CA-C 114.531 0.572 . . . . 0.0 114.531 179.336 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 49.7 tt0 -72.84 75.0 1.15 Allowed 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 124.551 1.14 . . . . 0.0 109.487 177.626 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -80.97 157.98 25.34 Favored 'General case' 0 N--CA 1.476 0.839 0 CA-C-N 115.287 -0.87 . . . . 0.0 111.707 -168.785 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 42.5 mm -107.9 139.84 28.49 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.755 0 C-N-CA 124.905 1.282 . . . . 0.0 110.379 -173.35 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 16.3 p -108.33 -9.84 15.42 Favored 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 123.584 0.754 . . . . 0.0 112.66 -179.885 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 13.1 p-10 -160.74 162.64 32.53 Favored 'General case' 0 N--CA 1.486 1.337 0 N-CA-C 112.348 0.499 . . . . 0.0 112.348 -168.378 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 3.8 ttm180 -59.92 -41.33 91.49 Favored 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 124.613 1.165 . . . . 0.0 112.17 -170.789 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 7.4 tmtm? -60.91 -54.43 45.12 Favored 'General case' 0 N--CA 1.478 0.929 0 CA-C-N 115.145 -0.934 . . . . 0.0 109.507 -176.622 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.415 ' HA ' ' HG3' ' A' ' 74' ' ' GLN . 87.3 mm-40 -64.2 -25.17 67.95 Favored 'General case' 0 N--CA 1.475 0.797 0 O-C-N 124.03 0.831 . . . . 0.0 111.45 -176.676 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.418 ' O ' ' HG ' ' A' ' 76' ' ' LEU . 0.6 OUTLIER -66.52 -52.67 43.32 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 123.375 0.67 . . . . 0.0 109.224 175.88 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -64.08 -50.54 67.92 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 123.634 0.774 . . . . 0.0 111.363 -175.602 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . 0.415 ' HG3' ' HA ' ' A' ' 71' ' ' GLN . 0.0 OUTLIER -66.16 -23.92 66.55 Favored 'General case' 0 CA--C 1.547 0.861 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.365 179.582 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 38.5 t80 -66.88 -51.79 51.2 Favored 'General case' 0 C--O 1.212 -0.873 0 C-N-CA 122.92 0.488 . . . . 0.0 109.736 171.703 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.418 ' HG ' ' O ' ' A' ' 72' ' ' LEU . 83.1 mt -62.51 -37.78 87.35 Favored 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 123.225 0.61 . . . . 0.0 112.495 -172.105 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.77 -26.57 57.49 Favored 'General case' 0 CA--C 1.553 1.072 0 CA-C-O 120.83 0.347 . . . . 0.0 110.95 178.033 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 41.6 t -83.19 -26.68 30.62 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 123.203 0.601 . . . . 0.0 111.044 175.834 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 53.6 m80 -125.7 89.54 52.24 Favored Pre-proline 0 C--O 1.241 0.613 0 C-N-CA 124.395 1.078 . . . . 0.0 108.594 -173.447 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -68.67 164.85 31.53 Favored 'Trans proline' 0 C--N 1.369 1.62 0 C-N-CA 122.311 2.007 . . . . 0.0 111.666 176.076 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 89.81 -29.46 6.34 Favored Glycine 0 CA--C 1.532 1.123 0 CA-C-N 116.468 -0.333 . . . . 0.0 112.678 -176.049 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 36.1 m-80 -71.73 141.05 84.39 Favored Pre-proline 0 CA--C 1.549 0.932 0 C-N-CA 123.871 0.868 . . . . 0.0 110.778 178.828 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -67.02 163.03 35.51 Favored 'Trans proline' 0 C--N 1.374 1.895 0 C-N-CA 123.114 2.543 . . . . 0.0 112.863 179.959 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -74.7 161.03 30.03 Favored 'General case' 0 N--CA 1.488 1.442 0 C-N-CA 124.017 0.927 . . . . 0.0 112.266 -170.317 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 16.3 tt -78.71 -19.93 13.1 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.253 0 CA-C-O 120.808 0.337 . . . . 0.0 111.158 179.283 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -61.89 -38.17 87.32 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 123.344 0.658 . . . . 0.0 111.777 177.991 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -83.89 -9.75 58.5 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 123.282 0.633 . . . . 0.0 111.51 179.322 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 5.5 m-30 -82.62 129.69 34.99 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 123.397 0.679 . . . . 0.0 110.17 177.769 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -84.57 125.79 32.75 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 123.893 0.877 . . . . 0.0 110.32 177.568 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 86.2 m95 -118.43 -11.56 9.97 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 123.969 0.908 . . . . 0.0 109.439 168.203 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 13.7 t . . . . . 0 CA--C 1.555 1.15 0 C-N-CA 124.371 1.069 . . . . 0.0 112.571 -163.728 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.2 mpt? . . . . . 0 N--CA 1.478 0.938 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 35.2 m170 -129.6 -55.91 1.15 Allowed 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 123.802 0.841 . . . . 0.0 109.704 178.094 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 20.3 m-70 61.31 84.44 0.13 Allowed 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 124.453 1.101 . . . . 0.0 111.251 -176.221 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 9.9 t-160 -106.1 119.28 38.8 Favored 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 179.122 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 51.3 t-80 -109.39 143.3 39.14 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 123.95 0.9 . . . . 0.0 110.149 -174.839 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 37.1 m170 -130.1 174.0 10.21 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 124.436 1.094 . . . . 0.0 110.204 175.934 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 56.3 p-80 -158.54 125.94 5.0 Favored 'General case' 0 CA--C 1.545 0.767 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 169.78 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 38.8 p -157.12 118.47 3.7 Favored 'General case' 0 C--O 1.238 0.467 0 C-N-CA 124.058 0.943 . . . . 0.0 109.096 179.077 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 26.0 m -87.95 -0.94 57.64 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 123.071 0.549 . . . . 0.0 111.036 178.757 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 106.63 -89.37 0.59 Allowed Glycine 0 C--N 1.348 1.203 0 CA-C-N 115.869 -0.605 . . . . 0.0 112.499 178.011 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 14.8 mmt85 -87.86 158.27 18.76 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 123.54 0.736 . . . . 0.0 110.972 -175.07 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.428 ' HG2' HD12 ' A' ' 14' ' ' LEU . 31.2 tt0 -130.99 77.04 1.76 Allowed 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 124.14 0.976 . . . . 0.0 108.421 176.279 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 28.0 t-20 -95.1 107.23 19.29 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-N 115.603 -0.726 . . . . 0.0 109.895 -179.685 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.428 HD12 ' HG2' ' A' ' 12' ' ' GLU . 0.0 OUTLIER -157.09 151.02 24.66 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 124.352 1.061 . . . . 0.0 108.802 -179.477 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 70.2 m-85 -132.13 109.48 10.0 Favored 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 123.239 0.615 . . . . 0.0 110.562 -172.793 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 59.7 t80 -96.85 38.05 1.25 Allowed 'General case' 0 CA--C 1.555 1.145 0 CA-C-O 122.598 1.189 . . . . 0.0 108.44 170.614 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 64.8 mm-40 -98.14 21.22 11.14 Favored 'General case' 0 N--CA 1.477 0.876 0 CA-C-N 115.347 -0.842 . . . . 0.0 111.341 -169.907 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -80.19 19.22 6.93 Favored Glycine 0 C--N 1.348 1.219 0 CA-C-N 116.302 -0.408 . . . . 0.0 114.068 -179.453 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 48.6 m-70 -109.49 119.79 40.53 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 123.838 0.855 . . . . 0.0 108.79 175.777 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 27.1 ptt? -75.83 -16.68 60.04 Favored 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 123.358 0.663 . . . . 0.0 111.075 175.374 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . 65.81 179.59 0.2 Allowed 'General case' 0 C--N 1.362 1.11 0 C-N-CA 125.315 1.446 . . . . 0.0 111.786 -177.367 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 16.9 t 61.01 -152.3 0.39 Allowed 'General case' 0 CA--C 1.56 1.336 0 C-N-CA 124.309 1.044 . . . . 0.0 111.057 178.219 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 99.55 8.06 52.89 Favored Glycine 0 C--N 1.35 1.317 0 N-CA-C 112.436 -0.266 . . . . 0.0 112.436 -179.107 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 13.8 m -93.26 166.12 12.47 Favored 'General case' 0 C--O 1.245 0.86 0 C-N-CA 123.755 0.822 . . . . 0.0 109.661 174.641 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -69.9 109.44 4.47 Favored 'General case' 0 N--CA 1.473 0.694 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 175.491 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -81.29 162.16 23.6 Favored 'General case' 0 CA--C 1.55 0.957 0 C-N-CA 123.349 0.66 . . . . 0.0 109.464 178.368 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 67.78 42.46 1.96 Allowed 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 124.63 1.172 . . . . 0.0 109.992 -179.607 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 5.7 m -98.97 126.18 52.25 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.08 0 CA-C-N 114.616 -1.174 . . . . 0.0 109.019 172.534 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 30.4 m -71.68 135.11 28.63 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.98 0 C-N-CA 123.722 0.809 . . . . 0.0 111.907 -172.376 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 60.9 p -143.69 129.35 19.21 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 123.526 0.731 . . . . 0.0 109.709 179.021 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 99.4 t -108.32 125.44 65.06 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 C-N-CA 124.337 1.055 . . . . 0.0 108.565 175.651 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -79.87 110.38 15.18 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 176.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.491 ' HB2' ' HG3' ' A' ' 41' ' ' LYS . 3.9 mm? -85.8 162.06 48.47 Favored Pre-proline 0 N--CA 1.485 1.29 0 C-N-CA 124.145 0.978 . . . . 0.0 109.399 178.959 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_endo -62.08 155.93 52.98 Favored 'Trans proline' 0 C--N 1.388 2.651 0 C-N-CA 122.628 2.219 . . . . 0.0 113.407 -179.667 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.472 ' HB2' ' CB ' ' A' ' 41' ' ' LYS . . . -161.65 171.2 7.08 Favored Pre-proline 0 N--CA 1.48 1.064 0 C-N-CA 123.741 0.816 . . . . 0.0 111.307 -171.11 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 13.7 Cg_endo -57.02 137.82 83.63 Favored 'Trans proline' 0 C--N 1.384 2.422 0 C-N-CA 122.053 1.835 . . . . 0.0 110.053 158.456 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 24.8 m -67.87 -15.9 63.84 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 123.601 0.76 . . . . 0.0 112.042 -176.383 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 17.8 p -69.15 -39.57 78.74 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 123.956 0.902 . . . . 0.0 110.455 172.646 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 25.5 m95 -105.03 -168.38 1.46 Allowed 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 123.92 0.888 . . . . 0.0 110.179 177.24 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.662 ' HB3' ' HB ' ' A' ' 59' ' ' VAL . 14.2 tppt? -143.77 144.2 31.7 Favored 'General case' 0 C--O 1.234 0.246 0 N-CA-C 107.581 -1.266 . . . . 0.0 107.581 167.93 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.515 ' NZ ' ' HB2' ' A' ' 43' ' ' PHE . 24.6 tptp -108.85 125.4 51.94 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 177.818 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 6.6 tt -122.41 141.76 51.25 Favored 'General case' 0 C--N 1.322 -0.622 0 C-N-CA 124.31 1.044 . . . . 0.0 108.259 174.894 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.515 ' HB2' ' NZ ' ' A' ' 41' ' ' LYS . 29.1 t80 -123.84 136.18 54.22 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 171.184 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . 0.529 ' HB3' ' HB ' ' A' ' 54' ' ' THR . 10.5 m-85 -96.03 100.84 7.17 Favored Pre-proline 0 CA--C 1.546 0.811 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 169.363 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 65.8 Cg_endo -80.65 -178.71 4.62 Favored 'Trans proline' 0 C--N 1.371 1.761 0 C-N-CA 122.329 2.019 . . . . 0.0 111.646 173.485 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 12.0 t-20 -153.35 -84.39 0.07 Allowed 'General case' 0 CA--C 1.538 0.494 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 172.536 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 67.0 mttm -135.65 -79.08 0.43 Allowed 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 123.255 0.622 . . . . 0.0 109.609 179.802 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 59.5 t -128.38 -72.34 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.055 0 N-CA-C 109.287 -0.634 . . . . 0.0 109.287 -178.329 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -171.97 -39.45 0.03 OUTLIER Glycine 0 C--N 1.354 1.568 0 C-N-CA 121.702 -0.285 . . . . 0.0 112.724 -176.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 50.0 m -80.83 60.04 3.94 Favored 'General case' 0 N--CA 1.486 1.325 0 C-N-CA 123.769 0.827 . . . . 0.0 110.381 176.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.405 HG23 ' HB2' ' A' ' 53' ' ' LYS . 9.5 m -143.53 -173.09 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.934 0 C-N-CA 125.384 1.474 . . . . 0.0 108.835 -176.899 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -59.34 -60.84 3.21 Favored 'General case' 0 N--CA 1.478 0.954 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 173.266 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.405 ' HB2' HG23 ' A' ' 51' ' ' VAL . 77.1 tttt 64.04 151.0 0.04 OUTLIER 'General case' 0 CA--C 1.558 1.285 0 C-N-CA 124.448 1.099 . . . . 0.0 112.906 173.096 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.529 ' HB ' ' HB3' ' A' ' 44' ' ' TYR . 8.3 m -132.31 158.71 41.18 Favored 'General case' 0 CA--C 1.554 1.125 0 N-CA-C 107.66 -1.237 . . . . 0.0 107.66 169.635 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -92.56 -168.19 1.91 Allowed 'General case' 0 N--CA 1.481 1.078 0 CA-C-O 121.409 0.623 . . . . 0.0 111.496 -174.86 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 42.9 t -82.66 137.36 21.17 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.723 0 C-N-CA 124.841 1.257 . . . . 0.0 110.661 -179.578 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 86.2 t -126.67 125.34 66.85 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.883 0 C-N-CA 124.224 1.01 . . . . 0.0 108.751 173.138 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.483 ' CZ ' ' HD3' ' A' ' 41' ' ' LYS . 14.0 m-85 -94.67 124.0 38.44 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 123.185 0.594 . . . . 0.0 109.65 172.254 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.662 ' HB ' ' HB3' ' A' ' 40' ' ' LYS . 6.0 t -80.88 128.82 38.4 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.522 0 C-N-CA 123.493 0.717 . . . . 0.0 109.681 174.648 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -87.27 153.16 53.61 Favored Pre-proline 0 CA--C 1.543 0.674 0 CA-C-N 115.079 -0.964 . . . . 0.0 110.429 -178.372 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_endo -63.03 -20.84 72.45 Favored 'Trans proline' 0 C--N 1.375 1.958 0 C-N-CA 123.213 2.609 . . . . 0.0 113.514 178.68 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.446 HG23 ' H ' ' A' ' 64' ' ' GLU . 10.5 t -101.83 -4.22 26.67 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 123.837 0.855 . . . . 0.0 111.834 178.956 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 91.31 -9.62 76.97 Favored Glycine 0 C--N 1.352 1.439 0 CA-C-O 119.895 -0.392 . . . . 0.0 113.728 -178.79 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.446 ' H ' HG23 ' A' ' 62' ' ' THR . 34.6 tt0 -76.98 73.42 3.57 Favored 'General case' 0 N--CA 1.486 1.35 0 CA-C-O 122.03 0.919 . . . . 0.0 109.248 178.207 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -72.65 159.82 33.25 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 114.384 -1.28 . . . . 0.0 112.239 -166.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.485 HG23 ' HB2' ' A' ' 71' ' ' GLN . 45.8 mm -115.24 123.32 70.71 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.676 0 C-N-CA 125.041 1.337 . . . . 0.0 109.588 -173.412 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 17.4 m -94.18 -22.22 18.57 Favored 'General case' 0 N--CA 1.486 1.331 0 C-N-CA 122.957 0.503 . . . . 0.0 112.096 -176.718 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 3.2 p-10 -148.59 155.08 40.63 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 123.032 0.533 . . . . 0.0 110.373 -172.799 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 74.0 ttt-85 -62.4 -31.35 72.02 Favored 'General case' 0 CA--C 1.554 1.117 0 C-N-CA 124.67 1.188 . . . . 0.0 113.682 -166.221 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 1.6 tmtp? -61.85 -46.89 87.48 Favored 'General case' 0 N--CA 1.486 1.355 0 C-N-CA 123.243 0.617 . . . . 0.0 109.627 177.519 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.485 ' HB2' HG23 ' A' ' 66' ' ' ILE . 96.7 mt-30 -61.0 -27.53 68.38 Favored 'General case' 0 N--CA 1.484 1.234 0 CA-C-N 115.646 -0.707 . . . . 0.0 111.599 -178.835 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.427 ' O ' ' HG ' ' A' ' 76' ' ' LEU . 0.6 OUTLIER -67.47 -53.83 25.44 Favored 'General case' 0 N--CA 1.477 0.893 0 O-C-N 123.883 0.739 . . . . 0.0 109.248 179.44 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -60.75 -47.28 87.01 Favored 'General case' 0 N--CA 1.485 1.31 0 C-N-CA 123.621 0.768 . . . . 0.0 111.669 -176.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 5.2 pp0? -68.99 -25.33 64.47 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.199 179.516 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 42.2 t80 -67.13 -50.97 59.54 Favored 'General case' 0 N--CA 1.475 0.813 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 174.858 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.427 ' HG ' ' O ' ' A' ' 72' ' ' LEU . 69.7 mt -62.29 -42.13 99.09 Favored 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 123.371 0.669 . . . . 0.0 111.935 -173.267 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -70.18 -26.64 64.0 Favored 'General case' 0 N--CA 1.478 0.965 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.973 178.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 48.6 m -92.99 -12.27 31.11 Favored 'General case' 0 N--CA 1.493 1.701 0 C-N-CA 123.34 0.656 . . . . 0.0 111.739 177.463 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 64.8 m80 -135.47 84.19 35.1 Favored Pre-proline 0 N--CA 1.484 1.227 0 C-N-CA 123.965 0.906 . . . . 0.0 109.409 -176.268 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -68.45 147.93 72.2 Favored 'Trans proline' 0 C--N 1.377 2.06 0 C-N-CA 122.608 2.206 . . . . 0.0 111.498 175.818 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 107.12 -31.51 8.08 Favored Glycine 0 C--N 1.341 0.861 0 N-CA-C 111.198 -0.761 . . . . 0.0 111.198 -172.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 40.4 m-80 -76.55 136.45 67.82 Favored Pre-proline 0 N--CA 1.48 1.025 0 C-N-CA 123.324 0.65 . . . . 0.0 110.085 177.364 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -66.91 162.38 38.1 Favored 'Trans proline' 0 C--N 1.38 2.195 0 C-N-CA 123.108 2.539 . . . . 0.0 113.141 -176.38 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -75.28 149.65 38.74 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-N 115.021 -0.99 . . . . 0.0 111.895 -172.878 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.4 ' HB ' HD12 ' A' ' 72' ' ' LEU . 15.8 tt -66.29 -11.81 13.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 C-N-CA 124.155 0.982 . . . . 0.0 111.814 -176.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -54.26 -41.93 69.36 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 123.95 0.9 . . . . 0.0 111.848 172.685 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -92.79 4.76 53.21 Favored 'General case' 0 N--CA 1.481 1.115 0 N-CA-C 112.089 0.403 . . . . 0.0 112.089 179.783 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -94.76 109.97 21.88 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 123.346 0.658 . . . . 0.0 109.545 176.85 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -84.43 85.96 7.33 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 123.981 0.912 . . . . 0.0 111.292 -176.155 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 93.5 m95 -77.85 -27.07 49.73 Favored 'General case' 0 CA--C 1.547 0.841 0 CA-C-N 115.341 -0.845 . . . . 0.0 109.909 169.179 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 14.7 t -86.58 11.52 12.57 Favored 'General case' 0 CA--C 1.557 1.224 0 C-N-CA 124.529 1.132 . . . . 0.0 112.252 -175.582 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 12.8 t -63.18 -24.97 68.13 Favored 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 123.346 0.658 . . . . 0.0 111.68 176.477 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 12.9 p -83.75 -30.58 26.55 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 124.453 1.101 . . . . 0.0 111.354 -179.521 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -106.28 -126.69 5.7 Favored Glycine 0 C--N 1.35 1.361 0 N-CA-C 111.773 -0.531 . . . . 0.0 111.773 -178.511 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 30.4 p . . . . . 0 C--O 1.25 1.092 0 C-N-CA 124.044 0.938 . . . . 0.0 109.611 -179.079 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 48.5 ttm . . . . . 0 N--CA 1.477 0.913 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 8.1 p80 -147.09 145.8 29.74 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 123.141 0.577 . . . . 0.0 109.985 -178.792 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 53.9 t-80 -153.9 -50.44 0.09 Allowed 'General case' 0 N--CA 1.47 0.529 0 N-CA-C 107.75 -1.204 . . . . 0.0 107.75 172.035 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 74.2 m-70 69.73 153.68 0.11 Allowed 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 124.775 1.23 . . . . 0.0 112.361 174.137 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 21.5 m80 -152.09 140.62 20.68 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 124.805 1.242 . . . . 0.0 109.382 177.01 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 17.3 m-70 -83.35 90.09 7.11 Favored 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 171.053 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 25.9 t-80 -80.28 113.22 18.29 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 115.303 -0.862 . . . . 0.0 109.876 179.551 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 33.4 t -85.31 179.67 7.14 Favored 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 123.729 0.811 . . . . 0.0 109.753 172.629 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 49.1 m -130.58 132.65 45.65 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 123.357 0.663 . . . . 0.0 110.035 -179.629 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -72.72 143.25 33.47 Favored Glycine 0 C--N 1.348 1.236 0 O-C-N 123.549 0.531 . . . . 0.0 112.805 -179.259 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 24.4 mmt85 -92.0 112.24 24.1 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 123.721 0.808 . . . . 0.0 109.444 -177.078 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -78.0 83.82 4.29 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 123.262 0.625 . . . . 0.0 109.832 179.873 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 6.7 t30 -86.81 78.55 9.05 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.644 -172.794 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -171.14 154.67 4.12 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 124.537 1.135 . . . . 0.0 109.484 171.538 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 6.3 p90 -75.93 94.89 3.44 Favored 'General case' 0 CA--C 1.546 0.811 0 CA-C-O 121.696 0.76 . . . . 0.0 109.404 175.067 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 16.2 t80 -89.47 23.05 2.71 Favored 'General case' 0 N--CA 1.484 1.267 0 CA-C-O 121.216 0.532 . . . . 0.0 110.738 -177.661 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 19.3 pt20 -66.81 -36.21 81.84 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 123.652 0.781 . . . . 0.0 111.221 174.636 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 75.89 153.45 4.42 Favored Glycine 0 C--N 1.352 1.445 0 CA-C-N 116.081 -0.509 . . . . 0.0 113.084 -175.063 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 14.6 t60 -104.94 128.94 53.41 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 175.445 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 26.6 ttt -146.29 119.32 8.79 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 123.397 0.679 . . . . 0.0 109.866 177.809 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -77.26 127.27 32.32 Favored 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 171.381 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 22.7 t -152.31 170.87 19.0 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 122.906 0.482 . . . . 0.0 110.851 -177.094 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 85.8 -79.35 1.88 Allowed Glycine 0 C--N 1.349 1.284 0 CA-C-N 116.046 -0.524 . . . . 0.0 111.935 -178.921 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 27.1 m -71.5 -28.56 64.0 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 123.49 0.716 . . . . 0.0 111.743 -178.267 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -78.47 86.43 4.5 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 123.008 0.523 . . . . 0.0 110.42 -178.439 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 59.58 -87.49 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 124.759 1.224 . . . . 0.0 111.895 175.628 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER 55.03 69.98 0.67 Allowed 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 125.081 1.352 . . . . 0.0 109.989 -178.74 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 22.0 m -107.68 160.48 6.82 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.052 0 C-N-CA 124.188 0.995 . . . . 0.0 110.993 -173.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 28.1 m -83.91 147.9 5.4 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.047 0 C-N-CA 122.959 0.503 . . . . 0.0 111.313 -179.458 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.401 ' HA ' ' HD2' ' A' ' 45' ' ' PRO . 36.6 p -157.64 122.37 4.37 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 124.317 1.047 . . . . 0.0 108.694 177.359 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 65.5 t -103.34 123.97 57.21 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 C-N-CA 123.885 0.874 . . . . 0.0 109.075 -177.121 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -83.38 114.63 21.57 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 123.08 0.552 . . . . 0.0 110.396 177.476 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.472 HD23 ' HB3' ' A' ' 43' ' ' PHE . 4.5 mm? -92.19 168.88 11.92 Favored Pre-proline 0 CA--C 1.562 1.438 0 C-N-CA 124.44 1.096 . . . . 0.0 109.766 -179.712 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -57.37 143.12 94.8 Favored 'Trans proline' 0 C--N 1.39 2.755 0 C-N-CA 122.739 2.293 . . . . 0.0 115.13 -177.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.755 ' HB2' ' HB3' ' A' ' 41' ' ' LYS . . . -144.97 167.07 15.57 Favored Pre-proline 0 N--CA 1.484 1.272 0 C-N-CA 124.648 1.179 . . . . 0.0 111.349 -177.501 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.587 ' HG2' ' HB2' ' A' ' 39' ' ' TRP . 31.3 Cg_endo -63.95 162.79 27.69 Favored 'Trans proline' 0 C--N 1.382 2.314 0 C-N-CA 122.645 2.23 . . . . 0.0 111.522 161.22 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 25.2 p -71.93 -24.77 61.68 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 123.52 0.728 . . . . 0.0 112.28 -176.756 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 45.7 m -75.38 -28.64 59.57 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 122.871 0.468 . . . . 0.0 111.319 176.107 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' TRP . . . . . 0.587 ' HB2' ' HG2' ' A' ' 36' ' ' PRO . 36.0 m95 -111.76 175.83 5.27 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 123.692 0.797 . . . . 0.0 110.563 -176.134 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 19.9 mtmt -140.92 128.34 21.2 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 165.5 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.755 ' HB3' ' HB2' ' A' ' 35' ' ' ALA . 13.6 tptm -99.95 126.49 46.12 Favored 'General case' 0 C--N 1.32 -0.679 0 C-N-CA 125.527 1.531 . . . . 0.0 108.502 -174.934 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 6.9 tt -129.07 132.52 47.45 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 114.495 -1.23 . . . . 0.0 107.84 178.867 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.472 ' HB3' HD23 ' A' ' 33' ' ' LEU . 28.9 t80 -110.84 141.93 43.55 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 124.148 0.979 . . . . 0.0 108.785 170.833 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -102.18 99.19 11.9 Favored Pre-proline 0 CA--C 1.55 0.945 0 C-N-CA 123.344 0.658 . . . . 0.0 110.064 174.038 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.401 ' HD2' ' HA ' ' A' ' 30' ' ' SER . 83.4 Cg_endo -79.83 141.54 15.25 Favored 'Trans proline' 0 C--N 1.377 2.035 0 C-N-CA 122.626 2.217 . . . . 0.0 111.114 171.057 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . 0.531 HD22 ' HB3' ' A' ' 53' ' ' LYS . 9.0 p30 -85.69 162.2 18.87 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 110.077 -0.342 . . . . 0.0 110.077 176.938 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 93.1 mttt -65.01 -40.37 94.81 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 123.679 0.792 . . . . 0.0 112.115 -172.347 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.434 ' HB ' HG22 ' A' ' 51' ' ' VAL . 53.2 t -72.93 -34.42 46.15 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.195 0 C-N-CA 123.589 0.756 . . . . 0.0 110.724 179.421 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 92.6 -50.71 2.63 Favored Glycine 0 CA--C 1.532 1.137 0 CA-C-N 115.392 -0.822 . . . . 0.0 112.47 -172.575 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 38.3 m -79.34 -27.76 42.03 Favored 'General case' 0 N--CA 1.479 0.986 0 N-CA-C 113.395 0.887 . . . . 0.0 113.395 -171.642 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.434 HG22 ' HB ' ' A' ' 48' ' ' VAL . 25.2 m -88.85 -167.26 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 N-CA-C 112.335 0.494 . . . . 0.0 112.335 -170.894 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 94.9 mttt -56.96 138.86 53.56 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 124.172 0.989 . . . . 0.0 111.898 179.176 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.537 ' H ' ' HE3' ' A' ' 53' ' ' LYS . 0.0 OUTLIER -140.17 154.84 47.08 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 124.126 0.97 . . . . 0.0 108.818 179.213 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 50.6 m -71.94 138.97 48.46 Favored 'General case' 0 C--O 1.243 0.752 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 171.901 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -69.07 -172.97 0.45 Allowed 'General case' 0 C--O 1.243 0.731 0 CA-C-O 121.995 0.903 . . . . 0.0 110.911 179.273 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 48.2 t -81.67 138.99 18.62 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.787 0 CA-C-N 114.821 -1.082 . . . . 0.0 111.199 -170.847 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 59.1 t -112.13 115.33 49.53 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.945 0 C-N-CA 124.336 1.055 . . . . 0.0 109.206 174.854 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 45.6 m-85 -100.1 113.41 26.02 Favored 'General case' 0 N--CA 1.481 1.124 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 172.362 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.402 HG23 ' HB3' ' A' ' 65' ' ' GLU . 5.1 p -81.27 131.93 32.74 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 N-CA-C 109.168 -0.679 . . . . 0.0 109.168 179.671 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -92.26 145.62 31.05 Favored Pre-proline 0 CA--C 1.546 0.792 0 C-N-CA 122.814 0.445 . . . . 0.0 112.066 -171.345 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_endo -60.14 -36.42 88.87 Favored 'Trans proline' 0 C--N 1.381 2.285 0 C-N-CA 124.104 3.203 . . . . 0.0 113.724 -177.025 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 6.6 t -77.86 -9.52 59.1 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 122.779 0.432 . . . . 0.0 111.283 -179.368 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 94.57 23.92 19.87 Favored Glycine 0 C--N 1.35 1.342 0 CA-C-N 116.348 -0.387 . . . . 0.0 113.826 179.294 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -112.96 71.31 0.74 Allowed 'General case' 0 N--CA 1.474 0.73 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 178.729 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.402 ' HB3' HG23 ' A' ' 59' ' ' VAL . 0.6 OUTLIER -58.81 145.78 39.5 Favored 'General case' 0 N--CA 1.48 1.032 0 CA-C-N 115.211 -0.904 . . . . 0.0 112.062 -173.299 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.435 HG13 HD22 ' A' ' 72' ' ' LEU . 44.5 mm -111.24 127.26 68.5 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.589 0 C-N-CA 124.301 1.04 . . . . 0.0 110.062 -172.347 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 42.8 p -101.27 -13.58 18.01 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 123.88 0.872 . . . . 0.0 111.754 -178.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 11.5 p-10 -160.01 152.2 20.64 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 123.228 0.611 . . . . 0.0 111.045 -167.65 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.547 ' HG3' HD11 ' A' ' 85' ' ' ILE . 72.5 ttt-85 -56.17 -36.09 67.95 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 125.194 1.397 . . . . 0.0 113.357 -171.562 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 7.4 tmtm? -57.57 -49.94 74.74 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 123.885 0.874 . . . . 0.0 110.281 178.868 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.49 ' HA ' ' HG3' ' A' ' 74' ' ' GLN . 86.7 mm-40 -68.1 -24.07 64.99 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 115.14 -0.937 . . . . 0.0 111.733 -175.602 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.438 HD12 ' HB ' ' A' ' 85' ' ' ILE . 0.3 OUTLIER -66.35 -50.46 63.47 Favored 'General case' 0 N--CA 1.477 0.913 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 175.636 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -64.16 -47.99 77.73 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 124.233 1.013 . . . . 0.0 111.211 -176.081 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . 0.49 ' HG3' ' HA ' ' A' ' 71' ' ' GLN . 0.0 OUTLIER -68.29 -26.99 65.92 Favored 'General case' 0 CA--C 1.548 0.903 0 CA-C-N 115.802 -0.636 . . . . 0.0 111.427 179.4 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 59.2 t80 -63.66 -52.36 61.05 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 122.943 0.497 . . . . 0.0 110.202 173.854 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 96.6 mt -64.9 -39.24 93.21 Favored 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 123.487 0.715 . . . . 0.0 112.461 -171.902 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -73.42 -21.6 60.43 Favored 'General case' 0 N--CA 1.479 0.982 0 CA-C-N 116.667 -0.242 . . . . 0.0 111.133 178.25 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 46.2 m -99.58 -6.37 27.51 Favored 'General case' 0 N--CA 1.487 1.414 0 C-N-CA 123.093 0.557 . . . . 0.0 112.393 175.309 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 73.8 m80 -141.92 80.88 15.1 Favored Pre-proline 0 N--CA 1.479 1.0 0 C-N-CA 124.022 0.929 . . . . 0.0 108.54 179.147 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -68.31 149.86 75.85 Favored 'Trans proline' 0 C--N 1.375 1.922 0 C-N-CA 122.541 2.16 . . . . 0.0 111.996 178.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 103.23 -20.65 42.14 Favored Glycine 0 C--N 1.34 0.795 0 CA-C-N 116.262 -0.426 . . . . 0.0 112.693 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 18.7 m120 -82.42 142.07 46.29 Favored Pre-proline 0 CA--C 1.548 0.893 0 C-N-CA 123.238 0.615 . . . . 0.0 110.555 179.343 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_endo -55.72 145.94 68.67 Favored 'Trans proline' 0 C--N 1.385 2.466 0 C-N-CA 123.428 2.752 . . . . 0.0 113.395 -174.929 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.415 ' O ' ' HG2' ' A' ' 87' ' ' GLU . . . -68.98 160.01 31.69 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 124.156 0.982 . . . . 0.0 112.332 -170.865 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.547 HD11 ' HG3' ' A' ' 69' ' ' ARG . 14.1 tt -73.19 -22.69 19.55 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.966 0 C-N-CA 123.071 0.548 . . . . 0.0 110.8 177.345 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -63.32 -26.69 68.88 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 123.658 0.783 . . . . 0.0 111.863 -179.83 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.415 ' HG2' ' O ' ' A' ' 84' ' ' ALA . 15.0 pt-20 -96.71 -3.17 43.03 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 122.972 0.509 . . . . 0.0 111.567 177.874 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 5.3 m-30 -93.13 120.47 33.46 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 123.524 0.729 . . . . 0.0 109.655 178.188 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 13.8 p-10 -91.59 98.87 11.92 Favored 'General case' 0 N--CA 1.476 0.826 0 CA-C-O 122.042 0.925 . . . . 0.0 111.182 -176.74 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 88.0 m95 -83.19 -25.68 31.56 Favored 'General case' 0 N--CA 1.48 1.063 0 CA-C-N 115.095 -0.957 . . . . 0.0 110.297 171.763 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 14.9 t -82.22 13.35 3.55 Favored 'General case' 0 CA--C 1.554 1.123 0 C-N-CA 124.372 1.069 . . . . 0.0 112.485 -173.863 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 15.0 t -62.73 -24.12 67.52 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 122.726 0.41 . . . . 0.0 111.269 174.807 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 27.1 p -82.4 -41.94 19.26 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 123.871 0.869 . . . . 0.0 110.362 172.782 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -89.45 58.92 3.79 Favored Glycine 0 C--N 1.347 1.189 0 CA-C-N 115.496 -0.774 . . . . 0.0 112.916 -176.508 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 3.7 t . . . . . 0 CA--C 1.56 1.341 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 173.891 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.1 tpt . . . . . 0 N--CA 1.488 1.463 0 N-CA-C 110.31 -0.256 . . . . 0.0 110.31 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 42.5 m80 -86.06 82.98 7.88 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 123.535 0.734 . . . . 0.0 109.724 -179.274 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 22.4 t-160 -136.06 -66.73 0.54 Allowed 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 123.126 0.57 . . . . 0.0 109.657 -179.942 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 10.0 p-80 -86.7 56.93 4.22 Favored 'General case' 0 N--CA 1.486 1.334 0 CA-C-O 121.808 0.814 . . . . 0.0 110.267 177.384 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 56.1 t-80 -164.27 154.39 14.56 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 108.312 -0.996 . . . . 0.0 108.312 -175.694 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 31.6 t60 -56.4 114.81 2.16 Favored 'General case' 0 N--CA 1.486 1.368 0 C-N-CA 123.219 0.607 . . . . 0.0 110.192 176.908 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 23.1 m170 -59.79 133.12 55.8 Favored 'General case' 0 CA--C 1.548 0.89 0 O-C-N 124.236 0.96 . . . . 0.0 111.113 -175.676 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 13.9 m -65.87 -26.05 67.46 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 124.463 1.105 . . . . 0.0 112.489 -172.904 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 34.4 t -71.24 -27.38 63.42 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 123.027 0.531 . . . . 0.0 110.824 176.69 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -92.68 26.76 12.76 Favored Glycine 0 C--N 1.346 1.117 0 CA-C-N 116.024 -0.534 . . . . 0.0 112.851 178.423 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 77.9 ttt180 -71.24 -38.0 71.97 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 123.387 0.675 . . . . 0.0 110.603 178.018 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -70.83 92.94 0.93 Allowed 'General case' 0 CA--C 1.545 0.777 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 -178.761 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 12.3 m120 -110.47 89.82 3.14 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 123.795 0.838 . . . . 0.0 108.806 179.277 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 1.1 pp -162.78 -47.89 0.04 OUTLIER 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 124.624 1.17 . . . . 0.0 108.624 -179.052 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 74.6 m-85 -143.92 -71.27 0.29 Allowed 'General case' 0 C--O 1.237 0.415 0 C-N-CA 124.729 1.212 . . . . 0.0 108.083 171.394 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 49.7 t80 57.11 30.18 17.84 Favored 'General case' 0 CA--C 1.556 1.184 0 C-N-CA 124.482 1.113 . . . . 0.0 111.028 -178.897 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 81.4 mm-40 -86.62 176.18 7.92 Favored 'General case' 0 N--CA 1.476 0.873 0 CA-C-N 114.96 -1.018 . . . . 0.0 110.769 -174.255 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -108.79 160.52 13.6 Favored Glycine 0 C--O 1.24 0.504 0 N-CA-C 111.003 -0.839 . . . . 0.0 111.003 171.367 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 23.2 p80 -69.91 122.04 18.52 Favored 'General case' 0 N--CA 1.484 1.261 0 CA-C-N 117.416 0.608 . . . . 0.0 109.555 178.168 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 46.1 ttm 62.85 95.26 0.04 OUTLIER 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 124.684 1.194 . . . . 0.0 111.174 -179.564 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -63.39 105.84 0.81 Allowed 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 123.796 0.838 . . . . 0.0 111.505 -175.264 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 21.1 t -155.84 143.05 19.22 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 124.189 0.995 . . . . 0.0 108.993 179.082 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 130.76 -5.52 5.8 Favored Glycine 0 N--CA 1.472 1.06 0 CA-C-O 119.358 -0.69 . . . . 0.0 113.159 -179.655 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 22.0 t 68.7 107.75 0.05 Allowed 'General case' 0 CA--C 1.553 1.076 0 C-N-CA 125.387 1.475 . . . . 0.0 110.815 -179.766 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -66.93 118.16 10.01 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 124.183 0.993 . . . . 0.0 111.812 -173.235 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 63.8 mm-40 55.81 34.02 22.64 Favored 'General case' 0 N--CA 1.489 1.5 0 C-N-CA 124.381 1.072 . . . . 0.0 112.507 174.727 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -66.92 99.81 0.67 Allowed 'General case' 0 C--N 1.355 0.815 0 CA-C-O 121.007 0.432 . . . . 0.0 110.328 -177.229 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 35.8 m -108.75 167.72 3.94 Favored 'Isoleucine or valine' 0 C--O 1.241 0.639 0 C-N-CA 124.239 1.016 . . . . 0.0 109.599 176.74 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 17.1 m -98.73 132.79 43.27 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 C-N-CA 123.365 0.666 . . . . 0.0 110.197 177.827 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 60.9 p -146.7 113.48 6.07 Favored 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 174.519 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 61.1 t -101.7 131.33 49.8 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 -178.233 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 -84.11 111.66 19.52 Favored 'General case' 0 CA--C 1.536 0.436 0 N-CA-C 108.971 -0.752 . . . . 0.0 108.971 178.521 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.489 ' HG ' HG21 ' A' ' 92' ' ' THR . 4.1 mm? -91.92 165.13 21.14 Favored Pre-proline 0 CA--C 1.559 1.321 0 C-N-CA 124.704 1.202 . . . . 0.0 109.95 -177.118 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_endo -59.76 143.96 99.53 Favored 'Trans proline' 0 C--N 1.393 2.908 0 C-N-CA 122.927 2.418 . . . . 0.0 113.356 -177.851 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.469 ' HB2' ' HB3' ' A' ' 41' ' ' LYS . . . -138.58 165.22 34.39 Favored Pre-proline 0 N--CA 1.474 0.746 0 C-N-CA 123.972 0.909 . . . . 0.0 111.632 -169.561 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.698 ' HG2' ' HB2' ' A' ' 39' ' ' TRP . 37.4 Cg_endo -65.09 155.61 67.35 Favored 'Trans proline' 0 C--N 1.381 2.253 0 C-N-CA 122.468 2.112 . . . . 0.0 110.8 162.663 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 34.3 t -57.55 -38.49 74.85 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 124.622 1.169 . . . . 0.0 112.895 -171.473 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 11.0 p -77.78 -40.19 41.6 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 123.342 0.657 . . . . 0.0 111.878 -177.582 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' TRP . . . . . 0.698 ' HB2' ' HG2' ' A' ' 36' ' ' PRO . 29.4 m95 -93.26 -174.63 3.59 Favored 'General case' 0 N--CA 1.478 0.944 0 CA-C-O 121.628 0.728 . . . . 0.0 111.336 -178.495 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.705 ' HB3' ' HB ' ' A' ' 59' ' ' VAL . 40.2 ttmt -143.55 144.83 32.12 Favored 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 107.336 -1.357 . . . . 0.0 107.336 173.452 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.469 ' HB3' ' HB2' ' A' ' 35' ' ' ALA . 18.4 tptp -120.23 125.9 49.28 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 124.063 0.945 . . . . 0.0 109.092 -174.511 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.461 HD22 ' HB ' ' A' ' 57' ' ' VAL . 4.3 tt -124.85 149.43 47.49 Favored 'General case' 0 C--O 1.236 0.393 0 C-N-CA 125.127 1.371 . . . . 0.0 108.694 176.648 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.423 ' HB3' HD23 ' A' ' 33' ' ' LEU . 34.3 t80 -135.26 135.58 41.0 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 124.943 1.297 . . . . 0.0 108.27 175.912 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 36.1 m-85 -95.93 103.96 15.05 Favored Pre-proline 0 N--CA 1.48 1.058 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 170.233 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 63.8 Cg_endo -83.4 -162.06 0.16 Allowed 'Trans proline' 0 C--N 1.37 1.669 0 C-N-CA 122.717 2.278 . . . . 0.0 111.397 170.452 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . 0.543 ' HB3' ' HA ' ' A' ' 51' ' ' VAL . 7.4 p30 -115.47 172.58 7.01 Favored 'General case' 0 N--CA 1.472 0.64 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 169.798 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 38.7 ttpt -111.25 -60.91 1.77 Allowed 'General case' 0 CA--C 1.539 0.543 0 N-CA-C 108.374 -0.973 . . . . 0.0 108.374 175.866 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 60.3 t -131.13 -63.68 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 N-CA-C 107.999 -1.111 . . . . 0.0 107.999 172.251 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -95.91 166.97 25.14 Favored Glycine 0 C--N 1.345 1.076 0 CA-C-N 115.272 -0.876 . . . . 0.0 112.66 179.581 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 25.6 m 58.33 69.82 0.7 Allowed 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 124.917 1.287 . . . . 0.0 111.6 179.05 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.543 ' HA ' ' HB3' ' A' ' 46' ' ' ASN . 33.5 m -72.59 142.88 14.59 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 CA-C-N 115.599 -0.728 . . . . 0.0 109.752 175.628 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 8.4 mtpm? 58.19 54.77 5.56 Favored 'General case' 0 N--CA 1.48 1.025 0 C-N-CA 123.863 0.865 . . . . 0.0 109.291 -169.758 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 7.1 tmtt? -55.9 -59.04 5.45 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 124.479 1.112 . . . . 0.0 109.667 -173.486 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 33.6 m -134.47 157.2 47.09 Favored 'General case' 0 CA--C 1.548 0.904 0 C-N-CA 124.614 1.165 . . . . 0.0 107.911 169.529 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -75.6 -169.52 1.06 Allowed 'General case' 0 CA--C 1.557 1.217 0 C-N-CA 123.478 0.711 . . . . 0.0 111.492 178.844 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 46.7 t -81.72 134.77 26.35 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.668 0 C-N-CA 124.2 1.0 . . . . 0.0 110.416 -176.263 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.461 ' HB ' HD22 ' A' ' 42' ' ' LEU . 96.7 t -120.4 122.65 68.72 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 C-N-CA 124.005 0.922 . . . . 0.0 108.913 177.745 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 24.7 m-85 -97.85 121.15 39.42 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 123.602 0.761 . . . . 0.0 109.864 172.266 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.705 ' HB ' ' HB3' ' A' ' 40' ' ' LYS . 11.0 t -79.43 129.92 36.86 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 172.134 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -84.45 158.42 60.38 Favored Pre-proline 0 CA--C 1.542 0.659 0 CA-C-N 114.904 -1.044 . . . . 0.0 110.912 -175.766 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -63.53 -25.72 69.94 Favored 'Trans proline' 0 C--N 1.374 1.893 0 C-N-CA 123.005 2.47 . . . . 0.0 113.1 176.226 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.457 HG22 ' OH ' ' A' ' 75' ' ' TYR . 14.7 t -97.52 -3.7 39.33 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 123.5 0.72 . . . . 0.0 111.241 177.729 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 93.79 -12.83 68.69 Favored Glycine 0 C--N 1.354 1.577 0 CA-C-O 119.701 -0.5 . . . . 0.0 113.473 179.351 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 44.6 tt0 -73.88 77.63 1.63 Allowed 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 123.903 0.881 . . . . 0.0 109.77 178.862 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -67.41 158.39 31.86 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-N 114.786 -1.097 . . . . 0.0 112.229 -170.006 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.4 HG23 ' HB2' ' A' ' 71' ' ' GLN . 47.7 mm -121.21 131.2 73.6 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.598 0 C-N-CA 125.168 1.387 . . . . 0.0 108.891 -172.201 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 24.3 p -105.86 -17.94 14.21 Favored 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 123.984 0.914 . . . . 0.0 112.141 179.206 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 9.2 p30 -143.64 157.24 44.56 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 122.538 0.335 . . . . 0.0 111.235 -173.284 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 29.7 ttp180 -63.38 -30.62 71.72 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 123.917 0.887 . . . . 0.0 112.342 -171.585 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 5.5 tmtm? -59.89 -54.85 41.39 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 123.793 0.837 . . . . 0.0 109.116 -179.67 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.411 ' HA ' ' HG3' ' A' ' 74' ' ' GLN . 88.3 mm-40 -64.1 -25.55 68.15 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-N 115.006 -0.997 . . . . 0.0 111.597 -177.791 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.407 ' O ' ' HG ' ' A' ' 76' ' ' LEU . 0.4 OUTLIER -66.47 -56.71 9.66 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 123.477 0.711 . . . . 0.0 109.131 176.672 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -58.74 -48.93 79.47 Favored 'General case' 0 N--CA 1.486 1.334 0 C-N-CA 124.393 1.077 . . . . 0.0 111.71 -176.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . 0.411 ' HG3' ' HA ' ' A' ' 71' ' ' GLN . 0.0 OUTLIER -70.6 -24.24 62.71 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-N 115.472 -0.785 . . . . 0.0 111.538 -177.375 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . 0.457 ' OH ' HG22 ' A' ' 62' ' ' THR . 18.9 t80 -68.18 -49.56 60.07 Favored 'General case' 0 N--CA 1.479 0.985 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 172.561 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.407 ' HG ' ' O ' ' A' ' 72' ' ' LEU . 69.0 mt -59.68 -41.36 90.51 Favored 'General case' 0 N--CA 1.485 1.306 0 C-N-CA 123.053 0.541 . . . . 0.0 111.563 -173.17 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 54.9 pttt -73.39 -34.54 65.58 Favored 'General case' 0 N--CA 1.479 1.014 0 O-C-N 123.181 0.301 . . . . 0.0 111.63 -179.729 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 80.9 p -83.02 -17.7 42.4 Favored 'General case' 0 N--CA 1.487 1.423 0 C-N-CA 122.828 0.451 . . . . 0.0 111.582 -178.181 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 75.5 m80 -122.89 102.79 37.59 Favored Pre-proline 0 N--CA 1.48 1.027 0 C-N-CA 123.832 0.853 . . . . 0.0 109.237 -177.465 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -67.68 154.69 72.62 Favored 'Trans proline' 0 C--N 1.378 2.099 0 C-N-CA 122.928 2.418 . . . . 0.0 113.051 -177.785 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 84.04 -9.73 62.58 Favored Glycine 0 C--N 1.349 1.285 0 CA-C-N 115.631 -0.713 . . . . 0.0 114.293 175.243 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 25.0 m-80 -74.65 148.1 85.04 Favored Pre-proline 0 N--CA 1.483 1.211 0 C-N-CA 123.432 0.693 . . . . 0.0 111.178 -178.058 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -68.92 163.99 35.36 Favored 'Trans proline' 0 C--N 1.377 2.068 0 C-N-CA 123.233 2.622 . . . . 0.0 113.176 -177.794 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.485 ' O ' ' HG2' ' A' ' 87' ' ' GLU . . . -71.48 150.74 44.58 Favored 'General case' 0 N--CA 1.476 0.841 0 CA-C-N 115.066 -0.97 . . . . 0.0 111.243 -175.698 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 19.6 tt -72.88 -20.83 19.19 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.111 0 CA-C-O 120.968 0.413 . . . . 0.0 110.877 179.759 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -63.93 -30.13 71.24 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 123.681 0.793 . . . . 0.0 112.377 -179.019 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.485 ' HG2' ' O ' ' A' ' 84' ' ' ALA . 13.4 pt-20 -88.61 -7.49 56.31 Favored 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 123.215 0.606 . . . . 0.0 111.275 178.553 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -83.14 116.48 22.36 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 123.64 0.776 . . . . 0.0 110.365 176.356 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -75.69 128.47 35.27 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 123.86 0.864 . . . . 0.0 110.268 175.662 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 81.1 m95 -119.0 -1.2 11.01 Favored 'General case' 0 CA--C 1.555 1.138 0 C-N-CA 123.28 0.632 . . . . 0.0 110.151 166.325 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 14.2 t -112.39 12.67 20.17 Favored 'General case' 0 CA--C 1.565 1.538 0 N-CA-C 113.569 0.952 . . . . 0.0 113.569 -165.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.489 HG21 ' HG ' ' A' ' 33' ' ' LEU . 15.1 t -63.28 -14.35 48.55 Favored 'General case' 0 N--CA 1.502 2.171 0 N-CA-C 113.515 0.931 . . . . 0.0 113.515 -174.342 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 32.4 p -61.44 -26.42 67.86 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 123.629 0.772 . . . . 0.0 111.803 178.093 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 110.03 91.53 2.12 Favored Glycine 0 C--N 1.344 1.007 0 N-CA-C 111.487 -0.645 . . . . 0.0 111.487 177.777 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 8.9 t . . . . . 0 CA--C 1.565 1.536 0 C-N-CA 123.688 0.795 . . . . 0.0 111.064 179.325 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.2 mmt . . . . . 0 N--CA 1.472 0.674 0 CA-C-O 120.714 0.293 . . . . 0.0 110.49 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 33.1 p80 -76.48 17.36 0.39 Allowed 'General case' 0 N--CA 1.486 1.35 0 N-CA-C 112.968 0.729 . . . . 0.0 112.968 -177.69 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 39.0 t60 -138.61 147.06 42.51 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 124.573 1.149 . . . . 0.0 108.204 171.747 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 54.9 m80 -130.86 147.9 52.56 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 123.102 0.561 . . . . 0.0 109.748 177.022 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 61.6 t-80 -96.59 153.53 17.8 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 124.03 0.932 . . . . 0.0 110.353 -175.261 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 30.0 m-70 -57.69 146.13 32.0 Favored 'General case' 0 N--CA 1.486 1.356 0 C-N-CA 123.483 0.713 . . . . 0.0 111.179 176.451 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 47.6 p-80 -154.74 143.28 20.62 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 123.88 0.872 . . . . 0.0 109.255 -178.119 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 22.5 p -72.53 -61.24 1.87 Allowed 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 175.808 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 73.8 m -160.41 -45.23 0.05 OUTLIER 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 124.563 1.145 . . . . 0.0 109.661 177.329 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 81.18 -152.29 32.54 Favored Glycine 0 C--N 1.346 1.122 0 CA-C-N 115.016 -0.993 . . . . 0.0 111.891 -175.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 76.1 ttt180 -151.42 110.59 3.92 Favored 'General case' 0 CA--C 1.538 0.481 0 N-CA-C 108.682 -0.858 . . . . 0.0 108.682 -179.882 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 3.3 tm-20 -145.79 97.79 3.02 Favored 'General case' 0 N--CA 1.472 0.672 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 -178.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 23.7 m-80 -149.8 85.18 1.42 Allowed 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 124.342 1.057 . . . . 0.0 108.209 177.583 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -137.9 141.21 40.65 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 123.421 0.688 . . . . 0.0 109.708 173.457 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 9.2 p90 -59.37 -36.56 75.98 Favored 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 123.42 0.688 . . . . 0.0 111.362 179.481 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 54.4 t80 66.62 -1.88 1.2 Allowed 'General case' 0 N--CA 1.489 1.485 0 C-N-CA 125.333 1.453 . . . . 0.0 113.282 173.558 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 15.4 mm100 -76.53 83.44 3.22 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 123.591 0.757 . . . . 0.0 109.377 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -148.96 127.16 2.43 Favored Glycine 0 C--N 1.339 0.747 0 N-CA-C 110.834 -0.906 . . . . 0.0 110.834 -178.443 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 68.5 m80 -84.46 118.84 24.53 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 123.834 0.854 . . . . 0.0 110.133 -177.74 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 21.0 ptt? -139.62 100.9 4.08 Favored 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 124.412 1.085 . . . . 0.0 108.83 -178.752 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -161.93 170.15 19.91 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.861 -174.634 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 38.1 t -150.94 134.07 16.04 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 123.621 0.769 . . . . 0.0 109.12 175.575 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -98.01 -1.94 58.31 Favored Glycine 0 C--N 1.348 1.225 0 O-C-N 123.353 0.408 . . . . 0.0 113.535 -178.851 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 52.8 p -64.72 111.31 2.71 Favored 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 123.136 0.574 . . . . 0.0 110.601 -177.811 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -155.14 121.74 5.35 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 123.056 0.543 . . . . 0.0 109.834 -174.794 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -167.69 114.81 0.74 Allowed 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 123.893 0.877 . . . . 0.0 108.648 176.384 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -78.24 103.69 8.34 Favored 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 177.046 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.415 HG23 ' HE2' ' A' ' 44' ' ' TYR . 24.1 m -71.42 140.51 18.1 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.959 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.82 178.167 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 28.8 m -63.86 122.86 15.55 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.188 0 C-N-CA 123.182 0.593 . . . . 0.0 112.311 -171.468 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.429 ' HB3' ' CE2' ' A' ' 44' ' ' TYR . 45.7 p -135.41 141.66 45.5 Favored 'General case' 0 C--O 1.241 0.646 0 C-N-CA 124.224 1.01 . . . . 0.0 109.376 -178.258 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 95.7 t -123.99 123.78 67.55 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 C-N-CA 124.266 1.026 . . . . 0.0 108.718 174.881 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -82.36 110.38 17.45 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 123.137 0.575 . . . . 0.0 110.201 176.472 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.517 ' HB2' ' HG3' ' A' ' 41' ' ' LYS . 4.1 mm? -85.38 165.19 37.32 Favored Pre-proline 0 CA--C 1.556 1.19 0 C-N-CA 124.584 1.154 . . . . 0.0 110.084 179.92 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 25.1 Cg_endo -59.88 149.46 83.57 Favored 'Trans proline' 0 C--N 1.389 2.674 0 C-N-CA 122.716 2.277 . . . . 0.0 113.834 179.838 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -149.32 170.29 7.88 Favored Pre-proline 0 CA--C 1.551 0.999 0 C-N-CA 124.32 1.048 . . . . 0.0 110.321 -172.264 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_exo -52.54 157.63 6.9 Favored 'Trans proline' 0 C--N 1.385 2.498 0 C-N-CA 122.946 2.43 . . . . 0.0 112.981 165.133 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 44.9 m -60.04 -29.72 68.71 Favored 'General case' 0 CA--C 1.552 1.021 0 C-N-CA 124.07 0.948 . . . . 0.0 112.233 -179.548 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 37.0 t -84.64 -24.57 29.02 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 123.121 0.568 . . . . 0.0 111.713 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 32.1 m95 -114.25 177.15 4.74 Favored 'General case' 0 N--CA 1.483 1.18 0 CA-C-O 121.467 0.651 . . . . 0.0 112.058 -173.331 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 33.5 mtmt -136.45 145.14 44.88 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 124.712 1.205 . . . . 0.0 108.179 170.093 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.523 ' NZ ' ' HB2' ' A' ' 43' ' ' PHE . 22.4 tptp -114.25 135.25 54.26 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 124.523 1.129 . . . . 0.0 108.707 -178.489 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.468 HD22 ' HB ' ' A' ' 57' ' ' VAL . 5.5 tt -125.95 142.42 51.53 Favored 'General case' 0 C--O 1.238 0.481 0 C-N-CA 124.166 0.986 . . . . 0.0 108.803 176.896 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.523 ' HB2' ' NZ ' ' A' ' 41' ' ' LYS . 65.5 t80 -127.09 144.9 50.92 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 124.884 1.274 . . . . 0.0 108.027 172.807 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . 0.429 ' CE2' ' HB3' ' A' ' 30' ' ' SER . 17.8 m-85 -102.44 97.65 9.25 Favored Pre-proline 0 CA--C 1.548 0.868 0 C-N-CA 122.557 0.343 . . . . 0.0 110.12 171.914 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -82.49 89.23 1.19 Allowed 'Trans proline' 0 C--N 1.38 2.234 0 C-N-CA 122.945 2.43 . . . . 0.0 112.006 176.029 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . 0.41 ' ND2' ' HA ' ' A' ' 53' ' ' LYS . 23.6 m120 -74.07 105.93 5.52 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 115.033 -0.985 . . . . 0.0 109.764 179.27 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.534 ' HA ' ' HE2' ' A' ' 47' ' ' LYS . 11.9 mmpt? -64.38 -38.39 90.86 Favored 'General case' 0 CA--C 1.543 0.694 0 CA-C-N 114.528 -1.215 . . . . 0.0 111.639 -174.819 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.534 HG12 ' H ' ' A' ' 50' ' ' SER . 71.4 t -122.15 131.6 72.81 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 N-CA-C 107.445 -1.317 . . . . 0.0 107.445 171.08 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -67.98 -16.03 67.93 Favored Glycine 0 CA--C 1.535 1.293 0 N-CA-C 114.087 0.395 . . . . 0.0 114.087 -177.649 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . 0.534 ' H ' HG12 ' A' ' 48' ' ' VAL . 25.6 m -73.45 -17.25 61.26 Favored 'General case' 0 CA--C 1.552 1.037 0 C-N-CA 123.531 0.732 . . . . 0.0 112.416 -179.738 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.486 HG22 ' O ' ' A' ' 48' ' ' VAL . 5.8 m -83.23 -175.77 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 C-N-CA 122.597 0.359 . . . . 0.0 110.796 -179.02 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 12.6 mptt -66.93 88.65 0.15 Allowed 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 123.134 0.574 . . . . 0.0 110.248 -179.39 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.556 ' H ' ' HD3' ' A' ' 53' ' ' LYS . 0.2 OUTLIER -77.5 120.81 23.0 Favored 'General case' 0 C--N 1.349 0.562 0 CA-C-N 115.595 -0.73 . . . . 0.0 109.897 -178.608 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 1.1 p -129.93 165.49 21.98 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 123.578 0.751 . . . . 0.0 109.852 -176.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -98.1 -167.11 1.46 Allowed 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 123.965 0.906 . . . . 0.0 111.671 -167.416 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.412 ' CG1' ' HE2' ' A' ' 41' ' ' LYS . 31.9 t -81.85 134.29 27.38 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.404 0 CA-C-N 114.891 -1.05 . . . . 0.0 110.052 177.52 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.468 ' HB ' HD22 ' A' ' 42' ' ' LEU . 98.6 t -121.11 130.23 74.88 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 C-N-CA 124.089 0.956 . . . . 0.0 108.928 175.137 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 9.1 m-85 -101.86 119.5 38.88 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 123.297 0.639 . . . . 0.0 109.281 171.376 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.42 ' HA ' ' HG2' ' A' ' 65' ' ' GLU . 14.8 t -78.37 123.81 35.78 Favored 'Isoleucine or valine' 0 C--O 1.239 0.532 0 C-N-CA 123.518 0.727 . . . . 0.0 109.744 176.331 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -82.07 151.98 67.62 Favored Pre-proline 0 CA--C 1.54 0.582 0 CA-C-N 114.335 -1.302 . . . . 0.0 110.873 -175.639 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_endo -60.48 -33.3 94.08 Favored 'Trans proline' 0 C--N 1.374 1.894 0 C-N-CA 123.245 2.63 . . . . 0.0 112.697 177.41 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.496 HG23 ' H ' ' A' ' 64' ' ' GLU . 11.4 t -85.82 -12.82 49.9 Favored 'General case' 0 CA--C 1.545 0.781 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.292 178.207 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 94.57 -1.12 65.98 Favored Glycine 0 C--N 1.357 1.7 0 CA-C-O 120.053 -0.304 . . . . 0.0 113.64 -177.276 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.496 ' H ' HG23 ' A' ' 62' ' ' THR . 33.0 tt0 -78.31 71.87 4.8 Favored 'General case' 0 N--CA 1.48 1.064 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 174.497 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.42 ' HG2' ' HA ' ' A' ' 59' ' ' VAL . 34.1 mt-10 -66.01 148.57 51.59 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-N 114.775 -1.102 . . . . 0.0 111.771 -169.138 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 48.6 mm -115.17 131.11 68.4 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.557 0 C-N-CA 124.44 1.096 . . . . 0.0 110.167 -168.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 61.0 p -101.52 -21.12 14.83 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 123.596 0.758 . . . . 0.0 112.482 -178.758 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 7.8 p30 -143.52 159.36 42.57 Favored 'General case' 0 N--CA 1.481 1.111 0 CA-C-O 120.8 0.333 . . . . 0.0 111.802 -172.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 55.1 ttt-85 -65.69 -29.29 69.81 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 124.144 0.978 . . . . 0.0 111.968 -171.913 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 7.8 tmtm? -61.18 -54.94 38.0 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 123.352 0.661 . . . . 0.0 109.318 176.782 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 14.2 mm100 -67.5 -20.13 65.41 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-N 115.591 -0.732 . . . . 0.0 111.821 -176.581 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.422 ' O ' ' HG ' ' A' ' 76' ' ' LEU . 0.6 OUTLIER -70.91 -56.45 6.22 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 176.221 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -62.94 -41.83 99.62 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 123.526 0.731 . . . . 0.0 111.191 -176.784 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.47 -28.69 66.31 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 122.684 0.394 . . . . 0.0 110.648 177.467 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . 0.426 ' OH ' HG22 ' A' ' 62' ' ' THR . 20.9 t80 -63.06 -49.72 73.41 Favored 'General case' 0 N--CA 1.482 1.128 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 172.789 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.422 ' HG ' ' O ' ' A' ' 72' ' ' LEU . 72.5 mt -61.62 -37.15 82.9 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 123.313 0.645 . . . . 0.0 111.869 -172.341 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.04 -35.71 49.4 Favored 'General case' 0 CA--C 1.548 0.885 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.13 176.847 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 30.0 t -79.03 -16.38 56.94 Favored 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 123.011 0.524 . . . . 0.0 111.541 -179.412 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 76.9 m-70 -129.57 82.81 66.5 Favored Pre-proline 0 CA--C 1.544 0.72 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 178.091 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -64.76 142.26 75.65 Favored 'Trans proline' 0 C--N 1.372 1.803 0 C-N-CA 122.776 2.318 . . . . 0.0 112.543 -178.902 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 105.18 -14.8 47.88 Favored Glycine 0 C--N 1.348 1.246 0 CA-C-N 116.125 -0.489 . . . . 0.0 112.67 -178.024 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 18.4 m-80 -76.62 146.49 76.88 Favored Pre-proline 0 N--CA 1.485 1.316 0 C-N-CA 123.588 0.755 . . . . 0.0 111.526 179.633 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -63.37 158.43 45.07 Favored 'Trans proline' 0 C--N 1.383 2.393 0 C-N-CA 123.019 2.479 . . . . 0.0 113.541 -178.023 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.441 ' O ' ' HG2' ' A' ' 87' ' ' GLU . . . -73.83 144.52 45.47 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-N 114.879 -1.055 . . . . 0.0 111.756 -174.941 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 16.7 tt -67.03 -12.32 14.98 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.311 0 C-N-CA 123.129 0.572 . . . . 0.0 111.657 179.736 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -57.0 -38.86 73.67 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 124.38 1.072 . . . . 0.0 112.297 173.687 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.441 ' HG2' ' O ' ' A' ' 84' ' ' ALA . 11.6 pt-20 -92.76 0.21 57.38 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 123.235 0.614 . . . . 0.0 111.518 -179.569 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -85.26 110.75 19.29 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 123.044 0.537 . . . . 0.0 109.746 177.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -83.17 93.78 7.72 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 123.962 0.905 . . . . 0.0 109.941 -178.625 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 78.7 m95 -79.43 -42.45 25.38 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 123.433 0.693 . . . . 0.0 109.996 171.418 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 12.8 t -82.05 13.84 3.16 Favored 'General case' 0 CA--C 1.559 1.294 0 C-N-CA 124.4 1.08 . . . . 0.0 112.483 -172.859 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 11.4 t -80.12 51.82 1.44 Allowed 'General case' 0 CA--C 1.561 1.397 0 CA-C-O 122.119 0.961 . . . . 0.0 110.716 172.79 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 14.9 p -58.59 105.55 0.31 Allowed 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 123.95 0.9 . . . . 0.0 110.771 179.597 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -59.37 105.73 0.78 Allowed Glycine 0 C--N 1.349 1.305 0 O-C-N 123.791 0.682 . . . . 0.0 112.316 179.022 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 34.5 p . . . . . 0 C--O 1.251 1.167 0 C-N-CA 124.398 1.079 . . . . 0.0 109.101 179.439 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.36 0 CA-C-O 120.835 0.35 . . . . 0.0 110.663 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 17.0 p80 -133.71 104.32 6.28 Favored 'General case' 0 C--O 1.246 0.921 0 N-CA-C 107.147 -1.427 . . . . 0.0 107.147 172.806 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 38.3 m80 64.03 -175.62 0.16 Allowed 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 123.903 0.881 . . . . 0.0 110.941 -171.229 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 95.8 m-70 -141.54 162.36 35.68 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 123.201 0.6 . . . . 0.0 111.328 -179.327 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 30.9 m-70 -97.95 148.37 23.53 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 114.836 -1.074 . . . . 0.0 110.173 176.913 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 8.6 p-80 -142.49 31.49 1.5 Allowed 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 124.044 0.938 . . . . 0.0 109.36 175.507 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 16.8 t60 -61.25 136.34 58.02 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 124.331 1.052 . . . . 0.0 110.572 -176.881 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 48.1 m -63.92 97.93 0.18 Allowed 'General case' 0 CA--C 1.547 0.828 0 O-C-N 123.636 0.585 . . . . 0.0 110.39 178.473 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 62.7 m -140.63 160.34 40.23 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-N 115.199 -0.909 . . . . 0.0 110.884 -173.273 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 108.64 141.03 9.36 Favored Glycine 0 C--N 1.349 1.265 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.578 -177.91 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -80.96 124.23 28.97 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 123.143 0.577 . . . . 0.0 109.72 179.792 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -150.29 155.49 39.78 Favored 'General case' 0 CA--C 1.552 1.026 0 N-CA-C 106.732 -1.581 . . . . 0.0 106.732 179.226 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 70.75 19.77 5.83 Favored 'General case' 0 N--CA 1.499 1.985 0 C-N-CA 124.126 0.97 . . . . 0.0 109.435 -169.977 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 2.5 pp -68.44 -43.8 76.29 Favored 'General case' 0 N--CA 1.478 0.944 0 CA-C-N 114.547 -1.206 . . . . 0.0 110.971 -178.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 76.3 m-85 -141.95 -84.73 0.18 Allowed 'General case' 0 CA--C 1.54 0.587 0 N-CA-C 106.948 -1.501 . . . . 0.0 106.948 171.327 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 54.5 t80 50.95 35.49 12.7 Favored 'General case' 0 CA--C 1.559 1.32 0 C-N-CA 124.374 1.07 . . . . 0.0 111.478 177.264 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 28.1 mm-40 -68.17 -59.69 3.04 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 124.578 1.151 . . . . 0.0 110.919 -176.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 137.85 81.63 0.1 OUTLIER Glycine 0 C--N 1.347 1.152 0 N-CA-C 111.785 -0.526 . . . . 0.0 111.785 179.089 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 39.0 p-80 -68.55 127.44 33.01 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 123.2 0.6 . . . . 0.0 110.077 176.044 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -100.81 121.04 41.02 Favored 'General case' 0 N--CA 1.473 0.721 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 173.097 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -79.88 -77.18 0.19 Allowed 'General case' 0 CA--C 1.545 0.785 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 178.843 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 28.5 t 179.95 164.32 1.13 Allowed 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 124.434 1.094 . . . . 0.0 109.025 179.122 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -167.0 -159.33 12.39 Favored Glycine 0 C--N 1.341 0.81 0 N-CA-C 111.569 -0.613 . . . . 0.0 111.569 -179.715 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 41.4 m -95.19 83.49 3.9 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 123.439 0.696 . . . . 0.0 110.098 179.183 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 11.6 tp10 -130.73 120.06 23.27 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 124.0 0.92 . . . . 0.0 109.874 177.83 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 4.5 mp0 -93.11 97.14 10.48 Favored 'General case' 0 C--O 1.242 0.678 0 N-CA-C 109.063 -0.718 . . . . 0.0 109.063 -178.227 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -79.88 78.47 6.48 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-O 121.654 0.74 . . . . 0.0 109.39 178.599 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 27.4 m -95.56 175.99 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 CA-C-N 115.008 -0.996 . . . . 0.0 110.984 -176.504 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.523 HG11 ' HG2' ' A' ' 47' ' ' LYS . 12.8 m -67.8 112.47 2.97 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.938 0 CA-C-N 115.359 -0.837 . . . . 0.0 110.98 178.539 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 15.5 p -145.93 137.32 24.83 Favored 'General case' 0 C--O 1.24 0.597 0 C-N-CA 124.671 1.188 . . . . 0.0 108.74 -178.605 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.407 HG12 HD22 ' A' ' 33' ' ' LEU . 86.3 t -125.62 125.54 68.78 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 C-N-CA 124.048 0.939 . . . . 0.0 108.972 -179.411 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -79.6 104.91 10.52 Favored 'General case' 0 CA--C 1.537 0.473 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 173.546 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.49 HD23 ' HB3' ' A' ' 43' ' ' PHE . 4.4 mm? -80.64 159.95 68.11 Favored Pre-proline 0 CA--C 1.552 1.023 0 C-N-CA 123.611 0.764 . . . . 0.0 109.537 177.068 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_endo -59.85 151.04 74.03 Favored 'Trans proline' 0 C--N 1.381 2.283 0 C-N-CA 122.378 2.052 . . . . 0.0 113.468 -178.016 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -144.81 168.13 12.99 Favored Pre-proline 0 N--CA 1.476 0.848 0 C-N-CA 124.203 1.001 . . . . 0.0 110.979 -168.698 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.537 ' HG2' ' HB2' ' A' ' 39' ' ' TRP . 30.3 Cg_endo -62.93 151.27 85.33 Favored 'Trans proline' 0 C--N 1.381 2.259 0 C-N-CA 122.0 1.8 . . . . 0.0 110.423 160.991 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 57.4 p -64.12 -23.33 67.28 Favored 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 123.528 0.731 . . . . 0.0 111.898 -177.225 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 18.3 m -74.64 -33.6 62.57 Favored 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 123.54 0.736 . . . . 0.0 111.745 178.226 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' TRP . . . . . 0.537 ' HB2' ' HG2' ' A' ' 36' ' ' PRO . 28.4 m95 -117.25 -174.38 2.59 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 123.942 0.897 . . . . 0.0 110.562 -176.866 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 44.8 mtmt -138.74 149.52 45.13 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 124.18 0.992 . . . . 0.0 108.612 168.888 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.559 ' HZ3' ' HB2' ' A' ' 43' ' ' PHE . 24.6 tptp -118.95 127.25 53.3 Favored 'General case' 0 C--N 1.331 -0.206 0 C-N-CA 124.815 1.246 . . . . 0.0 109.311 -175.214 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.416 HD22 ' HB ' ' A' ' 57' ' ' VAL . 4.1 tt -124.28 145.77 49.18 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 124.259 1.024 . . . . 0.0 108.647 174.68 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.559 ' HB2' ' HZ3' ' A' ' 41' ' ' LYS . 48.3 t80 -128.94 142.46 50.93 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 124.994 1.318 . . . . 0.0 108.124 170.934 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 36.5 m-85 -101.1 100.47 13.26 Favored Pre-proline 0 N--CA 1.48 1.058 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 171.243 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 62.2 Cg_endo -84.24 156.9 12.89 Favored 'Trans proline' 0 C--N 1.372 1.816 0 C-N-CA 122.736 2.291 . . . . 0.0 111.598 172.499 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 46.6 t-20 -83.76 152.07 24.87 Favored 'General case' 0 CA--C 1.545 0.768 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 171.22 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.523 ' HG2' HG11 ' A' ' 29' ' ' VAL . 96.4 mttt -62.19 -23.99 66.94 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 122.987 0.515 . . . . 0.0 111.435 179.007 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 65.3 t -60.52 -46.25 95.75 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.75 0 C-N-CA 123.127 0.571 . . . . 0.0 110.156 172.915 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 100.79 159.33 27.65 Favored Glycine 0 C--N 1.341 0.852 0 CA-C-N 115.496 -0.774 . . . . 0.0 111.387 -174.824 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . 0.494 ' HA ' ' HA ' ' A' ' 95' ' ' THR . 32.6 t 71.74 -66.22 0.31 Allowed 'General case' 0 N--CA 1.49 1.574 0 C-N-CA 125.644 1.577 . . . . 0.0 110.823 -176.94 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 34.0 m -68.47 148.31 11.85 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.75 0 CA-C-N 115.227 -0.897 . . . . 0.0 111.769 177.875 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 21.9 ptmt -79.0 158.06 28.0 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-N 114.196 -1.366 . . . . 0.0 111.157 179.301 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 12.9 tmtt? -102.38 -53.81 2.82 Favored 'General case' 0 N--CA 1.477 0.915 0 N-CA-C 106.626 -1.62 . . . . 0.0 106.626 169.442 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 26.4 m -132.04 162.11 31.57 Favored 'General case' 0 CA--C 1.55 0.946 0 N-CA-C 106.59 -1.633 . . . . 0.0 106.59 173.766 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -72.42 -171.01 0.72 Allowed 'General case' 0 CA--C 1.551 0.993 0 CA-C-O 121.731 0.777 . . . . 0.0 111.31 179.217 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 11.7 t -81.75 138.04 20.2 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.416 0 C-N-CA 124.581 1.152 . . . . 0.0 110.707 -174.657 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.416 ' HB ' HD22 ' A' ' 42' ' ' LEU . 49.3 t -123.13 116.12 47.66 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.744 0 C-N-CA 123.674 0.79 . . . . 0.0 109.059 171.848 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 15.2 m-85 -86.36 120.64 27.92 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 123.36 0.664 . . . . 0.0 109.585 170.395 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 2.8 t -78.71 127.98 38.63 Favored 'Isoleucine or valine' 0 C--O 1.238 0.494 0 C-N-CA 123.56 0.744 . . . . 0.0 109.039 174.414 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -86.53 153.41 55.79 Favored Pre-proline 0 CA--C 1.539 0.553 0 CA-C-N 114.959 -1.019 . . . . 0.0 110.801 -176.869 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -59.54 -29.88 91.04 Favored 'Trans proline' 0 C--N 1.369 1.613 0 C-N-CA 122.898 2.398 . . . . 0.0 113.076 173.893 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.408 HG23 ' H ' ' A' ' 64' ' ' GLU . 14.5 t -93.32 -3.97 52.51 Favored 'General case' 0 N--CA 1.486 1.343 0 C-N-CA 122.565 0.346 . . . . 0.0 111.522 176.894 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 90.04 -8.71 79.31 Favored Glycine 0 C--N 1.35 1.358 0 CA-C-O 119.576 -0.569 . . . . 0.0 113.996 -179.795 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.408 ' H ' HG23 ' A' ' 62' ' ' THR . 42.8 tt0 -72.63 77.64 1.09 Allowed 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 123.686 0.794 . . . . 0.0 109.306 175.316 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -73.06 158.34 35.57 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-N 115.013 -0.994 . . . . 0.0 111.581 -168.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.561 HG23 ' HB2' ' A' ' 71' ' ' GLN . 49.2 mm -122.14 115.42 46.16 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 CA-C-N 114.522 -1.217 . . . . 0.0 109.701 -166.723 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 14.1 p -88.5 -17.57 30.03 Favored 'General case' 0 CA--C 1.553 1.067 0 C-N-CA 123.765 0.826 . . . . 0.0 112.306 179.651 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 2.0 p-10 -156.67 157.65 35.57 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 112.133 0.42 . . . . 0.0 112.133 -174.558 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 41.9 mtm105 -56.6 -36.58 69.57 Favored 'General case' 0 N--CA 1.493 1.724 0 C-N-CA 124.35 1.06 . . . . 0.0 113.858 -170.868 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 7.0 tmtm? -54.62 -49.35 70.7 Favored 'General case' 0 N--CA 1.484 1.232 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 179.544 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.561 ' HB2' HG23 ' A' ' 66' ' ' ILE . 91.1 mt-30 -64.06 -35.16 79.84 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 123.693 0.797 . . . . 0.0 111.312 -179.544 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.458 HD12 ' HB ' ' A' ' 85' ' ' ILE . 0.6 OUTLIER -64.68 -51.71 61.06 Favored 'General case' 0 N--CA 1.483 1.178 0 O-C-N 123.739 0.649 . . . . 0.0 109.369 -179.813 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -69.34 -42.16 75.68 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 124.298 1.039 . . . . 0.0 111.599 -173.523 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 1.1 pp0? -66.44 -33.12 75.0 Favored 'General case' 0 N--CA 1.472 0.665 0 O-C-N 123.427 0.454 . . . . 0.0 109.897 176.091 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 12.2 t80 -61.92 -47.1 86.45 Favored 'General case' 0 C--N 1.357 0.909 0 O-C-N 123.656 0.597 . . . . 0.0 109.447 175.41 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.453 ' HG ' ' O ' ' A' ' 72' ' ' LEU . 81.9 mt -62.21 -48.98 77.6 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 123.038 0.535 . . . . 0.0 111.195 -175.738 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.76 -17.61 61.08 Favored 'General case' 0 CA--C 1.551 0.989 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.754 -176.806 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 30.7 t -92.77 -27.7 17.04 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 123.381 0.672 . . . . 0.0 110.781 175.654 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 51.9 m80 -127.72 92.25 43.19 Favored Pre-proline 0 N--CA 1.479 0.979 0 C-N-CA 124.204 1.002 . . . . 0.0 108.735 -174.334 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -64.63 159.79 43.25 Favored 'Trans proline' 0 C--N 1.371 1.756 0 C-N-CA 122.858 2.372 . . . . 0.0 112.551 179.131 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 91.62 -24.35 20.74 Favored Glycine 0 C--N 1.346 1.093 0 CA-C-N 115.989 -0.551 . . . . 0.0 112.971 179.06 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 41.7 m-80 -72.59 132.05 83.91 Favored Pre-proline 0 CA--C 1.546 0.817 0 C-N-CA 123.454 0.702 . . . . 0.0 110.308 177.651 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_endo -60.56 148.49 90.94 Favored 'Trans proline' 0 C--N 1.376 2.0 0 C-N-CA 123.226 2.617 . . . . 0.0 113.017 -176.123 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.406 ' O ' ' HG2' ' A' ' 87' ' ' GLU . . . -68.42 148.44 50.65 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 123.549 0.74 . . . . 0.0 112.088 -175.185 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.458 ' HB ' HD12 ' A' ' 72' ' ' LEU . 15.7 tt -63.49 -13.91 13.66 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.399 0 C-N-CA 124.329 1.052 . . . . 0.0 112.21 -177.459 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -57.76 -38.67 75.82 Favored 'General case' 0 CA--C 1.553 1.074 0 C-N-CA 124.153 0.981 . . . . 0.0 112.213 175.588 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.406 ' HG2' ' O ' ' A' ' 84' ' ' ALA . 11.3 pt-20 -90.55 -10.32 43.93 Favored 'General case' 0 N--CA 1.487 1.404 0 C-N-CA 122.993 0.517 . . . . 0.0 111.947 178.138 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -77.31 115.63 17.24 Favored 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 175.804 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 6.5 t0 -91.38 109.8 21.08 Favored 'General case' 0 CA--C 1.54 0.591 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 -176.122 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 69.8 m95 -96.99 -22.97 16.52 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 123.909 0.884 . . . . 0.0 110.106 176.119 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 12.9 t -88.16 7.81 29.98 Favored 'General case' 0 N--CA 1.486 1.329 0 C-N-CA 123.428 0.691 . . . . 0.0 111.718 -174.528 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 9.4 t -81.11 51.35 1.57 Allowed 'General case' 0 CA--C 1.56 1.344 0 CA-C-O 122.28 1.038 . . . . 0.0 111.431 175.79 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 46.4 m -74.13 101.84 4.06 Favored 'General case' 0 CA--C 1.545 0.751 0 CA-C-N 115.323 -0.853 . . . . 0.0 109.84 174.112 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -64.86 125.11 29.94 Favored Glycine 0 C--N 1.351 1.389 0 CA-C-N 115.684 -0.689 . . . . 0.0 112.918 -177.545 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . 0.494 ' HA ' ' HA ' ' A' ' 50' ' ' SER . 96.3 m . . . . . 0 CA--C 1.552 1.047 0 CA-C-O 118.595 -0.716 . . . . 0.0 110.563 177.327 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.6 ptp . . . . . 0 N--CA 1.493 1.698 0 CA-C-O 120.611 0.243 . . . . 0.0 110.761 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 85.3 t60 -155.85 103.27 2.23 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 123.125 0.57 . . . . 0.0 109.67 178.002 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 15.1 t-80 -155.52 -39.82 0.08 Allowed 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 124.785 1.234 . . . . 0.0 108.022 169.587 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 29.1 t-80 -77.8 90.89 4.07 Favored 'General case' 0 CA--C 1.547 0.845 0 N-CA-C 109.333 -0.618 . . . . 0.0 109.333 171.11 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 42.5 t-80 -111.83 90.62 3.39 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 124.259 1.024 . . . . 0.0 108.305 175.497 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 22.9 t-80 -164.38 112.76 1.12 Allowed 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 -177.089 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 48.6 m170 -103.12 119.22 38.46 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 123.415 0.686 . . . . 0.0 109.538 176.409 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 38.0 m -143.22 92.9 2.43 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 124.215 1.006 . . . . 0.0 108.666 173.19 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 50.3 m -141.01 113.36 8.02 Favored 'General case' 0 C--O 1.241 0.609 0 C-N-CA 124.002 0.921 . . . . 0.0 108.735 178.827 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -164.5 -171.89 31.31 Favored Glycine 0 C--N 1.339 0.724 0 O-C-N 123.664 0.602 . . . . 0.0 111.936 179.207 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 66.6 mtt-85 -123.72 117.86 25.9 Favored 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 177.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -72.66 78.35 1.09 Allowed 'General case' 0 N--CA 1.476 0.825 0 CA-C-O 121.698 0.761 . . . . 0.0 109.839 178.204 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 51.8 t-20 -132.19 92.56 3.12 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 107.654 -1.239 . . . . 0.0 107.654 -179.121 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -146.58 174.17 11.66 Favored 'General case' 0 C--O 1.244 0.775 0 CA-C-N 114.899 -1.046 . . . . 0.0 109.239 178.042 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 25.2 p90 -65.95 108.63 2.25 Favored 'General case' 0 CA--C 1.553 1.081 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 173.001 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 51.2 p90 -91.18 -16.92 26.92 Favored 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 123.466 0.706 . . . . 0.0 110.613 177.284 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 86.0 mm-40 56.42 80.86 0.14 Allowed 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 125.202 1.401 . . . . 0.0 111.839 178.646 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -85.19 62.65 4.48 Favored Glycine 0 C--N 1.348 1.212 0 CA-C-N 115.662 -0.699 . . . . 0.0 112.38 -179.573 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 5.8 p-80 -83.07 123.99 30.02 Favored 'General case' 0 CA--C 1.548 0.896 0 C-N-CA 124.067 0.947 . . . . 0.0 109.867 -179.926 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 69.17 -67.42 0.22 Allowed 'General case' 0 N--CA 1.489 1.485 0 C-N-CA 125.624 1.57 . . . . 0.0 110.594 -177.858 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -68.17 139.36 56.1 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 123.227 0.611 . . . . 0.0 110.253 172.305 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 22.8 t 68.21 25.32 7.29 Favored 'General case' 0 CA--C 1.556 1.174 0 C-N-CA 124.619 1.168 . . . . 0.0 111.436 -178.794 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -157.06 -71.4 0.01 OUTLIER Glycine 0 C--N 1.35 1.355 0 N-CA-C 111.15 -0.78 . . . . 0.0 111.15 176.019 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 47.7 t 58.7 68.58 0.81 Allowed 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 124.872 1.269 . . . . 0.0 110.485 179.274 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 -87.21 52.17 2.44 Favored 'General case' 0 CA--C 1.546 0.815 0 CA-C-N 115.219 -0.901 . . . . 0.0 108.849 177.105 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 58.31 -171.27 0.11 Allowed 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 124.393 1.077 . . . . 0.0 111.933 -170.401 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -132.56 86.79 2.35 Favored 'General case' 0 C--O 1.237 0.41 0 N-CA-C 106.617 -1.624 . . . . 0.0 106.617 170.073 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 33.6 m -64.51 152.48 8.54 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 CA-C-N 115.135 -0.938 . . . . 0.0 111.088 -177.508 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 15.3 m -63.42 104.81 0.41 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.884 0 CA-C-O 121.764 0.792 . . . . 0.0 110.345 -179.039 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 30.8 p -161.99 113.48 1.67 Allowed 'General case' 0 C--O 1.239 0.513 0 C-N-CA 124.52 1.128 . . . . 0.0 108.078 -177.34 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 83.3 t -105.59 124.33 60.53 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.517 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.451 ' HA ' ' HA ' ' A' ' 42' ' ' LEU . 51.6 mt-10 -76.72 113.21 14.12 Favored 'General case' 0 CA--C 1.533 0.317 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 173.761 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.46 HD23 ' HB3' ' A' ' 43' ' ' PHE . 3.7 mm? -87.28 166.4 26.03 Favored Pre-proline 0 CA--C 1.555 1.166 0 C-N-CA 123.69 0.796 . . . . 0.0 109.017 -179.786 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -51.54 134.72 46.9 Favored 'Trans proline' 0 C--N 1.388 2.633 0 C-N-CA 123.012 2.475 . . . . 0.0 113.161 175.854 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.451 ' HB2' ' HB3' ' A' ' 41' ' ' LYS . . . -128.91 158.97 70.89 Favored Pre-proline 0 N--CA 1.477 0.89 0 C-N-CA 125.335 1.454 . . . . 0.0 110.913 -170.648 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.647 ' HG2' ' HB2' ' A' ' 39' ' ' TRP . 58.9 Cg_endo -70.16 177.96 5.32 Favored 'Trans proline' 0 C--N 1.381 2.262 0 C-N-CA 122.686 2.257 . . . . 0.0 111.44 166.057 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 77.2 p -71.22 -47.67 55.96 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 123.694 0.798 . . . . 0.0 112.498 -169.741 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 22.2 m -74.65 -35.61 62.85 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 123.809 0.844 . . . . 0.0 110.884 -175.594 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' TRP . . . . . 0.647 ' HB2' ' HG2' ' A' ' 36' ' ' PRO . 39.7 m95 -100.3 174.3 6.19 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 123.693 0.797 . . . . 0.0 111.28 -175.297 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.785 ' HB3' ' HB ' ' A' ' 59' ' ' VAL . 15.7 tppt? -126.94 148.39 50.06 Favored 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 107.187 -1.412 . . . . 0.0 107.187 169.127 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.451 ' HB3' ' HB2' ' A' ' 35' ' ' ALA . 0.0 OUTLIER -120.97 127.94 52.26 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 107.688 -1.227 . . . . 0.0 107.688 179.41 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.451 ' HA ' ' HA ' ' A' ' 32' ' ' GLU . 4.5 tt -128.55 146.1 50.93 Favored 'General case' 0 C--N 1.324 -0.541 0 C-N-CA 125.29 1.436 . . . . 0.0 107.569 174.033 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.46 ' HB3' HD23 ' A' ' 33' ' ' LEU . 31.6 t80 -126.94 142.92 51.43 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 124.707 1.203 . . . . 0.0 107.923 172.509 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 14.1 m-85 -100.84 99.09 9.52 Favored Pre-proline 0 N--CA 1.488 1.44 0 C-N-CA 123.17 0.588 . . . . 0.0 110.91 174.084 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -82.36 89.41 1.18 Allowed 'Trans proline' 0 C--N 1.378 2.108 0 C-N-CA 123.066 2.511 . . . . 0.0 111.999 171.909 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 45.8 t-20 -71.09 147.91 48.01 Favored 'General case' 0 N--CA 1.479 0.979 0 CA-C-N 115.815 -0.63 . . . . 0.0 109.536 178.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 31.1 mmmt -51.07 -54.35 25.64 Favored 'General case' 0 N--CA 1.48 1.025 0 C-N-CA 124.485 1.114 . . . . 0.0 111.618 176.973 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 65.7 t -105.12 128.79 58.68 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 -179.704 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.41 ' HA2' ' HD3' ' A' ' 53' ' ' LYS . . . -78.34 -30.33 50.27 Favored Glycine 0 CA--C 1.53 1.011 0 CA-C-N 116.309 -0.405 . . . . 0.0 112.757 178.847 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 29.7 m -69.71 -24.44 63.56 Favored 'General case' 0 CA--C 1.551 0.994 0 C-N-CA 123.851 0.861 . . . . 0.0 112.464 -177.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 27.5 m -86.75 -169.82 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.408 0 C-N-CA 122.787 0.435 . . . . 0.0 109.942 175.607 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 19.0 ptpt -65.41 77.33 0.06 Allowed 'General case' 0 CA--C 1.558 1.251 0 C-N-CA 123.735 0.814 . . . . 0.0 112.534 178.09 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.41 ' HD3' ' HA2' ' A' ' 49' ' ' GLY . 23.6 pttm -78.24 104.43 8.82 Favored 'General case' 0 C--N 1.346 0.446 0 N-CA-C 107.449 -1.315 . . . . 0.0 107.449 171.295 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 20.1 m -61.18 139.35 58.14 Favored 'General case' 0 CA--C 1.543 0.701 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.605 -176.866 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 15.1 pt-20 -73.37 -165.92 0.29 Allowed 'General case' 0 CA--C 1.55 0.959 0 CA-C-O 121.86 0.838 . . . . 0.0 111.431 -174.236 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 75.4 t -80.28 137.57 21.28 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.76 0 CA-C-N 114.988 -1.005 . . . . 0.0 109.274 179.575 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.424 ' HB ' HD22 ' A' ' 42' ' ' LEU . 87.3 t -117.81 115.2 47.75 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 178.223 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.427 ' CZ ' ' HE3' ' A' ' 41' ' ' LYS . 19.6 m-85 -94.94 115.1 27.03 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 123.657 0.783 . . . . 0.0 109.378 174.635 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.785 ' HB ' ' HB3' ' A' ' 40' ' ' LYS . 2.8 t -79.48 129.84 36.97 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 175.359 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -84.31 153.62 62.54 Favored Pre-proline 0 CA--C 1.54 0.565 0 CA-C-N 114.939 -1.028 . . . . 0.0 111.003 -175.035 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_endo -61.02 -32.72 92.45 Favored 'Trans proline' 0 C--N 1.379 2.147 0 C-N-CA 122.913 2.408 . . . . 0.0 113.101 177.02 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.464 HG23 ' H ' ' A' ' 64' ' ' GLU . 13.2 t -84.49 -6.35 59.37 Favored 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 122.981 0.512 . . . . 0.0 111.627 179.796 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 94.16 -19.87 50.89 Favored Glycine 0 C--N 1.357 1.702 0 CA-C-O 119.686 -0.508 . . . . 0.0 113.179 179.486 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.464 ' H ' HG23 ' A' ' 62' ' ' THR . 42.7 tt0 -69.63 75.74 0.42 Allowed 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 124.299 1.039 . . . . 0.0 109.09 175.608 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -75.36 150.24 38.46 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-O 121.892 0.853 . . . . 0.0 111.548 -166.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 39.8 mm -102.27 123.32 55.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 114.047 -1.433 . . . . 0.0 109.555 -175.72 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 24.3 m -105.69 -1.34 24.63 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 123.153 0.581 . . . . 0.0 111.093 -179.404 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 14.5 p-10 -158.01 145.65 18.4 Favored 'General case' 0 C--N 1.353 0.749 0 C-N-CA 123.076 0.55 . . . . 0.0 111.241 -174.062 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.451 ' HG3' HD11 ' A' ' 85' ' ' ILE . 44.1 ttp180 -61.35 -30.61 70.63 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 124.839 1.255 . . . . 0.0 113.864 -166.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 6.4 tmtm? -62.28 -49.06 77.16 Favored 'General case' 0 N--CA 1.489 1.508 0 C-N-CA 123.139 0.576 . . . . 0.0 109.554 177.196 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.558 ' HA ' ' HG3' ' A' ' 74' ' ' GLN . 86.4 mm-40 -66.35 -21.61 66.25 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-N 115.406 -0.815 . . . . 0.0 111.515 -176.565 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.456 ' HB3' HD12 ' A' ' 85' ' ' ILE . 0.6 OUTLIER -65.44 -54.95 21.16 Favored 'General case' 0 N--CA 1.477 0.894 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 174.77 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -59.15 -49.74 76.69 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 123.877 0.871 . . . . 0.0 111.031 -176.05 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . 0.558 ' HG3' ' HA ' ' A' ' 71' ' ' GLN . 0.0 OUTLIER -67.57 -25.89 66.01 Favored 'General case' 0 CA--C 1.547 0.864 0 CA-C-N 115.414 -0.812 . . . . 0.0 111.369 -177.226 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 34.0 t80 -66.45 -50.43 63.38 Favored 'General case' 0 C--N 1.357 0.897 0 C-N-CA 123.211 0.605 . . . . 0.0 109.592 173.445 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 81.5 mt -58.28 -43.13 87.84 Favored 'General case' 0 N--CA 1.486 1.347 0 O-C-N 123.787 0.679 . . . . 0.0 111.873 -173.679 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 58.3 pttt -68.03 -41.0 82.78 Favored 'General case' 0 N--CA 1.478 0.932 0 O-C-N 123.32 0.387 . . . . 0.0 111.035 -179.354 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 77.4 p -85.52 -10.37 56.11 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 112.012 0.375 . . . . 0.0 112.012 -177.17 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 53.1 m-70 -130.06 84.25 60.95 Favored Pre-proline 0 N--CA 1.482 1.167 0 C-N-CA 124.322 1.049 . . . . 0.0 108.714 177.654 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -67.9 147.29 74.22 Favored 'Trans proline' 0 C--N 1.375 1.924 0 C-N-CA 122.631 2.22 . . . . 0.0 111.786 178.838 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 101.41 -6.43 55.63 Favored Glycine 0 CA--C 1.53 0.995 0 CA-C-N 116.071 -0.513 . . . . 0.0 112.698 -177.192 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 40.2 m-80 -90.68 141.05 26.68 Favored Pre-proline 0 N--CA 1.48 1.062 0 C-N-CA 123.164 0.586 . . . . 0.0 110.595 177.239 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_endo -62.0 149.57 89.79 Favored 'Trans proline' 0 C--N 1.38 2.236 0 C-N-CA 123.384 2.723 . . . . 0.0 112.783 179.091 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -66.28 158.89 27.84 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 124.22 1.008 . . . . 0.0 111.882 -173.162 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.456 HD12 ' HB3' ' A' ' 72' ' ' LEU . 19.3 tt -77.87 -17.58 14.0 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.544 177.485 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -60.7 -34.48 74.42 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 123.8 0.84 . . . . 0.0 111.471 177.089 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -92.81 -11.35 33.91 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 123.492 0.717 . . . . 0.0 110.976 179.65 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 5.8 m-30 -82.01 127.7 33.34 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 123.273 0.629 . . . . 0.0 109.832 176.083 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -92.47 122.18 34.66 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 123.909 0.884 . . . . 0.0 109.785 -178.317 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 77.5 m95 -115.73 6.7 14.48 Favored 'General case' 0 N--CA 1.488 1.471 0 C-N-CA 123.837 0.855 . . . . 0.0 110.729 176.637 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 9.9 t -108.55 17.41 22.05 Favored 'General case' 0 CA--C 1.557 1.22 0 C-N-CA 124.815 1.246 . . . . 0.0 110.662 -177.315 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 9.9 t -77.88 31.72 0.17 Allowed 'General case' 0 CA--C 1.563 1.452 0 C-N-CA 124.205 1.002 . . . . 0.0 113.027 -176.153 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 22.0 t -89.24 15.21 9.32 Favored 'General case' 0 CA--C 1.552 1.029 0 C-N-CA 124.096 0.958 . . . . 0.0 111.028 178.541 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 82.8 100.51 0.49 Allowed Glycine 0 C--N 1.354 1.541 0 N-CA-C 109.672 -1.371 . . . . 0.0 109.672 -168.518 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 37.8 p . . . . . 0 CA--C 1.558 1.263 0 C-N-CA 123.862 0.865 . . . . 0.0 111.219 -173.626 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 83.3 mtp . . . . . 0 N--CA 1.481 1.111 0 N-CA-C 110.329 -0.249 . . . . 0.0 110.329 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 20.5 t60 -110.41 23.6 14.05 Favored 'General case' 0 CA--C 1.554 1.099 0 C-N-CA 123.962 0.905 . . . . 0.0 108.774 175.47 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 27.5 t60 -56.0 -36.14 67.57 Favored 'General case' 0 N--CA 1.488 1.426 0 C-N-CA 124.121 0.969 . . . . 0.0 111.247 -177.308 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 65.9 t-80 -76.26 86.05 3.07 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.143 174.204 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 19.0 p-80 -106.52 130.61 54.27 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 115.714 -0.676 . . . . 0.0 109.916 179.237 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 58.0 t-80 -148.85 99.64 3.0 Favored 'General case' 0 N--CA 1.466 0.325 0 N-CA-C 108.663 -0.865 . . . . 0.0 108.663 174.447 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 64.3 t-80 -155.11 81.5 1.07 Allowed 'General case' 0 CA--C 1.545 0.767 0 N-CA-C 108.358 -0.979 . . . . 0.0 108.358 176.856 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 20.4 p -107.78 98.99 8.5 Favored 'General case' 0 CA--C 1.545 0.784 0 CA-C-N 115.363 -0.835 . . . . 0.0 109.92 179.934 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 25.9 p -89.81 100.67 13.43 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 123.148 0.579 . . . . 0.0 109.634 176.316 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -133.39 -152.77 6.93 Favored Glycine 0 C--N 1.349 1.294 0 N-CA-C 111.334 -0.706 . . . . 0.0 111.334 178.467 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 30.0 tpt180 -130.79 -57.72 1.04 Allowed 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 123.438 0.695 . . . . 0.0 109.359 179.141 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 69.08 160.68 0.19 Allowed 'General case' 0 CA--C 1.564 1.505 0 C-N-CA 125.09 1.356 . . . . 0.0 111.727 179.57 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 32.3 m-80 72.05 96.84 0.07 Allowed 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 125.488 1.515 . . . . 0.0 111.317 175.392 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -93.22 133.09 36.78 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 122.984 0.514 . . . . 0.0 110.146 176.535 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 5.1 p90 -98.26 -51.5 3.97 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 124.506 1.123 . . . . 0.0 109.08 177.676 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 47.4 t80 49.7 87.7 0.03 OUTLIER 'General case' 0 CA--C 1.559 1.313 0 C-N-CA 124.844 1.258 . . . . 0.0 112.314 177.267 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 11.1 pt20 -159.3 164.73 34.61 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 123.523 0.729 . . . . 0.0 111.097 -174.9 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 121.13 156.6 9.84 Favored Glycine 0 C--N 1.349 1.302 0 CA-C-N 115.843 -0.617 . . . . 0.0 113.127 176.169 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 30.0 p80 -81.79 135.58 35.45 Favored 'General case' 0 N--CA 1.476 0.845 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 174.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 51.2 ttm -162.0 -48.54 0.04 OUTLIER 'General case' 0 C--O 1.243 0.732 0 C-N-CA 123.389 0.676 . . . . 0.0 109.85 -173.001 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . 63.93 -88.48 0.03 OUTLIER 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 124.978 1.311 . . . . 0.0 110.199 -173.454 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 23.0 t 53.8 25.07 4.86 Favored 'General case' 0 C--N 1.369 1.443 0 C-N-CA 124.238 1.015 . . . . 0.0 112.271 176.173 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -90.72 26.64 10.29 Favored Glycine 0 C--N 1.35 1.346 0 C-N-CA 123.537 0.589 . . . . 0.0 114.012 -169.596 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 59.3 m -148.08 -46.61 0.16 Allowed 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 124.236 1.014 . . . . 0.0 109.008 177.183 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -129.43 143.58 50.9 Favored 'General case' 0 C--N 1.348 0.541 0 C-N-CA 123.905 0.882 . . . . 0.0 109.272 175.02 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -81.96 150.98 27.39 Favored 'General case' 0 C--O 1.241 0.645 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 174.132 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 31.9 mt-10 -63.85 100.43 0.3 Allowed 'General case' 0 CA--C 1.55 0.946 0 C-N-CA 123.394 0.678 . . . . 0.0 110.888 -172.445 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 32.6 m -68.04 129.12 32.39 Favored 'Isoleucine or valine' 0 C--O 1.245 0.867 0 C-N-CA 123.489 0.715 . . . . 0.0 110.904 -175.771 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 23.2 m -75.21 106.69 5.16 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.833 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 176.678 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.469 ' HA ' ' HD2' ' A' ' 45' ' ' PRO . 31.2 p -155.28 129.78 9.08 Favored 'General case' 0 C--O 1.239 0.508 0 CA-C-N 114.97 -1.013 . . . . 0.0 109.09 -173.143 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 65.4 t -114.36 124.89 71.45 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 175.784 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.446 ' HA ' ' HA ' ' A' ' 42' ' ' LEU . 47.1 mt-10 -80.33 110.47 15.79 Favored 'General case' 0 C--O 1.237 0.433 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 177.856 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.523 HD23 ' HB3' ' A' ' 43' ' ' PHE . 4.2 mm? -86.61 160.42 50.54 Favored Pre-proline 0 N--CA 1.476 0.841 0 C-N-CA 123.814 0.846 . . . . 0.0 108.779 -178.775 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 14.0 Cg_endo -51.54 125.68 17.42 Favored 'Trans proline' 0 C--N 1.39 2.735 0 C-N-CA 123.073 2.515 . . . . 0.0 113.101 -172.65 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.46 ' HB2' ' HB3' ' A' ' 41' ' ' LYS . . . -110.51 153.68 43.4 Favored Pre-proline 0 N--CA 1.469 0.483 0 CA-C-N 114.659 -1.155 . . . . 0.0 111.39 -170.876 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.689 ' HG2' ' HB2' ' A' ' 39' ' ' TRP . 56.3 Cg_endo -68.29 153.49 74.24 Favored 'Trans proline' 0 C--N 1.373 1.835 0 C-N-CA 122.584 2.189 . . . . 0.0 109.811 165.561 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 21.0 m -64.23 -29.31 70.42 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 123.468 0.707 . . . . 0.0 112.815 -172.138 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 16.0 m -83.56 -29.26 27.98 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 123.312 0.645 . . . . 0.0 111.609 -176.42 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' TRP . . . . . 0.689 ' HB2' ' HG2' ' A' ' 36' ' ' PRO . 17.5 m95 -114.19 -178.55 3.4 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 123.812 0.845 . . . . 0.0 109.668 -177.283 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.488 ' HB2' ' HB ' ' A' ' 59' ' ' VAL . 0.0 OUTLIER -119.7 165.63 14.26 Favored 'General case' 0 N--CA 1.473 0.713 0 N-CA-C 107.836 -1.172 . . . . 0.0 107.836 164.861 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.46 ' HB3' ' HB2' ' A' ' 35' ' ' ALA . 14.4 tptm -150.73 119.49 6.58 Favored 'General case' 0 C--O 1.238 0.496 0 C-N-CA 124.187 0.995 . . . . 0.0 108.77 -172.776 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.446 ' HA ' ' HA ' ' A' ' 32' ' ' GLU . 2.7 tt -129.1 150.21 50.59 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 113.579 -1.646 . . . . 0.0 108.29 -175.872 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.523 ' HB3' HD23 ' A' ' 33' ' ' LEU . 33.8 t80 -130.24 139.82 50.76 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 124.353 1.061 . . . . 0.0 108.398 170.07 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 22.2 m-85 -96.8 103.11 13.52 Favored Pre-proline 0 CA--C 1.552 1.028 0 C-N-CA 122.849 0.46 . . . . 0.0 109.952 173.696 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.469 ' HD2' ' HA ' ' A' ' 30' ' ' SER . 95.3 Cg_endo -76.28 154.25 36.46 Favored 'Trans proline' 0 C--N 1.373 1.854 0 C-N-CA 122.526 2.151 . . . . 0.0 111.983 172.61 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -80.17 -15.33 57.29 Favored 'General case' 0 CA--C 1.555 1.165 0 C-N-CA 123.686 0.794 . . . . 0.0 109.312 174.98 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 84.8 tttt 68.97 34.25 3.21 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 125.674 1.59 . . . . 0.0 108.579 -174.189 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 60.1 t -129.76 -44.13 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 CA-C-N 114.39 -1.277 . . . . 0.0 108.192 179.364 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 96.93 146.65 21.38 Favored Glycine 0 C--N 1.351 1.378 0 CA-C-N 115.111 -0.95 . . . . 0.0 110.818 -171.786 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 30.0 t 73.7 -68.05 0.24 Allowed 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 125.33 1.452 . . . . 0.0 111.641 179.803 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 15.6 m -64.46 130.63 29.72 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.921 0 C-N-CA 123.568 0.747 . . . . 0.0 111.446 177.885 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 46.1 mtmt -101.44 114.71 28.96 Favored 'General case' 0 N--CA 1.472 0.651 0 N-CA-C 108.925 -0.768 . . . . 0.0 108.925 178.39 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -72.13 -51.22 22.4 Favored 'General case' 0 N--CA 1.475 0.812 0 CA-C-O 122.064 0.935 . . . . 0.0 108.784 171.396 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 58.7 m -133.04 156.74 46.81 Favored 'General case' 0 CA--C 1.553 1.061 0 CA-C-N 114.369 -1.287 . . . . 0.0 108.768 176.242 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -90.26 -166.86 1.69 Allowed 'General case' 0 CA--C 1.555 1.162 0 C-N-CA 124.14 0.976 . . . . 0.0 111.713 -174.929 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 86.9 t -82.95 138.77 18.79 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.885 0 C-N-CA 125.056 1.342 . . . . 0.0 110.529 -178.162 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 61.4 t -121.17 115.39 46.57 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.002 0 C-N-CA 124.039 0.936 . . . . 0.0 109.327 175.423 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 23.8 m-85 -88.8 112.93 23.79 Favored 'General case' 0 N--CA 1.479 1.014 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 170.282 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.488 ' HB ' ' HB2' ' A' ' 40' ' ' LYS . 9.1 t -79.14 133.49 29.83 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 CA-C-O 121.231 0.539 . . . . 0.0 109.907 -179.843 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -86.5 154.15 56.34 Favored Pre-proline 0 CA--C 1.543 0.681 0 CA-C-N 114.567 -1.197 . . . . 0.0 111.785 -172.92 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_endo -61.06 -26.17 82.5 Favored 'Trans proline' 0 C--N 1.377 2.057 0 C-N-CA 123.386 2.724 . . . . 0.0 113.31 173.816 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.533 HG23 ' H ' ' A' ' 64' ' ' GLU . 9.8 t -89.2 -12.27 41.37 Favored 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 122.537 0.335 . . . . 0.0 111.213 176.217 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 95.45 -8.21 68.99 Favored Glycine 0 C--N 1.355 1.607 0 CA-C-O 119.621 -0.544 . . . . 0.0 113.942 -178.164 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.533 ' H ' HG23 ' A' ' 62' ' ' THR . 40.4 tt0 -76.15 78.15 2.97 Favored 'General case' 0 N--CA 1.481 1.092 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 172.47 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -65.34 134.28 53.21 Favored 'General case' 0 CA--C 1.543 0.705 0 CA-C-N 115.325 -0.852 . . . . 0.0 110.781 -173.325 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.635 HG23 ' HB2' ' A' ' 71' ' ' GLN . 44.7 mm -91.69 122.7 43.37 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.659 0 C-N-CA 125.068 1.347 . . . . 0.0 110.114 -175.094 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 6.0 p -94.63 -19.83 20.11 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 123.725 0.81 . . . . 0.0 111.989 177.491 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . 0.418 HD21 ' HG3' ' A' ' 71' ' ' GLN . 1.9 p-10 -150.87 150.23 30.64 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 122.959 0.504 . . . . 0.0 111.417 -173.139 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 65.8 mtp85 -55.57 -30.11 60.24 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 125.193 1.397 . . . . 0.0 114.149 -170.922 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 6.4 tmtm? -58.69 -50.61 73.26 Favored 'General case' 0 N--CA 1.48 1.063 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 179.572 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.635 ' HB2' HG23 ' A' ' 66' ' ' ILE . 54.1 mt-30 -63.27 -35.27 79.79 Favored 'General case' 0 N--CA 1.477 0.912 0 O-C-N 124.312 1.008 . . . . 0.0 111.073 -179.766 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.44 ' O ' ' HG ' ' A' ' 76' ' ' LEU . 0.2 OUTLIER -60.52 -52.31 65.73 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 123.482 0.713 . . . . 0.0 109.158 179.004 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -63.1 -50.02 72.16 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 123.839 0.855 . . . . 0.0 111.537 -175.949 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -66.87 -24.98 66.19 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.147 0.579 . . . . 0.0 111.261 -178.459 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 28.8 t80 -69.12 -47.22 65.69 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 123.818 0.847 . . . . 0.0 109.591 175.194 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.453 HD13 ' HA ' ' A' ' 84' ' ' ALA . 92.7 mt -66.01 -44.92 83.36 Favored 'General case' 0 N--CA 1.481 1.09 0 O-C-N 123.822 0.701 . . . . 0.0 111.815 -174.281 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -69.36 -25.89 64.4 Favored 'General case' 0 N--CA 1.48 1.069 0 CA-C-N 116.531 -0.304 . . . . 0.0 110.278 179.106 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 47.0 t -79.71 -29.37 40.68 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 123.046 0.538 . . . . 0.0 111.016 175.117 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 54.6 m80 -132.5 89.43 36.24 Favored Pre-proline 0 CA--C 1.546 0.791 0 C-N-CA 123.548 0.739 . . . . 0.0 109.562 -172.146 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -68.76 151.15 74.55 Favored 'Trans proline' 0 C--N 1.38 2.195 0 C-N-CA 122.664 2.243 . . . . 0.0 112.593 -177.287 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 95.05 -22.85 36.1 Favored Glycine 0 C--N 1.347 1.151 0 CA-C-N 116.141 -0.481 . . . . 0.0 113.052 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 14.7 m120 -68.0 131.52 92.31 Favored Pre-proline 0 N--CA 1.482 1.133 0 CA-C-O 119.102 -0.475 . . . . 0.0 109.821 173.162 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -55.78 141.53 84.69 Favored 'Trans proline' 0 C--N 1.38 2.209 0 C-N-CA 123.133 2.555 . . . . 0.0 112.723 -175.258 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.453 ' HA ' HD13 ' A' ' 76' ' ' LEU . . . -66.53 159.52 27.13 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 123.937 0.895 . . . . 0.0 112.811 -170.675 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.44 ' HB ' HD12 ' A' ' 72' ' ' LEU . 16.3 tt -67.9 -20.72 26.28 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.014 0 C-N-CA 123.863 0.865 . . . . 0.0 110.567 176.26 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -63.68 -36.54 84.17 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 124.457 1.103 . . . . 0.0 112.204 179.741 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -92.35 -1.49 57.01 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 123.442 0.697 . . . . 0.0 111.213 179.086 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 5.3 m-30 -93.82 112.38 24.23 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 123.923 0.889 . . . . 0.0 109.864 178.008 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 11.0 p-10 -86.65 115.06 23.86 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-O 121.494 0.664 . . . . 0.0 110.221 -179.502 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 74.2 m95 -94.12 -20.05 20.25 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 123.588 0.755 . . . . 0.0 109.701 172.822 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 15.1 t -73.82 7.0 2.79 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 125.01 1.324 . . . . 0.0 112.65 -176.734 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.456 HG21 ' HE2' ' A' ' 41' ' ' LYS . 2.7 t -64.11 -18.34 64.31 Favored 'General case' 0 CA--C 1.553 1.063 0 C-N-CA 123.276 0.63 . . . . 0.0 111.81 177.206 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 16.8 p -61.55 -30.26 70.54 Favored 'General case' 0 CA--C 1.549 0.929 0 C-N-CA 124.207 1.003 . . . . 0.0 111.167 174.593 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 136.06 -147.94 19.44 Favored Glycine 0 C--N 1.343 0.939 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.627 175.226 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 4.3 t . . . . . 0 C--O 1.251 1.134 0 C-N-CA 124.011 0.924 . . . . 0.0 109.168 175.363 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.3 mpt? . . . . . 0 N--CA 1.475 0.795 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 38.6 m170 -86.6 114.54 23.41 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 123.447 0.699 . . . . 0.0 109.462 176.213 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 61.0 m80 -75.37 -29.07 59.75 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 124.395 1.078 . . . . 0.0 111.632 -177.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 11.4 m-70 68.64 115.24 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.693 0 C-N-CA 124.861 1.264 . . . . 0.0 112.23 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 36.6 m80 -120.45 137.39 54.36 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 123.672 0.789 . . . . 0.0 109.283 173.498 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 40.2 t60 -155.56 81.33 1.03 Allowed 'General case' 0 CA--C 1.542 0.638 0 N-CA-C 107.373 -1.343 . . . . 0.0 107.373 173.202 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 18.1 p-80 -82.56 136.98 34.7 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 123.857 0.863 . . . . 0.0 110.263 -178.403 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 20.1 m -82.84 -63.56 1.34 Allowed 'General case' 0 C--O 1.243 0.713 0 C-N-CA 122.974 0.51 . . . . 0.0 109.977 178.136 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 23.5 m 57.15 39.96 28.57 Favored 'General case' 0 CA--C 1.552 1.033 0 C-N-CA 124.13 0.972 . . . . 0.0 111.218 178.117 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -66.06 -23.35 71.23 Favored Glycine 0 C--N 1.357 1.698 0 CA-C-N 115.555 -0.748 . . . . 0.0 113.751 -175.437 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 26.1 mtm180 -99.73 142.05 31.73 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 123.394 0.678 . . . . 0.0 110.272 174.679 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -70.77 -56.64 5.91 Favored 'General case' 0 CA--C 1.539 0.557 0 O-C-N 124.241 0.963 . . . . 0.0 109.436 172.058 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 65.4 t30 58.64 18.84 6.18 Favored 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 125.281 1.432 . . . . 0.0 112.118 175.651 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.431 HD12 ' HB2' ' A' ' 15' ' ' TYR . 3.9 pp -80.66 -46.18 16.02 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 123.099 0.56 . . . . 0.0 111.173 -173.76 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.431 ' HB2' HD12 ' A' ' 14' ' ' LEU . 33.1 m-85 -153.65 -80.6 0.09 Allowed 'General case' 0 N--CA 1.483 1.175 0 C-N-CA 124.336 1.054 . . . . 0.0 108.404 178.833 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 76.9 t80 47.59 77.61 0.09 Allowed 'General case' 0 CA--C 1.552 1.043 0 C-N-CA 125.498 1.519 . . . . 0.0 112.105 -178.388 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -123.94 -61.24 1.38 Allowed 'General case' 0 N--CA 1.479 1.002 0 N-CA-C 107.742 -1.207 . . . . 0.0 107.742 178.218 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 117.25 117.17 2.88 Favored Glycine 0 C--N 1.352 1.442 0 CA-C-N 115.155 -0.929 . . . . 0.0 111.486 179.354 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 18.6 p80 -85.06 132.24 34.35 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 122.919 0.488 . . . . 0.0 110.122 -179.338 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 22.5 ptp -83.67 -31.91 25.88 Favored 'General case' 0 N--CA 1.474 0.768 0 CA-C-N 115.846 -0.616 . . . . 0.0 111.302 -177.845 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . 52.33 93.44 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.379 0 C-N-CA 124.825 1.25 . . . . 0.0 112.52 177.302 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 28.3 m -60.88 -49.97 75.3 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 122.872 0.469 . . . . 0.0 111.183 -175.875 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 63.48 -95.62 0.15 Allowed Glycine 0 C--N 1.353 1.484 0 CA-C-N 115.483 -0.78 . . . . 0.0 111.486 -178.401 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 22.7 t -169.61 -179.39 3.35 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 124.628 1.171 . . . . 0.0 108.223 175.253 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 28.3 tt0 -145.42 29.13 1.16 Allowed 'General case' 0 N--CA 1.483 1.185 0 CA-C-O 121.956 0.884 . . . . 0.0 109.721 175.133 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -78.4 118.77 20.89 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 115.047 -0.979 . . . . 0.0 110.4 -179.53 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -91.48 30.04 1.38 Allowed 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 124.491 1.117 . . . . 0.0 110.8 -179.824 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 33.6 m -73.51 157.71 6.28 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.789 0 C-N-CA 124.784 1.234 . . . . 0.0 110.766 -177.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 17.1 m -68.36 109.27 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.988 0 CA-C-O 121.639 0.733 . . . . 0.0 110.422 -178.604 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 13.6 p -151.08 113.79 4.69 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 124.561 1.145 . . . . 0.0 108.408 -177.858 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 82.3 t -111.79 122.76 66.73 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 C-N-CA 124.38 1.072 . . . . 0.0 108.843 -176.759 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -79.5 116.74 19.89 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 123.112 0.565 . . . . 0.0 110.109 178.772 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.509 HD23 ' HB3' ' A' ' 43' ' ' PHE . 4.3 mm? -94.27 160.6 31.62 Favored Pre-proline 0 CA--C 1.555 1.167 0 C-N-CA 124.438 1.095 . . . . 0.0 109.128 177.362 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 13.1 Cg_endo -53.7 147.8 38.73 Favored 'Trans proline' 0 C--N 1.391 2.797 0 C-N-CA 123.22 2.613 . . . . 0.0 113.687 -177.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.599 ' HB2' ' HB3' ' A' ' 41' ' ' LYS . . . -152.23 167.24 13.61 Favored Pre-proline 0 CA--C 1.538 0.498 0 C-N-CA 123.884 0.874 . . . . 0.0 111.871 -167.92 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_exo -56.1 146.57 69.59 Favored 'Trans proline' 0 C--N 1.38 2.214 0 C-N-CA 122.571 2.181 . . . . 0.0 110.83 158.059 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 61.4 p -66.34 -33.74 76.41 Favored 'General case' 0 CA--C 1.552 1.026 0 C-N-CA 123.149 0.58 . . . . 0.0 110.695 177.451 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 37.1 m -64.79 -41.3 95.93 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 124.686 1.194 . . . . 0.0 111.3 177.136 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' TRP . . . . . 0.427 ' HE1' ' HD2' ' A' ' 83' ' ' PRO . 41.8 m95 -102.04 -166.48 1.29 Allowed 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 123.93 0.892 . . . . 0.0 110.127 178.735 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.493 ' HB3' ' HB ' ' A' ' 59' ' ' VAL . 1.1 tppt? -148.41 154.35 39.79 Favored 'General case' 0 CA--C 1.535 0.38 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 164.468 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.599 ' HB3' ' HB2' ' A' ' 35' ' ' ALA . 17.5 tptm -121.66 122.48 39.7 Favored 'General case' 0 N--CA 1.468 0.444 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 -179.055 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 4.5 tt -124.55 136.93 54.38 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 175.359 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.509 ' HB3' HD23 ' A' ' 33' ' ' LEU . 28.9 t80 -115.62 133.88 55.6 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 125.007 1.323 . . . . 0.0 108.021 172.81 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 13.2 m-85 -94.77 106.75 26.42 Favored Pre-proline 0 CA--C 1.547 0.854 0 C-N-CA 123.284 0.634 . . . . 0.0 109.479 171.66 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -82.72 -161.26 0.14 Allowed 'Trans proline' 0 C--N 1.37 1.66 0 C-N-CA 122.728 2.286 . . . . 0.0 111.522 169.41 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 34.7 t30 -155.82 -82.35 0.07 Allowed 'General case' 0 CA--C 1.544 0.735 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 172.59 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 58.7 tttp 176.64 -54.91 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 125.162 1.385 . . . . 0.0 107.759 -178.327 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 63.5 t -121.96 137.04 56.87 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.759 0 C-N-CA 124.104 0.962 . . . . 0.0 108.604 173.541 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -87.41 29.61 5.2 Favored Glycine 0 C--N 1.348 1.243 0 N-CA-C 113.958 0.343 . . . . 0.0 113.958 -177.454 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 44.7 m -106.97 7.44 29.92 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 123.707 0.803 . . . . 0.0 111.263 178.617 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 31.3 m -100.03 -172.01 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.055 0 C-N-CA 124.166 0.986 . . . . 0.0 109.836 178.507 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 80.9 tttt -63.77 -58.44 6.85 Favored 'General case' 0 CA--C 1.549 0.939 0 N-CA-C 109.581 -0.526 . . . . 0.0 109.581 170.133 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 28.8 ttpt 66.63 164.73 0.2 Allowed 'General case' 0 N--CA 1.486 1.368 0 C-N-CA 125.207 1.403 . . . . 0.0 110.326 -174.653 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 16.5 m -110.33 151.35 27.53 Favored 'General case' 0 CA--C 1.545 0.772 0 N-CA-C 108.134 -1.062 . . . . 0.0 108.134 173.281 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -83.45 -170.13 2.9 Favored 'General case' 0 CA--C 1.557 1.213 0 C-N-CA 123.826 0.85 . . . . 0.0 111.888 -172.186 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 64.4 t -83.11 131.08 34.59 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 C-N-CA 124.06 0.944 . . . . 0.0 109.745 176.705 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 61.0 t -121.91 117.81 53.59 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.858 0 C-N-CA 124.052 0.941 . . . . 0.0 109.297 179.448 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 36.1 m-85 -87.18 131.1 34.28 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 123.61 0.764 . . . . 0.0 110.064 169.6 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.541 ' HA ' ' HG3' ' A' ' 65' ' ' GLU . 10.8 t -82.35 129.27 37.75 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 171.045 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -85.26 150.41 54.65 Favored Pre-proline 0 CA--C 1.542 0.672 0 CA-C-N 114.889 -1.051 . . . . 0.0 110.71 179.052 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_endo -61.4 -24.86 79.19 Favored 'Trans proline' 0 CA--C 1.557 1.643 0 C-N-CA 123.543 2.829 . . . . 0.0 111.477 169.715 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 85.2 m -74.53 -35.08 63.13 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 125.296 1.438 . . . . 0.0 112.078 176.193 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 94.2 11.24 57.64 Favored Glycine 0 CA--C 1.534 1.227 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.763 -162.538 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -94.72 70.37 3.49 Favored 'General case' 0 CA--C 1.542 0.641 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 174.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.541 ' HG3' ' HA ' ' A' ' 59' ' ' VAL . 0.7 OUTLIER -57.78 129.89 43.95 Favored 'General case' 0 N--CA 1.478 0.943 0 CA-C-N 115.501 -0.772 . . . . 0.0 111.738 -174.599 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.422 HG23 ' HB2' ' A' ' 71' ' ' GLN . 40.2 mm -100.7 128.45 52.8 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 CA-C-N 114.982 -1.008 . . . . 0.0 109.58 -177.906 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 12.2 p -110.27 -0.73 17.61 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 124.064 0.946 . . . . 0.0 111.451 -178.226 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 11.8 p-10 -162.26 149.82 14.11 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 122.757 0.423 . . . . 0.0 111.113 -169.577 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.527 ' HG2' HD11 ' A' ' 85' ' ' ILE . 16.3 mtp180 -52.53 -40.3 62.33 Favored 'General case' 0 N--CA 1.486 1.337 0 C-N-CA 124.346 1.058 . . . . 0.0 112.831 -175.555 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 5.0 tmtm? -53.63 -56.6 15.85 Favored 'General case' 0 N--CA 1.48 1.07 0 O-C-N 124.29 0.993 . . . . 0.0 109.307 -177.857 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.422 ' HB2' HG23 ' A' ' 66' ' ' ILE . 14.8 mm100 -67.18 -25.74 66.29 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 115.485 -0.78 . . . . 0.0 111.814 -175.314 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.453 HD12 ' HB ' ' A' ' 85' ' ' ILE . 0.6 OUTLIER -69.12 -54.68 13.69 Favored 'General case' 0 N--CA 1.482 1.155 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 178.398 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -68.49 -41.15 80.5 Favored 'General case' 0 C--O 1.241 0.642 0 C-N-CA 123.81 0.844 . . . . 0.0 111.005 -171.731 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -68.63 -29.41 67.9 Favored 'General case' 0 C--N 1.355 0.805 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.87 175.484 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 47.1 t80 -64.89 -40.96 95.91 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 122.882 0.473 . . . . 0.0 110.398 174.105 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 79.9 mt -68.07 -37.21 81.01 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 122.974 0.51 . . . . 0.0 111.604 -176.756 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.1 -16.96 36.36 Favored 'General case' 0 N--CA 1.484 1.26 0 C-N-CA 122.772 0.429 . . . . 0.0 111.661 -179.91 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 34.1 t -93.77 -22.0 18.96 Favored 'General case' 0 N--CA 1.492 1.652 0 C-N-CA 123.12 0.568 . . . . 0.0 110.78 174.785 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 54.2 m80 -135.81 79.36 46.18 Favored Pre-proline 0 CA--C 1.547 0.855 0 N-CA-C 107.364 -1.347 . . . . 0.0 107.364 179.95 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_endo -61.92 144.06 96.17 Favored 'Trans proline' 0 C--N 1.376 1.98 0 C-N-CA 123.386 2.724 . . . . 0.0 112.838 -179.113 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 115.21 -33.55 5.24 Favored Glycine 0 C--N 1.344 0.995 0 CA-C-N 116.195 -0.457 . . . . 0.0 112.756 178.136 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 54.0 m-80 -68.17 140.19 93.03 Favored Pre-proline 0 CA--C 1.555 1.142 0 C-N-CA 122.922 0.489 . . . . 0.0 111.323 -177.965 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.427 ' HD2' ' HE1' ' A' ' 39' ' ' TRP . 81.9 Cg_exo -46.78 150.58 2.5 Favored 'Trans proline' 0 C--N 1.381 2.262 0 C-N-CA 124.682 3.588 . . . . 0.0 115.194 -178.375 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -71.99 158.17 36.47 Favored 'General case' 0 N--CA 1.484 1.258 0 C-N-CA 124.145 0.978 . . . . 0.0 112.247 -171.608 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.527 HD11 ' HG2' ' A' ' 69' ' ' ARG . 16.8 tt -76.79 -22.15 14.87 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.825 0 N-CA-C 110.253 -0.277 . . . . 0.0 110.253 175.051 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -64.58 -19.38 65.62 Favored 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 123.759 0.824 . . . . 0.0 112.616 178.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 -102.54 -14.86 16.61 Favored 'General case' 0 CA--C 1.553 1.076 0 C-N-CA 123.189 0.596 . . . . 0.0 110.85 174.65 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 7.1 m-30 -81.51 113.41 19.54 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 123.659 0.784 . . . . 0.0 110.352 179.612 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -80.59 125.2 29.7 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 123.439 0.696 . . . . 0.0 109.556 177.396 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 64.1 m95 -111.56 -8.25 14.25 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 124.139 0.976 . . . . 0.0 109.623 169.741 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 9.4 t -107.65 15.56 24.57 Favored 'General case' 0 CA--C 1.553 1.085 0 C-N-CA 124.111 0.964 . . . . 0.0 112.667 -163.579 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 13.2 t -62.42 -16.7 56.52 Favored 'General case' 0 N--CA 1.496 1.861 0 C-N-CA 122.987 0.515 . . . . 0.0 111.452 175.766 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 15.7 t -60.47 -24.52 65.32 Favored 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 124.139 0.976 . . . . 0.0 112.251 177.965 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -139.8 -65.87 0.04 OUTLIER Glycine 0 C--N 1.347 1.192 0 N-CA-C 112.48 -0.248 . . . . 0.0 112.48 -178.203 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 2.7 t . . . . . 0 CA--C 1.562 1.411 0 C-N-CA 123.319 0.648 . . . . 0.0 110.728 -170.735 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 63.4 mtt . . . . . 0 N--CA 1.475 0.798 0 N-CA-C 109.832 -0.433 . . . . 0.0 109.832 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -176.15 92.21 0.05 OUTLIER 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 124.822 1.249 . . . . 0.0 109.257 168.19 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 55.5 t60 -72.46 87.72 1.19 Allowed 'General case' 0 CA--C 1.54 0.589 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 174.264 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 20.2 t60 -132.04 125.77 32.27 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 123.477 0.711 . . . . 0.0 109.854 -173.392 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 55.0 m80 -126.25 133.87 51.34 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 123.763 0.825 . . . . 0.0 108.776 174.607 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 6.0 t60 -132.09 112.28 12.19 Favored 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 107.937 -1.135 . . . . 0.0 107.937 177.715 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 81.1 m-70 -114.58 153.34 30.27 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 123.753 0.821 . . . . 0.0 109.22 174.274 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 24.9 t -157.37 164.49 37.5 Favored 'General case' 0 C--O 1.242 0.659 0 C-N-CA 123.236 0.614 . . . . 0.0 110.303 -174.416 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 32.4 p -79.76 -29.08 40.37 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 124.017 0.927 . . . . 0.0 111.173 -179.667 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 77.39 29.42 55.99 Favored Glycine 0 C--N 1.351 1.364 0 CA-C-N 116.002 -0.545 . . . . 0.0 112.224 -177.802 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 36.0 mmt180 -68.59 134.05 49.4 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 123.812 0.845 . . . . 0.0 111.62 -177.824 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -120.86 135.5 55.16 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 124.605 1.162 . . . . 0.0 109.482 -177.13 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 58.7 t30 -153.89 124.05 6.92 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 123.872 0.869 . . . . 0.0 108.724 174.58 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -146.08 179.64 7.35 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 124.626 1.17 . . . . 0.0 109.537 -179.094 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 40.0 p90 -81.83 127.79 33.36 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 122.795 0.438 . . . . 0.0 110.554 178.678 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 38.6 p90 -104.9 7.26 34.23 Favored 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 124.095 0.958 . . . . 0.0 111.078 -179.304 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 12.6 pt20 -61.16 147.31 44.53 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 124.142 0.977 . . . . 0.0 111.477 179.071 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -179.43 72.29 0.07 OUTLIER Glycine 0 C--N 1.342 0.882 0 CA-C-N 115.991 -0.549 . . . . 0.0 111.983 -179.299 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 34.3 m170 -103.65 126.87 51.07 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 123.312 0.645 . . . . 0.0 110.182 175.853 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 54.5 ttm -152.25 113.18 4.2 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 123.081 0.552 . . . . 0.0 110.384 177.144 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -147.55 101.86 3.39 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 107.742 -1.206 . . . . 0.0 107.742 173.876 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 65.4 p -159.3 172.23 18.38 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 123.008 0.523 . . . . 0.0 111.157 -173.445 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 95.3 137.82 9.27 Favored Glycine 0 C--N 1.348 1.247 0 CA-C-N 115.534 -0.757 . . . . 0.0 112.177 177.498 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 50.8 p -82.79 162.68 21.61 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 123.176 0.59 . . . . 0.0 110.515 174.684 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -79.17 71.93 5.7 Favored 'General case' 0 N--CA 1.477 0.904 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 176.041 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -138.34 99.54 3.88 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 123.963 0.905 . . . . 0.0 108.82 179.662 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -81.0 83.55 6.68 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 123.563 0.745 . . . . 0.0 109.127 175.652 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 2.8 m -136.03 145.61 30.73 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.874 0 C-N-CA 124.831 1.253 . . . . 0.0 109.391 -179.293 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 27.2 m -80.29 128.53 38.57 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.922 0 CA-C-O 121.398 0.618 . . . . 0.0 110.408 179.448 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.402 ' HA ' ' HD2' ' A' ' 45' ' ' PRO . 24.6 p -142.46 118.05 10.38 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 123.974 0.91 . . . . 0.0 108.773 177.41 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 65.7 t -100.31 115.55 41.82 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 -175.144 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -80.61 105.99 12.28 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 123.423 0.689 . . . . 0.0 109.94 -179.367 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.463 HD23 ' HB3' ' A' ' 43' ' ' PHE . 4.5 mm? -83.68 163.94 47.0 Favored Pre-proline 0 N--CA 1.484 1.239 0 C-N-CA 124.281 1.033 . . . . 0.0 109.69 178.933 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -63.2 150.31 88.94 Favored 'Trans proline' 0 C--N 1.385 2.489 0 C-N-CA 122.025 1.817 . . . . 0.0 113.339 -175.407 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -141.8 167.77 15.82 Favored Pre-proline 0 CA--C 1.545 0.759 0 C-N-CA 124.226 1.01 . . . . 0.0 110.255 -173.484 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.401 ' HG2' ' HB2' ' A' ' 39' ' ' TRP . 33.0 Cg_endo -63.5 155.76 60.66 Favored 'Trans proline' 0 C--N 1.383 2.362 0 C-N-CA 121.902 1.735 . . . . 0.0 110.575 162.463 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 21.6 m -61.81 -23.53 66.29 Favored 'General case' 0 N--CA 1.484 1.274 0 C-N-CA 123.586 0.754 . . . . 0.0 111.511 179.205 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 12.6 m -71.24 -38.3 71.96 Favored 'General case' 0 CA--C 1.552 1.033 0 C-N-CA 124.134 0.974 . . . . 0.0 111.841 179.293 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' TRP . . . . . 0.401 ' HB2' ' HG2' ' A' ' 36' ' ' PRO . 26.5 m95 -119.24 -172.44 2.31 Favored 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 124.091 0.957 . . . . 0.0 111.051 -173.885 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 37.3 mtmt -138.7 143.87 39.32 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 124.677 1.191 . . . . 0.0 108.677 168.007 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 17.2 tptm -114.14 118.17 33.27 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 125.631 1.572 . . . . 0.0 108.638 -179.471 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 8.6 tt -120.02 125.96 49.65 Favored 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 175.698 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.463 ' HB3' HD23 ' A' ' 33' ' ' LEU . 87.0 t80 -103.58 134.57 46.7 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 124.441 1.096 . . . . 0.0 108.137 171.663 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . 0.419 ' HB2' ' O ' ' A' ' 55' ' ' GLU . 0.6 OUTLIER -100.01 104.52 29.47 Favored Pre-proline 0 CA--C 1.552 1.027 0 N-CA-C 109.392 -0.596 . . . . 0.0 109.392 174.635 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.402 ' HD2' ' HA ' ' A' ' 30' ' ' SER . 85.5 Cg_endo -79.38 158.89 26.02 Favored 'Trans proline' 0 C--N 1.37 1.71 0 C-N-CA 122.328 2.019 . . . . 0.0 110.431 166.452 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 24.5 t-20 -121.49 -84.45 0.66 Allowed 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 -178.828 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -137.77 -93.44 0.21 Allowed 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 123.605 0.762 . . . . 0.0 109.413 179.252 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 85.6 t -142.47 -60.39 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 N-CA-C 107.874 -1.158 . . . . 0.0 107.874 179.432 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -173.03 178.05 45.2 Favored Glycine 0 C--N 1.353 1.482 0 CA-C-N 115.796 -0.638 . . . . 0.0 112.76 -178.311 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 27.2 m 60.41 33.52 20.69 Favored 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 124.859 1.264 . . . . 0.0 111.107 -174.402 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 17.5 m -129.04 170.52 18.45 Favored 'Isoleucine or valine' 0 C--O 1.242 0.69 0 C-N-CA 124.555 1.142 . . . . 0.0 110.124 -174.738 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 60.3 pttt -65.23 -41.61 94.2 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 123.881 0.873 . . . . 0.0 110.164 174.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 66.14 141.85 0.03 OUTLIER 'General case' 0 C--N 1.372 1.582 0 C-N-CA 125.063 1.345 . . . . 0.0 111.851 175.71 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 6.1 p -110.65 153.54 25.07 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 123.969 0.908 . . . . 0.0 111.026 -177.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.419 ' O ' ' HB2' ' A' ' 44' ' ' TYR . 0.4 OUTLIER -102.69 -178.09 3.57 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 125.019 1.328 . . . . 0.0 112.387 -166.87 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.448 HG22 ' HD1' ' A' ' 43' ' ' PHE . 79.7 t -84.09 132.83 30.6 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.963 0 C-N-CA 124.651 1.18 . . . . 0.0 110.353 179.019 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 98.9 t -122.37 120.93 62.46 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 C-N-CA 123.842 0.857 . . . . 0.0 109.617 173.627 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 15.3 m-85 -90.93 123.96 34.83 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 123.233 0.613 . . . . 0.0 109.378 170.364 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 5.2 t -80.94 124.27 38.5 Favored 'Isoleucine or valine' 0 C--O 1.237 0.431 0 C-N-CA 123.377 0.671 . . . . 0.0 109.317 172.607 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -81.61 153.49 70.68 Favored Pre-proline 0 N--CA 1.468 0.473 0 CA-C-N 114.946 -1.024 . . . . 0.0 110.186 -179.701 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_endo -59.34 -33.19 97.65 Favored 'Trans proline' 0 C--N 1.377 2.073 0 C-N-CA 123.186 2.591 . . . . 0.0 112.787 178.063 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 14.8 t -91.09 -7.22 52.33 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 123.569 0.748 . . . . 0.0 111.551 -179.059 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 93.59 -1.58 69.17 Favored Glycine 0 C--N 1.351 1.365 0 CA-C-O 119.52 -0.6 . . . . 0.0 113.952 179.337 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -80.99 75.04 7.97 Favored 'General case' 0 N--CA 1.481 1.086 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 173.85 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -65.9 145.33 56.06 Favored 'General case' 0 CA--C 1.543 0.686 0 CA-C-N 114.886 -1.052 . . . . 0.0 111.879 -170.392 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.442 HG13 HD22 ' A' ' 72' ' ' LEU . 46.4 mm -101.11 127.31 54.46 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.571 0 C-N-CA 124.39 1.076 . . . . 0.0 109.813 -179.2 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 21.9 p -98.21 -14.5 20.3 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 123.668 0.787 . . . . 0.0 111.896 -177.878 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 13.1 p-10 -155.33 145.02 21.32 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 123.281 0.632 . . . . 0.0 110.543 -167.331 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.521 ' HG3' HD11 ' A' ' 85' ' ' ILE . 69.1 ttt180 -63.38 -26.74 68.89 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 124.459 1.104 . . . . 0.0 113.897 -165.559 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 1.4 tmtp? -66.0 -48.47 71.1 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 176.852 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.439 ' HA ' ' HG3' ' A' ' 74' ' ' GLN . 15.2 mm100 -63.76 -23.94 67.57 Favored 'General case' 0 N--CA 1.477 0.916 0 O-C-N 123.654 0.597 . . . . 0.0 112.034 -177.837 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.451 ' HB3' HD12 ' A' ' 85' ' ' ILE . 0.4 OUTLIER -64.28 -54.03 39.67 Favored 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 175.759 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -63.34 -46.5 86.35 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 123.85 0.86 . . . . 0.0 111.212 -174.02 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . 0.439 ' HG3' ' HA ' ' A' ' 71' ' ' GLN . 0.0 OUTLIER -69.97 -25.54 63.67 Favored 'General case' 0 CA--C 1.551 0.989 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.018 -178.851 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 28.1 t80 -65.34 -51.28 61.59 Favored 'General case' 0 C--N 1.358 0.959 0 C-N-CA 123.355 0.662 . . . . 0.0 109.534 173.47 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.409 ' HG ' ' O ' ' A' ' 72' ' ' LEU . 85.0 mt -60.83 -45.37 94.75 Favored 'General case' 0 N--CA 1.488 1.445 0 C-N-CA 123.668 0.787 . . . . 0.0 112.073 -172.621 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 19.0 ptpt -67.22 -32.54 73.65 Favored 'General case' 0 N--CA 1.481 1.122 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.207 178.688 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 34.8 t -85.54 -13.83 47.76 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 123.55 0.74 . . . . 0.0 111.594 -179.312 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 54.9 m80 -136.63 92.38 15.0 Favored Pre-proline 0 N--CA 1.485 1.298 0 C-N-CA 123.62 0.768 . . . . 0.0 109.368 -176.321 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -72.96 154.44 53.05 Favored 'Trans proline' 0 C--N 1.374 1.902 0 C-N-CA 122.7 2.267 . . . . 0.0 112.258 -179.3 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 102.81 -20.9 42.25 Favored Glycine 0 C--N 1.346 1.136 0 CA-C-N 115.893 -0.594 . . . . 0.0 112.205 -174.076 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 21.1 m120 -87.76 137.01 32.03 Favored Pre-proline 0 CA--C 1.553 1.069 0 C-N-CA 124.181 0.992 . . . . 0.0 110.194 179.422 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -72.38 159.43 49.34 Favored 'Trans proline' 0 C--N 1.38 2.234 0 C-N-CA 123.17 2.58 . . . . 0.0 112.908 -176.009 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -68.03 149.69 49.37 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 123.578 0.751 . . . . 0.0 112.138 -174.433 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.521 HD11 ' HG3' ' A' ' 69' ' ' ARG . 15.5 tt -68.05 -11.65 14.54 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.18 0 C-N-CA 123.922 0.889 . . . . 0.0 111.797 -178.928 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -56.92 -31.59 65.08 Favored 'General case' 0 CA--C 1.552 1.027 0 C-N-CA 124.311 1.045 . . . . 0.0 112.218 175.501 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -99.38 3.04 45.75 Favored 'General case' 0 N--CA 1.49 1.538 0 C-N-CA 123.4 0.68 . . . . 0.0 112.274 178.011 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -93.78 113.86 26.0 Favored 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 123.484 0.714 . . . . 0.0 109.386 -179.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -78.33 124.92 28.64 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 123.044 0.538 . . . . 0.0 110.454 -179.58 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 86.1 m95 -115.72 -6.55 12.14 Favored 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 123.821 0.848 . . . . 0.0 110.321 171.126 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 9.0 t -104.47 14.6 29.75 Favored 'General case' 0 N--CA 1.488 1.454 0 C-N-CA 124.708 1.203 . . . . 0.0 112.307 -166.261 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 12.9 t -65.7 -7.47 15.68 Favored 'General case' 0 N--CA 1.491 1.625 0 N-CA-C 113.571 0.952 . . . . 0.0 113.571 -176.718 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 15.7 m -45.9 100.52 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 125.382 1.473 . . . . 0.0 112.548 -175.676 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 95.79 -115.42 5.15 Favored Glycine 0 C--N 1.349 1.285 0 N-CA-C 110.981 -0.848 . . . . 0.0 110.981 -173.614 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 19.2 p . . . . . 0 N--CA 1.484 1.245 0 C-N-CA 124.133 0.973 . . . . 0.0 109.518 178.297 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.3 mpt? . . . . . 0 N--CA 1.479 1.021 0 N-CA-C 110.319 -0.252 . . . . 0.0 110.319 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 59.2 t-80 -132.05 75.42 1.64 Allowed 'General case' 0 N--CA 1.474 0.767 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 174.893 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 72.2 m-70 -132.88 156.71 46.71 Favored 'General case' 0 N--CA 1.482 1.162 0 CA-C-N 115.19 -0.914 . . . . 0.0 110.226 -179.689 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 73.1 m80 -105.5 130.97 53.45 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 123.672 0.789 . . . . 0.0 110.172 178.537 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 69.6 m-70 -134.32 150.14 50.94 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 124.539 1.135 . . . . 0.0 109.017 177.384 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 59.2 t-80 59.76 71.95 0.55 Allowed 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 124.432 1.093 . . . . 0.0 110.597 -178.349 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 9.4 t-160 -86.35 101.82 13.44 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-N 116.002 -0.545 . . . . 0.0 109.595 -179.629 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 17.1 m -67.69 106.85 2.35 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 123.709 0.804 . . . . 0.0 110.056 177.175 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 48.9 m -140.12 157.53 45.48 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 123.894 0.878 . . . . 0.0 110.317 -177.599 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -157.01 104.42 0.25 Allowed Glycine 0 C--N 1.344 1.027 0 CA-C-N 116.375 -0.375 . . . . 0.0 112.667 179.46 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 33.6 mmt180 -128.46 94.49 3.89 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 123.959 0.904 . . . . 0.0 109.483 179.446 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -118.11 104.71 11.1 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 124.639 1.176 . . . . 0.0 108.597 175.009 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 48.6 t-20 -146.93 127.0 13.7 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 123.659 0.784 . . . . 0.0 109.314 179.098 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -165.69 -179.0 5.12 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 124.605 1.162 . . . . 0.0 109.193 178.582 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 4.9 p90 -99.05 103.83 15.81 Favored 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 170.91 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 69.9 t80 -83.24 83.87 7.7 Favored 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 179.196 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 10.3 pt20 -163.2 151.3 13.64 Favored 'General case' 0 C--O 1.248 0.996 0 CA-C-N 115.459 -0.791 . . . . 0.0 109.315 -179.607 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -141.9 83.28 0.22 Allowed Glycine 0 C--N 1.341 0.825 0 N-CA-C 111.068 -0.813 . . . . 0.0 111.068 -178.287 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 58.6 m170 -70.99 138.07 49.63 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 123.446 0.698 . . . . 0.0 110.553 -178.742 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 19.6 ptp -108.08 102.88 12.0 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 123.502 0.721 . . . . 0.0 109.35 177.795 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -149.24 143.08 25.66 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 123.912 0.885 . . . . 0.0 109.872 -177.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 37.9 m -133.44 100.41 4.81 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 123.853 0.861 . . . . 0.0 109.168 179.667 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -150.16 -99.54 0.2 Allowed Glycine 0 C--N 1.347 1.191 0 N-CA-C 111.878 -0.489 . . . . 0.0 111.878 -179.901 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 55.8 p -169.57 165.45 10.26 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 124.249 1.019 . . . . 0.0 109.801 179.301 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -142.92 80.27 1.68 Allowed 'General case' 0 N--CA 1.479 0.983 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 178.117 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -124.22 85.87 2.48 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 123.436 0.694 . . . . 0.0 109.39 -177.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 11.7 tp10 -92.47 98.16 11.29 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-N 115.304 -0.862 . . . . 0.0 109.429 178.337 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 27.4 m -81.33 138.2 20.0 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.043 0 C-N-CA 122.93 0.492 . . . . 0.0 110.035 177.589 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 31.6 m -69.24 125.13 26.56 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.795 0 CA-C-O 121.204 0.526 . . . . 0.0 110.05 -179.894 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 3.8 m -142.96 128.2 18.73 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 123.998 0.919 . . . . 0.0 108.661 -175.619 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.405 HG23 ' HG3' ' A' ' 45' ' ' PRO . 26.2 t -122.4 124.76 71.6 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.935 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 178.75 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.479 ' HA ' ' HA ' ' A' ' 42' ' ' LEU . 48.0 mt-10 -82.31 108.05 15.45 Favored 'General case' 0 C--O 1.237 0.432 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 174.74 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.577 HD23 ' HB3' ' A' ' 43' ' ' PHE . 3.8 mm? -77.89 159.88 75.25 Favored Pre-proline 0 CA--C 1.555 1.167 0 CA-C-N 115.206 -0.907 . . . . 0.0 109.352 178.756 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -53.78 127.0 23.75 Favored 'Trans proline' 0 C--N 1.385 2.475 0 C-N-CA 122.952 2.435 . . . . 0.0 112.693 -174.293 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -113.15 158.1 39.03 Favored Pre-proline 0 N--CA 1.468 0.469 0 C-N-CA 124.063 0.945 . . . . 0.0 111.576 -169.187 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.647 ' HG2' ' HB2' ' A' ' 39' ' ' TRP . 46.6 Cg_endo -68.66 142.88 54.43 Favored 'Trans proline' 0 C--N 1.374 1.871 0 C-N-CA 122.007 1.804 . . . . 0.0 110.046 162.453 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 36.8 m -58.15 -25.38 61.41 Favored 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 124.095 0.958 . . . . 0.0 112.823 -175.007 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 45.8 t -74.61 -41.47 60.36 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 123.175 0.59 . . . . 0.0 110.822 178.185 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' TRP . . . . . 0.647 ' HB2' ' HG2' ' A' ' 36' ' ' PRO . 21.4 m95 -108.2 -167.61 1.26 Allowed 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 123.678 0.791 . . . . 0.0 110.724 -175.418 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.502 ' HB2' ' HB ' ' A' ' 59' ' ' VAL . 8.4 mtmt -137.47 150.32 47.49 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 124.679 1.192 . . . . 0.0 108.099 167.739 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 18.8 tptm -127.59 115.7 19.2 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 124.855 1.262 . . . . 0.0 108.289 -173.194 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.479 ' HA ' ' HA ' ' A' ' 32' ' ' GLU . 3.6 tt -119.26 147.49 44.21 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 124.407 1.083 . . . . 0.0 108.951 178.536 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.577 ' HB3' HD23 ' A' ' 33' ' ' LEU . 45.6 t80 -134.18 140.54 46.6 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 124.844 1.258 . . . . 0.0 108.392 171.734 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . 0.405 ' CE1' HD21 ' A' ' 42' ' ' LEU . 33.3 m-85 -97.16 105.57 25.51 Favored Pre-proline 0 CA--C 1.55 0.948 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 173.141 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.405 ' HG3' HG23 ' A' ' 31' ' ' VAL . 79.1 Cg_endo -73.99 151.56 45.05 Favored 'Trans proline' 0 C--N 1.377 2.036 0 C-N-CA 122.497 2.132 . . . . 0.0 112.719 174.793 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 17.1 p-10 -90.8 129.0 36.91 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.077 174.578 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 58.0 tptt -57.85 -52.97 63.28 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 124.423 1.089 . . . . 0.0 110.681 -178.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 42.3 t -96.81 151.03 4.21 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 C-N-CA 124.282 1.033 . . . . 0.0 108.522 174.722 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -71.74 165.7 53.6 Favored Glycine 0 CA--C 1.543 1.814 0 CA-C-O 120.249 -0.195 . . . . 0.0 112.881 177.214 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 16.6 m 76.02 -47.35 0.56 Allowed 'General case' 0 N--CA 1.498 1.935 0 C-N-CA 126.157 1.783 . . . . 0.0 113.185 176.833 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 22.4 m -62.61 134.63 27.78 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.113 0 C-N-CA 123.623 0.769 . . . . 0.0 112.261 -178.4 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 57.4 mtpt -86.74 109.29 19.13 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 123.338 0.655 . . . . 0.0 110.646 -178.833 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.53 ' HE3' ' HA ' ' A' ' 53' ' ' LYS . 0.1 OUTLIER -93.61 -177.26 4.33 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 123.556 0.742 . . . . 0.0 109.979 171.806 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 23.9 m -55.86 142.69 34.25 Favored 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 124.013 0.925 . . . . 0.0 111.153 -178.329 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -77.33 -165.67 0.62 Allowed 'General case' 0 CA--C 1.55 0.959 0 C-N-CA 123.883 0.873 . . . . 0.0 111.223 -176.493 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 47.1 t -79.26 138.43 20.02 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.637 0 C-N-CA 123.974 0.909 . . . . 0.0 109.912 -179.735 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 60.5 t -125.46 118.43 52.42 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.663 0 C-N-CA 123.823 0.849 . . . . 0.0 108.824 174.791 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 24.7 m-85 -86.71 126.69 34.73 Favored 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 170.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.502 ' HB ' ' HB2' ' A' ' 40' ' ' LYS . 4.6 t -81.72 128.54 38.63 Favored 'Isoleucine or valine' 0 C--O 1.241 0.623 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 170.213 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -84.65 147.91 50.39 Favored Pre-proline 0 C--O 1.242 0.7 0 CA-C-N 115.246 -0.888 . . . . 0.0 110.916 -178.747 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 27.4 Cg_endo -63.18 -23.47 72.89 Favored 'Trans proline' 0 C--N 1.371 1.713 0 C-N-CA 123.112 2.541 . . . . 0.0 112.826 174.569 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.637 HG23 ' H ' ' A' ' 64' ' ' GLU . 12.9 t -91.94 -10.95 37.62 Favored 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 123.059 0.544 . . . . 0.0 111.413 176.308 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 91.99 -8.8 77.67 Favored Glycine 0 C--N 1.355 1.607 0 CA-C-O 120.03 -0.317 . . . . 0.0 113.813 -178.034 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.637 ' H ' HG23 ' A' ' 62' ' ' THR . 9.4 tp10 -76.94 76.68 3.51 Favored 'General case' 0 N--CA 1.486 1.335 0 N-CA-C 108.612 -0.885 . . . . 0.0 108.612 173.137 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -63.76 149.17 47.39 Favored 'General case' 0 C--O 1.241 0.611 0 CA-C-N 115.083 -0.962 . . . . 0.0 111.706 -171.299 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.487 HG23 ' HB2' ' A' ' 71' ' ' GLN . 46.7 mm -115.59 119.96 63.35 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.732 0 CA-C-N 114.638 -1.165 . . . . 0.0 109.309 -174.726 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 14.4 p -106.47 -8.99 16.85 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 123.403 0.681 . . . . 0.0 112.511 -177.0 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 10.9 p30 -144.36 159.26 43.01 Favored 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 122.499 0.32 . . . . 0.0 111.084 175.231 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.513 ' HG3' HD11 ' A' ' 85' ' ' ILE . 50.7 ttt-85 -60.1 -35.85 76.14 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 124.446 1.098 . . . . 0.0 112.349 -173.49 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 1.8 tmtp? -59.91 -51.21 70.66 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 123.255 0.622 . . . . 0.0 109.372 179.189 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.487 ' HB2' HG23 ' A' ' 66' ' ' ILE . 84.1 mm-40 -57.86 -31.49 66.74 Favored 'General case' 0 CA--C 1.55 0.963 0 O-C-N 123.932 0.77 . . . . 0.0 110.949 -179.003 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -67.73 -51.28 51.2 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 123.666 0.786 . . . . 0.0 109.52 178.334 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -61.65 -50.87 70.77 Favored 'General case' 0 N--CA 1.484 1.259 0 C-N-CA 124.087 0.955 . . . . 0.0 111.472 -175.663 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 1.3 pp0? -65.86 -32.2 73.59 Favored 'General case' 0 CA--C 1.544 0.747 0 CA-C-N 115.495 -0.775 . . . . 0.0 111.178 -178.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 29.8 t80 -60.64 -51.11 70.77 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 123.334 0.654 . . . . 0.0 110.213 176.1 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.481 HD13 ' HA ' ' A' ' 84' ' ' ALA . 89.0 mt -65.33 -45.21 85.15 Favored 'General case' 0 N--CA 1.479 0.986 0 O-C-N 123.799 0.687 . . . . 0.0 111.994 -172.191 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.28 -20.24 63.05 Favored 'General case' 0 N--CA 1.481 1.094 0 CA-C-O 120.902 0.382 . . . . 0.0 111.211 179.601 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 34.2 t -92.53 -18.78 22.69 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 123.766 0.826 . . . . 0.0 111.574 175.184 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 54.3 m80 -135.2 93.7 16.6 Favored Pre-proline 0 N--CA 1.476 0.86 0 C-N-CA 123.587 0.755 . . . . 0.0 109.663 -174.71 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -71.92 162.71 41.1 Favored 'Trans proline' 0 C--N 1.371 1.732 0 C-N-CA 122.394 2.063 . . . . 0.0 111.804 175.742 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 87.9 -4.06 85.75 Favored Glycine 0 N--CA 1.472 1.05 0 CA-C-N 116.413 -0.358 . . . . 0.0 113.298 -177.51 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 32.0 m-80 -97.43 145.0 28.91 Favored Pre-proline 0 N--CA 1.482 1.171 0 C-N-CA 123.659 0.784 . . . . 0.0 109.991 177.698 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_endo -65.32 144.43 80.45 Favored 'Trans proline' 0 C--N 1.377 2.049 0 C-N-CA 122.561 2.174 . . . . 0.0 111.878 179.286 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.481 ' HA ' HD13 ' A' ' 76' ' ' LEU . . . -70.68 162.03 29.75 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 123.809 0.843 . . . . 0.0 112.305 -171.219 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.513 HD11 ' HG3' ' A' ' 69' ' ' ARG . 17.5 tt -74.29 -15.54 16.45 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.095 0 CA-C-O 120.941 0.401 . . . . 0.0 110.924 179.24 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -60.02 -34.35 73.25 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 124.304 1.042 . . . . 0.0 112.081 175.649 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.449 ' HG2' ' O ' ' A' ' 84' ' ' ALA . 10.2 pt-20 -98.13 -2.65 39.5 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 123.761 0.825 . . . . 0.0 111.172 -178.715 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 3.6 m-30 -90.49 152.48 20.92 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 123.471 0.708 . . . . 0.0 110.144 176.055 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -120.3 122.74 41.5 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 123.464 0.706 . . . . 0.0 109.943 178.167 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 88.9 m95 -111.64 -2.0 15.54 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 123.798 0.839 . . . . 0.0 110.512 172.075 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 12.5 t -107.54 15.83 24.39 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 123.639 0.776 . . . . 0.0 112.145 -168.252 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 15.4 t -62.05 -20.12 63.63 Favored 'General case' 0 N--CA 1.492 1.64 0 C-N-CA 123.077 0.551 . . . . 0.0 111.734 -179.908 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 15.3 p -72.55 79.88 1.07 Allowed 'General case' 0 CA--C 1.553 1.064 0 C-N-CA 123.835 0.854 . . . . 0.0 110.455 176.776 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -91.76 123.22 7.11 Favored Glycine 0 C--N 1.346 1.123 0 CA-C-N 115.519 -0.764 . . . . 0.0 111.212 176.091 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 31.8 p . . . . . 0 C--O 1.252 1.212 0 C-N-CA 123.505 0.722 . . . . 0.0 110.27 179.198 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.3 mpt? . . . . . 0 N--CA 1.48 1.051 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 35.5 t-80 -170.59 135.45 1.17 Allowed 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 124.416 1.086 . . . . 0.0 108.375 -179.38 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 13.8 t60 -87.11 75.3 9.47 Favored 'General case' 0 N--CA 1.479 0.981 0 CA-C-O 120.953 0.406 . . . . 0.0 109.961 -176.97 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 63.6 m170 53.52 -91.97 0.03 OUTLIER 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 125.496 1.518 . . . . 0.0 112.367 -179.505 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 3.2 p80 174.0 147.79 0.07 Allowed 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 125.35 1.46 . . . . 0.0 108.608 -176.831 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 92.4 m-70 -139.02 112.48 8.22 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 123.627 0.771 . . . . 0.0 109.252 179.831 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 62.3 m80 -144.98 135.11 23.94 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 124.457 1.103 . . . . 0.0 110.05 177.816 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 37.7 t -85.08 129.54 34.78 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 124.326 1.051 . . . . 0.0 109.753 -179.849 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 25.5 p -84.78 88.89 7.42 Favored 'General case' 0 CA--C 1.551 0.99 0 C-N-CA 123.841 0.856 . . . . 0.0 110.745 -176.709 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -103.07 161.2 16.51 Favored Glycine 0 C--N 1.347 1.15 0 CA-C-N 115.173 -0.921 . . . . 0.0 111.802 176.646 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 2.4 mpt_? -115.05 154.31 29.1 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 123.773 0.829 . . . . 0.0 109.617 -175.418 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -100.93 -63.35 1.14 Allowed 'General case' 0 N--CA 1.476 0.845 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 168.586 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 7.9 t30 56.53 83.93 0.09 Allowed 'General case' 0 C--N 1.357 0.906 0 C-N-CA 125.129 1.372 . . . . 0.0 112.144 179.88 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -118.17 128.48 54.76 Favored 'General case' 0 N--CA 1.477 0.915 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 170.111 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 27.8 p90 -94.61 -54.13 3.62 Favored 'General case' 0 C--O 1.239 0.502 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 171.285 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 41.7 t80 51.22 25.96 2.71 Favored 'General case' 0 CA--C 1.566 1.568 0 C-N-CA 125.467 1.507 . . . . 0.0 112.034 177.691 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 14.2 pt20 -100.03 147.32 25.74 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 124.119 0.968 . . . . 0.0 110.102 -175.902 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -171.03 133.47 2.78 Favored Glycine 0 C--N 1.338 0.688 0 N-CA-C 111.466 -0.654 . . . . 0.0 111.466 -177.998 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 50.3 p-80 -86.54 124.3 32.69 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 123.456 0.702 . . . . 0.0 109.157 178.917 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 3.9 mmt -133.41 122.04 23.14 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 123.59 0.756 . . . . 0.0 109.703 -179.735 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -109.28 -19.24 13.37 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 123.798 0.839 . . . . 0.0 111.017 177.565 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 44.2 m -80.49 126.56 31.37 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 123.464 0.706 . . . . 0.0 110.217 179.254 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -73.74 -48.31 17.52 Favored Glycine 0 C--N 1.344 1.026 0 O-C-N 123.669 0.605 . . . . 0.0 111.982 178.921 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 56.0 p -80.68 79.69 7.28 Favored 'General case' 0 C--O 1.247 0.928 0 C-N-CA 123.519 0.727 . . . . 0.0 109.795 174.643 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -86.46 111.33 20.44 Favored 'General case' 0 C--O 1.239 0.505 0 CA-C-N 115.2 -0.909 . . . . 0.0 108.879 179.557 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 -102.07 33.38 3.08 Favored 'General case' 0 CA--C 1.552 1.049 0 C-N-CA 123.838 0.855 . . . . 0.0 110.724 -177.577 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 16.4 mm-40 -78.65 81.55 4.96 Favored 'General case' 0 N--CA 1.479 0.989 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 172.398 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 27.5 m -101.14 174.95 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 CA-C-N 114.166 -1.379 . . . . 0.0 110.558 -175.144 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 19.2 m -71.11 104.74 1.44 Allowed 'Isoleucine or valine' 0 CA--C 1.555 1.162 0 CA-C-O 121.898 0.856 . . . . 0.0 109.815 175.657 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 39.9 p -171.91 141.22 1.34 Allowed 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 125.202 1.401 . . . . 0.0 107.948 -177.972 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.479 HG23 ' HG3' ' A' ' 45' ' ' PRO . 59.9 t -117.92 126.51 74.9 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 -178.972 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -84.97 105.13 15.5 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 123.58 0.752 . . . . 0.0 108.982 176.512 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.501 HD23 ' HB3' ' A' ' 43' ' ' PHE . 4.4 mm? -82.56 163.54 51.48 Favored Pre-proline 0 N--CA 1.48 1.057 0 C-N-CA 123.82 0.848 . . . . 0.0 110.192 -178.564 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -57.25 137.16 80.45 Favored 'Trans proline' 0 C--N 1.39 2.759 0 C-N-CA 122.683 2.255 . . . . 0.0 112.797 -179.536 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.571 ' HB2' ' HB3' ' A' ' 41' ' ' LYS . . . -123.48 161.72 44.19 Favored Pre-proline 0 N--CA 1.476 0.86 0 C-N-CA 124.298 1.039 . . . . 0.0 111.742 -172.766 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.704 ' HG2' ' HB2' ' A' ' 39' ' ' TRP . 31.6 Cg_endo -63.72 146.36 92.07 Favored 'Trans proline' 0 C--N 1.375 1.926 0 C-N-CA 122.551 2.167 . . . . 0.0 109.669 159.028 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 18.5 m -59.04 -37.95 78.18 Favored 'General case' 0 N--CA 1.489 1.477 0 C-N-CA 124.179 0.992 . . . . 0.0 112.838 -169.734 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 48.5 m -69.81 -35.05 74.51 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 123.574 0.75 . . . . 0.0 111.528 -179.907 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' TRP . . . . . 0.704 ' HB2' ' HG2' ' A' ' 36' ' ' PRO . 33.3 m95 -104.6 -179.89 4.08 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 123.782 0.833 . . . . 0.0 110.566 -175.678 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.36 152.42 51.44 Favored 'General case' 0 N--CA 1.476 0.844 0 N-CA-C 107.556 -1.276 . . . . 0.0 107.556 173.743 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.571 ' HB3' ' HB2' ' A' ' 35' ' ' ALA . 18.2 tptm -132.53 117.8 18.45 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 123.922 0.889 . . . . 0.0 109.812 -171.717 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 2.3 tt -122.24 144.7 48.82 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 124.762 1.225 . . . . 0.0 108.604 174.459 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.501 ' HB3' HD23 ' A' ' 33' ' ' LEU . 47.6 t80 -128.1 147.64 50.54 Favored 'General case' 0 C--O 1.238 0.482 0 C-N-CA 124.701 1.201 . . . . 0.0 108.98 171.405 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 18.2 m-85 -102.18 100.97 16.78 Favored Pre-proline 0 CA--C 1.551 0.994 0 C-N-CA 123.651 0.781 . . . . 0.0 110.147 171.895 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.479 ' HG3' HG23 ' A' ' 31' ' ' VAL . 30.9 Cg_endo -86.71 -174.65 1.46 Allowed 'Trans proline' 0 C--N 1.373 1.852 0 C-N-CA 123.435 2.756 . . . . 0.0 113.342 175.993 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . 0.63 ' HB2' ' HA ' ' A' ' 51' ' ' VAL . 3.9 p-10 -127.44 148.02 50.29 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 124.283 1.033 . . . . 0.0 108.765 174.251 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 73.0 mmtt -127.21 97.47 4.93 Favored 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 123.372 0.669 . . . . 0.0 111.461 -172.456 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 32.6 t 43.55 84.25 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 C-N-CA 126.179 1.792 . . . . 0.0 113.48 169.545 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 87.17 -46.54 3.54 Favored Glycine 0 C--N 1.341 0.828 0 CA-C-N 116.28 -0.418 . . . . 0.0 112.492 -177.986 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 49.4 m -71.19 81.52 0.71 Allowed 'General case' 0 C--N 1.359 0.984 0 CA-C-O 121.656 0.741 . . . . 0.0 109.999 175.122 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.63 ' HA ' ' HB2' ' A' ' 46' ' ' ASN . 16.4 m -94.87 115.85 34.75 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.613 0 CA-C-N 114.965 -1.016 . . . . 0.0 110.238 -178.235 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 44.5 tptt -155.7 30.54 0.37 Allowed 'General case' 0 CA--C 1.549 0.917 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 177.9 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -63.95 135.07 56.19 Favored 'General case' 0 C--N 1.354 0.796 0 CA-C-N 114.928 -1.033 . . . . 0.0 110.063 -178.549 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 24.9 m -130.82 162.49 29.47 Favored 'General case' 0 C--O 1.241 0.633 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 -177.097 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -60.4 172.95 0.75 Allowed 'General case' 0 CA--C 1.549 0.939 0 CA-C-O 122.547 1.165 . . . . 0.0 112.16 176.363 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 20.5 t -80.52 145.88 8.41 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.668 0 CA-C-N 113.764 -1.562 . . . . 0.0 110.519 -174.512 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 49.1 t -121.77 116.55 49.72 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.804 0 C-N-CA 123.969 0.908 . . . . 0.0 109.007 172.219 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 33.9 m-85 -90.3 132.79 35.36 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 123.618 0.767 . . . . 0.0 110.255 171.424 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.414 ' HA ' ' HG2' ' A' ' 65' ' ' GLU . 14.8 t -85.59 132.19 32.49 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 168.477 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -87.4 153.7 53.6 Favored Pre-proline 0 C--O 1.244 0.772 0 CA-C-N 115.317 -0.856 . . . . 0.0 110.638 179.739 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_endo -69.43 -3.02 10.94 Favored 'Trans proline' 0 C--N 1.376 1.974 0 C-N-CA 122.865 2.377 . . . . 0.0 113.062 177.667 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.564 HG23 ' H ' ' A' ' 64' ' ' GLU . 12.3 t -115.62 -7.97 12.13 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 124.129 0.972 . . . . 0.0 111.401 -179.902 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 94.16 -15.2 63.72 Favored Glycine 0 C--N 1.358 1.783 0 CA-C-O 119.695 -0.503 . . . . 0.0 113.791 -179.547 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.564 ' H ' HG23 ' A' ' 62' ' ' THR . 42.9 tt0 -78.4 80.12 4.81 Favored 'General case' 0 N--CA 1.484 1.265 0 CA-C-O 121.67 0.748 . . . . 0.0 109.335 173.394 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.414 ' HG2' ' HA ' ' A' ' 59' ' ' VAL . 28.3 mt-10 -69.73 156.46 38.96 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 124.43 1.092 . . . . 0.0 111.73 -170.224 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 41.0 mm -111.19 122.51 65.78 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.613 0 C-N-CA 123.855 0.862 . . . . 0.0 109.481 178.138 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 61.6 p -99.65 -11.45 20.91 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 123.481 0.712 . . . . 0.0 112.506 -177.817 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -153.94 150.54 28.43 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 122.598 0.359 . . . . 0.0 111.315 -177.804 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.455 ' HG3' HD11 ' A' ' 85' ' ' ILE . 41.5 ttm105 -54.98 -32.4 61.64 Favored 'General case' 0 N--CA 1.491 1.588 0 C-N-CA 125.369 1.468 . . . . 0.0 114.143 -168.196 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -60.05 -54.37 46.83 Favored 'General case' 0 N--CA 1.487 1.404 0 C-N-CA 123.356 0.662 . . . . 0.0 109.648 -179.798 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.474 ' O ' ' HB2' ' A' ' 75' ' ' TYR . 90.1 mm-40 -64.2 -20.97 66.38 Favored 'General case' 0 N--CA 1.476 0.841 0 CA-C-N 115.347 -0.842 . . . . 0.0 111.778 -176.564 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.44 ' O ' ' HG ' ' A' ' 76' ' ' LEU . 0.9 OUTLIER -69.85 -52.97 20.43 Favored 'General case' 0 N--CA 1.481 1.091 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 175.697 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -58.0 -54.42 47.11 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 123.971 0.908 . . . . 0.0 111.766 -178.752 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . 0.442 ' HG3' ' HA ' ' A' ' 71' ' ' GLN . 0.0 OUTLIER -67.5 -24.29 65.56 Favored 'General case' 0 CA--C 1.551 0.993 0 CA-C-N 115.455 -0.793 . . . . 0.0 111.077 -177.685 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . 0.474 ' HB2' ' O ' ' A' ' 71' ' ' GLN . 35.6 t80 -65.94 -55.27 17.71 Favored 'General case' 0 C--N 1.36 1.032 0 C-N-CA 123.097 0.559 . . . . 0.0 109.706 174.383 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.44 ' HG ' ' O ' ' A' ' 72' ' ' LEU . 71.2 mt -59.96 -39.47 85.71 Favored 'General case' 0 N--CA 1.489 1.514 0 C-N-CA 123.436 0.694 . . . . 0.0 111.855 -172.629 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.95 -14.35 58.66 Favored 'General case' 0 N--CA 1.484 1.269 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.824 -179.517 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 37.5 t -102.02 -9.6 20.47 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 123.621 0.768 . . . . 0.0 111.198 172.697 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 86.5 m-70 -137.45 87.23 18.05 Favored Pre-proline 0 N--CA 1.481 1.083 0 C-N-CA 124.189 0.995 . . . . 0.0 109.363 -177.132 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 63.2 Cg_endo -71.35 141.65 39.4 Favored 'Trans proline' 0 C--N 1.374 1.874 0 C-N-CA 122.403 2.069 . . . . 0.0 111.126 174.993 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 116.58 -20.24 12.24 Favored Glycine 0 N--CA 1.471 1.032 0 N-CA-C 111.695 -0.562 . . . . 0.0 111.695 -174.245 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 39.4 m-80 -91.67 140.51 25.17 Favored Pre-proline 0 CA--C 1.548 0.892 0 C-N-CA 123.435 0.694 . . . . 0.0 109.717 177.351 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -70.07 159.42 53.24 Favored 'Trans proline' 0 C--N 1.377 2.045 0 C-N-CA 122.845 2.363 . . . . 0.0 112.983 -178.65 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -70.0 154.55 41.81 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 123.949 0.9 . . . . 0.0 112.477 -173.432 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.455 HD11 ' HG3' ' A' ' 69' ' ' ARG . 16.2 tt -66.82 -12.01 14.34 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.209 0 C-N-CA 124.171 0.988 . . . . 0.0 111.686 -179.227 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -52.89 -39.8 62.99 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 124.505 1.122 . . . . 0.0 112.05 174.977 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -94.4 -8.14 39.57 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 123.526 0.73 . . . . 0.0 112.044 178.902 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -86.56 110.86 20.09 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 123.444 0.698 . . . . 0.0 109.314 176.39 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -87.63 126.56 35.02 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 123.683 0.793 . . . . 0.0 109.882 -178.744 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 85.2 m95 -118.29 -3.96 10.96 Favored 'General case' 0 CA--C 1.555 1.173 0 C-N-CA 125.126 1.37 . . . . 0.0 110.106 172.456 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 15.1 t -108.62 14.13 24.73 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 124.025 0.93 . . . . 0.0 112.18 -168.046 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 9.4 t -62.39 -15.31 48.12 Favored 'General case' 0 N--CA 1.493 1.709 0 C-N-CA 123.0 0.52 . . . . 0.0 112.248 178.617 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 10.4 p -57.93 -12.47 3.26 Favored 'General case' 0 CA--C 1.554 1.107 0 C-N-CA 125.549 1.539 . . . . 0.0 113.693 176.469 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -167.99 158.27 30.97 Favored Glycine 0 C--N 1.338 0.675 0 N-CA-C 111.551 -0.62 . . . . 0.0 111.551 173.63 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 12.4 t . . . . . 0 CA--C 1.559 1.293 0 C-N-CA 122.915 0.486 . . . . 0.0 110.089 177.619 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.5 mpp? . . . . . 0 N--CA 1.478 0.944 0 N-CA-C 109.519 -0.548 . . . . 0.0 109.519 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 22.4 m-70 -102.94 113.64 27.27 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 173.854 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 7.8 p-80 -68.35 -31.49 70.93 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 123.383 0.673 . . . . 0.0 112.115 -178.503 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 71.4 m-70 63.15 163.69 0.11 Allowed 'General case' 0 N--CA 1.493 1.684 0 C-N-CA 124.863 1.265 . . . . 0.0 111.679 -175.034 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 16.1 m170 -148.7 90.73 1.8 Allowed 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 123.859 0.864 . . . . 0.0 109.068 174.854 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 54.9 t-80 -80.03 86.2 5.53 Favored 'General case' 0 C--O 1.242 0.672 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 176.876 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 8.4 p80 -97.42 114.26 26.07 Favored 'General case' 0 C--O 1.242 0.658 0 CA-C-N 115.163 -0.926 . . . . 0.0 109.181 176.807 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 49.9 m -141.8 82.25 1.8 Allowed 'General case' 0 C--O 1.24 0.575 0 C-N-CA 123.628 0.771 . . . . 0.0 109.808 -179.528 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 47.9 p -156.78 133.98 10.51 Favored 'General case' 0 C--O 1.24 0.554 0 CA-C-N 114.825 -1.08 . . . . 0.0 108.959 -177.999 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 150.04 52.67 0.02 OUTLIER Glycine 0 C--N 1.346 1.125 0 N-CA-C 112.574 -0.21 . . . . 0.0 112.574 178.331 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 97.9 mtt180 -92.35 146.52 23.63 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 123.432 0.693 . . . . 0.0 109.665 175.411 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 13.3 tp10 -76.94 -64.9 1.02 Allowed 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 123.301 0.64 . . . . 0.0 109.693 178.316 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 4.6 m-20 59.45 21.12 9.52 Favored 'General case' 0 N--CA 1.493 1.694 0 C-N-CA 124.659 1.184 . . . . 0.0 112.65 176.85 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -84.66 116.7 23.34 Favored 'General case' 0 CA--C 1.536 0.414 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 -176.738 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.421 ' HD2' ' HG2' ' A' ' 17' ' ' GLN . 19.5 p90 -110.44 -52.43 2.78 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 123.571 0.748 . . . . 0.0 110.646 178.332 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 45.1 t80 40.28 79.51 0.03 OUTLIER 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 125.761 1.624 . . . . 0.0 111.606 -171.651 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . 0.421 ' HG2' ' HD2' ' A' ' 15' ' ' TYR . 14.0 pt20 -135.85 -12.66 1.97 Allowed 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 123.239 0.616 . . . . 0.0 111.411 -173.502 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -85.65 52.31 4.58 Favored Glycine 0 C--N 1.351 1.403 0 CA-C-O 120.413 -0.104 . . . . 0.0 113.307 -175.842 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 23.9 p80 -84.69 116.82 23.42 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-O 121.309 0.576 . . . . 0.0 109.588 178.834 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 64.0 mtt -104.57 -65.58 1.02 Allowed 'General case' 0 C--O 1.242 0.672 0 N-CA-C 108.277 -1.009 . . . . 0.0 108.277 178.026 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . 51.12 33.65 9.68 Favored 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 124.213 1.005 . . . . 0.0 111.959 175.965 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 66.5 p -70.96 79.9 0.65 Allowed 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 124.342 1.057 . . . . 0.0 111.786 -167.351 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 81.04 -50.45 4.17 Favored Glycine 0 C--N 1.348 1.219 0 CA-C-N 115.408 -0.815 . . . . 0.0 113.278 -179.175 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 23.0 t 58.7 31.73 21.45 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 124.342 1.057 . . . . 0.0 109.438 -166.499 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -107.5 94.47 5.1 Favored 'General case' 0 C--O 1.241 0.625 0 C-N-CA 125.127 1.371 . . . . 0.0 108.578 -176.021 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 69.0 134.56 0.03 OUTLIER 'General case' 0 CA--C 1.55 0.978 0 C-N-CA 125.194 1.398 . . . . 0.0 111.97 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -150.4 103.84 3.18 Favored 'General case' 0 CA--C 1.542 0.666 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 178.177 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 25.2 m -95.36 176.54 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.982 0 C-N-CA 123.53 0.732 . . . . 0.0 110.469 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.488 HG11 ' HG3' ' A' ' 47' ' ' LYS . 15.3 m -87.17 125.62 40.98 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.774 0 CA-C-N 115.767 -0.651 . . . . 0.0 109.854 170.798 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 50.1 p -152.99 123.83 7.37 Favored 'General case' 0 C--O 1.239 0.541 0 C-N-CA 123.934 0.893 . . . . 0.0 108.804 178.249 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 48.6 t -103.15 119.83 52.17 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 -178.582 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.441 ' HA ' ' HA ' ' A' ' 42' ' ' LEU . 37.4 mt-10 -79.11 117.07 19.81 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.011 177.166 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.442 HD23 ' HB3' ' A' ' 43' ' ' PHE . 3.0 mm? -92.0 164.1 24.83 Favored Pre-proline 0 N--CA 1.483 1.195 0 C-N-CA 124.26 1.024 . . . . 0.0 109.6 -178.033 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -53.46 140.15 64.4 Favored 'Trans proline' 0 C--N 1.394 2.968 0 C-N-CA 123.127 2.551 . . . . 0.0 114.027 179.927 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.768 ' HB2' ' HB3' ' A' ' 41' ' ' LYS . . . -140.19 156.84 69.9 Favored Pre-proline 0 N--CA 1.472 0.672 0 C-N-CA 124.419 1.087 . . . . 0.0 111.473 -170.068 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -58.41 140.73 95.68 Favored 'Trans proline' 0 C--N 1.372 1.784 0 C-N-CA 122.798 2.332 . . . . 0.0 110.504 155.269 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 70.5 p -63.51 -28.15 69.75 Favored 'General case' 0 N--CA 1.487 1.422 0 C-N-CA 122.993 0.517 . . . . 0.0 111.884 -177.007 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 31.8 m -67.24 -40.03 86.24 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 123.282 0.633 . . . . 0.0 110.612 176.911 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 33.8 m95 -100.46 -179.46 4.11 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 123.743 0.817 . . . . 0.0 110.25 179.266 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.5 150.51 52.15 Favored 'General case' 0 N--CA 1.469 0.482 0 N-CA-C 106.768 -1.568 . . . . 0.0 106.768 169.893 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.768 ' HB3' ' HB2' ' A' ' 35' ' ' ALA . 15.2 tptm -133.0 128.96 37.52 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.676 0.751 . . . . 0.0 108.998 -174.493 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.441 ' HA ' ' HA ' ' A' ' 32' ' ' GLU . 3.3 tt -135.37 151.32 50.37 Favored 'General case' 0 C--O 1.241 0.607 0 CA-C-N 114.001 -1.454 . . . . 0.0 108.62 -177.146 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.442 ' HB3' HD23 ' A' ' 33' ' ' LEU . 32.9 t80 -133.61 137.84 45.65 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.782 1.233 . . . . 0.0 108.267 173.735 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . 0.434 ' CE1' HD21 ' A' ' 42' ' ' LEU . 38.5 m-85 -100.59 103.53 24.7 Favored Pre-proline 0 N--CA 1.484 1.231 0 C-N-CA 122.692 0.397 . . . . 0.0 111.025 175.544 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.675 ' HA ' ' HA ' ' A' ' 52' ' ' LYS . 65.0 Cg_endo -83.64 168.17 12.83 Favored 'Trans proline' 0 C--N 1.371 1.727 0 C-N-CA 122.421 2.081 . . . . 0.0 110.994 166.676 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . 0.476 ' HA ' ' HB2' ' A' ' 53' ' ' LYS . 48.3 t-20 -68.43 -44.3 75.25 Favored 'General case' 0 N--CA 1.478 0.929 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 169.787 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.535 ' HG2' HG23 ' A' ' 48' ' ' VAL . 36.8 ttpt 177.86 -75.3 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.618 0 O-C-N 125.229 1.581 . . . . 0.0 108.339 166.753 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.535 HG23 ' HG2' ' A' ' 47' ' ' LYS . 51.9 t -127.58 156.09 39.17 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.301 0 C-N-CA 124.317 1.047 . . . . 0.0 109.11 -177.592 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 105.59 7.98 35.83 Favored Glycine 0 C--N 1.349 1.303 0 C-N-CA 123.078 0.37 . . . . 0.0 112.339 -177.865 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 26.8 m 69.43 -3.83 1.5 Allowed 'General case' 0 N--CA 1.495 1.804 0 C-N-CA 125.593 1.557 . . . . 0.0 112.592 -177.816 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 26.6 m -74.53 140.0 18.29 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.454 0 C-N-CA 123.825 0.85 . . . . 0.0 110.526 -175.67 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.675 ' HA ' ' HA ' ' A' ' 45' ' ' PRO . 16.7 ptpt -93.6 160.97 14.54 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-N 115.636 -0.711 . . . . 0.0 111.089 178.407 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.476 ' HB2' ' HA ' ' A' ' 46' ' ' ASN . 88.3 tttt -121.13 -41.8 2.51 Favored 'General case' 0 N--CA 1.479 0.978 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 178.74 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.411 ' HB ' ' HB2' ' A' ' 44' ' ' TYR . 17.9 m -130.94 161.83 31.04 Favored 'General case' 0 CA--C 1.544 0.732 0 CA-C-N 114.529 -1.214 . . . . 0.0 108.008 176.391 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 4.0 pm0 -69.94 -177.97 1.45 Allowed 'General case' 0 CA--C 1.555 1.164 0 C-N-CA 123.658 0.783 . . . . 0.0 111.674 179.102 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 75.2 t -83.02 141.87 14.33 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.695 0 C-N-CA 124.33 1.052 . . . . 0.0 110.241 -177.317 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 57.7 t -123.56 124.01 68.6 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 C-N-CA 123.737 0.815 . . . . 0.0 109.555 179.594 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 29.6 m-85 -101.83 113.68 27.09 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 123.582 0.753 . . . . 0.0 109.27 171.774 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 3.4 t -79.1 130.45 36.11 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 C-N-CA 123.323 0.649 . . . . 0.0 109.587 175.939 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -84.18 154.47 63.48 Favored Pre-proline 0 CA--C 1.541 0.622 0 CA-C-N 115.022 -0.99 . . . . 0.0 111.593 -175.796 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 26.5 Cg_endo -60.42 -33.6 93.95 Favored 'Trans proline' 0 C--N 1.377 2.071 0 C-N-CA 123.251 2.634 . . . . 0.0 113.179 177.226 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 14.8 t -85.47 -2.49 58.18 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 123.027 0.531 . . . . 0.0 111.602 179.256 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 94.21 -18.01 57.71 Favored Glycine 0 C--N 1.35 1.308 0 CA-C-O 119.635 -0.536 . . . . 0.0 113.682 178.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -72.46 76.82 1.04 Allowed 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 123.983 0.913 . . . . 0.0 109.638 178.198 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -65.57 157.86 28.64 Favored 'General case' 0 N--CA 1.477 0.881 0 CA-C-N 115.024 -0.989 . . . . 0.0 111.682 -172.744 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 47.4 mm -118.44 122.52 69.72 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.445 0 CA-C-N 114.83 -1.077 . . . . 0.0 109.386 -170.741 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 7.6 p -93.82 -21.26 19.39 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 123.932 0.893 . . . . 0.0 112.403 -178.44 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 2.4 p-10 -153.95 165.95 34.52 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 122.674 0.39 . . . . 0.0 111.393 -172.401 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 34.8 ttp180 -58.91 -41.93 88.45 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 124.314 1.046 . . . . 0.0 111.954 -171.059 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 5.0 tmtm? -55.99 -51.6 67.15 Favored 'General case' 0 N--CA 1.486 1.335 0 C-N-CA 123.821 0.848 . . . . 0.0 109.76 -179.52 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 77.5 mt-30 -60.3 -31.63 70.44 Favored 'General case' 0 N--CA 1.476 0.839 0 O-C-N 124.144 0.903 . . . . 0.0 111.422 -178.729 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -67.62 -50.42 58.19 Favored 'General case' 0 N--CA 1.481 1.12 0 N-CA-C 109.338 -0.615 . . . . 0.0 109.338 177.898 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -62.8 -51.0 68.77 Favored 'General case' 0 C--O 1.242 0.693 0 CA-C-N 115.236 -0.893 . . . . 0.0 111.225 -174.897 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -66.36 -29.42 69.6 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 122.556 0.343 . . . . 0.0 111.223 179.799 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 43.7 t80 -62.53 -54.68 36.28 Favored 'General case' 0 C--N 1.357 0.913 0 C-N-CA 122.946 0.498 . . . . 0.0 109.824 176.06 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 67.1 mt -60.71 -44.5 96.5 Favored 'General case' 0 N--CA 1.481 1.095 0 O-C-N 123.579 0.549 . . . . 0.0 111.847 -173.143 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -69.1 -25.04 64.21 Favored 'General case' 0 N--CA 1.48 1.037 0 CA-C-N 116.589 -0.278 . . . . 0.0 111.402 -177.813 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 100.0 p -98.47 -12.4 21.36 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 122.91 0.484 . . . . 0.0 111.811 178.715 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 90.4 m-70 -130.84 91.02 38.15 Favored Pre-proline 0 N--CA 1.476 0.841 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 179.673 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_endo -67.01 166.04 24.26 Favored 'Trans proline' 0 C--N 1.372 1.783 0 C-N-CA 122.412 2.075 . . . . 0.0 112.071 175.661 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 90.81 -17.22 55.98 Favored Glycine 0 C--N 1.347 1.15 0 CA-C-N 116.565 -0.289 . . . . 0.0 113.259 -179.776 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 40.2 m-80 -84.16 144.64 44.42 Favored Pre-proline 0 CA--C 1.547 0.856 0 C-N-CA 123.652 0.781 . . . . 0.0 111.269 -178.013 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_exo -56.18 152.01 40.28 Favored 'Trans proline' 0 C--N 1.378 2.081 0 C-N-CA 123.875 3.05 . . . . 0.0 112.794 170.97 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -77.04 161.56 28.22 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 123.526 0.73 . . . . 0.0 112.207 -173.997 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 16.9 tt -72.93 -23.45 20.38 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.222 0 C-N-CA 123.347 0.659 . . . . 0.0 111.488 -178.71 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -65.13 -31.58 72.85 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 123.308 0.643 . . . . 0.0 111.854 -177.728 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -90.52 0.2 57.42 Favored 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 123.432 0.693 . . . . 0.0 111.247 177.106 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 6.0 m-30 -92.74 111.42 23.02 Favored 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 123.499 0.72 . . . . 0.0 109.248 177.149 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -84.0 88.79 7.17 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 123.559 0.744 . . . . 0.0 110.618 -175.872 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 89.5 m95 -76.19 -17.69 59.42 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 122.695 0.398 . . . . 0.0 110.902 173.171 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 14.5 t -81.49 16.5 1.67 Allowed 'General case' 0 N--CA 1.488 1.425 0 C-N-CA 125.623 1.569 . . . . 0.0 111.979 177.697 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 4.8 t -62.68 -12.32 22.81 Favored 'General case' 0 CA--C 1.559 1.321 0 N-CA-C 114.965 1.469 . . . . 0.0 114.965 -163.073 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 50.2 m -67.78 90.28 0.28 Allowed 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 123.118 0.567 . . . . 0.0 110.26 177.338 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 66.57 -102.32 0.74 Allowed Glycine 0 C--N 1.349 1.303 0 N-CA-C 111.18 -0.768 . . . . 0.0 111.18 -172.891 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 8.5 t . . . . . 0 CA--C 1.553 1.06 0 C-N-CA 123.541 0.736 . . . . 0.0 109.864 175.605 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.8 mmt . . . . . 0 N--CA 1.481 1.093 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 33.9 t-80 -171.67 99.92 0.18 Allowed 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 124.299 1.04 . . . . 0.0 109.476 -178.609 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 38.4 m170 -123.5 141.81 51.63 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 123.655 0.782 . . . . 0.0 110.138 174.442 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 73.2 m80 -91.96 80.76 5.15 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 123.415 0.686 . . . . 0.0 109.515 -179.946 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 8.3 p80 -83.81 119.95 25.46 Favored 'General case' 0 N--CA 1.475 0.823 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 176.522 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 59.4 t-80 -148.43 142.26 25.71 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 123.915 0.886 . . . . 0.0 108.837 -178.947 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 45.1 m80 -65.11 121.67 15.26 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 122.761 0.424 . . . . 0.0 110.188 177.505 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 28.7 m -58.19 -39.68 79.56 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 123.658 0.783 . . . . 0.0 110.719 179.01 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 23.2 t 59.48 19.19 7.6 Favored 'General case' 0 CA--C 1.557 1.224 0 C-N-CA 124.701 1.2 . . . . 0.0 112.645 169.399 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -161.0 76.64 0.18 Allowed Glycine 0 C--N 1.343 0.942 0 N-CA-C 112.063 -0.415 . . . . 0.0 112.063 -175.78 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 53.8 ttp180 -86.35 98.04 10.76 Favored 'General case' 0 CA--C 1.541 0.623 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 173.293 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -85.54 74.18 10.35 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 123.53 0.732 . . . . 0.0 109.944 -176.035 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 89.0 m-20 -149.75 116.01 5.75 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 125.371 1.468 . . . . 0.0 108.536 -179.24 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -158.86 146.84 17.98 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 122.859 0.464 . . . . 0.0 110.242 171.65 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 22.1 m-85 -132.25 98.88 4.52 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-O 121.984 0.897 . . . . 0.0 109.045 169.484 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 25.5 p90 -81.61 10.12 6.52 Favored 'General case' 0 CA--C 1.55 0.971 0 CA-C-N 113.958 -1.474 . . . . 0.0 111.469 -178.878 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 8.0 mm100 -70.77 128.13 34.98 Favored 'General case' 0 C--O 1.241 0.648 0 C-N-CA 124.297 1.039 . . . . 0.0 109.839 -178.659 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -158.68 171.5 35.4 Favored Glycine 0 C--O 1.242 0.638 0 N-CA-C 111.51 -0.636 . . . . 0.0 111.51 176.52 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 52.5 m-70 -89.38 117.25 28.18 Favored 'General case' 0 N--CA 1.466 0.374 0 C-N-CA 122.749 0.42 . . . . 0.0 110.031 -175.852 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 25.8 mmt -81.22 -14.9 57.04 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 123.621 0.768 . . . . 0.0 110.827 174.036 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . 66.82 -169.96 0.2 Allowed 'General case' 0 C--N 1.355 0.814 0 C-N-CA 124.669 1.188 . . . . 0.0 111.186 -179.052 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 29.0 t -162.16 170.82 18.44 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 123.109 0.563 . . . . 0.0 110.177 179.893 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -89.92 37.05 3.4 Favored Glycine 0 C--N 1.344 1.012 0 CA-C-N 115.994 -0.548 . . . . 0.0 112.304 172.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 26.1 m -87.12 40.32 0.91 Allowed 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 124.213 1.005 . . . . 0.0 110.006 -178.502 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -116.41 -170.51 1.83 Allowed 'General case' 0 C--O 1.242 0.663 0 C-N-CA 124.686 1.194 . . . . 0.0 109.858 -174.125 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -151.89 141.99 22.23 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 122.947 0.499 . . . . 0.0 109.908 -179.063 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -69.67 107.16 3.33 Favored 'General case' 0 C--N 1.349 0.556 0 C-N-CA 123.323 0.649 . . . . 0.0 109.292 176.232 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 15.5 m -127.5 141.04 47.44 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 C-N-CA 123.821 0.848 . . . . 0.0 109.398 -178.754 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 34.7 m -76.71 110.62 12.45 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.019 0 CA-C-O 121.444 0.64 . . . . 0.0 110.435 -177.05 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 56.2 p -134.71 124.29 25.04 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 124.013 0.925 . . . . 0.0 109.87 -176.064 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 95.4 t -109.55 116.61 52.6 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.448 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 174.372 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.494 ' HA ' ' HA ' ' A' ' 42' ' ' LEU . 44.0 mt-10 -77.27 125.3 29.1 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 123.257 0.623 . . . . 0.0 110.387 177.455 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -100.64 169.03 8.4 Favored Pre-proline 0 CA--C 1.559 1.304 0 C-N-CA 124.613 1.165 . . . . 0.0 109.316 -177.144 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -54.94 126.44 22.54 Favored 'Trans proline' 0 C--N 1.395 3.005 0 C-N-CA 122.99 2.46 . . . . 0.0 113.147 -177.745 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.46 ' HB2' ' HB3' ' A' ' 41' ' ' LYS . . . -114.9 156.83 44.57 Favored Pre-proline 0 N--CA 1.48 1.069 0 C-N-CA 124.374 1.069 . . . . 0.0 111.88 -171.697 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.592 ' HG2' ' HB2' ' A' ' 39' ' ' TRP . 72.6 Cg_endo -73.25 171.07 18.38 Favored 'Trans proline' 0 C--N 1.372 1.806 0 C-N-CA 122.544 2.163 . . . . 0.0 111.13 166.727 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 43.6 p -66.57 -46.13 77.02 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 123.421 0.689 . . . . 0.0 111.803 -176.937 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.444 ' HB2' ' HD1' ' A' ' 39' ' ' TRP . 9.8 m -72.68 -40.74 66.02 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-N 115.174 -0.921 . . . . 0.0 111.78 -174.187 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' TRP . . . . . 0.592 ' HB2' ' HG2' ' A' ' 36' ' ' PRO . 18.4 m95 -105.02 -173.86 2.4 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 123.535 0.734 . . . . 0.0 110.989 -175.273 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -130.28 158.02 40.93 Favored 'General case' 0 C--O 1.239 0.537 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 172.222 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.46 ' HB3' ' HB2' ' A' ' 35' ' ' ALA . 16.7 tptm -136.88 126.64 25.56 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.741 0.782 . . . . 0.0 109.135 -174.973 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.494 ' HA ' ' HA ' ' A' ' 32' ' ' GLU . 3.3 tt -136.05 151.97 50.41 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 113.653 -1.612 . . . . 0.0 108.195 -177.613 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 31.5 t80 -132.89 140.26 47.8 Favored 'General case' 0 C--O 1.235 0.309 0 C-N-CA 124.154 0.982 . . . . 0.0 108.491 171.405 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . 0.434 ' CB ' ' HB ' ' A' ' 54' ' ' THR . 25.3 m-85 -102.7 99.53 13.74 Favored Pre-proline 0 CA--C 1.547 0.833 0 C-N-CA 122.933 0.493 . . . . 0.0 109.687 174.654 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_endo -83.38 177.38 6.49 Favored 'Trans proline' 0 C--N 1.368 1.603 0 C-N-CA 122.765 2.31 . . . . 0.0 111.705 173.942 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . 0.409 ' HB3' ' HB2' ' A' ' 53' ' ' LYS . 8.8 p30 -87.24 172.12 10.12 Favored 'General case' 0 C--O 1.243 0.724 0 CA-C-N 115.949 -0.569 . . . . 0.0 109.676 170.661 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 5.1 tmtt? -76.52 -74.29 0.24 Allowed 'General case' 0 CA--C 1.553 1.075 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 173.894 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 59.9 t -141.66 109.97 2.43 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.213 0 N-CA-C 108.088 -1.079 . . . . 0.0 108.088 172.75 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 174.87 163.86 28.72 Favored Glycine 0 C--N 1.344 1.003 0 O-C-N 123.28 0.362 . . . . 0.0 112.677 176.776 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 69.4 p -90.36 40.44 1.01 Allowed 'General case' 0 CA--C 1.551 1.019 0 C-N-CA 123.738 0.815 . . . . 0.0 110.408 178.231 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 30.8 m -117.21 162.97 14.77 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 C-N-CA 124.217 1.007 . . . . 0.0 109.636 -178.687 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 39.7 ttmt -81.47 -32.62 32.45 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 123.355 0.662 . . . . 0.0 109.339 174.008 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.409 ' HB2' ' HB3' ' A' ' 46' ' ' ASN . 14.8 tmtt? 71.33 -78.79 0.04 OUTLIER 'General case' 0 CA--C 1.553 1.065 0 C-N-CA 125.068 1.347 . . . . 0.0 109.716 -176.274 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.434 ' HB ' ' CB ' ' A' ' 44' ' ' TYR . 72.7 m -135.39 160.1 39.5 Favored 'General case' 0 CA--C 1.552 1.029 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 174.073 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -87.44 -169.82 2.77 Favored 'General case' 0 CA--C 1.557 1.235 0 CA-C-O 121.325 0.583 . . . . 0.0 111.631 -178.398 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 87.5 t -82.1 144.66 9.91 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.77 0 C-N-CA 124.848 1.259 . . . . 0.0 110.353 -179.104 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 60.7 t -126.82 129.16 71.41 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.068 0 C-N-CA 124.325 1.05 . . . . 0.0 109.333 177.545 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.404 ' CZ ' ' HD3' ' A' ' 41' ' ' LYS . 31.2 m-85 -105.84 114.98 29.46 Favored 'General case' 0 N--CA 1.477 0.879 0 N-CA-C 108.752 -0.832 . . . . 0.0 108.752 170.622 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 6.9 t -80.14 133.91 28.61 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 C-N-CA 123.073 0.549 . . . . 0.0 109.764 178.11 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -85.94 155.57 58.25 Favored Pre-proline 0 CA--C 1.542 0.64 0 CA-C-N 115.166 -0.925 . . . . 0.0 111.4 -176.337 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -69.79 7.49 0.99 Allowed 'Trans proline' 0 N--CA 1.504 2.131 0 C-N-CA 123.258 2.639 . . . . 0.0 114.702 -179.016 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.524 HG23 ' H ' ' A' ' 64' ' ' GLU . 9.0 t -128.93 -7.1 4.97 Favored 'General case' 0 N--CA 1.484 1.26 0 C-N-CA 123.484 0.714 . . . . 0.0 111.263 -176.478 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 95.57 -11.03 68.82 Favored Glycine 0 C--N 1.351 1.382 0 CA-C-O 119.572 -0.571 . . . . 0.0 114.497 -176.687 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.524 ' H ' HG23 ' A' ' 62' ' ' THR . 44.3 tt0 -79.76 73.22 6.5 Favored 'General case' 0 N--CA 1.483 1.204 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 172.932 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -69.73 158.04 36.16 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-N 114.823 -1.08 . . . . 0.0 111.568 -171.298 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.435 HD12 ' HB3' ' A' ' 71' ' ' GLN . 44.7 mm -113.95 120.31 63.41 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 CA-C-N 115.157 -0.929 . . . . 0.0 109.757 -173.741 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 77.4 p -93.06 -24.33 18.34 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 123.691 0.797 . . . . 0.0 111.762 -177.147 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 8.9 p30 -141.23 157.8 44.75 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 122.775 0.43 . . . . 0.0 111.325 -175.42 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 70.1 ttt180 -62.92 -27.33 69.3 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 124.524 1.13 . . . . 0.0 112.562 -173.391 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 6.5 tmtm? -65.51 -50.37 65.52 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 123.316 0.646 . . . . 0.0 109.298 176.483 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.435 ' HB3' HD12 ' A' ' 66' ' ' ILE . 46.9 mt-30 -55.82 -31.37 62.63 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 123.942 0.897 . . . . 0.0 111.562 179.463 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.429 ' O ' ' HG ' ' A' ' 76' ' ' LEU . 0.2 OUTLIER -64.7 -51.77 60.72 Favored 'General case' 0 CA--C 1.551 1.017 0 O-C-N 123.613 0.571 . . . . 0.0 109.722 178.801 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -59.99 -50.4 73.88 Favored 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 122.859 0.464 . . . . 0.0 111.504 -178.116 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.2 -25.54 66.18 Favored 'General case' 0 CA--C 1.543 0.694 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.385 -177.033 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 22.1 t80 -65.64 -49.51 68.4 Favored 'General case' 0 C--N 1.351 0.662 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 171.794 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.429 ' HG ' ' O ' ' A' ' 72' ' ' LEU . 80.2 mt -66.42 -39.4 88.94 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 123.135 0.574 . . . . 0.0 112.404 -172.24 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.02 -24.3 61.53 Favored 'General case' 0 N--CA 1.481 1.117 0 CA-C-O 120.817 0.342 . . . . 0.0 110.753 178.094 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 43.8 t -85.21 -27.57 26.01 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 123.409 0.684 . . . . 0.0 111.131 175.536 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 59.9 m80 -132.61 88.48 38.51 Favored Pre-proline 0 N--CA 1.475 0.781 0 C-N-CA 123.694 0.798 . . . . 0.0 109.511 -172.44 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -70.02 160.17 50.6 Favored 'Trans proline' 0 C--N 1.373 1.856 0 C-N-CA 122.468 2.112 . . . . 0.0 111.341 177.011 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 95.46 -32.78 5.95 Favored Glycine 0 CA--C 1.532 1.119 0 N-CA-C 112.353 -0.299 . . . . 0.0 112.353 -176.799 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 32.2 m-80 -65.49 143.72 98.75 Favored Pre-proline 0 CA--C 1.551 0.998 0 C-N-CA 123.593 0.757 . . . . 0.0 110.698 176.66 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.418 ' HB2' ' CE2' ' A' ' 88' ' ' PHE . 42.5 Cg_exo -53.98 157.12 11.22 Favored 'Trans proline' 0 C--N 1.375 1.944 0 C-N-CA 123.809 3.006 . . . . 0.0 113.587 -179.008 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -68.78 152.37 45.41 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 123.983 0.913 . . . . 0.0 111.412 -177.603 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.413 HD12 ' HB3' ' A' ' 72' ' ' LEU . 12.8 tt -75.11 -21.61 16.63 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.17 0 CA-C-O 120.744 0.307 . . . . 0.0 110.288 175.08 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -58.85 -40.07 83.2 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 124.246 1.018 . . . . 0.0 112.078 178.011 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -84.48 -8.89 58.79 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 123.474 0.71 . . . . 0.0 111.587 179.583 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.418 ' CE2' ' HB2' ' A' ' 83' ' ' PRO . 4.4 m-30 -84.45 112.93 20.81 Favored 'General case' 0 N--CA 1.476 0.835 0 CA-C-O 121.652 0.739 . . . . 0.0 109.778 177.483 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 19.4 p-10 -93.12 88.52 6.11 Favored 'General case' 0 CA--C 1.543 0.703 0 CA-C-N 114.451 -1.25 . . . . 0.0 111.191 -171.166 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 76.0 m95 -76.23 -21.89 55.84 Favored 'General case' 0 N--CA 1.485 1.309 0 CA-C-N 115.441 -0.799 . . . . 0.0 110.51 173.406 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 10.7 t -86.27 16.01 4.78 Favored 'General case' 0 CA--C 1.556 1.209 0 C-N-CA 125.652 1.581 . . . . 0.0 111.775 -178.761 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 9.9 t -59.3 -39.28 82.53 Favored 'General case' 0 CA--C 1.551 0.983 0 C-N-CA 124.336 1.054 . . . . 0.0 113.77 -166.259 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 65.6 m -158.4 125.89 5.06 Favored 'General case' 0 C--O 1.241 0.621 0 C-N-CA 123.867 0.867 . . . . 0.0 109.576 -176.982 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -80.78 73.39 2.56 Favored Glycine 0 C--N 1.346 1.101 0 N-CA-C 109.959 -1.256 . . . . 0.0 109.959 167.889 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 74.9 p . . . . . 0 CA--C 1.56 1.346 0 C-N-CA 125.725 1.61 . . . . 0.0 111.766 -168.567 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.482 ' SD ' ' N ' ' A' ' 1' ' ' MET . 0.9 OUTLIER . . . . . 0 N--CA 1.488 1.447 0 N-CA-C 110.4 -0.222 . . . . 0.0 110.4 . . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 31.7 m170 -75.18 -43.8 50.16 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 123.517 0.727 . . . . 0.0 111.249 -178.216 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 58.0 t-80 -78.7 88.11 4.6 Favored 'General case' 0 N--CA 1.475 0.815 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 178.314 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 97.0 m-70 -62.11 127.86 33.37 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-N 115.229 -0.896 . . . . 0.0 111.242 -174.767 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 44.3 m-70 -68.21 -21.01 64.88 Favored 'General case' 0 N--CA 1.48 1.067 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.586 175.563 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 65.5 m80 -79.83 120.66 24.38 Favored 'General case' 0 CA--C 1.537 0.455 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 166.285 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 7.1 t-160 -94.18 20.14 8.42 Favored 'General case' 0 CA--C 1.557 1.25 0 C-N-CA 123.365 0.666 . . . . 0.0 109.846 175.638 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 46.7 m -67.58 102.41 1.16 Allowed 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 124.181 0.992 . . . . 0.0 110.51 175.376 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 45.1 t -162.55 -42.31 0.04 OUTLIER 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 123.804 0.842 . . . . 0.0 109.638 -178.272 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 82.09 21.63 60.63 Favored Glycine 0 C--N 1.352 1.446 0 CA-C-N 115.525 -0.762 . . . . 0.0 112.46 -176.816 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 74.7 mtm180 66.28 127.51 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 C-N-CA 125.282 1.433 . . . . 0.0 112.275 -179.239 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -72.93 88.59 1.37 Allowed 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 172.747 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 8.0 t30 -136.27 -34.0 0.8 Allowed 'General case' 0 N--CA 1.472 0.659 0 CA-C-N 115.156 -0.929 . . . . 0.0 109.315 -177.805 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 3.3 mm? 63.66 -170.08 0.19 Allowed 'General case' 0 C--N 1.362 1.143 0 C-N-CA 124.44 1.096 . . . . 0.0 111.131 -177.59 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 20.4 p90 -142.68 -48.61 0.34 Allowed 'General case' 0 C--O 1.241 0.632 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 171.892 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 52.9 t80 46.18 61.82 2.55 Favored 'General case' 0 CA--C 1.554 1.108 0 C-N-CA 125.444 1.497 . . . . 0.0 111.342 -179.53 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 11.4 pt20 -136.6 111.74 9.03 Favored 'General case' 0 C--O 1.243 0.719 0 CA-C-N 114.86 -1.064 . . . . 0.0 108.49 -178.558 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 88.29 166.22 42.09 Favored Glycine 0 CA--C 1.532 1.099 0 CA-C-N 115.437 -0.801 . . . . 0.0 111.732 -169.51 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 12.6 m170 -78.87 112.9 16.5 Favored 'General case' 0 N--CA 1.476 0.852 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 179.888 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 68.5 mtt -149.55 142.87 25.19 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 124.751 1.22 . . . . 0.0 108.371 -179.417 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . 60.07 37.94 20.81 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 124.122 0.969 . . . . 0.0 109.93 -167.858 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 16.5 m -63.12 -24.51 67.93 Favored 'General case' 0 N--CA 1.481 1.088 0 CA-C-N 114.101 -1.409 . . . . 0.0 112.568 -175.881 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -81.76 60.06 4.79 Favored Glycine 0 C--N 1.343 0.963 0 CA-C-N 115.58 -0.736 . . . . 0.0 112.054 176.398 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 25.3 m -80.39 90.43 5.61 Favored 'General case' 0 C--O 1.24 0.58 0 C-N-CA 123.983 0.913 . . . . 0.0 109.779 -179.233 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -109.88 81.99 1.52 Allowed 'General case' 0 CA--C 1.54 0.579 0 N-CA-C 107.66 -1.237 . . . . 0.0 107.66 -178.387 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 66.06 9.22 6.05 Favored 'General case' 0 N--CA 1.488 1.462 0 C-N-CA 125.266 1.426 . . . . 0.0 113.049 -178.179 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 48.3 65.15 1.4 Allowed 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 125.649 1.579 . . . . 0.0 112.459 176.942 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 15.5 m -68.91 128.75 32.88 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.877 0 CA-C-N 115.213 -0.903 . . . . 0.0 110.875 178.839 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.48 HG11 ' HG2' ' A' ' 47' ' ' LYS . 14.9 m -69.92 111.91 4.26 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 CA-C-O 121.703 0.763 . . . . 0.0 111.347 -175.671 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 3.8 p -144.44 118.12 9.22 Favored 'General case' 0 C--O 1.239 0.515 0 C-N-CA 124.305 1.042 . . . . 0.0 109.304 -179.507 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 90.4 t -101.65 130.98 50.43 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.483 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 179.268 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -81.89 107.17 14.39 Favored 'General case' 0 C--O 1.238 0.474 0 C-N-CA 123.09 0.556 . . . . 0.0 109.873 175.084 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.541 HD23 ' HB3' ' A' ' 43' ' ' PHE . 4.3 mm? -83.31 161.06 58.27 Favored Pre-proline 0 CA--C 1.553 1.064 0 C-N-CA 124.324 1.049 . . . . 0.0 109.742 -179.836 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -53.37 136.46 63.15 Favored 'Trans proline' 0 C--N 1.388 2.645 0 C-N-CA 122.988 2.459 . . . . 0.0 113.178 -179.149 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -121.18 163.39 30.31 Favored Pre-proline 0 N--CA 1.481 1.086 0 C-N-CA 124.361 1.065 . . . . 0.0 112.961 -164.142 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.623 ' HG2' ' HB2' ' A' ' 39' ' ' TRP . 40.9 Cg_endo -67.72 156.96 63.94 Favored 'Trans proline' 0 C--N 1.381 2.27 0 C-N-CA 122.52 2.147 . . . . 0.0 110.587 161.324 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 55.2 p -62.36 -39.04 91.85 Favored 'General case' 0 N--CA 1.486 1.354 0 N-CA-C 113.874 1.064 . . . . 0.0 113.874 -166.725 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 15.0 p -89.21 -21.6 23.18 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 112.375 0.509 . . . . 0.0 112.375 -174.952 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' TRP . . . . . 0.623 ' HB2' ' HG2' ' A' ' 36' ' ' PRO . 16.3 m95 -109.97 174.37 5.89 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-O 121.758 0.79 . . . . 0.0 110.469 179.463 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.452 ' HB2' ' HB ' ' A' ' 59' ' ' VAL . 0.0 OUTLIER -117.54 158.14 25.09 Favored 'General case' 0 C--O 1.24 0.559 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 170.371 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.406 ' HD3' ' CZ ' ' A' ' 58' ' ' PHE . 16.8 tptm -130.33 122.14 27.34 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 124.445 1.098 . . . . 0.0 108.133 -176.862 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.498 HD22 ' HB ' ' A' ' 57' ' ' VAL . 4.7 tt -125.19 150.31 47.1 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 124.743 1.217 . . . . 0.0 108.668 177.443 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.541 ' HB3' HD23 ' A' ' 33' ' ' LEU . 36.2 t80 -136.78 145.33 44.42 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 125.053 1.341 . . . . 0.0 108.347 174.064 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 16.4 m-85 -102.14 96.75 7.35 Favored Pre-proline 0 CA--C 1.555 1.17 0 C-N-CA 123.113 0.565 . . . . 0.0 110.114 174.33 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -82.72 163.49 16.26 Favored 'Trans proline' 0 C--N 1.374 1.906 0 C-N-CA 122.734 2.289 . . . . 0.0 111.806 175.437 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -81.79 147.95 29.14 Favored 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 170.363 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.48 ' HG2' HG11 ' A' ' 29' ' ' VAL . 96.5 mttt -62.73 -40.27 96.68 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 123.413 0.685 . . . . 0.0 111.706 -176.693 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 41.7 t -80.78 -36.34 15.48 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.958 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 173.548 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 104.25 -160.49 15.85 Favored Glycine 0 C--N 1.346 1.122 0 CA-C-N 115.225 -0.898 . . . . 0.0 112.316 -178.572 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 57.1 m 67.34 -71.56 0.1 Allowed 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 125.486 1.514 . . . . 0.0 111.769 -179.36 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 34.2 m -75.1 170.5 1.47 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.794 0 C-N-CA 123.553 0.741 . . . . 0.0 110.576 174.935 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 4.8 ttmp? -108.61 135.32 50.06 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 123.997 0.919 . . . . 0.0 110.031 -175.36 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -78.18 -71.18 0.44 Allowed 'General case' 0 CA--C 1.55 0.953 0 N-CA-C 107.195 -1.409 . . . . 0.0 107.195 174.086 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 15.8 m -133.73 162.12 32.84 Favored 'General case' 0 CA--C 1.547 0.864 0 N-CA-C 106.947 -1.501 . . . . 0.0 106.947 173.607 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -73.01 -168.03 0.45 Allowed 'General case' 0 CA--C 1.552 1.049 0 CA-C-O 121.419 0.628 . . . . 0.0 111.168 178.783 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 48.9 t -81.33 138.67 19.21 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.661 0 C-N-CA 124.145 0.978 . . . . 0.0 110.435 -176.723 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.498 ' HB ' HD22 ' A' ' 42' ' ' LEU . 87.2 t -123.5 115.82 46.5 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.952 0 C-N-CA 124.738 1.215 . . . . 0.0 108.512 176.213 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.406 ' CZ ' ' HD3' ' A' ' 41' ' ' LYS . 15.9 m-85 -91.99 118.39 30.73 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 123.465 0.706 . . . . 0.0 109.873 177.227 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.452 ' HB ' ' HB2' ' A' ' 40' ' ' LYS . 3.3 t -80.2 131.17 34.71 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 C-N-CA 123.439 0.696 . . . . 0.0 110.712 179.914 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -88.35 158.95 48.36 Favored Pre-proline 0 N--CA 1.476 0.834 0 C-N-CA 124.276 1.031 . . . . 0.0 111.677 -173.905 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -68.29 -19.18 44.33 Favored 'Trans proline' 0 C--N 1.38 2.223 0 C-N-CA 122.878 2.386 . . . . 0.0 113.191 178.305 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.565 HG23 ' H ' ' A' ' 64' ' ' GLU . 14.8 t -88.09 -11.31 47.47 Favored 'General case' 0 CA--C 1.55 0.957 0 C-N-CA 123.327 0.651 . . . . 0.0 111.198 175.934 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 96.36 -25.64 25.03 Favored Glycine 0 C--N 1.355 1.605 0 C-N-CA 122.601 0.143 . . . . 0.0 113.206 -177.609 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.565 ' H ' HG23 ' A' ' 62' ' ' THR . 37.7 tt0 -72.74 83.94 1.18 Allowed 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 124.08 0.952 . . . . 0.0 109.717 174.326 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.43 159.14 24.92 Favored 'General case' 0 N--CA 1.473 0.707 0 CA-C-N 114.878 -1.055 . . . . 0.0 112.072 -177.027 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.463 HG23 ' HB2' ' A' ' 71' ' ' GLN . 35.1 mm -102.44 127.53 55.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 C-N-CA 125.33 1.452 . . . . 0.0 109.08 177.522 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 29.9 m -97.59 -30.03 13.09 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 122.774 0.43 . . . . 0.0 111.504 -174.5 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 2.8 p-10 -135.08 159.43 41.54 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 123.038 0.535 . . . . 0.0 110.47 -179.068 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 32.3 ttm180 -64.79 -30.43 71.43 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 124.271 1.028 . . . . 0.0 113.155 -168.45 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 6.2 tmtm? -63.73 -47.73 79.89 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 123.384 0.674 . . . . 0.0 109.449 176.341 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.463 ' HB2' HG23 ' A' ' 66' ' ' ILE . 68.0 mt-30 -55.27 -32.76 62.62 Favored 'General case' 0 N--CA 1.49 1.547 0 C-N-CA 123.679 0.792 . . . . 0.0 111.598 179.341 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.475 ' O ' ' HG ' ' A' ' 76' ' ' LEU . 0.4 OUTLIER -61.22 -52.94 62.68 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 123.125 0.57 . . . . 0.0 109.56 -179.276 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -67.85 -42.91 80.64 Favored 'General case' 0 C--O 1.248 0.992 0 C-N-CA 123.781 0.832 . . . . 0.0 111.691 -174.372 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.36 -22.65 61.87 Favored 'General case' 0 N--CA 1.478 0.971 0 CA-C-N 116.779 -0.192 . . . . 0.0 111.094 179.263 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 39.7 t80 -70.36 -42.83 71.3 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 122.969 0.508 . . . . 0.0 109.822 172.214 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.475 ' HG ' ' O ' ' A' ' 72' ' ' LEU . 80.1 mt -64.19 -33.83 76.7 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 123.166 0.586 . . . . 0.0 111.739 -175.991 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 14.3 ptpt -79.98 -32.61 39.79 Favored 'General case' 0 N--CA 1.482 1.171 0 N-CA-C 111.607 0.225 . . . . 0.0 111.607 175.06 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 40.9 t -71.28 -29.91 65.64 Favored 'General case' 0 N--CA 1.485 1.302 0 CA-C-O 121.427 0.632 . . . . 0.0 110.955 178.737 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 42.1 m80 -143.01 86.08 9.47 Favored Pre-proline 0 C--O 1.24 0.563 0 C-N-CA 124.677 1.191 . . . . 0.0 108.423 -178.267 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -67.58 163.01 36.66 Favored 'Trans proline' 0 C--N 1.378 2.09 0 C-N-CA 122.652 2.235 . . . . 0.0 111.704 173.516 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 101.82 -31.21 8.95 Favored Glycine 0 C--N 1.342 0.889 0 N-CA-C 111.283 -0.727 . . . . 0.0 111.283 -173.658 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 37.0 m-80 -66.79 144.52 98.62 Favored Pre-proline 0 CA--C 1.553 1.08 0 C-N-CA 123.535 0.734 . . . . 0.0 110.606 174.464 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -63.77 154.25 70.64 Favored 'Trans proline' 0 C--N 1.373 1.862 0 C-N-CA 123.067 2.511 . . . . 0.0 112.984 -176.097 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.49 ' O ' ' HG2' ' A' ' 87' ' ' GLU . . . -71.02 146.41 49.38 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 114.6 -1.182 . . . . 0.0 111.396 -174.745 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 17.1 tt -64.81 -14.41 16.24 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.258 0 C-N-CA 123.637 0.775 . . . . 0.0 111.739 -179.274 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -53.76 -40.26 66.05 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 124.205 1.002 . . . . 0.0 112.576 175.325 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.49 ' HG2' ' O ' ' A' ' 84' ' ' ALA . 10.6 pt-20 -86.32 -17.81 33.59 Favored 'General case' 0 N--CA 1.486 1.35 0 C-N-CA 123.306 0.643 . . . . 0.0 111.429 178.619 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -77.31 109.04 10.88 Favored 'General case' 0 N--CA 1.478 0.959 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 177.92 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -94.83 121.01 35.98 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-O 121.311 0.577 . . . . 0.0 109.725 -177.71 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 49.6 m95 -103.38 -3.7 25.14 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 123.857 0.863 . . . . 0.0 109.446 174.981 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 14.8 t -91.03 13.42 16.79 Favored 'General case' 0 CA--C 1.55 0.976 0 C-N-CA 125.118 1.367 . . . . 0.0 112.14 -176.041 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 7.1 t -62.36 -16.96 57.65 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 123.722 0.809 . . . . 0.0 112.577 -175.801 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 10.1 m -72.85 86.69 1.28 Allowed 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 123.324 0.65 . . . . 0.0 109.794 177.541 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -81.01 68.11 3.49 Favored Glycine 0 C--N 1.351 1.371 0 N-CA-C 111.068 -0.813 . . . . 0.0 111.068 175.624 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 1.8 t . . . . . 0 CA--C 1.559 1.301 0 C-N-CA 124.37 1.068 . . . . 0.0 110.95 -173.122 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.407 ' SD ' ' N ' ' A' ' 1' ' ' MET . 0.9 OUTLIER . . . . . 0 N--CA 1.482 1.146 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 . . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 62.4 t-80 -72.18 -48.81 40.45 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 123.443 0.697 . . . . 0.0 111.501 -173.914 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 8.9 p80 -112.2 132.64 54.79 Favored 'General case' 0 N--CA 1.48 1.038 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 178.978 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 49.0 t-80 -102.91 138.49 39.72 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 123.703 0.801 . . . . 0.0 111.759 -172.551 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 32.3 m170 -131.18 172.27 12.33 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 124.64 1.176 . . . . 0.0 109.456 169.627 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 46.4 m80 -93.42 93.36 8.1 Favored 'General case' 0 N--CA 1.469 0.483 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 170.295 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 53.3 t-80 -66.43 99.02 0.53 Allowed 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 123.271 0.628 . . . . 0.0 110.017 179.461 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 19.6 m 63.43 19.76 11.87 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 124.491 1.116 . . . . 0.0 112.128 175.509 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 41.2 p -124.35 163.48 21.63 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 123.794 0.838 . . . . 0.0 110.164 -178.357 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -129.75 -141.28 4.98 Favored Glycine 0 C--N 1.335 0.501 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.761 -178.667 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 26.5 mmm180 59.83 32.9 21.53 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 124.889 1.275 . . . . 0.0 111.597 -179.566 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -79.14 -8.99 59.43 Favored 'General case' 0 CA--C 1.554 1.13 0 C-N-CA 124.105 0.962 . . . . 0.0 110.191 175.869 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 24.8 p-10 -79.79 79.3 6.32 Favored 'General case' 0 CA--C 1.557 1.239 0 CA-C-O 122.105 0.955 . . . . 0.0 110.726 176.342 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -141.55 -176.39 4.73 Favored 'General case' 0 N--CA 1.478 0.943 0 CA-C-N 115.467 -0.788 . . . . 0.0 109.605 173.521 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 4.1 p90 -75.69 65.98 1.94 Allowed 'General case' 0 CA--C 1.561 1.398 0 CA-C-O 122.335 1.064 . . . . 0.0 110.762 175.56 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 58.7 t80 -81.15 77.46 8.04 Favored 'General case' 0 CA--C 1.543 0.704 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 177.56 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 9.0 pt20 -135.05 -47.0 0.72 Allowed 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 115.131 -0.94 . . . . 0.0 110.279 -171.688 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -111.78 42.76 1.87 Allowed Glycine 0 C--N 1.346 1.106 0 N-CA-C 111.904 -0.478 . . . . 0.0 111.904 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 31.9 t60 -78.56 117.41 19.72 Favored 'General case' 0 CA--C 1.542 0.658 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 176.24 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 39.8 tpp -135.97 148.06 48.3 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 123.569 0.747 . . . . 0.0 109.947 -178.147 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -144.01 18.82 1.78 Allowed 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 123.095 0.558 . . . . 0.0 111.675 -174.498 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 19.4 m 60.39 97.42 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 C-N-CA 124.632 1.173 . . . . 0.0 111.398 -176.687 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 103.26 -178.31 25.42 Favored Glycine 0 C--N 1.342 0.864 0 N-CA-C 110.707 -0.957 . . . . 0.0 110.707 -167.433 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 32.9 t 76.7 -32.98 0.2 Allowed 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 124.932 1.293 . . . . 0.0 113.332 176.005 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -56.25 102.96 0.09 Allowed 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 124.12 0.968 . . . . 0.0 111.43 -177.363 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 47.76 26.3 0.86 Allowed 'General case' 0 N--CA 1.497 1.885 0 C-N-CA 126.427 1.891 . . . . 0.0 112.746 -177.88 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -73.43 118.4 16.34 Favored 'General case' 0 C--O 1.24 0.566 0 CA-C-N 115.223 -0.899 . . . . 0.0 110.441 -170.96 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 34.6 m -77.91 154.63 5.24 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 C-N-CA 124.36 1.064 . . . . 0.0 110.899 -177.764 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 27.1 m -89.34 130.97 37.8 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.642 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 174.631 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 39.2 p -157.33 118.65 3.65 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 123.943 0.897 . . . . 0.0 108.891 -177.929 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 48.1 t -106.06 125.71 61.61 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 C-N-CA 123.879 0.872 . . . . 0.0 109.056 -177.514 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.461 ' HA ' ' HA ' ' A' ' 42' ' ' LEU . 45.6 mt-10 -79.66 101.54 8.43 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 123.068 0.547 . . . . 0.0 110.092 178.942 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -81.21 152.77 71.33 Favored Pre-proline 0 CA--C 1.559 1.298 0 C-N-CA 124.379 1.071 . . . . 0.0 110.773 -176.178 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -62.84 137.74 64.7 Favored 'Trans proline' 0 C--N 1.384 2.401 0 C-N-CA 123.073 2.515 . . . . 0.0 114.085 -177.718 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -146.07 169.98 8.71 Favored Pre-proline 0 CA--C 1.557 1.218 0 C-N-CA 124.276 1.03 . . . . 0.0 108.933 -178.541 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -51.25 145.26 27.45 Favored 'Trans proline' 0 C--N 1.392 2.848 0 C-N-CA 122.691 2.26 . . . . 0.0 112.168 173.894 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 49.2 m -64.01 -20.04 65.62 Favored 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 113.164 0.802 . . . . 0.0 113.164 -171.717 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 33.4 m -72.23 -40.23 67.93 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 123.197 0.599 . . . . 0.0 110.16 174.581 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 25.6 m95 -104.83 -168.3 1.46 Allowed 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 123.958 0.903 . . . . 0.0 110.038 179.449 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.525 ' HB3' ' HB ' ' A' ' 59' ' ' VAL . 40.7 ttmt -156.41 170.78 21.51 Favored 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 106.565 -1.643 . . . . 0.0 106.565 171.584 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.716 ' HD2' HG11 ' A' ' 56' ' ' VAL . 21.3 pttm -151.34 154.06 35.97 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-O 121.845 0.831 . . . . 0.0 110.904 171.434 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.461 ' HA ' ' HA ' ' A' ' 32' ' ' GLU . 0.8 OUTLIER -127.0 130.76 50.66 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 113.348 -1.751 . . . . 0.0 107.726 178.433 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 28.7 t80 -101.39 141.04 34.85 Favored 'General case' 0 CA--C 1.542 0.647 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 170.728 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . 0.403 ' CE1' HD21 ' A' ' 42' ' ' LEU . 11.6 m-85 -99.37 100.14 9.86 Favored Pre-proline 0 N--CA 1.481 1.111 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 171.487 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -79.49 168.17 20.17 Favored 'Trans proline' 0 C--N 1.365 1.413 0 C-N-CA 122.411 2.074 . . . . 0.0 112.43 175.489 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . 0.494 ' HB2' ' HB ' ' A' ' 51' ' ' VAL . 30.1 p30 -86.95 156.7 19.69 Favored 'General case' 0 C--O 1.241 0.605 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 168.447 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -77.88 -87.3 0.05 Allowed 'General case' 0 N--CA 1.475 0.782 0 CA-C-O 119.33 -0.367 . . . . 0.0 111.2 -175.314 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 57.9 t -134.37 142.43 40.82 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.382 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 -179.789 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 85.34 -112.12 3.63 Favored Glycine 0 C--N 1.348 1.195 0 N-CA-C 111.43 -0.668 . . . . 0.0 111.43 -177.077 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 28.3 t -145.08 79.12 1.58 Allowed 'General case' 0 C--O 1.24 0.574 0 CA-C-O 121.784 0.802 . . . . 0.0 109.14 175.881 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.494 ' HB ' ' HB2' ' A' ' 46' ' ' ASN . 21.5 t -85.66 158.28 3.36 Favored 'Isoleucine or valine' 0 C--O 1.246 0.889 0 N-CA-C 107.555 -1.276 . . . . 0.0 107.555 170.099 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.602 ' HD3' ' H ' ' A' ' 52' ' ' LYS . 0.0 OUTLIER -68.08 109.25 3.42 Favored 'General case' 0 CA--C 1.553 1.082 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 174.933 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 25.3 pttm -79.87 139.42 37.16 Favored 'General case' 0 C--N 1.353 0.748 0 N-CA-C 107.896 -1.15 . . . . 0.0 107.896 172.818 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 96.3 m -102.74 141.39 35.62 Favored 'General case' 0 CA--C 1.538 0.489 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 177.673 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -61.28 177.98 0.32 Allowed 'General case' 0 CA--C 1.549 0.905 0 CA-C-O 122.11 0.957 . . . . 0.0 112.133 179.267 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.716 HG11 ' HD2' ' A' ' 41' ' ' LYS . 51.0 t -82.35 147.42 6.04 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.771 0 CA-C-N 114.799 -1.091 . . . . 0.0 111.376 -168.896 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 65.8 t -124.52 116.5 47.73 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.693 0 C-N-CA 125.074 1.35 . . . . 0.0 107.681 175.276 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 36.7 m-85 -87.25 123.77 32.61 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 123.486 0.714 . . . . 0.0 110.982 -179.146 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.525 ' HB ' ' HB3' ' A' ' 40' ' ' LYS . 6.8 t -81.16 130.28 36.12 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.411 0 C-N-CA 123.677 0.791 . . . . 0.0 110.141 175.534 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -85.59 157.21 58.5 Favored Pre-proline 0 N--CA 1.475 0.794 0 O-C-N 124.157 0.911 . . . . 0.0 111.211 -178.618 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -63.7 -22.49 69.82 Favored 'Trans proline' 0 C--N 1.382 2.314 0 C-N-CA 122.934 2.423 . . . . 0.0 112.703 176.491 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.626 HG23 ' H ' ' A' ' 64' ' ' GLU . 12.1 t -91.53 -12.17 35.25 Favored 'General case' 0 CA--C 1.549 0.924 0 C-N-CA 123.822 0.849 . . . . 0.0 111.181 178.957 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 95.23 -11.73 68.81 Favored Glycine 0 C--N 1.349 1.283 0 CA-C-O 119.769 -0.462 . . . . 0.0 113.559 -177.591 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.626 ' H ' HG23 ' A' ' 62' ' ' THR . 36.4 tt0 -77.97 78.14 4.47 Favored 'General case' 0 N--CA 1.481 1.121 0 CA-C-N 117.576 0.688 . . . . 0.0 109.341 174.334 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -67.96 139.22 56.38 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-N 115.119 -0.946 . . . . 0.0 111.028 -174.075 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 36.8 mm -94.77 130.92 42.92 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.663 0 C-N-CA 124.484 1.114 . . . . 0.0 109.883 -179.927 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 6.0 p -96.59 -11.65 25.06 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 123.784 0.834 . . . . 0.0 112.414 -175.375 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 11.1 p-10 -153.53 151.32 29.67 Favored 'General case' 0 N--CA 1.48 1.052 0 N-CA-C 111.941 0.349 . . . . 0.0 111.941 -168.044 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 30.1 ttm180 -59.06 -39.55 82.42 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 124.759 1.224 . . . . 0.0 112.817 -168.582 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 4.3 tmtm? -59.71 -54.4 46.79 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 123.419 0.688 . . . . 0.0 109.923 -177.743 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.425 ' HA ' ' HG3' ' A' ' 74' ' ' GLN . 87.4 mm-40 -66.2 -22.32 66.34 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-N 115.032 -0.985 . . . . 0.0 111.309 -175.674 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.495 ' O ' ' HG ' ' A' ' 76' ' ' LEU . 0.8 OUTLIER -66.47 -56.36 11.3 Favored 'General case' 0 CA--C 1.544 0.742 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 174.318 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -57.41 -50.24 73.62 Favored 'General case' 0 N--CA 1.486 1.355 0 C-N-CA 124.404 1.082 . . . . 0.0 111.473 -176.314 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . 0.425 ' HG3' ' HA ' ' A' ' 71' ' ' GLN . 0.0 OUTLIER -70.31 -25.04 63.13 Favored 'General case' 0 CA--C 1.545 0.768 0 CA-C-N 115.4 -0.818 . . . . 0.0 111.608 -177.903 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 45.5 t80 -66.44 -45.99 77.96 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 122.75 0.42 . . . . 0.0 109.907 174.503 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.495 ' HG ' ' O ' ' A' ' 72' ' ' LEU . 52.4 mt -62.58 -45.23 93.86 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 123.033 0.533 . . . . 0.0 110.913 -175.36 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.11 -24.16 59.41 Favored 'General case' 0 CA--C 1.551 0.983 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.589 -179.835 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 46.3 t -78.19 -27.68 47.95 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 122.857 0.463 . . . . 0.0 110.806 174.949 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 59.0 m80 -127.4 84.89 62.22 Favored Pre-proline 0 N--CA 1.472 0.671 0 C-N-CA 123.401 0.681 . . . . 0.0 109.751 -175.435 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -62.8 122.18 10.38 Favored 'Trans proline' 0 C--N 1.372 1.788 0 C-N-CA 122.953 2.435 . . . . 0.0 111.709 177.431 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 133.23 -30.56 3.02 Favored Glycine 0 C--N 1.342 0.888 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.795 -174.042 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 40.2 m-80 -72.5 137.13 80.73 Favored Pre-proline 0 N--CA 1.476 0.864 0 C-N-CA 123.468 0.707 . . . . 0.0 110.456 177.109 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -62.88 154.25 67.67 Favored 'Trans proline' 0 C--N 1.375 1.971 0 C-N-CA 123.111 2.541 . . . . 0.0 112.777 -179.138 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.498 ' O ' ' HG2' ' A' ' 87' ' ' GLU . . . -73.96 148.07 42.46 Favored 'General case' 0 N--CA 1.476 0.842 0 CA-C-N 115.313 -0.858 . . . . 0.0 111.866 -173.674 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 17.3 tt -65.44 -11.72 12.5 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.194 0 C-N-CA 124.087 0.955 . . . . 0.0 112.366 -176.629 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -57.23 -38.66 74.13 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 123.678 0.791 . . . . 0.0 112.08 174.044 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.498 ' HG2' ' O ' ' A' ' 84' ' ' ALA . 12.6 pt-20 -90.81 -3.98 56.98 Favored 'General case' 0 N--CA 1.487 1.414 0 C-N-CA 123.14 0.576 . . . . 0.0 111.769 178.31 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -87.81 107.82 18.85 Favored 'General case' 0 N--CA 1.477 0.911 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 176.709 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 14.5 p-10 -93.48 88.0 5.76 Favored 'General case' 0 CA--C 1.547 0.842 0 CA-C-O 122.21 1.005 . . . . 0.0 111.174 -172.405 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 82.2 m95 -69.25 -26.15 64.63 Favored 'General case' 0 N--CA 1.481 1.111 0 CA-C-N 115.064 -0.971 . . . . 0.0 110.202 170.216 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 12.5 t -78.98 8.87 4.92 Favored 'General case' 0 CA--C 1.556 1.184 0 C-N-CA 125.196 1.398 . . . . 0.0 112.64 -175.443 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 14.1 t -63.0 -25.26 68.3 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 123.058 0.543 . . . . 0.0 111.13 176.482 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 21.3 p -68.4 99.29 0.93 Allowed 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 123.795 0.838 . . . . 0.0 109.676 175.062 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -69.81 136.29 27.33 Favored Glycine 0 C--N 1.348 1.199 0 CA-C-N 116.04 -0.527 . . . . 0.0 112.076 178.376 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 39.6 p . . . . . 0 CA--C 1.554 1.113 0 C-N-CA 123.863 0.865 . . . . 0.0 110.553 -178.683 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 52.8 ttp . . . . . 0 N--CA 1.481 1.106 0 N-CA-C 108.952 -0.758 . . . . 0.0 108.952 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 3.2 p80 -131.78 124.97 30.77 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 122.997 0.519 . . . . 0.0 109.968 -176.58 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 96.5 m-70 -128.93 95.0 3.97 Favored 'General case' 0 N--CA 1.472 0.651 0 N-CA-C 108.512 -0.922 . . . . 0.0 108.512 174.666 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 13.2 m-70 -89.42 45.09 1.25 Allowed 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 124.502 1.121 . . . . 0.0 110.891 -176.127 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 26.5 m170 -141.5 170.41 15.78 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 124.523 1.129 . . . . 0.0 109.547 175.456 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 26.9 p80 -69.5 168.13 15.25 Favored 'General case' 0 N--CA 1.483 1.202 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.641 -179.477 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 31.7 m170 -68.47 121.15 15.74 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.356 -179.084 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 28.0 t -146.08 176.99 9.3 Favored 'General case' 0 C--O 1.244 0.78 0 C-N-CA 124.084 0.953 . . . . 0.0 108.956 -179.037 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 32.8 t -76.58 70.02 3.07 Favored 'General case' 0 CA--C 1.555 1.157 0 C-N-CA 123.489 0.716 . . . . 0.0 109.752 177.495 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -97.39 76.89 0.65 Allowed Glycine 0 C--N 1.354 1.569 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.843 -175.092 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 6.8 mpt_? -81.1 -30.74 34.55 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 124.011 0.925 . . . . 0.0 110.047 179.658 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -77.21 -159.96 0.15 Allowed 'General case' 0 CA--C 1.558 1.286 0 C-N-CA 124.223 1.009 . . . . 0.0 111.023 178.652 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 33.3 m-80 72.18 69.63 0.14 Allowed 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 125.062 1.345 . . . . 0.0 109.86 -174.997 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -153.5 -166.77 2.5 Favored 'General case' 0 CA--C 1.548 0.874 0 CA-C-N 114.003 -1.453 . . . . 0.0 109.564 -179.956 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -145.85 95.51 2.65 Favored 'General case' 0 CA--C 1.55 0.966 0 C-N-CA 123.415 0.686 . . . . 0.0 109.741 -172.735 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 64.3 t80 -80.78 98.52 7.82 Favored 'General case' 0 N--CA 1.475 0.815 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 176.772 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 16.8 pt20 -160.18 178.59 9.5 Favored 'General case' 0 C--O 1.243 0.754 0 CA-C-N 115.115 -0.948 . . . . 0.0 109.594 -178.173 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -97.7 -134.88 8.46 Favored Glycine 0 C--N 1.343 0.937 0 N-CA-C 111.517 -0.633 . . . . 0.0 111.517 173.159 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 13.2 p-80 -89.31 150.38 22.62 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 123.818 0.847 . . . . 0.0 111.121 -179.293 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 63.7 mtt -144.47 109.42 5.02 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 124.285 1.034 . . . . 0.0 108.758 172.887 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -84.28 158.19 21.3 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 122.812 0.445 . . . . 0.0 110.103 177.107 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 78.8 p -80.92 -165.65 0.95 Allowed 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 123.394 0.678 . . . . 0.0 109.591 173.065 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -174.71 168.63 41.36 Favored Glycine 0 C--N 1.341 0.834 0 C-N-CA 121.219 -0.515 . . . . 0.0 112.589 177.614 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 22.7 t 64.54 -173.06 0.17 Allowed 'General case' 0 CA--C 1.556 1.182 0 C-N-CA 124.776 1.23 . . . . 0.0 111.536 177.303 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.415 ' HG2' ' H ' ' A' ' 26' ' ' GLU . 22.7 tt0 -153.55 -179.81 8.13 Favored 'General case' 0 CA--C 1.549 0.94 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 173.568 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.415 ' H ' ' HG2' ' A' ' 25' ' ' GLU . 40.4 tt0 -51.47 139.74 19.32 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 123.565 0.746 . . . . 0.0 111.685 175.063 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -72.39 86.42 1.13 Allowed 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 123.507 0.723 . . . . 0.0 110.111 -176.834 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 13.9 m -80.67 107.3 12.88 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.675 0 CA-C-O 121.858 0.837 . . . . 0.0 108.996 173.722 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 13.8 m -91.05 122.8 42.82 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 CA-C-N 114.823 -1.081 . . . . 0.0 110.686 -170.622 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 54.7 p -142.82 114.06 7.79 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 123.53 0.732 . . . . 0.0 109.5 178.604 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 62.1 t -101.85 127.81 54.95 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 C-N-CA 124.16 0.984 . . . . 0.0 108.959 179.565 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 53.3 mt-10 -83.02 106.79 15.13 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-O 121.011 0.434 . . . . 0.0 109.987 178.517 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.479 HD23 ' HB3' ' A' ' 43' ' ' PHE . 3.6 mm? -82.7 164.26 47.84 Favored Pre-proline 0 CA--C 1.559 1.325 0 C-N-CA 124.619 1.167 . . . . 0.0 109.877 178.938 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -49.89 143.42 23.75 Favored 'Trans proline' 0 C--N 1.393 2.891 0 C-N-CA 123.334 2.689 . . . . 0.0 114.097 -175.914 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -146.03 155.49 51.24 Favored Pre-proline 0 CA--C 1.542 0.673 0 C-N-CA 123.633 0.773 . . . . 0.0 111.255 -167.396 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_exo -58.51 149.82 72.71 Favored 'Trans proline' 0 C--N 1.381 2.255 0 C-N-CA 123.158 2.572 . . . . 0.0 110.598 163.525 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 20.7 p -58.66 -42.66 88.92 Favored 'General case' 0 CA--C 1.551 1.019 0 C-N-CA 123.72 0.808 . . . . 0.0 111.914 -176.241 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 26.6 t -67.49 -33.65 75.54 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 123.768 0.827 . . . . 0.0 111.452 -179.966 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 21.7 m95 -105.45 -176.12 2.99 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 123.469 0.707 . . . . 0.0 111.211 -177.095 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 45.3 mtmt -137.98 149.16 45.87 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 114.926 -1.034 . . . . 0.0 108.51 162.881 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.702 ' HZ1' ' HB2' ' A' ' 43' ' ' PHE . 19.6 tptp -117.13 121.12 40.37 Favored 'General case' 0 N--CA 1.464 0.265 0 C-N-CA 124.899 1.28 . . . . 0.0 107.552 178.487 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.49 HD22 ' HB ' ' A' ' 57' ' ' VAL . 5.7 tt -119.19 143.92 46.98 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 124.171 0.988 . . . . 0.0 108.968 177.932 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.702 ' HB2' ' HZ1' ' A' ' 41' ' ' LYS . 24.3 t80 -130.63 128.14 40.37 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 125.293 1.437 . . . . 0.0 107.822 174.881 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . 0.499 ' CG ' ' HB ' ' A' ' 54' ' ' THR . 24.8 m-85 -86.63 111.55 40.47 Favored Pre-proline 0 CA--C 1.55 0.979 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 169.456 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -76.65 -170.48 0.9 Allowed 'Trans proline' 0 C--N 1.372 1.769 0 C-N-CA 122.427 2.085 . . . . 0.0 111.034 165.724 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . 0.534 ' HB2' ' HB ' ' A' ' 51' ' ' VAL . 7.6 p30 -123.07 -175.12 3.1 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 123.756 0.822 . . . . 0.0 109.774 179.626 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.423 ' H ' HG21 ' A' ' 51' ' ' VAL . 45.2 mmtm -85.0 -78.27 0.26 Allowed 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 110.017 -0.364 . . . . 0.0 110.017 172.821 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 44.7 t -130.61 75.71 0.48 Allowed 'Isoleucine or valine' 0 CA--C 1.553 1.074 0 C-N-CA 123.375 0.67 . . . . 0.0 109.948 -173.874 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 70.57 -78.68 0.46 Allowed Glycine 0 N--CA 1.476 1.326 0 N-CA-C 115.67 1.028 . . . . 0.0 115.67 169.851 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 26.7 p -82.77 43.17 0.82 Allowed 'General case' 0 CA--C 1.552 1.033 0 C-N-CA 125.196 1.398 . . . . 0.0 112.607 -170.022 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.534 ' HB ' ' HB2' ' A' ' 46' ' ' ASN . 16.9 t -102.93 153.41 5.59 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 C-N-CA 123.736 0.815 . . . . 0.0 109.094 179.679 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -65.61 -53.0 47.7 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 123.531 0.732 . . . . 0.0 110.742 -179.625 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 15.5 pttp 51.94 -168.7 0.04 OUTLIER 'General case' 0 CA--C 1.559 1.301 0 C-N-CA 126.143 1.777 . . . . 0.0 112.094 -177.893 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.499 ' HB ' ' CG ' ' A' ' 44' ' ' TYR . 51.4 m -122.31 159.66 26.96 Favored 'General case' 0 CA--C 1.55 0.976 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 175.628 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -78.83 -167.09 1.02 Allowed 'General case' 0 CA--C 1.557 1.232 0 C-N-CA 123.123 0.569 . . . . 0.0 111.524 179.525 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 37.5 t -80.51 130.87 35.25 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.625 0 C-N-CA 123.917 0.887 . . . . 0.0 110.038 -179.581 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.49 ' HB ' HD22 ' A' ' 42' ' ' LEU . 38.3 t -122.92 120.7 61.34 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.695 0 C-N-CA 123.525 0.73 . . . . 0.0 109.503 179.589 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.48 ' CZ ' ' HD3' ' A' ' 41' ' ' LYS . 27.0 m-85 -92.87 118.38 31.06 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 123.231 0.612 . . . . 0.0 109.947 174.1 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 2.0 t -78.43 123.82 35.87 Favored 'Isoleucine or valine' 0 C--O 1.239 0.509 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 177.049 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.485 ' HB3' ' H ' ' A' ' 64' ' ' GLU . . . -88.72 147.4 39.2 Favored Pre-proline 0 CA--C 1.544 0.734 0 CA-C-N 114.796 -1.093 . . . . 0.0 111.087 -175.478 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_endo -61.9 -30.69 84.19 Favored 'Trans proline' 0 C--N 1.369 1.636 0 C-N-CA 123.871 3.047 . . . . 0.0 114.064 -179.437 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 5.7 t -87.05 -1.46 57.9 Favored 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 122.242 0.217 . . . . 0.0 111.013 179.328 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 77.97 61.72 2.48 Favored Glycine 0 C--N 1.353 1.516 0 N-CA-C 112.011 -0.436 . . . . 0.0 112.011 -177.072 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.485 ' H ' ' HB3' ' A' ' 60' ' ' ALA . 40.8 tt0 -151.02 70.65 0.99 Allowed 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 107.999 -1.112 . . . . 0.0 107.999 179.318 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -65.4 158.15 27.43 Favored 'General case' 0 CA--C 1.544 0.74 0 CA-C-N 115.203 -0.908 . . . . 0.0 112.237 -171.885 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.584 HG23 ' HB2' ' A' ' 71' ' ' GLN . 44.4 mm -121.8 110.12 26.56 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 CA-C-N 115.169 -0.923 . . . . 0.0 110.484 -163.21 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 11.1 p -83.94 -17.08 41.85 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 123.249 0.62 . . . . 0.0 112.265 178.954 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 2.2 p-10 -157.26 152.52 26.19 Favored 'General case' 0 N--CA 1.476 0.854 0 N-CA-C 111.779 0.289 . . . . 0.0 111.779 -174.943 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 85.2 mtt180 -55.43 -31.76 62.15 Favored 'General case' 0 N--CA 1.493 1.686 0 C-N-CA 124.743 1.217 . . . . 0.0 114.215 -169.784 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 1.8 tmtp? -54.88 -53.92 49.18 Favored 'General case' 0 N--CA 1.486 1.371 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 177.861 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.584 ' HB2' HG23 ' A' ' 66' ' ' ILE . 84.3 mt-30 -61.68 -34.27 75.45 Favored 'General case' 0 N--CA 1.475 0.797 0 CA-C-N 114.741 -1.118 . . . . 0.0 111.126 -177.239 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.446 HD22 HG13 ' A' ' 66' ' ' ILE . 0.6 OUTLIER -60.74 -53.3 59.02 Favored 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 123.65 0.78 . . . . 0.0 109.755 179.153 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -68.41 -49.52 59.42 Favored 'General case' 0 C--O 1.238 0.491 0 CA-C-N 114.976 -1.011 . . . . 0.0 111.326 -172.782 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -63.5 -24.2 67.72 Favored 'General case' 0 C--N 1.356 0.865 0 O-C-N 123.635 0.584 . . . . 0.0 110.935 178.981 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 36.8 t80 -67.29 -50.62 59.59 Favored 'General case' 0 C--N 1.356 0.849 0 C-N-CA 123.224 0.61 . . . . 0.0 109.488 173.058 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.463 HD13 ' HA ' ' A' ' 84' ' ' ALA . 85.0 mt -61.84 -45.22 94.74 Favored 'General case' 0 N--CA 1.487 1.401 0 C-N-CA 123.337 0.655 . . . . 0.0 111.243 -174.4 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.06 -7.23 56.66 Favored 'General case' 0 CA--C 1.555 1.166 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.972 179.229 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 43.4 t -96.42 -22.99 16.81 Favored 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 123.744 0.818 . . . . 0.0 111.039 168.535 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 74.4 m80 -132.56 95.73 19.87 Favored Pre-proline 0 N--CA 1.476 0.871 0 C-N-CA 124.053 0.941 . . . . 0.0 109.43 -172.387 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -75.18 153.07 40.66 Favored 'Trans proline' 0 C--N 1.37 1.687 0 C-N-CA 122.382 2.055 . . . . 0.0 111.857 177.442 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 87.95 7.32 74.36 Favored Glycine 0 C--N 1.345 1.074 0 CA-C-N 115.975 -0.557 . . . . 0.0 112.686 -174.426 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 25.2 m-80 -103.69 127.33 29.71 Favored Pre-proline 0 N--CA 1.479 0.982 0 C-N-CA 123.801 0.84 . . . . 0.0 110.026 177.447 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -54.45 143.53 66.26 Favored 'Trans proline' 0 C--N 1.38 2.197 0 C-N-CA 123.606 2.871 . . . . 0.0 113.13 -178.058 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.463 ' HA ' HD13 ' A' ' 76' ' ' LEU . . . -71.16 159.1 35.28 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 123.649 0.78 . . . . 0.0 112.206 -172.283 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.431 ' HB ' HD12 ' A' ' 72' ' ' LEU . 15.1 tt -67.64 -16.21 20.76 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.218 0 C-N-CA 123.698 0.799 . . . . 0.0 111.385 -179.536 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -61.02 -29.91 69.99 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 124.351 1.061 . . . . 0.0 112.937 179.229 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.429 ' HG3' ' HD2' ' A' ' 88' ' ' PHE . 10.0 pt-20 -97.57 -8.05 29.9 Favored 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 122.728 0.411 . . . . 0.0 111.327 177.271 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.429 ' HD2' ' HG3' ' A' ' 87' ' ' GLU . 4.3 m-30 -85.23 116.38 23.55 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 123.423 0.689 . . . . 0.0 110.344 -176.471 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -94.37 124.79 38.61 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 123.114 0.566 . . . . 0.0 110.97 -174.721 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 52.3 m95 -110.36 -20.68 12.53 Favored 'General case' 0 CA--C 1.551 0.989 0 C-N-CA 124.451 1.101 . . . . 0.0 109.632 176.889 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 11.3 t -80.86 5.46 15.99 Favored 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 123.767 0.827 . . . . 0.0 112.298 -172.501 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.445 HG21 ' NZ ' ' A' ' 41' ' ' LYS . 13.9 t -61.74 -21.42 64.51 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 123.251 0.621 . . . . 0.0 111.394 176.318 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 6.2 m -65.07 -27.28 68.67 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 124.977 1.311 . . . . 0.0 111.741 177.24 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 118.97 165.16 13.07 Favored Glycine 0 C--N 1.342 0.88 0 N-CA-C 110.632 -0.987 . . . . 0.0 110.632 -172.553 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 1.2 t . . . . . 0 C--O 1.252 1.194 0 CA-C-O 118.252 -0.88 . . . . 0.0 109.267 -179.088 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.482 1.142 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 65.3 m80 -98.09 -35.42 10.42 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 123.573 0.749 . . . . 0.0 111.276 -176.894 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 36.6 m80 66.39 104.75 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 C-N-CA 125.31 1.444 . . . . 0.0 111.578 -176.526 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 76.7 m80 -105.42 119.71 39.78 Favored 'General case' 0 N--CA 1.472 0.674 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 173.543 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 31.4 m-70 -104.19 65.28 0.79 Allowed 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 123.678 0.791 . . . . 0.0 109.86 -176.545 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 29.7 m80 -139.13 102.5 4.53 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 123.641 0.776 . . . . 0.0 110.669 -179.908 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 10.5 p-80 -146.12 39.52 1.11 Allowed 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 125.158 1.383 . . . . 0.0 108.212 172.293 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 7.3 m -77.09 -4.25 43.41 Favored 'General case' 0 N--CA 1.479 0.992 0 CA-C-N 114.672 -1.149 . . . . 0.0 112.667 -173.405 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 32.3 m -74.52 113.42 11.75 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 123.312 0.645 . . . . 0.0 110.903 -177.502 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -153.32 54.89 0.44 Allowed Glycine 0 C--N 1.342 0.87 0 N-CA-C 111.354 -0.698 . . . . 0.0 111.354 -179.061 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 46.3 mtm180 -98.99 11.96 37.42 Favored 'General case' 0 N--CA 1.484 1.225 0 C-N-CA 123.964 0.905 . . . . 0.0 110.961 -178.567 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 44.3 tt0 -60.88 107.18 0.67 Allowed 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 123.639 0.776 . . . . 0.0 110.364 -177.812 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 32.4 t30 -128.2 96.83 4.57 Favored 'General case' 0 C--O 1.239 0.51 0 C-N-CA 124.031 0.932 . . . . 0.0 109.415 -174.697 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -110.18 135.32 51.14 Favored 'General case' 0 C--O 1.241 0.613 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 168.511 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 21.1 p90 -91.3 -36.58 13.79 Favored 'General case' 0 CA--C 1.537 0.474 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 169.502 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 35.0 t80 46.57 58.53 4.55 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 126.13 1.772 . . . . 0.0 111.764 173.534 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 13.8 pt20 -150.76 162.31 40.98 Favored 'General case' 0 C--O 1.241 0.613 0 CA-C-N 115.107 -0.952 . . . . 0.0 110.032 -176.998 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -170.3 174.53 44.34 Favored Glycine 0 C--O 1.24 0.53 0 CA-C-N 114.889 -1.05 . . . . 0.0 111.093 178.752 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 28.2 p-80 -88.55 137.57 32.21 Favored 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 109.781 -0.452 . . . . 0.0 109.781 177.726 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 25.7 mmt -118.38 102.12 8.7 Favored 'General case' 0 N--CA 1.477 0.912 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 -179.929 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -71.12 98.75 1.73 Allowed 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 123.471 0.709 . . . . 0.0 110.205 -179.522 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 20.7 m -133.53 68.77 1.49 Allowed 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 124.206 1.002 . . . . 0.0 108.604 179.833 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -90.3 -122.37 2.42 Favored Glycine 0 C--N 1.349 1.293 0 CA-C-N 115.397 -0.82 . . . . 0.0 111.539 175.861 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 60.0 p -87.38 27.09 1.12 Allowed 'General case' 0 CA--C 1.553 1.07 0 C-N-CA 123.61 0.764 . . . . 0.0 111.808 179.074 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -65.32 128.84 37.49 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 123.446 0.698 . . . . 0.0 111.051 179.175 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -88.4 143.05 27.23 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 123.767 0.827 . . . . 0.0 110.073 -179.525 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -84.93 83.45 8.05 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 123.403 0.681 . . . . 0.0 110.139 -175.435 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 32.8 m -99.33 128.69 50.79 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.959 0 C-N-CA 123.185 0.594 . . . . 0.0 109.399 175.867 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 16.7 m -73.74 105.48 3.07 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 178.888 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 23.7 p -162.68 118.15 1.84 Allowed 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 122.915 0.486 . . . . 0.0 110.7 -171.685 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 63.1 t -105.77 133.4 50.23 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 C-N-CA 124.372 1.069 . . . . 0.0 108.533 176.835 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -83.37 113.49 20.77 Favored 'General case' 0 CA--C 1.539 0.523 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 176.148 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.543 HD23 ' HB3' ' A' ' 43' ' ' PHE . 3.8 mm? -89.88 165.13 25.9 Favored Pre-proline 0 CA--C 1.556 1.208 0 C-N-CA 124.337 1.055 . . . . 0.0 110.088 -179.797 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -56.72 142.74 91.48 Favored 'Trans proline' 0 C--N 1.394 2.941 0 C-N-CA 122.92 2.414 . . . . 0.0 113.113 179.192 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.523 ' HB2' ' HB3' ' A' ' 41' ' ' LYS . . . -136.24 166.04 31.0 Favored Pre-proline 0 CA--C 1.539 0.537 0 C-N-CA 124.216 1.007 . . . . 0.0 111.098 -169.091 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 81.5 Cg_exo -52.58 164.32 1.48 Allowed 'Trans proline' 0 C--N 1.376 2.011 0 C-N-CA 123.161 2.574 . . . . 0.0 112.538 160.8 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 66.0 p -63.95 -39.92 95.26 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 123.535 0.734 . . . . 0.0 111.748 -176.251 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 22.0 m -82.1 -37.8 25.78 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 123.641 0.776 . . . . 0.0 111.554 -177.612 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 45.0 m95 -97.17 158.12 15.6 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 123.369 0.668 . . . . 0.0 111.059 -173.389 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.54 ' HB2' ' HB ' ' A' ' 59' ' ' VAL . 0.1 OUTLIER -111.86 152.63 27.72 Favored 'General case' 0 C--O 1.236 0.352 0 N-CA-C 107.906 -1.146 . . . . 0.0 107.906 168.632 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.523 ' HB3' ' HB2' ' A' ' 35' ' ' ALA . 17.1 tptm -126.74 119.13 26.17 Favored 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 -175.309 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 4.8 tt -115.1 144.91 42.92 Favored 'General case' 0 C--N 1.322 -0.599 0 C-N-CA 124.726 1.21 . . . . 0.0 108.638 174.322 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.543 ' HB3' HD23 ' A' ' 33' ' ' LEU . 27.6 t80 -131.21 128.75 40.59 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 125.31 1.444 . . . . 0.0 108.436 174.975 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 39.0 m-85 -87.74 105.46 8.95 Favored Pre-proline 0 CA--C 1.554 1.132 0 N-CA-C 108.782 -0.822 . . . . 0.0 108.782 170.649 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -78.82 158.36 27.76 Favored 'Trans proline' 0 C--N 1.37 1.684 0 C-N-CA 122.735 2.29 . . . . 0.0 112.173 173.28 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . 0.472 ' HB2' ' HB3' ' A' ' 53' ' ' LYS . 24.6 t-20 -99.21 154.55 18.06 Favored 'General case' 0 N--CA 1.477 0.899 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 173.561 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 51.2 mtpt -57.03 -39.52 74.96 Favored 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 123.747 0.819 . . . . 0.0 111.673 -178.758 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 58.5 t -116.56 85.7 0.87 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.834 0 C-N-CA 124.139 0.976 . . . . 0.0 108.522 174.779 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 68.5 -101.55 0.78 Allowed Glycine 0 C--N 1.345 1.081 0 CA-C-N 115.772 -0.649 . . . . 0.0 113.786 175.926 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 48.7 m -127.77 -58.92 1.22 Allowed 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 123.412 0.685 . . . . 0.0 110.998 -174.227 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 46.2 t 50.83 -89.56 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 C-N-CA 124.758 1.223 . . . . 0.0 112.255 179.191 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -140.85 41.09 1.83 Allowed 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 124.45 1.1 . . . . 0.0 108.905 -177.982 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.487 ' HE3' ' HB3' ' A' ' 93' ' ' SER . 24.0 pttm -58.34 153.55 15.29 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 124.599 1.16 . . . . 0.0 112.041 -176.793 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 26.0 m -66.9 140.0 57.75 Favored 'General case' 0 CA--C 1.555 1.171 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 169.917 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -74.56 -178.31 3.52 Favored 'General case' 0 N--CA 1.482 1.137 0 N-CA-C 112.9 0.704 . . . . 0.0 112.9 -171.762 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 64.9 t -82.86 140.82 15.78 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.847 0 C-N-CA 124.455 1.102 . . . . 0.0 111.519 -170.648 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 63.2 t -122.23 128.61 75.56 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.9 0 C-N-CA 124.052 0.941 . . . . 0.0 108.97 176.819 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 13.3 m-85 -102.05 123.02 45.22 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 123.282 0.633 . . . . 0.0 109.563 171.583 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.54 ' HB ' ' HB2' ' A' ' 40' ' ' LYS . 2.3 t -79.58 129.47 37.51 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.611 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 174.456 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -83.85 154.61 64.67 Favored Pre-proline 0 CA--C 1.539 0.556 0 CA-C-N 114.901 -1.045 . . . . 0.0 111.446 -176.368 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -62.14 -22.86 74.92 Favored 'Trans proline' 0 C--N 1.379 2.164 0 C-N-CA 123.153 2.568 . . . . 0.0 113.447 177.251 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.423 HG22 ' OH ' ' A' ' 75' ' ' TYR . 12.1 t -99.86 -7.23 25.59 Favored 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 123.027 0.531 . . . . 0.0 111.86 177.798 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 94.16 -4.17 70.54 Favored Glycine 0 CA--C 1.531 1.043 0 CA-C-O 119.849 -0.417 . . . . 0.0 113.859 -179.386 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.407 ' H ' HG23 ' A' ' 62' ' ' THR . 36.2 tt0 -78.97 75.76 5.47 Favored 'General case' 0 N--CA 1.482 1.127 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 174.801 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -67.48 157.77 33.47 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-O 121.979 0.895 . . . . 0.0 111.596 -168.833 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.535 HG23 ' HB2' ' A' ' 71' ' ' GLN . 42.7 mm -116.61 120.15 64.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 C-N-CA 125.141 1.376 . . . . 0.0 108.876 -171.016 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 18.5 p -89.19 -19.94 24.82 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 123.315 0.646 . . . . 0.0 112.349 -176.665 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 2.0 p-10 -157.95 165.33 35.42 Favored 'General case' 0 N--CA 1.481 1.109 0 CA-C-O 120.968 0.413 . . . . 0.0 111.651 -174.919 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 20.3 ttm180 -57.51 -42.17 82.25 Favored 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 125.211 1.404 . . . . 0.0 113.101 -167.702 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 8.6 tmtm? -54.27 -49.92 68.45 Favored 'General case' 0 N--CA 1.487 1.378 0 C-N-CA 123.953 0.901 . . . . 0.0 110.527 -179.702 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.535 ' HB2' HG23 ' A' ' 66' ' ' ILE . 80.5 mt-30 -61.96 -32.74 73.2 Favored 'General case' 0 N--CA 1.475 0.802 0 CA-C-N 114.765 -1.107 . . . . 0.0 111.254 -179.136 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.417 ' O ' ' HG ' ' A' ' 76' ' ' LEU . 0.5 OUTLIER -65.82 -50.88 63.05 Favored 'General case' 0 CA--C 1.551 1.004 0 C-N-CA 123.466 0.707 . . . . 0.0 109.283 179.043 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -66.29 -43.98 84.81 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 124.155 0.982 . . . . 0.0 111.81 -174.705 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -68.24 -26.69 65.81 Favored 'General case' 0 N--CA 1.482 1.144 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.799 177.872 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . 0.423 ' OH ' HG22 ' A' ' 62' ' ' THR . 19.7 t80 -69.55 -47.09 64.83 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 123.374 0.67 . . . . 0.0 109.914 176.106 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.417 ' HG ' ' O ' ' A' ' 72' ' ' LEU . 74.8 mt -69.89 -28.43 65.62 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 113.03 0.752 . . . . 0.0 113.03 -172.631 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 66.0 pttt -75.51 -36.2 60.61 Favored 'General case' 0 N--CA 1.476 0.846 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 173.485 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 34.2 t -73.97 -20.36 60.37 Favored 'General case' 0 N--CA 1.485 1.292 0 C-N-CA 123.593 0.757 . . . . 0.0 111.125 176.206 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 58.3 m80 -137.25 76.14 44.83 Favored Pre-proline 0 CA--C 1.548 0.867 0 C-N-CA 124.394 1.077 . . . . 0.0 108.354 -177.29 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -67.64 -16.75 47.35 Favored 'Trans proline' 0 C--N 1.381 2.253 0 C-N-CA 123.032 2.488 . . . . 0.0 113.155 -178.269 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -70.84 -14.75 73.28 Favored Glycine 0 C--N 1.347 1.161 0 CA-C-N 116.046 -0.525 . . . . 0.0 112.928 175.108 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 16.1 m120 -94.29 146.08 30.9 Favored Pre-proline 0 CA--C 1.547 0.845 0 C-N-CA 123.959 0.904 . . . . 0.0 110.214 176.108 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -68.97 159.94 51.89 Favored 'Trans proline' 0 C--N 1.378 2.104 0 C-N-CA 123.05 2.5 . . . . 0.0 113.752 -170.808 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -71.5 148.93 46.28 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 124.295 1.038 . . . . 0.0 112.166 -174.474 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 17.8 tt -68.08 -11.62 14.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 C-N-CA 123.778 0.831 . . . . 0.0 111.457 -179.068 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -58.7 -28.96 66.28 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 124.458 1.103 . . . . 0.0 112.797 174.263 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -100.69 -8.26 23.01 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 122.947 0.499 . . . . 0.0 111.515 176.666 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -80.42 110.02 15.48 Favored 'General case' 0 N--CA 1.48 1.03 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 177.768 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -78.43 119.81 22.27 Favored 'General case' 0 CA--C 1.537 0.45 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 175.509 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 76.2 m95 -109.13 -7.79 15.26 Favored 'General case' 0 CA--C 1.55 0.972 0 C-N-CA 124.215 1.006 . . . . 0.0 109.451 168.081 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 15.0 t -107.08 14.3 26.48 Favored 'General case' 0 CA--C 1.558 1.267 0 C-N-CA 124.28 1.032 . . . . 0.0 112.598 -164.286 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 14.6 t -61.32 -25.35 67.08 Favored 'General case' 0 N--CA 1.499 1.981 0 CA-C-O 121.393 0.616 . . . . 0.0 110.463 173.644 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . 0.487 ' HB3' ' HE3' ' A' ' 53' ' ' LYS . 7.4 m -61.44 -30.37 70.54 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 125.529 1.532 . . . . 0.0 112.065 -179.838 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 71.0 -90.7 0.42 Allowed Glycine 0 C--N 1.345 1.057 0 N-CA-C 109.571 -1.412 . . . . 0.0 109.571 -167.121 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 18.1 p . . . . . 0 C--O 1.252 1.234 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 165.655 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.555 1.145 0 CA-C-O 121.936 0.874 . . . . 0.0 109.716 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 94.4 m-70 -145.95 124.4 12.39 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 124.019 0.927 . . . . 0.0 109.262 177.049 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 59.2 m80 -83.0 99.46 9.84 Favored 'General case' 0 CA--C 1.538 0.519 0 N-CA-C 107.707 -1.22 . . . . 0.0 107.707 170.97 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 14.9 t-80 -64.94 93.05 0.11 Allowed 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 123.982 0.913 . . . . 0.0 111.574 -171.65 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 31.7 m170 -101.24 71.16 1.36 Allowed 'General case' 0 C--O 1.244 0.789 0 C-N-CA 123.728 0.811 . . . . 0.0 109.305 178.005 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 47.8 t-80 -81.46 118.15 22.47 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 114.767 -1.106 . . . . 0.0 109.901 179.116 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 12.1 m170 -88.24 138.2 31.65 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.517 176.647 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 53.6 p -105.91 32.97 4.01 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 124.511 1.124 . . . . 0.0 109.037 169.113 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 24.5 m -64.17 111.29 2.51 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 124.091 0.957 . . . . 0.0 111.768 -176.886 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -95.99 125.85 8.57 Favored Glycine 0 CA--C 1.529 0.963 0 CA-C-N 115.598 -0.728 . . . . 0.0 111.583 175.981 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 2.0 tmt_? -72.12 -32.64 67.14 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 123.211 0.605 . . . . 0.0 109.625 177.315 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -64.15 93.06 0.09 Allowed 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 123.327 0.651 . . . . 0.0 109.77 175.739 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 8.1 t30 -135.68 73.01 1.45 Allowed 'General case' 0 C--O 1.242 0.674 0 N-CA-C 107.753 -1.203 . . . . 0.0 107.753 177.478 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -154.58 177.16 11.51 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 114.155 -1.384 . . . . 0.0 110.179 -178.755 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 18.6 p90 -55.57 -46.5 77.21 Favored 'General case' 0 CA--C 1.554 1.098 0 C-N-CA 123.827 0.851 . . . . 0.0 111.537 174.408 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 12.8 t80 54.89 26.93 8.37 Favored 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 125.082 1.353 . . . . 0.0 111.771 179.886 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 19.0 mm-40 -91.01 47.41 1.4 Allowed 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 124.497 1.119 . . . . 0.0 110.22 -178.083 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -80.48 65.3 3.89 Favored Glycine 0 C--N 1.345 1.028 0 CA-C-N 115.896 -0.593 . . . . 0.0 112.579 179.483 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 88.8 m-70 -112.31 138.24 49.3 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 124.198 0.999 . . . . 0.0 109.91 -177.711 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 67.4 mtt -123.09 -58.61 1.63 Allowed 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 123.513 0.725 . . . . 0.0 109.257 176.168 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . 62.36 100.24 0.03 OUTLIER 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 124.573 1.149 . . . . 0.0 112.54 173.981 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 75.2 p -147.75 134.49 19.99 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 123.491 0.716 . . . . 0.0 110.19 -178.875 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -177.43 -172.43 41.95 Favored Glycine 0 C--N 1.344 1.008 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.73 178.681 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 23.5 m 57.66 41.38 25.52 Favored 'General case' 0 N--CA 1.484 1.25 0 C-N-CA 123.856 0.862 . . . . 0.0 112.112 177.477 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -92.74 35.93 1.03 Allowed 'General case' 0 N--CA 1.486 1.356 0 CA-C-O 122.283 1.04 . . . . 0.0 110.3 -179.263 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -136.51 107.46 6.68 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 124.036 0.935 . . . . 0.0 108.816 176.445 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -71.71 91.83 1.15 Allowed 'General case' 0 C--O 1.246 0.899 0 CA-C-O 121.595 0.712 . . . . 0.0 109.401 174.878 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 24.9 m -91.59 151.1 3.59 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 CA-C-N 115.069 -0.969 . . . . 0.0 110.468 -178.228 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.532 HG21 ' HB2' ' A' ' 47' ' ' LYS . 30.9 m -112.46 132.97 59.69 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.109 0 C-N-CA 123.435 0.694 . . . . 0.0 109.918 178.371 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.472 ' HA ' ' HD2' ' A' ' 45' ' ' PRO . 76.2 p -148.1 145.85 28.57 Favored 'General case' 0 C--O 1.241 0.635 0 C-N-CA 123.274 0.63 . . . . 0.0 110.336 -178.495 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 43.9 t -114.6 131.22 67.35 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.405 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 172.992 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -81.55 109.88 16.41 Favored 'General case' 0 CA--C 1.54 0.586 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 173.803 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.512 HD23 ' HB3' ' A' ' 43' ' ' PHE . 4.2 mm? -87.76 168.98 15.2 Favored Pre-proline 0 CA--C 1.557 1.222 0 C-N-CA 123.849 0.86 . . . . 0.0 109.885 -177.065 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -53.68 129.03 31.95 Favored 'Trans proline' 0 C--N 1.397 3.101 0 C-N-CA 122.949 2.433 . . . . 0.0 113.118 -177.173 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -114.98 154.0 47.08 Favored Pre-proline 0 N--CA 1.48 1.031 0 C-N-CA 123.998 0.919 . . . . 0.0 112.466 -167.815 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.804 ' HG2' ' HB2' ' A' ' 39' ' ' TRP . 38.4 Cg_endo -70.96 148.01 56.35 Favored 'Trans proline' 0 C--N 1.377 2.054 0 C-N-CA 122.388 2.059 . . . . 0.0 110.233 166.091 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 33.2 t -64.43 -25.39 67.99 Favored 'General case' 0 N--CA 1.485 1.287 0 C-N-CA 123.595 0.758 . . . . 0.0 112.983 -169.967 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 40.7 t -81.46 -37.24 28.3 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 123.122 0.569 . . . . 0.0 110.766 177.823 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' TRP . . . . . 0.804 ' HB2' ' HG2' ' A' ' 36' ' ' PRO . 20.7 m95 -107.09 -164.99 1.03 Allowed 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 123.603 0.761 . . . . 0.0 110.639 -173.746 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.659 ' HB3' ' HB ' ' A' ' 59' ' ' VAL . 34.1 ttmt -142.7 152.64 42.58 Favored 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 171.248 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.443 ' HD3' ' CZ ' ' A' ' 58' ' ' PHE . 16.0 tptm -130.25 127.8 40.32 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 123.66 0.784 . . . . 0.0 109.983 -170.367 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.435 HD21 ' CE1' ' A' ' 44' ' ' TYR . 3.2 tt -134.48 149.72 50.74 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 114.784 -1.098 . . . . 0.0 109.302 179.254 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.512 ' HB3' HD23 ' A' ' 33' ' ' LEU . 32.6 t80 -135.34 136.97 41.95 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 125.317 1.447 . . . . 0.0 108.484 175.653 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . 0.441 ' CG ' ' HB ' ' A' ' 54' ' ' THR . 40.5 m-85 -96.32 106.17 27.29 Favored Pre-proline 0 CA--C 1.55 0.958 0 C-N-CA 122.975 0.51 . . . . 0.0 109.661 172.025 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.472 ' HD2' ' HA ' ' A' ' 30' ' ' SER . 94.8 Cg_endo -79.3 156.22 25.59 Favored 'Trans proline' 0 C--N 1.374 1.883 0 C-N-CA 122.961 2.441 . . . . 0.0 112.383 172.797 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -85.8 105.03 16.02 Favored 'General case' 0 N--CA 1.474 0.767 0 N-CA-C 107.451 -1.315 . . . . 0.0 107.451 173.637 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.532 ' HB2' HG21 ' A' ' 29' ' ' VAL . 33.4 ttpt -55.24 -51.65 65.94 Favored 'General case' 0 N--CA 1.485 1.287 0 C-N-CA 123.438 0.695 . . . . 0.0 111.58 -174.37 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 93.4 t -80.82 -56.14 7.01 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 C-N-CA 123.532 0.733 . . . . 0.0 109.898 176.611 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.5 ' H ' HG23 ' A' ' 51' ' ' VAL . . . 143.19 -50.69 0.68 Allowed Glycine 0 C--N 1.343 0.923 0 CA-C-N 115.265 -0.88 . . . . 0.0 111.316 -178.259 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 20.0 m -82.75 21.05 1.05 Allowed 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 123.721 0.808 . . . . 0.0 111.757 178.584 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.5 HG23 ' H ' ' A' ' 49' ' ' GLY . 12.7 t -77.9 150.01 5.75 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 C-N-CA 123.619 0.767 . . . . 0.0 109.389 -179.053 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.45 ' O ' ' HG2' ' A' ' 53' ' ' LYS . 22.1 tptm -61.76 -35.92 79.53 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 123.373 0.669 . . . . 0.0 110.333 177.079 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.5 ' H ' HG12 ' A' ' 51' ' ' VAL . 9.8 ptmm? 60.61 173.39 0.1 Allowed 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 126.306 1.842 . . . . 0.0 112.184 -178.139 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.441 ' HB ' ' CG ' ' A' ' 44' ' ' TYR . 26.1 m -126.83 160.26 31.45 Favored 'General case' 0 CA--C 1.552 1.028 0 N-CA-C 107.039 -1.467 . . . . 0.0 107.039 170.067 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.511 ' HG3' ' O ' ' A' ' 67' ' ' SER . 1.1 pm0 -77.54 -171.24 2.09 Favored 'General case' 0 CA--C 1.551 0.996 0 CA-C-O 121.491 0.662 . . . . 0.0 112.586 -174.075 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 77.6 t -80.62 121.07 33.43 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 CA-C-N 115.151 -0.931 . . . . 0.0 108.54 175.18 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 40.4 t -111.64 118.97 58.84 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.572 0 C-N-CA 123.099 0.56 . . . . 0.0 109.569 -178.465 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.443 ' CZ ' ' HD3' ' A' ' 41' ' ' LYS . 36.1 m-85 -93.15 120.31 33.3 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 123.458 0.703 . . . . 0.0 109.507 171.541 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.659 ' HB ' ' HB3' ' A' ' 40' ' ' LYS . 3.3 t -79.71 126.61 39.3 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.449 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 174.027 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.581 ' HB3' ' H ' ' A' ' 64' ' ' GLU . . . -84.61 148.57 52.21 Favored Pre-proline 0 CA--C 1.541 0.616 0 CA-C-N 114.97 -1.014 . . . . 0.0 110.781 -177.488 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -63.04 -17.36 59.78 Favored 'Trans proline' 0 N--CA 1.494 1.557 0 C-N-CA 123.394 2.729 . . . . 0.0 114.143 -176.705 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 14.1 t -110.83 0.36 17.21 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 123.365 0.666 . . . . 0.0 111.738 -178.878 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 76.35 65.32 2.03 Favored Glycine 0 CA--C 1.533 1.182 0 CA-C-O 121.385 0.436 . . . . 0.0 112.064 -175.976 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.581 ' H ' ' HB3' ' A' ' 60' ' ' ALA . 39.0 tt0 -150.6 72.54 1.09 Allowed 'General case' 0 N--CA 1.474 0.746 0 N-CA-C 106.622 -1.621 . . . . 0.0 106.622 175.244 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 4.6 mp0 -66.99 155.47 38.51 Favored 'General case' 0 N--CA 1.475 0.812 0 CA-C-N 114.756 -1.111 . . . . 0.0 112.094 -165.418 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.463 HG23 ' HB2' ' A' ' 71' ' ' GLN . 48.5 mm -116.87 143.86 26.05 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.508 0 C-N-CA 124.941 1.297 . . . . 0.0 108.965 -176.741 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.511 ' O ' ' HG3' ' A' ' 55' ' ' GLU . 35.9 p -129.37 -2.8 4.95 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 122.93 0.492 . . . . 0.0 112.038 178.533 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 9.6 p30 -151.67 158.81 43.92 Favored 'General case' 0 N--CA 1.486 1.352 0 O-C-N 121.842 -0.536 . . . . 0.0 111.123 176.442 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 55.3 mtp180 -60.61 -31.84 70.99 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 123.89 0.876 . . . . 0.0 112.78 -176.64 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 2.7 tmtp? -60.69 -54.16 48.6 Favored 'General case' 0 N--CA 1.478 0.934 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 178.4 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.463 ' HB2' HG23 ' A' ' 66' ' ' ILE . 45.8 mt-30 -54.86 -40.53 69.77 Favored 'General case' 0 N--CA 1.48 1.045 0 O-C-N 124.12 0.887 . . . . 0.0 111.849 177.867 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.486 HD12 ' HB ' ' A' ' 85' ' ' ILE . 0.7 OUTLIER -64.74 -53.04 53.41 Favored 'General case' 0 N--CA 1.478 0.949 0 O-C-N 123.699 0.624 . . . . 0.0 110.074 -175.912 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -71.08 -37.23 72.45 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 123.184 0.593 . . . . 0.0 111.692 -172.374 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.98 -26.46 63.16 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 122.245 0.218 . . . . 0.0 111.049 174.653 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 20.0 t80 -65.08 -49.93 68.11 Favored 'General case' 0 N--CA 1.479 0.99 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 175.147 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.478 ' HG ' ' O ' ' A' ' 72' ' ' LEU . 68.3 mt -60.91 -47.29 87.09 Favored 'General case' 0 N--CA 1.479 0.995 0 O-C-N 123.983 0.802 . . . . 0.0 111.936 -173.91 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -69.53 -26.93 64.75 Favored 'General case' 0 CA--C 1.551 1.009 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.873 -177.846 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 59.2 m -89.0 -23.68 22.56 Favored 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 123.024 0.53 . . . . 0.0 111.792 178.177 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 92.8 m-70 -124.72 94.29 44.64 Favored Pre-proline 0 N--CA 1.474 0.731 0 C-N-CA 123.483 0.713 . . . . 0.0 109.959 -173.759 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -68.54 149.66 74.47 Favored 'Trans proline' 0 C--N 1.376 1.992 0 C-N-CA 122.707 2.272 . . . . 0.0 112.448 178.501 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 100.99 -20.08 49.28 Favored Glycine 0 C--N 1.345 1.051 0 CA-C-N 116.167 -0.47 . . . . 0.0 112.723 -178.821 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 40.6 m-80 -77.42 144.42 70.3 Favored Pre-proline 0 CA--C 1.549 0.939 0 C-N-CA 123.132 0.573 . . . . 0.0 110.4 176.527 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -74.8 158.9 42.64 Favored 'Trans proline' 0 C--N 1.374 1.913 0 C-N-CA 122.6 2.2 . . . . 0.0 112.625 177.462 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.432 ' HA ' HD13 ' A' ' 76' ' ' LEU . . . -75.03 153.69 38.33 Favored 'General case' 0 N--CA 1.477 0.89 0 CA-C-N 115.389 -0.823 . . . . 0.0 112.561 -173.045 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.486 ' HB ' HD12 ' A' ' 72' ' ' LEU . 15.9 tt -68.08 -11.64 14.55 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.335 0 C-N-CA 123.899 0.88 . . . . 0.0 111.436 179.954 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -55.68 -31.87 62.78 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 124.226 1.01 . . . . 0.0 112.262 174.138 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -98.08 -15.74 19.86 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 122.988 0.515 . . . . 0.0 111.908 176.477 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -81.27 108.86 15.26 Favored 'General case' 0 N--CA 1.484 1.241 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 177.016 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 10.3 p-10 -97.11 120.62 37.81 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-O 121.395 0.617 . . . . 0.0 110.196 -177.558 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 65.4 m95 -96.72 -9.01 29.92 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 124.053 0.941 . . . . 0.0 109.791 173.762 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 11.0 t -85.75 16.21 4.18 Favored 'General case' 0 CA--C 1.557 1.225 0 C-N-CA 125.581 1.552 . . . . 0.0 111.294 179.665 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 5.0 t -62.18 -24.8 67.41 Favored 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 124.187 0.995 . . . . 0.0 113.476 -170.172 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 33.4 p -68.41 -23.42 64.64 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 123.967 0.907 . . . . 0.0 111.77 178.333 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 133.59 -159.93 23.83 Favored Glycine 0 C--N 1.34 0.801 0 N-CA-C 110.866 -0.894 . . . . 0.0 110.866 178.631 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 33.5 p . . . . . 0 C--O 1.253 1.244 0 CA-C-O 118.687 -0.673 . . . . 0.0 109.501 176.0 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.3 mpp? . . . . . 0 N--CA 1.483 1.205 0 N-CA-C 110.143 -0.317 . . . . 0.0 110.143 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 43.5 m-70 65.43 -80.6 0.03 OUTLIER 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 124.96 1.304 . . . . 0.0 111.17 -175.718 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 62.2 t-80 57.61 79.69 0.19 Allowed 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 124.308 1.043 . . . . 0.0 110.0 -176.011 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 27.2 t-80 -137.72 131.33 31.18 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 123.798 0.839 . . . . 0.0 110.565 -170.879 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 14.1 m-70 -119.1 126.6 52.02 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 169.152 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 13.6 t-80 -72.97 120.83 19.15 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 123.258 0.623 . . . . 0.0 111.014 -177.775 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 13.4 p80 -151.51 89.56 1.5 Allowed 'General case' 0 CA--C 1.543 0.684 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 170.216 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 47.6 m -79.62 72.92 6.32 Favored 'General case' 0 CA--C 1.538 0.507 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 174.004 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 11.2 m -84.25 79.78 9.42 Favored 'General case' 0 C--O 1.24 0.577 0 CA-C-N 114.678 -1.146 . . . . 0.0 110.698 -169.657 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 52.54 50.24 49.16 Favored Glycine 0 C--N 1.349 1.277 0 O-C-N 124.171 0.92 . . . . 0.0 113.834 177.604 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 27.4 mmt180 -75.8 -1.31 24.53 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 123.445 0.698 . . . . 0.0 112.786 -176.573 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.45 ' HB3' ' HG ' ' A' ' 14' ' ' LEU . 51.4 mt-10 -118.18 -74.76 0.59 Allowed 'General case' 0 CA--C 1.551 0.996 0 C-N-CA 123.095 0.558 . . . . 0.0 110.103 174.487 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 29.0 m-80 59.17 23.67 11.98 Favored 'General case' 0 N--CA 1.494 1.771 0 C-N-CA 124.226 1.011 . . . . 0.0 111.894 -171.344 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.499 HD12 ' H ' ' A' ' 15' ' ' TYR . 1.1 pp -63.69 -42.91 97.94 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 123.482 0.713 . . . . 0.0 112.482 -175.44 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.499 ' H ' HD12 ' A' ' 14' ' ' LEU . 13.1 m-85 42.73 83.22 0.02 OUTLIER 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 124.528 1.131 . . . . 0.0 112.83 -175.696 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 39.4 t80 -79.61 72.34 6.28 Favored 'General case' 0 N--CA 1.479 0.981 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 177.112 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 10.1 pt20 -151.16 106.06 3.29 Favored 'General case' 0 C--O 1.244 0.783 0 C-N-CA 124.328 1.051 . . . . 0.0 108.972 -176.661 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 178.23 154.96 13.23 Favored Glycine 0 C--O 1.244 0.754 0 N-CA-C 110.894 -0.883 . . . . 0.0 110.894 -177.591 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 22.9 t-80 -68.76 117.23 10.2 Favored 'General case' 0 CA--C 1.543 0.674 0 N-CA-C 110.153 -0.314 . . . . 0.0 110.153 -178.622 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 33.2 mmt -95.8 146.07 24.84 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 123.967 0.907 . . . . 0.0 109.075 173.99 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -154.22 -59.84 0.12 Allowed 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 123.486 0.714 . . . . 0.0 110.596 -177.913 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 33.0 t 66.38 160.72 0.14 Allowed 'General case' 0 N--CA 1.489 1.5 0 C-N-CA 124.705 1.202 . . . . 0.0 111.417 -175.859 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 155.31 85.56 0.05 OUTLIER Glycine 0 C--N 1.345 1.055 0 O-C-N 122.061 -0.4 . . . . 0.0 112.525 178.579 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 23.3 t -133.05 2.61 3.64 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 123.696 0.798 . . . . 0.0 110.829 175.988 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 44.3 tt0 -88.18 131.56 34.68 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 123.218 0.607 . . . . 0.0 109.998 -177.361 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -99.23 176.96 5.36 Favored 'General case' 0 C--O 1.244 0.799 0 C-N-CA 123.749 0.82 . . . . 0.0 110.036 -179.149 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -73.2 94.43 1.97 Allowed 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 123.291 0.636 . . . . 0.0 109.5 179.984 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 33.6 m -92.05 146.34 6.43 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.014 0 C-N-CA 123.957 0.903 . . . . 0.0 110.556 -177.255 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 17.7 m -78.36 108.95 12.46 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.993 0 CA-C-O 121.464 0.65 . . . . 0.0 110.078 178.985 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 11.0 p -159.87 127.05 4.56 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 124.167 0.987 . . . . 0.0 109.425 -176.083 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 96.7 t -117.92 127.53 75.17 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 C-N-CA 123.885 0.874 . . . . 0.0 108.839 179.406 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.475 ' HA ' ' HA ' ' A' ' 42' ' ' LEU . 2.6 mp0 -87.48 117.0 25.98 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-O 121.206 0.527 . . . . 0.0 110.172 179.609 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.499 HD23 ' HB3' ' A' ' 43' ' ' PHE . 3.3 mm? -94.89 169.57 9.29 Favored Pre-proline 0 N--CA 1.491 1.583 0 C-N-CA 124.635 1.174 . . . . 0.0 110.354 -171.788 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -51.03 137.14 44.86 Favored 'Trans proline' 0 C--N 1.397 3.091 0 C-N-CA 123.195 2.597 . . . . 0.0 113.044 176.241 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -130.56 156.98 78.9 Favored Pre-proline 0 CA--C 1.544 0.725 0 C-N-CA 123.661 0.784 . . . . 0.0 112.417 -164.474 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_exo -54.62 138.07 74.67 Favored 'Trans proline' 0 C--N 1.375 1.947 0 C-N-CA 123.38 2.72 . . . . 0.0 110.786 157.354 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 57.1 p -63.15 -28.84 70.33 Favored 'General case' 0 CA--C 1.55 0.961 0 C-N-CA 123.719 0.808 . . . . 0.0 112.641 -175.146 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 35.3 t -85.16 -14.19 47.74 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 123.362 0.665 . . . . 0.0 111.765 179.356 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 16.3 m95 -122.74 -169.16 1.87 Allowed 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 124.034 0.934 . . . . 0.0 110.186 -178.815 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 28.7 mtmt -140.13 145.67 37.86 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 124.491 1.116 . . . . 0.0 108.462 169.184 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.513 ' NZ ' ' HB2' ' A' ' 43' ' ' PHE . 23.4 tptp -114.66 130.97 56.87 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 124.642 1.177 . . . . 0.0 109.349 -175.961 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.475 ' HA ' ' HA ' ' A' ' 32' ' ' GLU . 6.5 tt -128.36 149.16 50.64 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 124.478 1.111 . . . . 0.0 108.936 175.629 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.513 ' HB2' ' NZ ' ' A' ' 41' ' ' LYS . 25.9 t80 -131.32 139.71 49.61 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 125.06 1.344 . . . . 0.0 108.349 174.917 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . 0.512 ' HB3' ' HB ' ' A' ' 54' ' ' THR . 10.2 m-85 -103.4 98.52 12.56 Favored Pre-proline 0 CA--C 1.552 1.02 0 C-N-CA 122.944 0.498 . . . . 0.0 109.861 173.391 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -77.41 144.0 22.47 Favored 'Trans proline' 0 C--N 1.37 1.669 0 C-N-CA 121.963 1.775 . . . . 0.0 110.231 168.231 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 23.6 t-20 -65.12 -52.55 54.69 Favored 'General case' 0 N--CA 1.478 0.943 0 N-CA-C 108.369 -0.974 . . . . 0.0 108.369 173.311 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -145.17 -60.36 0.35 Allowed 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 125.065 1.346 . . . . 0.0 107.628 170.679 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 89.3 t -131.42 -64.77 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 172.499 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -173.72 -150.97 7.87 Favored Glycine 0 C--N 1.347 1.145 0 CA-C-N 115.24 -0.891 . . . . 0.0 111.567 -178.017 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 33.8 t 65.91 -75.53 0.05 Allowed 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 125.299 1.44 . . . . 0.0 110.823 -176.231 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 26.9 m -61.88 162.62 1.5 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.119 0 C-N-CA 124.059 0.944 . . . . 0.0 112.175 177.242 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 20.0 tptm -69.27 101.74 1.57 Allowed 'General case' 0 CA--C 1.546 0.814 0 CA-C-N 115.305 -0.862 . . . . 0.0 110.91 -172.66 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 50.6 pttt -84.93 166.99 16.33 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 125.165 1.386 . . . . 0.0 110.329 176.983 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.512 ' HB ' ' HB3' ' A' ' 44' ' ' TYR . 65.3 m -84.97 152.0 23.79 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 123.781 0.832 . . . . 0.0 108.948 176.562 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -69.53 177.63 2.84 Favored 'General case' 0 CA--C 1.551 1.018 0 CA-C-O 121.903 0.858 . . . . 0.0 112.246 -174.549 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 15.3 t -82.4 138.77 18.87 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 C-N-CA 124.72 1.208 . . . . 0.0 110.417 -178.865 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.444 ' HB ' HD22 ' A' ' 42' ' ' LEU . 68.7 t -121.21 124.62 72.45 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.772 0 C-N-CA 124.173 0.989 . . . . 0.0 109.531 175.81 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.467 ' CZ ' ' HD3' ' A' ' 41' ' ' LYS . 16.0 m-85 -98.24 123.79 42.5 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 123.356 0.662 . . . . 0.0 109.904 173.179 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 3.4 t -79.17 122.73 34.99 Favored 'Isoleucine or valine' 0 C--O 1.241 0.606 0 C-N-CA 123.47 0.708 . . . . 0.0 109.359 175.936 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -81.45 154.53 71.56 Favored Pre-proline 0 CA--C 1.542 0.651 0 CA-C-N 114.238 -1.346 . . . . 0.0 110.956 -176.266 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_endo -62.17 -27.52 78.72 Favored 'Trans proline' 0 C--N 1.375 1.955 0 C-N-CA 122.759 2.306 . . . . 0.0 112.947 178.939 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.403 HG22 ' OH ' ' A' ' 75' ' ' TYR . 12.4 t -96.89 -7.71 32.69 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 122.72 0.408 . . . . 0.0 111.085 177.309 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 93.99 -1.04 67.42 Favored Glycine 0 C--N 1.353 1.483 0 CA-C-O 119.866 -0.408 . . . . 0.0 113.957 178.816 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -78.79 73.27 5.34 Favored 'General case' 0 N--CA 1.479 0.982 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 174.477 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -67.76 158.43 32.42 Favored 'General case' 0 C--N 1.35 0.594 0 CA-C-N 114.98 -1.009 . . . . 0.0 112.01 -168.777 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 47.3 mm -116.04 125.44 73.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 C-N-CA 124.707 1.203 . . . . 0.0 109.354 -166.879 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 12.3 p -110.93 5.36 20.38 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 123.645 0.778 . . . . 0.0 112.797 -175.184 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 11.2 p30 -163.31 164.56 24.82 Favored 'General case' 0 N--CA 1.486 1.335 0 C-N-CA 122.988 0.515 . . . . 0.0 110.393 172.085 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 19.7 ttp180 -63.67 -34.42 77.82 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 123.683 0.793 . . . . 0.0 112.218 -171.856 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 8.2 tmtm? -60.86 -50.41 73.54 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 123.434 0.694 . . . . 0.0 109.828 179.015 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 75.5 mt-30 -55.84 -34.89 65.82 Favored 'General case' 0 N--CA 1.477 0.917 0 O-C-N 124.288 0.993 . . . . 0.0 111.406 179.123 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.424 ' O ' ' HG ' ' A' ' 76' ' ' LEU . 0.5 OUTLIER -65.33 -54.95 21.44 Favored 'General case' 0 CA--C 1.547 0.858 0 N-CA-C 109.489 -0.559 . . . . 0.0 109.489 179.559 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -59.86 -47.16 86.86 Favored 'General case' 0 N--CA 1.486 1.364 0 C-N-CA 124.19 0.996 . . . . 0.0 111.633 -175.117 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 5.3 pp0? -68.15 -30.77 69.98 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.374 -179.308 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . 0.403 ' OH ' HG22 ' A' ' 62' ' ' THR . 32.9 t80 -65.83 -45.17 83.22 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 123.248 0.619 . . . . 0.0 109.523 176.732 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.424 ' HG ' ' O ' ' A' ' 72' ' ' LEU . 69.9 mt -63.14 -44.09 96.54 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 123.108 0.563 . . . . 0.0 111.655 -176.115 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.92 -19.39 58.84 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 122.806 0.442 . . . . 0.0 111.414 -179.842 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 46.1 t -91.62 -12.31 34.61 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 123.236 0.615 . . . . 0.0 111.382 174.006 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 57.7 m-70 -133.55 83.51 48.47 Favored Pre-proline 0 CA--C 1.551 1.007 0 C-N-CA 123.462 0.705 . . . . 0.0 109.631 -179.402 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -65.73 128.62 20.35 Favored 'Trans proline' 0 C--N 1.379 2.143 0 C-N-CA 122.802 2.334 . . . . 0.0 112.065 176.691 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 124.01 -22.53 6.75 Favored Glycine 0 C--N 1.342 0.91 0 CA-C-N 115.76 -0.655 . . . . 0.0 111.837 -177.96 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 12.3 m120 -74.25 151.85 87.99 Favored Pre-proline 0 CA--C 1.553 1.072 0 C-N-CA 123.064 0.546 . . . . 0.0 110.785 177.379 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -69.61 160.45 49.7 Favored 'Trans proline' 0 C--N 1.375 1.927 0 C-N-CA 122.73 2.287 . . . . 0.0 112.853 178.887 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -75.82 148.71 38.19 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 123.565 0.746 . . . . 0.0 111.167 -176.299 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 16.1 tt -65.63 -12.53 14.01 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.383 0 C-N-CA 123.729 0.811 . . . . 0.0 112.371 -177.59 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -57.97 -35.46 71.21 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 124.49 1.116 . . . . 0.0 112.215 176.156 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -91.03 -11.88 37.47 Favored 'General case' 0 N--CA 1.485 1.282 0 N-CA-C 112.38 0.511 . . . . 0.0 112.38 177.883 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 4.9 m-85 -76.16 108.55 9.16 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 177.259 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 4.5 t0 -86.97 102.24 14.19 Favored 'General case' 0 CA--C 1.541 0.635 0 CA-C-N 115.995 -0.548 . . . . 0.0 109.964 -173.0 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 82.1 m95 -89.6 -31.94 17.34 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 123.746 0.819 . . . . 0.0 109.99 174.251 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 8.9 t -75.39 -6.49 50.26 Favored 'General case' 0 CA--C 1.557 1.215 0 C-N-CA 124.059 0.944 . . . . 0.0 112.532 -172.373 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 14.9 t -69.16 -7.92 40.77 Favored 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 123.451 0.7 . . . . 0.0 111.803 175.255 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 68.3 p -61.77 -34.36 75.73 Favored 'General case' 0 C--N 1.355 0.846 0 C-N-CA 123.989 0.915 . . . . 0.0 110.667 172.467 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 123.88 127.0 3.15 Favored Glycine 0 C--N 1.348 1.244 0 CA-C-N 115.245 -0.888 . . . . 0.0 111.285 -179.652 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 18.3 p . . . . . 0 C--O 1.25 1.096 0 C-N-CA 123.879 0.872 . . . . 0.0 108.699 177.431 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.1 mpt? . . . . . 0 N--CA 1.482 1.148 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 18.7 p80 -156.81 112.17 2.87 Favored 'General case' 0 N--CA 1.479 1.008 0 CA-C-O 121.253 0.549 . . . . 0.0 110.488 178.019 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 98.6 m-70 -132.15 141.46 49.13 Favored 'General case' 0 N--CA 1.475 0.808 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 171.447 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 34.0 m170 -79.1 120.69 24.0 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.825 -171.846 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 30.1 p-80 -104.87 154.75 19.65 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 124.358 1.063 . . . . 0.0 109.278 173.527 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 69.1 m-70 -78.57 150.15 32.85 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 123.244 0.618 . . . . 0.0 110.116 178.149 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 14.0 t-80 -62.95 99.11 0.15 Allowed 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 123.78 0.832 . . . . 0.0 110.833 -175.936 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 16.3 m -84.06 112.21 20.0 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 123.806 0.842 . . . . 0.0 108.953 178.39 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 42.4 p -156.9 138.09 13.7 Favored 'General case' 0 C--O 1.244 0.771 0 C-N-CA 123.386 0.674 . . . . 0.0 110.347 -177.857 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -89.09 148.73 20.35 Favored Glycine 0 C--N 1.344 0.988 0 N-CA-C 110.652 -0.979 . . . . 0.0 110.652 177.203 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 26.3 tpt180 -138.49 -67.95 0.46 Allowed 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 123.71 0.804 . . . . 0.0 109.471 -176.061 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -95.21 78.52 3.49 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 123.068 0.547 . . . . 0.0 109.841 -176.034 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 63.7 t30 -164.18 75.24 0.31 Allowed 'General case' 0 N--CA 1.475 0.793 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 173.118 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -167.32 155.37 9.33 Favored 'General case' 0 N--CA 1.478 0.937 0 CA-C-N 115.084 -0.962 . . . . 0.0 108.908 179.481 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 74.9 m-85 -135.45 -64.35 0.64 Allowed 'General case' 0 N--CA 1.475 0.775 0 C-N-CA 122.971 0.508 . . . . 0.0 110.183 -178.772 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 58.8 t80 64.73 14.44 9.11 Favored 'General case' 0 CA--C 1.565 1.524 0 O-C-N 124.14 0.9 . . . . 0.0 111.14 -179.165 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -128.63 -166.38 1.63 Allowed 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 124.4 1.08 . . . . 0.0 109.835 -176.748 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 88.43 15.16 60.7 Favored Glycine 0 C--N 1.347 1.191 0 CA-C-N 116.402 -0.363 . . . . 0.0 113.695 172.989 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 58.1 t-80 -101.22 117.26 34.64 Favored 'General case' 0 C--O 1.24 0.594 0 N-CA-C 109.419 -0.586 . . . . 0.0 109.419 173.945 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 2.7 mpp? -113.61 128.12 56.32 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 124.235 1.014 . . . . 0.0 108.859 175.833 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -76.49 81.53 3.19 Favored 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 109.125 -0.695 . . . . 0.0 109.125 171.341 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 50.5 m -146.89 143.31 28.45 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 123.702 0.801 . . . . 0.0 110.469 -173.378 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -169.27 40.78 0.21 Allowed Glycine 0 C--N 1.345 1.067 0 N-CA-C 111.547 -0.621 . . . . 0.0 111.547 178.459 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 21.0 m -64.69 131.24 46.35 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 123.802 0.841 . . . . 0.0 110.494 -179.744 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -143.36 79.95 1.66 Allowed 'General case' 0 N--CA 1.47 0.543 0 N-CA-C 108.312 -0.995 . . . . 0.0 108.312 179.884 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -107.05 124.78 50.14 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 124.196 0.998 . . . . 0.0 109.072 -178.507 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 12.5 tp10 -78.38 92.42 4.57 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 123.656 0.783 . . . . 0.0 110.422 -174.317 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 19.0 m -129.11 147.76 33.34 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.028 0 C-N-CA 124.652 1.181 . . . . 0.0 109.881 -178.021 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 21.0 m -85.26 110.97 20.06 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 CA-C-O 121.222 0.534 . . . . 0.0 110.325 178.404 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 58.5 p -140.46 123.74 16.79 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 123.826 0.85 . . . . 0.0 109.49 177.569 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 48.5 t -110.83 124.45 67.64 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 C-N-CA 124.184 0.994 . . . . 0.0 109.464 178.559 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 53.4 mt-10 -80.9 104.08 11.16 Favored 'General case' 0 CA--C 1.545 0.76 0 CA-C-O 121.235 0.54 . . . . 0.0 110.188 176.758 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.459 HD23 ' HB3' ' A' ' 43' ' ' PHE . 3.9 mm? -79.32 163.3 60.16 Favored Pre-proline 0 CA--C 1.564 1.519 0 C-N-CA 124.881 1.272 . . . . 0.0 110.409 177.573 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo -60.04 145.51 98.23 Favored 'Trans proline' 0 C--N 1.391 2.769 0 C-N-CA 122.741 2.294 . . . . 0.0 114.157 -174.467 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.536 ' HB2' ' HB3' ' A' ' 41' ' ' LYS . . . -157.29 163.06 26.19 Favored Pre-proline 0 CA--C 1.542 0.671 0 C-N-CA 124.18 0.992 . . . . 0.0 110.839 -172.2 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_exo -52.73 147.66 30.76 Favored 'Trans proline' 0 C--N 1.379 2.139 0 C-N-CA 123.004 2.469 . . . . 0.0 112.122 164.319 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 37.4 p -71.42 -15.22 62.34 Favored 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 123.519 0.728 . . . . 0.0 111.929 -176.818 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 42.7 t -75.93 -34.85 59.9 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 123.585 0.754 . . . . 0.0 110.19 172.007 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 28.2 m95 -109.83 -169.93 1.56 Allowed 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 123.883 0.873 . . . . 0.0 110.86 -175.515 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.733 ' HB3' ' HB ' ' A' ' 59' ' ' VAL . 1.7 tpmt? -148.35 144.64 27.67 Favored 'General case' 0 CA--C 1.533 0.327 0 CA-C-N 114.939 -1.028 . . . . 0.0 108.266 166.821 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.536 ' HB3' ' HB2' ' A' ' 35' ' ' ALA . 19.6 tptp -112.74 115.48 28.59 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 177.183 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.426 HD22 ' HB ' ' A' ' 57' ' ' VAL . 7.3 tt -111.43 139.78 46.56 Favored 'General case' 0 C--N 1.319 -0.748 0 C-N-CA 124.518 1.127 . . . . 0.0 108.262 174.635 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.459 ' HB3' HD23 ' A' ' 33' ' ' LEU . 38.1 t80 -125.74 135.57 52.21 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 124.619 1.168 . . . . 0.0 107.9 173.286 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 8.6 m-85 -94.24 103.02 9.56 Favored Pre-proline 0 CA--C 1.55 0.969 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 172.812 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -81.99 -163.43 0.22 Allowed 'Trans proline' 0 C--N 1.374 1.905 0 C-N-CA 122.951 2.434 . . . . 0.0 111.792 172.752 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 6.4 p30 -166.81 177.19 6.59 Favored 'General case' 0 CA--C 1.545 0.75 0 C-N-CA 123.842 0.857 . . . . 0.0 110.078 179.444 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 50.9 mtpt -79.03 -51.03 10.14 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 123.434 0.694 . . . . 0.0 112.337 -173.394 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.567 ' HB ' HG22 ' A' ' 51' ' ' VAL . 93.2 t -63.26 -39.39 85.1 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.224 0 C-N-CA 123.117 0.567 . . . . 0.0 111.211 -175.476 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 90.98 -50.7 3.14 Favored Glycine 0 C--N 1.343 0.943 0 CA-C-N 115.764 -0.653 . . . . 0.0 112.408 179.772 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 28.9 m -67.9 -32.81 73.54 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 123.461 0.704 . . . . 0.0 111.934 -179.279 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.567 HG22 ' HB ' ' A' ' 48' ' ' VAL . 24.1 m -77.55 144.13 11.9 Favored 'Isoleucine or valine' 0 C--O 1.239 0.55 0 N-CA-C 109.651 -0.5 . . . . 0.0 109.651 175.283 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -110.12 88.75 2.83 Favored 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 107.625 -1.25 . . . . 0.0 107.625 178.103 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 9.8 tmtt? -67.45 -67.73 0.43 Allowed 'General case' 0 CA--C 1.554 1.101 0 C-N-CA 123.449 0.7 . . . . 0.0 109.97 -171.548 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 85.1 m -129.06 149.32 50.93 Favored 'General case' 0 CA--C 1.545 0.776 0 N-CA-C 108.771 -0.825 . . . . 0.0 108.771 -179.682 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -84.71 -169.02 2.43 Favored 'General case' 0 CA--C 1.554 1.13 0 C-N-CA 123.842 0.857 . . . . 0.0 112.085 -172.473 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 48.1 t -82.58 140.09 16.88 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.594 0 C-N-CA 124.909 1.284 . . . . 0.0 110.578 -179.157 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.426 ' HB ' HD22 ' A' ' 42' ' ' LEU . 81.6 t -123.97 130.69 73.76 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.682 0 C-N-CA 124.079 0.951 . . . . 0.0 109.062 173.022 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 16.2 m-85 -102.03 122.22 43.68 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 123.198 0.599 . . . . 0.0 109.504 171.228 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.733 ' HB ' ' HB3' ' A' ' 40' ' ' LYS . 4.3 t -81.15 130.52 35.72 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 173.122 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -95.06 155.65 38.76 Favored Pre-proline 0 CA--C 1.548 0.87 0 C-N-CA 124.167 0.987 . . . . 0.0 110.754 -176.175 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -66.01 -8.19 19.24 Favored 'Trans proline' 0 C--N 1.38 2.236 0 C-N-CA 123.067 2.511 . . . . 0.0 114.202 -177.259 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 9.6 t -120.98 12.66 11.23 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 123.602 0.761 . . . . 0.0 111.412 -175.174 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 81.03 -22.83 4.79 Favored Glycine 0 C--N 1.353 1.494 0 N-CA-C 114.531 0.572 . . . . 0.0 114.531 179.336 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 49.7 tt0 -72.84 75.0 1.15 Allowed 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 124.551 1.14 . . . . 0.0 109.487 177.626 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -80.97 157.98 25.34 Favored 'General case' 0 N--CA 1.476 0.839 0 CA-C-N 115.287 -0.87 . . . . 0.0 111.707 -168.785 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 42.5 mm -107.9 139.84 28.49 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.755 0 C-N-CA 124.905 1.282 . . . . 0.0 110.379 -173.35 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 16.3 p -108.33 -9.84 15.42 Favored 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 123.584 0.754 . . . . 0.0 112.66 -179.885 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 13.1 p-10 -160.74 162.64 32.53 Favored 'General case' 0 N--CA 1.486 1.337 0 N-CA-C 112.348 0.499 . . . . 0.0 112.348 -168.378 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 3.8 ttm180 -59.92 -41.33 91.49 Favored 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 124.613 1.165 . . . . 0.0 112.17 -170.789 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 7.4 tmtm? -60.91 -54.43 45.12 Favored 'General case' 0 N--CA 1.478 0.929 0 CA-C-N 115.145 -0.934 . . . . 0.0 109.507 -176.622 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.415 ' HA ' ' HG3' ' A' ' 74' ' ' GLN . 87.3 mm-40 -64.2 -25.17 67.95 Favored 'General case' 0 N--CA 1.475 0.797 0 O-C-N 124.03 0.831 . . . . 0.0 111.45 -176.676 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.418 ' O ' ' HG ' ' A' ' 76' ' ' LEU . 0.6 OUTLIER -66.52 -52.67 43.32 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 123.375 0.67 . . . . 0.0 109.224 175.88 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -64.08 -50.54 67.92 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 123.634 0.774 . . . . 0.0 111.363 -175.602 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . 0.415 ' HG3' ' HA ' ' A' ' 71' ' ' GLN . 0.0 OUTLIER -66.16 -23.92 66.55 Favored 'General case' 0 CA--C 1.547 0.861 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.365 179.582 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 38.5 t80 -66.88 -51.79 51.2 Favored 'General case' 0 C--O 1.212 -0.873 0 C-N-CA 122.92 0.488 . . . . 0.0 109.736 171.703 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.418 ' HG ' ' O ' ' A' ' 72' ' ' LEU . 83.1 mt -62.51 -37.78 87.35 Favored 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 123.225 0.61 . . . . 0.0 112.495 -172.105 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.77 -26.57 57.49 Favored 'General case' 0 CA--C 1.553 1.072 0 CA-C-O 120.83 0.347 . . . . 0.0 110.95 178.033 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 41.6 t -83.19 -26.68 30.62 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 123.203 0.601 . . . . 0.0 111.044 175.834 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 53.6 m80 -125.7 89.54 52.24 Favored Pre-proline 0 C--O 1.241 0.613 0 C-N-CA 124.395 1.078 . . . . 0.0 108.594 -173.447 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -68.67 164.85 31.53 Favored 'Trans proline' 0 C--N 1.369 1.62 0 C-N-CA 122.311 2.007 . . . . 0.0 111.666 176.076 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 89.81 -29.46 6.34 Favored Glycine 0 CA--C 1.532 1.123 0 CA-C-N 116.468 -0.333 . . . . 0.0 112.678 -176.049 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 36.1 m-80 -71.73 141.05 84.39 Favored Pre-proline 0 CA--C 1.549 0.932 0 C-N-CA 123.871 0.868 . . . . 0.0 110.778 178.828 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -67.02 163.03 35.51 Favored 'Trans proline' 0 C--N 1.374 1.895 0 C-N-CA 123.114 2.543 . . . . 0.0 112.863 179.959 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -74.7 161.03 30.03 Favored 'General case' 0 N--CA 1.488 1.442 0 C-N-CA 124.017 0.927 . . . . 0.0 112.266 -170.317 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 16.3 tt -78.71 -19.93 13.1 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.253 0 CA-C-O 120.808 0.337 . . . . 0.0 111.158 179.283 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -61.89 -38.17 87.32 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 123.344 0.658 . . . . 0.0 111.777 177.991 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -83.89 -9.75 58.5 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 123.282 0.633 . . . . 0.0 111.51 179.322 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 5.5 m-30 -82.62 129.69 34.99 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 123.397 0.679 . . . . 0.0 110.17 177.769 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . 0.429 ' OD1' ' HB ' ' A' ' 92' ' ' THR . 3.5 t70 -84.57 125.79 32.75 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 123.893 0.877 . . . . 0.0 110.32 177.568 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 86.2 m95 -118.43 -11.56 9.97 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 123.969 0.908 . . . . 0.0 109.439 168.203 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 13.7 t -102.93 13.52 34.15 Favored 'General case' 0 CA--C 1.555 1.15 0 C-N-CA 124.371 1.069 . . . . 0.0 112.571 -163.728 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.431 HG21 ' HG ' ' A' ' 33' ' ' LEU . 14.5 t -62.49 -21.08 65.21 Favored 'General case' 0 N--CA 1.49 1.535 0 C-N-CA 122.764 0.426 . . . . 0.0 111.93 -179.549 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 14.7 m -60.62 -17.79 49.17 Favored 'General case' 0 CA--C 1.55 0.947 0 C-N-CA 124.607 1.163 . . . . 0.0 112.31 179.88 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 84.42 -67.52 3.68 Favored Glycine 0 C--N 1.352 1.44 0 N-CA-C 110.458 -1.057 . . . . 0.0 110.458 -178.408 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 29.9 p . . . . . 0 C--O 1.256 1.416 0 C-N-CA 124.408 1.083 . . . . 0.0 109.476 174.337 . . . . . . . . 0 0 . 1 stop_ save_